PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Costa, KC; Glasser, NR; Conway, SJ; Newman, DK				Costa, Kyle C.; Glasser, Nathaniel R.; Conway, Stuart J.; Newman, Dianne K.			Pyocyanin degradation by a tautomerizing demethylase inhibits Pseudomonas aeruginosa biofilms	SCIENCE			English	Article							STRUCTURE PREDICTION; EXTRACELLULAR DNA; REDOX; BIOCHEMISTRY; ANTIBIOTICS; PATHWAYS; BACTERIA; OXYGEN	The opportunistic pathogen Pseudomonas aeruginosa produces colorful redox-active metabolites called phenazines, which underpin biofilm development, virulence, and clinical outcomes. Although phenazines exist in many forms, the best studied is pyocyanin. Here, we describe pyocyanin demethylase (PodA), a hitherto uncharacterized protein that oxidizes the pyocyanin methyl group to formaldehyde and reduces the pyrazine ring via an unusual tautomerizing demethylation reaction. Treatment with PodA disrupts P. aeruginosa biofilm formation similarly to DNase, suggesting interference with the pyocyanin-dependent release of extracellular DNA into the matrix. PodA-dependent pyocyanin demethylation also restricts established biofilm aggregate populations experiencing anoxic conditions. Together, these results show that modulating extracellular redox-active metabolites can influence the fitness of a biofilm-forming microorganism.	[Costa, Kyle C.; Glasser, Nathaniel R.; Newman, Dianne K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Conway, Stuart J.] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England; [Newman, Dianne K.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; University of Oxford; California Institute of Technology	Newman, DK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dkn@caltech.edu	Conway, Stuart/AAP-3526-2020	Conway, Stuart/0000-0002-5148-117X	Ruth L. Kirschstein National Research Service Award from the National Institute of Allergy and Infectious Diseases, NIH [F32AI112248]; National Science Foundation [1144469]; Howard Hughes Medical Institute (HHMI), NIH [5R01HL117328-03]; Molecular Observatory at the Beckman Institute, California Institute of Technology; Gordon and Betty Moore Foundation; Sanofi-Aventis Bioengineering Research Program at Caltech; Stanford Synchrotron Radiation Lightsource - U.S. Department of Energy; NIH; St. Hugh's College, Oxford; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI112248] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/L000067/1, EP/K000888/1] Funding Source: researchfish; EPSRC [EP/K000888/1, EP/L000067/1] Funding Source: UKRI	Ruth L. Kirschstein National Research Service Award from the National Institute of Allergy and Infectious Diseases, NIH; National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute (HHMI), NIH; Molecular Observatory at the Beckman Institute, California Institute of Technology; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Sanofi-Aventis Bioengineering Research Program at Caltech; Stanford Synchrotron Radiation Lightsource - U.S. Department of Energy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Hugh's College, Oxford; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The final model and native data set for PodA were submitted to the wwPDB under accession code 5K21. We thank E. Perry, L. Meirelles, W. DePas, and D. Rees for assistance in experimental design and interpretation. K.C.C. was supported by a Ruth L. Kirschstein National Research Service Award from the National Institute of Allergy and Infectious Diseases, NIH, grant no. F32AI112248. N.R.G. was supported by the National Science Foundation Graduate Research Fellowship, grant no. 1144469. This work was further supported by the Howard Hughes Medical Institute (HHMI), NIH (grant 5R01HL117328-03), and the Molecular Observatory at the Beckman Institute, California Institute of Technology and through the Gordon and Betty Moore Foundation and the Sanofi-Aventis Bioengineering Research Program at Caltech. Additional support was provided by the Stanford Synchrotron Radiation Lightsource, which is funded by the U.S. Department of Energy and NIH. S.J.C. thanks St. Hugh's College, Oxford for research support. K.C.C. and D.K.N. conceived the project. K.C.C., N.R.G., and D.K.N. designed the experiments. K.C.C. and N.R.G. performed the experiments. K.C.C., N.R.G., S.J.C., and D.K.N. analyzed and interpreted the results. K.C.C., S.J.C., and D.K.N. wrote the paper.	Anand R, 2007, J BIOL CHEM, V282, P35425, DOI 10.1074/jbc.R700027200; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Costa KC, 2015, MBIO, V6, DOI 10.1128/mBio.01520-15; Cowley ES, 2015, MBIO, V6, DOI 10.1128/mBio.00767-15; Das T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08398; Das Theerthankar, 2013, Commun Integr Biol, V6, pe23570, DOI 10.4161/cib.23570; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Glasser NR, 2014, MOL MICROBIOL, V92, P399, DOI 10.1111/mmi.12566; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Hagel JM, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00014; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kragh KN, 2016, MBIO, V7, DOI 10.1128/mBio.00237-16; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Moree WJ, 2012, P NATL ACAD SCI USA, V109, P13811, DOI 10.1073/pnas.1206855109; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Summers RM, 2012, J BACTERIOL, V194, P2041, DOI 10.1128/JB.06637-11; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; TURNER JM, 1986, ADV MICROB PHYSIOL, V27, P211, DOI 10.1016/S0065-2911(08)60306-9; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yang ZJ, 2007, CURR MICROBIOL, V55, P284, DOI 10.1007/s00284-006-0522-7	30	34	37	4	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2017	355	6321					170	+		10.1126/science.aag3180	http://dx.doi.org/10.1126/science.aag3180			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH4LW	27940577	Green Accepted, Green Submitted			2022-12-28	WOS:000391743700040
J	Zhang, ZZ; Li, Y; Loh, YR; Phoo, WW; Hung, AW; Kang, CB; Luo, DH				Zhang, Zhenzhen; Li, Yan; Loh, Ying Ru; Phoo, Wint Wint; Hung, Alvin W.; Kang, CongBao; Luo, Dahai			Crystal structure of unlinked NS2B-NS3 protease from Zika virus	SCIENCE			English	Article							NS3 PROTEASE; NMR ANALYSIS; DENGUE; INHIBITORS; COFACTOR; HELICASE; BINDING	Zika virus (ZIKV) has rapidly emerged as a global public health concern. Viral NS2B-NS3 protease processes viral polyprotein and is essential for the virus replication, making it an attractive antiviral drug target. We report crystal structures at 1.58-angstrom resolution of the unlinked NS2B-NS3 protease from ZIKV as free enzyme and bound to a peptide reversely oriented at the active site. The unlinked NS2B-NS3 protease adopts a closed conformation in which NS2B engages NS3 to form an empty substrate-binding site. A second protease in the same crystal binds to the residues K14K15G16E17 from the neighboring NS3 in reverse orientation, resisting proteolysis. These features of ZIKV NS2B-NS3 protease may accelerate the discovery of structure-based antiviral drugs against ZIKV and related pathogenic flaviviruses.	[Zhang, Zhenzhen; Phoo, Wint Wint; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, Expt Med Bldg 03-07,59 Nanyang Dr, Singapore 636921, Singapore; [Zhang, Zhenzhen; Phoo, Wint Wint; Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, Expt Med Bldg 06-01,59 Nanyang Dr, Singapore 636921, Singapore; [Li, Yan; Loh, Ying Ru; Hung, Alvin W.; Kang, CongBao] ASTAR, Ctr Expt Therapeut, 31 Biopolis Way,Nanos 03-01, Singapore 0301, Singapore; [Phoo, Wint Wint] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Luo, DH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Expt Med Bldg 03-07,59 Nanyang Dr, Singapore 636921, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, Expt Med Bldg 06-01,59 Nanyang Dr, Singapore 636921, Singapore.; Kang, CB (corresponding author), ASTAR, Ctr Expt Therapeut, 31 Biopolis Way,Nanos 03-01, Singapore 0301, Singapore.	cbkang@etc.a-star.edu.sg; luodahai@ntu.edu.sg	Luo, Dahai/J-6022-2012; Li, Yan/G-4642-2013; Kang, Congbao/AAP-7572-2020	Luo, Dahai/0000-0001-7637-7275; Li, Yan/0000-0003-1963-839X; Kang, Congbao/0000-0002-9886-9374	Lee Kong Chian School of Medicine, Nanyang Technological University; National Medical Research Council [CBRG15May045]; A*STAR Joint Council Office [1431AFG102/1331A028]	Lee Kong Chian School of Medicine, Nanyang Technological University(Nanyang Technological University); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); A*STAR Joint Council Office(Agency for Science Technology & Research (A*STAR))	We thank W. Bin, E. Abbas, C. Liew (Nanyang Technological University), and scientists from the Australian Light Source MX beamline and the Swiss Light Source X06DA (PXIII) beamline for their help with diffraction data collection. We thank S. Liu for technical support for fragment screening. We thank A. Matter and T. H. Keller for critical reading of this manuscript. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. The corresponding coordinates and structure factors are available from the PDB under accession codes 5GPI for bZiPro and 5H4I for its complex with EN300. Assignments of protease in the absence and presence of AcKR have been deposited in the Biological Magnetic Resonance Data Bank with accession numbers 26928 and 26927, respectively. This work was supported by (i) a start-up grant from Lee Kong Chian School of Medicine, Nanyang Technological University; (ii) National Medical Research Council grant CBRG15May045 to D.L.'s laboratory; and (iii) A*STAR Joint Council Office grant 1431AFG102/1331A028 to C.K. The authors declare no competing financial interests.	Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898; Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09; de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729; Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008; Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723; Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Lindenbach B. D., 2013, FIELDS VIROLOGY, P712; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014; Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q; Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410; Pierson TC., 2013, FIELDS VIROLOGY, V6th ed., P747; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010	27	117	125	5	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1597	1600		10.1126/science.aai9309	http://dx.doi.org/10.1126/science.aai9309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	27940580	Green Accepted			2022-12-28	WOS:000390254300056
J	Perrin, Y; Canals, B; Rougemaille, N				Perrin, Yann; Canals, Benjamin; Rougemaille, Nicolas			Extensive degeneracy, Coulomb phase and magnetic monopoles in artificial square ice	NATURE			English	Article							SPIN-ICE; FRUSTRATION; LATTICE	Artificial spin-ice systems are lithographically patterned arrangements of interacting magnetic nanostructures that were introduced as way of investigating the effects of geometric frustration in a controlled manner(1-4). This approach has enabled unconventional states of matter to be visualized directly in real space(5-18), and has triggered research at the frontier between nanomagnetism, statistical thermodynamics and condensed matter physics. Despite efforts to create an artificial realization of the square-ice model-a two-dimensional geometrically frustrated spin-ice system defined on a square lattice-no simple geometry based on arrays of nanomagnets has successfully captured the macroscopically degenerate ground-state manifold of the model(19). Instead, square lattices of nanomagnets are characterized by a magnetically ordered ground state that consists of local loop configurations with alternating chirality(1,20-26). Here we show that all of the characteristics of the square-ice model are observed in an artificial square-ice system that consists of two sublattices of nanomagnets that are vertically separated by a small distance. The spin configurations we image after demagnetizing our arrays reveal unambiguous signatures of a Coulomb phase and algebraic spin-spin correlations, which are characterized by the presence of 'pinch' points in the associated magnetic structure factor. Local excitations-the classical analogues of magnetic monopoles(27)-are free to evolve in an extensively degenerate, divergence-free vacuum. We thus provide a protocol that could be used to investigate collective magnetic phenomena, including Coulomb phases(28) and the physics of ice-like materials.	[Perrin, Yann; Canals, Benjamin; Rougemaille, Nicolas] CNRS, Inst NEEL, F-38000 Grenoble, France; [Perrin, Yann; Canals, Benjamin; Rougemaille, Nicolas] Univ Grenoble Alpes, Inst NEEL, F-38000 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Rougemaille, N (corresponding author), CNRS, Inst NEEL, F-38000 Grenoble, France.; Rougemaille, N (corresponding author), Univ Grenoble Alpes, Inst NEEL, F-38000 Grenoble, France.	nicolas.rougemaille@neel.cnrs.fr	Rougemaille, Nicolas/S-7248-2017	Perrin, Yann/0000-0002-3572-7395	Agence Nationale de la Recherche [ANR12-BS04-009]; Nanofab team at the Institut NEEL	Agence Nationale de la Recherche(French National Research Agency (ANR)); Nanofab team at the Institut NEEL	This work was supported by the Agence Nationale de la Recherche through project number ANR12-BS04-009 'Frustrated'. We acknowledge support from the Nanofab team at the Institut NEEL and thank S. Le-Denmat and O. Fruchart for technical help during atomic force microscope and magnetic force microscope measurements.	Anghinolfi L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9278; Brooks-Bartlett ME, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011007; Budrikis Z, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/035014; Budrikis Z, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.217204; Canals B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11446; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Chioar IA, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.214410; Chioar IA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.220407; Chioar IA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064411; Cumings J, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075016; Da Col S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.180405; Donahue M. J., 1999, 6376 NISTIR; Drisko J, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.224406; Farhan A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.057204; Fennell T, 2009, SCIENCE, V326, P415, DOI 10.1126/science.1177582; Garanin DA, 1999, PHYS REV B, V59, P443, DOI 10.1103/PhysRevB.59.443; Gilbert I, 2014, NAT PHYS, V10, P671, DOI [10.1038/NPHYS3037, 10.1038/nphys3037]; Henley CL, 2010, ANNU REV CONDEN MA P, V1, P179, DOI 10.1146/annurev-conmatphys-070909-104138; Henry L.-P., 2013, THESIS; Heyderman LJ, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/36/363201; Isakov SV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.217201; Jamet S, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.144428; Kapaklis V, 2014, NAT NANOTECHNOL, V9, P514, DOI [10.1038/NNANO.2014.104, 10.1038/nnano.2014.104]; Kimling J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174406; Ladak S, 2010, NAT PHYS, V6, P359, DOI 10.1038/NPHYS1628; LIEB EH, 1967, PHYS REV, V162, P162, DOI 10.1103/PhysRev.162.162; Mengotti E, 2011, NAT PHYS, V7, P68, DOI [10.1038/nphys1794, 10.1038/NPHYS1794]; Moller G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.237202; Montaigne F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05702; Morgan JP, 2013, FRONT PHYS-LAUSANNE, V1, DOI 10.3389/fphy.2013.00028; Morgan JP, 2011, NAT PHYS, V7, P75, DOI 10.1038/NPHYS1853; Nisoli C, 2013, REV MOD PHYS, V85, P1473, DOI 10.1103/RevModPhys.85.1473; Nisoli C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047205; Phatak C, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174431; Porro JM, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/5/055012; Rougemaille N, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/3/035026; Rougemaille N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.057209; Thonig D, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/26/266006; Wang RF, 2007, J APPL PHYS, V101, DOI 10.1063/1.2712528; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447; Zeissler K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01252; Zhang S, 2013, NATURE, V500, P553, DOI 10.1038/nature12399; Zhang S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.087201	43	134	134	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					410	+		10.1038/nature20155	http://dx.doi.org/10.1038/nature20155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27894124	Green Submitted			2022-12-28	WOS:000389716800037
J	Pala, C				Pala, Christopher			CLIMATE Corals tie stronger El Ninos to climate change	SCIENCE			English	News Item																			0	1	1	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1210	1210		10.1126/science.354.6317.1210	http://dx.doi.org/10.1126/science.354.6317.1210			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940821				2022-12-28	WOS:000389598800008
J	Sessi, P; Di Sante, D; Szczerbakow, A; Glott, F; Wilfert, S; Schmidt, H; Bathon, T; Dziawa, P; Greiter, M; Neupert, T; Sangiovanni, G; Story, T; Thomale, R; Bode, M				Sessi, Paolo; Di Sante, Domenico; Szczerbakow, Andrzej; Glott, Florian; Wilfert, Stefan; Schmidt, Henrik; Bathon, Thomas; Dziawa, Piotr; Greiter, Martin; Neupert, Titus; Sangiovanni, Giorgio; Story, Tomasz; Thomale, Ronny; Bode, Matthias			Robust spin-polarized midgap states at step edges of topological crystalline insulators	SCIENCE			English	Article							EXPERIMENTAL REALIZATION; TEXTURE; PHASE; SNTE	Topological crystalline insulators are materials in which the crystalline symmetry leads to topologically protected surface states with a chiral spin texture, rendering them potential candidates for spintronics applications. Using scanning tunneling spectroscopy, we uncover the existence of one-dimensional (1D) midgap states at odd-atomic surface step edges of the three-dimensional topological crystalline insulator (Pb,Sn)Se. A minimal toy model and realistic tight-binding calculations identify them as spin-polarized flat bands connecting two Dirac points. This nontrivial origin provides the 1D midgap states with inherent stability and protects them from backscattering. We experimentally show that this stability results in a striking robustness to defects, strong magnetic fields, and elevated temperature.	[Sessi, Paolo; Glott, Florian; Wilfert, Stefan; Schmidt, Henrik; Bathon, Thomas; Bode, Matthias] Univ Wurzburg, Phys Inst, Expt Phys 2, D-97074 Wurzburg, Germany; [Di Sante, Domenico; Greiter, Martin; Sangiovanni, Giorgio; Thomale, Ronny] Univ Wurzburg, Inst Theoret Phys, D-97074 Wurzburg, Germany; [Szczerbakow, Andrzej; Dziawa, Piotr; Story, Tomasz] Polish Acad Sci, Inst Phys, Aleja Lotnikow 32-46, PL-02668 Warsaw, Poland; [Neupert, Titus] Univ Zurich, Phys Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Bode, Matthias] Univ Wurzburg, Wilhelm Conrad Rontgen Ctr Complex Mat Syst RCCM, D-97074 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; University of Zurich; University of Wurzburg	Sessi, P (corresponding author), Univ Wurzburg, Phys Inst, Expt Phys 2, D-97074 Wurzburg, Germany.	sessi@physik.uni-wuerzburg.de	Story, Tomasz/H-2963-2018; Story, Tomasz/AAD-7440-2019; Dziawa, Piotr/K-9009-2016; Sangiovanni, Giorgio/L-5893-2013; Bode, Matthias/S-3249-2016; Szczerbakow, Andrzej/A-6467-2008; Sessi, Paolo/L-6186-2015; Sessi, Paolo/AAN-5964-2020; Di Sante, Domenico/L-8931-2013; Szczerbakow, Andrzej/AAD-1448-2019	Story, Tomasz/0000-0001-5428-9602; Story, Tomasz/0000-0001-5428-9602; Sangiovanni, Giorgio/0000-0003-2218-2901; Bode, Matthias/0000-0001-7514-5560; Szczerbakow, Andrzej/0000-0001-8535-3400; Sessi, Paolo/0000-0003-1261-0386; Sessi, Paolo/0000-0003-1261-0386; Szczerbakow, Andrzej/0000-0001-8535-3400; Di Sante, Domenico/0000-0001-9956-1411; Dziawa, Piotr/0000-0002-9181-5656	DFG [SFB 1170]; Polish National Science Centre NCN [2014/15/B/ST3/03833, 2012/07/B/ST3/03607]; European Research Council (ERC) [ERC-StG-TOPOLECTRICS-Thomale-336012]; Gauss Centre for Supercomputing e.V.	DFG(German Research Foundation (DFG)); Polish National Science Centre NCN; European Research Council (ERC)(European Research Council (ERC)European Commission); Gauss Centre for Supercomputing e.V.	This research was supported by DFG (through SFB 1170) "ToCoTronics", projects A02, B04, and C05) and by the Polish National Science Centre NCN grants 2014/15/B/ST3/03833 and 2012/07/B/ST3/03607. We further acknowledge support by the European Research Council (ERC) through ERC-StG-TOPOLECTRICS-Thomale-336012. D.D.S. and G.S. gratefully acknowledge the Gauss Centre for Supercomputing e.V. (www.gauss-centre.eu) for funding this project by providing computing tare on the GCS Supercomputer SuperMUC Leibniz Supercomputing Centre (LRZ, wwvv.lrz.de).	Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Dziawa P, 2012, NAT MATER, V11, P1023, DOI [10.1038/nmat3449, 10.1038/NMAT3449]; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Gyenis A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125414; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hirahara T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.166801; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh TH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1969; Knez I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.136603; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Liu JW, 2014, NAT MATER, V13, P178, DOI [10.1038/nmat3828, 10.1038/NMAT3828]; Okada Y, 2013, SCIENCE, V341, P1496, DOI 10.1126/science.1239451; Pauly C, 2015, NAT PHYS, V11, P338, DOI [10.1038/nphys3264, 10.1038/NPHYS3264]; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; Tanaka Y, 2012, NAT PHYS, V8, P800, DOI [10.1038/nphys2442, 10.1038/NPHYS2442]; Wojek BM, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.161202; Zeljkovic I, 2015, NAT MATER, V14, P318, DOI [10.1038/nmat4215, 10.1038/NMAT4215]; Zeljkovic I, 2014, NAT PHYS, V10, P572, DOI 10.1038/NPHYS3012; Zhang DM, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.245445; Zhang T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266803; Zhang Y, 2010, NAT PHYS, V6, P584, DOI 10.1038/NPHYS1689	24	76	76	3	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1269	1273		10.1126/science.aah6233	http://dx.doi.org/10.1126/science.aah6233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940869	Green Submitted			2022-12-28	WOS:000389598800056
J	Stephan, DW				Stephan, Douglas W.			The broadening reach of frustrated Lewis pair chemistry	SCIENCE			English	Review							METAL-FREE HYDROGENATION; FREE CATALYTIC-HYDROGENATION; H BOND ACTIVATION; ENANTIOSELECTIVE HYDROGENATION; ASYMMETRIC HYDROGENATION; DIHYDROGEN ACTIVATION; MOLECULAR-HYDROGEN; PROPARGYL ESTERS; BORENIUM CATIONS; CARBON-MONOXIDE	The revelation that combinations of Lewis acids and bases for which dative bonding is impeded can activate dihydrogen led to the concept of "frustrated Lewis pairs" (FLPs). Over the past decade, a range of FLP systems and substrate molecules have precipitated a paradigm change in main-group chemistry and metal-free catalysis. The FLP motif has also found application in a growing body of chemical problems in organic synthesis, transition metal and free radical chemistry, materials, enzymatic models, and surface chemistry. The current state of FLP chemistry is assessed herein, and the outlook for the future considered.	[Stephan, Douglas W.] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S3H6, Canada	University of Toronto	Stephan, DW (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S3H6, Canada.	dstephan@chem.utoronto.ca	Stephan, Douglas W/E-4393-2011	Stephan, Douglas W/0000-0001-8140-8355	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	D.W.S. is grateful for the support of the Natural Sciences and Engineering Research Council of Canada and the award of a Canada Research Chair. L. Longobardi and T. Johnstone are thanked for helpful comments.	Abolhasani M, 2014, ANGEW CHEM, V126, P8126, DOI [10.1002/ange.201403719, DOI 10.1002/ANGE.201403719]; Ashley AE, 2009, ANGEW CHEM INT EDIT, V48, P9839, DOI 10.1002/anie.200905466; Bayne JM, 2016, CHEM SOC REV, V45, P765, DOI 10.1039/c5cs00516g; Boone MP, 2014, CHEM-EUR J, V20, P3333, DOI 10.1002/chem.201304289; Boone MP, 2014, ORGANOMETALLICS, V33, P387, DOI 10.1021/om401118n; Boone MP, 2013, J AM CHEM SOC, V135, P8508, DOI 10.1021/ja403912n; Bullock RM, 2015, ACCOUNTS CHEM RES, V48, P2017, DOI 10.1021/acs.accounts.5b00069; Cade IA, 2014, CHEM-EUR J, V20, P12874, DOI 10.1002/chem.201403614; Caputo CB, 2013, SCIENCE, V341, P1374, DOI 10.1126/science.1241764; Cardenas AJP, 2011, ANGEW CHEM INT EDIT, V50, P7567, DOI 10.1002/anie.201101622; Chapman AM, 2016, INORG CHEM, V55, P1017, DOI 10.1021/acs.inorgchem.5b01424; Chase PA, 2007, ANGEW CHEM INT EDIT, V46, P8050, DOI 10.1002/anie.200702908; Chauvier C, 2015, CHEM SCI, V6, P2938, DOI 10.1039/c5sc00394f; Chen DJ, 2008, CHEM COMMUN, P2130, DOI 10.1039/b801806e; Chen DJ, 2010, ANGEW CHEM INT EDIT, V49, P9475, DOI 10.1002/anie.201004525; Chernichenko K, 2016, J AM CHEM SOC, V138, P4860, DOI 10.1021/jacs.6b00819; Chernichenko K, 2013, NAT CHEM, V5, P718, DOI [10.1038/NCHEM.1693, 10.1038/nchem.1693]; Clark ER, 2014, ANGEW CHEM INT EDIT, V53, P11306, DOI 10.1002/anie.201406122; Clark ER, 2013, ORGANOMETALLICS, V32, P6712, DOI 10.1021/om400463r; Courtemanche MA, 2014, J AM CHEM SOC, V136, P10708, DOI 10.1021/ja5047846; DeMott JC, 2013, CHEM SCI, V4, P642, DOI 10.1039/c2sc21385k; Dobrovetsky R, 2013, J AM CHEM SOC, V135, P4974, DOI 10.1021/ja401492s; Dobrovetsky R, 2013, ANGEW CHEM INT EDIT, V52, P2516, DOI 10.1002/anie.201208817; Dureen MA, 2009, J AM CHEM SOC, V131, P8396, DOI 10.1021/ja903650w; Eisenberger P, 2015, ANGEW CHEM INT EDIT, V54, P2467, DOI 10.1002/anie.201409250; Eisenberger P, 2012, J AM CHEM SOC, V134, P17384, DOI 10.1021/ja307374j; Eros G, 2012, CHEM-EUR J, V18, P574, DOI 10.1002/chem.201102438; Farrell JM, 2015, CHEM SCI, V6, P2010, DOI 10.1039/c4sc03675a; Farrell JM, 2012, J AM CHEM SOC, V134, P15728, DOI 10.1021/ja307995f; Forrest SJK, 2015, ANGEW CHEM INT EDIT, V54, P2223, DOI 10.1002/anie.201409872; Ghuman KK, 2016, J AM CHEM SOC, V138, P1206, DOI 10.1021/jacs.5b10179; Ghuman KK, 2015, PHYS CHEM CHEM PHYS, V17, P14623, DOI 10.1039/c5cp02613j; Grimme S, 2010, ANGEW CHEM INT EDIT, V49, P1402, DOI 10.1002/anie.200905484; Hansmann MM, 2014, CHEM COMMUN, V50, P7243, DOI 10.1039/c4cc01370k; Hansmann MM, 2014, J AM CHEM SOC, V136, P777, DOI 10.1021/ja4110842; He JH, 2014, SYNLETT, V25, P1534, DOI 10.1055/s-0033-1341248; Holtrichter-Rossmann T, 2013, ANGEW CHEM INT EDIT, V52, P7135, DOI 10.1002/anie.201301970; Hounjet LJ, 2013, ANGEW CHEM INT EDIT, V52, P7492, DOI 10.1002/anie.201303166; Jiang YF, 2013, J AM CHEM SOC, V135, P7751, DOI 10.1021/ja402381d; Kalz KF, 2014, J AM CHEM SOC, V136, P16626, DOI 10.1021/ja509186d; Karunananda MK, 2015, J AM CHEM SOC, V137, P14598, DOI 10.1021/jacs.5b10357; Lambic NS, 2016, J AM CHEM SOC, V138, P4832, DOI 10.1021/jacs.6b00705; Lawrence EJ, 2016, CHEM SCI, V7, P2537, DOI 10.1039/c5sc04564a; Lawrence EJ, 2015, CHEM-EUR J, V21, P900, DOI 10.1002/chem.201404242; Legare MA, 2015, SCIENCE, V349, P513, DOI 10.1126/science.aab3591; Lin TP, 2014, J AM CHEM SOC, V136, P13672, DOI 10.1021/ja504667f; Lindqvist M, 2015, J AM CHEM SOC, V137, P4038, DOI 10.1021/ja512658m; Liu YB, 2013, J AM CHEM SOC, V135, P12968, DOI 10.1021/ja406761j; Liu YB, 2013, J AM CHEM SOC, V135, P6810, DOI 10.1021/ja4025808; Longobardi LE, 2016, J AM CHEM SOC, V138, P2500, DOI 10.1021/jacs.5b12823; Longobardi LE, 2015, ANGEW CHEM INT EDIT, V54, P809, DOI 10.1002/anie.201409969; Longobardi LE, 2014, DALTON T, V43, P15723, DOI 10.1039/c4dt02648a; Lu G, 2014, CHEM SCI, V5, P1082, DOI 10.1039/c3sc52851k; Mahdi T, 2015, ANGEW CHEM INT EDIT, V54, P8511, DOI 10.1002/anie.201503087; Mahdi T, 2014, J AM CHEM SOC, V136, P15809, DOI 10.1021/ja508829x; Mahdi T, 2013, ANGEW CHEM INT EDIT, V52, P12418, DOI 10.1002/anie.201307254; Mahdi T, 2013, ORGANOMETALLICS, V32, P1971, DOI 10.1021/om4000727; Mahdi T, 2012, J AM CHEM SOC, V134, P4088, DOI 10.1021/ja300228a; Mankad NP, 2016, CHEM-EUR J, V22, P5822, DOI 10.1002/chem.201505002; Mazzacano TJ, 2015, CHEM COMMUN, V51, P5379, DOI 10.1039/c4cc09180a; McCahill JSJ, 2007, ANGEW CHEM INT EDIT, V46, P4968, DOI 10.1002/anie.200701215; McGough JS, 2016, CHEM SCI, V7, P3384, DOI 10.1039/c5sc04798f; Melen RL, 2015, ORGANOMETALLICS, V34, P4127, DOI 10.1021/acs.organomet.5b00546; Melen RL, 2013, CHEM-EUR J, V19, P11928, DOI 10.1002/chem.201301899; Menard G, 2013, J AM CHEM SOC, V135, P6446, DOI 10.1021/ja402964h; Mohr J, 2014, ANGEW CHEM INT EDIT, V53, P13278, DOI 10.1002/anie.201407324; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Paradies J, 2014, ANGEW CHEM INT EDIT, V53, P3552, DOI 10.1002/anie.201309253; Parks DJ, 1996, J AM CHEM SOC, V118, P9440, DOI 10.1021/ja961536g; Parmelee SR, 2015, ACS CATAL, V5, P3689, DOI 10.1021/acscatal.5b00275; Raugei S, 2012, CHEM-EUR J, V18, P6493, DOI 10.1002/chem.201103346; Ren XY, 2016, J AM CHEM SOC, V138, P810, DOI 10.1021/jacs.5b13104; Rokob TA, 2008, ANGEW CHEM INT EDIT, V47, P2435, DOI 10.1002/anie.200705586; Rokob TA, 2013, J AM CHEM SOC, V135, P4425, DOI 10.1021/ja312387q; Rokob TA, 2009, J AM CHEM SOC, V131, P10701, DOI 10.1021/ja903878z; Rokob TA, 2009, J AM CHEM SOC, V131, P2029, DOI 10.1021/ja809125r; Sajid M, 2013, ANGEW CHEM INT EDIT, V52, P2243, DOI 10.1002/anie.201208750; Sajid M, 2012, J AM CHEM SOC, V134, P10156, DOI 10.1021/ja302652a; Scott DJ, 2014, J AM CHEM SOC, V136, P15813, DOI 10.1021/ja5088979; Segawa Y, 2012, CHEM COMMUN, V48, P11963, DOI 10.1039/c2cc37190a; Sgro MJ, 2012, ANGEW CHEM INT EDIT, V51, P11343, DOI 10.1002/anie.201205741; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Spies P, 2007, CHEM COMMUN, P5072, DOI 10.1039/b710475h; Stephan DW, 2015, ANGEW CHEM INT EDIT, V54, P6400, DOI 10.1002/anie.201409800; Stephan DW, 2014, CHEM SCI, V5, P2625, DOI 10.1039/c4sc00395k; Stephan DW, 2010, ANGEW CHEM INT EDIT, V49, P46, DOI 10.1002/anie.200903708; STEPHAN DW, 2013, TOPICS IN CURRENT CH, V332; STEPHAN DW, 2013, TOPICS IN CURRENT CH, V334; Tsao FA, 2015, J AM CHEM SOC, V137, P13264, DOI 10.1021/jacs.5b09526; Tutusaus O, 2013, J AM CHEM SOC, V135, P3403, DOI 10.1021/ja400962h; vom Stein T, 2015, ANGEW CHEM INT EDIT, V54, P10178, DOI 10.1002/anie.201504109; Wei SM, 2014, J AM CHEM SOC, V136, P12261, DOI 10.1021/ja507536n; Welch GC, 2007, J AM CHEM SOC, V129, P1880, DOI 10.1021/ja067961j; Welch GC, 2006, SCIENCE, V314, P1124, DOI 10.1126/science.1134230; Whittemore SM, 2015, CATAL TODAY, V251, P28, DOI 10.1016/j.cattod.2014.10.040; Wilkins LC, 2015, ORGANOMETALLICS, V34, P5298, DOI 10.1021/acs.organomet.5b00753; Xu TQ, 2014, J AM CHEM SOC, V136, P1774, DOI 10.1021/ja412445n; Ye JY, 2015, ACS CATAL, V5, P2921, DOI 10.1021/acscatal.5b00396; Ye KY, 2016, ANGEW CHEM INT EDIT, V55, P9216, DOI 10.1002/anie.201603760; Zhang YT, 2012, DALTON T, V41, P9119, DOI 10.1039/c2dt30427a; Zhang YT, 2010, ANGEW CHEM INT EDIT, V49, P10158, DOI 10.1002/anie.201005534; Zhang ZH, 2015, ANGEW CHEM INT EDIT, V54, P623, DOI 10.1002/anie.201409471; Zhu JT, 2016, ANGEW CHEM INT EDIT, V55, P8448, DOI 10.1002/anie.201603627; Zhu J, 2016, ANGEW CHEM INT EDIT, V55, P1417, DOI 10.1002/anie.201510494	104	664	662	26	620	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317							aaf7229	10.1126/science.aaf7229	http://dx.doi.org/10.1126/science.aaf7229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940818				2022-12-28	WOS:000389598800050
J	Contou, D; de Prost, N				Contou, Damien; de Prost, Nicolas			Skin Mottling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Contou, Damien; de Prost, Nicolas] Hop Henri Mondor, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Contou, D (corresponding author), Hop Henri Mondor, Creteil, France.	damien.contou@aphp.fr							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					2187	2187		10.1056/NEJMicm1602055	http://dx.doi.org/10.1056/NEJMicm1602055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED7GN	27959752				2022-12-28	WOS:000389030400010
J	Owens, B				Owens, Brian			Multiple Sclerosis	NATURE			English	Editorial Material																			0	18	19	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					S1	S1		10.1038/540S1a	http://dx.doi.org/10.1038/540S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27902684				2022-12-28	WOS:000388916600001
J	Thaiss, CA; Levy, M; Korem, T; Dohnalova, L; Shapiro, H; Jaitin, DA; David, E; Winter, DR; Gury-BenAri, M; Tatirovsky, E; Tuganbaev, T; Federici, S; Zmora, N; Zeevi, D; Dori-Bachash, M; Pevsner-Fischer, M; Kartvelishvily, E; Brandis, A; Harmelin, A; Shibolet, O; Halpern, Z; Honda, K; Amit, I; Segal, E; Elinav, E				Thaiss, Christoph A.; Levy, Maayan; Korem, Tal; Dohnalova, Lenka; Shapiro, Hagit; Jaitin, Diego A.; David, Eyal; Winter, Deborah R.; Gury-BenAri, Meital; Tatirovsky, Evgeny; Tuganbaev, Timur; Federici, Sara; Zmora, Niv; Zeevi, David; Dori-Bachash, Mally; Pevsner-Fischer, Meirav; Kartvelishvily, Elena; Brandis, Alexander; Harmelin, Alon; Shibolet, Oren; Halpern, Zamir; Honda, Kenya; Amit, Ido; Segal, Eran; Elinav, Eran			Microbiota Diumal Rhythmicity Programs Host Transcriptome Oscillations	CELL			English	Article							CIRCADIAN CLOCK; GENE-EXPRESSION; PROMOTES; TIME; ACETAMINOPHEN; METABOLISM; LANDSCAPE; ALIGNMENT; DRIVEN; CYCLE	The intestinal microbiota undergoes diurnal compositional and functional oscillations that affect metabolic homeostasis, but the mechanisms by which the rhythmic microbiota influences host circadian activity remain elusive. Using integrated multi-omics and imaging approaches, we demonstrate that the gut microbiota features oscillating biogeographical localization and metabolome patterns that determine the rhythmic exposure of the intestinal epithelium to different bacterial species and their metabolites over the course of a day. This diurnal microbial behavior drives, in turn, the global programming of the host circadian transcriptional, epigenetic, and metabolite oscillations. Surprisingly, disruption of homeostatic microbiome rhythmicity not only abrogates normal chromatin and transcriptional oscillations of the host, but also incites genome-wide de novo oscillations in both intestine and liver, thereby impacting diurnal fluctuations of host physiology and disease susceptibility. As such, the rhythmic biogeography and metabolome of the intestinal microbiota regulates the temporal organization and functional outcome of host transcriptional and epigenetic programs.	[Thaiss, Christoph A.; Levy, Maayan; Dohnalova, Lenka; Shapiro, Hagit; Jaitin, Diego A.; David, Eyal; Winter, Deborah R.; Gury-BenAri, Meital; Tatirovsky, Evgeny; Tuganbaev, Timur; Federici, Sara; Zmora, Niv; Dori-Bachash, Mally; Pevsner-Fischer, Meirav; Amit, Ido; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel; [Korem, Tal; Zeevi, David; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel; [Korem, Tal; Zeevi, David; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Kartvelishvily, Elena] Weizmann Inst Sci, Electron Microscopy Unit, IL-7610001 Rehovot, Israel; [Brandis, Alexander] Weizmann Inst Sci, Targeted Metabol Unit, Life Sci Core Facil, IL-7610001 Rehovot, Israel; [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-7610001 Rehovot, Israel; [Shibolet, Oren; Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Sackler Fac Med, IL-6423906 Tel Aviv, Israel; [Shibolet, Oren; Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-6423906 Tel Aviv, Israel; [Shibolet, Oren; Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Digest Ctr, IL-6423906 Tel Aviv, Israel; [Honda, Kenya] RIKEN Ctr Integrat Med Sci IMS, Yokohama, Kanagawa 2300045, Japan; [Honda, Kenya] Keio Univ, Dept Microbiol & Immunol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; RIKEN; Keio University	Elinav, E (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.	eran.segal@weizmann.ac.il; eran.elinav@weizmann.ac.il	Korem, Tal/D-4155-2018; Winter, Deborah R./AAQ-9253-2020; Shapiro, Hagit/F-8648-2015; Segal, Eran/AAF-4855-2019; Federici, Sara/ABD-4056-2021; Elinav, Eran/ABE-8881-2020	Korem, Tal/0000-0002-0609-0858; Winter, Deborah R./0000-0003-1806-673X; Elinav, Eran/0000-0002-5775-2110; Zeevi, David/0000-0002-6492-6078; Segal, Eran/0000-0002-6859-1164; Federici, Sara/0000-0002-3663-5142; Tuganbaev, Timur/0000-0002-4940-0000; Dohnalova, Lenka/0000-0002-2761-2547	Boehringer Ingelheim Fonds PhD Fellowship; Ministry of Science, Technology Space, Israel; Gilead Sciences International Research Scholars Program in Liver Disease; CREST, Japan Agency for Medical Research and Development; Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council; Israel Science Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; CNRS (Centre National de la Recherche Scientifique); estate of Samuel and Alwyn J. Weber; German-Israel Binational Foundation; Minerva Foundation; Rising Tide Foundation; Alon Foundation scholar award	Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Ministry of Science, Technology Space, Israel(Ministry of Science, Technology and Space (MOST), Israel); Gilead Sciences International Research Scholars Program in Liver Disease; CREST, Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Leona M. and Harry B. Helmsley Charitable Trust; Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); estate of Samuel and Alwyn J. Weber; German-Israel Binational Foundation; Minerva Foundation; Rising Tide Foundation; Alon Foundation scholar award	We thank the members of the E.E. and E.S. labs for discussions and Ilan Rosenshine for sharing important tools. We acknowledge Ziv Zwighaft and Gad Asher for providing polyamine-deficient animal diet and helpful advice, and Tevie Mehlman, Carmit Bar-Nathan, Osnat Amram, as well as the Weizmann Histology Unit for technical support. C.A.T. received a Boehringer Ingelheim Fonds PhD Fellowship and thanks Shalev Itzkovitz and Yair Raisner for insightful discussions. T.K. is supported by the Ministry of Science, Technology & Space, Israel. N.Z. is supported by the Gilead Sciences International Research Scholars Program in Liver Disease. K.H. is supported by CREST, Japan Agency for Medical Research and Development. E.S. is supported by the Crown Human Genome Center; the Else Kroener Fresenius Foundation; Donald L. Schwarz, Sherman Oaks, CA; Jack N. Halpern, New York, NY; Leesa Steinberg, Canada; and grants funded by the European Research Council and the Israel Science Foundation. E.E. is supported by Yael and Rami Ungar, Israel; Leona M. and Harry B. Helmsley Charitable Trust; the Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; John L. and Vera Schwartz, Pacific Palisades; Alan Markovitz, Canada; Cynthia Adelson, Canada; CNRS (Centre National de la Recherche Scientifique); estate of Samuel and Alwyn J. Weber; Mr. and Mrs. Donald L. Schwarz, Sherman Oaks; grants funded by the European Research Council; the German-Israel Binational Foundation; the Israel Science Foundation; the Minerva Foundation; the Rising Tide Foundation; and the Alon Foundation scholar award. E.E. is the incumbent of the Rina Gudinski Career Development Chair and a senior fellow of the Canadian Institute For Advanced Research (CIFAR).	Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Aguilar-Arnal L, 2013, NAT STRUCT MOL BIOL, V20, P1206, DOI 10.1038/nsmb.2667; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boughton BA, 2011, ANAL CHEM, V83, P7523, DOI 10.1021/ac201610x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Johnson BP, 2014, P NATL ACAD SCI USA, V111, P18757, DOI 10.1073/pnas.1421708111; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim YC, 1998, TOXICOLOGY, V128, P53, DOI 10.1016/S0300-483X(98)00046-8; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Liang X, 2015, P NATL ACAD SCI USA, V112, P10479, DOI 10.1073/pnas.1501305112; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Masri S, 2016, CELL, V165, P896, DOI 10.1016/j.cell.2016.04.039; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Murakami M, 2016, EMBO REP, V17, P1292, DOI 10.15252/embr.201642463; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Neufeld-Cohen A, 2016, P NATL ACAD SCI USA, V113, pE1673, DOI 10.1073/pnas.1519650113; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2004, J BIOL RHYTHM, V19, P374, DOI 10.1177/0748730404269008; Perelis M, 2015, SCIENCE, V350, DOI 10.1126/science.aac4250; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; Thaiss CA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005113; Thaiss CA, 2015, GUT MICROBES, V6, P137, DOI 10.1080/19490976.2015.1016690; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Voigt RM, 2016, ALCOHOL CLIN EXP RES, V40, P335, DOI 10.1111/acer.12943; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zwighaft Z, 2015, CELL METAB, V22, P874, DOI 10.1016/j.cmet.2015.09.011	52	397	418	19	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1495	+		10.1016/j.cell.2016.11.003	http://dx.doi.org/10.1016/j.cell.2016.11.003			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912059	Green Submitted, Bronze			2022-12-28	WOS:000389470500013
J	Tooze, SA; Dikic, I				Tooze, Sharon A.; Dikic, Ivan			Autophagy Captures the Nobel Prize	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; MUTANTS; CYTOPLASM; INDUCTION; VACUOLE	This year's Nobel Prize in Physiology or Medicine has been awarded to Yoshinori Ohsumi for the discovery of the molecular principles governing autophagy, an intracellular degradation pathway routed via lysosomes or vacuoles. It is a story of a simple yet insightful yeast genetic screen that revealed the inner circuitry of one of the most powerful quality-control pathways in cells.	[Tooze, Sharon A.] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Dikic, Ivan] Goethe Univ, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Dikic, Ivan] Goethe Univ, Buchmann Inst Mol Life Sci, Max von Laue Str 15, D-60438 Frankfurt, Germany	Francis Crick Institute; Goethe University Frankfurt; Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.; Dikic, I (corresponding author), Goethe Univ, Buchmann Inst Mol Life Sci, Max von Laue Str 15, D-60438 Frankfurt, Germany.	dikic@biochem2.uni-frankfurt.de	Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511; Tooze, Sharon/0000-0002-2182-3116				Eskelinen EL, 2011, AUTOPHAGY, V7, P935, DOI 10.4161/auto.7.9.15760; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E	15	43	45	1	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1433	1435		10.1016/j.cell.2016.11.023	http://dx.doi.org/10.1016/j.cell.2016.11.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912049	Bronze			2022-12-28	WOS:000389470500002
J	Sweetser, DA; Lin, AE; Troulis, MJ; Chen, TC; Westra, SJ				Sweetser, David A.; Lin, Angela E.; Troulis, Maria J.; Chen, Teresa C.; Westra, Sjirk J.			Case 34-2016: A 17-Year-Old Boy with Myopia and Craniofacial and Skeletal Abnormalities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEILL-MARCHESANI-SYNDROME; MARFAN-SYNDROME; HOMOCYSTINURIA		[Sweetser, David A.; Lin, Angela E.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Troulis, Maria J.] Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Boston, MA 02114 USA; [Westra, Sjirk J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Sweetser, David A.; Lin, Angela E.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Chen, Teresa C.] Harvard Med Sch, Dept Ophthalmol, Boston, MA USA; [Westra, Sjirk J.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Troulis, Maria J.] Harvard Sch Dent Med, Dept Oral & Maxillofacial Surg, Boston, MA USA; [Chen, Teresa C.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Harvard University; Massachusetts Eye & Ear Infirmary	Sweetser, DA (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.; Sweetser, DA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.		Sweetser, David/ABB-9347-2021	Sweetser, David/0000-0002-1621-3284; Westra, Sjirk/0000-0002-9952-6891; Chen, Teresa/0000-0001-5327-2016				Botto LD, 2000, AM J EPIDEMIOL, V151, P862; BRENTON DP, 1977, POSTGRAD MED J, V53, P488, DOI 10.1136/pgmj.53.622.488; BURKE JP, 1989, BRIT J OPHTHALMOL, V73, P427, DOI 10.1136/bjo.73.6.427; Cecchi A, 2013, AM J MED GENET A, V161, P2305, DOI 10.1002/ajmg.a.36044; ELKINGTON AR, 1973, BRIT J OPHTHALMOL, V57, P325, DOI 10.1136/bjo.57.5.325; Faivre L, 2003, AM J MED GENET A, V123A, P204, DOI 10.1002/ajmg.a.20289; Hochwall WR, 1932, NEW ENGL J MED, V207, P1054; JOHNSTON SS, 1968, BRIT J OPHTHALMOL, V52, P251, DOI 10.1136/bjo.52.3.251; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; MUDD SH, 1985, AM J HUM GENET, V37, P1; Murphy WA, 2013, RADIOLOGY, V268, P323, DOI 10.1148/radiol.13122478; Picker JD, 2014, GENEREVIEWS     1113; Rosenblatt DS., 1995, METABOLIC MOL BASES, VSeventh, P3111; Snyderman SE, 1997, EARLY HUM DEV, V48, P203, DOI 10.1016/S0378-3782(96)01860-9; VANDERBERG W, 1990, BRIT J OPHTHALMOL, V74, P696, DOI 10.1136/bjo.74.11.696; Yap S., 2007, ORPHANET         JUL; Zschocke J, 2004, VADEMECUM METABOLICU	17	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					1879	1890		10.1056/NEJMcpc1610096	http://dx.doi.org/10.1056/NEJMcpc1610096			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB6ZK	27959664				2022-12-28	WOS:000387534200012
J	Greenlee, MC; D'Angelo, L; Harms, SR; Kuo, AA; Landry, M; McManus, M; Talente, GM; White, P				Greenlee, M. Carol; D'Angelo, Lawrence; Harms, Stacey R.; Kuo, Alice A.; Landry, Michael; McManus, Margaret; Talente, Gregg M.; White, Patience		Amer Coll Phys Council Subspecialt	Enhancing the Role of Internists in the Transition From Pediatric to Adult Health Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERSPECTIVES; YOUTH		Western Slope Endocrinol, Grand Junction, CO USA; Childrens Natl Med Ctr, Amer Coll Phys, Natl Alliance Adv Adolescent Hlth, Washington, DC 20010 USA; George Washington Univ, Sch Med, Washington, DC USA; Univ Calif Los Angeles, Los Angeles, CA USA; Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; Southeast Louisiana Vet Healthcare Syst, New Orleans, LA USA; Univ South Carolina, Columbia, SC USA	American College of Physicians; Children's National Health System; George Washington University; University of California System; University of California Los Angeles; Tulane University; University of South Carolina System; University of South Carolina Columbia	Harms, SR (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave Northwest,Suite 700, Washington, DC 20001 USA.	sharms@acponline.org						American College of Physicians, 2016, PED AD CAR TRANS IN; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052; Committee on Improving the Health, 2014, INV HLTH WELL BEING; Garvey KC, 2016, DIABETES CARE, V39, P190, DOI 10.2337/dc15-1775; Kirzinger W, 2012, HLTH CARE ACCESS UTI; Lotstein DS, 2008, J ADOLESCENT HEALTH, V43, P23, DOI 10.1016/j.jadohealth.2007.12.013; Peter NG, 2009, PEDIATRICS, V123, P417, DOI 10.1542/peds.2008-0740; Quinn CT, 2010, BLOOD, V115, P3447, DOI 10.1182/blood-2009-07-233700; Reiss JG, 2005, PEDIATRICS, V115, P112, DOI 10.1542/peds.2004-1321	10	8	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					299	+		10.7326/M16-0514	http://dx.doi.org/10.7326/M16-0514			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL7FO	27894127				2022-12-28	WOS:000394786700021
J	Yan, WD				Yan, Wudan			BIOMEDICINE Carbon monoxide, the silent killer, may have met its match	SCIENCE			English	News Item																			0	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1215	1215		10.1126/science.354.6317.1215	http://dx.doi.org/10.1126/science.354.6317.1215			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940826				2022-12-28	WOS:000389598800013
J	Aron, L; Yankner, BA				Aron, Liviu; Yankner, Bruce A.			Neural synchronization in Alzheimer's disease	NATURE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; EEG SYNCHRONIZATION; PATHOLOGY; RHYTHMS	Electrical oscillations generated by neural circuits are disrupted in Alzheimer's disease. Restoring these oscillations in mouse models activates immune cells to clear disease-associated amyloid-beta protein from the brain. SEE ARTICLE p.230	[Aron, Liviu; Yankner, Bruce A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yankner, BA (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	bruce_yankner@hms.harvard.edu	Aron, LIviu/E-5192-2013		NIA NIH HHS [DP1 AG044161, P01 AG027916, R01 AG046174] Funding Source: Medline; NIH HHS [DP1 OD006849] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG046174, DP1AG044161] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gillespie AK, 2016, NEURON, V90, P740, DOI 10.1016/j.neuron.2016.04.009; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pijnenburg YAL, 2004, CLIN NEUROPHYSIOL, V115, P1332, DOI 10.1016/j.clinph.2003.12.029; Pooler AM, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt214; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	18	27	28	5	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					207	208		10.1038/540207a	http://dx.doi.org/10.1038/540207a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27929001				2022-12-28	WOS:000389548700043
J	Minute, M; Cozzi, G; Barbi, E				Minute, Marta; Cozzi, Giorgio; Barbi, Egidio			An adolescent with disabling abdominal pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Minute, Marta; Cozzi, Giorgio; Barbi, Egidio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy	IRCCS Burlo Garofolo	Minute, M (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.	martaminute@gmail.com	Barbi, Egidio/K-4016-2018	Barbi, Egidio/0000-0002-6343-846X; Cozzi, Giorgio/0000-0002-6427-1366				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Basch MC, 2015, J PAIN RES, V8, P675, DOI 10.2147/JPR.S55586; Bujoreanu Simona, 2014, Hosp Pediatr, V4, P283, DOI 10.1542/hpeds.2014-0023; Campo JV, 2012, J CHILD PSYCHOL PSYC, V53, P575, DOI 10.1111/j.1469-7610.2012.02535.x; Campo JV, 2001, PSYCHOSOMATICS, V42, P467, DOI 10.1176/appi.psy.42.6.467; Cottrell DJ, 2016, ARCH DIS CHILDHOOD-E, V101, P114, DOI 10.1136/archdischild-2015-309344; Flaherty EG, 2013, PEDIATRICS, V132, P590, DOI 10.1542/peds.2013-2045; Knook LME, 2011, EUR CHILD ADOLES PSY, V20, P39, DOI 10.1007/s00787-010-0146-0; Schieveld JNM, 2013, J NEUROPSYCH CLIN N, V25, P111, DOI 10.1176/appi.neuropsych.12020028	9	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2016	355								i6101	10.1136/bmj.i6101	http://dx.doi.org/10.1136/bmj.i6101			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF0SX	27927676				2022-12-28	WOS:000390037400003
J	Lucey, C; Levinson, W; Ginsburg, S				Lucey, Catherine; Levinson, Wendy; Ginsburg, Shiphra			Medical Student Mistreatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lucey, Catherine] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Levinson, Wendy] Univ Toronto, Dept Med, St Michaels Hosp, Toronto, ON, Canada; [Ginsburg, Shiphra] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ginsburg, Shiphra] Mt Sinai Hosp, Toronto, ON, Canada	University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Levinson, W (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med Res, 250 Yonge St,Sixth Floor,Room 648, Toronto, ON M5G 1B1, Canada.	wendy.levinson@utoronto.ca	Ginsburg, Shiphra R/C-1695-2008	Ginsburg, Shiphra R/0000-0002-4595-6650				ABIM Foundation ACP Foundation and European Federation of Internal Medicine, 2007, PHYS CART MED PROF N; Billings Martha E, 2011, J Grad Med Educ, V3, P503, DOI 10.4300/JGME-D-11-00044.1; Gittell JH., 2009, HIGH PERFORMANCE HEA; Leape LL, 2012, ACAD MED, V87, P845, DOI 10.1097/ACM.0b013e318258338d; Levinson W, 2015, UNDERSTANDING MED PR, P55; Mann S, 2012, AAMC REPORTER; Rosenstein AH, 2008, JT COMM J QUAL PATIE, V34, P464, DOI 10.1016/S1553-7250(08)34058-6; Saxton Rebecca, 2009, J Patient Saf, V5, P180, DOI 10.1097/PTS.0b013e3181b4c5d7; Smetzer JL, 2005, JT COMM J QUAL PATIE, V31, P594, DOI 10.1016/S1553-7250(05)31077-4	9	7	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2016	316	21					2263	2264		10.1001/jama.2016.17752	http://dx.doi.org/10.1001/jama.2016.17752			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YV	27923095				2022-12-28	WOS:000389307400012
J	Moher, D; Moher, E				Moher, David; Moher, Ester			Stop Predatory Publishers Now Response	ANNALS OF INTERNAL MEDICINE			English	Letter									[Moher, David] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Moher, Ester] Privacy Analyt, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute	Moher, D (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.		Moher, David/I-3408-2019	Moher, David/0000-0003-2434-4206				Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; MOHER D, 1992, EUR J VASCULAR SURG, V6, P647, DOI 10.1016/S0950-821X(05)80844-8	2	1	1	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					826	827		10.7326/L16-0415	http://dx.doi.org/10.7326/L16-0415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27919084				2022-12-28	WOS:000389263900017
J	Dulai, PS; Singh, S; Marquez, E; Khera, R; Prokop, LJ; Limburg, PJ; Gupta, S; Murad, MH				Dulai, Parambir S.; Singh, Siddharth; Marquez, Evelyn; Khera, Rohan; Prokop, Larry J.; Limburg, Paul J.; Gupta, Samir; Murad, Mohammad Hassan			Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CARDIOVASCULAR RISK; ADENOMA RECURRENCE; PRIMARY PREVENTION; RANDOMIZED-TRIAL; TASK-FORCE; FOLIC-ACID; ASPIRIN; COLONOSCOPY; CALCIUM	OBJECTIVE To assess the comparative efficacy and safety of candidate agents (low and high dose aspirin, nonaspirin non-steroidal anti-inflammatory drugs (NSAIDs), calcium, vitamin D, folic acid, alone or in combination) for prevention of advanced metachronous neoplasia (that is, occurring at different times after resection of initial neoplasia) in individuals with previous colorectal neoplasia, through a systematic review and network meta-analysis. DATA SOURCES Medline, Embase, Web of Science, from inception to 15 October 2015; clinical trial registries. STUDY SELECTION Randomized controlled trials in adults with previous colorectal neoplasia, treated with candidate chemoprevention agents, and compared with placebo or another candidate agent. Primary efficacy outcome was risk of advanced metachronous neoplasia; safety outcome was serious adverse events. DATA EXTRACTION Two investigators identified studies and abstracted data. A Bayesian network meta-analysis was performed and relative ranking of agents was assessed with surface under the cumulative ranking (SUCRA) probabilities (ranging from 1, indicating that the treatment has a high likelihood to be best, to 0, indicating the treatment has a high likelihood to be worst). Quality of evidence was appraised with GRADE criteria. RESULTS 15 randomized controlled trials (12 234 patients) comparing 10 different strategies were included. Compared with placebo, non-aspirin NSAIDs were ranked best for preventing advanced metachronous neoplasia (odds ratio 0.37, 95% credible interval 0.24 to 0.53; SUCRA=0.98; high quality evidence), followed by low-dose aspirin (0.71, 0.41 to 1.23; SUCRA=0.67; low quality evidence). Low dose aspirin, however, was ranked the safest among chemoprevention agents (0.78, 0.43 to 1.38; SUCRA=0.84), whereas non-aspirin NSAIDs (1.23, 0.95 to 1.64; SUCRA=0.26) were ranked low for safety. High dose aspirin was comparable with low dose aspirin in efficacy (1.12, 0.59 to 2.10; SUCRA=0.58) but had an inferior safety profile (SUCRA=0.51). Efficacy of agents for reducing metachronous colorectal cancer could not be estimated. CONCLUSIONS Among individuals with previous colorectal neoplasia, non-aspirin NSAIDs are the most effective agents for the prevention of advanced metachronous neoplasia, whereas low dose aspirin has the most favorable risk: benefit profile.	[Dulai, Parambir S.; Singh, Siddharth; Marquez, Evelyn] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA; [Singh, Siddharth] Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA; [Khera, Rohan] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Prokop, Larry J.] Mayo Clin, Dept Lib Serv, Rochester, MN USA; [Limburg, Paul J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Gupta, Samir] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Gupta, Samir] Univ San Diego, Moores Canc Ctr, La Jolla, CA USA; Mayo Clin, Evidence Based Practice Ctr, Rochester, MN USA; [Murad, Mohammad Hassan] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of San Diego; Mayo Clinic; Mayo Clinic	Singh, S (corresponding author), Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA.; Singh, S (corresponding author), Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA.	sis040@ucsd.edu	Dulai, Parambir/AAE-2983-2021; Khera, Rohan/P-2378-2019; Murad, M. Hassan/AAW-4367-2020; Dulai, Parambir/AAF-4408-2020; Khera, Rohan/AAQ-6838-2021	Khera, Rohan/0000-0001-9467-6199; Murad, Mohammad Hassan/0000-0001-5502-5975	NIDDK [5T32DK007202]; NIH/NLM [T15LM011271]; American College of Gastroenterology; NCI [2 U54CA132379-06A1]; US Department of Veterans Affairs Health Services Research and Development Service of the VA Office of Research and Development [1 I01 HX001574-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL125247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); American College of Gastroenterology(General Electric); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Veterans Affairs Health Services Research and Development Service of the VA Office of Research and Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: PSD and EM are supported by the NIDDK training grant 5T32DK007202. SS is supported by the NIH/NLM training grant T15LM011271 and the American College of Gastroenterology junior faculty development award. SG is partly supported by NCI 2 U54CA132379-06A1, as well as merit review award No 1 I01 HX001574-01A1 from the US Department of Veterans Affairs Health Services Research and Development Service of the VA Office of Research and Development. The views expressed in this article are those of the author(s) and do not necessarily represent the views of the Department of Veterans Affairs.	Adler J, 2015, AM J GASTROENTEROL, V110, P1657, DOI 10.1038/ajg.2015.365; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Arber N, 2011, AM J GASTROENTEROL, V106, P1135, DOI 10.1038/ajg.2011.116; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2015, NEW ENGL J MED, V373, P1519, DOI 10.1056/NEJMoa1500409; Bello AE, 2014, DRUG SAFETY, V37, P897, DOI 10.1007/s40264-014-0207-2; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bertagnolli MM, 2009, CANCER PREV RES, V2, P310, DOI 10.1158/1940-6207.CAPR-08-0206; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; Brenner H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2467; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brenner H, 2013, CANCER EPIDEM BIOMAR, V22, P1043, DOI 10.1158/1055-9965.EPI-13-0162; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chan AT, 2016, GASTROENTEROLOGY, V150, P14, DOI 10.1053/j.gastro.2015.11.018; Chu DZJ, 2011, CLIN COLORECTAL CANC, V10, P310, DOI 10.1016/j.clcc.2011.06.005; Chu DZJ, 2003, ANN SURG ONCOL, V10, P870, DOI 10.1245/ASO.2003.03.037; Chubak J, 2015, US PREVENTIVE SERVIC; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Cooper K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI [10.3310/hta.14320, 10.3310/hta14320]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Drew DA, 2016, NAT REV CANCER, V16, P173, DOI 10.1038/nrc.2016.4; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Hartung J, 2001, STAT MED, V20, P3875, DOI 10.1002/sim.1009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Ishikawa H, 2014, GUT, V63, P1755, DOI 10.1136/gutjnl-2013-305827; Johnson MR, 2015, GASTROENTEROLOGY, V149, P938, DOI 10.1053/j.gastro.2015.06.026; Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mainous AG, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000989; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Murphy CC, 2015, AM J GASTROENTEROL, V110, P633, DOI 10.1038/ajg.2014.344; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Nan HM, 2015, JAMA-J AM MED ASSOC, V313, P1133, DOI 10.1001/jama.2015.1815; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Patel N, 2015, DIGEST DIS SCI, V60, P2937, DOI 10.1007/s10620-015-3685-x; Pommergaard HC, 2016, GASTROENTEROLOGY, V150, P114, DOI 10.1053/j.gastro.2015.09.010; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Rostom A, 2007, PREVENTIVE SERVICES; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Roy HK, 2015, GUT; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Singh S, 2015, HEPATOLOGY, V62, P1417, DOI 10.1002/hep.27999; Singh S, 2014, AM J GASTROENTEROL, V109, P1375, DOI 10.1038/ajg.2014.171; Stafford RS, 2005, PLOS MED, V2, P1292, DOI 10.1371/journal.pmed.0020353; WOLFF WI, 1989, AM J GASTROENTEROL, V84, P1017; Wu K, 2009, AM J CLIN NUTR, V90, P1623, DOI 10.3945/ajcn.2009.28319; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	64	48	50	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2016	355								i6188	10.1136/bmj.i6188	http://dx.doi.org/10.1136/bmj.i6188			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SU	27919915	Green Published, hybrid			2022-12-28	WOS:000390037100002
J	Benci, JL; Xu, BH; Qiu, Y; Wu, TJ; Dada, H; Twyman-Saint Victor, C; Cucolo, L; Lee, DSM; Pauken, KE; Huang, AC; Gangadhar, TC; Amaravadi, RK; Schuchter, LM; Feldman, MD; Ishwaran, H; Vonderheide, RH; Maity, A; Wherry, EJ; Minn, AJ				Benci, Joseph L.; Xu, Bihui; Qiu, Yu; Wu, Tony J.; Dada, Hannah; Twyman-Saint Victor, Christina; Cucolo, Lisa; Lee, David S. M.; Pauken, Kristen E.; Huang, Alexander C.; Gangadhar, Tara C.; Amaravadi, Ravi K.; Schuchter, Lynn M.; Feldman, Michael D.; Ishwaran, Hemant; Vonderheide, Robert H.; Maity, Amit; Wherry, E. John; Minn, Andy J.			Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade	CELL			English	Article							CD8(+) T-CELLS; CHRONIC VIRAL-INFECTION; PD-1 BLOCKADE; I INTERFERON; CANCER; THERAPY; EXHAUSTION; RADIATION; RECEPTORS; REJECTION	Therapeutic blocking of the PD1 pathway results in significant tumor responses, but resistance is common. We demonstrate that prolonged interferon signaling orchestrates PDL1-dependent and PDL1-independent resistance to immune checkpoint blockade (ICB) and to combinations such as radiation plus anti-CTLA4. Persistent type II interferon signaling allows tumors to acquire STAT1-related epigenomic changes and augments expression of interferon-stimulated genes and ligands for multiple T cell inhibitory receptors. Both type I and II interferons maintain this resistance program. Crippling the program genetically or pharmacologically interferes with multiple inhibitory pathways and expands distinct T cell populations with improved function despite expressing markers of severe exhaustion. Consequently, tumors resistant to multi-agent ICB are rendered responsive to ICB monotherapy. Finally, we observe that biomarkers for interferon-driven resistance associate with clinical progression after anti-PD1 therapy. Thus, the duration of tumor interferon signaling augments adaptive resistance and inhibition of the interferon response bypasses requirements for combinatorial ICB therapies.	[Benci, Joseph L.; Xu, Bihui; Qiu, Yu; Wu, Tony J.; Dada, Hannah; Cucolo, Lisa; Lee, David S. M.; Maity, Amit; Minn, Andy J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Twyman-Saint Victor, Christina; Huang, Alexander C.; Gangadhar, Tara C.; Amaravadi, Ravi K.; Schuchter, Lynn M.; Vonderheide, Robert H.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Pauken, Kristen E.; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Feldman, Michael D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Pauken, Kristen E.; Huang, Alexander C.; Vonderheide, Robert H.; Wherry, E. John; Minn, Andy J.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Vonderheide, Robert H.; Wherry, E. John; Minn, Andy J.] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Benci, Joseph L.; Xu, Bihui; Qiu, Yu; Wu, Tony J.; Dada, Hannah; Twyman-Saint Victor, Christina; Cucolo, Lisa; Lee, David S. M.; Vonderheide, Robert H.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Ishwaran, Hemant] Univ Miami, Dept Epidemiol & Publ Hlth, Div Biostat, Miami, FL 33136 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Miami	Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	andyminn@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; Pauken, Kristen E./ABA-9363-2020	Minn, Andy/0000-0003-1418-0906; Ishwaran, Hemant/0000-0003-2758-9647; Maity, Amit/0000-0001-7151-2845; Twyman-Saint Victor, Christina/0000-0001-7253-6179; Benci, Joseph/0000-0002-1759-4621; Wu, Tony James/0000-0002-5049-6986; Lee, David/0000-0002-8821-9028	Melanoma Research Alliance; Parker Institute for Cancer Immunotherapy; Robertson Foundation/Cancer Research Institute Irvington Fellowship; NIH [P50CA174523, R01CA163739, R01CA158186, P30CA016520, U19AI082630, R01AI105343, U01AI095608, P01AI112521]; Basser Research Center for BRCA; Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer; NIH/NCI [R01CA172651]; Merck; NATIONAL CANCER INSTITUTE [P30CA016520, P50CA174523, R01CA163739, R01CA158186, R01CA172651] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI112521, U01AI095608, U19AI082630, R01AI105343] Funding Source: NIH RePORTER	Melanoma Research Alliance; Parker Institute for Cancer Immunotherapy; Robertson Foundation/Cancer Research Institute Irvington Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basser Research Center for BRCA; Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Merck(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A.J.M., R.H.V., and E.J.W. were supported by the Melanoma Research Alliance and the Parker Institute for Cancer Immunotherapy; K.E.P. was supported by a Robertson Foundation/Cancer Research Institute Irvington Fellowship; and M.D.F was supported by a grant from the NIH (P50CA174523). A.J.M. and R.H.V. were supported by the Basser Research Center for BRCA. H.I. and A.J.M. were supported by a grant from the NIH (R01CA163739). R.H.V. was supported by grants from the NIH (R01CA158186, P30CA016520) and by the Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer. E.J.W. was supported by funding from NIH (U19AI082630, R01AI105343, U01AI095608, and P01AI112521). A.J.M. is a Department of Defense Era of Hope Scholar (W81XWH-09-1-0339) and was supported by funding from the NIH/NCI (R01CA172651). This work was partly supported by a grant from Merck.	Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Gajewski TF, 2011, CURR OPIN IMMUNOL, V23, P286, DOI 10.1016/j.coi.2010.11.013; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; McWilliams JA, 2006, J IMMUNOL, V177, P155, DOI 10.4049/jimmunol.177.1.155; Minn AJ, 2016, CELL, V165, P272, DOI 10.1016/j.cell.2016.03.031; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken K. E., 2016, SCIENCE; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vanpouille-Box C, 2015, CANCER RES, V75, P2232, DOI 10.1158/0008-5472.CAN-14-3511; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	40	563	585	5	141	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1540	+		10.1016/j.cell.2016.11.022	http://dx.doi.org/10.1016/j.cell.2016.11.022			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912061	Green Accepted, Bronze			2022-12-28	WOS:000389470500016
J	Davidson, EA				Davidson, Eric A.			BIOGEOCHEMISTRY Projections of the soil-carbon deficit	NATURE			English	Editorial Material								Changes in the amount of carbon stored in soil might be a crucial feedback to climate change. Experimental field studies show that warming-induced soil carbon losses are greatest where carbon stocks are largest. SEELETTER p.104	[Davidson, Eric A.] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21536 USA	University System of Maryland; University of Maryland Center for Environmental Science	Davidson, EA (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21536 USA.	edavidson@umces.edu	Davidson, Eric A/K-4984-2013	Davidson, Eric A/0000-0002-8525-8697				Abbott BW, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034014; BILLINGS WD, 1987, QUATERNARY SCI REV, V6, P165, DOI 10.1016/0277-3791(87)90032-1; Crowther TW, 2016, NATURE, V540, P104, DOI 10.1038/nature20150; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Todd-Brown KEO, 2014, BIOGEOSCIENCES, V11, P2341, DOI 10.5194/bg-11-2341-2014; Wieder WR, 2015, GLOBAL BIOGEOCHEM CY, V29, P1782, DOI 10.1002/2015GB005188	6	6	6	7	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					47	48		10.1038/540047a	http://dx.doi.org/10.1038/540047a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905445				2022-12-28	WOS:000388916600044
J	LeDoux, J; Phelps, L; Alberini, C				LeDoux, Joe; Phelps, Liz; Alberini, Cristina			What We Talk About When We Talk About Emotions	CELL			English	Editorial Material								Emotions are a fundamental part of our living experience, yet our grasp on what they are and how to study them is still tenuous. Cell editor Mirna Kvajo talked with Joe LeDoux, Cristina Alberini, and Liz Phelps about the challenges in researching emotions and whether studies in animals can teach us about them. An excerpt of the conversation appears below, and the full conversation is available with the article online.	[LeDoux, Joe; Phelps, Liz; Alberini, Cristina] NYU, New York, NY 10003 USA	New York University	LeDoux, J (corresponding author), NYU, New York, NY 10003 USA.								0	11	12	2	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1443	1445						3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912051	Bronze			2022-12-28	WOS:000389470500005
J	Cousins, S				Cousins, Sophie			WAR ON DRUGS Five thousand dead and counting: the Philippines' bloody war on drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophcousins@gmail.com						Dangerous Drugs Board, NAT SURV NAT EXT DRU; Human Rights Watch, PHIL WAR DRUGS; Paddock R., 2016, NY TIMES; UN Office on Drugs and Crime, PATT TRENDS AMPH TYP; United Nations Office on Drugs and Crime, 2015, CHALL SYNTH DRUG E	5	3	3	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2016	355								i6177	10.1136/bmj.i6177	http://dx.doi.org/10.1136/bmj.i6177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YW	27895061				2022-12-28	WOS:000389307600001
J	Gulland, A				Gulland, Anne			BRIEFING Passport to healthcare: NHS charges become the new normal for overseas patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Department of Health, 2013, QUANT ASS VIS MIGR U; Department of Health, 2016, GUID IMPL OV VIS HOS; National Audit Office, 2016, REC COST NHS TREATM	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2016	355								i6379	10.1136/bmj.i6379	http://dx.doi.org/10.1136/bmj.i6379			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YW	27895054				2022-12-28	WOS:000389307600010
J	Friedman, LS; Lee, SR; Nelson, SB; Masia, R				Friedman, Lawrence S.; Lee, Stephen R.; Nelson, Sandra B.; Masia, Ricard			Case 36-2016: A 50-Year-Old Man with Acute Liver Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-E-VIRUS; TRANSPLANT RECIPIENTS; E INFECTION; FAILURE; DISEASE		[Friedman, Lawrence S.] Newton Wellesley Hosp, Dept Med, Newton, MA 02462 USA; [Friedman, Lawrence S.; Nelson, Sandra B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Lee, Stephen R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Masia, Ricard] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Friedman, Lawrence S.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Friedman, Lawrence S.; Nelson, Sandra B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Lee, Stephen R.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Masia, Ricard] Harvard Med Sch, Dept Pathol, Boston, MA USA	Newton Wellesley Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Tufts University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Friedman, LS (corresponding author), Newton Wellesley Hosp, Dept Med, Newton, MA 02462 USA.; Friedman, LS (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Friedman, LS (corresponding author), Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA.; Friedman, LS (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Abbas Z, 2014, ANTIVIR THER, V19, P125, DOI 10.3851/IMP2705; Au WY, 2011, ANN HEMATOL, V90, P1237, DOI 10.1007/s00277-011-1167-6; Au WY, 2012, SINGAP MED J, V53, P148; Badiye B., 2013, RES J RECENT SCI, V2, P58; Bazerbachi F, 2016, GASTROENTEROL REP, V4, P1, DOI 10.1093/gastro/gov042; Chijioke O, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00020; Davern TJ, 2011, GASTROENTEROLOGY, V141, P1665, DOI 10.1053/j.gastro.2011.07.051; Gyarmati P, 2007, J VIROL METHODS, V146, P226, DOI 10.1016/j.jviromet.2007.07.014; Hepatitis E, 1993, MMWR-MORBID MORTAL W, V42, P1; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2014, NEW ENGL J MED, V370, P1111, DOI 10.1056/NEJMoa1215246; Kaur S, 2011, INDIAN J HEMATOL BLO, V27, P117, DOI 10.1007/s12288-011-0064-4; Korman JD, 2008, HEPATOLOGY, V48, P1167, DOI 10.1002/hep.22446; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Nayak Hemanta Kumar, 2013, Case Reports Hepatol, V2013, P531235, DOI 10.1155/2013/531235; Prchal JT, 2016, CLIN FEATURES DIAGNO; Protzer U, 2015, MODERN PATHOL, V28, P523, DOI 10.1038/modpathol.2014.147; Rosario C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-185; Schram AM, 2015, BLOOD, V125, P1548, DOI 10.1182/blood-2014-10-602607; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Yang CC, 2004, VET HUM TOXICOL, V46, P321	23	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2082	2092		10.1056/NEJMcpc1610099	http://dx.doi.org/10.1056/NEJMcpc1610099			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC9KU	27959737				2022-12-28	WOS:000388464300012
J	Peterson, KA				Peterson, Kevin A.			Balancing Primary Diabetes Care Quality and Services	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Peterson, Kevin A.] Univ Minnesota, Mayo Mem Bldg,Suite A674-2,420 Delaware St SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Peterson, KA (corresponding author), Univ Minnesota, Mayo Mem Bldg,Suite A674-2,420 Delaware St SE, Minneapolis, MN 55455 USA.	peter223@umn.edu						Altschuler J, 2012, ANN FAM MED, V10, P396, DOI 10.1370/afm.1400; Centers for Disease Control and Prevention, 1994, AG ADJ PERC AD AG 18; Cheung A, 2017, ANN INTERN MED, V166, P240, DOI 10.7326/M16-1056; Garrison RW, 2001, TIME MONEY MACROECON, P253; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					303	304		10.7326/M16-2768	http://dx.doi.org/10.7326/M16-2768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	27951590				2022-12-28	WOS:000394786700023
J	Bruix, J; Qin, SK; Merle, P; Granito, A; Huang, YH; Bodoky, G; Pracht, M; Yokosuka, O; Rosmorduc, O; Breder, V; Gerolami, R; Masi, G; Ross, PJ; Song, TQ; Bronowicki, JP; Ollivier-Hourmand, I; Kudo, M; Cheng, AL; Llovet, JM; Finn, RS; LeBerre, MA; Baumhauer, A; Meinhardt, G; Han, GH				Bruix, Jordi; Qin, Shukui; Merle, Philippe; Granito, Alessandro; Huang, Yi-Hsiang; Bodoky, Gyrogy; Pracht, Marc; Yokosuka, Osamu; Rosmorduc, Olivier; Breder, Valeriy; Gerolami, Rene; Masi, Gianluca; Ross, Paul J.; Song, Tianqiang; Bronowicki, Jean-Pierre; Ollivier-Hourmand, Isabelle; Kudo, Masatoshi; Cheng, Ann-Lii; Llovet, Josep M.; Finn, Richard S.; LeBerre, Marie-Aude; Baumhauer, Annette; Meinhardt, Gerold; Han, Guohong		Resorce Investigators	Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							CLINICAL-PRACTICE GUIDELINES; 1ST-LINE THERAPY; MULTICENTER; MANAGEMENT; SUNITINIB; SURVIVAL; BRIVANIB; FAILURE	Background There are no systemic treatments for patients with hepatocellular carcinoma (HCC) whose disease progresses during sorafenib treatment. We aimed to assess the efficacy and safety of regorafenib in patients with HCC who have progressed during sorafenib treatment. Methods In this randomised, double-blind, parallel-group, phase 3 trial done at 152 sites in 21 countries, adults with HCC who tolerated sorafenib (>= 400 mg/day for >= 20 of last 28 days of treatment), progressed on sorafenib, and had Child-Pugh A liver function were enrolled. Participants were randomly assigned (2: 1) by a computer-generated randomisation list and interactive voice response system and stratified by geographical region, Eastern Cooperative Oncology Group performance status, macrovascular invasion, extrahepatic disease, and a-fetoprotein level to best supportive care plus oral regorafenib 160 mg or placebo once daily during weeks 1-3 of each 4-week cycle. Investigators, patients, and the funder were masked to treatment assignment. The primary endpoint was overall survival (defined as time from randomisation to death due to any cause) and analysed by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01774344. Findings Between May 14, 2013, and Dec 31, 2015, 843 patients were screened, of whom 573 were enrolled and randomised (379 to regorafenib and 194 to placebo; population for efficacy analyses), and 567 initiated treatment (374 received regorafenib and 193 received placebo; population for safety analyses). Regorafenib improved overall survival with a hazard ratio of 0.63 (95% CI 0.50-0.79; one-sided p<0.0001); median survival was 10.6 months (95% CI 9.1-12.1) for regorafenib versus 7.8 months (6.3-8.8) for placebo. Adverse events were reported in all regorafenib recipients (374 [100%] of 374) and 179 (93%) of 193 placebo recipients. The most common clinically relevant grade 3 or 4 treatment-emergent events were hypertension (57 patients [15%] in the regorafenib group vs nine patients [5%] in the placebo group), hand-foot skin reaction (47 patients [13%] vs one [1%]), fatigue (34 patients [9%] vs nine patients [5%]), and diarrhoea (12 patients [3%] vs no patients). Of the 88 deaths (grade 5 adverse events) reported during the study (50 patients [13%] assigned to regorafenib and 38 [20%] assigned to placebo), seven (2%) were considered by the investigator to be related to study drug in the regorafenib group and two (1%) in the placebo group, including two patients (1%) with hepatic failure in the placebo group. Interpretation Regorafenib is the only systemic treatment shown to provide survival benefit in HCC patients progressing on sorafenib treatment. Future trials should explore combinations of regorafenib with other systemic agents and third-line treatments for patients who fail or who do not tolerate the sequence of sorafenib and regorafenib. Funding Bayer.	[Bruix, Jordi; Llovet, Josep M.] Univ Barcelona, CIBERehd, IDIBAPS Hosp Clin Barcelona, Barcelona Clin Liver Canc BCLC Grp,Liver Unit, Catalonia, Spain; [Qin, Shukui] Chinese Peoples Liberat Army, Ctr Canc, Nanjing Bayi Hosp, Nanjing, Jiangsu, Peoples R China; [Merle, Philippe] Grp Hosp Lyon Nord, Hepatol Unit, Lyon, France; [Granito, Alessandro] Univ Bologna, S Orsola Malpighi Hosp, Dept Med & Surg Sci, Bologna, Italy; [Huang, Yi-Hsiang] Natl Yang Ming Univ, Inst Clin Med, Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Bodoky, Gyrogy] St Laszlo Teaching Hosp, Budapest, Hungary; [Pracht, Marc] Ctr Eugene Marquis, Serv Oncol Med, Rennes, France; [Yokosuka, Osamu] Chiba Univ, Dept Gastroenterol & Nephrol, Chiba, Japan; [Rosmorduc, Olivier] Hop La Pitie Salpetriere, AP HP, Dept Hepatol, Paris, France; [Rosmorduc, Olivier] Sorbonne Univ, Univ Pierre & Marie Curie, Paris, France; [Breder, Valeriy] Russian Canc Res Ctr, Moscow, Russia; [Gerolami, Rene] Univ Mediterranee, CHU Timone, Marseille, France; [Masi, Gianluca] Azienda Osped Univ Pisana, Pisa, Italy; [Ross, Paul J.] Kings Coll Hosp NHS Fdn Trust, London, England; [Song, Tianqiang] Tianjin Med Univ, Canc Hosp, Tianjin, Peoples R China; [Bronowicki, Jean-Pierre] Univ Lorraine, CHU Nancy, INSERM 954, Nancy, France; [Ollivier-Hourmand, Isabelle] CHU, Serv Hepatogastroenterol, Caen, France; [Kudo, Masatoshi] Kindai Univ, Fac Med, Osaka, Japan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Med Oncol, Taipei, Taiwan; [Llovet, Josep M.] Icahn Sch Med Mt Sinai, Dept Med, Tisch Canc Inst, Liver Canc Program,Div Liver Dis, New York, NY 10029 USA; [Llovet, Josep M.] ICREA, Barcelona, Spain; [Finn, Richard S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [LeBerre, Marie-Aude] Bayer HealthCare SAS, Loos, France; [Baumhauer, Annette] Bayer Vital GmbH, Bayer Pharmaceut, Leverkusen, Germany; [Meinhardt, Gerold] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Han, Guohong] Fourth Mil Med Univ, Affiliated Hosp 1, Xijing Hosp, Xian, Peoples R China	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Nanjing University of Chinese Medicine; CHU Lyon; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; UNICANCER; Centre Eugene Marquis; Chiba University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Pisa; Azienda Ospedaliero Universitaria Pisana; King's College Hospital NHS Foundation Trust; Tianjin Medical University; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Caen NORMANDIE; Universite de Caen Normandie; Kindai University (Kinki University); National Taiwan University; National Taiwan University Hospital; Icahn School of Medicine at Mount Sinai; ICREA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Air Force Military Medical University	Bruix, J (corresponding author), Univ Barcelona, Hosp Clin, BCLC Grp, IDIBAPS,CIBEREHD, Villarroel 170, E-08036 Barcelona, Spain.	jbruix@clinic.ub.es	Masi, Gianluca/AAD-1637-2021; Masi, Gianluca/AAJ-8388-2020; Granito, Alessandro/G-9563-2013; Llovet, Josep M/D-4340-2014; Kudo, Masatoshi/AAA-9744-2019; Llovet, Josep M/ABB-6264-2021	Granito, Alessandro/0000-0002-0637-739X; Llovet, Josep M/0000-0003-0547-2667; Kudo, Masatoshi/0000-0002-4102-3474; Llovet, Josep M/0000-0003-0547-2667; Bruix, Jordi/0000-0002-9826-0753; Breder, Valeriy/0000-0002-6244-4294; MASI, GIANLUCA/0000-0001-8329-8989; Huang, Yi-Hsiang/0000-0001-5241-5425; Cheng, Ann-Lii/0000-0002-9152-6512	Bayer; ICREA Funding Source: Custom	Bayer(Bayer AG); ICREA(ICREA)	Bayer.	Abou-Alfa GK, 2016, P AM SOC CLIN ONCOL, V34; Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; [Anonymous], 2016, STIV PRESCR INF; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Bruix J, 2013, EUR J CANCER, V49, P3412, DOI 10.1016/j.ejca.2013.05.028; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Kudo M, 2014, LIVER CANCER, V3, P458, DOI 10.1159/000343875; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2013, J CLIN ONCOL, V31, P3509, DOI 10.1200/JCO.2012.47.3009; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Mazzoccoli G, 2016, CURR DRUG TARGETS, V17, P783, DOI 10.2174/1389450117666151209120831; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Reig M, 2014, J HEPATOL, V61, P318, DOI 10.1016/j.jhep.2014.03.030; Reig M, 2013, HEPATOLOGY, V58, P2023, DOI 10.1002/hep.26586; Steel JL, 2006, ANN ONCOL, V17, P304, DOI 10.1093/annonc/mdj072; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Zhu AX, 2016, CLIN CANCER RES, V22, P4870, DOI 10.1158/1078-0432.CCR-15-2883; Zhu AX, 2015, LANCET ONCOL, V16, P859, DOI 10.1016/S1470-2045(15)00050-9; Zhu AX, 2015, J CLIN ONCOL, V33, P559, DOI 10.1200/JCO.2013.53.7746; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189	30	2050	2143	15	301	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2017	389	10064					56	66		10.1016/S0140-6736(16)32453-9	http://dx.doi.org/10.1016/S0140-6736(16)32453-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7VH	27932229	Green Submitted, Green Published			2022-12-28	WOS:000391264000038
J	Kaiser, J				Kaiser, Jocelyn			Qatar's genome effort slowly gears up	SCIENCE			English	Editorial Material																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1220	1220		10.1126/science.354.6317.1220	http://dx.doi.org/10.1126/science.354.6317.1220			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940829				2022-12-28	WOS:000389598800016
J	Soares, S; Atallah, BV; Paton, JJ				Soares, Sofia; Atallah, Bassam V.; Paton, Joseph J.			Midbrain dopamine neurons control judgment of time	SCIENCE			English	Article							REWARD PREDICTION ERROR; INTERNAL CLOCK; D-AMPHETAMINE; HALOPERIDOL; PERCEPTION; METHAMPHETAMINE; REPRODUCTION; UNCERTAINTY; PUNISHMENT; ATTENTION	Our sense of time is far from constant. For instance, time flies when we are having fun, and it slows to a trickle when we are bored. Midbrain dopamine neurons have been implicated in variable time estimation. However, a direct link between signals carried by dopamine neurons and temporal judgments is lacking. We measured and manipulated the activity of dopamine neurons as mice judged the duration of time intervals. We found that pharmacogenetic suppression of dopamine neurons decreased behavioral sensitivity to time and that dopamine neurons encoded information about trial-to-trial variability in time estimates. Last, we found that transient activation or inhibition of dopamine neurons was sufficient to slow down or speed up time estimation, respectively. Dopamine neuron activity thus reflects and can directly control the judgment of time.	[Soares, Sofia; Atallah, Bassam V.; Paton, Joseph J.] Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal	Fundacao Champalimaud	Atallah, BV; Paton, JJ (corresponding author), Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal.	bassam.atallah@gmail.com; joe.paton@neuro.fchampalimaud.org	Core, Vector/CAF-4832-2022	Paton, Joseph/0000-0002-1663-6455	Bial Foundation [188/12]; Simons Foundation (Simons Collaboration on the Global Brain award) [325476]; Fundacao para Ciencia e Tecnologia [SFRH/BD/51895/2012]; European Molecular Biology Organization [983-2012]; Marie Curie Actions [FP7-PEOPLE-2012-IIF 326398]; Champalimaud Foundation	Bial Foundation(Bial Foundation); Simons Foundation (Simons Collaboration on the Global Brain award); Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie Actions(European Commission); Champalimaud Foundation	We thank A. Braga for assistance with behavioral training; M. Duarte for assistance with mouse colonies; G. Lopes for assistance with Bonsai T. Mortteiro T. Gouvea other members of the Paton laboratory, B. Lau, E. Lottem, M. Murakami C. Poo, A. Renart, and T. Akam for discussions and/or comments on the manuscript; Z. Mainen for support; platforms at the Champalimaud Centre for histology support and animal care; and V. Jayaraman, R. A. Kerr, D. S. Kim, L. L. Looger, and K. Svaboda from the GENIE (Genetically-Encoded Neuronal Indicator are Effector) Project at the Howard Hughes Medical Institute's Janelia Farm Research Campus tor providing the AAV-GCaMP6f through the University of Pennsylvania Vector Core. Viruses for expression of NpHR3.0 and EYFP are available from the University of North Carolina Vector CO re meet a material transfer agreement with K. Deisseroth. Viruses for expression of GCaMP6f and TdTornato are available from the University of Pennsylvania Vector Core under a material transfer agreement with the trustees of the University of Pennsylvania on behalf of J. Wilson. The work was funded by the Bial Foundation (188/12 to J.J.P.), the Simons Foundation (Simons Collaboration on the Global Brain award 325476 to J.J.P.), Fundacao para Ciencia e Tecnologia (SFRH/BD/51895/2012 to S.S) the European Molecular Biology Organization (Advanced Long Term Fellowship 983-2012 to B.V.A.), Marie Curie Actions (FP7-PEOPLE-2012-IIF 326398 to B.V.A.), and the Champalimaud Foundation (internal funding to J.J.P.). Data presented in this paper can be found at www.dropbox.com/sh/ip6forddl84028j/ AAAsa3ry41bu4acYk1BI3KDra?dl=0.	Ahrens MB, 2011, CURR BIOL, V21, P200, DOI 10.1016/j.cub.2010.12.043; Balci F, 2010, BRAIN RES, V1325, P89, DOI 10.1016/j.brainres.2010.02.034; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; Buhusi CV, 2002, BEHAV NEUROSCI, V116, P291, DOI 10.1037//0735-7044.116.2.291; BUNNEY BS, 1978, N-S ARCH PHARMACOL, V304, P255, DOI 10.1007/BF00507966; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; de Lafuente V, 2011, P NATL ACAD SCI USA, V108, P19767, DOI 10.1073/pnas.1117636108; Drew MR, 2007, J NEUROSCI, V27, P7731, DOI 10.1523/JNEUROSCI.1736-07.2007; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Eshel N, 2016, NAT NEUROSCI, V19, P479, DOI 10.1038/nn.4239; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Fried I, 2001, NAT NEUROSCI, V4, P201, DOI 10.1038/84041; Gable PA, 2012, PSYCHOL SCI, V23, P879, DOI 10.1177/0956797611435817; Gouvea TS, 2015, ELIFE, V4, DOI 10.7554/eLife.11386; HICKS RE, 1976, AM J PSYCHOL, V89, P719, DOI 10.2307/1421469; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Lake JI, 2013, NEUROPSYCHOLOGIA, V51, P284, DOI 10.1016/j.neuropsychologia.2012.09.014; Luthi A, 2014, NAT NEUROSCI, V17, P1635, DOI 10.1038/nn.3849; MARICQ AV, 1983, PSYCHOPHARMACOLOGY, V79, P10, DOI 10.1007/BF00433008; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Noreika V, 2013, NEUROPSYCHOLOGIA, V51, P235, DOI 10.1016/j.neuropsychologia.2012.09.036; Odum AL, 2002, J EXP ANAL BEHAV, V78, P195, DOI 10.1901/jeab.2002.78-195; Oleson EB, 2012, J NEUROSCI, V32, P14804, DOI 10.1523/JNEUROSCI.3087-12.2012; Panigrahi B, 2015, CELL, V162, P1418, DOI 10.1016/j.cell.2015.08.014; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Pasquereau B, 2015, J NEUROPHYSIOL, V113, P1110, DOI 10.1152/jn.00401.2014; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Sutton R. S., 1998, INTRO REINFORCEMENT, V135; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; WAHL OF, 1980, PERCEPT MOTOR SKILL, V50, P535, DOI 10.2466/pms.1980.50.2.535; WATTS FN, 1984, PERCEPT MOTOR SKILL, V59, P597, DOI 10.2466/pms.1984.59.2.597; Wittmann M, 2007, DRUG ALCOHOL DEPEN, V90, P183, DOI 10.1016/j.drugalcdep.2007.03.005	39	143	148	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1273	1277		10.1126/science.aah5234	http://dx.doi.org/10.1126/science.aah5234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940870				2022-12-28	WOS:000389598800057
J	Capewell, S; Lilford, R				Capewell, Simon; Lilford, Richard			Are nanny states healthier states?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TOBACCO; ALCOHOL; FOOD		[Capewell, Simon] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Lilford, Richard] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Liverpool; University of Warwick	Capewell, S (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England.	capewell@liverpool.ac.uk; r.j.lilford@warwick.ac.uk		Lilford, Richard/0000-0002-0634-984X	Medical Research Council [G0900847] Funding Source: researchfish; MRC [G0900847] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson P, 2009, CURR OPIN PSYCHIATR, V22, P253, DOI 10.1097/YCO.0b013e328329ed75; Askew C, 2016, HUFFINGTON POST; CHAMBLISS W, 1995, SOCIAL JUSTICE, V0022; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; DAUBE M, 1993, TOB CONTROL, V2, P183, DOI DOI 10.1136/TC.2.3.183; Dolmetsch C, 2014, BLOOMBERG; He FJ, 2015, PFLUG ARCH EUR J PHY, V467, P577, DOI 10.1007/s00424-014-1677-x; Hoek J, 2015, PUBLIC HEALTH, V129, P1038, DOI 10.1016/j.puhe.2015.03.009; Hyseni L, 2016, J EPIDEMIOL COMMU S1, V70, P7; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; Knai C, 2015, FOOD POLICY, V54, P1, DOI 10.1016/j.foodpol.2015.04.002; Mackenzie G, CENTURY PUBLIC HLTH; Maslow A, 1943, THEORY HUMAN MOTIVAT; McGill R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1781-7; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Tobacco Tactics, 2012, IEA HIST CLOS TIES T; WHO, 2013, WHO DIR GEN ADDR HLT	17	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2016	355								i6341	10.1136/bmj.i6341	http://dx.doi.org/10.1136/bmj.i6341			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF0SX	27927622				2022-12-28	WOS:000390037400007
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Awkward questions about NHS management consultancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Alderwick H, 2016, SUSTAINABILITY TRANS; [Anonymous], 2013, YORKSHIRE POST  0503; Burne James S., 2016, PR WEEK         0223; Butcher D., RADIO TIMES; Campbell, 2014, GUARDIAN; Consultancy.co.uk, 2014, NHS SPENDS 640M MAN; Greer D., 2014, GUARDIAN; King's Fund, 2016, CART REV PROD NHS HO; Knapton S., 2014, TELEGRAPH; Lay K, 2014, TIMES; McCartney M., 2016, STATE MED; Oliver D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7243; Rose D, 2012, MAIL; Syal R, 2015, GUARDIAN	14	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2016	355								i6529	10.1136/bmj.i6529	http://dx.doi.org/10.1136/bmj.i6529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SW	27923807	Green Published, Bronze			2022-12-28	WOS:000390037300001
J	Akiyama, BM; Laurence, HM; Massey, AR; Costantino, DA; Xie, XP; Yang, YJ; Shi, PY; Nix, JC; Beckham, JD; Kieft, JS				Akiyama, Benjamin M.; Laurence, Hannah M.; Massey, Aaron R.; Costantino, David A.; Xie, Xuping; Yang, Yujiao; Shi, Pei-Yong; Nix, Jay C.; Beckham, J. David; Kieft, Jeffrey S.			Zika virus produces noncoding RNAs using a multi-pseudoknot structure that confounds a cellular exonuclease	SCIENCE			English	Article							SUBGENOMIC FLAVIVIRUS RNA; WEST-NILE; JAPANESE ENCEPHALITIS; EXORIBONUCLEASE XRN1; HOST ADAPTATION; INTERFERON; CELLS; BINDS	A specialized bone marrow microenvironment (niche) regulates hematopoietic stem cell (HSC) self-renewal and commitment. For successful donor-HSC engraftment, the niche must be emptied via myeloablative irradiation or chemotherapy. However, myeloablation can cause severe complications and even mortality. Here we report that the essential amino acid valine is indispensable for the proliferation and maintenance of HSCs. Both mouse and human HSCs failed to proliferate when cultured in valine-depleted conditions. In mice fed a valine-restricted diet, HSC frequency fell dramatically within 1 week. Furthermore, dietary valine restriction emptied the mouse bone marrow niche and afforded donor-HSC engraftment without chemoirradiative myeloablation. These findings indicate a critical role for valine in HSC maintenance and suggest that dietary valine restriction may reduce iatrogenic complications in HSC transplantation.	[Akiyama, Benjamin M.; Laurence, Hannah M.; Costantino, David A.; Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Laurence, Hannah M.] Univ Colorado Denver, HHMI, Sch Med, Aurora, CO 80045 USA; [Laurence, Hannah M.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Massey, Aaron R.; Beckham, J. David] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO 80045 USA; [Xie, Xuping; Yang, Yujiao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Nix, Jay C.] Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA; [Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, RNA BioSci Initiat, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Davis; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Kieft, JS (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.; Kieft, JS (corresponding author), Univ Colorado Denver, Sch Med, RNA BioSci Initiat, Aurora, CO 80045 USA.	jeffrey.kieft@ucdenver.edu	Xie, Xuping/AAD-7406-2019; Beckham, John/AAE-6694-2020	Beckham, John/0000-0001-9305-2683; Massey, Aaron/0000-0002-8747-0114	NIH [F32GM117730, R35GM118070, R01GM081346, R01AI087856, S10OD012033]; HHMI; HHMI-Burroughs Wellcome Fund medical research fellowship; University of Colorado School of Medicine; University of Colorado Department of Medicine; Novartis Institutes for BioMedical Research; University of Texas Medical Branch; University of Texas; UC Cancer Center [P30CA046934]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129569, R01AI087856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118070, F32GM117730, R01GM081346] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); HHMI-Burroughs Wellcome Fund medical research fellowship; University of Colorado School of Medicine; University of Colorado Department of Medicine; Novartis Institutes for BioMedical Research; University of Texas Medical Branch; University of Texas; UC Cancer Center; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Kieft lab for discussions; C. Musselman and M. Stone for critical reading of this manuscript; and R. Soto from the M. Garcia-Blanco and S. Bradrick laboratories for sharing their protocol for sfRNA blots. Supported by NIH fellowship F32GM117730 (B.M.A.); an HHMI Early Career Scientist award and NIH grants R35GM118070 and R01GM081346 (J.S.K.); a HHMI-Burroughs Wellcome Fund medical research fellowship (H.M.L.); University of Colorado School of Medicine and Department of Medicine institutional pilot funds (A.R.M. and J.D.B.); a postdoctoral fellowship from Novartis Institutes for BioMedical Research (X.X.); and a University of Texas Medical Branch startup award, a University of Texas STARs award, and NIH grant R01AI087856 (P.-Y.S.). The UC Denver X-ray Facility is supported by UC Cancer Center support grant P30CA046934 and NIH grant S10OD012033. The Advanced Light Source is supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Coordinates and structure factors have been deposited with PDB accession code 5TPY.	Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242; Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984; Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026; Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892; Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897; Durbin AP, 2005, J INFECT DIS, V191, P710, DOI 10.1086/427780; Emara MM, 2008, J VIROL, V82, P10657, DOI 10.1128/JVI.00991-08; Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10; Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599; Leontis N.B., 2001, NUCLEIC ACIDS RES, V7, P499; LEVITT M, 1969, NATURE, V224, P759, DOI 10.1038/224759a0; Lindenbach B. D., 2007, FIELDS VIROLOGY; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194; Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004; Sherlin LD, 2000, J MOL BIOL, V299, P431, DOI 10.1006/jmbi.2000.3749; Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10; Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002; Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604; Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836	30	145	149	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1148	1152		10.1126/science.aah3963	http://dx.doi.org/10.1126/science.aah3963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934765	Green Accepted, Green Submitted			2022-12-28	WOS:000388916400042
J	Dagdeviren, C				Dagdeviren, Canan			TRANSLATIONAL MEDICINE The future of bionic dynamos	SCIENCE			English	Editorial Material							CONTRACTION		[Dagdeviren, Canan] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA; [Dagdeviren, Canan] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Dagdeviren, C (corresponding author), Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA.; Dagdeviren, C (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	canand@mit.edu		Dagdeviren, Canan/0000-0002-2032-792X				ANZOLA J, 1956, AM J PHYSIOL, V184, P567, DOI 10.1152/ajplegacy.1956.184.3.567; Dagdeviren C, 2015, NAT MATER, V14, P728, DOI [10.1038/NMAT4289, 10.1038/nmat4289]; Dagdeviren C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5496; Dagdeviren C, 2014, P NATL ACAD SCI USA, V111, P1927, DOI 10.1073/pnas.1317233111; Dagdeviren C, 2013, SMALL, V9, P3398, DOI 10.1002/smll.201300146; Fritz J, 2005, J COMPUT ASSIST TOMO, V29, P725, DOI 10.1097/01.rct.0000179596.86221.38; Karami MA, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3679102; MCHALE PA, 1973, CIRC RES, V33, P303, DOI 10.1161/01.RES.33.3.303	8	13	13	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316								10.1126/science.aal2190	http://dx.doi.org/10.1126/science.aal2190			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934727				2022-12-28	WOS:000388916400025
J	Dolgin, E				Dolgin, Elie			THERAPIES Progressive steps	NATURE			English	Editorial Material							MULTIPLE-SCLEROSIS; DOUBLE-BLIND; TRIAL											Barkhof F, 2010, NEUROLOGY, V74, P1033, DOI 10.1212/WNL.0b013e3181d7d651; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Kosa P, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00131; Lublin F, 2016, LANCET, V387, P1075, DOI 10.1016/S0140-6736(15)01314-8; Vesterinen HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117705	5	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					S7	S9		10.1038/540S7a	http://dx.doi.org/10.1038/540S7a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27902682				2022-12-28	WOS:000388916600004
J	Safikhani, Z; El-Hachem, N; Smirnov, P; Freeman, M; Goldenberg, A; Birkbak, NJ; Beck, AH; Aerts, HJWL; Quackenbush, J; Haibe-Kains, B				Safikhani, Zhaleh; El-Hachem, Nehme; Smirnov, Petr; Freeman, Mark; Goldenberg, Anna; Birkbak, Nicolai J.; Beck, Andrew H.; Aerts, Hugo J. W. L.; Quackenbush, John; Haibe-Kains, Benjamin			Consistency in large pharmacogenomic studies Reply	NATURE			English	Letter							LINE GENE-EXPRESSION; DRUG-SENSITIVITY		[Safikhani, Zhaleh; Smirnov, Petr; Freeman, Mark; Haibe-Kains, Benjamin] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Safikhani, Zhaleh; Haibe-Kains, Benjamin] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [El-Hachem, Nehme] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Goldenberg, Anna] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Goldenberg, Anna; Haibe-Kains, Benjamin] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; [Birkbak, Nicolai J.] UCL, Francis Crick Inst, London NW1 1AT, England; [Birkbak, Nicolai J.] UCL, Inst Canc, London WC1E 6BT, England; [Beck, Andrew H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Beck, Andrew H.; Aerts, Hugo J. W. L.] Harvard Med Sch, Boston, MA 02115 USA; [Aerts, Hugo J. W. L.; Quackenbush, John] Dana Farber Canc Inst, Boston, MA 02115 USA; [Aerts, Hugo J. W. L.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Quackenbush, John] Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Haibe-Kains, Benjamin] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Francis Crick Institute; University of London; University College London; University of London; University College London; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Haibe-Kains, B (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Haibe-Kains, B (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.; Haibe-Kains, B (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada.; Haibe-Kains, B (corresponding author), Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada.	bhaibeka@uhnresearch.ca	Smirnov, Petr A/N-9652-2015; Aerts, Hugo/ABF-2821-2020; Haibe-Kains, Benjamin/D-3702-2011	Aerts, Hugo/0000-0002-2122-2003; Birkbak, Nicolai/0000-0003-1613-9587; El-Hachem, Nehme/0000-0002-5778-5342; Haibe-Kains, Benjamin/0000-0002-7684-0079				Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cortes-Ciriano I, 2016, BIOINFORMATICS, V32, P85, DOI 10.1093/bioinformatics/btv529; Dong ZL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1492-6; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Geeleher P, 2016, NATURE, V540, pE1, DOI 10.1038/nature19838; Geeleher P, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r47; Goodspeed A, 2016, MOL CANCER RES, V14, P3, DOI 10.1158/1541-7786.MCR-15-0189; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Jang IS, 2014, BIOCOMPUT-PAC SYM, P63; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Papillon-Cavanagh S, 2013, J AM MED INFORM ASSN, V20, P597, DOI 10.1136/amiajnl-2012-001442; Safikhani Z., 2016, F1000RESEARCH; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Stransky N, 2015, NATURE, V528, P84, DOI 10.1038/nature15736	15	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					E2	E4		10.1038/nature19839	http://dx.doi.org/10.1038/nature19839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905430				2022-12-28	WOS:000388916600009
J	Tarlungeanu, DC; Deliu, E; Dotter, CP; Kara, M; Janiesch, PC; Scalise, M; Galluccio, M; Tesulov, M; Morelli, E; Sonmez, FM; Bilguvar, K; Ohgaki, R; Kanai, Y; Johansen, A; Esharif, S; Ben-Omran, T; Topcu, M; Schlessinger, A; Indiveri, C; Duncan, KE; Caglayan, AO; Gunel, M; Gleeson, JG; Novarino, G				Tarlungeanu, Dora C.; Deliu, Elena; Dotter, Christoph P.; Kara, Majdi; Janiesch, Philipp Christoph; Scalise, Mariafrancesca; Galluccio, Michele; Tesulov, Mateja; Morelli, Emanuela; Sonmez, Fatma Mujgan; Bilguvar, Kaya; Ohgaki, Ryuichi; Kanai, Yoshikatsu; Johansen, Anide; Esharif, Seham; Ben-Omran, Tawfeg; Topcu, Meral; Schlessinger, Avner; Indiveri, Cesare; Duncan, Kent E.; Caglayan, Ahmet Okay; Gunel, Murat; Gleeson, Joseph G.; Novarino, Gaia			Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder	CELL			English	Article							TRANSGENIC MICE; SYSTEM-L; EXPRESSION; MECHANISM; DISCOVERY; LAT1; ATF4	Autism spectrum disorders (ASD) are a group of genetic disorders often overlapping with other neurological conditions. We previously described abnormalities in the branched-chain amino acid (BCAA) catabolic pathway as a cause of ASD. Here, we show that the solute carrier transporter 7a5 (SLC7A5), a large neutral amino acid transporter localized at the bloodbrainbarrier (BBB), has an essential role in maintaining normal levels of brain BCAAs. In mice, deletion of Slc7a5 from the endothelial cells of theBBBleads to atypical brain amino acid profile, abnormal mRNA translation, and severe neurological abnormalities. Furthermore, we identified several patients with autistic traits and motor delay carrying deleterious homozygous mutations in the SLC7A5 gene. Finally, we demonstrate that BCAA intracerebroventricular administration ameliorates abnormal behaviors in adult mutant mice. Our data elucidate a neurological syndrome defined by SLC7A5 mutations and support an essential role for the BCAA in human brain function.	[Tarlungeanu, Dora C.; Deliu, Elena; Dotter, Christoph P.; Tesulov, Mateja; Morelli, Emanuela; Novarino, Gaia] IST Austria, A-3400 Klosterneuburg, Austria; [Kara, Majdi; Esharif, Seham] Tripoli Childrens Hosp, Dept Pediat, Tripoli, Libya; [Janiesch, Philipp Christoph; Duncan, Kent E.] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, D-20251 Hamburg, Germany; [Scalise, Mariafrancesca; Galluccio, Michele; Indiveri, Cesare] Univ Calabria, Dept DiBEST, Unit Biochem & Mol Biotechnol, Arcavacata Di Rende, Italy; [Sonmez, Fatma Mujgan] Assoc Dev Child Neurol, Ankara, Turkey; [Bilguvar, Kaya] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bilguvar, Kaya] Yale Sch Med, Yale Ctr Genome Anal, Orange, CT 06477 USA; [Ohgaki, Ryuichi; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Biosyst Pharmacol, Suita, Osaka 5650871, Japan; [Johansen, Anide; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, San Diego, CA 92093 USA; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Sect Clin & Metab Genet, Doha, Qatar; [Topcu, Meral] Hacettepe Univ, Dept Pediat Neurol, Childrens Hosp, Ankara, Turkey; [Schlessinger, Avner] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Caglayan, Ahmet Okay] Istanbul Bilim Univ, Sch Med, Dept Med Genet, Istanbul, Turkey; [Caglayan, Ahmet Okay; Gunel, Murat] Yale Sch Med, Yale Program Neurogenet, Program Brain Tumor Res, Dept Neurosurg, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Gunel, Murat] Yale Sch Med, Yale Program Neurogenet, Program Brain Tumor Res, Dept Genet, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Gunel, Murat] Yale Sch Med, Yale Program Neurogenet, Program Brain Tumor Res, Dept Neurobiol, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Gunel, Murat] Yale Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA	Institute of Science & Technology - Austria; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Calabria; Yale University; Osaka University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Hamad Medical Corporation; Hacettepe University; Icahn School of Medicine at Mount Sinai; Demiroglu Bilim University; Yale University; Yale University; Yale University; Yale University	Novarino, G (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.	gnovarino@ist.ac.at	Galluccio, Michele/AAA-3972-2020; Galluccio, Michele/AAE-1478-2021; Deliu, Elena/O-7379-2019; Caglayan, Ahmet O/D-1066-2012	Galluccio, Michele/0000-0001-6268-9489; Caglayan, Ahmet O/0000-0002-2332-322X; SCALISE, Mariafrancesca/0000-0003-3860-6844; Dotter, Christoph/0000-0002-9033-9096; Ohgaki, Ryuichi/0000-0002-6894-7239; Duncan, Kent/0000-0003-4290-2670; Rybiczka-Tesulov, Mateja/0000-0003-2679-2889; Morelli, Emanuela/0000-0001-8704-9330	Broad Institute Center for Mendelian Disorders [UM1HG008900]; Yale Center for Mendelian Disorders [U54HG006504]; Gregory M. Kiez and Mehmet Kutman Foundation; Italian Ministry of Instruction University and Research [PON01_00937]; NIH [R01-GM108911]; NICHD [P01HD070494]; SFARI [275275]; FWF [SFB35_3523];  [X01HG008823]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009141, UM1HG008900, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108911] Funding Source: NIH RePORTER	Broad Institute Center for Mendelian Disorders; Yale Center for Mendelian Disorders; Gregory M. Kiez and Mehmet Kutman Foundation; Italian Ministry of Instruction University and Research(Ministry of Education, Universities and Research (MIUR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); SFARI; FWF(Austrian Science Fund (FWF)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A.C. Manzano, Mike Liu, and F. Marr for technical assistance, and R. Shigemoto and the IST Austria Electron Microscopy (EM) Facility for assistance. We acknowledge support from CIDR for genome-wide SNP analysis (X01HG008823) and Broad Institute Center for Mendelian Disorders (UM1HG008900 to D. MacArthur), the Yale Center for Mendelian Disorders (U54HG006504 to M.G.), the Gregory M. Kiez and Mehmet Kutman Foundation (M.G.), Italian Ministry of Instruction University and Research (PON01_00937 to C.I.), and NIH (R01-GM108911 to A.S.). This work was supported by NICHD (P01HD070494) and SFARI (grant 275275) to J.G.G., and FWF (SFB35_3523) to G.N.	Angelastro JM, 2003, J NEUROSCI, V23, P4590; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Banko JL, 2008, PROG BRAIN RES, V169, P59, DOI 10.1016/S0079-6123(07)00004-0; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; BRAUN LD, 1980, J NEUROCHEM, V34, P147, DOI 10.1111/j.1471-4159.1980.tb04633.x; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DeVos SL, 2013, JOVE-J VIS EXP, DOI 10.3791/50326; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Galluccio M, 2015, TOXICOL SCI, V144, P105, DOI 10.1093/toxsci/kfu259; Galluccio M, 2013, PROTEIN J, V32, P442, DOI 10.1007/s10930-013-9503-4; Galluccio M, 2012, MOL BIOTECHNOL, V50, P1, DOI 10.1007/s12033-011-9406-6; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Geier EG, 2013, P NATL ACAD SCI USA, V110, P5480, DOI 10.1073/pnas.1218165110; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Green TA, 2008, J NEUROSCI, V28, P2025, DOI 10.1523/JNEUROSCI.5273-07.2008; Guyenet Stephan J, 2010, J Vis Exp, DOI 10.3791/1787; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lam WK, 1996, ARCH DIS CHILD, V74, P343, DOI 10.1136/adc.74.4.343; LEFAUCONNIER JM, 1983, DEV BRAIN RES, V6, P175, DOI 10.1016/0165-3806(83)90095-0; Matsuo H, 2000, NEUROREPORT, V11, P3507, DOI 10.1097/00001756-200011090-00021; MENKES JH, 1954, PEDIATRICS, V14, P462; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Napolitano L, 2015, INT J BIOCHEM CELL B, V67, P25, DOI 10.1016/j.biocel.2015.08.004; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Romano E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064407; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Scalise M, 2014, AMINO ACIDS, V46, P2463, DOI 10.1007/s00726-014-1808-x; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wang Q, 2011, CANCER RES, V71, P7525, DOI 10.1158/0008-5472.CAN-11-1821; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zinnanti WJ, 2009, BRAIN, V132, P903, DOI 10.1093/brain/awp024	49	161	165	3	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1481	+		10.1016/j.cell.2016.11.013	http://dx.doi.org/10.1016/j.cell.2016.11.013			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912058	Green Accepted, Bronze			2022-12-28	WOS:000389470500012
J	Packer, M; McMurray, JJV				Packer, Milton; McMurray, John J. V.			Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure	LANCET			English	Review							CONVERTING-ENZYME-INHIBITORS; ATRIAL-NATRIURETIC-PEPTIDE; NEUTRAL ENDOPEPTIDASE INHIBITION; LEFT-VENTRICULAR DYSFUNCTION; II-RECEPTOR BLOCKERS; ACUTE MYOCARDIAL-INFARCTION; KALLIKREIN-KININ SYSTEM; INCREASED PLASMA-LEVELS; AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE	The magnitude of the clinical benefits produced by inhibitors of the renin-angiotensin system in heart failure has been modest, possibly because of the ability of renin-angiotensin activity to escape from suppression during long-term treatment. Efforts to intensify pharmacological blockade by use of dual inhibitors that interfere with the renin-angiotensin system at multiple sites have not yielded consistent incremental clinical benefits, but have been associated with serious adverse reactions. By contrast, potentiation of endogenous compensatory vasoactive peptides can act to enhance the survival effects of inhibitors of the renin-angiotensin system, as evidenced by trials that have compared angiotensin-converting enzyme inhibitors with drugs that inhibit both the renin-angiotensin system and neprilysin. Several endogenous vasoactive peptides act as adaptive mechanisms, and their augmentation could help to broaden the benefits of renin-angiotensin system inhibitors for patients with heart failure.	[Packer, Milton] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst Dallas, 621 N Hall St, Dallas, TX 75226 USA; [McMurray, John J. V.] Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, Glasgow, Lanark, Scotland	Baylor University; Baylor University Medical Center; University of Glasgow	Packer, M (corresponding author), Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst Dallas, 621 N Hall St, Dallas, TX 75226 USA.	milton.packer@baylorhealth.edu	mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975	Novartis; Cardiorentis; Amgen; Bayer; GlaxoSmithKline; Theracos; Abbvie; Dalcor; Pfizer; Merck	Novartis(Novartis); Cardiorentis; Amgen(Amgen); Bayer(Bayer AG); GlaxoSmithKline(GlaxoSmithKline); Theracos; Abbvie(AbbVie); Dalcor; Pfizer(Pfizer); Merck(Merck & Company)	MP and JJVM have been involved in the development of inhibitors of the renin-angiotensin system for heart failure for the past 30 years. Most recently, they collaborated on the development of angiotensin neprilysin inhibitors; this research was initially supported by Bristol-Myers Squibb 10-15 years ago, and by Novartis over the past 5-10 years. MP received consulting fees, in relation to his involvement as a principal investigator and an executive committee member, with omapatrilat from 1998-2003 and for similar roles with sacubitril-valsartan from 2008-15. JJVM's employer, University of Glasgow, was paid for this time spent in similar roles with both drugs during both time periods; he received no personal payment in relation to these activities, and his salary from the University was not determined by this extramural support. MP no longer has any financial association with either Bristol-Myers Squibb or Novartis in relation to any project, but he has recently consulted for Admittance, Amgen, AstraZeneca, Bayer, BioControl, Boehringer Ingelheim, Celyad, Cardiokinetix, Cardiorentis, Cytokinetics, Daiichi Sankyo, GlaxoSmithKline, Takeda, and ZS Pharma. JJVM's employer, University of Glasgow, also has received support from Novartis, Cardiorentis, Amgen, Bayer, GlaxoSmithKline, Theracos, Abbvie, Dalcor, Pfizer, and Merck for his time spent as an executive committee member and consultant. None of these additional consultancies are in relation to inhibitors of the renin-angiotensin system or neprilysin.	Abdulla J, 2004, EUR J HEART FAIL, V6, P927, DOI 10.1016/j.ejheart.2004.02.002; Amann K, 2000, KIDNEY INT, V58, P153, DOI 10.1046/j.1523-1755.2000.00163.x; [Anonymous], 2005, Prescrire Int, V14, P180; Athyros VG, 2007, EXPERT OPIN PHARMACO, V8, P529, DOI 10.1517/14656566.8.5.529; Autelitano DJ, 2003, REGUL PEPTIDES, V112, P131, DOI 10.1016/S0167-0115(03)00031-4; Baerts L, 2012, VET J, V194, P34, DOI 10.1016/j.tvjl.2012.06.019; Baker WL, 2009, ANN INTERN MED, V151, P861, DOI [10.7326/0000605-200912150-00162, 10.7326/0003-4819-151-12-200912150-00162]; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Bas M, 2015, NEW ENGL J MED, V372, P418, DOI 10.1056/NEJMoa1312524; Bayes-Genis A, 2015, J AM COLL CARDIOL, V65, P657, DOI 10.1016/j.jacc.2014.11.048; BEIERWALTES WH, 1988, AM J PHYSIOL, V255, pF408, DOI 10.1152/ajprenal.1988.255.3.F408; Benter IF, 2007, AM J PHYSIOL-HEART C, V292, pH666, DOI 10.1152/ajpheart.00372.2006; Bloch Michael J, 2010, J Clin Hypertens (Greenwich), V12, P809, DOI 10.1111/j.1751-7176.2010.00358.x; Bloch S, 2015, MICROCIRCULATION, V22, P159, DOI 10.1111/micc.12193; BOUAZIZ H, 1994, BRIT J PHARMACOL, V113, P717, DOI 10.1111/j.1476-5381.1994.tb17052.x; BRANDT RR, 1993, J AM COLL CARDIOL, V22, pA86, DOI 10.1016/0735-1097(93)90468-G; Campbell DJ, 2001, CLIN EXP PHARMACOL P, V28, P1060, DOI 10.1046/j.1440-1681.2001.03564.x; CAMPBELL DJ, 1995, J CARDIOVASC PHARM, V26, P233, DOI 10.1097/00005344-199508000-00009; Cataliotti A, 2011, CIRCULATION, V123, P1297, DOI 10.1161/CIRCULATIONAHA.110.981720; Chappell MC, 2001, NEPHROL DIAL TRANSPL, V16, P22, DOI 10.1093/ndt/16.suppl_1.22; Charles CJ, 2003, REGUL PEPTIDES, V112, P41, DOI 10.1016/S0167-0115(03)00021-1; Charloux A, 2003, EUR J CLIN INVEST, V33, P769, DOI 10.1046/j.1365-2362.2003.01222.x; Chen HH, 2002, CIRCULATION, V105, P999, DOI 10.1161/hc0802.104282; Cheng CP, 1998, J AM COLL CARDIOL, V31, P1679, DOI 10.1016/S0735-1097(98)00159-4; Cheng J, 2014, JAMA INTERN MED, V174, P773, DOI 10.1001/jamainternmed.2014.348; COCKCROFT JR, 1993, J CARDIOVASC PHARM, V22, P579, DOI 10.1097/00005344-199310000-00011; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Cruden NLM, 2004, HYPERTENSION, V44, P913, DOI 10.1161/01.HYP.0000146483.78994.56; Davie AP, 1999, HYPERTENSION, V34, P457, DOI 10.1161/01.HYP.34.3.457; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; Dong YF, 2011, FASEB J, V25, P2911, DOI 10.1096/fj.11-182873; DZAU VJ, 1984, NEW ENGL J MED, V310, P347, DOI 10.1056/NEJM198402093100603; Edelbauer H, 2005, J NEUROCHEM, V93, P1110, DOI 10.1111/j.1471-4159.2005.03084.x; Edvinsson ML, 2014, J GERIATR CARDIOL, V11, P50, DOI 10.3969/j.issn.1671-5411.2014.01.004; EISKJAER H, 1991, INT J CARDIOL, V33, P61, DOI 10.1016/0167-5273(91)90153-G; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Erdos EG, 2002, J MOL CELL CARDIOL, V34, P1569, DOI 10.1006/jmcc.2002.2080; Erhardt LR, 2005, INT J CLIN PRACT, V59, P571, DOI 10.1111/j.1368-5031.2005.00513.x; Farina NK, 2000, J HYPERTENS, V18, P749, DOI 10.1097/00004872-200018060-00013; Feldman AM, 2016, JAMA-J AM MED ASSOC, V315, P25, DOI 10.1001/jama.2015.17632; Ferrario CM, 2002, AM J HYPERTENS, V15, P557, DOI 10.1016/S0895-7061(02)02268-9; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Florkowski CM, 1997, CLIN SCI, V92, P255, DOI 10.1042/cs0920255; Fournier A, 2009, EXPERT REV NEUROTHER, V9, P1413, DOI 10.1586/ERN.09.89; Fryer RM, 2008, BRIT J PHARMACOL, V153, P947, DOI 10.1038/sj.bjp.0707641; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Gheorghiade M, 2013, JAMA-J AM MED ASSOC, V309, P1125, DOI 10.1001/jama.2013.1954; Goulter AB, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-19; Gradman AH, 2009, AM HEART J, V157, pS17, DOI 10.1016/j.ahj.2009.04.007; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Grilo A, 2011, PHARMACOGENET GENOM, V21, P10, DOI 10.1097/FPC.0b013e328341041c; Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932; Guan H, 2009, J NEUROSCI RES, V87, P1462, DOI 10.1002/jnr.21944; GUNDERSEN T, 1994, EUR HEART J, V15, P1659; HARTMAN JC, 1993, J CARDIOVASC PHARM, V21, P996, DOI 10.1097/00005344-199306000-00022; Hegde LG, 2011, J CARDIOVASC PHARM, V57, P495, DOI 10.1097/FJC.0b013e318210fc7e; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Heran BS, 2012, COCHRANE DB SYST REV, V4; Heran BS, 2012, SYST REV, V4; HIROOKA Y, 1990, CIRCULATION, V82, P147, DOI 10.1161/01.CIR.82.1.147; HOFFMAN A, 1991, AM J HYPERTENS, V4, P597, DOI 10.1093/ajh/4.7.597; Jorde UP, 2000, CIRCULATION, V101, P844, DOI 10.1161/01.CIR.101.8.844; Kario K, 2014, HYPERTENSION, V63, P698, DOI 10.1161/HYPERTENSIONAHA.113.02002; Kasama S, 2007, J AM COLL CARDIOL, V49, P667, DOI 10.1016/j.jacc.2006.09.048; KASTNER PR, 1982, AM J PHYSIOL, V243, pF260, DOI 10.1152/ajprenal.1982.243.3.F260; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Keidar S, 2007, CARDIOVASC RES, V73, P463, DOI 10.1016/j.cardiores.2006.09.006; Kemp BA, 2014, CIRC RES, V115, P388, DOI 10.1161/CIRCRESAHA.115.304110; Knecht M, 2002, LIFE SCI, V71, P2701, DOI 10.1016/S0024-3205(02)01990-2; Kokkonen JO, 2000, TRENDS CARDIOVAS MED, V10, P42, DOI 10.1016/S1050-1738(00)00034-7; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; Krum H, 2011, CARDIOVASC THER, V29, P89, DOI 10.1111/j.1755-5922.2010.00185.x; KUBO SH, 1987, AM J CARDIOL, V60, P1322, DOI 10.1016/0002-9149(87)90615-1; Kurisu S, 2003, HYPERTENSION, V41, P99, DOI 10.1161/01.HYP.0000050101.90932.14; Lakhdar R, 2008, J CARD FAIL, V14, P181, DOI 10.1016/j.cardfail.2007.11.008; Langenickel TH, 2016, BRIT J CLIN PHARMACO, V81, P878, DOI 10.1111/bcp.12861; Lee EYW, 1996, AM J PHYSIOL-RENAL, V271, pF3, DOI 10.1152/ajprenal.1996.271.1.F3; LEE ME, 1985, AM J PHYSIOL, V248, pR641, DOI 10.1152/ajpregu.1985.248.5.R641; Leong PKK, 2002, AM J PHYSIOL-REG I, V283, pR837, DOI 10.1152/ajpregu.00089.2002; Li YW, 2009, HYPERTENS RES, V32, P369, DOI 10.1038/hr.2009.25; Maggioni AP, 2002, J AM COLL CARDIOL, V40, P1414, DOI 10.1016/S0735-1097(02)02304-5; Makani H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f360; Maric C, 2006, NEPHRON PHYSIOL, V103, P149, DOI 10.1159/000092457; Marr RA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00187; Martin FL, 2005, KIDNEY INT, V67, P1723, DOI 10.1111/j.1523-1755.2005.00269.x; MCDONALD KM, 1995, CIRCULATION, V91, P2043, DOI 10.1161/01.CIR.91.7.2043; McKinney CA, 2014, CLIN SCI, V126, P815, DOI 10.1042/CS20130436; McMurray J, 2015, EUR HEART J, V36, P434, DOI 10.1093/eurheartj/ehu455; McMurray JJV, 2016, NEW ENGL J MED, V374, P1521, DOI 10.1056/NEJMoa1514859; McMurray JJV, 2014, NEW ENGL J MED, V371, P2336, DOI 10.1056/NEJMc1412654; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Minami K, 2001, JPN J PHARMACOL, V86, P159, DOI 10.1254/jjp.86.159; Miners JS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00238; Miners JS, 2011, BRAIN PATHOL, V21, P594, DOI 10.1111/j.1750-3639.2011.00486.x; Moller JE, 2004, AM HEART J, V147, P494, DOI 10.1016/j.ahj.2003.10.031; Mori J, 2014, AM J PHYSIOL-RENAL, V306, pF812, DOI 10.1152/ajprenal.00655.2013; Moro ML, 2012, ACTA NEUROPATHOL, V124, P809, DOI 10.1007/s00401-012-1061-x; Nakamura R, 2004, CIRCULATION, V110, P426, DOI 10.1161/01.CIR.0000136085.34185.83; Nanas JN, 2000, J AM COLL CARDIOL, V36, P2090, DOI 10.1016/S0735-1097(00)01025-1; Newaz M, 2010, RENAL FAILURE, V32, P384, DOI 10.3109/08860221003611745; Nicholls MG, 2001, PEPTIDES, V22, P1745, DOI 10.1016/S0196-9781(01)00508-3; NISHIKIMI T, 1995, J AM COLL CARDIOL, V26, P1424, DOI 10.1016/0735-1097(95)00338-X; O'Meara E, 2004, EUR HEART J, V25, P1920, DOI 10.1016/j.ehj.2004.07.025; Ong Hean Teik, 2013, ISRN Cardiol, V2013, P478597, DOI 10.1155/2013/478597; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; PACKER M, 1992, LANCET, V340, P88, DOI 10.1016/0140-6736(92)90405-R; PACKER M, 1988, CIRCULATION, V77, P64; PACKER M, 1987, AM J CARDIOL, V60, P179, DOI 10.1016/0002-9149(87)91009-5; PACKER M, 1986, CIRCULATION, V74, P766, DOI 10.1161/01.CIR.74.4.766; Packer M, 2016, EUR J HEART FAIL, V18, P1211, DOI 10.1002/ejhf.623; Packer M, 2015, CIRCULATION, V131, P54, DOI 10.1161/CIRCULATIONAHA.114.013748; Papinska A.M., 2015, BR J PHARM; Park MH, 2013, BRAIN RES, V1529, P113, DOI 10.1016/j.brainres.2013.05.045; Patel BM, 2012, EUR J PHARMACOL, V697, P1, DOI 10.1016/j.ejphar.2012.09.034; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Phillips CO, 2007, ARCH INTERN MED, V167, P1930, DOI 10.1001/archinte.167.18.1930; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Pons S, 2008, EUR J HEART FAIL, V10, P343, DOI 10.1016/j.ejheart.2008.02.002; Poole-Wilson P, 1998, EUR HEART J, V19, P481; Rademaker MT, 2008, CIRC-HEART FAIL, V1, P134, DOI 10.1161/CIRCHEARTFAILURE.107.755504; Rademaker MT, 1998, J CARDIOVASC PHARM, V31, P116, DOI 10.1097/00005344-199801000-00017; Rademaker MT, 1996, CLIN SCI, V91, P283, DOI 10.1042/cs0910283; Rhaleb NE, 2011, COMPR PHYSIOL, V1, P971, DOI 10.1002/cphy.c100053; RICHARDS AM, 1993, J HYPERTENS, V11, P407, DOI 10.1097/00004872-199304000-00011; RICHARDS AM, 1992, CIRC RES, V71, P1501, DOI 10.1161/01.RES.71.6.1501; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Rosenkranz AC, 1999, CLIN EXP PHARMACOL P, V26, P519; Rouleau JL, 2000, LANCET, V356, P615, DOI 10.1016/S0140-6736(00)02602-7; RUBINSTEIN I, 1994, BASIC RES CARDIOL, V89, P487, DOI 10.1007/BF00788284; Savarese G, 2013, J AM COLL CARDIOL, V61, P131, DOI 10.1016/j.jacc.2012.10.011; SCHEUER DA, 1989, AM J PHYSIOL, V257, pR194, DOI 10.1152/ajpregu.1989.257.1.R194; SCHMITT F, 1994, AM J PHYSIOL, V267, pF20, DOI 10.1152/ajprenal.1994.267.1.F20; Shefer G, 2016, HYPERTENSION, V68, P378, DOI 10.1161/HYPERTENSIONAHA.116.07088; STEVENS TL, 1995, J CLIN INVEST, V95, P1101, DOI 10.1172/JCI117757; Struthers A D, 1996, J Card Fail, V2, P47, DOI 10.1016/S1071-9164(96)80009-1; Sukumaran V, 2012, MOL CELL ENDOCRINOL, V351, P208, DOI 10.1016/j.mce.2011.12.010; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Taal MW, 2001, J AM SOC NEPHROL, V12, P2051, DOI 10.1681/ASN.V12102051; Takahama K, 1996, J PHARM PHARMACOL, V48, P1027, DOI 10.1111/j.2042-7158.1996.tb05895.x; Tanaka Y, 2004, HYPERTENS RES, V27, P865, DOI 10.1291/hypres.27.865; Thai H, 2003, J PHARMACOL EXP THER, V307, P1171, DOI 10.1124/jpet.103.054916; Trippodo NC, 1999, J CARDIOVASC PHARM, V34, P782, DOI 10.1097/00005344-199912000-00003; TRIPPODO NC, 1991, J CARDIOVASC PHARM, V18, P308, DOI 10.1097/00005344-199109000-00002; TRIPPODO NC, 1995, J PHARMACOL EXP THER, V275, P745; Troughton RW, 2000, HYPERTENSION, V36, P523, DOI 10.1161/01.HYP.36.4.523; van de Wal RMA, 2006, INT J CARDIOL, V106, P367, DOI 10.1016/j.ijcard.2005.02.016; Velez JCQ, 2009, HYPERTENSION, V53, P790, DOI 10.1161/HYPERTENSIONAHA.109.128819; Vodovar N, 2015, JACC-HEART FAIL, V3, P629, DOI 10.1016/j.jchf.2015.03.011; Vodovar N, 2015, EUR HEART J, V36, P902, DOI 10.1093/eurheartj/ehv015; WADA A, 1994, CIRCULATION, V89, P2232, DOI 10.1161/01.CIR.89.5.2232; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Wang T, 2005, HYPERTENS RES, V28, P611, DOI 10.1291/hypres.28.611; Wang XF, 2007, CLIN EXP PHARMACOL P, V34, P861, DOI 10.1111/j.1440-1681.2007.04678.x; Wegner M, 1996, CARDIOVASC RES, V31, P891; Wharton W, 2012, J ALZHEIMERS DIS, V32, P147, DOI 10.3233/JAD-2012-120763; Wilkinson IB, 2001, BRIT J CLIN PHARMACO, V52, P159, DOI 10.1046/j.0306-5251.2001.1420.x; Witherow FN, 2001, CIRCULATION, V104, P2177, DOI 10.1161/hc4301.098252; Xu CY, 2013, NEPHROLOGY, V18, P761, DOI 10.1111/nep.12146; Xu JA, 2010, AM J PHYSIOL-HEART C, V299, pH1328, DOI 10.1152/ajpheart.00538.2010; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Ye R, 2015, INT J CLIN PRACT, V69, P674, DOI 10.1111/ijcp.12626; Yoshida H, 2001, BRIT J PHARMACOL, V134, P150, DOI 10.1038/sj.bjp.0704219; Yousif MHM, 2012, PHARMACOL RES, V66, P269, DOI 10.1016/j.phrs.2012.05.001; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369; Zhu YC, 1997, AM J CARDIOL, V80, pA110, DOI 10.1016/S0002-9149(97)00465-7; Zou K, 2007, J NEUROSCI, V27, P8628, DOI 10.1523/JNEUROSCI.1549-07.2007	172	38	39	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1831	1840		10.1016/S0140-6736(16)30969-2	http://dx.doi.org/10.1016/S0140-6736(16)30969-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET8KW	27919443				2022-12-28	WOS:000400549300032
J	Thorpe, JM; Thorpe, CT; Gellad, WF; Good, CB; Hanlon, JT; Mor, MK; Pleis, JR; Schleiden, LJ; Van Houtven, CH				Thorpe, Joshua M.; Thorpe, Carolyn T.; Gellad, Walid F.; Good, Chester B.; Hanlon, Joseph T.; Mor, Maria K.; Pleis, John R.; Schleiden, Loren J.; Van Houtven, Courtney Harold			Dual Health Care System Use and High-Risk Prescribing in Patients With Dementia	ANNALS OF INTERNAL MEDICINE			English	Article							OF-VETERANS-AFFAIRS; INAPPROPRIATE MEDICATION USE; ANTIPSYCHOTIC-DRUG TREATMENT; OLDER-ADULTS; ANTICHOLINERGIC BURDEN; ALZHEIMER-DISEASE; CONTROLLED-TRIAL; VA; ASSOCIATION; INFORMATION	Background: Recent federal policy changes attempt to expand veterans' access to providers outside the Department of Veterans Affairs (VA). Receipt of prescription medications across unconnected systems of care may increase the risk for unsafe prescribing, particularly in persons with dementia. Objective: To investigate the association between dual health care system use and potentially unsafe medication (PUM) prescribing. Design: Retrospective cohort study. Setting: National VA outpatient care facilities in 2010. Participants: 75 829 veterans with dementia who were continuously enrolled in Medicare from 2007 to 2010; 80% were VA-only users, and 20% were VA-Medicare Part D (dual) users. Measurements: Augmented inverse propensity weighting was used to estimate the effect of dual-system versus VA-only prescribing on 4 indicators of PUM prescribing in 2010: any exposure to Healthcare Effectiveness Data and Information Set (HEDIS) high-risk medication in older adults (PUM-HEDIS), any daily exposure to prescriptions with a cumulative Anticholinergic Cognitive Burden (ACB) score of 3 or higher (PUM-ACB), any antipsychotic prescription (PUM-antipsychotic), and any PUM exposure (any-PUM). The annual number of days of each PUM exposure was also examined. Results: Compared with VA-only users, dual users had more than double the odds of exposure to any-PUM (odds ratio [OR], 2.2 [95% CI, 2.2 to 2.3]), PUM-HEDIS (OR, 2.4 [CI, 2.2 to 2.8]), and PUM-ACB (OR, 2.1 [CI, 2.0 to 2.2]). The odds of PUM-antipsychotic exposure were also greater in dual users (OR, 1.5 [CI, 1.4 to 1.6]). Dual users had an adjusted average of 44.1 additional days of any-PUM exposure (CI, 37.2 to 45.0 days). Limitation: Observational study design of veteran outpatients only. Conclusion: Among veterans with dementia, rates of PUM prescribing are significantly higher among dual-system users than with VA-only users.	Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; [Thorpe, Joshua M.; Thorpe, Carolyn T.; Gellad, Walid F.; Good, Chester B.; Hanlon, Joseph T.; Pleis, John R.; Schleiden, Loren J.] Vet Affairs Pittsburgh Healthcare Syst, Univ Dr 151C, Pittsburgh, PA 15240 USA; [Van Houtven, Courtney Harold] US Dept Vet Affairs, Durham Vet Affairs Med Ctr, 508 Fulton St, Durham, NC 27705 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Thorpe, JM (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Univ Dr 151C, Pittsburgh, PA 15240 USA.	Joshua.Thorpe@va.gov	Good, Chester B/K-2818-2019	Good, Chester B/0000-0003-4388-4558; Pleis, John/0000-0002-0928-9192; Van Houtven, Courtney/0000-0002-0783-1611	U.S. Department of Veterans Affairs, Health Services Research & Development Merit Award [IIR 12-379]; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs, Health Services Research & Development Merit Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the U.S. Department of Veterans Affairs, Health Services Research & Development Merit Award (IIR 12-379; all authors).	Adams K, 2003, PRIOR AR NAT ACT TRA; Ajmera M, 2011, J GEN INTERN MED, V26, pS669, DOI 10.1007/s11606-011-1788-4; Atkins DC, 2013, HSR D FORUM TRANSLAT; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Blalock Susan J, 2005, Am J Geriatr Pharmacother, V3, P168, DOI 10.1016/S1543-5946(05)80023-6; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Byrne CM, 2014, INT J MED INFORM, V83, P537, DOI 10.1016/j.ijmedinf.2014.04.005; Byrne MM, 2006, MED CARE, V44, P768, DOI 10.1097/01.mlr.0000218786.44722.14; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Carey K, 2008, HEALTH SERV RES, V43, P1164, DOI 10.1111/j.1475-6773.2008.00840.x; Centers for Medicare and Medicaid Services, 2013, CHRON COND DAT WAR; Cooley SG, 2010, GENERATIONS, V34, P57; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Gellad WF, 2016, J GEN INTERN MED, V31, P153, DOI 10.1007/s11606-015-3492-2; Gellad WF, 2015, JAMA INTERN MED, V175, P26, DOI 10.1001/jamainternmed.2014.5405; Gellad WF, 2012, MED CARE, V50, P954, DOI 10.1097/MLR.0b013e31825fb21d; Gill SS, 2005, ARCH INTERN MED, V165, P808, DOI 10.1001/archinte.165.7.808; Good CB, 2007, AM J PUBLIC HEALTH, V97, P2129, DOI 10.2105/AJPH.2007.124008; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; Holmes HM, 2013, PHARMACOEPIDEM DR S, V22, P728, DOI 10.1002/pds.3431; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Little R.J.A., 2002, STAT ANAL MISSING DA; Lu CJ, 2003, AM J GERIAT PSYCHIAT, V11, P458, DOI 10.1176/appi.ajgp.11.4.458; Naples JG, 2015, J AM GERIATR SOC, V63, P2120, DOI 10.1111/jgs.13647; National Committee for Quality Assurance, 2010, HEDIS QUAL MEAS HEDI; Sarter M, 2014, EXP NEUROL, V257, P120, DOI 10.1016/j.expneurol.2014.04.032; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Tan L, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0102-9; Tarlov E, 2012, CANCER EPIDEM BIOMAR, V21, P2231, DOI 10.1158/1055-9965.EPI-12-0548; Taylor DH, 2002, J CLIN EPIDEMIOL, V55, P929, DOI 10.1016/S0895-4356(02)00452-3; Thorpe JM, 2012, AM J GERIATR PHARMAC, V10, P230, DOI 10.1016/j.amjopharm.2012.05.001; U. S. Department of Agriculture Economic Research Service, 2003, MEAS RUR URB INFL CO; U.S. Department of Health and Human Services, 2012, HLTH PEOPL 2020; Weeks WB, 2005, J RURAL HEALTH, V21, P167, DOI 10.1111/j.1748-0361.2005.tb00077.x; West T, 2013, J AM PHARM ASSOC, V53, P496, DOI 10.1331/JAPhA.2013.12138; Wolinsky FD, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-70; Wolinsky FD, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-131; World Health Organization, 2012, DEM PUBL HLTH POL	44	35	35	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					157	+		10.7326/M16-0551	http://dx.doi.org/10.7326/M16-0551			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL7DL	27919104	Green Accepted			2022-12-28	WOS:000394781200004
J	Grant, JT; Carrero, CA; Goeltl, F; Venegas, J; Mueller, P; Burt, SP; Specht, SE; McDermott, WP; Chieregato, A; Hermans, I				Grant, J. T.; Carrero, C. A.; Goeltl, F.; Venegas, J.; Mueller, P.; Burt, S. P.; Specht, S. E.; McDermott, W. P.; Chieregato, A.; Hermans, I.			Selective oxidative dehydrogenation of propane to propene using boron nitride catalysts	SCIENCE			English	Article							VANADIUM-OXIDE CATALYSTS; RAMAN-SPECTROSCOPY; GRAPHENE OXIDE; LIGHT ALKANES; NANOTUBES; NANOSHEETS; KINETICS; OLEFINS; METALS; SITES	The exothermic oxidative dehydrogenation of propane reaction to generate propene has the potential to be a game-changing technology in the chemical industry. However, even after decades of research, selectivity to propene remains too low to be commercially attractive because of overoxidation of propene to thermodynamically favored CO2. Here, we report that hexagonal boron nitride and boron nitride nanotubes exhibit unique and hitherto unanticipated catalytic properties, resulting in great selectivity to olefins. As an example, at 14% propane conversion, we obtain selectivity of 79% propene and 12% ethene, another desired alkene. Based on catalytic experiments, spectroscopic insights, and ab initio modeling, we put forward a mechanistic hypothesis in which oxygen-terminated armchair boron nitride edges are proposed to be the catalytic active sites.	[Grant, J. T.; Carrero, C. A.; Goeltl, F.; Mueller, P.; Specht, S. E.; McDermott, W. P.; Chieregato, A.; Hermans, I.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Venegas, J.; Burt, S. P.; Hermans, I.] Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hermans, I (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.; Hermans, I (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.	hermans@chem.wisc.edu	Carrero, Carlos A./N-6008-2019	Carrero, Carlos A./0000-0001-9909-7647; McDermott, William/0000-0002-5638-140X; Venegas, Juan/0000-0002-3603-4312	Wisconsin Alumni Research Foundation (WARF)	Wisconsin Alumni Research Foundation (WARF)	We thank the Wisconsin Alumni Research Foundation (WARF) for funding through the WARF Accelerator Program. We thank S. Stahl and J. Dumesic for their helpful feedback when reviewing this manuscript. J.T.G., C.A.C, J.V., A.C., and I.H. are inventors on patent application U.S. 15/260,649, submitted by the WARF, that covers BN as catalysts for ODHP and other related reactions. All data are reported in the main paper and supplementary materials.	Carrero CA, 2014, ACS CATAL, V4, P3357, DOI 10.1021/cs5003417; Carrero C, 2014, CATAL SCI TECHNOL, V4, P786, DOI 10.1039/c3cy00625e; Cavani F, 2007, CATAL TODAY, V127, P113, DOI 10.1016/j.cattod.2007.05.009; Cavani F, 2009, CHEMSUSCHEM, V2, P508, DOI 10.1002/cssc.200900020; Chen KD, 2000, J PHYS CHEM B, V104, P1292, DOI 10.1021/jp9933875; Chen KD, 1999, J CATAL, V186, P325, DOI 10.1006/jcat.1999.2510; Chen Y, 2004, APPL PHYS LETT, V84, P2430, DOI 10.1063/1.1667278; CHOPRA NG, 1995, SCIENCE, V269, P966, DOI 10.1126/science.269.5226.966; Christodoulakis A, 2004, J CATAL, V222, P293, DOI 10.1016/j.jcat.2003.10.007; Degnan T., 2016, FOCUS CATAL, V2016; Dreyer DR, 2010, ANGEW CHEM INT EDIT, V49, P6813, DOI 10.1002/anie.201002160; Frank B, 2007, APPL CATAL A-GEN, V323, P66, DOI 10.1016/j.apcata.2007.02.006; Frank B, 2009, ANGEW CHEM INT EDIT, V48, P6913, DOI 10.1002/anie.200901826; Grabow LC, 2011, ACS CATAL, V1, P365, DOI 10.1021/cs200055d; Grant JT, 2015, ACS CATAL, V5, P5787, DOI 10.1021/acscatal.5b01679; Kibsgaard J, 2012, NAT MATER, V11, P963, DOI [10.1038/NMAT3439, 10.1038/nmat3439]; Kondratenko EV, 2005, J CATAL, V234, P131, DOI 10.1016/j.jcat.2005.05.025; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Leveles L, 2002, APPL CATAL A-GEN, V227, P287, DOI 10.1016/S0926-860X(01)00944-9; Lin Y, 2012, NANOSCALE, V4, P6908, DOI 10.1039/c2nr32201c; Liu Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3541; Lopez-Bezanilla A, 2012, J PHYS CHEM C, V116, P15675, DOI 10.1021/jp3036583; Mestl G, 2001, ANGEW CHEM INT EDIT, V40, P2066, DOI 10.1002/1521-3773(20010601)40:11<2066::AID-ANIE2066>3.0.CO;2-I; Nautiyal P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29498; Pakdel A, 2014, CHEM SOC REV, V43, P934, DOI 10.1039/c3cs60260e; Ren T, 2006, ENERGY, V31, P425, DOI 10.1016/j.energy.2005.04.001; Rightor EG, 2015, CATAL TODAY, V258, P226, DOI 10.1016/j.cattod.2015.02.023; Rozanska X, 2007, J PHYS CHEM C, V111, P6041, DOI 10.1021/jp071409e; Sainsbury T, 2012, J AM CHEM SOC, V134, P18758, DOI 10.1021/ja3080665; Sattler JJHB, 2014, CHEM REV, V114, P10613, DOI 10.1021/cr5002436; Sun XY, 2015, CHEM COMMUN, V51, P9145, DOI 10.1039/c5cc00588d; Trionfetti C, 2006, APPL CATAL A-GEN, V310, P105, DOI 10.1016/j.apcata.2006.05.029; Turra N, 2013, CHEMPHYSCHEM, V14, P1666, DOI 10.1002/cphc.201300130; Wu ZL, 2005, J PHYS CHEM B, V109, P2793, DOI 10.1021/jp046011m; Zhang J, 2008, SCIENCE, V322, P73, DOI 10.1126/science.1161916	36	385	400	60	982	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1570	1573		10.1126/science.aaf7885	http://dx.doi.org/10.1126/science.aaf7885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	27934702				2022-12-28	WOS:000390254300048
J	Ng, SWK; Mitchell, A; Kennedy, JA; Chen, WC; McLeod, J; Ibrahimova, N; Arruda, A; Popescu, A; Gupta, V; Schimmer, AD; Schuh, AC; Yee, KW; Bullinger, L; Herold, T; Gorlich, D; Buchner, T; Hiddemann, W; Berdel, WE; Wormann, B; Cheok, M; Preudhomme, C; Dombret, H; Metzeler, K; Buske, C; Lowenberg, B; Valk, PJM; Zandstra, PW; Minden, MD; Dick, JE; Wang, JCY				Ng, Stanley W. K.; Mitchell, Amanda; Kennedy, James A.; Chen, Weihsu C.; McLeod, Jessica; Ibrahimova, Narmin; Arruda, Andrea; Popescu, Andreea; Gupta, Vikas; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen W.; Bullinger, Lars; Herold, Tobias; Goerlich, Dennis; Buechner, Thomas; Hiddemann, Wolfgang; Berdel, Wolfgang E.; Woermann, Bernhard; Cheok, Meyling; Preudhomme, Claude; Dombret, Herve; Metzeler, Klaus; Buske, Christian; Lowenberg, Bob; Valk, Peter J. M.; Zandstra, Peter W.; Minden, Mark D. .; Dick, John E.; Wang, Jean C. Y.			A 17-gene stemness score for rapid determination of risk in acute leukaemia	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; PROPORTIONAL HAZARDS MODEL; GENE-EXPRESSION SIGNATURE; GEMTUZUMAB OZOGAMICIN; REGULARIZATION PATHS; ADULT PATIENTS; AML; RECOMMENDATIONS; RESISTANCE; SURVIVAL	Refractoriness to induction chemotherapy and relapse after achievement of remission are the main obstacles to cure in acute myeloid leukaemia (AML)(1). After standard induction chemotherapy, patients are assigned to different post-remission strategies on the basis of cytogenetic and molecular abnormalities that broadly define adverse, intermediate and favourable risk categories(2,3). However, some patients do not respond to induction therapy and another subset will eventually relapse despite the lack of adverse risk factors(4). There is an urgent need for better biomarkers to identify these high-risk patients before starting induction chemotherapy, to enable testing of alternative induction strategies in clinical trials(5). The high rate of relapse in AML has been attributed to the persistence of leukaemia stem cells (LSCs), which possess a number of stem cell properties, including quiescence, that are linked to therapy resistance(6-10). Here, to develop predictive and/or prognostic biomarkers related to stemness, we generated a list of genes that are differentially expressed between 138 LSC+ and 89 LSC- cell fractions from 78 AML patients validated by xenotransplantation. To extract the core transcriptional components of stemness relevant to clinical outcomes, we performed sparse regression analysis of LSC gene expression against survival in a large training cohort, generating a 17-gene LSC score (LSC17). The LSC17 score was highly prognostic in five independent cohorts comprising patients of diverse AML subtypes (n = 908) and contributed greatly to accurate prediction of initial therapy resistance. Patients with high LSC17 scores had poor outcomes with current treatments including allogeneic stem cell transplantation. The LSC17 score provides clinicians with a rapid and powerful tool to identify AML patients who do not benefit from standard therapy and who should be enrolled in trials evaluating novel upfront or post-remission strategies.	[Ng, Stanley W. K.; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5G 1A1, Canada; [Mitchell, Amanda; Kennedy, James A.; Chen, Weihsu C.; McLeod, Jessica; Ibrahimova, Narmin; Arruda, Andrea; Popescu, Andreea; Gupta, Vikas; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen W.; Minden, Mark D. .; Dick, John E.; Wang, Jean C. Y.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Kennedy, James A.; Gupta, Vikas; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen W.; Minden, Mark D. .; Wang, Jean C. Y.] Univ Hlth Network, Div Med Oncol & Hematol, Dept Med, Toronto, ON M5G 2M9, Canada; [Kennedy, James A.; Gupta, Vikas; Schimmer, Aaron D.; Schuh, Andre C.; Yee, Karen W.; Minden, Mark D. .; Wang, Jean C. Y.] Univ Toronto, Dept Med, Toronto, ON M5G 1A1, Canada; [Schimmer, Aaron D.; Minden, Mark D. .] Univ Toronto, Dept Med Biophys, Toronto, ON M5G IA1, Canada; [Bullinger, Lars] Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Herold, Tobias; Hiddemann, Wolfgang; Metzeler, Klaus] Univ Munich, Dept Internal Med 3, D-81377 Munich, Germany; [Herold, Tobias; Hiddemann, Wolfgang; Metzeler, Klaus] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Goerlich, Dennis] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Buechner, Thomas; Berdel, Wolfgang E.] Univ Munster, Dept Med Hematol & Oncol, D-48149 Munster, Germany; [Woermann, Bernhard] Charite, Dept Hematol Oncol & Tumor Immunol, Campus Virchow, D-10117 Berlin, Germany; [Cheok, Meyling] Jean Pierre AUBERT Res Ctr, Inst Canc Res Lille, UMR S 1172, F-59045 Lille, France; [Preudhomme, Claude] Univ Hosp Lille, Ctr Pathol, Hematol Lab, F-59037 Lille, France; [Dombret, Herve] Univ Paris Diderot, Dept Hematol, St Louis Hosp, F-75010 Paris, France; [Buske, Christian] Univ Hosp Ulm, Inst Expt Canc Res, Comprehens Canc Ctr Ulm, D-89081 Ulm, Germany; [Lowenberg, Bob; Valk, Peter J. M.] Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 CE Rotterdam, Netherlands; [Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1A1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Ulm University; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munster; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Ulm University; Erasmus University Rotterdam; Erasmus MC; University of Toronto	Wang, JCY (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Wang, JCY (corresponding author), Univ Hlth Network, Div Med Oncol & Hematol, Dept Med, Toronto, ON M5G 2M9, Canada.; Wang, JCY (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5G 1A1, Canada.	jwang@uhnresearch.ca	Metzeler, Klaus H./C-2118-2009; Preudhomme, Claude/T-8553-2018; Herold, Tobias/AAD-1072-2019; Cheok, Meyling h/C-3822-2014; Valk, Peter/AAX-2823-2020; Görlich, Dennis/C-8950-2012; Bullinger, Lars/AAL-7965-2020; Cheok, Meyling/AFS-4025-2022	Metzeler, Klaus H./0000-0003-3920-7490; Preudhomme, Claude/0000-0002-1267-9546; Herold, Tobias/0000-0002-9615-9432; Cheok, Meyling h/0000-0002-7820-8026; Görlich, Dennis/0000-0002-2574-9419; Cheok, Meyling/0000-0002-7820-8026; Schimmer, Aaron/0000-0003-4023-3899; Wang, Jean/0000-0001-7543-3917; Dick, John/0000-0002-9527-8317; Bullinger, Lars/0000-0002-5890-5510	Ontario Institute for Cancer Research; province of Ontario; Cancer Stem Cell Consortium; Government of Canada through Genome Canada; Ontario Genomics Institute [OGI-047]; Canadian Institutes of Health Research [CSC-105367]; Canadian Cancer Society; Terry Fox Foundation; Canada Research Chair; Philip S. Orsino Chair in Leukemia Research; Collaborative Translational Cancer Research Grant from the Princess Margaret Cancer Centre (formerly Ontario Cancer Institute); Leukemia & Lymphoma Society of Canada [493946]; Stem Cell Network [492019]; Ontario Graduate Scholarships; Ontario Ministry of Health and Long Term Care (OMOHLTC); Deutsche Forschungsgemeinschaft (Heisenberg-Professur) [BU 1339/8-1]; Wilhelm-Sander-Stiftung [2013.086.1]; Deutsche Forschungsgemeinschaft [DFG SFB 1243]; European Hematology Association [TRTH1, RG11] Funding Source: researchfish	Ontario Institute for Cancer Research; province of Ontario; Cancer Stem Cell Consortium; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Philip S. Orsino Chair in Leukemia Research; Collaborative Translational Cancer Research Grant from the Princess Margaret Cancer Centre (formerly Ontario Cancer Institute); Leukemia & Lymphoma Society of Canada; Stem Cell Network; Ontario Graduate Scholarships(Ontario Graduate Scholarship); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Deutsche Forschungsgemeinschaft (Heisenberg-Professur)(German Research Foundation (DFG)); Wilhelm-Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Hematology Association	This work was supported by grants from the Ontario Institute for Cancer Research with funds from the province of Ontario, the Cancer Stem Cell Consortium with funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-047), and the Canadian Institutes of Health Research (CSC-105367), Canadian Cancer Society, Terry Fox Foundation, a Canada Research Chair to J.E.D., the Philip S. Orsino Chair in Leukemia Research to M.D.M., and a Collaborative Translational Cancer Research Grant from the Princess Margaret Cancer Centre (formerly Ontario Cancer Institute). This research was funded in part by the Leukemia & Lymphoma Society of Canada (493946) and the Stem Cell Network (492019), Ontario Graduate Scholarships, and the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. L.B. was supported in part by the Deutsche Forschungsgemeinschaft (Heisenberg-Professur BU 1339/8-1). T.H. was supported by the Wilhelm-Sander-Stiftung (grant 2013.086.1). K.M. and W.H. received grant support from Deutsche Forschungsgemeinschaft (DFG SFB 1243). We thank The Centre for Applied Genomics (Hospital for Sick Children) and the Princess Margaret Genomics Centre for the generation of GE data for the PM sorted cell fractions and validation cohort. We thank M. Pintilie for discussions regarding time-dependent covariates in survival analysis. We thank S. Geffroy for technical support and running the microarrays for the ALFA-0701 trial cohort.	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 2014, LANG ENV STAT COMP; Castaigne S, 2012, LANCET, V379, P1508, DOI 10.1016/S0140-6736(12)60485-1; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cornelissen JJ, 2012, NAT REV CLIN ONCOL, V9, P579, DOI 10.1038/nrclinonc.2012.150; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Gerds T. A., 2016, RISKREGRESSION RISK; Gray B, 2014, CMPRSK SUBDISTRIBUTI; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Grimwade D, 2016, BLOOD, V127, P29, DOI 10.1182/blood-2015-07-604496; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hills RK, 2014, LANCET ONCOL, V15, P986, DOI 10.1016/S1470-2045(14)70281-5; Jung N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9489; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Klco JM, 2015, JAMA-J AM MED ASSOC, V314, P811, DOI 10.1001/jama.2015.9643; Kohlmann A, 2010, LEUKEMIA, V24, P1216, DOI 10.1038/leu.2010.73; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Lechman ER, 2016, CANCER CELL, V29, P214, DOI 10.1016/j.ccell.2015.12.011; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li L, 2014, CELL STEM CELL, V15, P431, DOI 10.1016/j.stem.2014.08.001; MacRae T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072884; MANTEL N, 1974, J AM STAT ASSOC, V69, P81, DOI 10.2307/2285503; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Nielsen T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-177; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Qiao WL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002838; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rollig C, 2011, J CLIN ONCOL, V29, P2758, DOI 10.1200/JCO.2010.32.8500; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Simon N, 2011, J STAT SOFTW, V39, P1; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Therneau TM, 2000, MODELING SURVIVAL DA; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Walter RB, 2015, LEUKEMIA, V29, P312, DOI 10.1038/leu.2014.242; Wu J, 2016, GCRMA BACKGROUND ADJ	53	412	425	9	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					433	+		10.1038/nature20598	http://dx.doi.org/10.1038/nature20598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27926740				2022-12-28	WOS:000389716800042
J	Gadagkar, V; Puzerey, PA; Chen, R; Baird-Daniel, E; Farhang, AR; Goldberg, JH				Gadagkar, Vikram; Puzerey, Pavel A.; Chen, Ruidong; Baird-Daniel, Eliza; Farhang, Alexander R.; Goldberg, Jesse H.			Dopamine neurons encode performance error in singing birds	SCIENCE			English	Article							BASAL GANGLIA; ZEBRA FINCH; SONGBIRD; REWARD; PREDICTION; FEEDBACK; ERP	Many behaviors are learned through trial and error by matching performance to internal goals. Yet neural mechanisms of performance evaluation remain poorly understood. We recorded basal ganglia-projecting dopamine neurons in singing zebra finches as we controlled perceived song quality with distorted auditory feedback. Dopamine activity was phasically suppressed after distorted syllables, consistent with a worse-than-predicted outcome, and was phasically activated at the precise moment of the song when a predicted distortion did not occur, consistent with a better-than-predicted outcome. Error response magnitude depended on distortion probability. Thus, dopaminergic error signals can evaluate behaviors that are not learned for reward and are instead learned by matching performance outcomes to internal goals.	[Gadagkar, Vikram; Puzerey, Pavel A.; Chen, Ruidong; Baird-Daniel, Eliza; Farhang, Alexander R.; Goldberg, Jesse H.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Baird-Daniel, Eliza] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY 10065 USA; [Farhang, Alexander R.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Cornell University; Cornell University; University of California System; University of California San Francisco	Goldberg, JH (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jessehgoldberg@gmail.com		Puzerey, Pavel/0000-0002-2961-110X; Goldberg, Jesse/0000-0003-0422-8902; Chen, Ruidong/0000-0003-0163-979X; Farhang, Alexander/0000-0002-4554-4736	NIH [R01NS094667]; Pew Charitable Trusts; Klingenstein Neuroscience Foundation; Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094667, F32NS098634] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; Klingenstein Neuroscience Foundation(Klingenstein Philanthropies); Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Fetch, M. Warden, M. Long, A. Andalman and D. Aronoy for comments on the manuscript; J. Cohen for mouse VIA recording data; T. Bollu and D. Murdoch for technical support; J. Wu and K. Maher for histology; and A. Treska for art. Funding support was provided to J.H.G. by NIH (grant R01NS094667), Pew Charitable Trusts, and Klingenstein Neuroscience Foundation and to V.G. by Simons Foundation. V.G. and J.H.G. designed the research, analyzed the data, and wrote the paper. V.G., P.A.P., R.C., A.R.F., E.B.-D., and J.H.G. performed experiments. The authors declare no competing financial interests. Data can be accessed at www.nbb.cornell.edu/goldberg/.	Ali F, 2013, NEURON, V80, P494, DOI 10.1016/j.neuron.2013.07.049; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Doya K, 1996, ADV NEURAL INFORMATI, P101; Fee MS, 2011, NEUROSCIENCE, V198, P152, DOI 10.1016/j.neuroscience.2011.09.069; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Hahnloser RHR, 2013, PRINCIPLES OF NEURAL CODING, P547; Hamaguchi K, 2014, ELIFE, V3, DOI 10.7554/eLife.01833; Hoffmann LA, 2016, J NEUROSCI, V36, P2176, DOI 10.1523/JNEUROSCI.3883-15.2016; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Katahira K, 2008, NEUROSCI RES, V61, P120, DOI 10.1016/j.neures.2008.02.001; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Konishi M., Z TIERPSYCHOL, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Maidhof C, 2010, J COGNITIVE NEUROSCI, V22, P2401, DOI 10.1162/jocn.2009.21332; Mandelblat-Cerf Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02152; Person AL, 2008, J COMP NEUROL, V508, P840, DOI 10.1002/cne.21699; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Singh S, 2010, IEEE T AUTON MENT DE, V2, P70, DOI 10.1109/TAMD.2010.2051031; Trewartha KM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00763; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112	24	108	109	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1278	1282		10.1126/science.aah6837	http://dx.doi.org/10.1126/science.aah6837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940871	Green Accepted			2022-12-28	WOS:000389598800058
J	Voosen, P				Voosen, Paul			FORECASTING US Congress wants to know the weather weeks ahead	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1212	1212		10.1126/science.354.6317.1212	http://dx.doi.org/10.1126/science.354.6317.1212			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940823				2022-12-28	WOS:000389598800010
J	Bourzac, K				Bourzac, Katherine			New nerves for old	NATURE			English	Editorial Material							SPINAL-CORD-INJURY; STEM-CELLS; GROWTH											Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Steinberg GK, 2016, STROKE, V47, P1817, DOI 10.1161/STROKEAHA.116.012995	4	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					S52	S54		10.1038/540S52a	http://dx.doi.org/10.1038/540S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27926699	Bronze			2022-12-28	WOS:000389548700002
J	Brody, H				Brody, Herb			REGENERATIVE MEDICINE	NATURE			English	Editorial Material																			0	5	7	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					S49	S49		10.1038/540S49a	http://dx.doi.org/10.1038/540S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27926698	Bronze			2022-12-28	WOS:000389548700001
J	Hayman, DTS				Hayman, David T. S.			As the bat flies	SCIENCE			English	Editorial Material							RABIES; VIRUS; HOST		[Hayman, David T. S.] Massey Univ, Mol Epidemiol & Publ Hlth Lab, Hopkirk Res Inst, Private Bag 11-222, Palmerston North, New Zealand	Massey University	Hayman, DTS (corresponding author), Massey Univ, Mol Epidemiol & Publ Hlth Lab, Hopkirk Res Inst, Private Bag 11-222, Palmerston North, New Zealand.	d.t.s.hayman@massey.ac.nz		Hayman, David/0000-0003-0087-3015				Amman BR, 2015, J WILDLIFE DIS, V51, P113, DOI 10.7589/2014-08-198; Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P20837, DOI 10.1073/pnas.1308817110; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Han BA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004815; Hassanin A, 2016, CR BIOL, V339, P517, DOI 10.1016/j.crvi.2016.09.005; Hayman DTS, 2016, ANNU REV VIROL, V3, P77, DOI 10.1146/annurev-virology-110615-042203; Hayman DTS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2591; Luis AD, 2015, ECOL LETT, V18, P1153, DOI 10.1111/ele.12491; Peel AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3770; Streicker DG, 2016, P NATL ACAD SCI USA, V113, P10926, DOI 10.1073/pnas.1606587113; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Zhou P, 2016, P NATL ACAD SCI USA, V113, P2696, DOI 10.1073/pnas.1518240113	15	6	6	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1099	1100		10.1126/science.aaj1818	http://dx.doi.org/10.1126/science.aaj1818			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934719				2022-12-28	WOS:000388916400017
J	Bar, KJ; Sneller, MC; Harrison, LJ; Justement, JS; Overton, ET; Petrone, ME; Salantes, DB; Seamon, CA; Scheinfeld, B; Kwan, RW; Learn, GH; Proschan, MA; Kreider, EF; Blazkova, J; Bardsley, M; Refsland, EW; Messer, M; Clarridge, KE; Tustin, NB; Madden, PJ; Oden, KS; O'Dell, SJ; Jarocki, B; Shiakolas, AR; Tressler, RL; Doria-Rose, NA; Bailer, RT; Ledgerwood, JE; Capparelli, EV; Lynch, RM; Graham, BS; Moir, S; Koup, RA; Mascola, JR; Hoxie, JA; Fauci, AS; Tebas, P; Chun, TW				Bar, K. J.; Sneller, M. C.; Harrison, L. J.; Justement, J. S.; Overton, E. T.; Petrone, M. E.; Salantes, D. B.; Seamon, C. A.; Scheinfeld, B.; Kwan, R. W.; Learn, G. H.; Proschan, M. A.; Kreider, E. F.; Blazkova, J.; Bardsley, M.; Refsland, E. W.; Messer, M.; Clarridge, K. E.; Tustin, N. B.; Madden, P. J.; Oden, K. S.; O'Dell, S. J.; Jarocki, B.; Shiakolas, A. R.; Tressler, R. L.; Doria-Rose, N. A.; Bailer, R. T.; Ledgerwood, J. E.; Capparelli, E. V.; Lynch, R. M.; Graham, B. S.; Moir, S.; Koup, R. A.; Mascola, J. R.; Hoxie, J. A.; Fauci, A. S.; Tebas, P.; Chun, T-W			Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; IMMUNODEFICIENCY-VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; MONOCLONAL-ANTIBODIES; CONTROLLED-TRIAL; COMBINATION; PROTECTION; RESERVOIR; VIREMIA; POTENT	BACKGROUND The discovery of potent and broadly neutralizing antibodies (bNAbs) against human immunodeficiency virus (HIV) has made passive immunization a potential strategy for the prevention and treatment of HIV infection. We sought to determine whether passive administration of VRC01, a bNAb targeting the HIV CD4-binding site, can safely prevent or delay plasma viral rebound after the discontinuation of antiretroviral therapy (ART). METHODS We conducted two open-label trials (AIDS Clinical Trials Group [ACTG] A5340 and National Institutes of Health [NIH] 15-I-0140) of the safety, side-effect profile, pharmacokinetic properties, and antiviral activity of VRC01 in persons with HIV infection who were undergoing interruption of ART. RESULTS A total of 24 participants were enrolled, and one serious alcohol-related adverse event occurred. Viral rebound occurred despite plasma VRC01 concentrations greater than 50 mu g per milliliter. The median time to rebound was 4 weeks in the A5340 trial and 5.6 weeks in the NIH trial. Study participants were more likely than historical controls to have viral suppression at week 4 (38% vs. 13%, P = 0.04 by a two-sided Fisher's exact test in the A5340 trial; and 80% vs. 13%, P<0.001 by a two-sided Fisher's exact test in the NIH trial) but the difference was not significant at week 8. Analyses of virus populations before ART as well as before and after ART interruption showed that VRC01 exerted pressure on rebounding virus, resulting in restriction of recrudescent viruses and selection for preexisting and emerging antibody neutralization-resistant virus. CONCLUSIONS VRC01 slightly delayed plasma viral rebound in the trial participants, as compared with historical controls, but it did not maintain viral suppression by week 8. In the small number of participants enrolled in these trials, no safety concerns were identified with passive immunization with a single bNAb (VRC01). (Funded by the National Institute of Allergy and Infectious Diseases and others; ACTG A5340 and NIH 15-I-0140 ClinicalTrials.gov numbers, NCT02463227 and NCT02471326.)	[Bar, K. J.; Salantes, D. B.; Scheinfeld, B.; Learn, G. H.; Kreider, E. F.; Bardsley, M.; Hoxie, J. A.; Tebas, P.] Univ Penn, Philadelphia, PA 19104 USA; [Tustin, N. B.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Sneller, M. C.; Justement, J. S.; Petrone, M. E.; Blazkova, J.; Refsland, E. W.; Clarridge, K. E.; Moir, S.; Fauci, A. S.; Chun, T-W] NIAID, Immunoregulat Lab, Bldg 10, Bethesda, MD 20892 USA; [Proschan, M. A.] NIAID, Biostat Res Branch, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Madden, P. J.; O'Dell, S. J.; Shiakolas, A. R.; Doria-Rose, N. A.; Bailer, R. T.; Ledgerwood, J. E.; Lynch, R. M.; Graham, B. S.; Koup, R. A.; Mascola, J. R.] NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Tressler, R. L.] NIAID, Div Aids, Bethesda, MD 20892 USA; [Seamon, C. A.; Kwan, R. W.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Seamon, C. A.; Kwan, R. W.] NIH, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA; [Oden, K. S.] AIDS Clin Trials Grp, Silver Spring, MD USA; [Tressler, R. L.] Columbus Technol & Serv, Greenbelt, MD USA; [Harrison, L. J.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Overton, E. T.; Messer, M.] Univ Alabama Birmingham, Birmingham, AL USA; [Jarocki, B.] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA; [Capparelli, E. V.] Univ Calif San Diego, La Jolla, CA 92093 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Harvard University; Harvard T.H. Chan School of Public Health; University of Alabama System; University of Alabama Birmingham; Frontier Science Foundation; University of California System; University of California San Diego	Bar, KJ (corresponding author), Univ Penn, Dept Med, 502D Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.; Chun, TW (corresponding author), NIAID, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bark@mail.med.upenn.edu; twchun@nih.gov	Graham, Barney S./AAC-5898-2019; Learn, Jerry/E-3356-2012; Chun, Tae-Wook/W-9187-2019; Kreider, Edward/GSD-5998-2022; Mascola, John/AAI-7193-2021; Moir, Susan/AAC-3676-2020; Chun, Tae-Wook/AAC-3101-2020	Graham, Barney S./0000-0001-8112-0853; Chun, Tae-Wook/0000-0001-5153-7340; Oden, KaSaundra/0000-0002-1812-7507; Madden, Patrick/0000-0003-4527-5692; Kreider, Edward/0000-0003-2330-8430; Shiakolas, Andrea/0000-0001-9391-5434; Overton, Edgar/0000-0002-4013-536X; Tebas, Pablo/0000-0001-5345-7942	National Institute of Allergy and Infectious Diseases (NIAID) [U01AI068636]; Penn Center for AIDS Research [P30 AI045008]; Penn Clinical Trials Unit [AI069534]; University of Alabama at Birmingham (UAB) Center for AIDS Research [P30 AI027767]; UAB Clinical Trials Unit [AI069452]; AIDS Clinical Trials Group Statistical and Data Analysis Center [UM1 AI068634]; NIAID [1-R21-AI118431]; Ruth L. Kirschstein National Research Service Award [F30 AI112426]; Intramural Research Program of the NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, UM1AI069452, R21AI118431, U01AI068636, U01AI069452, F30AI112426, U01AI032783, P30AI045008, UM1AI068634, U01AI069534, UM1AI069534, P30AI027767, ZIAAI000851, UM1AI126620, UM1AI068636, ZIAAI005048, UM1AI106701] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Penn Center for AIDS Research; Penn Clinical Trials Unit; University of Alabama at Birmingham (UAB) Center for AIDS Research; UAB Clinical Trials Unit; AIDS Clinical Trials Group Statistical and Data Analysis Center; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by an award from the National Institute of Allergy and Infectious Diseases (NIAID) (U01AI068636); grants from the Penn Center for AIDS Research (P30 AI045008), the Penn Clinical Trials Unit (AI069534), the University of Alabama at Birmingham (UAB) Center for AIDS Research (P30 AI027767), the UAB Clinical Trials Unit (AI069452), the AIDS Clinical Trials Group Statistical and Data Analysis Center (UM1 AI068634), the NIAID (1-R21-AI118431, for A5340 viral analyses); and a Ruth L. Kirschstein National Research Service Award (F30 AI112426, to Dr. Kreider). The National Institutes of Health (NIH) study was funded by the Intramural Research Program of the NIAID, NIH.	Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bednar MM, 2016, J INFECT DIS, V214, P403, DOI 10.1093/infdis/jiw172; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bouvin-Pley M, 2014, J VIROL, V88, P13910, DOI 10.1128/JVI.02083-14; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; Chun TW, 2014, P NATL ACAD SCI USA, V111, P13151, DOI 10.1073/pnas.1414148111; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Delaney M, 2010, AIDS RES HUM RETROV, V26, P501, DOI 10.1089/aid.2010.0064; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Halper-Stromberg A, 2016, J CLIN INVEST, V126, P415, DOI 10.1172/JCI80561; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Kearney MF, 2016, J VIROL, V90, P1369, DOI 10.1128/JVI.02139-15; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Ledgerwood JE, 2015, CLIN EXP IMMUNOL, V182, P289, DOI 10.1111/cei.12692; Li JZ, 2016, AIDS, V30, P343, DOI 10.1097/QAD.0000000000000953; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Rothenberger MK, 2015, P NATL ACAD SCI USA, V112, pE1126, DOI 10.1073/pnas.1414926112; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	44	287	296	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2037	2050		10.1056/NEJMoa1608243	http://dx.doi.org/10.1056/NEJMoa1608243			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC9KU	27959728	Green Accepted, Bronze			2022-12-28	WOS:000388464300006
J	Edelman, EJ; Fiellin, DA				Edelman, E. Jennifer; Fiellin, David A.			Can Primary Care Practices Help Address the Health Crisis Fueled by Prescription Opioids?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BUPRENORPHINE; DEPENDENCE		[Edelman, E. Jennifer; Fiellin, David A.] Yale Univ, Sch Med, 367 Cedar St,ESH A, New Haven, CT 06510 USA	Yale University	Edelman, EJ (corresponding author), Yale Univ, Sch Med, 367 Cedar St,ESH A, New Haven, CT 06510 USA.	ejennifer.edelman@yale.edu						Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004147.pub4; DOLE VP, 1965, NEW YORK STATE J MED, V65, P927; Doot Martin C, 2004, Sci Pract Perspect, V2, P20; Fiellin DA, 2002, ANN INTERN MED, V137, P688, DOI 10.7326/0003-4819-137-8-200210150-00014; JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501; Korthuis PT, 2017, ANN INTERN MED, V166, P268, DOI 10.7326/M16-2149; Loxterkamp D, 2006, ANN FAM MED, V4, P168, DOI 10.1370/afm.518; Saloner B, 2015, JAMA-J AM MED ASSOC, V314, P1515, DOI 10.1001/jama.2015.10345; Schwartz RP, 2016, J ADDICT MED, V10, P283, DOI 10.1097/ADM.0000000000000236; Turner L, 2015, AM J ADDICTION, V24, P24, DOI 10.1111/ajad.12174	10	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					307	+		10.7326/M16-2666	http://dx.doi.org/10.7326/M16-2666			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	27919106				2022-12-28	WOS:000394786700025
J	Ezzati, M; Baumgartner, JC				Ezzati, Majid; Baumgartner, Jill C.			Household energy and health: where next for research and practice?	LANCET			English	Editorial Material							INDOOR AIR-POLLUTION; DEVELOPING-COUNTRIES; SOURCE APPORTIONMENT; RISK-FACTORS; EXPOSURE; COOKING; BURDEN		[Ezzati, Majid] Imperial Coll London, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Ezzati, Majid] Imperial Coll London, WHO Collaborating Ctr NCD Surveillance & Epidemio, London W2 1PG, England; [Baumgartner, Jill C.] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Baumgartner, Jill C.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Imperial College London; Imperial College London; McGill University; McGill University	Ezzati, M (corresponding author), Imperial Coll London, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England.; Ezzati, M (corresponding author), Imperial Coll London, WHO Collaborating Ctr NCD Surveillance & Epidemio, London W2 1PG, England.	majid.ezzati@imperial.ac.uk			Wellcome Trust [100693] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AGARWAL B, 1983, WORLD DEV, V11, P359, DOI 10.1016/0305-750X(83)90047-5; ANDERSON HR, 1978, INT J EPIDEMIOL, V7, P63, DOI 10.1093/ije/7.1.63; Curtis V, 2000, TROP MED INT HEALTH, V5, P22, DOI 10.1046/j.1365-3156.2000.00512.x; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2002, ENVIRON HEALTH PERSP, V110, P1057, DOI 10.1289/ehp.021101057; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Huang W, 2015, ATMOS ENVIRON, V104, P79, DOI 10.1016/j.atmosenv.2014.12.066; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MANIBOG FR, 1984, ANNU REV ENERGY, V9, P199, DOI 10.1146/annurev.eg.09.110184.001215; Mortimer K., 2016, LANCET, V389, P67; Sinton JE, 2004, ENERGY SUSTAIN DEV, V8, P33, DOI [10.1016/S0973-0826(08)60465-2, DOI 10.1016/S0973-0826(08)60465-2]; Smith KR, 2014, SCIENCE, V345, P603, DOI 10.1126/science.1259026; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Smith KR, 2010, J EXPO SCI ENV EPID, V20, P406, DOI 10.1038/jes.2009.30; Zhou Z, 2006, J INEQUAL APPL, DOI 10.1155/JIA/2006/90742; Zhou Z, 2014, ENVIRON SCI TECHNOL, V48, P1343, DOI 10.1021/es404185m; Zhou Z, 2011, P NATL ACAD SCI USA, V108, P11028, DOI 10.1073/pnas.1019183108	17	31	31	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					130	132		10.1016/S0140-6736(16)32506-5	http://dx.doi.org/10.1016/S0140-6736(16)32506-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EH9UT	27939060	hybrid, Green Published			2022-12-28	WOS:000392117600005
J	van Delden, JJM; van der Graaf, R				van Delden, Johannes J. M.; van der Graaf, Rieke			Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[van Delden, Johannes J. M.; van der Graaf, Rieke] Univ Med Ctr Utrecht, Julius Ctr, Dept Med Humanities, POB 85500, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van Delden, JJM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr, Dept Med Humanities, POB 85500, NL-3508 GA Utrecht, Netherlands.	j.j.m.vandelden@umcutrecht.nl	Van der Graaf, Rieke/AAF-6142-2019	Van der Graaf, Rieke/0000-0003-4907-7044				Council for International Organizations of Medical Sciences, 2016, INT ETH GUID HLTH RE; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Hurst SA, 2008, BIOETHICS, V22, P191, DOI 10.1111/j.1467-8519.2008.00631.x; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; London AJ, 2012, J LAW MED ETHICS, V40, P930, DOI 10.1111/j.1748-720X.2012.00722.x; Luna F, 2013, BIOETHICS, V27, P325, DOI 10.1111/bioe.12035; United Nations Educational Scientific and Cultural Organization, UN DECL BIOETH HUM R	7	65	67	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2017	317	2					135	136		10.1001/jama.2016.18977	http://dx.doi.org/10.1001/jama.2016.18977			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EH5PV	27923072				2022-12-28	WOS:000391826200012
J	Hiatt, WR; Fowkes, FGR; Heizer, G; Berger, JS; Baumgartner, I; Held, P; Katona, BG; Mahaffey, KW; Norgren, L; Jones, WS; Blomster, J; Millegard, M; Reist, C; Patel, MR				Hiatt, William R.; Fowkes, F. Gerry R.; Heizer, Gretchen; Berger, Jeffrey S.; Baumgartner, Iris; Held, Peter; Katona, Brian G.; Mahaffey, Kenneth W.; Norgren, Lars; Jones, W. Schuyler; Blomster, Juuso; Millegard, Marcus; Reist, Craig; Patel, Manesh R.		EUCLID Trial Steering Comm	Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR EVENTS; PREVENTION; ASPIRIN	BACKGROUND Peripheral artery disease is considered to be a manifestation of systemic atherosclerosis with associated adverse cardiovascular and limb events. Data from previous trials have suggested that patients receiving clopidogrel monotherapy had a lower risk of cardiovascular events than those receiving aspirin. We wanted to compare clopidogrel with ticagrelor, a potent antiplatelet agent, in patients with peripheral artery disease. METHODS In this double-blind, event-driven trial, we randomly assigned 13,885 patients with symptomatic peripheral artery disease to receive monotherapy with ticagrelor (90 mg twice daily) or clopidogrel (75 mg once daily). Patients were eligible if they had an ankle-brachial index (ABI) of 0.80 or less or had undergone previous revascularization of the lower limbs. The primary efficacy end point was a composite of adjudicated cardiovascular death, myocardial infarction, or ischemic stroke. The primary safety end point was major bleeding. The median follow-up was 30 months. RESULTS The median age of the patients was 66 years, and 72% were men; 43% were enrolled on the basis of the ABI and 57% on the basis of previous revascularization. The mean baseline ABI in all patients was 0.71, 76.6% of the patients had claudication, and 4.6% had critical limb ischemia. The primary efficacy end point occurred in 751 of 6930 patients (10.8%) receiving ticagrelor and in 740 of 6955 (10.6%) receiving clopidogrel (hazard ratio, 1.02; 95% confidence interval [CI], 0.92 to 1.13; P = 0.65). In each group, acute limb ischemia occurred in 1.7% of the patients (hazard ratio, 1.03; 95% CI, 0.79 to 1.33; P = 0.85) and major bleeding in 1.6% (hazard ratio, 1.10; 95% CI, 0.84 to 1.43; P = 0.49). CONCLUSIONS In patients with symptomatic peripheral artery disease, ticagrelor was not shown to be superior to clopidogrel for the reduction of cardiovascular events. Major bleeding occurred at similar rates among the patients in the two trial groups. (Funded by AstraZeneca; EUCLID ClinicalTrials.gov number, NCT01732822.)	[Hiatt, William R.] Univ Colorado, Sch Med, Aurora, CO USA; [Hiatt, William R.] CPC Clin Res, Aurora, CO USA; [Fowkes, F. Gerry R.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Heizer, Gretchen; Jones, W. Schuyler; Reist, Craig; Patel, Manesh R.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Berger, Jeffrey S.] NYU, Sch Med, Dept Med, New York, NY USA; [Berger, Jeffrey S.] NYU, Sch Med, Dept Surg, New York, NY USA; [Baumgartner, Iris] Univ Bern, Univ Hosp Bern, Inselspital, Swiss Cardiovasc Ctr, Bern, Switzerland; [Held, Peter; Blomster, Juuso; Millegard, Marcus] AstraZeneca Gothenburg, Molndal, Sweden; [Norgren, Lars] Univ Orebro, Fac Med & Hlth, Orebro, Sweden; [Katona, Brian G.] Astra Zeneca Gaithersburg, Gaithersburg, MD USA; [Mahaffey, Kenneth W.] Stanford Univ, Stanford Ctr Clin Res, Sch Med, Stanford, CA 94305 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Edinburgh; Duke University; New York University; New York University; University of Bern; University Hospital of Bern; AstraZeneca; Orebro University; Stanford University	Patel, MR (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St,Rm 0311 Terrace Level, Durham, NC 27705 USA.	manesh.patel@duke.edu	Maslovskyi, Valentyn/V-3896-2019; Couffinhal, Thierry/M-6857-2014; Lozano-Vilardell, Pascual/K-5807-2018; Maslovskyi, Valentyn/GQO-9125-2022; Lozano-Vilardell, Pascual/M-3180-2019; Lanéelle, Damien/X-3908-2019; Patel, Manesh/AAC-5385-2019; Gillgren, Peter/AAB-4724-2020; Quere, Isabelle/AAB-8519-2020; Navarro, Tulio P/H-2781-2014; Belch, Jill/AAE-9189-2019	Maslovskyi, Valentyn/0000-0001-5184-1799; Couffinhal, Thierry/0000-0002-9217-2533; Lozano-Vilardell, Pascual/0000-0002-3443-0792; Maslovskyi, Valentyn/0000-0001-5184-1799; Lozano-Vilardell, Pascual/0000-0002-3443-0792; Lanéelle, Damien/0000-0002-0598-3929; Gillgren, Peter/0000-0003-0538-3496; Quere, Isabelle/0000-0002-1492-9764; Navarro, Tulio P/0000-0001-8134-5825; Belch, Jill/0000-0001-8280-6689; Cacoub, Patrice/0000-0002-6727-4992; Farkas, Katalin/0000-0001-5577-6808; Rha, Seung-Woon/0000-0001-9456-9852; Madaric, Juraj/0000-0003-1326-2336; Berger, Jeffrey/0000-0001-8216-4647; Geremek, Maciej/0000-0002-6484-8751; Stansby, Gerard/0000-0001-5539-3049; Perrakis, Aristotelis/0000-0003-3972-1174; chetter, ian/0000-0002-2566-6859; GIMENEZ-GAIBAR, ANTONIO/0000-0002-1837-4989; Kashyap, Vikram/0000-0003-1780-979X	AstraZeneca	AstraZeneca(AstraZeneca)	Funded by AstraZeneca.	Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berger JS, 2016, AM HEART J, V175, P86, DOI 10.1016/j.ahj.2016.01.018; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bonaca MP, 2016, J AM COLL CARDIOL, V67, P2719, DOI 10.1016/j.jacc.2016.03.524; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Nambi V, 2009, PLATELETS, V20, P199, DOI 10.1080/09537100902780643; Patel MR, 2015, EUR J PREV CARDIOL, V22, P734, DOI 10.1177/2047487314533215; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327	14	363	379	4	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2017	376	1					32	40		10.1056/NEJMoa1611688	http://dx.doi.org/10.1056/NEJMoa1611688			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SS	27959717	Green Published			2022-12-28	WOS:000391177100006
J	Taggart, DP; Altman, DG; Gray, AM; Lees, B; Gerry, S; Benedetto, U; Flather, M				Taggart, David P.; Altman, Douglas G.; Gray, Alastair M.; Lees, Belinda; Gerry, Stephen; Benedetto, Umberto; Flather, Marcus		ART Investigators	Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANGIOGRAPHIC FOLLOW-UP; REVASCULARIZATION TRIAL; BYPASS-SURGERY; CORONARY-BYPASS; METAANALYSIS APPROACH; VEIN GRAFTS; OFF-PUMP; ON-PUMP; SURVIVAL; PATENCY	BACKGROUND The use of bilateral internal thoracic (mammary) arteries for coronary-artery bypass grafting (CABG) may improve long-term outcomes as compared with the use of a single internal-thoracic-artery plus vein grafts. METHODS We randomly assigned patients scheduled for CABG to undergo single or bilateral internal-thoracic-artery grafting in 28 cardiac surgical centers in seven countries. The primary outcome was death from any cause at 10 years. The composite of death from any cause, myocardial infarction, or stroke was a secondary outcome. Interim analyses were prespecified at 5 years of follow-up. RESULTS A total of 3102 patients were enrolled; 1554 were randomly assigned to undergo single internal-thoracic-artery grafting (the single-graft group) and 1548 to undergo bilateral internal-thoracic-artery grafting (the bilateral-graft group). At 5 years of follow-up, the rate of death was 8.7% in the bilateral-graft group and 8.4% in the single-graft group (hazard ratio, 1.04; 95% confidence interval [CI], 0.81 to 1.32; P=0.77), and the rate of the composite of death from any cause, myocardial infarction, or stroke was 12.2% and 12.7%, respectively (hazard ratio, 0.96; 95% CI, 0.79 to 1.17; P=0.69). The rate of sternal wound complication was 3.5% in the bilateral-graft group versus 1.9% in the single-graft group (P=0.005), and the rate of sternal reconstruction was 1.9% versus 0.6% (P=0.002). CONCLUSIONS Among patients undergoing CABG, there was no significant difference between those receiving single internal-thoracic-artery grafts and those receiving bilateral internal-thoracic-artery grafts with regard to mortality or the rates of cardiovascular events at 5 years of follow-up. There were more sternal wound complications with bilateral internal-thoracic-artery grafting than with single internal-thoracicartery grafting. Ten-year follow-up is ongoing. (Funded by the British Heart Foundation and others; ART Current Controlled Trials number, ISRCTN46552265.)	[Taggart, David P.; Lees, Belinda] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Altman, Douglas G.; Gerry, Stephen] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England; [Gray, Alastair M.] Univ Oxford, Hlth Econ Res Ctr, Nuffield Dept Populat Hlth, Oxford, England; [Benedetto, Umberto] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Benedetto, Umberto] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England; [Flather, Marcus] Univ East Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Flather, Marcus] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England	University of Oxford; University of Oxford; University of Oxford; University of Bristol; Bristol Royal Infirmary; University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Flather, M (corresponding author), Univ East Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	m.flather@uea.ac.uk	Kotecha, Dipak/Q-2827-2016; clark, Stephen/N-1748-2019; Zamvar, Vipin/J-3430-2013; Dato, Guglielmo Mario Actis/AAO-6904-2020	Kotecha, Dipak/0000-0002-2570-9812; clark, Stephen/0000-0002-2193-4705; Zamvar, Vipin/0000-0003-2447-828X; Dato, Guglielmo Mario Actis/0000-0003-4209-2866; Bochenek, Andrzej/0000-0002-3046-3001; Cisowski, Marek/0000-0002-0971-2528; Bernecker, Oliver/0000-0002-9106-8339; Gray, Alastair/0000-0003-0239-7278; Dark, John Henry/0000-0002-4727-6085; Gerry, Stephen/0000-0003-4654-7311; Yusuf, Salim/0000-0003-4776-5601; Jasinski, Marek/0000-0002-9989-7748; Benedetto, Umberto/0000-0002-7074-7949; Widenka, Kazimierz/0000-0002-9150-8410; Cooper, Graham/0000-0002-1950-0078; Iles-Smith, Heather/0000-0002-0520-2694	British Heart Foundation; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [G0200390] Funding Source: researchfish; MRC [G0200390] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the British Heart Foundation and others	Aldea GS, 2016, ANN THORAC SURG, V101, P801, DOI 10.1016/j.athoracsur.2015.09.100; Benedetto U, 2016, J THORAC CARDIOV SUR, V152, P270, DOI 10.1016/j.jtcvs.2016.03.056; Benedetto U, 2015, EUR J CARDIO-THORAC, V47, P59, DOI 10.1093/ejcts/ezu111; Benedetto U, 2014, J THORAC CARDIOV SUR, V148, P2706, DOI 10.1016/j.jtcvs.2014.07.088; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Buxton BF, 2000, EUR J CARDIO-THORAC, V18, P255, DOI 10.1016/S1010-7940(00)00527-3; Calafiore AM, 2000, J THORAC CARDIOV SUR, V120, P990, DOI 10.1067/mtc.2000.110249; Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402; Collins P, 2008, CIRCULATION, V117, P2859, DOI 10.1161/CIRCULATIONAHA.107.736215; Dion R, 2000, EUR J CARDIO-THORAC, V17, P407, DOI 10.1016/S1010-7940(00)00370-5; Domanski MJ, 2000, J AM COLL CARDIOL, V36, P1877, DOI 10.1016/S0735-1097(00)00973-6; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Gansera B, 2007, THORAC CARDIOV SURG, V55, P412, DOI 10.1055/s-2007-965372; Gaudino M, 2015, J AM COLL CARDIOL, V66, P1729, DOI 10.1016/j.jacc.2015.08.395; Glineur D, 2016, EUR J CARDIOTHORAC S; Hlatky MA, 2011, J THORAC CARDIOV SUR, V142, P829, DOI 10.1016/j.jtcvs.2010.09.063; Ioannidis JPA, 2001, J AM COLL CARDIOL, V37, P521, DOI 10.1016/S0735-1097(00)01112-8; Kappetein AP, 2010, EUR HEART J, V31, P2444, DOI 10.1093/eurheartj/ehq341; Kieser TM, 2011, ANN THORAC SURG, V92, P1269, DOI 10.1016/j.athoracsur.2011.05.083; KOLESOV VI, 1991, J THORAC CARDIOV SUR, V101, P360; Kurlansky P, 2010, WORLD J SURG, V34, P646, DOI 10.1007/s00268-009-0242-9; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P538, DOI 10.1136/jech.57.7.538; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X; Lytle BW, 2001, CIRCULATION, V104, P2152, DOI 10.1161/circ.104.18.2152; Mohammadi S, 2008, EUR J CARDIO-THORAC, V33, P977, DOI 10.1016/j.ejcts.2008.03.026; Parasca CA, 2015, J THORAC CARDIOV SUR, V150, P597, DOI 10.1016/j.jtcvs.2015.05.010; Rizzoli G, 2002, EUR J CARDIO-THORAC, V22, P781, DOI 10.1016/S1010-7940(02)00470-0; Sabik JF, 2008, CIRCULATION, V118, pS210, DOI 10.1161/CIRCULATIONAHA.107.760827; Tabata M, 2009, CIRCULATION, V120, P935, DOI 10.1161/CIRCULATIONAHA.108.832444; Taggart DP, 2006, ANN THORAC SURG, V82, P1966, DOI 10.1016/j.athoracsur.2006.06.035; Taggart DP, 2015, EUR J CARDIO-THORAC, V47, P1059, DOI 10.1093/ejcts/ezu349; Taggart DP, 2010, EUR HEART J, V31, P2470, DOI 10.1093/eurheartj/ehq318; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Taggart DP, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-7; Takagi H, 2014, J THORAC CARDIOV SUR, V148, P1282, DOI 10.1016/j.jtcvs.2014.01.010; Tatoulis J, 2011, CURR OPIN CARDIOL, V26, P528, DOI 10.1097/HCO.0b013e32834b9f87; Tatoulis J, 2011, ANN THORAC SURG, V92, P9, DOI 10.1016/j.athoracsur.2011.03.099; Tatoulis J, 2009, ANN THORAC SURG, V88, P23, DOI 10.1016/j.athoracsur.2009.03.086; Vallely MP, 2013, ANN CARDIOTHORAC SUR, V2, P570, DOI 10.3978/j.issn.2225-319X.2013.06.03; Ware JE, 2007, USERS MANUAL SF 36V2; WEINTRAUB WS, 1994, AM J CARDIOL, V73, P103, DOI 10.1016/0002-9149(94)90198-8; Weiss AJ, 2013, ANN CARDIOTHORAC SUR, V2, P390, DOI 10.3978/j.issn.2225-319X.2013.07.16; Yi GJ, 2014, CIRCULATION, V130, P539, DOI 10.1161/CIRCULATIONAHA.113.004255; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	46	268	288	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2540	2549		10.1056/NEJMoa1610021	http://dx.doi.org/10.1056/NEJMoa1610021			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SC	27959712	Green Accepted, Bronze, Green Published, Green Submitted			2022-12-28	WOS:000391175300007
J	Wang, L; Luo, JY; Li, BC; Tian, XY; Chen, LJ; Huang, YH; Liu, J; Deng, D; Lau, CW; Wan, S; Ai, D; Mak, KLK; Tong, KK; Kwan, KM; Wang, NP; Chiu, JJ; Zhu, Y; Huang, Y				Wang, Li; Luo, Jiang-Yun; Li, Bochuan; Tian, Xiao Yu; Chen, Li-Jing; Huang, Yuhong; Liu, Jian; Deng, Dan; Lau, Chi Wai; Wan, Song; Ai, Ding; Mak, King-Lun Kingston; Tong, Ka Kui; Kwan, Kin Ming; Wang, Nanping; Chiu, Jeng-Jiann; Zhu, Yi; Huang, Yu			Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow	NATURE			English	Article							ENDOTHELIAL-CELLS; HIPPO PATHWAY; OUTSIDE-IN; STRESS; YAP; ACTIVATION; EXPRESSION; SUBUNIT; VIVO; TEAD	The Yorkie homologues YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif, also known as WWTR1), effectors of the Hippo pathway, have been identified as mediators for mechanical stimuli(1). However, the role of YAP/TAZ in haemodynamics-induced mechanotransduction and pathogenesis of atherosclerosis remains unclear. Here we show that endothelial YAP/TAZ activity is regulated by different patterns of blood flow, and YAP/TAZ inhibition suppresses inflammation and retards atherogenesis. Atheroprone-disturbed flow increases whereas atheroprotective unidirectional shear stress inhibits YAP/TAZ activity. Unidirectional shear stress activates integrin and promotes integrin-G alpha(13) interaction, leading to RhoA inhibition and YAP phosphorylation and suppression. YAP/TAZ inhibition suppresses JNK signalling and downregulates pro-inflammatory genes expression, thereby reducing monocyte attachment and infiltration. In vivo endothelial-specific YAP overexpression exacerbates, while CRISPR/Cas9-mediated Yap knockdown in endothelium retards, plaque formation in ApoE(-/-) mice. We also show several existing anti-atherosclerotic agents such as statins inhibit YAP/TAZ transactivation. On the other hand, simvastatin fails to suppress constitutively active YAP/TAZ-induced pro-inflammatory gene expression in endothelial cells, indicating that YAP/TAZ inhibition could contribute to the anti-inflammatory effect of simvastatin. Furthermore, activation of integrin by oral administration of MnCl2 reduces plaque formation. Taken together, our results indicate that integrin-G alpha(13)-RhoA-YAP pathway holds promise as a novel drug target against atherosclerosis.	[Wang, Li; Luo, Jiang-Yun; Tian, Xiao Yu; Huang, Yuhong; Liu, Jian; Deng, Dan; Lau, Chi Wai; Huang, Yu] Chinese Univ Hong Kong, Shenzhen Res Inst, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Li; Luo, Jiang-Yun; Tian, Xiao Yu; Huang, Yuhong; Liu, Jian; Deng, Dan; Lau, Chi Wai; Huang, Yu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Li; Luo, Jiang-Yun; Tian, Xiao Yu; Huang, Yuhong; Mak, King-Lun Kingston; Huang, Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Bochuan; Ai, Ding; Zhu, Yi] Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin 300070, Peoples R China; [Li, Bochuan; Ai, Ding; Zhu, Yi] Tianjin Med Univ, Dept Physiol & Pathophysiol, Tianjin 300070, Peoples R China; [Chen, Li-Jing; Chiu, Jeng-Jiann] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli 35053, Taiwan; [Wan, Song] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tong, Ka Kui; Kwan, Kin Ming] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Tianjin Medical University; Tianjin Medical University; National Health Research Institutes - Taiwan; Chinese University of Hong Kong; Chinese University of Hong Kong; Dalian Medical University	Huang, Y (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China.; Huang, Y (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.; Huang, Y (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.; Zhu, Y (corresponding author), Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin 300070, Peoples R China.; Zhu, Y (corresponding author), Tianjin Med Univ, Dept Physiol & Pathophysiol, Tianjin 300070, Peoples R China.	zhuyi@tmu.edu.cn; yu-huang@cuhk.edu.hk	Huang, Yu/K-2866-2017; Wan, Song/AAV-6696-2020; Tian, Xiao Yu/P-1092-2016; Wan, Song/N-7352-2016	Huang, Yu/0000-0002-1277-6784; Wan, Song/0000-0002-9394-1672; Tian, Xiao Yu/0000-0003-3472-9898; Wang, Nanping/0000-0002-8528-8132; Liu, Jian/0000-0001-9719-2923; Kwan, Kin Ming/0000-0002-1246-2398; Li, Wang/0000-0002-3377-8092; Ai, Ding/0000-0001-5992-9904; Mak, Kingston King-Lun/0000-0002-4733-9146; Luo, Jiang-Yun/0000-0002-9087-227X; Huang, Yu/0000-0002-4079-7830	Hong Kong Research Grants Council [CUHK2/CRF/12G]; Natural Science Foundation of China [91339117, 81130002, 31430045]; RGC [T12-402/13-N, C7055-14G, CUHK14105814]; Croucher Foundation; CUHK Vice Chancellor's Discretionary Fund; Lui Che Woo Foundation; Ministry of Science and Technology, Taiwan [MOST104-2321-B-400-017, MOST104-2320-B-400-002-MY3]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); RGC(Hong Kong Research Grants Council); Croucher Foundation; CUHK Vice Chancellor's Discretionary Fund; Lui Che Woo Foundation; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	We thank S. Chien for commenting on the manuscript, and C.-I. Lee and T.-E. Lin for conducting clip experiments. This study was supported by the Hong Kong Research Grants Council (CUHK2/CRF/12G), Natural Science Foundation of China (91339117, 81130002, 31430045), RGC (T12-402/13-N, C7055-14G, CUHK14105814), Croucher Foundation, CUHK Vice Chancellor's Discretionary Fund, Lui Che Woo Foundation, and the Ministry of Science and Technology, Taiwan (MOST104-2321-B-400-017, MOST104-2320-B-400-002-MY3).	Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Estevez B, 2015, ARTERIOSCL THROM VAS, V35, P24, DOI 10.1161/ATVBAHA.114.303411; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; HOSHIGA M, 1995, CIRC RES, V77, P1129, DOI 10.1161/01.RES.77.6.1129; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Liu XF, 2016, CELL REP, V14, P1169, DOI 10.1016/j.celrep.2015.12.104; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Ma XJ, 2015, P NATL ACAD SCI USA, V112, P1065, DOI 10.1073/pnas.1415020112; Miao H, 2005, J VASC RES, V42, P77, DOI 10.1159/000083094; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sun XL, 2016, P NATL ACAD SCI USA, V113, P769, DOI 10.1073/pnas.1524523113; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Takabe W, 2011, ANTIOXID REDOX SIGN, V15, P1379, DOI 10.1089/ars.2010.3645; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Varadi K, 2012, GENE THER, V19, P800, DOI 10.1038/gt.2011.143; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vijayan KV, 2003, FEBS LETT, V540, P41, DOI 10.1016/S0014-5793(03)00170-4; Wang NP, 2006, BIOCHEM BIOPH RES CO, V341, P1244, DOI 10.1016/j.bbrc.2006.01.089; Weng S, 2003, P NATL ACAD SCI USA, V100, P6730, DOI 10.1073/pnas.1137612100; YLANNE J, 1995, J BIOL CHEM, V270, P9550; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou J, 2012, P NATL ACAD SCI USA, V109, P7770, DOI 10.1073/pnas.1205476109	38	306	316	10	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					579	+		10.1038/nature20602	http://dx.doi.org/10.1038/nature20602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27926730				2022-12-28	WOS:000391190500051
J	Thompson, V				Thompson, Valerie			Calling all kid scientists	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1222	1222						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940830				2022-12-28	WOS:000389598800017
J	Tran, E; Robbins, PF; Lu, YC; Prickett, TD; Gartner, JJ; Jia, L; Pasetto, A; Zheng, ZL; Ray, S; Groh, EM; Kriley, IR; Rosenberg, SA				Tran, Eric; Robbins, Paul F.; Lu, Yong-Chen; Prickett, Todd D.; Gartner, Jared J.; Jia, Li; Pasetto, Anna; Zheng, Zhili; Ray, Satyajit; Groh, Eric M.; Kriley, Isaac R.; Rosenberg, Steven A.			T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CTLA-4 BLOCKADE; PD-1 BLOCKADE; TUMOR; IDENTIFICATION; PATIENT; LYMPHOCYTES; SENSITIVITY	We identified a polyclonal CD8+ T-cell response against mutant KRAS G12D in tumor-infiltrating lymphocytes obtained from a patient with metastatic colorectal cancer. We observed objective regression of all seven lung metastases after the infusion of approximately 1.11x10(11) HLA-C*08: 02-restricted tumor-infiltrating lymphocytes that were composed of four different T-cell clonotypes that specifically targeted KRAS G12D. However, one of these lesions had progressed on evaluation 9 months after therapy. The lesion was resected and found to have lost the chromosome 6 haplotype encoding the HLA-C*08: 02 class I major histocompatibility complex (MHC) molecule. The loss of expression of this molecule provided a direct mechanism of tumor immune evasion. Thus, the infusion of CD8+ cells targeting mutant KRAS mediated effective antitumor immunotherapy against a cancer that expressed mutant KRAS G12D and HLA-C*08: 02.	[Tran, Eric; Robbins, Paul F.; Lu, Yong-Chen; Prickett, Todd D.; Gartner, Jared J.; Jia, Li; Pasetto, Anna; Zheng, Zhili; Ray, Satyajit; Groh, Eric M.; Kriley, Isaac R.; Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Surg Branch, 10 Ctr Dr,MSC 1201, Bethesda, MD 20892 USA.	sar@nih.gov	Pasetto, Anna/K-6430-2012; Pasetto, Anna/AAD-6141-2019; Lu, Yong-Chen/G-4520-2014	Pasetto, Anna/0000-0002-5254-2173; Lu, Yong-Chen/0000-0002-0275-9825	Center for Cancer Research Intramural Research Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010984, ZIABC010985] Funding Source: NIH RePORTER	Center for Cancer Research Intramural Research Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Center for Cancer Research Intramural Research Program of the National Cancer Institute.	Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Cohen CJ, 2015, J CLIN INVEST, V125, P3981, DOI 10.1172/JCI82416; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Garrido F, 2016, CURR OPIN IMMUNOL, V39, P44, DOI 10.1016/j.coi.2015.12.007; Goff SL, 2016, J CLIN ONCOL, V34, P2389, DOI 10.1200/JCO.2016.66.7220; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vaughn CP, 2011, GENE CHROMOSOME CANC, V50, P307, DOI 10.1002/gcc.20854; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Wang QJ, 2016, CANCER IMMUNOL RES, V4, P204, DOI 10.1158/2326-6066.CIR-15-0188	24	682	740	9	148	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2255	2262		10.1056/NEJMoa1609279	http://dx.doi.org/10.1056/NEJMoa1609279			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZQ	27959684	Green Accepted			2022-12-28	WOS:000389310000008
J	Villanueva, G; Murphy, MS; Vickers, D; Harrop, E; Dworzynski, K				Villanueva, Gemma; Murphy, M. Stephen; Vickers, David; Harrop, Emily; Dworzynski, Katharina			GUIDELINES End of life care for infants, children and young people with life limiting conditions: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Villanueva, Gemma; Murphy, M. Stephen; Dworzynski, Katharina] Royal Coll Gynaecologists & Obstetricians, Natl Guideline Alliance, London NW1 4RG, England; [Vickers, David] Cambridgeshire Community Serv NHS Trust, St Ives PE27 4LG, England; [Vickers, David] East Anglias Childrens Hosp, Milton Keynes CB24 6DF, Bucks, England; [Harrop, Emily] Helen & Douglas House, Oxford OX4 1RW, England		Dworzynski, K (corresponding author), Royal Coll Gynaecologists & Obstetricians, Natl Guideline Alliance, London NW1 4RG, England.	KDworzynskikdworzynski@rcog.org.uk	Villanueva, Gemma/AAB-3822-2019	Harrop, Emily/0000-0002-2480-2062; Villanueva, Gemma/0000-0002-1306-1721				National Institute for Health and Care Excellence, 2016, END LIF CAR INF CHIL; WHO, 1998, CANC PAIN REL PALL C	2	12	12	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2016	355								i6385	10.1136/bmj.i6385	http://dx.doi.org/10.1136/bmj.i6385			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SY	27932317				2022-12-28	WOS:000390037500001
J	Rotenstein, LS; Ramos, MA; Torre, M; Segal, JB; Peluso, MJ; Guille, C; Sen, S; Mata, DA				Rotenstein, Lisa S.; Ramos, Marco A.; Torre, Matthew; Segal, J. Bradley; Peluso, Michael J.; Guille, Constance; Sen, Srijan; Mata, Douglas A.			Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students A Systematic Review and Meta-Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							KING ABDULAZIZ UNIVERSITY; IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; MENTAL-HEALTH; SUBSTANCE USE; PSYCHOLOGICAL DISTRESS; ACADEMIC-PERFORMANCE; SEXUAL SATISFACTION; PERCEIVED STRESS; HELP-SEEKING	IMPORTANCE Medical students are at high risk for depression and suicidal ideation. However, the prevalence estimates of these disorders vary between studies. OBJECTIVE To estimate the prevalence of depression, depressive symptoms, and suicidal ideation in medical students. DATA SOURCES AND STUDY SELECTION Systematic search of EMBASE, ERIC, MEDLINE, psycARTICLES, and psycINFO without language restriction for studies on the prevalence of depression, depressive symptoms, or suicidal ideation in medical students published before September 17, 2016. Studies that were published in the peer-reviewed literature and used validated assessment methods were included. DATA EXTRACTION AND SYNTHESIS Information on study characteristics; prevalence of depression or depressive symptoms and suicidal ideation; and whether students who screened positive for depression sought treatmentwas extracted independently by 3 investigators. Estimateswere pooled using random-effects meta-analysis. Differences by study-level characteristics were estimated using stratified meta-analysis and meta-regression. MAIN OUTCOMES AND MEASURES Point or period prevalence of depression, depressive symptoms, or suicidal ideation as assessed by validated questionnaire or structured interview. RESULTS Depression or depressive symptom prevalence data were extracted from 167 cross-sectional studies (n = 116 628) and 16 longitudinal studies (n = 5728) from 43 countries. All but 1 study used self-report instruments. The overall pooled crude prevalence of depression or depressive symptoms was 27.2%(37 933/122 356 individuals; 95% CI, 24.7% to 29.9%, I-2 = 98.9%). Summary prevalence estimates ranged across assessment modalities from 9.3% to 55.9%. Depressive symptom prevalence remained relatively constant over the period studied (baseline survey year range of 1982-2015; slope, 0.2% increase per year [95% CI, -0.2% to 0.7%]). In the 9 longitudinal studies that assessed depressive symptoms before and during medical school (n = 2432), the median absolute increase in symptoms was 13.5% (range, 0.6% to 35.3%). Prevalence estimates did not significantly differ between studies of only preclinical students and studies of only clinical students (23.7%[95% CI, 19.5% to 28.5%] vs 22.4%[95% CI, 17.6% to 28.2%]; P =.72). The percentage of medical students screening positive for depression who sought psychiatric treatment was 15.7%(110/954 individuals; 95% CI, 10.2% to 23.4%, I-2 = 70.1%). Suicidal ideation prevalence data were extracted from 24 cross-sectional studies (n = 21 002) from 15 countries. All but 1 study used self-report instruments. The overall pooled crude prevalence of suicidal ideation was 11.1% (2043/21002 individuals; 95% CI, 9.0% to 13.7%, I-2 = 95.8%). Summary prevalence estimates ranged across assessment modalities from 7.4% to 24.2%. CONCLUSIONS AND RELEVANCE In this systematic review, the summary estimate of the prevalence of depression or depressive symptoms among medical students was 27.2% and that of suicidal ideation was 11.1%. Further research is needed to identify strategies for preventing and treating these disorders in this population.	[Rotenstein, Lisa S.; Torre, Matthew; Segal, J. Bradley; Peluso, Michael J.; Mata, Douglas A.] Harvard Med Sch, Boston, MA USA; [Rotenstein, Lisa S.] Harvard Sch Business, Boston, MA USA; [Ramos, Marco A.] Yale Univ, Yale Sch Med, New Haven, CT USA; [Torre, Matthew] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Peluso, Michael J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Guille, Constance] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA; [Sen, Srijan] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Sen, Srijan] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Mata, Douglas A.] Brigham & Womens Hosp, Div MPE Mol Pathol Epidemiol, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Mata, Douglas A.] Brigham Educ Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Medical University of South Carolina; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital	Mata, DA (corresponding author), Harvard Med Sch, Div MPE Mol Pathol Epidemiol, Dept Pathol, Brigham Educ Inst,Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	dmata@bwh.harvard.edu	Mata, Douglas A./P-1040-2019; Sen, Srijan/J-8053-2013; Rotenstein, Lisa/AAD-9280-2022	Mata, Douglas A./0000-0002-8059-8668; Sen, Srijan/0000-0003-4495-495X; Ramos, Marco/0000-0002-1649-7547	National Institutes of Health [MSTP TG 2T32GM07205, R01MH101459]; US Department of State; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101459, F31MH064299, K23MH095109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of State; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by the National Institutes of Health (MSTP TG 2T32GM07205 awarded to Mr Ramos and grant RO1MH101459 awarded to Dr Sen) and the US Department of State (Fulbright Scholarship awarded to Dr Mata).	Adamiak Grazyna, 2004, Psychiatr Pol, V38, P631; Aghakhani N, 2011, IRAN J PSYCHIATRY BE, V5, P131; Ahmed I, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.06.003; Ahmed SA, 2016, J FORENSIC LEG MED, V44, P1, DOI 10.1016/j.jflm.2016.08.009; Akbari V, 2014, OPEN PSYCHOL J, V7, P29; Aktekin M, 2001, MED EDUC, V35, P12, DOI 10.1046/j.1365-2923.2001.00726.x; Akvardar Y, 2004, SOC PSYCH PSYCH EPID, V39, P502, DOI 10.1007/s00127-004-0765-1; Akvardar Y, 2003, DRUG ALCOHOL DEPEN, V72, P117, DOI 10.1016/S0376-8716(03)00192-3; Al-Faris EA, 2012, MED TEACH, V34, pS32, DOI 10.3109/0142159X.2012.656755; Alem A, 2005, ETHIOPIAN MED J, V43, P159; Alexandrino-Silva C, 2009, REV BRAS PSIQUIATR, V31, P338, DOI 10.1590/S1516-44462009005000006; AlFaris Eiad Abdelmohsen, 2014, BMC Med Educ, V14, P192, DOI 10.1186/1472-6920-14-192; Ali FA, 2015, PAK J MED HEALTH SCI, V9, P119; Ali R V, 1994, Indian J Psychiatry, V36, P138; Alvi T, 2010, JCPSP-J COLL PHYSICI, V20, P122, DOI 02.2010/JCPSP.122126; Amaral Geraldo Francisco do, 2008, Rev. psiquiatr. Rio Gd. Sul, V30, P124, DOI 10.1590/S0101-81082008000300008; Amir M., 2010, JPPS, V7, P71, DOI [10.5455/pms.20180825014739, DOI 10.5455/PMS.20180825014739]; Amiri L, 2013, CRISIS, V34, P116, DOI 10.1027/0227-5910/a000170; Angkurawaranon C, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2267-5; Aniebue PN, 2008, TROP DOCT, V38, P157, DOI 10.1258/td.2007.070202; Ashor AW, 2012, PAK J MED SCI, V28, P670; ASHTON CH, 1995, MED EDUC, V29, P187, DOI 10.1111/j.1365-2923.1995.tb02828.x; Aziz NAHA, 2011, J TAIBAH UNIV MED SC, V6, P139; Baldassin Sergio, 2008, BMC Med Educ, V8, P60, DOI 10.1186/1472-6920-8-60; Basnet B, 2012, Kathmandu Univ Med J (KUMJ), V10, P56; Bassols AM, 2014, REV BRAS PSIQUIATR, V36, P233, DOI 10.1590/1516-4446-2013-1183; Bayati A, 2009, Pak J Biol Sci, V12, P1371; Baykan Z, 2012, ACAD PSYCHIATR, V36, P64, DOI 10.1176/appi.ap.11060125; Bore M, 2016, ADV MED EDUC PRACT, V7, P125, DOI 10.2147/AMEP.S96802; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Borst Jorien M, 2016, Int J Adolesc Med Health, V28, P349, DOI 10.1515/ijamh-2015-0021; Bunevicius A, 2008, INT J SOC PSYCHIATR, V54, P494, DOI 10.1177/0020764008090843; CAMP DL, 1994, ACAD MED, V69, pS25, DOI 10.1097/00001888-199410000-00031; Carter FA, 2014, NEW ZEAL MED J, V127, P54; Castaldelli-Maia JM, 2012, J AFFECT DISORDERS, V139, P291, DOI 10.1016/j.jad.2012.02.003; Cavestro Julio de Melo, 2006, J. bras. psiquiatr., V55, P264; CHAN DW, 1992, J AFFECT DISORDERS, V24, P109, DOI 10.1016/0165-0327(92)90025-2; CHAN DW, 1991, COMPR PSYCHIAT, V32, P170, DOI 10.1016/0010-440X(91)90010-A; Chandavarkar U, 2007, DEPRESS ANXIETY, V24, P103, DOI 10.1002/da.20185; Chang E, 2012, ACAD PSYCHIATR, V36, P177, DOI 10.1176/appi.ap.11040079; Chen Jing-qi, 2004, Zhonghua Er Ke Za Zhi, V42, P39; Choi Jaewon, 2015, Korean J Med Educ, V27, P301, DOI 10.3946/kjme.2015.27.4.301; CLARK DC, 1988, JAMA-J AM MED ASSOC, V260, P2521, DOI 10.1001/jama.260.17.2521; Clarke DM, 2009, MED J AUSTRALIA, V190, pS54; Dahlin M, 2005, MED EDUC, V39, P594, DOI 10.1111/j.1365-2929.2005.02176.x; Dahlin M, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-92; David MA, 2013, INT J PHARM MED BIOL, V2, P27; Costa EFD, 2012, REV ASSOC MED BRAS, V58, P53; Leao PBDES, 2011, REV ASSOC MED BRAS, V57, P379; De Sousa Lima L, 2010, REV NEUROCIENCIAS, V18, P8; Del-Ben CM, 2013, MED TEACH, V35, P404, DOI 10.3109/0142159X.2013.769675; Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008; Dyrbye LN, 2007, ARCH INTERN MED, V167, P2103, DOI 10.1001/archinte.167.19.2103; Dyrbye LN, 2015, ACAD MED, V90, P961, DOI 10.1097/ACM.0000000000000655; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dyrbye LN, 2011, MED TEACH, V33, P756, DOI 10.3109/0142159X.2011.577468; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eisenberg D, 2007, AM J ORTHOPSYCHIAT, V77, P534, DOI 10.1037/0002-9432.77.4.534; El-Gilany AH, 2008, ANN SAUDI MED, V28, P442; Eller T, 2006, DEPRESS ANXIETY, V23, P250, DOI 10.1002/da.20166; Berner JE, 2014, ACAD PSYCHIATR, V38, P11, DOI 10.1007/s40596-013-0022-6; Eskin M, 2011, SOC PSYCH PSYCH EPID, V46, P813, DOI 10.1007/s00127-010-0254-7; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Farahangiz S, 2016, INT J HEALTH SCI-IJH, V10, P49, DOI 10.12816/0031216; Farwa Rizvi, 2015, British Journal of Medicine and Medical Research, V8, P69, DOI 10.9734/BJMMR/2015/17193; Ghodasara SL, 2011, ACAD MED, V86, P116, DOI 10.1097/ACM.0b013e3181ffb056; Givens JL, 2002, ACAD MED, V77, P918, DOI 10.1097/00001888-200209000-00024; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4; Goebert D, 2009, ACAD MED, V84, P236, DOI 10.1097/ACM.0b013e31819391bb; Gold JA, 2015, ACAD PSYCHIATR, V39, P37, DOI 10.1007/s40596-014-0202-z; Lopez JBG, 2013, GAC MED MEX, V149, P598; Gulec M, 2005, PSYCHIAT RES, V134, P281, DOI 10.1016/j.psychres.2003.02.001; Gupta S, 2013, INDIAN J PSYCHIAT, V55, P287, DOI 10.4103/0019-5545.117151; Guthrie E, 1998, J ROY SOC MED, V91, P237, DOI 10.1177/014107689809100502; Haglund MEM, 2009, ACAD MED, V84, P258, DOI 10.1097/ACM.0b013e31819381b1; Hardeman RR, 2015, J RACIAL ETHN HEALTH, V2, P403, DOI 10.1007/s40615-015-0087-x; Helmers KF, 1997, ACAD MED, V72, P708, DOI 10.1097/00001888-199708000-00018; HENDRYX MS, 1991, J PERS ASSESS, V56, P227, DOI 10.1207/s15327752jpa5602_4; HERZOG DB, 1987, J MED EDUC, V62, P651; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirata FC, 2007, CHRONOBIOL INT, V24, P939, DOI 10.1080/07420520701657730; Honney K, 2010, CLIN TEACH, V7, P180, DOI 10.1111/j.1743-498X.2010.00384.x; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; Ibrahim MB, 2015, ALEX J MED, V51, P167, DOI 10.1016/j.ajme.2014.06.002; Ibrahim N, 2013, IRAN J PUBLIC HEALTH, V42, P726; Ibrahim NKR, 2013, LIBYAN J MED, V8, DOI 10.3402/ljm.v8i0.21287; Imran N, 2016, ACAD PSYCHIATR, V40, P92, DOI 10.1007/s40596-015-0413-y; Inam S N B, 2003, J Pak Med Assoc, V53, P44; Inam Sn Bazmi, 2007, Int J Health Sci (Qassim), V1, P295; Iqbal S, 2015, INDIAN J MED RES, V141, P354; Jackson ER, 2016, ACAD MED, V91, P1251, DOI 10.1097/ACM.0000000000001138; Jadoon NA, 2010, J PAK MED ASSOC, V60, P699; James D, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-48; Jeong Y, 2010, EPIDEMIOL HEALTH, V32, DOI 10.4178/epih/e2010009; Jurkat HB, 2011, NERVENARZT, V82, P646, DOI 10.1007/s00115-010-3039-z; Karaoglu N., 2011, Turk Silahli Kuvvetleri,  Koruyucu Hekimlik Bulteni, V10, P303, DOI 10.5455/pmb.20101231125146; Kaya M, 2007, TURK PSIKIYATR DERG, V18, P137; Kerr LK, 2001, WESTERN J MED, V175, P349, DOI 10.1136/ewjm.175.5.349; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khan MA, 2015, RAWAL MED J, V40, P21; Khan Muhammad S., 2006, JPMA Journal of the Pakistan Medical Association, V56, P583; Khokher S, 2005, CRISIS, V26, P125, DOI 10.1027/0227-5910.26.3.125; Kim Bomi, 2014, Korean J Med Educ, V26, P53, DOI 10.3946/kjme.2014.26.1.53; Kotter T, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-134; Kohls N, 2012, Z PSYCHOSOM MED PSYC, V58, P409, DOI 10.13109/zptm.2012.58.4.409; Kongsomboon Kittipong, 2010, J Med Assoc Thai, V93 Suppl 2, pS106; Krill PR, 2016, J ADDICT MED, V10, P46, DOI 10.1097/ADM.0000000000000182; Kulsoom B, 2015, NEUROPSYCH DIS TREAT, V11, P1713, DOI 10.2147/NDT.S83577; Kumar Ganesh S, 2012, Indian J Psychiatry, V54, P223, DOI 10.4103/0019-5545.102412; Lapinski J, 2016, ACAD PSYCHIATR, V40, P55, DOI 10.1007/s40596-015-0375-0; Levine RE, 2006, ACAD PSYCHIATR, V30, P235, DOI 10.1176/appi.ap.30.3.235; Liao YH, 2010, COMPR PSYCHIAT, V51, P516, DOI 10.1016/j.comppsych.2009.11.007; Ludwig AB, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0425-z; Lupo MK, 2011, ISR MED ASSOC J, V13, P613; MacLean L, 2016, ACAD PSYCHIATR, V40, P89, DOI 10.1007/s40596-015-0301-5; Manaf NA, 2016, J CLIN DIAGN RES, V10, pVC1, DOI 10.7860/JCDR/2016/16678.7341; Mancevska S, 2008, BRATISL MED J, V109, P568; Marakoglu K, 2006, BAGIMLIK DERGISI, V7, P129; Marwat M. A., 2013, Journal of Postgraduate Medical Institute, V27, P26; Mata DA, 2016, ACAD MED, V91, P1244, DOI 10.1097/ACM.0000000000001227; Mata DA, 2015, JAMA-J AM MED ASSOC, V314, P2373, DOI 10.1001/jama.2015.15845; Mata DA, 2015, MED EDUC, V49, P741, DOI 10.1111/medu.12742; Matheson KM, 2016, ACAD PSYCHIATR, V40, P63, DOI 10.1007/s40596-015-0395-9; Mayda AS, 2010, GAZI MED J, V21, P23; Mehanna Z, 2006, ENCEPHALE, V32, P976; Melo-Carrillo A, 2012, J AFFECT DISORDERS, V136, P1098, DOI 10.1016/j.jad.2011.10.040; Menezes RG, 2012, LEGAL MED-TOKYO, V14, P183, DOI 10.1016/j.legalmed.2012.02.004; Miletic V, 2015, SOC PSYCH PSYCH EPID, V50, P633, DOI 10.1007/s00127-014-0950-9; Moher David, 2009, Open Med, V3, pe123; Mojs EH, 2015, ARCH MED SCI, V11, P605, DOI 10.5114/aoms.2013.38179; MOSLEY TH, 1994, ACAD MED, V69, P765, DOI 10.1097/00001888-199409000-00024; Mousa OY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156554; Myers M, 2003, ACAD PSYCHIATR, V27, P19, DOI 10.1176/appi.ap.27.1.19; Naja WJ, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.4551; Nasioudis D, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0058-x; Newbury-Birch D, 2001, DRUG ALCOHOL DEPEN, V64, P265, DOI 10.1016/S0376-8716(01)00128-4; OKASHA A, 1981, ACTA PSYCHIAT SCAND, V63, P409, DOI 10.1111/j.1600-0447.1981.tb00690.x; Oku Afiong, 2015, Open Access Maced J Med Sci, V3, P356, DOI 10.3889/oamjms.2015.068; Osama M, 2014, J FORENSIC LEG MED, V27, P65, DOI 10.1016/j.jflm.2014.08.006; Pan XF, 2016, PSYCHOL HEALTH MED, V21, P882, DOI 10.1080/13548506.2015.1127395; Paro HBMS, 2010, MED EDUC, V44, P227, DOI 10.1111/j.1365-2923.2009.03587.x; Peleg-Sagy T, 2013, J SEX MED, V10, P1737, DOI 10.1111/jsm.12176; Peleg-Sagy T, 2012, PSYCHIATRY, V75, P167, DOI 10.1521/psyc.2012.75.2.167; Pereyra-Elías Reneé, 2010, Rev. perú. med. exp. salud publica, V27, P520, DOI 10.1590/s1726-46342010000400005; Perveen Shagufta, 2016, J Ayub Med Coll Abbottabad, V28, P94; Phillips LC, 2006, REV HOSP PSIQUIATRIC, V3; Pickard M, 2000, MED EDUC, V34, P148, DOI 10.1046/j.1365-2923.2000.00491.x; Pillay Narushni, 2016, S. Afr. j. psyc., V22, P1, DOI [10.4102/sajpsychiatry.v22i1.731, 10.4102/Sajpsychiatry. v22i1.731]; Pratt Laura A, 2014, NCHS Data Brief, P1; Prinz Patrick, 2012, GMS Z Med Ausbild, V29, pDoc10, DOI 10.3205/zma000780; Puthran R, 2016, MED EDUC, V50, P456, DOI 10.1111/medu.12962; Quince TA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001519; Tran QA, 2015, ASIA-PAC J PUBLIC HE, V27, p26S, DOI 10.1177/1010539515589812; R Development Core Team, 2009, R LANG ENV STAT COMP; Rab F., 2008, Eastern Mediterranean Health Journal, V14, P126; Ristic-Ignjatovic D, 2013, ACTA CLIN CROAT, V52, P157; Roh MS, 2009, MED EDUC, V43, P133, DOI 10.1111/j.1365-2923.2008.03255.x; Nava FR, 2013, SALUD MENT, V36, P375; Romo-Nava F, 2016, CHRONOBIOL INT, V33, P1359, DOI 10.1080/07420528.2016.1217230; Rosal MC, 1997, ACAD MED, V72, P542, DOI 10.1097/00001888-199706000-00022; Rosenthal JM, 2005, NEW ENGL J MED, V353, P1085, DOI 10.1056/NEJMp058183; Saeed AA, 2016, J FAM COMMUNITY MED, V23, P166, DOI 10.4103/2230-8229.189132; Samaranayake CB, 2011, NEW ZEAL MED J, V124, P12; Saravanan Coumaravelou, 2014, ScientificWorldJournal, V2014, P737382, DOI 10.1155/2014/737382; Schwenk TL, 2010, JAMA-J AM MED ASSOC, V304, P1181, DOI 10.1001/jama.2010.1300; Serra Rosana Denobile, 2015, J. bras. psiquiatr., V64, P213, DOI 10.1590/0047-2085000000081; Seweryn M, 2015, PSYCH DAN, V27, pS216; Shah AA, 2009, SUBST ABUS, V30, P141, DOI 10.1080/08897070902802067; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7; Shariatpanaahi MV, 2007, EUR J CLIN NUTR, V61, P532, DOI 10.1038/sj.ejcn.1602542; Shen L, 2009, J GASTROEN HEPATOL, V24, P1885, DOI 10.1111/j.1440-1746.2009.05943.x; Sherina M S, 2004, Med J Malaysia, V59, P207; Shi M, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0710-3; Shi M, 2015, PERS INDIV DIFFER, V83, P55, DOI 10.1016/j.paid.2015.03.050; Shindel AW, 2011, J SEX MED, V8, P391, DOI 10.1111/j.1743-6109.2010.02085.x; Sidana S, 2012, AUSTRALAS MED J, V5, P247, DOI 10.4066/AMJ.2012.750; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Smith Carol Klose, 2007, Psychol Health Med, V12, P31, DOI 10.1080/13548500500429387; Smith JF, 2011, J SEX MED, V8, P3363, DOI 10.1111/j.1743-6109.2011.02463.x; Smith JF, 2010, J SEX MED, V7, P3909, DOI 10.1111/j.1743-6109.2010.02033.x; Sobowale K, 2014, INT J MED EDUC, V5, P31, DOI 10.5116/ijme.52e3.a465; Spring L, 2011, MED EDUC, V45, P867, DOI 10.1111/j.1365-2923.2011.03989.x; Sreeramareddy Chandrashekhar T, 2007, BMC Med Educ, V7, P26, DOI 10.1186/1472-6920-7-26; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Steptoe A, 2007, INT J BEHAV MED, V14, P97, DOI 10.1007/BF03004175; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun L, 2011, INT J PSYCHIAT MED, V42, P29, DOI 10.2190/PM.42.1.c; Supe A N, 1998, J Postgrad Med, V44, P1; Tan S T, 2015, Med J Malaysia, V70, P1; Tang Q.S., 2005, CHINESE J CLIN REHAB, V9, P90; Thomas MR, 2007, J GEN INTERN MED, V22, P177, DOI 10.1007/s11606-006-0039-6; Thompson D, 2010, ACAD MED, V85, P1635, DOI 10.1097/ACM.0b013e3181f0b49c; Thompson G, 2016, TEACH LEARN MED, V28, P174, DOI 10.1080/10401334.2016.1146611; Tjia J, 2005, J AM COLL HEALTH, V53, P219, DOI 10.3200/JACH.53.5.219-224; Tyssen R, 2001, J AFFECT DISORDERS, V64, P69, DOI 10.1016/S0165-0327(00)00205-6; Valle Rubén, 2013, Rev. perú. med. exp. salud publica, V30, P54, DOI 10.1590/s1726-46342013000100011; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Vankar Jagdish R, 2014, Indian J Psychol Med, V36, P246, DOI 10.4103/0253-7176.135372; Vaysse B, 2014, SANTE PUBLIQUE, V26, P613, DOI 10.3917/spub.145.0613; VITALIANO PP, 1988, J BEHAV MED, V11, P311, DOI 10.1007/BF00844933; Voltmer E, 2012, MED TEACH, V34, P840, DOI 10.3109/0142159X.2012.706339; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wahed WYA, 2017, ALEX J MED, V53, P77, DOI 10.1016/j.ajmc.2016.01.005; Walkiewicz M, 2012, MED TEACH, V34, pE611, DOI 10.3109/0142159X.2012.687478; Wallin U, 2003, EUR PSYCHIAT, V18, P329, DOI 10.1016/j.eurpsy.2003.03.006; Wan Yu-hui, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P474; Waqas A, 2015, CUREUS, V7, DOI 10.7759/cureus.337; Wege N, 2016, PUBLIC HEALTH, V132, P92, DOI 10.1016/j.puhe.2015.12.014; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; Williams DE, 2016, OCHSNER J, V16, P14; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; Wimsatt LA, 2015, AM J PREV MED, V49, P703, DOI 10.1016/j.amepre.2015.03.021; Wolf MR, 2017, ACAD PSYCHIATR, V41, P174, DOI 10.1007/s40596-016-0526-y; Wongpakaran N, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-6; Yang F, 2014, J HUAZHONG U SCI-MED, V34, P443, DOI 10.1007/s11596-014-1298-9; Yilmaz Y, 2014, ERCIYES MED J, V36, P75, DOI 10.5152/etd.2014.6472; Yoon S, 2014, ACAD PSYCHIATR, V38, P661, DOI 10.1007/s40596-014-0140-9; Youssef FF, 2016, ACAD PSYCHIATR, V40, P69, DOI 10.1007/s40596-015-0468-9; Yusoff Muhamad S B, 2013, Sultan Qaboos Univ Med J, V13, P107; Yusoff MSB, 2013, PSYCHOL HEALTH MED, V18, P420, DOI 10.1080/13548506.2012.740162; Yusoff MSB, 2011, INT MED J, V18, P305; ZELDOW PB, 1987, J PERS ASSESS, V51, P3, DOI 10.1207/s15327752jpa5101_1; ZOCCOLILLO M, 1986, J AFFECT DISORDERS, V11, P91, DOI 10.1016/0165-0327(86)90065-0	230	882	927	32	224	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2016	316	21					2214	2236		10.1001/jama.2016.17324	http://dx.doi.org/10.1001/jama.2016.17324			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0YV	27923088	Green Accepted			2022-12-28	WOS:000389307400009
J	Bouhaddou, M; DiStefano, MS; Riesel, EA; Carrasco, E; Holzapfel, HY; Jones, DC; Smith, GR; Stern, AD; Somani, SS; Thompson, TV; Birtwistle, MR				Bouhaddou, Mehdi; DiStefano, Matthew S.; Riesel, Eric A.; Carrasco, Emilce; Holzapfel, Hadassa Y.; Jones, DeAnalisa C.; Smith, Gregory R.; Stern, Alan D.; Somani, Sulaiman S.; Thompson, T. Victoria; Birtwistle, Marc R.			Drug response consistency in CCLE and CGP	NATURE			English	Letter							SENSITIVITY		[Bouhaddou, Mehdi; DiStefano, Matthew S.; Riesel, Eric A.; Carrasco, Emilce; Holzapfel, Hadassa Y.; Jones, DeAnalisa C.; Smith, Gregory R.; Stern, Alan D.; Somani, Sulaiman S.; Thompson, T. Victoria; Birtwistle, Marc R.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Birtwistle, Marc R.] Icahn Sch Med Mt Sinai, DToXS LINCS Ctr, New York, NY 10029 USA; [Birtwistle, Marc R.] Icahn Sch Med Mt Sinai, Syst Biol Ctr New York, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Birtwistle, MR (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.; Birtwistle, MR (corresponding author), Icahn Sch Med Mt Sinai, DToXS LINCS Ctr, New York, NY 10029 USA.; Birtwistle, MR (corresponding author), Icahn Sch Med Mt Sinai, Syst Biol Ctr New York, New York, NY 10029 USA.	marc.birtwistle@mssm.edu		Bouhaddou, Mehdi/0000-0002-9526-1427; Birtwistle, Marc/0000-0002-0341-0705; Thompson, Taylor/0000-0002-0378-0052; Smith, Gregory/0000-0003-0112-6134; Somani, Sulaiman/0000-0003-0913-8674; Jones, DeAnalisa/0000-0002-8737-6152	NATIONAL CANCER INSTITUTE [R21CA196418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104184, P50GM071558, T32GM062754] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA196418] Funding Source: Medline; NHGRI NIH HHS [U54 HG008098] Funding Source: Medline; NIGMS NIH HHS [R01 GM104184, P50 GM071558, T32 GM062754] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831	3	36	36	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					E9	+		10.1038/nature20580	http://dx.doi.org/10.1038/nature20580			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905419	Green Accepted			2022-12-28	WOS:000388916600012
J	Sampson, TR; Debelius, JW; Thron, T; Janssen, S; Shastri, GG; Ilhan, ZE; Challis, C; Schretter, CE; Rocha, S; Gradinaru, V; Chesselet, MF; Keshavarzian, A; Shannon, KM; Krajmalnik-Brown, R; Wittung-Stafshede, P; Knight, R; Mazmanian, SK				Sampson, Timothy R.; Debelius, Justine W.; Thron, Taren; Janssen, Stefan; Shastri, Gauri G.; Ilhan, Zehra Esra; Challis, Collin; Schretter, Catherine E.; Rocha, Sandra; Gradinaru, Viviana; Chesselet, Marie-Francoise; Keshavarzian, Ali; Shannon, Kathleen M.; Krajmalnik-Brown, Rosa; Wittung-Stafshede, Pernilla; Knight, Rob; Mazmanian, Sarkis K.			Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease	CELL			English	Article							CHAIN FATTY-ACIDS; ALPHA-SYNUCLEIN; BRAIN-DEVELOPMENT; GROWTH-FACTOR; MICROGLIA; BEHAVIOR; SYSTEM; INFLAMMATION; METABOLITES; DIVERSITY	The intestinal microbiota influence neurodevelopment, modulate behavior, and contribute to neurological disorders. However, a functional link between gut bacteria and neurodegenerative diseases remains unexplored. Synucleinopathies are characterized by aggregation of the protein alpha-synuclein (alpha Syn), often resulting in motor dysfunction as exemplified by Parkinson's disease (PD). Using mice that overexpress aSyn, we report herein that gut microbiota are required for motor deficits, microglia activation, and alpha Syn pathology. Antibiotic treatment ameliorates, while microbial re-colonization promotes, pathophysiology in adult animals, suggesting that postnatal signaling between the gut and the brain modulates disease. Indeed, oral administration of specific microbial metabolites to germ-free mice promotes neuroinflammation and motor symptoms. Remarkably, colonization of alpha Syn-overexpressing mice with microbiota from PD-affected patients enhances physical impairments compared to microbiota transplants from healthy human donors. These findings reveal that gut bacteria regulate movement disorders in mice and suggest that alterations in the human microbiome represent a risk factor for PD.	[Sampson, Timothy R.; Thron, Taren; Shastri, Gauri G.; Challis, Collin; Schretter, Catherine E.; Gradinaru, Viviana; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Debelius, Justine W.; Janssen, Stefan; Knight, Rob] Univ Calif San Diego, Dept Pediat, San Diego, CA 92110 USA; [Ilhan, Zehra Esra; Krajmalnik-Brown, Rosa] Arizona State Univ, Biodesign Inst, Swette Ctr Environm Biotechnol, Tempe, AZ 85287 USA; [Rocha, Sandra; Wittung-Stafshede, Pernilla] Chalmers Univ Technol, Biol & Biol Engn Dept, S-41296 Gothenburg, Sweden; [Chesselet, Marie-Francoise] UCLA, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Keshavarzian, Ali] Rush Univ, Div Gastroenterol, Dept Internal Med, Med Ctr, Chicago, IL 60612 USA; [Shannon, Kathleen M.] Rush Univ, Sect Movement Disorders, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92093 USA; [Shannon, Kathleen M.] Univ Wisconsin, Dept Neurol, Madison, WI 53705 USA	California Institute of Technology; University of California System; University of California San Diego; Arizona State University; Arizona State University-Tempe; Chalmers University of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Rush University; Rush University; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison	Sampson, TR; Mazmanian, SK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	trsamps@caltech.edu; sarkis@caltech.edu	Krajmalnik-Brown, Rosa/AAA-4803-2021; wittung-stafshede, pernilla/AAV-4392-2021; , Beloeil/I-5451-2014; Rocha, Sandra/Q-8427-2019; Debelius, Justine/ABE-7272-2021; Rocha, Sandra/G-6677-2013	wittung-stafshede, pernilla/0000-0003-1058-1964; , Beloeil/0000-0002-1474-3898; Sampson, Timothy/0000-0002-2486-8766; Ilhan, Zehra Esra/0000-0002-3387-9424; Janssen, Stefan/0000-0003-0955-0589; Challis, Collin/0000-0003-4716-6086; Schretter, Catherine/0000-0002-3957-6838; Knight, Rob/0000-0002-0975-9019; Krajmalnik-Brown, Rosa/0000-0001-6064-3524; Rocha, Sandra/0000-0002-4530-3537	Caltech Beckman Institute; Arnold and Mabel Beckman Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council; NIH [NS085910]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085910] Funding Source: NIH RePORTER	Caltech Beckman Institute; Arnold and Mabel Beckman Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Hsiao, M. Sampson, and the S.K.M. laboratory for helpful critiques. We are grateful to K. Ly, A. Maskell, and M. Quintos for animal husbandry and Y. Garcia-Flores, G. Ackermann, G. Humphrey, and H. Derderian for technical support. Imaging and analysis was performed in the Caltech Biological Imaging Facility, with the support of the Caltech Beckman Institute and the Arnold and Mabel Beckman Foundation. T.R.S. is a Larry L. Hillblom Foundation postdoctoral fellow. This project was supported by funds from the Knut and Alice Wallenberg Foundation and Swedish Research Council to P.W.-S.; a gift from Mrs. and Mr. Larry Field to A. K.; the Heritage Medical Research Institute to V.G. and S.K.M.; and NIH grant NS085910 to S.K.M.	Beilina A, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13266; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Burke RE, 2008, ANN NEUROL, V64, P485, DOI 10.1002/ana.21541; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P297, DOI 10.1007/s13311-012-0104-2; Chorell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140194; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Cleynen I, 2014, GUT, V63, P1265, DOI 10.1136/gutjnl-2012-303205; Del Tredici K, 2008, ACTA NEUROPATHOL, V115, P379, DOI 10.1007/s00401-008-0355-5; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Dinan TG, 2015, CURR OPIN CLIN NUTR, V18, P552, DOI 10.1097/MCO.0000000000000221; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Gao B, 2016, ENV HLTH PERSPECT; Gao HM, 2011, ENVIRON HEALTH PERSP, V119, P807, DOI 10.1289/ehp.1003013; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hoban AE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.42; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Klucken J, 2006, ACTA NEUROPATHOL, V111, P101, DOI 10.1007/s00401-005-0027-7; Kohman RA, 2013, BEHAV BRAIN RES, V242, P17, DOI 10.1016/j.bbr.2012.12.032; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lin R, 2014, J DIGEST DIS, V15, P597, DOI 10.1111/1751-2980.12179; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mayer EA, 2014, BIOESSAYS, V36, P933, DOI 10.1002/bies.201400075; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Ritz Beate R, 2016, Curr Environ Health Rep, V3, P40, DOI 10.1007/s40572-016-0083-2; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Selkrig J, 2014, GUT MICROBES, V5, P369, DOI 10.4161/gmic.28681; Shannon KM, 2012, MOVEMENT DISORD, V27, P716, DOI 10.1002/mds.25020; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; Valera E, 2016, MOVEMENT DISORD, V31, P225, DOI 10.1002/mds.26428; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Verbaan D, 2007, NEUROLOGY, V69, P333, DOI 10.1212/01.wnl.0000266593.50534.e8; Wall R, 2014, ADV EXP MED BIOL, V817, P221, DOI 10.1007/978-1-4939-0897-4_10; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wang L, 2012, NEUROGASTROENT MOTIL, V24, pe425, DOI 10.1111/j.1365-2982.2012.01974.x; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zhang JP, 2014, J NEUROGENET, V28, P98, DOI 10.3109/01677063.2014.892486	71	1623	1715	77	942	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1469	+		10.1016/j.cell.2016.11.018	http://dx.doi.org/10.1016/j.cell.2016.11.018			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912057	Bronze, Green Accepted			2022-12-28	WOS:000389470500011
J	Nieto, T; Inston, N; Cockwell, P				Nieto, Tom; Inston, Nicholas; Cockwell, Paul			Renal transplantation in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE; DELAYED GRAFT FUNCTION; REPLACEMENT THERAPY; CANCER INCIDENCE; KIDNEY; RECIPIENTS; SURVIVAL; PREGNANCY; OUTCOMES; RISK		[Nieto, Tom; Inston, Nicholas; Cockwell, Paul] Univ Birmingham, Coll Med & Dent Sci, Renal Serv, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Nieto, T (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Renal Serv, Birmingham B15 2TT, W Midlands, England.	t.nieto@bham.ac.uk		Cockwell, Paul/0000-0003-1975-266X				Akkina SK, 2009, AM J TRANSPLANT, V9, P1460, DOI 10.1111/j.1600-6143.2009.02651.x; [Anonymous], 2016, ANN REP KIDN TRANSPL; Ansell D, 2008, TRANSPLANTATION, V86, P314, DOI [DOI 10.1097/01.TP.0000331846.01658.38, 10.1097/01]; Bailey P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4746; Berger JC, 2011, CLIN J AM SOC NEPHRO, V6, P2887, DOI 10.2215/CJN.04160511; British Transplantation Society and the Renal Association, 2011, UK GUID LIV DON KIDN; Bunnapradist S, 2010, CLIN J AM SOC NEPHRO, V5, P1910, DOI 10.2215/CJN.08731010; Cross NB, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003598.pub2; Cunningham J, 2005, TRANSPLANTATION, V79, P629, DOI 10.1097/01.TP.0000149698.79739.EF; Danziger-Isakov L, 2013, AM J TRANSPLANT, V13, P311, DOI 10.1111/ajt.12122; Davis CL, 2010, CURR OPIN NEPHROL HY, V19, P592, DOI 10.1097/MNH.0b013e32833e04f5; Dudley C, 2011, NEPHRON CLIN PRACT, V118, pC209, DOI 10.1159/000328070; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Farrugia D, 2014, TRANSPL INT, V27, P262, DOI 10.1111/tri.12218; Ferro CJ, 2015, CLIN TRANSPLANT, V29, P1004, DOI 10.1111/ctr.12621; Fischer MJ, 2004, AM J KIDNEY DIS, V43, P415, DOI 10.1053/j.ajkd.2003.10.041; Gaston RS, 2009, AM J TRANSPLANT, V9, P1811, DOI 10.1111/j.1600-6143.2009.02696.x; Haller MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005632.pub3; Hauch A, 2015, SURGERY, V158, P1049, DOI 10.1016/j.surg.2015.05.024; Holdaas H, 2003, Minerva Urol Nefrol, V55, P111; Hou S, 1999, AM J KIDNEY DIS, V33, P235, DOI 10.1016/S0272-6386(99)70296-9; Kasiske BL, 2010, KIDNEY INT, V77, P299, DOI 10.1038/ki.2009.377; Krishnan N, 2010, TRANSPLANTATION, V89, P1456, DOI 10.1097/TP.0b013e3181da6019; Machnicki G, 2011, ARCH MED SCI, V7, P278, DOI 10.5114/aoms.2011.22079; MacNeill SJ, 2016, NEPHRON, V132, P41, DOI 10.1159/000444816; McKay DB, 2006, NEW ENGL J MED, V354, P1281, DOI 10.1056/NEJMra050431; Michelle Barclay LB, 2013, TRANSPLANT 1 TIMELY; Mitterbauer C, 2006, NEPHROL DIAL TRANSPL, V21, P2275, DOI 10.1093/ndt/gfl104; National Institue for Health and Care Excellence, 2016, KIDN TRANSPL AD IMM; Oniscu GC, 2005, J AM SOC NEPHROL, V16, P1859, DOI 10.1681/ASN.2004121092; Orandi BJ, 2015, TRANSPLANTATION, V99, P997, DOI 10.1097/TP.0000000000000450; Palmer SC, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007784.pub2, 10.1590/1516-3180.20141325T1]; Palovaara S, 2000, BRIT J CLIN PHARMACO, V50, P333, DOI 10.1046/j.1365-2125.2000.00271.x; Pilmore HL, 2011, TRANSPLANTATION, V91, P542, DOI 10.1097/TP.0b013e31820437bd; Pippias M, 2015, CLIN KIDNEY J, V8, P248, DOI 10.1093/ckj/sfv014; Reddy KS, 2003, AM J KIDNEY DIS, V41, P464, DOI 10.1053/ajkd.2003.50057; Sharif A, 2016, LANCET DIABETES ENDO, V4, P337, DOI 10.1016/S2213-8587(15)00387-3; Sifontis NM, 2006, TRANSPLANTATION, V82, P1698, DOI 10.1097/01.tp.0000252683.74584.29; Steenkamp R, 2016, NEPHRON, V132, P111, DOI 10.1159/000444819; Tennankore KK, 2014, J AM SOC NEPHROL, V25, P2113, DOI 10.1681/ASN.2013111180; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; Wanner C, 2014, KIDNEY INT, V85, P1303, DOI 10.1038/ki.2014.31; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zalewska K., 2016, KIDNEY TRANSPLANTATI	45	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2016	355								i6158	10.1136/bmj.i6158	http://dx.doi.org/10.1136/bmj.i6158			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZD	27903494				2022-12-28	WOS:000389308600006
J	Mayor, S				Mayor, Susan			One in three with mild cognitive impairment has depression, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ismail Z, 2017, JAMA PSYCHIAT, V74, P58, DOI 10.1001/jamapsychiatry.2016.3162	1	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2016	355								i6387	10.1136/bmj.i6387	http://dx.doi.org/10.1136/bmj.i6387			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YW	27895031				2022-12-28	WOS:000389307600012
J	Fabi, R; Saloner, B				Fabi, Rachel; Saloner, Brendan			Covering Undocumented Immigrants - State Innovation in California	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fabi, Rachel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fabi, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.							[Anonymous], 2015, HLTH INSURANCE CO PL; Artiga S., 2016, HLTH COVERAGE CARE I; Ponce Ninez, 2011, Policy Brief UCLA Cent Health Policy Res, P1; Saloner B, 2014, HEALTH AFFAIR, V33, P832, DOI 10.1377/hlthaff.2013.1363; Wallace, 2012, UNDOCUMENTED IMMIGRA	5	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1913	1915		10.1056/NEJMp1609468	http://dx.doi.org/10.1056/NEJMp1609468			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC1HS	27959599				2022-12-28	WOS:000387856100001
J	Sacks, CA; Goldstein, RH; Walensky, RP				Sacks, Chana A.; Goldstein, Robert H.; Walensky, Rochelle P.			Rethinking the Ban - The US Blood Supply and Men Who Have Sex with Men	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSFUSION		[Sacks, Chana A.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Sacks, Chana A.; Goldstein, Robert H.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Goldstein, Robert H.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.] Harvard Univ, Ctr AIDS Res, Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sacks, CA (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.; Sacks, CA (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.							[Anonymous], SUMM SAF EFF DAT HUM; BALDWIN T, 2016, COMMUNICATION; Brailsford SR, 2015, TRANSFUSION MED, V25, P234, DOI 10.1111/tme.12225; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; CUMMING PD, 1989, NEW ENGL J MED, V321, P941, DOI 10.1056/NEJM198910053211405; Custer B, 2015, TRANSFUSION, V55, P2826, DOI 10.1111/trf.13247; Food and Drug Administration, 2016, GUID IND REV REC RED; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Lynch Blake, 2016, NY TIMES; Makadon HJ, 2006, NEW ENGL J MED, V354, P895, DOI 10.1056/NEJMp058259; Pear Robert, 1985, NY TIMES; Shilts R., 2007, BAND PLAYED POLITICS; Starr Douglas, 1998, BLOOD EPIC HIST MED; WEISS SH, 1985, JAMA-J AM MED ASSOC, V253, P221, DOI 10.1001/jama.253.2.221	14	21	21	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2017	376	2					174	177		10.1056/NEJMms1613425	http://dx.doi.org/10.1056/NEJMms1613425			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI0XI	27959708				2022-12-28	WOS:000392198400015
J	Bakker, P; Clark, PU; Golledge, NR; Schmittner, A; Weber, ME				Bakker, Pepijn; Clark, Peter U.; Golledge, Nicholas R.; Schmittner, Andreas; Weber, Michael E.			Centennial-scale Holocene climate variations amplified by Antarctic Ice Sheet discharge	NATURE			English	Article							SOUTHERN-OCEAN; LAST DEGLACIATION; VARIABILITY; MODEL; SEA; HEMISPHERE; ATLANTIC	Proxy-based indicators of past climate change show that current global climate models systematically underestimate Holocene-epoch climate variability on centennial to multi-millennial timescales, with the mismatch increasing for longer periods(1-5). Proposed explanations for the discrepancy include ocean-atmosphere coupling that is too weak in models(6), insufficient energy cascades from smaller to larger spatial and temporal scales(7), or that global climate models do not consider slow climate feedbacks related to the carbon cycle or interactions between ice sheets and climate(4). Such interactions, however, are known to have strongly affected centennial-to orbital-scale climate variability during past glaciations(8-11), and are likely to be important in future climate change(12-14). Here we show that fluctuations in Antarctic Ice Sheet discharge caused by relatively small changes in subsurface ocean temperature can amplify multi-centennial climate variability regionally and globally, suggesting that a dynamic Antarctic Ice Sheet may have driven climate fluctuations during the Holocene. We analysed high-temporal-resolution records of iceberg-rafted debris derived from the Antarctic Ice Sheet, and performed both high-spatial-resolution ice-sheet modelling of the Antarctic Ice Sheet and multi-millennial global climate model simulations. Ice-sheet responses to decadal-scale ocean forcing appear to be less important, possibly indicating that the future response of the Antarctic Ice Sheet will be governed more by long-term anthropogenic warming combined with multi-centennial natural variability than by annual or decadal climate oscillations.	[Bakker, Pepijn; Clark, Peter U.; Schmittner, Andreas] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Golledge, Nicholas R.] Victoria Univ Wellington, Antarct Res Ctr, Wellington, New Zealand; [Golledge, Nicholas R.] GNS Sci, Lower Hutt, New Zealand; [Weber, Michael E.] Univ Bonn, Steinmann Inst, Bonn, Germany; [Weber, Michael E.] Univ Cambridge, Dept Earth Sci, Cambridge, England	Oregon State University; Victoria University Wellington; GNS Science - New Zealand; University of Bonn; University of Cambridge	Bakker, P (corresponding author), Univ Bremen, Ctr Marine Environm Sci, MARUM, Bremen, Germany.	pbakker@marum.de	Schmittner, Andreas/O-9647-2015	Schmittner, Andreas/0000-0002-8376-0843; Golledge, Nicholas/0000-0001-7676-8970; Weber, Michael E/0000-0003-2175-8980	National Oceanographic and Atmospheric Administration [NA15OAR4310239]; Antarctic Glaciology Program of the National Science Foundation [1043517]; Royal Society of New Zealand's Marsden Fund [VUW1203]; Deutsche Forschungsgemeinschaft (DFG) [We2039/8-1]; NASA [NNX13AM16G, NNX13AK27G]	National Oceanographic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Antarctic Glaciology Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Royal Society of New Zealand's Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by a grant from the National Oceanographic and Atmospheric Administration (award number NA15OAR4310239 to P.B. and A.S.), the Antarctic Glaciology Program of the National Science Foundation (grant number 1043517 to P.U.C.), the Royal Society of New Zealand's Marsden Fund (grant number VUW1203 to N.R.G.) and the Deutsche Forschungsgemeinschaft (DFG grant number We2039/8-1 to M.E.W.). We thank L. Menviel for providing us with the LOVECLIM-based Southern Ocean subsurface temperature data. Development of PISM is supported by NASA grants NNX13AM16G and NNX13AK27G.	Abram NJ, 2016, NATURE, V536, P411, DOI 10.1038/nature19082; Bakker P., ICEBERG RAFTED DEBRI; Bentley MJ, 2014, QUATERNARY SCI REV, V100, P1, DOI 10.1016/j.quascirev.2014.06.025; Bothe O, 2015, CLIM PAST, V11, P1673, DOI 10.5194/cp-11-1673-2015; Broecker W, 1992, CLIM DYNAM, V6, P265, DOI 10.1007/BF00193540; Bueler E, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001179; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; Collins M, 2002, J CLIMATE, V15, P1497, DOI 10.1175/1520-0442(2002)015&lt;1497:ACOTVO&gt;2.0.CO;2; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Cuzzone JK, 2016, EARTH PLANET SC LETT, V448, P34, DOI 10.1016/j.epsl.2016.05.019; Delworth TL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052107; Ferrari R, 2009, ANNU REV FLUID MECH, V41, P253, DOI 10.1146/annurev.fluid.40.111406.102139; Fischer H, 2007, EARTH PLANET SC LETT, V260, P340, DOI 10.1016/j.epsl.2007.06.014; Fogwill CJ, 2015, EARTHS FUTURE, V3, P317, DOI 10.1002/2015EF000306; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Golledge NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6107; Goosse H, 2005, QUATERNARY SCI REV, V24, P1345, DOI 10.1016/j.quascirev.2004.12.009; Green JAM, 2015, J CLIMATE, V28, P9221, DOI 10.1175/JCLI-D-15-0110.1; Laepple T, 2014, P NATL ACAD SCI USA, V111, P16682, DOI 10.1073/pnas.1412077111; Liu Y, 2015, P NATL ACAD SCI USA, V112, P3263, DOI 10.1073/pnas.1415137112; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Lovejoy S, 2013, EARTH SYST DYNAM, V4, P439, DOI 10.5194/esd-4-439-2013; Menary MB, 2012, CLIM DYNAM, V38, P2377, DOI 10.1007/s00382-011-1172-4; Menviel L, 2011, QUATERNARY SCI REV, V30, P1155, DOI 10.1016/j.quascirev.2011.02.005; Menviel L, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001892; Sprenk D, 2013, GEOL SOC SPEC PUBL, V381, P245, DOI 10.1144/SP381.17; Swingedouw D, 2015, CLIM DYNAM, V44, P3261, DOI 10.1007/s00382-014-2270-x; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; Weber ME, 2014, NATURE, V510, P134, DOI 10.1038/nature13397; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016; Zorita E, 2010, CLIMATIC CHANGE, V101, P143, DOI 10.1007/s10584-010-9824-7; Zunz V, 2013, CRYOSPHERE, V7, P451, DOI 10.5194/tc-7-451-2013	34	43	46	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					72	+		10.1038/nature20582	http://dx.doi.org/10.1038/nature20582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	27951585				2022-12-28	WOS:000396119500031
J	Heintz, C; Doktor, TK; Lanjuin, A; Escoubas, CC; Zhang, Y; Weir, HJ; Dutta, S; Silva-Garcia, CG; Bruun, GH; Morantte, I; Hoxhaj, G; Manning, BD; Andresen, BS; Mair, WB				Heintz, Caroline; Doktor, Thomas K.; Lanjuin, Anne; Escoubas, Caroline C.; Zhang, Yue; Weir, Heather J.; Dutta, Sneha; Silva-Garcia, Carlos Giovanni; Bruun, Gitte H.; Morantte, Ianessa; Hoxhaj, Gerta; Manning, Brendan D.; Andresen, Brage S.; Mair, William B.			Splicing factor 1 modulates dietary restriction and TORC1 pathway longevity in C. elegans	NATURE			English	Article							U2AF LARGE SUBUNIT; LIFE-SPAN; FACTOR SF1; PROTEIN; INTERACTS; GENETICS; REVEALS; DISEASE; CRTC-1; GENES	Ageing is driven by a loss of transcriptional and protein homeostasis(1-3) and is the key risk factor for multiple chronic diseases. Interventions that attenuate or reverse systemic dysfunction associated with age therefore have the potential to reduce overall disease risk in the elderly. Precursor mRNA (pre-mRNA) splicing is a fundamental link between gene expression and the proteome, and deregulation of the splicing machinery is linked to several age-related chronic illnesses(4,5). However, the role of splicing homeostasis in healthy ageing remains unclear. Here we demonstrate that pre-mRNA splicing homeostasis is a biomarker and predictor of life expectancy in Caenorhabditis elegans. Using transcriptomics and in-depth splicing analysis in young and old animals fed ad libitum or subjected to dietary restriction, we find defects in global pre-mRNA splicing with age that are reduced by dietary restriction via splicing factor 1 (SFA-1; the C. elegans homologue of SF1, also known as branchpoint binding protein, BBP). We show that SFA-1 is specifically required for lifespan extension by dietary restriction and by modulation of the TORC1 pathway components AMPK, RAGA-1 and RSKS-1/S6 kinase. We also demonstrate that overexpression of SFA-1 is sufficient to extend lifespan. Together, these data demonstrate a role for RNA splicing homeostasis in dietary restriction longevity and suggest that modulation of specific spliceosome components may prolong healthy ageing.	[Heintz, Caroline; Lanjuin, Anne; Escoubas, Caroline C.; Zhang, Yue; Weir, Heather J.; Dutta, Sneha; Silva-Garcia, Carlos Giovanni; Morantte, Ianessa; Hoxhaj, Gerta; Manning, Brendan D.; Mair, William B.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Doktor, Thomas K.; Bruun, Gitte H.; Andresen, Brage S.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Doktor, Thomas K.; Bruun, Gitte H.; Andresen, Brage S.] Univ Southern Denmark, Villum Ctr Bioanalyt Sci, DK-5230 Odense, Denmark; [Escoubas, Caroline C.] Univ Nice Sophia Antipolis, Fac Med, CNRS, IRCAN,INSERM U1081,UMR7284, F-06107 Nice, France; [Morantte, Ianessa] Rockefeller Univ, Lab Neurophysiol & Behav, New York, NY 10065 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Southern Denmark; University of Southern Denmark; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Rockefeller University	Mair, WB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	wmair@hsph.harvard.edu	Andresen, Brage/D-2515-2012; Doktor, Thomas K/G-9923-2014; Doktor, Thomas/AAB-2216-2020; Manning, Brendan/ABD-6528-2021; Heintz, Caroline/R-3272-2017	Andresen, Brage/0000-0001-7488-3035; Doktor, Thomas K/0000-0002-5315-8325; Doktor, Thomas/0000-0002-5315-8325; Manning, Brendan/0000-0003-3895-5956; Mair, William/0000-0002-0661-1342; Hoxhaj, Gerta/0000-0001-6179-3583	Swiss National Science Foundation [P2ZHP3_151609]; Fonds National de la Recherche Luxembourg [AFR7883116]; Lawrence Ellison Medical Foundation [U54CA155626]; Glenn Foundation for Medical Research; National Institutes of Health (NIH) [1R01AG044346]; Ligue Nationale contre le Cancer; Novo Nordisk Foundation [NNF13OC0007939]; Novo Nordisk Fonden [NNF13OC0007939] Funding Source: researchfish; Villum Fonden [00007292] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U54CA155626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044346] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds National de la Recherche Luxembourg(Luxembourg National Research Fund); Lawrence Ellison Medical Foundation; Glenn Foundation for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation); Villum Fonden(Villum Fonden); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	C.H. is supported by the Swiss National Science Foundation (P2ZHP3_151609) and the Fonds National de la Recherche Luxembourg (AFR7883116). W.B.M. is funded by The Lawrence Ellison Medical Foundation (U54CA155626), The Glenn Foundation for Medical Research and the National Institutes of Health (NIH, 1R01AG044346). C.E. is supported by the Ligue Nationale contre le Cancer. G.H.B and T.K.D. were supported through a grant to B.S.A. from The Novo Nordisk Foundation (NNF13OC0007939). We are grateful to H. Kuroyanagi for providing the splicing reporter strain and corresponding plasmids. We thank K. Blackwell for providing the glp-4 mutant strain and RNAi constructs. We also thank the Caenorhabditis Genetics Center for providing worm strains. We also thank the Mair laboratory members for comments and discussion on the project and manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burkewitz K, 2015, CELL, V160, P842, DOI 10.1016/j.cell.2015.02.004; Ching TT, 2011, JOVE-J VIS EXP, DOI 10.3791/2701; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gao XY, 2014, RNA BIOL, V11, P1148, DOI 10.4161/rna.36100; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KRAMER A, 1992, MOL CELL BIOL, V12, P4545; Kuroyanagi H, 2013, NUCLEIC ACIDS RES, V41, P4015, DOI 10.1093/nar/gkt097; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee BP, 2016, AGING CELL, V15, P903, DOI 10.1111/acel.12499; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Ma L, 2011, RNA, V17, P2201, DOI 10.1261/rna.027458.111; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000708; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mazin P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.67; Ramani AK, 2011, GENOME RES, V21, P342, DOI 10.1101/gr.114645.110; Rodriguez SA, 2016, AGING CELL, V15, P267, DOI 10.1111/acel.12433; Seo M, 2016, CELL CYCLE, V15, P1821, DOI 10.1080/15384101.2016.1183845; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Vermulst M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9065; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zahler A., 2012, WORMBOOK; Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086; Zhang T, 2012, J BIOL CHEM, V287, P8371, DOI 10.1074/jbc.M111.311977	41	88	91	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					102	+		10.1038/nature20789	http://dx.doi.org/10.1038/nature20789			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	27919065	Green Accepted, Green Submitted			2022-12-28	WOS:000396119500038
J	Yan, LJ; Wang, L; Tian, YY; Xia, X; Chen, ZC				Yan, Lijuan; Wang, Li; Tian, Yuanyuan; Xia, Xian; Chen, Zhucheng			Structure and regulation of the chromatin remodeller ISWI	NATURE			English	Article							HISTONE H4 TAIL; DNA TRANSLOCATION; CONCERTED ACTION; ATPASE; SWI2/SNF2; SWI/SNF; DOMAIN; FAMILY; RECOGNITION; REQUIRES	ISWI is a member of the SWI2/SNF2 family of chromatin remodellers(1,2), which also includes Snf2, Chd1, and Ino80. ISWI is the catalytic subunit of several chromatin remodelling complexes, which mobilize nucleosomes along genomic DNA, promoting replication progression, transcription repression, heterochromatin formation, and many other nuclear processes(3-5). The ATPase motor of ISWI is an autonomous remodelling machine(6), whereas its carboxy (C)-terminal HAND-SAND-SLIDE (HSS) domain functions in binding extranucleosomal linker DNA(7-10). The activity of the catalytic core of ISWI is inhibited by the regulatory AutoN and NegC domains, which are in turn antagonized by the H4 tail and extranucleosomal DNA, respectively, to ensure the appropriate chromatin landscape in cells(11). How AutoN and NegC inhibit ISWI and regulate its nucleosome-centring activity remains elusive. Here we report the crystal structures of ISWI from the thermophilic yeast Myceliophthora thermophila and its complex with a histone H4 peptide. Our data show the amino (N)-terminal AutoN domain contains two inhibitory elements, which collectively bind the second RecA-like domain (core2), holding the enzyme in an inactive conformation. The H4 peptide binds to the core2 domain coincident with one of the AutoN-binding sites, explaining the ISWI activation by H4. The H4-binding surface is conserved in Snf2 and functions beyond AutoN regulation. The C-terminal NegC domain is involved in binding to the core2 domain and functions as an allosteric element for ISWI to respond to the extranucleosomal DNA length.	[Yan, Lijuan; Wang, Li; Tian, Yuanyuan; Xia, Xian; Chen, Zhucheng] Tsinghua Univ, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Yan, Lijuan; Wang, Li; Tian, Yuanyuan; Xia, Xian; Chen, Zhucheng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Chen, ZC (corresponding author), Tsinghua Univ, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.; Chen, ZC (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	Zhucheng_chen@tsinghua.edu.cn		Yan, Lijuan/0000-0001-5003-5437; Xia, Xian/0000-0001-9833-5017	Chinese Key Research Plan-Protein Sciences [2014CB910100]; National Natural Science Foundation of China [31570731, 31270762]; 'Junior One Thousand Talents' program	Chinese Key Research Plan-Protein Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 'Junior One Thousand Talents' program	We thank S. Fan at the centre of structure biology (Tsinghua University) and the staff at beamline BL17U of Shanghai Synchrotron Radiation Facility for help with diffraction data collection, and the Tsinghua University Branch of the China National Center for Protein Sciences Beijing for providing facility support. This work was supported by the Chinese Key Research Plan-Protein Sciences (2014CB910100), the National Natural Science Foundation of China (31570731, 31270762), and the 'Junior One Thousand Talents' program to Z.C.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Clapier CR, 2016, MOL CELL, V62, P453, DOI 10.1016/j.molcel.2016.03.032; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Hota SK, 2013, NAT STRUCT MOL BIOL, V20, P222, DOI 10.1038/nsmb.2486; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Leonard JD, 2015, MOL CELL, V57, P850, DOI 10.1016/j.molcel.2015.01.008; Ludwigsen J, 2013, EMBO REP, V14, P1092, DOI 10.1038/embor.2013.160; Manning BJ, 2013, NAT STRUCT MOL BIOL, V20, P5, DOI 10.1038/nsmb.2482; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Racki LR, 2014, J MOL BIOL, V426, P2034, DOI 10.1016/j.jmb.2014.02.021; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Sen P, 2013, MOL CELL BIOL, V33, P360, DOI 10.1128/MCB.00922-12; Sen P, 2011, NUCLEIC ACIDS RES, V39, P9155, DOI 10.1093/nar/gkr622; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Xia X, 2016, NAT STRUCT MOL BIOL, V23, P722, DOI 10.1038/nsmb.3259; Yang XF, 2007, NAT STRUCT MOL BIOL, V14, P540, DOI 10.1038/nsmb1238; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	31	57	57	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					466	+		10.1038/nature20590	http://dx.doi.org/10.1038/nature20590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27919072				2022-12-28	WOS:000389716800049
J	Kriek, M; Conroy, C; van Dokkum, PG; Shapley, AE; Choi, J; Reddy, NA; Siana, B; van de Voort, F; Coil, AL; Mobasher, B				Kriek, Mariska; Conroy, Charlie; van Dokkum, Pieter G.; Shapley, Alice E.; Choi, Jieun; Reddy, Naveen A.; Siana, Brian; van de Voort, Freeke; Coil, Alison L.; Mobasher, Bahram			A massive, quiescent, population II galaxy at a redshift of 2.1	NATURE			English	Article							ABSORPTION-LINE SPECTROSCOPY; ELEMENT ABUNDANCE RATIOS; STELLAR POPULATIONS; IA SUPERNOVAE; EVOLUTION; MODELS; GROWTH; UNCERTAINTIES; METALLICITY; PROPAGATION	Unlike spiral galaxies such as the Milky Way, the majority of the stars in massive elliptical galaxies were formed in a short period early in the history of the Universe. The duration of this formation period can be measured using the ratio of magnesium to iron abundance ([Mg/Fe]) in spectra(1-4), which reflects the relative enrichment by core-collapse and type Ia supernovae. For local galaxies, [Mg/Fe] probes the combined formation history of all stars currently in the galaxy, including younger and metal-poor stars that were added during late-time mergers. Therefore, to directly constrain the initial star-formation period, we must study galaxies at earlier epochs. The most distant galaxy for which [Mg/Fe] had previously been measured(6) is at a redshift of z approximate to 1.4, with [Mg/Fe] = 0.45(-0.19)(+0.05) A slightly earlier epoch (z approximate to 1.6) was probed by combining the spectra of 24 massive quiescent galaxies, yielding an average [Mg/Fe] = 0.31 +/- 0.12 (ref. 7). However, the relatively low signal-tonoise ratio of the data and the use of index analysis techniques for both of these studies resulted in measurement errors that are too large to allow us to form strong conclusions. Deeper spectra at even earlier epochs in combination with analysis techniques based on full spectral fitting are required to precisely measure the abundance pattern shortly after the major star-forming phase (z > 2). Here we report a measurement of [Mg/Fe] for a massive quiescent galaxy at a redshift of z= 2.1, when the Universe was three billion years old. With [Mg/Fe] = 0.59 +/- 0.11, this galaxy is the most Mg-enhanced massive galaxy found so far, having twice the Mg enhancement of similar -mass galaxies today. The abundance pattern of the galaxy is consistent with enrichment exclusively by core-collapse supernovae and with a star -formation timescale of 0.1 to 0.5 billion years-characteristics that are similar to population II stars in the Milky Way. With an average past star -formation rate of 600 to 3,000 solar masses per year, this galaxy was among the most vigorous star forming galaxies in the Universe.	[Kriek, Mariska; van de Voort, Freeke] Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA; [Conroy, Charlie; Choi, Jieun] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA; [van Dokkum, Pieter G.] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Shapley, Alice E.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Reddy, Naveen A.; Siana, Brian; Mobasher, Bahram] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Coil, Alison L.] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA	University of California System; University of California Berkeley; Harvard University; Yale University; University of California System; University of California Los Angeles; University of California System; University of California Riverside; University of California System; University of California San Diego	Kriek, M (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	mkriek@berkeley.edu		van de Voort, Freeke/0000-0002-6301-638X; Choi, Jieun/0000-0002-8822-1355	W. M. Keck Foundation; NSF MG collaborative grants [AST-1312780, 1312547, 1312764, 1313171]; NASA through Space Telescope Science Institute [AR-13907]; NASA [NNX13AI46G]; NSF [AST-1313280]; Packard Foundation; Direct For Mathematical & Physical Scien [1313171] Funding Source: National Science Foundation	W. M. Keck Foundation(W.M. Keck Foundation); NSF MG collaborative grants; NASA through Space Telescope Science Institute(Space Telescope Science Institute); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	M.K. acknowledges discussions with J. Greene and E. Quataert. The data presented in this paper were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership between the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. The Observatory was made possible by the financial support of the W. M. Keck Foundation. We acknowledge the cultural role that the summit of Mauna Kea has within the indigenous Hawaiian community. We acknowledge support from NSF MG collaborative grants AST-1312780, 1312547, 1312764 and 1313171 and archival grant AR-13907, provided by NASA through a grant from the Space Telescope Science Institute. C.C. acknowledges support from NASA grant NNX13AI46G, NSF grant AST-1313280 and the Packard Foundation.	Belli S, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L29; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Choi J, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/95; Conroy C, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/33; Conroy C, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/71; Conroy C, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/69; Conroy C, 2010, ASTROPHYS J, V712, P833, DOI 10.1088/0004-637X/712/2/833; Conroy C, 2009, ASTROPHYS J, V699, P486, DOI 10.1088/0004-637X/699/1/486; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Fulbright JP, 2007, ASTROPHYS J, V661, P1152, DOI 10.1086/513710; Kobayashi C, 2006, ASTROPHYS J, V653, P1145, DOI 10.1086/508914; Kriek M, 2015, ASTROPHYS J SUPPL S, V218, DOI 10.1088/0067-0049/218/2/15; Kriek M, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L16; Kriek M, 2009, ASTROPHYS J, V700, P221, DOI 10.1088/0004-637X/700/1/221; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Lonoce I, 2015, MON NOT R ASTRON SOC, V454, P3912, DOI 10.1093/mnras/stv2150; Maoz D, 2012, MON NOT R ASTRON SOC, V426, P3282, DOI 10.1111/j.1365-2966.2012.21871.x; Maraston C, 2005, MON NOT R ASTRON SOC, V362, P799, DOI 10.1111/j.1365-2966.2005.09270.x; MATTEUCCI F, 1994, ASTRON ASTROPHYS, V288, P57; McLean IS, 2012, PROC SPIE, V8446, DOI 10.1117/12.924794; Momcheva I. G., 2015, PREPRINT; Naab T, 2009, ASTROPHYS J LETT, V699, pL178, DOI 10.1088/0004-637X/699/2/L178; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Onodera M, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/2/161; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Skelton RE, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/24; Thielemann FK, 1996, ASTROPHYS J, V460, P408, DOI 10.1086/176980; Thomas D, 2005, ASTROPHYS J, V621, P673, DOI 10.1086/426932; Thomas D, 2003, MON NOT R ASTRON SOC, V339, P897, DOI 10.1046/j.1365-8711.2003.06248.x; Trager SC, 2000, ASTRON J, V120, P165, DOI 10.1086/301442; van de Sande J, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/85; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; van Dokkum PG, 2010, ASTROPHYS J, V709, P1018, DOI 10.1088/0004-637X/709/2/1018; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WORTHEY G, 1994, ASTROPHYS J SUPPL S, V94, P687, DOI 10.1086/192087	40	65	65	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					248	+		10.1038/nature20570	http://dx.doi.org/10.1038/nature20570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27929014	Green Submitted, Green Accepted			2022-12-28	WOS:000389548700052
J	McWilliams, JM				McWilliams, J. Michael			Cost Containment and the Tale of Care Coordination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ORGANIZATIONS		[McWilliams, J. Michael] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McWilliams, JM (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.; McWilliams, JM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.				NIA NIH HHS [P01 AG032952] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG032952] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; McWilliams JM, 2015, NEW ENGL J MED, V372, P1927, DOI 10.1056/NEJMsa1414929; McWilliams JM, 2014, NEW ENGL J MED, V371, P1715, DOI 10.1056/NEJMsa1406552; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126	4	57	57	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2218	2220		10.1056/NEJMp1610821	http://dx.doi.org/10.1056/NEJMp1610821			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0ZQ	27959672	Green Accepted			2022-12-28	WOS:000389310000003
J	Hofer, TP; Hayward, RA				Hofer, Timothy P.; Hayward, Rodney A.			New Studies Do Not Challenge the American College of Cardiology/American Heart Association Lipid Guidelines Response	ANNALS OF INTERNAL MEDICINE			English	Letter									[Hofer, Timothy P.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Hofer, Timothy P.] Univ Michigan, Inst Hlth Policy & Innovat, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Inst Hlth Policy & Innovat, Natl Clinician Scholars Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hofer, TP (corresponding author), Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48109 USA.; Hofer, TP (corresponding author), Univ Michigan, Inst Hlth Policy & Innovat, Ann Arbor, MI 48109 USA.		Hofer, Timothy Philip/AAC-9238-2022					Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Sussman J, 2013, CIRCULATION, V128, P2309, DOI 10.1161/CIRCULATIONAHA.113.002290	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					827	828		10.7326/L16-0417	http://dx.doi.org/10.7326/L16-0417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27919086				2022-12-28	WOS:000389263900019
J	Xantheas, SS				Xantheas, Sotiris S.			Spying on the neighbors' pool	SCIENCE			English	Editorial Material							LIQUID WATER; PROTON		[Xantheas, Sotiris S.] Pacific Northwest Natl Lab, Div Phys Sci, 902 Battelle Blvd,MS K1-83, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Xantheas, SS (corresponding author), Pacific Northwest Natl Lab, Div Phys Sci, 902 Battelle Blvd,MS K1-83, Richland, WA 99352 USA.	sotiris.xantheas@pnnl.gov	Xantheas, Sotiris/L-1239-2015	Xantheas, Sotiris/0000-0002-6303-1037				Costentin C, 2010, ACCOUNTS CHEM RES, V43, P1019, DOI 10.1021/ar9002812; DeCoursey TE, 2013, PHYSIOL REV, V93, P599, DOI 10.1152/physrev.00011.2012; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Huggins ML, 1936, J PHYS CHEM-US, V40, P723, DOI 10.1021/j150375a004; Mayer JM, 2004, ANNU REV PHYS CHEM, V55, P363, DOI 10.1146/annurev.physchem.55.091602.094446; Thamer M, 2015, SCIENCE, V350, P78, DOI 10.1126/science.aab3908; Vendrell O, 2009, ANGEW CHEM INT EDIT, V48, P352, DOI 10.1002/anie.200804646; Wolke CT, 2016, SCIENCE, V354, P1131, DOI 10.1126/science.aaf8425; Wolke CT, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4941285; Wu YJ, 2008, J PHYS CHEM B, V112, P467, DOI 10.1021/jp076658h; Xantheas SS, 2009, NATURE, V457, P673, DOI 10.1038/457673a	11	5	5	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1101	1101		10.1126/science.aal1413	http://dx.doi.org/10.1126/science.aal1413			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934720				2022-12-28	WOS:000388916400018
J	Burton, C; Chesterton, LS; Davenport, G				Burton, Claire; Chesterton, Linda S.; Davenport, Graham			10-MINUTE CONSULTATION A painful tingling hand	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARPAL-TUNNEL-SYNDROME; NEUROPATHIES		[Burton, Claire; Chesterton, Linda S.; Davenport, Graham] Keele Univ, Arthrit Res UK Primary Care Ctr, Primary Care Sci, Keele, Staffs, England	Keele University	Burton, C (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Primary Care Sci, Keele, Staffs, England.	c.burton@keele.ac.uk	Burton, Claire/AAB-1782-2021	Burton, Claire/0000-0003-4688-3075	National Institute for Health Research [NIHR-IPF-2013-07-02] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		American Academy of Orthopaedic Surgeons, 2007, CLIN PRACT GUID DIAG; American Academy of Orthopaedic Surgeons, 2016, MAN CARP TUNN SYNDR; Aroori Somaiah, 2008, Ulster Med J, V77, P6; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Bland JDP, 2003, J NEUROL NEUROSUR PS, V74, P1674, DOI 10.1136/jnnp.74.12.1674; Bland JDP, 2007, BMJ-BRIT MED J, V335, P343, DOI 10.1136/bmj.39282.623553.AD; Burton CL, 2013, P SOC AC PRIM CAR AN; Cowan J, 2012, J HAND SURG-AM, V37A, P18, DOI 10.1016/j.jhsa.2011.10.033; Cutts S, 2007, POSTGRAD MED J, V83, P28, DOI 10.1136/pgmj.2006.047456; Dang AC, 2009, J HAND SURG-AM, V34A, P1915, DOI 10.1016/j.jhsa.2009.10.017; Fertl E, 1998, ACTA NEUROL SCAND, V98, P328; GESSINI L, 1983, SURG NEUROL, V19, P112, DOI 10.1016/0090-3019(83)90405-6; Gray H., ANATOMY HUMAN BODY; Ibrahim I, 2012, Open Orthop J, V6, P69, DOI 10.2174/1874325001206010069; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P263, DOI 10.1136/jnnp.2005.066696; Marshall S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001554.pub2; Middleton SD, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6437; O'Connor D, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003219, DOI 10.1002/14651858.CD003219]; Padua L, 2001, NEUROLOGY, V56, P1459, DOI 10.1212/WNL.56.11.1459; Page MJ, 2012, COCHRANE DB SYST REV, V7, DOI [10.1002/14651858.CD010003, DOI 10.1002/14651858.CD010003.PMID:22786532]; Thatte Mukund R, 2011, Indian J Plast Surg, V44, P283, DOI 10.4103/0970-0358.85350	21	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2016	355								i6386	10.1136/bmj.i6386	http://dx.doi.org/10.1136/bmj.i6386			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZO	27908865				2022-12-28	WOS:000389309800002
J	Lowe, D; Fehlhaber, K; Coyne, J; Timmer, J				Lowe, Derek; Fehlhaber, Kate; Coyne, Jerry; Timmer, John			What Drives You to Blog?	CELL			English	Editorial Material								Science blogs come in all shapes and sizes. We asked a spectrum of science communicators to share what first sparked their interest in blogging.	[Lowe, Derek] In the Pipeline, Chicago, IL USA; [Fehlhaber, Kate] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Coyne, Jerry] Univ Chicago, Chicago, IL 60637 USA; [Timmer, John] Ars Tech, Chicago, IL USA	University of California System; University of California Los Angeles; University of Chicago	Lowe, D (corresponding author), In the Pipeline, Chicago, IL USA.								0	1	1	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1446	1447						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912052	Bronze			2022-12-28	WOS:000389470500006
J	Moroishi, T; Hayashi, T; Pan, WW; Fujita, Y; Holt, MV; Qin, J; Carson, DA; Guan, KL				Moroishi, Toshiro; Hayashi, Tomoko; Pan, Wei-Wei; Fujita, Yu; Holt, Matthew V.; Qin, Jun; Carson, Dennis A.; Guan, Kun-Liang			The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity	CELL			English	Article							INTERFERON RESPONSE; SIZE-CONTROL; ORGAN SIZE; MECHANISM; INNATE; YAP; INACTIVATION; DROSOPHILA	Poorly immunogenic tumor cells evade host immunity and grow even in the presence of an intact immune system, but the complex mechanisms regulating tumor immunogenicity have not been elucidated. Here, we discovered an unexpected role of the Hippo pathway in suppressing anti-tumor immunity. We demonstrate that, in three different murine syngeneic tumor models (B16, SCC7, and 4T1), loss of the Hippo pathway kinases LATS1/2 (large tumor suppressor 1 and 2) in tumor cells inhibits tumor growth. Tumor regression by LATS1/2 deletion requires adaptive immune responses, and LATS1/2 deficiency enhances tumor vaccine efficacy. Mechanistically, LATS1/2-null tumor cells secrete nucleic-acid-rich extracellular vesicles, which induce a type I interferon response via the Toll-like receptors- MYD88/TRIF pathway. LATS1/2 deletion in tumors thus improves tumor immunogenicity, leading to tumor destruction by enhancing anti-tumor immune responses. Our observations uncover a key role of the Hippo pathway in modulating tumor immunogenicity and demonstrate a proof of concept for targeting LATS1/2 in cancer immunotherapy.	[Moroishi, Toshiro; Pan, Wei-Wei; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Moroishi, Toshiro; Hayashi, Tomoko; Pan, Wei-Wei; Fujita, Yu; Carson, Dennis A.; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Hayashi, Tomoko; Carson, Dennis A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Fujita, Yu] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Pan, Wei-Wei] Jiaxing Univ, Coll Med, Jiaxing 314001, Peoples R China; [Holt, Matthew V.; Qin, Jun] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Jiaxing University; Baylor College of Medicine	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Fujita, Yu/0000-0002-8916-7303; Moroishi, Toshiro/0000-0001-6419-3882	NIH [EY22611, CA196878, GM51586, HHSN272201400051C]; Whitworth Immunotherapy Foundation; NATIONAL CANCER INSTITUTE [R35CA196878] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitworth Immunotherapy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kimberly C. Lin for critical reading of this manuscript; Shiyin Yao, Fumi Kaneko, Alast Ahmadiiveli, Tadashi Hosoya, Julissa Trahan, Baodong Qin, Le Yu, Min Luo, and Tuomas Vaisanen for technical assistance; Shizuo Akira, Bruce Beutler, Richard A. Flavell, Maripat Corr, Russell Vance, and Michael J. Bevan for mice; John Lee for SCC7 cells; Yang-Xin Fu, Wenxian Fu, Hyun Woo Park, Zhipeng Meng, David A. Cheresh, and Laetitia Seguin for discussion; and Emi Kosano for illustrating the mouse cartoon in Figure 4. This work was supported by grants from the NIH (EY22611, CA196878, and GM51586 to K.-L.G.; HHSN272201400051C to D.A.C.) and the Whitworth Immunotherapy Foundation (to D.A.C. and T.H.). K.-L.G. is a co-founder of Vivace Therapeutics.	Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562; de Coana YP, 2015, TRENDS MOL MED, V21, P482, DOI 10.1016/j.molmed.2015.05.005; Dewey EB, 2015, CURR BIOL, V25, P2751, DOI 10.1016/j.cub.2015.09.025; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dranoff G, 2012, NAT REV IMMUNOL, V12, P61, DOI 10.1038/nri3129; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Junt T, 2015, NAT REV IMMUNOL, V15, P529, DOI 10.1038/nri3875; Keder A, 2015, CURR BIOL, V25, P2739, DOI 10.1016/j.cub.2015.08.064; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Moya IM, 2014, CELL RES, V24, P137, DOI 10.1038/cr.2014.6; Nowell CS, 2016, NAT CELL BIOL, V18, P168, DOI 10.1038/ncb3290; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Wang H, 2014, CANCER METAST REV, V33, P173, DOI 10.1007/s10555-013-9463-3; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	39	244	262	5	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1525	+		10.1016/j.cell.2016.11.005	http://dx.doi.org/10.1016/j.cell.2016.11.005			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912060	Green Accepted, Bronze			2022-12-28	WOS:000389470500015
J	Schiermeier, Q				Schiermeier, Quirin			Speedy drills start hunt for oldest ice	NATURE			English	News Item																			0	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					18	19		10.1038/540018a	http://dx.doi.org/10.1038/540018a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905453	Bronze			2022-12-28	WOS:000388916600021
J	Woodhead, M				Woodhead, Michael			Hospitals overwhelmed with patients after "thunderstorm asthma" hits Melbourne	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Karvelas P., ABC RADIO NATL; Medew J., 2016, AGE; Mitchell N., 3AW A	3	10	10	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2016	355								i6391	10.1136/bmj.i6391	http://dx.doi.org/10.1136/bmj.i6391			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YW	27895034				2022-12-28	WOS:000389307600014
J	Levitsky, J; Verna, EC; O'Leary, JG; Bzowej, NH; Moonka, DK; Hyland, RH; Arterburn, S; Dvory-Sobol, H; Brainard, DM; McHutchison, JG; Terrault, NA				Levitsky, Josh; Verna, Elizabeth C.; O'Leary, Jacqueline G.; Bzowej, Natalie H.; Moonka, Dilip K.; Hyland, Robert H.; Arterburn, Sarah; Dvory-Sobol, Hadas; Brainard, Diana M.; McHutchison, John G.; Terrault, Norah A.			Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Levitsky, Josh] Northwestern Univ, Chicago, IL 60611 USA; [Verna, Elizabeth C.] Columbia Univ, New York, NY USA; [O'Leary, Jacqueline G.] Baylor Univ, Dallas, TX USA; [Bzowej, Natalie H.] Ochsner Clin Fdn, New Orleans, LA USA; [Moonka, Dilip K.] Henry Ford Hosp, Detroit, MI 48202 USA; [Hyland, Robert H.; Arterburn, Sarah; Dvory-Sobol, Hadas; Brainard, Diana M.; McHutchison, John G.] Gilead Sci, Foster City, CA USA; [Terrault, Norah A.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Northwestern University; Columbia University; Baylor University; Ochsner Health System; Henry Ford Health System; Henry Ford Hospital; Gilead Sciences; University of California System; University of California San Francisco	Levitsky, J (corresponding author), Northwestern Univ, Chicago, IL 60611 USA.	jlevitsk@nm.org	Levitsky, Josh/AAF-8662-2019	Levitsky, Josh/0000-0001-7527-6093				Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Kwo PY, 2014, NEW ENGL J MED, V371, P2375, DOI 10.1056/NEJMoa1408921; Saxena V, 2015, CLIN LIVER DIS, V19, P669, DOI 10.1016/j.cld.2015.06.007	4	57	60	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2106	2108		10.1056/NEJMc1611829	http://dx.doi.org/10.1056/NEJMc1611829			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC9KU	27959735				2022-12-28	WOS:000388464300025
J	Veselka, J; Anavekar, NS; Charron, P				Veselka, Josef; Anavekar, Nandan S.; Charron, Philippe			Hypertrophic obstructive cardiomyopathy	LANCET			English	Review							CARDIOVASCULAR MAGNETIC-RESONANCE; ALCOHOL SEPTAL ABLATION; LEFT-VENTRICULAR HYPERTROPHY; SUDDEN CARDIAC DEATH; OUTFLOW TRACT OBSTRUCTION; LATE GADOLINIUM ENHANCEMENT; CARDIOLOGY WORKING GROUP; LONG-TERM OUTCOMES; BINDING PROTEIN-C; CONTEMPORARY MANAGEMENT STRATEGIES	Hypertrophic obstructive cardiomyopathy is an inherited myocardial disease defined by cardiac hypertrophy (wall thickness >= 15 mm) that is not explained by abnormal loading conditions, and left ventricular obstruction greater than or equal to 30 mm Hg. Typical symptoms include dyspnoea, chest pain, palpitations, and syncope. The diagnosis is usually suspected on clinical examination and confirmed by imaging. Some patients are at increased risk of sudden cardiac death, heart failure, and atrial fibrillation. Patients with an increased risk of sudden cardiac death undergo cardioverter-defibrillator implantation; in patients with severe symptoms related to ventricular obstruction, septal reduction therapy (myectomy or alcohol septal ablation) is recommended. Life-long anticoagulation is indicated after the first episode of atrial fibrillation.	[Veselka, Josef] Charles Univ Prague, Dept Cardiol, Sch Med 2, Prague 15000 5, Czech Republic; [Veselka, Josef] Motol Univ Hosp, Prague 15000 5, Czech Republic; [Anavekar, Nandan S.] Mayo Clin, Dept Cardiol, Rochester, MN USA; [Anavekar, Nandan S.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Charron, Philippe] Univ Paris Sud, UVSQ, INSERM, U1018,CESP, Boulogne, France; [Charron, Philippe] Hop La Pitie Salpetriere, APHP, ICAN, Paris, France	Charles University Prague; Motol University Hospital; Mayo Clinic; Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Veselka, J (corresponding author), Charles Univ Prague, Dept Cardiol, Sch Med 2, Prague 15000 5, Czech Republic.; Veselka, J (corresponding author), Motol Univ Hosp, Prague 15000 5, Czech Republic.	veselka.josef@seznam.cz		Charron, Philippe/0000-0002-1782-1118	Boehringer; Genzyme; MyoKardia; Sanofi; Servier; Shire	Boehringer(Boehringer Ingelheim); Genzyme(Sanofi-AventisGenzyme Corporation); MyoKardia; Sanofi(Sanofi-Aventis); Servier(Servier); Shire	JV has received consultancies, honoraria, speaker's fees, and travel or accommodation payments from Boston Scientific and Servier; PC has received consultancies, honoraria, speaker's fees, and travel or accommodation payments from Boehringer, Genzyme, MyoKardia, Sanofi, Servier, and Shire. NSA declares no competing interests.	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Alpert C, 2015, CLIN SPORT MED, V34, P489, DOI 10.1016/j.csm.2015.03.005; Alpert NR, 2005, AM J PHYSIOL-HEART C, V288, pH1097, DOI 10.1152/ajpheart.00650.2004; Bharucha T, 2015, J AM COLL CARDIOL, V65, P2302, DOI 10.1016/j.jacc.2015.03.552; Biagini E, 2014, AM J CARDIOL, V114, P769, DOI 10.1016/j.amjcard.2014.05.065; Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Bos JM, 2014, MAYO CLIN PROC, V89, P727, DOI 10.1016/j.mayocp.2014.01.025; Bottillo I, 2016, GENE, V577, P227, DOI 10.1016/j.gene.2015.11.048; Briasoulis A, 2015, HEART, V101, P1406, DOI 10.1136/heartjnl-2015-307682; BROCK R, 1957, Guys Hosp Rep, V106, P221; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; CANNON RO, 1992, CIRCULATION, V85, P1039, DOI 10.1161/01.CIR.85.3.1039; CANNON RO, 1985, CIRCULATION, V71, P234, DOI 10.1161/01.CIR.71.2.234; Cardim N, 2015, EUR HEART J-CARD IMG, V16, P280, DOI 10.1093/ehjci/jeu291; Chan RH, 2014, CIRCULATION, V130, P484, DOI 10.1161/CIRCULATIONAHA.113.007094; Charron P, 1998, EUR HEART J, V19, P1377, DOI 10.1053/euhj.1998.1049; Charron P, 2004, PRENATAL DIAG, V24, P701, DOI 10.1002/pd.969; Charron P, 1997, CIRCULATION, V96, P214; Charron P, 1998, CIRCULATION, V97, P2230, DOI 10.1161/01.CIR.97.22.2230; Charron P, 2010, EUR HEART J, V31, P2715, DOI 10.1093/eurheartj/ehq271; Choudhury L, 1996, EUR HEART J, V17, P1703; Christiaans I, 2011, EUR HEART J, V32, P1161, DOI 10.1093/eurheartj/ehr092; Christiaans I, 2009, HEART RHYTHM, V6, P1366, DOI 10.1016/j.hrthm.2009.04.029; Colan SD, 2007, CIRCULATION, V115, P773, DOI 10.1161/CIRCULATIONAHA.106.621185; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; DAVIES MJ, 1995, HISTOPATHOLOGY, V26, P493, DOI 10.1111/j.1365-2559.1995.tb00267.x; Desai MY, 2014, JACC-CARDIOVASC IMAG, V7, P26, DOI 10.1016/j.jcmg.2013.08.010; Desai MY, 2013, CIRCULATION, V128, P209, DOI 10.1161/CIRCULATIONAHA.112.000849; DILSIZIAN V, 1993, J AM COLL CARDIOL, V22, P796, DOI 10.1016/0735-1097(93)90193-5; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Elliott PM, 2006, EUR HEART J, V27, P1933, DOI 10.1093/eurheartj/ehl041; Ennis DB, 2003, MAGNET RESON MED, V50, P638, DOI 10.1002/mrm.10543; FACTOR SM, 1991, J AM COLL CARDIOL, V17, P1343, DOI 10.1016/S0735-1097(10)80145-7; FANANAPAZIR L, 1994, CIRCULATION, V90, P2731, DOI 10.1161/01.CIR.90.6.2731; Ferrazzi P, 2015, J AM COLL CARDIOL, V66, P1687, DOI 10.1016/j.jacc.2015.07.069; Fujita T, 2013, JACC-HEART FAIL, V1, P459, DOI 10.1016/j.jchf.2013.08.007; Galve E, 2010, HEART, V96, P352, DOI 10.1136/hrt.2008.158915; Gandjbakhch E, 2010, EUR HEART J, V31, P1599, DOI 10.1093/eurheartj/ehq101; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; Gersh BJ, 2011, CIRCULATION, V124, pE783, DOI 10.1161/CIR.0b013e318223e2bd; Gimeno JR, 2009, EUR HEART J, V30, P2599, DOI 10.1093/eurheartj/ehp327; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Gray B, 2011, INT J CARDIOL, V152, P258, DOI 10.1016/j.ijcard.2011.07.095; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Green JJ, 2012, JACC-CARDIOVASC IMAG, V5, P370, DOI 10.1016/j.jcmg.2011.11.021; Gruner C, 2013, CIRC-CARDIOVASC GENE, V6, P19, DOI 10.1161/CIRCGENETICS.112.963363; Guttmann OP, 2015, EUR J HEART FAIL, V17, P837, DOI 10.1002/ejhf.316; Guttmann OP, 2014, HEART, V100, P465, DOI 10.1136/heartjnl-2013-304276; Hamada M, 2014, J CARDIOL, V64, P1, DOI 10.1016/j.jjcc.2014.02.022; Haruki S, 2016, STROKE, V47, P936, DOI 10.1161/STROKEAHA.115.012130; Ho CY, 2015, CARDIOVASC RES, V105, P397, DOI 10.1093/cvr/cvv025; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Ingles J, 2015, CIRC-CARDIOVASC GENE, V8, P852, DOI 10.1161/CIRCGENETICS.115.001093; Jahnlova D, 2015, INT J CARDIOL, V186, P3, DOI 10.1016/j.ijcard.2015.03.207; Jensen MK, 2015, INT J CARDIOVAS IMAG, V31, P1511, DOI 10.1007/s10554-015-0723-x; Jensen MK, 2013, HEART, V99, P1012, DOI 10.1136/heartjnl-2012-303339; Jensen MK, 2013, CIRCULATION, V127, P48, DOI 10.1161/CIRCULATIONAHA.111.090514; Jensen MK, 2011, CIRC-CARDIOVASC INTE, V4, P256, DOI 10.1161/CIRCINTERVENTIONS.110.959718; Kappenberger L, 1997, EUR HEART J, V18, P1249; Kebed KY, 2014, AM J CARDIOL, V114, P777, DOI 10.1016/j.amjcard.2014.05.067; Kebed KY, 2014, INT J CARDIOVAS IMAG, V30, P591, DOI 10.1007/s10554-013-0355-y; Kim LK, 2016, JAMA CARDIOL, V1, P324, DOI 10.1001/jamacardio.2016.0252; Kim YJ, 2008, J MAGN RESON IMAGING, V27, P1054, DOI 10.1002/jmri.21366; Kimura A, 2016, J HUM GENET, V61, P41, DOI 10.1038/jhg.2015.83; Knollmann BC, 2003, CIRC RES, V92, P428, DOI 10.1161/01.RES.0000059562.91384.1A; Kuliev A, 2012, REPROD BIOMED ONLINE, V24, P443, DOI 10.1016/j.rbmo.2011.12.009; Kumar Kartik R, 2015, Card Electrophysiol Clin, V7, P173, DOI 10.1016/j.ccep.2015.03.002; Kwon DH, 2009, J AM COLL CARDIOL, V54, P242, DOI 10.1016/j.jacc.2009.04.026; Lee MS, 2014, TRANSPL P, V46, P1502, DOI 10.1016/j.transproceed.2013.12.052; Leschka S, 2008, RADIOLOGY, V246, P754, DOI 10.1148/radiol.2463062071; Li Q, 2014, CIRC-CARDIOVASC GENE, V7, P416, DOI 10.1161/CIRCGENETICS.113.000331; Liebregts M, 2015, JACC-HEART FAIL, V3, P896, DOI 10.1016/j.jchf.2015.06.011; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Lopes LR, 2013, J MED GENET, V50, P228, DOI 10.1136/jmedgenet-2012-101270; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Magnusson P, 2015, J CARDIOVASC ELECTR, V26, P1088, DOI 10.1111/jce.12750; Marian AJ, 2009, J CARDIOVASC TRANSL, V2, P483, DOI 10.1007/s12265-009-9132-7; Maron BJ, 2016, CIRCULATION, V133, P62, DOI 10.1161/CIRCULATIONAHA.115.017633; Maron BJ, 2015, CIRCULATION, V132, pE273, DOI 10.1161/CIR.0000000000000239; Maron BJ, 2015, J AM COLL CARDIOL, V66, P1307, DOI 10.1016/j.jacc.2015.06.1333; Maron BJ, 2015, AM J CARDIOL, V116, P757, DOI 10.1016/j.amjcard.2015.05.047; Maron BJ, 2015, J AM COLL CARDIOL, V65, P1915, DOI 10.1016/j.jacc.2015.02.061; Maron BJ, 2015, TRENDS CARDIOVAS MED, V25, P54, DOI 10.1016/j.tcm.2014.09.004; Maron BJ, 2013, CIRCULATION, V127, P585, DOI 10.1161/CIRCULATIONAHA.112.136085; MARON BJ, 1979, CIRCULATION, V60, P685, DOI 10.1161/01.CIR.60.3.685; Maron BJ, 1999, CIRCULATION, V99, P2927, DOI 10.1161/01.CIR.99.22.2927; Maron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9; Maron BJ, 2016, AM J MED; Maron MS, 2012, CIRC-CARDIOVASC IMAG, V5, P441, DOI 10.1161/CIRCIMAGING.112.972760; Maron MS, 2011, CIRCULATION, V124, P40, DOI 10.1161/CIRCULATIONAHA.110.985812; Maron MS, 2009, J AM COLL CARDIOL, V54, P866, DOI 10.1016/j.jacc.2009.04.072; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Marziliano N, 2012, NEONATOLOGY, V102, P254, DOI 10.1159/000339847; MCKENNA WJ, 1990, BRIT HEART J, V63, P287; McLeod CJ, 2007, EUR HEART J, V28, P2583, DOI 10.1093/eurheartj/ehm117; McLeod CJ, 2009, J AM COLL CARDIOL, V54, P229, DOI 10.1016/j.jacc.2009.02.071; Meder B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322; Mogensen J, 2015, EUR HEART J, V36, P1367, DOI 10.1093/eurheartj/ehv122; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Moon JCC, 2004, HEART, V90, P645, DOI 10.1136/hrt.2003.014969; Moravsky G, 2013, JACC-CARDIOVASC IMAG, V6, P587, DOI 10.1016/j.jcmg.2012.09.018; Morise AP, 2011, CIRCULATION, V123, P216, DOI 10.1161/CIRCULATIONAHA.109.914762; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nishimura RA, 1997, J AM COLL CARDIOL, V29, P435, DOI 10.1016/S0735-1097(96)00473-1; Noureldin RA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-17; Nugent AW, 2005, CIRCULATION, V112, P1332, DOI 10.1161/CIRCULATIONAHA.104.530303; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; O'Mahony C, 2012, HEART; O'Mahony C, 2014, EUR HEART J, V35, P2010, DOI 10.1093/eurheartj/eht439; OGARA PT, 1987, CIRCULATION, V76, P1214, DOI 10.1161/01.CIR.76.6.1214; Oliveira TGM, 2015, J MOL DIAGN, V17, P420, DOI 10.1016/j.jmoldx.2015.02.003; Olivotto I, 2015, GLOB CARDIOL SCI PRA, V7, P1; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Olivotto Iacopo, 2004, Ital Heart J, V5, P572; Ommen SR, 2005, J AM COLL CARDIOL, V46, P470, DOI 10.1016/j.jacc.2005.02.090; Panaich SS, 2014, AM J CARDIOL, V114, P1390, DOI 10.1016/j.amjcard.2014.07.075; Papavassiliu T, 2005, EUR HEART J, V26, P2395, DOI 10.1093/eurheartj/ehi518; Rapezzi C, 2013, EUR HEART J, V34, P1448, DOI 10.1093/eurheartj/ehs397; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Richard P, 2012, BRIT J SPORT MED, V46, P59, DOI 10.1136/bjsports-2012-091318; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Risgaard B, 2014, CIRC-ARRHYTHMIA ELEC, V7, P205, DOI 10.1161/CIRCEP.113.001421; Rowin EJ, 2012, JACC-CARDIOVASC IMAG, V5, P119, DOI 10.1016/j.jcmg.2011.08.020; Schaff HV, 2012, J THORAC CARDIOV SUR, V143, P303, DOI 10.1016/j.jtcvs.2011.10.059; Schlossarek S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00484; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; SHAPIRO LM, 1983, J AM COLL CARDIOL, V2, P437, DOI 10.1016/S0735-1097(83)80269-1; Sherrid MV, 2016, CURR CARDIOL REV, V12, P52, DOI 10.2174/1573403X1201160126125403; Sherrid MV, 2013, CIRC-HEART FAIL, V6, P694, DOI 10.1161/CIRCHEARTFAILURE.112.000122; Sherrid MV, 2005, J AM COLL CARDIOL, V45, P1251, DOI 10.1016/j.jacc.2005.01.012; SIGWART U, 1995, LANCET, V346, P211, DOI 10.1016/S0140-6736(95)91267-3; Song JK, 2014, CIRC J, V78, P1808, DOI 10.1253/circj.CJ-14-0524; Sorajja P, 2012, CIRCULATION, V126, P2374, DOI 10.1161/CIRCULATIONAHA.111.076257; Sorajja P, 2009, J AM COLL CARDIOL, V54, P234, DOI 10.1016/j.jacc.2009.01.079; Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940; Spirito P, 1999, CIRCULATION, V99, P2132, DOI 10.1161/01.CIR.99.16.2132; Spirito P, 2014, AM J CARDIOL, V113, P1550, DOI 10.1016/j.amjcard.2014.01.435; Suk T, 2008, HEART LUNG CIRC, V17, P370, DOI 10.1016/j.hlc.2008.03.080; Tanaka H, 2014, CIRC J, V78, P2501, DOI 10.1253/circj.CJ-14-0541; TANAKA M, 1987, CIRCULATION, V75, P1130, DOI 10.1161/01.CIR.75.6.1130; TEARE D, 1958, BRIT HEART J, V20, P1; Teekakirikul P, 2012, J CELL BIOL, V199, P417, DOI 10.1083/jcb.201207033; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Varnava A, 1999, HEART, V82, P621, DOI 10.1136/hrt.82.5.621; Vatasescu Radu, 2012, Indian Pacing Electrophysiol J, V12, P114; Veselka J, 2016, EUR HEART J, V37, P1517, DOI 10.1093/eurheartj/ehv693; Veselka J, 2016, INT J CARDIOL, V209, P194, DOI 10.1016/j.ijcard.2016.02.077; Veselka J, 2015, CAN J CARDIOL, V31, P1245, DOI 10.1016/j.cjca.2015.02.010; Veselka J, 2014, EUR HEART J, V35, P2040, DOI 10.1093/eurheartj/eht495; Veselka J, 2011, CAN J CARDIOL, V27, P763, DOI 10.1016/j.cjca.2011.09.001; Vulpian A., 1868, ARCH PHYSIOL-PARIS, V3, P456; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; Wilke I, 2016, J CARDIOVASC ELECTR, V27, P779, DOI 10.1111/jce.12982; Witjas-Paalberends ER, 2013, CARDIOVASC RES, V99, P432, DOI 10.1093/cvr/cvt119; Zemanek D, 2008, INT HEART J, V49, P371, DOI 10.1536/ihj.49.371	160	123	138	2	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1253	1267		10.1016/S0140-6736(16)31321-6	http://dx.doi.org/10.1016/S0140-6736(16)31321-6			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP1KL	27912983				2022-12-28	WOS:000397143700037
J	Gibson, CM; Mehran, R; Bode, C; Halperin, J; Verheugt, FW; Wildgoose, P; Birmingham, M; Ianus, J; Burton, P; van Eickels, M; Korjian, S; Daaboul, Y; Lip, GYH; Cohen, M; Husted, S; Peterson, ED; Fox, KA				Gibson, C. Michael; Mehran, Roxana; Bode, Christoph; Halperin, Jonathan; Verheugt, Freek W.; Wildgoose, Peter; Birmingham, Mary; Ianus, Juliana; Burton, Paul; van Eickels, Martin; Korjian, Serge; Daaboul, Yazan; Lip, Gregory Y. H.; Cohen, Marc; Husted, Steen; Peterson, Eric D.; Fox, Keith A.			Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ANTITHROMBOTIC STRATEGIES; OPEN-LABEL; RIVAROXABAN; THERAPY; ANTICOAGULATION	BACKGROUND In patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) with placement of stents, standard anticoagulation with a vitamin K antagonist plus dual antiplatelet therapy (DAPT) with a P2Y(12) inhibitor and aspirin reduces the risk of thrombosis and stroke but increases the risk of bleeding. The effectiveness and safety of anticoagulation with rivaroxaban plus either one or two antiplatelet agents are uncertain. METHODS We randomly assigned 2124 participants with nonvalvular atrial fibrillation who had undergone PCI with stenting to receive, in a 1:1:1 ratio, low-dose rivaroxaban (15 mg once daily) plus a P2Y(12) inhibitor for 12 months (group 1), very-low-dose rivaroxaban (2.5 mg twice daily) plus DAPT for 1, 6, or 12 months (group 2), or standard therapy with a dose-adjusted vitamin K antagonist (once daily) plus DAPT for 1, 6, or 12 months (group 3). The primary safety outcome was clinically significant bleeding (a composite of major bleeding or minor bleeding according to Thrombolysis in Myocardial Infarction [TIMI] criteria or bleeding requiring medical attention). RESULTS The rates of clinically significant bleeding were lower in the two groups receiving rivaroxaban than in the group receiving standard therapy (16.8% in group 1, 18.0% in group 2, and 26.7% in group 3; hazard ratio for group 1 vs. group 3, 0.59; 95% confidence interval [CI], 0.47 to 0.76; P<0.001; hazard ratio for group 2 vs. group 3, 0.63; 95% CI, 0.50 to 0.80; P<0.001). The rates of death from cardiovascular causes, myocardial infarction, or stroke were similar in the three groups (Kaplan-Meier estimates, 6.5% in group 1, 5.6% in group 2, and 6.0% in group 3; P values for all comparisons were nonsignificant). CONCLUSIONS In participants with atrial fibrillation undergoing PCI with placement of stents, the administration of either low-dose rivaroxaban plus a P2Y(12) inhibitor for 12 months or very-low-dose rivaroxaban plus DAPT for 1, 6, or 12 months was associated with a lower rate of clinically significant bleeding than was standard therapy with a vitamin K antagonist plus DAPT for 1, 6, or 12 months. The three groups had similar efficacy rates, although the observed broad confidence intervals diminish the surety of any conclusions regarding efficacy. (Funded by Janssen Scientific Affairs and Bayer Pharmaceuticals; PIONEER AF-PCI ClinicalTrials.gov number, NCT01830543.)	[Gibson, C. Michael; Korjian, Serge; Daaboul, Yazan] Harvard Med Sch, Cardiovasc Div, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Mehran, Roxana; Halperin, Jonathan] Icahn Sch Med Mt Sinai, Mt Sinai Med Ctr, Cardiovasc Inst, New York, NY 10029 USA; [Bode, Christoph] Univ Freiburg, Dept Cardiol & Angiol 1, Ctr Heart, Freiburg, Germany; [van Eickels, Martin] Bayer Pharmaceut, Leverkusen, Germany; [Verheugt, Freek W.] OLVG, Amsterdam, Netherlands; [Wildgoose, Peter; Birmingham, Mary; Ianus, Juliana; Burton, Paul] Janssen Pharmaceut, Titusville, NJ USA; [Cohen, Marc] Newark Beth Israel Med Ctr, Div Cardiol, Newark, NJ USA; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England; [Husted, Steen] Aarhus Univ Hosp, Dept Med, Hosp Unit West, Herning, Denmark; [Peterson, Eric D.] Duke Clin Res Inst, Durham, NC USA; [Fox, Keith A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Fox, Keith A.] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Icahn School of Medicine at Mount Sinai; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Bayer AG; Bayer Healthcare Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA; Newark Beth Israel Medical Center; University of Birmingham; Aarhus University; Duke University; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Gibson, CM (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Overland 540, Boston, MA 02215 USA.	mgibson@bidmc.harvard.edu	Peterson, Eric David/ABF-5033-2021; Halperin, Jonathan/AAJ-4721-2020; Daaboul, Yazan/AAP-7792-2020; Malynovsky, Yaroslav/T-1898-2017; Mehran, Roxana/ABF-4160-2021; Gibson, C. Michael/AAE-8212-2019; Chi, Gerald/M-7855-2017; Fox, keith A A/I-3742-2013	Halperin, Jonathan/0000-0002-8318-5471; Malynovsky, Yaroslav/0000-0002-9118-1104; Chi, Gerald/0000-0002-8371-1689; Fox, Keith/0000-0002-0140-2752	Janssen Scientific Affairs; Bayer Pharmaceuticals	Janssen Scientific Affairs; Bayer Pharmaceuticals(Bayer AG)	Funded by Janssen Scientific Affairs and Bayer Pharmaceuticals	Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Gibson CM, 2015, AM HEART J, V169, P472, DOI 10.1016/j.ahj.2014.12.006; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Paikin JS, 2010, CIRCULATION, V121, P2067, DOI 10.1161/CIRCULATIONAHA.109.924944; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Perez-Gomez F, 2004, J AM COLL CARDIOL, V44, P1557, DOI 10.1016/j.jacc.2004.05.084; Popma CJ, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003114; Rubboli A, 2007, CORONARY ARTERY DIS, V18, P193, DOI 10.1097/MCA.0b013e328012a964; Wang TY, 2008, AM HEART J, V155, P361, DOI 10.1016/j.ahj.2007.09.003	13	966	1008	3	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2423	2434		10.1056/NEJMoa1611594	http://dx.doi.org/10.1056/NEJMoa1611594			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1NL	27959713	Green Published			2022-12-28	WOS:000390091500006
J	Tippett, MK; Lepore, C; Cohen, JE				Tippett, Michael K.; Lepore, Chiara; Cohen, Joel E.			More tornadoes in the most extreme US tornado outbreaks	SCIENCE			English	Article							ATLANTIC MULTIDECADAL OSCILLATION; UNITED-STATES; VARIABILITY; INCREASES	Tornadoes and severe thunderstorms kill people and damage property every year. Estimated U.S. insured losses due to severe thunderstorms in the first half of 2016 were $8.5 billion (US). The largest U.S. effects of tornadoes result from tornado outbreaks, which are sequences of tornadoes that occur in close succession. Here, using extreme value analysis, we find that the frequency of U.S. outbreaks with many tornadoes is increasing and that it is increasing faster for more extreme outbreaks. We model this behavior by extreme value distributions with parameters that are linear functions of time or of some indicators of multidecadal climatic variability. Extreme meteorological environments associated with severe thunderstorms show consistent upward trends, but the trends do not resemble those currently expected to result from global warming.	[Tippett, Michael K.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA; [Tippett, Michael K.] King Abdulaziz Univ, Dept Meteorol, Ctr Excellence Climate Change Res, Jeddah, Saudi Arabia; [Lepore, Chiara] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Cohen, Joel E.] Rockefeller Univ, Lab Populat, New York, NY 10065 USA; [Cohen, Joel E.] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Cohen, Joel E.] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Cohen, Joel E.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	Columbia University; King Abdulaziz University; Columbia University; Rockefeller University; Columbia University; Columbia University; University of Chicago	Tippett, MK (corresponding author), Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA.; Tippett, MK (corresponding author), King Abdulaziz Univ, Dept Meteorol, Ctr Excellence Climate Change Res, Jeddah, Saudi Arabia.	mkt14@columbia.edu		Lepore, Chiara/0000-0002-1606-6982	Columbia University Research Initiatives for Science and Engineering (RISE) award; Office of Naval Research [N00014-12-1-0911, N00014-16-1-2073]; NOAA's Climate Program Office's Modeling, Analysis, Predictions, and Projections program [NA14OAR4310185]; Willis Research Network; U.S. National Science Foundation [DMS-1225529]; National Science Foundation; Direct For Mathematical & Physical Scien [1225529] Funding Source: National Science Foundation	Columbia University Research Initiatives for Science and Engineering (RISE) award; Office of Naval Research(Office of Naval Research); NOAA's Climate Program Office's Modeling, Analysis, Predictions, and Projections program; Willis Research Network; U.S. National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank A. Rhimes and K. McKinnon for suggestions on the use of quantile regression, with count data. We thank two reviewers who provided constructive and helpful comments. M.K.T. and C.L. were partially supported by a Columbia University Research Initiatives for Science and Engineering (RISE) award; Office of Naval Research awards N00014-12-1-0911 and N00014-16-1-2073; NOAA's Climate Program Office's Modeling, Analysis, Predictions, and Projections program award NA14OAR4310185; and the Willis Research Network. J.E.C. was partially supported by U.S. National Science Foundation grant DMS-1225529 and thanks P. K. Rogerson for assistance during this work. The views expressed herein are those of the authors and do not necessarily reflect the views of any of the sponsoring agencies. The study was led by M.K.T.; calculations were carried out and the manuscript was drafted by M.K.T. C.L. prepared the environmental data. All authors were involved with designing the research, analyzing the results, and revising and editing the manuscript. All the authors declare no competing interests. Correspondence and material requests should be addressed to M.K.T. U.S. tornado report data come from NOAA's Storm Prediction Center www.spc.noaa..gov/wcm. North American Regional Reanalysis data am provided by the NOAA/Office of Oceanic and Atmospheric Research/Earth System Research Laboratory Physical Sciences Division, Boulder, Colorado, USA, from their website at www.esrl.noaa.gov/psd and the Data Support Section, of the Computational and Information Systems Laboratory at the National Center for Atmospheric Research (NCAR). NCAR is supported by grants from the National Science Foundation.	Agee E, 2016, J APPL METEOROL CLIM, V55, P1681, DOI 10.1175/JAMC-D-15-0342.1; Allen JT, 2015, NAT GEOSCI, V8, P278, DOI 10.1038/NGEO2385; Brooks HE, 2014, SCIENCE, V346, P349, DOI 10.1126/science.1257460; Brooks HE, 2008, CLIMATE EXTREMES AND SOCIETY, P35, DOI 10.1017/CBO9780511535840.006; Clement A, 2015, SCIENCE, V350, P320, DOI 10.1126/science.aab3980; Diffenbaugh NS, 2013, P NATL ACAD SCI USA, V110, P16361, DOI 10.1073/pnas.1307758110; Elsner JB, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024018; Elsner JB, 2015, CLIM DYNAM, V45, P651, DOI 10.1007/s00382-014-2277-3; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fuhrmann CM, 2014, WEATHER FORECAST, V29, P684, DOI 10.1175/WAF-D-13-00128.1; Lu MQ, 2015, GEOPHYS RES LETT, V42, P4224, DOI 10.1002/2015GL063968; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Robinson ED, 2013, J APPL METEOROL CLIM, V52, P2147, DOI 10.1175/JAMC-D-12-0131.1; Sander J, 2013, WEATHER CLIM SOC, V5, P317, DOI 10.1175/WCAS-D-12-00023.1; Tippett MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10668; Tippett MK, 2014, GEOPHYS RES LETT, V41, P6956, DOI 10.1002/2014GL061347; Trapp RJ, 2016, J CLIMATE, V29, P5251, DOI 10.1175/JCLI-D-15-0623.1; Trapp RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036203; Verbout SM, 2006, WEATHER FORECAST, V21, P86, DOI 10.1175/WAF910.1; Weaver SJ, 2012, J CLIMATE, V25, P6666, DOI 10.1175/JCLI-D-11-00568.1	20	60	61	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1419	1423		10.1126/science.aah7393	http://dx.doi.org/10.1126/science.aah7393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27934705				2022-12-28	WOS:000390261300042
J	Oswald, C; Rappas, M; Kean, J; Dore, AS; Errey, JC; Bennett, K; Eflorian, FD; Christopher, JA; Jazayeri, A; Mason, JS; Congreve, M; Cooke, RM; Marshall, FH				Oswald, Christine; Rappas, Mathieu; Kean, James; Dore, Andrew S.; Errey, James C.; Bennett, Kirstie; Eflorian, Francesca D.; Christopher, John A.; Jazayeri, Ali; Mason, Jonathan S.; Congreve, Miles; Cooke, Robert M.; Marshall, Fiona H.			Intracellular allosteric antagonism of the CCR9 receptor	NATURE			English	Article							CHEMOKINE RECEPTOR; BINDING-SITE; CRYSTAL-STRUCTURE; REFINEMENT; GPCR; ACTIVATION	Chemokines and their G-protein-coupled receptors play a diverse role in immune defence by controlling the migration, activation and survival of immune cells(1). They are also involved in viral entry, tumour growth and metastasis and hence are important drug targets in a wide range of diseases(2,3). Despite very significant efforts by the pharmaceutical industry to develop drugs, with over 50 small-molecule drugs directed at the family entering clinical development, only two compounds have reached the market: maraviroc (CCR5) for HIV infection and plerixafor (CXCR4) for stem-cell mobilization4. The high failure rate may in part be due to limited understanding of the mechanism of action of chemokine antagonists and an inability to optimize compounds in the absence of structural information(5). CC chemokine receptor type 9 (CCR9) activation by CCL25 plays a key role in leukocyte recruitment to the gut and represents a therapeutic target in inflammatory bowel disease(6). The selective CCR9 antagonist vercirnon progressed to phase 3 clinical trials in Crohn's disease but efficacy was limited, with the need for very high doses to block receptor activation(6). Here we report the crystal structure of the CCR9 receptor in complex with vercirnon at 2.8 angstrom resolution. Remarkably, vercirnon binds to the intracellular side of the receptor, exerting allosteric antagonism and preventing G-protein coupling. This binding site explains the need for relatively lipophilic ligands and describes another example of an allosteric site on G-protein-coupled receptors(7) that can be targeted for drug design, not only at CCR9, but potentially extending to other chemokine receptors.	[Oswald, Christine; Rappas, Mathieu; Kean, James; Dore, Andrew S.; Errey, James C.; Bennett, Kirstie; Eflorian, Francesca D.; Christopher, John A.; Jazayeri, Ali; Mason, Jonathan S.; Congreve, Miles; Cooke, Robert M.; Marshall, Fiona H.] Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England	Heptares Therapeutics Ltd.	Marshall, FH (corresponding author), Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England.	fiona.marshall@heptares.com	Marshall, Fiona/AAZ-9626-2020					Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Andrews G, 2008, MOL PHARMACOL, V73, P855, DOI 10.1124/mol.107.039321; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Changeux JP, 2016, CELL, V166, P1084, DOI 10.1016/j.cell.2016.08.015; de Kruijf P, 2009, J PHARMACOL EXP THER, V329, P783, DOI 10.1124/jpet.108.148387; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gonsiorek W, 2007, J PHARMACOL EXP THER, V322, P477, DOI 10.1124/jpet.106.118927; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Lazaar AL, 2011, BRIT J CLIN PHARMACO, V72, P282, DOI 10.1111/j.1365-2125.2011.03968.x; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Nugent T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-276; Pease J, 2012, J MED CHEM, V55, P9363, DOI 10.1021/jm300682j; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Salchow K, 2010, BRIT J PHARMACOL, V159, P1429, DOI 10.1111/j.1476-5381.2009.00623.x; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Solari R, 2015, EUR J PHARMACOL, V746, P363, DOI 10.1016/j.ejphar.2014.06.060; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tchernychev B, 2010, P NATL ACAD SCI USA, V107, P22255, DOI 10.1073/pnas.1009633108; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Ungashe S., 2006, US patent, Patent No. [2006/0111351A1, 20060111351]; Vela M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00012; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Wendt E, 2015, CLIN EXP GASTROENTER, V8, P119, DOI 10.2147/CEG.S48305; Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	41	145	146	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					462	+		10.1038/nature20606	http://dx.doi.org/10.1038/nature20606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27926729				2022-12-28	WOS:000389716800048
J	Huitfeldt, A				Huitfeldt, Anders			CHRISTMAS 2016: FOOD FOR THOUGHT Is caviar a risk factor for being a millionaire?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-HEART-DISEASE; CHOLESTEROL; PREDICTION; HEALTH		[Huitfeldt, Anders] Stanford Univ, Sch Med, Meta Res Innovat Ctr Stanford, Palo Alto, CA 94304 USA	Stanford University	Huitfeldt, A (corresponding author), Stanford Univ, Sch Med, Meta Res Innovat Ctr Stanford, Palo Alto, CA 94304 USA.	ahuitfel@stanford.edu	Huitfeldt, Anders/U-1046-2019	Huitfeldt, Anders/0000-0002-0904-4945				Aronowitz RA, 2015, RISKY MED OUR QUEST, DOI [10.7208/chicago/9780226049854.001.0001, DOI 10.7208/CHICAGO/9780226049854.001]; BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58; Dawber TR, 2015, INT J EPIDEMIOL, V44, P1767, DOI 10.1093/ije/dyv346; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Gelman A, 2013, 19614 NBER; GREENLAND S, 1988, AM J EPIDEMIOL, V128, P1185, DOI 10.1093/oxfordjournals.aje.a115073; Hendriksen JMT, 2013, J THROMB HAEMOST, V11, P129, DOI 10.1111/jth.12262; Hernan MA., 2016, CAUSAL INFERENCE; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Khullar D, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1417; LEVINE GN, 1995, NEW ENGL J MED, V332, P512, DOI 10.1056/NEJM199502233320807; Porta M, 2014, DICT EPIDEMIOLOGY; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Shmueli G, 2011, MANAGE INF SYST Q, V35; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Skinner JS, 2010, HEART, V96, P974, DOI 10.1136/hrt.2009.190066; Smith GD, 2008, BIOSOCIAL SURVEYS; Suzuki E, 2012, AM J EPIDEMIOL, V175, P567, DOI 10.1093/aje/kwr333; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yudkowsky ES, 2015, RATIONALITY AI ZOMBI	20	10	10	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2016	355								i6536	10.1136/bmj.i6536	http://dx.doi.org/10.1136/bmj.i6536			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SZ	27940434				2022-12-28	WOS:000390037600004
J	Burns, C; Valentine, J				Burns, Carrick; Valentine, Johannah			Tinea Imbricata	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Burns, Carrick; Valentine, Johannah] Naval Med Ctr San Diego, San Diego, CA 92134 USA	United States Department of Defense; United States Navy; Naval Medical Center San Diego	Burns, C (corresponding author), Naval Med Ctr San Diego, San Diego, CA 92134 USA.	carrick.t.burns.mil@mail.mil							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2272	2272		10.1056/NEJMicm1516757	http://dx.doi.org/10.1056/NEJMicm1516757			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0ZQ	27959674				2022-12-28	WOS:000389310000010
J	Dolgin, E				Dolgin, Elie			Encapsulating the problem	NATURE			English	Editorial Material							BETA-CELLS; PRIMATES; ISLETS											Ludwig B, 2013, P NATL ACAD SCI USA, V110, P19054, DOI 10.1073/pnas.1317561110; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Tomei AA, 2014, P NATL ACAD SCI USA, V111, P10514, DOI 10.1073/pnas.1402216111; Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]	6	26	28	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					S60	S62		10.1038/540S60a	http://dx.doi.org/10.1038/540S60a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27926697	Bronze			2022-12-28	WOS:000389548700006
J	Painter, G				Painter, George			A Prescription for Change The Looming Crisis in Drug Development	SCIENCE			English	Book Review									[Painter, George] Emory Univ, Emory Inst Drug Discovery, Atlanta, GA 30329 USA	Emory University	Painter, G (corresponding author), Emory Univ, Emory Inst Drug Discovery, Atlanta, GA 30329 USA.	george.r.painter@emory.edu						Kinch MS, 2016, LUTHER HODGES SER BU, P1	1	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1111	1111		10.1126/science.aaj1906	http://dx.doi.org/10.1126/science.aaj1906			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934731				2022-12-28	WOS:000388916400029
J	Hamperl, S; Cimprich, KA				Hamperl, Stephan; Cimprich, Karlene A.			Conflict Resolution in the Genome: How Transcription and Replication Make It Work	CELL			English	Review							RNA-POLYMERASE-II; FRAGILE SITE INSTABILITY; R-LOOPS; FORK PROGRESSION; DNA-REPLICATION; MESSENGER-RNA; RNA/DNA HYBRIDS; PAUSE SITES; S-PHASE; GENES	The complex machineries involved in replication and transcription translocate along the same DNA template, often in opposing directions and at different rates. These processes routinely interfere with each other in prokaryotes, and mounting evidence now suggests that RNA polymerase complexes also encounter replication forks in higher eukaryotes. Indeed, cells rely on numerous mechanisms to avoid, tolerate, and resolve such transcription-replication conflicts, and the absence of these mechanisms can lead to catastrophic effects on genome stability and cell viability. In this article, we review the cellular responses to transcription-replication conflicts and highlight how these inevitable encounters shape the genome and impact diverse cellular processes.	[Hamperl, Stephan; Cimprich, Karlene A.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, 318 Campus Dr, Stanford, CA 94305 USA	Stanford University	Cimprich, KA (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, 318 Campus Dr, Stanford, CA 94305 USA.	cimprich@stanford.edu		Hamperl, Stephan/0000-0002-1658-7948	NIH [GM119334]; Komen Foundation [IIR12222368]; German Research Foundation [6996/1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to all scientists whose work we could not cite due to space limitations. We are especially grateful to Dr. Caroline Stork and Dr. Madzia Crossley for critical reading and helpful comments on the manuscript. K.A.C. is supported by grants from the NIH (GM119334) and the Komen Foundation (IIR12222368). S.H. has been supported by a fellowship from the German Research Foundation (DFG HA 6996/1-1).	Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; Blythe SA, 2015, CELL, V160, P1169, DOI 10.1016/j.cell.2015.01.050; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Castel SE, 2014, CELL, V159, P572, DOI 10.1016/j.cell.2014.09.031; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Chan YJA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004288; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; de Oliveira FMB, 2015, MOL CELL, V57, P1124, DOI 10.1016/j.molcel.2015.01.043; Dimitrova DS, 2011, J CELL SCI, V124, P2743, DOI 10.1242/jcs.082230; Duch A, 2013, NATURE, V493, P116, DOI 10.1038/nature11675; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; Felipe-Abrio I, 2015, EMBO J, V34, P236, DOI 10.15252/embj.201488544; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Ganesan A, 2012, PROG MOL BIOL TRANSL, V110, P25, DOI 10.1016/B978-0-12-387665-2.00002-X; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garcia-Rubio ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005674; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gomez-Gonzalez B, 2009, MOL CELL BIOL, V29, P5203, DOI 10.1128/MCB.00402-09; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Gowrishankar J, 2013, TRANSCR-AUSTIN, V4, P153, DOI 10.4161/trns.25101; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004630; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Gros J, 2015, MOL CELL, V60, P797, DOI 10.1016/j.molcel.2015.10.022; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Guy L, 2004, GENE, V340, P45, DOI 10.1016/j.gene.2004.06.056; Gwynn EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078141; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Hatchi E, 2015, MOL CELL, V57, P636, DOI 10.1016/j.molcel.2015.01.011; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; Le Tallec B, 2014, CELL MOL LIFE SCI, V71, P4489, DOI 10.1007/s00018-014-1720-2; Le Tallec B, 2013, CELL REP, V4, P420, DOI 10.1016/j.celrep.2013.07.003; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; Loomis EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004294; McGuffee SR, 2013, MOL CELL, V50, P123, DOI 10.1016/j.molcel.2013.03.004; McKay BC, 2002, DNA REPAIR, V1, P811, DOI 10.1016/S1568-7864(02)00109-X; Merrikh CN, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005289; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Meryet-Figuiere M, 2014, CELL CYCLE, V13, P3241, DOI 10.4161/15384101.2014.953876; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Nguyen VC, 2010, NAT STRUCT MOL BIOL, V17, P976, DOI 10.1038/nsmb.1857; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paul S, 2013, NATURE, V495, P512, DOI 10.1038/nature11989; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Petryk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10208; Poli J, 2016, GENE DEV, V30, P337, DOI 10.1101/gad.273813.115; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Powell SK, 2015, EMBO J, V34, P531, DOI 10.15252/embj.201488307; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Roghanian M, 2015, NUCLEIC ACIDS RES, V43, P1529, DOI 10.1093/nar/gkv003; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; Sankar TS, 2016, NATURE, V535, P178, DOI 10.1038/nature18316; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Saponaro M, 2014, CELL, V157, P1037, DOI 10.1016/j.cell.2014.03.048; Schwab RA, 2015, MOL CELL, V60, P351, DOI 10.1016/j.molcel.2015.09.012; Sekedat MD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.8; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Sollier J, 2015, TRENDS CELL BIOL, V25, P514, DOI 10.1016/j.tcb.2015.05.003; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Stirling PC, 2012, GENE DEV, V26, P163, DOI 10.1101/gad.179721.111; Stork CT, 2016, ELIFE, V5, DOI 10.7554/eLife.17548; Stuckey R, 2015, P NATL ACAD SCI USA, V112, P5779, DOI 10.1073/pnas.1501769112; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Washburn RS, 2011, P NATL ACAD SCI USA, V108, P792, DOI 10.1073/pnas.1009564108; Wei PC, 2016, CELL, V164, P644, DOI 10.1016/j.cell.2015.12.039; Wei XY, 1998, SCIENCE, V281, P1502, DOI 10.1126/science.281.5382.1502; Weissman IL, 2016, CELL, V164, P593, DOI 10.1016/j.cell.2016.01.048; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Wilson MD, 2013, CELL, V154, P983, DOI 10.1016/j.cell.2013.07.028; Yuce O, 2013, MOL CELL BIOL, V33, P406, DOI 10.1128/MCB.01195-12	100	139	139	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1455	1467		10.1016/j.cell.2016.09.053	http://dx.doi.org/10.1016/j.cell.2016.09.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912056	Green Accepted, Bronze			2022-12-28	WOS:000389470500010
J	Khakimov, RI; Henson, BM; Shin, DK; Hodgman, SS; Dall, RG; Baldwin, KGH; Truscott, AG				Khakimov, R. I.; Henson, B. M. .; Shin, D. K.; Hodgman, S. S.; Dall, R. G.; Baldwin, K. G. H.; Truscott, A. G.			Ghost imaging with atoms	NATURE			English	Article							DIFFRACTION; QUANTUM; LIGHT; WAVES	Ghost imaging is a counter-intuitive phenomenon-first realized in quantum optics(1,2)-that enables the image of a two-dimensional object (mask) to be reconstructed using the spatio-temporal properties of a beam of particles with which it never interacts. Typically, two beams of correlated photons are used: one passes through the mask to a single-pixel (bucket) detector while the spatial profile of the other is measured by a high-resolution (multi-pixel) detector. The second beam never interacts with the mask. Neither detector can reconstruct the mask independently, but temporal cross-correlation between the two beams can be used to recover a 'ghost' image. Here we report the realization of ghost imaging using massive particles instead of photons. In our experiment, the two beams are formed by correlated pairs of ultracold, metastable helium atoms(3), which originate from s-wave scattering of two colliding Bose-Einstein condensates(4,5). We use higher-order Kapitza-Dirac scattering(6-8) to generate a large number of correlated atom pairs, enabling the creation of a clear ghost image with submillimetre resolution. Future extensions of our technique could lead to the realization of ghost interference(9), and enable tests of Einstein-Podolsky-Rosen entanglement(9) and Bell's inequalities(10) with atoms.	[Khakimov, R. I.; Henson, B. M. .; Shin, D. K.; Hodgman, S. S.; Dall, R. G.; Baldwin, K. G. H.; Truscott, A. G.] Australian Natl Univ, Res Sch Phys & Engn, Canberra, ACT 2601, Australia	Australian National University	Truscott, AG (corresponding author), Australian Natl Univ, Res Sch Phys & Engn, Canberra, ACT 2601, Australia.	andrew.truscott@anu.edu.au	Henson, Bryce/B-4512-2015; Baldwin, Kenneth G H/A-4928-2008; Hodgman, Sean/AAV-2779-2021; Truscott, Andrew/A-8086-2011; Khakimov, Roman I./E-7950-2015	Henson, Bryce/0000-0002-3451-8188; Baldwin, Kenneth G H/0000-0002-2043-5330; Truscott, Andrew/0000-0003-2106-8613; Shin, Dongki/0000-0002-6520-0463; Khakimov, Roman I./0000-0003-1483-1748; Hodgman, Sean/0000-0002-2417-350X	Australian Research Council (ARC) [FT100100468, DP120101390]; ARC through the DECRA [DE150100315]	Australian Research Council (ARC)(Australian Research Council); ARC through the DECRA(Australian Research Council)	A.G.T. acknowledges the support of the Australian Research Council (ARC) through the Future Fellowship grant FT100100468 and the Discovery grant DP120101390. S.S.H. acknowledges the support of the ARC through the DECRA Fellowship DE150100315. We thank A. T. Friberg for discussions.	Belinskii A. V., 1994, Journal of Experimental and Theoretical Physics, V78, P259; Bennink RS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.033601; Bennink RS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.113601; Brida G, 2010, NAT PHOTONICS, V4, P227, DOI 10.1038/NPHOTON.2010.29; Dall RG, 2007, OPT COMMUN, V270, P255, DOI 10.1016/j.optcom.2006.09.031; Dall RG, 2013, NAT PHYS, V9, P341, DOI [10.1038/nphys2632, 10.1038/NPHYS2632]; Erkmen BI, 2010, ADV OPT PHOTONICS, V2, P405, DOI 10.1364/AOP.2.000405; Ferri F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183602; GOULD PL, 1986, PHYS REV LETT, V56, P827, DOI 10.1103/PhysRevLett.56.827; Hardy ND, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.023820; Hodgman SS, 2011, SCIENCE, V331, P1046, DOI 10.1126/science.1198481; Jack B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.083602; Jaskula JC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.190402; Jeltes T, 2007, NATURE, V445, P402, DOI 10.1038/nature05513; Kapitza PL, 1933, P CAMB PHILOS SOC, V29, P297, DOI 10.1017/S0305004100011105; Klyshko D. N., 1988, Soviet Physics - JETP, V67, P1131; Kofler J, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032115; Lewis-Swan RJ, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.052114; Lewis-Swan RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4752; Manning AG, 2015, NAT PHYS, V11, P539, DOI 10.1038/NPHYS3343; Morris PA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6913; Ovchinnikov YB, 1999, PHYS REV LETT, V83, P284, DOI 10.1103/PhysRevLett.83.284; Perrin A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150405; PITTMAN TB, 1995, PHYS REV A, V52, pR3429, DOI 10.1103/PhysRevA.52.R3429; Ryczkowski P, 2016, NAT PHOTONICS, V10, P167, DOI [10.1038/NPHOTON.2015.274, 10.1038/nphoton.2015.274]; Shapiro JH, 2012, QUANTUM INF PROCESS, V11, P949, DOI 10.1007/s11128-011-0356-5; STREKALOV DV, 1995, PHYS REV LETT, V74, P3600, DOI 10.1103/PhysRevLett.74.3600; Sun B, 2013, SCIENCE, V340, P844, DOI 10.1126/science.1234454; Vassen W, 2012, REV MOD PHYS, V84, P175, DOI 10.1103/RevModPhys.84.175; Yasuda M, 1996, PHYS REV LETT, V77, P3090, DOI 10.1103/PhysRevLett.77.3090; Yu H, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.113901; Yuan S, 2016, OPT COMMUN, V365, P180, DOI 10.1016/j.optcom.2015.12.013	33	105	108	6	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					100	+		10.1038/nature20154	http://dx.doi.org/10.1038/nature20154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905444	Green Submitted			2022-12-28	WOS:000388916600056
J	Cristofanilli, M				Cristofanilli, Massimo			Metastatic breast cancer: focus on endocrine sensitivity	LANCET			English	Editorial Material							POSTMENOPAUSAL WOMEN; 1ST-LINE THERAPY; PHASE-III; LETROZOLE; PALBOCICLIB; FULVESTRANT; COMBINATION		[Cristofanilli, Massimo] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Dept Med,Div Hematol & Oncol, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Cristofanilli, M (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Dept Med,Div Hematol & Oncol, Chicago, IL 60611 USA.	massimo.cristofanilli@nm.org						Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Chandarlapaty S, 2016, JAMA ONCOL, V2, P1310, DOI 10.1001/jamaoncol.2016.1279; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Di Leo A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt337; Finn RS, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.507; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Mehta RS, 2012, NEW ENGL J MED, V367, P435, DOI 10.1056/NEJMoa1201622; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Prat A, 2016, JAMA ONCOL, V2, P1287, DOI 10.1001/jamaoncol.2016.0922; Robertson JFR, 2016, LANCET	12	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2961	2962		10.1016/S0140-6736(16)32418-7	http://dx.doi.org/10.1016/S0140-6736(16)32418-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27908455				2022-12-28	WOS:000390112300005
J	Finkel, RS; Chiriboga, CA; Vajsar, J; Day, JW; Montes, J; De Vivo, DC; Yamashita, M; Rigo, F; Hung, G; Schneider, E; Norris, DA; Xia, ST; Bennett, CF; Bishop, KM				Finkel, Richard S.; Chiriboga, Claudia A.; Vajsar, Jiri; Day, John W.; Montes, Jacqueline; De Vivo, Darryl C.; Yamashita, Mason; Rigo, Frank; Hung, Gene; Schneider, Eugene; Norris, Daniel A.; Xia, Shuting; Bennett, C. Frank; Bishop, Kathie M.			Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study	LANCET			English	Article							SURVIVAL MOTOR-NEURON; NATURAL-HISTORY; CLINICAL-TRIALS; SMA; CHILDREN; GENE; HYBRIDIZATION; DIAGNOSIS; SEVERITY; TYPE-1	Background Nusinersen is a 2'-O-methoxyethyl phosphorothioate-modified antisense drug being developed to treat spinal muscular atrophy. Nusinersen is specifically designed to alter splicing of SMN2 pre-mRNA and thus increase the amount of functional survival motor neuron (SMN) protein that is deficient in patients with spinal muscular atrophy. Methods This open-label, phase 2, escalating dose clinical study assessed the safety and tolerability, pharmacokinetics, and clinical efficacy of multiple intrathecal doses of nusinersen (6 mg and 12 mg dose equivalents) in patients with infantile-onset spinal muscular atrophy. Eligible participants were of either gender aged between 3 weeks and 7 months old with onset of spinal muscular atrophy symptoms between 3 weeks and 6 months, who had SMN1 homozygous gene deletion or mutation. Safety assessments included adverse events, physical and neurological examinations, vital signs, clinical laboratory tests, cerebrospinal fluid laboratory tests, and electrocardiographs. Clinical efficacy assessments included event free survival, and change from baseline of two assessments of motor function: the motor milestones portion of the Hammersmith Infant Neurological Exam-Part 2 (HINE-2) and the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP-INTEND) motor function test, and compound motor action potentials. Autopsy tissue was analysed for target engagement, drug concentrations, and pharmacological activity. HINE-2, CHOP-INTEND, and compound motor action potential were compared between baseline and last visit using the Wilcoxon signed-rank test. Age at death or permanent ventilation was compared with natural history using the log-rank test. The study is registered at ClinicalTrials.gov, number NCT01839656. Findings 20 participants were enrolled between May 3, 2013, and July 9, 2014, and assessed through to an interim analysis done on Jan 26, 2016. All participants experienced adverse events, with 77 serious adverse events reported in 16 participants, all considered by study investigators not related or unlikely related to the study drug. In the 12 mg dose group, incremental achievements of motor milestones (p< 0 . 0001), improvements in CHOP-INTEND motor function scores (p= 0 . 0013), and increased compound muscle action potential amplitude of the ulnar nerve (p= 0 . 0103) and peroneal nerve (p< 0 . 0001), compared with baseline, were observed. Median age at death or permanent ventilation was not reached and the Kaplan-Meier survival curve diverged from a published natural history case series (p= 0 . 0014). Analysis of autopsy tissue from patients exposed to nusinersen showed drug uptake into motor neurons throughout the spinal cord and neurons and other cell types in the brainstem and other brain regions, exposure at therapeutic concentrations, and increased SMN2 mRNA exon 7 inclusion and SMN protein concentrations in the spinal cord. Interpretation Administration of multiple intrathecal doses of nusinersen showed acceptable safety and tolerability, pharmacology consistent with its intended mechanism of action, and encouraging clinical efficacy. Results informed the design of an ongoing, sham-controlled, phase 3 clinical study of nusinersen in infantile-onset spinal muscular atrophy.	[Finkel, Richard S.] Nemours Childrens Hosp, 13535 Nemours Pkwy, Orlando, FL 32827 USA; [Chiriboga, Claudia A.; Montes, Jacqueline; De Vivo, Darryl C.] Columbia Univ, Med Ctr, New York, NY USA; [Vajsar, Jiri] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Day, John W.] Stanford Univ, Sch Med, Stanford, CA USA; [Yamashita, Mason; Rigo, Frank; Hung, Gene; Schneider, Eugene; Norris, Daniel A.; Xia, Shuting; Bennett, C. Frank; Bishop, Kathie M.] Ionis Pharmaceut Inc, Carlsbad, CA USA	Columbia University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stanford University; Ionis Pharmaceuticals, Inc.	Finkel, RS (corresponding author), Nemours Childrens Hosp, 13535 Nemours Pkwy, Orlando, FL 32827 USA.	rfinkel@nemours.org		Day, John/0000-0002-0086-9529	Biogen; SMA Foundation; Cure SMA	Biogen(Biogen); SMA Foundation; Cure SMA	We would like to sincerely thank the parents and guardians of the participants in this study, who both enabled and supported their participation and made the study possible. We appreciate the hard work and dedication of many people who contributed to this study at the Nemours clinical site, Columbia clinical site, Sick Kid's clinical site, Stanford University clinical site, and Ionis Pharmaceuticals, Inc. We thank the members of the data safety and monitoring board for this study and the support of the SMA Foundation and Cure SMA. We also thank Charlotte Sumner and David Valdivia from Johns Hopkins University for generously providing control autopsy material used in the analyses in this report. We would like to thank Matthew Schniederjan (Children's Healthcare of Atlanta, USA) and Martha Burt (University of Florida, Gainesville, FL, USA) for performing autopsies. Karen Spach (Excel Scientific Solutions, Southport, CT, USA), with funding from Biogen, provided support in editing the authors' drafts of the manuscript, and Elizabeth Cassell (Excel Scientific Solutions, Southport, CT, USA) copyedited and styled the manuscript per journal requirements. Biogen and Ionis Pharmaceuticals, Inc reviewed and provided feedback on the paper. The authors had full editorial control of the paper and provided their final approval of all content.	Arnold WD, 2015, MUSCLE NERVE, V51, P157, DOI 10.1002/mus.24497; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Finkel RS, 2014, NEUROLOGY, V83, P810, DOI 10.1212/WNL.0000000000000741; Frisone MF, 2002, J PEDIATR-US, V140, P57, DOI 10.1067/mpd.2002.119626; Glanzman AM, 2010, NEUROMUSCULAR DISORD, V20, P155, DOI 10.1016/j.nmd.2009.11.014; Hache M, 2016, J CHILD NEUROL, V31, P899, DOI 10.1177/0883073815627882; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Hung GN, 2013, NUCLEIC ACID THER, V23, P369, DOI 10.1089/nat.2013.0443; Kolb SJ, 2016, ANN CLIN TRANSL NEUR, V3, P132, DOI 10.1002/acn3.283; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lemoine TJ, 2012, PEDIATR CRIT CARE ME, V13, pE161, DOI 10.1097/PCC.0b013e3182388ad1; Lewelt A, 2010, MUSCLE NERVE, V42, P703, DOI 10.1002/mus.21838; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; Mercuri E, 2008, Neuromuscul Disord, V18, P894, DOI 10.1016/j.nmd.2008.07.003; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Rigo F, 2014, J PHARMACOL EXP THER, V350, P46, DOI 10.1124/jpet.113.212407; Rudnik-Schoneborn S, 2009, CLIN GENET, V76, P168, DOI 10.1111/j.1399-0004.2009.01200.x; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Yu RZ, 2002, ANAL BIOCHEM, V304, P19, DOI 10.1006/abio.2002.5576; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	30	563	586	4	109	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					3017	3026		10.1016/S0140-6736(16)31408-8	http://dx.doi.org/10.1016/S0140-6736(16)31408-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27939059				2022-12-28	WOS:000390112300034
J	Sakmar, TP; Huber, T				Sakmar, Thomas P.; Huber, Thomas			PHARMACOLOGY Inside-out receptor inhibition	NATURE			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CHEMOKINE; COMPLEX; CXCR4; RECOGNITION; ACTIVATION	Structures of two chemokine receptor proteins in complex with small molecules reveal a previously unknown binding pocket that could be a drug target for treating a range of diseases involving this receptor family. See Letters p.458 & p.462	[Sakmar, Thomas P.; Huber, Thomas] Rockefeller Univ, Lab Chem Biol & Signal Transduct, New York, NY 10065 USA	Rockefeller University	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Chem Biol & Signal Transduct, New York, NY 10065 USA.	sakmar@rockefeller.edu; hubert@rockefeller.edu	Huber, Thomas/A-8016-2008; Sakmar, Thomas P/D-1833-2015	Huber, Thomas/0000-0002-1844-262X; Sakmar, Thomas P/0000-0002-2836-8953				Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Oswald C, 2016, NATURE, V540, P462, DOI 10.1038/nature20606; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tchernychev B, 2010, P NATL ACAD SCI USA, V107, P22255, DOI 10.1073/pnas.1009633108; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Zheng Y, 2016, NATURE, V540, P458, DOI 10.1038/nature20605; Zweemer AJM, 2013, MOL PHARMACOL, V84, P551, DOI 10.1124/mol.113.086850	12	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					344	345		10.1038/nature20486	http://dx.doi.org/10.1038/nature20486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE6JR	27926728				2022-12-28	WOS:000389716800022
J	Araki, M; Bandi, MM; Yazaki-Sugiyama, Y				Araki, Makoto; Bandi, M. M.; Yazaki-Sugiyama, Yoko			Mind the gap: Neural coding of species identity in birdsong prosody	SCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; ZEBRA FINCH; INNATE RECOGNITION; NATURAL SOUNDS; SONG; SELECTIVITY; SPARROW; FOREBRAIN; NEURONS	Juvenile songbirds learn vocal communication from adult tutors of the same species but not from adults of other species. How species-specific learning emerges from the basic features of song prosody remains unknown. In the zebra finch auditory cortex, we discovered a class of neurons that register the silent temporal gaps between song syllables and are distinct from neurons encoding syllable morphology. Behavioral learning and neuronal coding of temporal gap structure resisted song tutoring from other species: Zebra finches fostered by Bengalese finch parents learned Bengalese finch song morphology transposed onto zebra finch temporal gaps. During the vocal learning period, temporal gap neurons fired selectively to zebra finch song. The innate temporal coding of intersyllable silent gaps suggests a neuronal barcode for conspecific vocal learning and social communication in acoustically diverse environments.	[Araki, Makoto; Yazaki-Sugiyama, Yoko] Grad Univ, OIST, Neuronal Mechanism Crit Period Unit, Onna, Okinawa, Japan; [Bandi, M. M.] Grad Univ, OIST, Collect Interact Unit, Onna, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University; Okinawa Institute of Science & Technology Graduate University	Yazaki-Sugiyama, Y (corresponding author), Grad Univ, OIST, Neuronal Mechanism Crit Period Unit, Onna, Okinawa, Japan.	yazaki-sugiyama@oist.jp	Yazaki-Sugiyama, Yoko/G-4950-2015; Araki, Makoto/G-5455-2015	Yazaki-Sugiyama, Yoko/0000-0003-2052-4162; Araki, Makoto/0000-0002-6941-2842	OIST Graduate University; JSPS KAKENHI [24500403]	OIST Graduate University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C. Yokoyama for continuous thoughtful discussions on this project and valuable help in preparing the manuscript; C. P. Connaughton for valuable discussions and for providing Matlab code for phase scrambling; R. Mooney M. J. Coleman and N. Shannon for critical reading of We manuscript; Y. Morohashi for maintenance of the experimental animals and help with behavioral experiments; and K. Wada and M. Soma for providing star finch and Java sparrow songs, respectively. Supported by OIST Graduate University and a JSPS KAKENHI Grant-in-Aid for Scientific Research (C) (24500403) (Y.Y.-S.). All relevant data are stored at OIST Graduate University and are available from the authors on request and/or are included in the manuscript and supplementary materials. Author contributions: Y.Y.-S., M.M.B., and M.A. designed the experiments; Y.Y.-S. performed the behavioral experiments; M.A. performed all other experiments; M.A., Y.Y.-S., and M.M.B. analyzed We data; and Y.Y.-S. and M.M.B wrote the paper.	Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Becker P. H., 1982, ACOUSTIC COMMUNICATI, P297; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; BROOKS RJ, 1975, CAN J ZOOL, V53, P879, DOI 10.1139/z75-101; Colombelli-Negrel D, 2012, CURR BIOL, V22, P2155, DOI 10.1016/j.cub.2012.09.025; DOOLING R, 1980, DEV PSYCHOBIOL, V13, P499, DOI 10.1002/dev.420130508; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Gao X, 2015, NEURON, V86, P292, DOI 10.1016/j.neuron.2015.03.004; Gardner TJ, 2005, SCIENCE, V308, P1046, DOI 10.1126/science.1108214; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Heiligenberg W., 1991, NEURAL NETS ELECT FI; KONISHI M, 1992, HARVEY LECT, V86, P47; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; MARLER P, 1977, SCIENCE, V198, P519, DOI 10.1126/science.198.4316.519; Marler P., 1976, SIMPLER NETWORKS BEH, P314; NELSON DA, 1993, ANIM BEHAV, V46, P806, DOI 10.1006/anbe.1993.1258; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Roper A, 2006, ETHOLOGY, V112, P458, DOI 10.1111/j.1439-0310.2005.01169.x; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Soha JA, 2000, ANIM BEHAV, V60, P297, DOI 10.1006/anbe.2000.1499; Tchernichovski O, 1998, P NATL ACAD SCI USA, V95, P8951, DOI 10.1073/pnas.95.15.8951; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Whaling CS, 1997, P NATL ACAD SCI USA, V94, P12694, DOI 10.1073/pnas.94.23.12694; Yazaki-Sugiyama Y, 2004, J NEUROPHYSIOL, V92, P2771, DOI 10.1152/jn.00467.2004	29	35	35	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1282	1287		10.1126/science.aah6799	http://dx.doi.org/10.1126/science.aah6799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940872				2022-12-28	WOS:000389598800059
J	Calderwood, S; Calderwood, R				Calderwood, Sandra; Calderwood, Robin			David Kells O'Donel Calderwood OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		ODONEL DK, PUBLICATION LIST	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2016	355								i6579	10.1136/bmj.i6579	http://dx.doi.org/10.1136/bmj.i6579			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SZ	27940969				2022-12-28	WOS:000390037600010
J	Gibbons, A				Gibbons, Ann			SCIENTIFIC COMMUNITY Curator resigns after sexual misconduct investigations	SCIENCE			English	News Item																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1216	1216		10.1126/science.354.6317.1216	http://dx.doi.org/10.1126/science.354.6317.1216			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940827				2022-12-28	WOS:000389598800014
J	Schmidt, J; Choi, J; Liu, AT; Slusarczyk, M; Fu, GC				Schmidt, Jens; Choi, Junwon; Liu, Albert Tianxiang; Slusarczyk, Martin; Fu, Gregory C.			A general, modular method for the catalytic asymmetric synthesis of alkylboronate esters	SCIENCE			English	Article							TERTIARY BORONIC ESTERS; NEGISHI ARYLATIONS; CROSS-COUPLINGS; SECONDARY; ALKYL; ELECTROPHILES; BROMIDES	Alkylboron compounds are an important family of target molecules, serving as useful intermediates, as well as end points, in fields such as pharmaceutical science and organic chemistry. Facile transformation of carbon-boron bonds into a wide variety of carbon-X bonds (where X is, for example, carbon, nitrogen, oxygen, or a halogen), with stereochemical fidelity, renders the generation of enantioenriched alkylboronate esters a powerful tool in synthesis. Here we report the use of a chiral nickel catalyst to achieve stereoconvergent alkyl-alkyl couplings of readily available racemic alpha-haloboronates with organozinc reagents under mild conditions. We demonstrate that this method provides straightforward access to a diverse array of enantioenriched alkylboronate esters, in which boron is bound to a stereogenic carbon, and we highlight the utility of these compounds in synthesis.	[Schmidt, Jens; Choi, Junwon; Liu, Albert Tianxiang; Slusarczyk, Martin; Fu, Gregory C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Fu, GC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	gcfu@caltech.edu	Liu, Albert/AAP-8811-2020; Schmidt, Jens/E-6859-2016	Liu, Albert/0000-0001-8854-5854; Choi, Junwon/0000-0001-6004-5524; Schmidt, Jens/0000-0002-8697-5671	National Institutes of Health (National Institute of General Medical Sciences) [R01-GM62871]; Alexander von Humboldt Foundation; German National Merit Foundation; David S. Koons SURF (Summer Undergraduate Research Fellowship) Endowment; Gordon and Betty Moore Foundation (for the Caltech Center for Catalysis and Chemical Synthesis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062871, R01GM062871] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German National Merit Foundation; David S. Koons SURF (Summer Undergraduate Research Fellowship) Endowment; Gordon and Betty Moore Foundation (for the Caltech Center for Catalysis and Chemical Synthesis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support has been provided by the National Institutes of Health (National Institute of General Medical Sciences, R01-GM62871), the Alexander von Humboldt Foundation (fellowship for J.S.), the German National Merit Foundation (fellowship for M.S.), the David S. Koons SURF (Summer Undergraduate Research Fellowship) Endowment (fellowship for A.T.L.), and the Gordon and Betty Moore Foundation (for the Caltech Center for Catalysis and Chemical Synthesis). We thank J. M. Ahn, L. M. Henling, M. K. Takase (Caged) X-Ray Crystallography Facility), N. D. Schley, M. Shahgholi (Caltech Mass Spectrometry Facility), D. G. VanderVelde (Caged) NMR Facility), and S. C. Virgil (Caltech Center for Catalysis and Chemical Synthesis) for assistance and helpful discussions. Experimental procedures and characterization data are provided in the supplementary materials. Crystallographic data are available free of charge from the Cambridge Crystallographic Data Centre under reference CCDC-1512445.	BERRISFORD DJ, 1995, ANGEW CHEM INT EDIT, V34, P1059, DOI 10.1002/anie.199510591; Bissember AC, 2012, J AM CHEM SOC, V134, P14232, DOI 10.1021/ja306323x; Bonet A, 2014, NAT CHEM, V6, P584, DOI [10.1038/NCHEM.1971, 10.1038/nchem.1971]; Brown H. C., 1980, HYDROBORATION; BROWN HC, 1961, J AM CHEM SOC, V83, P486, DOI 10.1021/ja01463a055; Burns M, 2014, NATURE, V513, P183, DOI 10.1038/nature13711; Collins KD, 2013, NAT CHEM, V5, P597, DOI [10.1038/NCHEM.1669, 10.1038/nchem.1669]; Fischer C, 2005, J AM CHEM SOC, V127, P4594, DOI 10.1021/ja0506509; Ganic A, 2012, CHEM-EUR J, V18, P6724, DOI 10.1002/chem.201200246; Hall D. G, 2011, BORONIC ACIDS PREPAR, V1; Hall D. G., 2011, BORONIC ACIDS PREPAR, V2; Larouche-Gauthier R, 2011, J AM CHEM SOC, V133, P16794, DOI 10.1021/ja2077813; Leonori D, 2015, ANGEW CHEM INT EDIT, V54, P1082, DOI 10.1002/anie.201407701; Liang YF, 2015, J AM CHEM SOC, V137, P9523, DOI 10.1021/jacs.5b04725; Matteson DS, 2005, BORONIC ACIDS: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS AND MEDICINE, P305, DOI 10.1002/3527606548.ch8; Matteson DS., 1995, STEREODIRECTED SYNTH; Miyaura N., 2007, COMPREHENSIVE ORGANO, V9; Mlynarski SN, 2012, J AM CHEM SOC, V134, P16449, DOI 10.1021/ja305448w; Ni N., 2011, BORONIC ACIDS PREPAR, V2; Schley ND, 2014, J AM CHEM SOC, V136, P16588, DOI 10.1021/ja508718m; Smoum R, 2012, CHEM REV, V112, P4156, DOI 10.1021/cr608202m; Suzuki A, 2011, ANGEW CHEM INT EDIT, V50, P6722, DOI 10.1002/anie.201101379; Wang YH, 2016, ANGEW CHEM INT EDIT, V55, P4270, DOI 10.1002/anie.201600599; Wilsily A, 2012, J AM CHEM SOC, V134, P5794, DOI 10.1021/ja301612y; Xi YM, 2016, J AM CHEM SOC, V138, P6703, DOI 10.1021/jacs.6b02478; Xu S., 2014, METAL CATALYZED CROS, V1; Zhang L, 2016, SCIENCE, V351, P70, DOI 10.1126/science.aad6080	27	128	129	9	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1265	1269		10.1126/science.aai8611	http://dx.doi.org/10.1126/science.aai8611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940868	Green Accepted			2022-12-28	WOS:000389598800055
J	Blard, PH; Leduc, G				Blard, Pierre-Henri; Leduc, Guillaume			The history of Greenland's ice	NATURE			English	Editorial Material								Global sea levels would rise by several metres if the Greenland Ice Sheet melted completely. Two studies have examined its past behaviour in an effort to evaluate its vulnerability in a warming world and have come to seemingly conflicting conclusions. Two geochemists and a glaciologist discuss the issues. SEE LETTERS P.252 P.256	[Blard, Pierre-Henri] Univ Lorraine, CNRS, Ctr Rech Petrograph & Geochim, F-54500 Vandoeuvre Les Nancy, France; [Leduc, Guillaume] Aix Marseille Univ, CNRS, IRD,Europole Mediterranneen Arbois, Ctr Europeen Rech & Enseignement Geosci Environm, F-13545 Aix En Provence, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Blard, PH (corresponding author), Univ Lorraine, CNRS, Ctr Rech Petrograph & Geochim, F-54500 Vandoeuvre Les Nancy, France.	blard@crpg.cnrs-nancy.fr; leduc@cerege.fr	BLARD, Pierre-Henri/ABB-9401-2021	Blard, Pierre-Henri/0000-0002-8455-8014					0	2	2	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					202	203		10.1038/540202a	http://dx.doi.org/10.1038/540202a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27929019	Green Submitted, Bronze			2022-12-28	WOS:000389548700039
J	Chhabria, BA; Bhalla, A				Chhabria, Bharath A.; Bhalla, Ashish			Tongue Fasciculations in Organophosphate Poisoning	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Chhabria, Bharath A.; Bhalla, Ashish] Postgrad Inst Med Educ & Res, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Chhabria, BA (corresponding author), Postgrad Inst Med Educ & Res, Chandigarh, India.	bharath6189@gmail.com							0	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					E47	E47		10.1056/NEJMicm1605077	http://dx.doi.org/10.1056/NEJMicm1605077			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0ZQ	27959689				2022-12-28	WOS:000389310000011
J	Behjati, S				Behjati, Sam			GENOMICS AND PROTEOMICS Retracing embryological fate	SCIENCE			English	Editorial Material									[Behjati, Sam] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Behjati, Sam] Univ Cambridge, Dept Pediat, Cambridge CB2 1TN, England	Wellcome Trust Sanger Institute; University of Cambridge	Behjati, S (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.; Behjati, S (corresponding author), Univ Cambridge, Dept Pediat, Cambridge CB2 1TN, England.	sb31@sanger.ac.uk		Behjati, Sam/0000-0002-6600-7665				Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Carlson CA, 2012, NAT METHODS, V9, P78, DOI [10.1038/nmeth.1781, 10.1038/NMETH.1781]; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Wasserstrom A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001939	5	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316								10.1126/science.aal2189	http://dx.doi.org/10.1126/science.aal2189			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934728	Bronze			2022-12-28	WOS:000388916400026
J	Si, LL; Xu, H; Zhou, XY; Zhang, ZW; Tian, ZY; Wang, Y; Wu, YM; Zhang, B; Niu, ZL; Zhang, CL; Fu, G; Xiao, SL; Xia, Q; Zhang, LH; Zhou, DM				Si, Longlong; Xu, Huan; Zhou, Xueying; Zhang, Ziwei; Tian, Zhenyu; Wang, Yan; Wu, Yiming; Zhang, Bo; Niu, Zhenlan; Zhang, Chuanling; Fu, Ge; Xiao, Sulong; Xia, Qing; Zhang, Lihe; Zhou, Demin			Generation of influenza A viruses as live but replication-incompetent virus vaccines	SCIENCE			English	Article							GENETIC-CODE EXPANSION; AMINO-ACIDS; ATTENUATION; PROSPECTS; VECTORS; ENTRY	The conversion of life-threatening viruses into live but avirulent vaccines represents a revolution in vaccinology. In a proof-of-principle study, we expanded the genetic code of the genome of influenza A virus via a transgenic cell line containing orthogonal translation machinery. This generated premature termination codon (PTC)-harboring viruses that exerted full infectivity but were replication-incompetent in conventional cells. Genomewide optimization of the sites for incorporation of multiple PTCs resulted in highly reproductive and genetically stable progeny viruses in transgenic cells. In mouse, ferret, and guinea pig models, vaccination with PTC viruses elicited robust humoral, mucosal, and T cell-mediated immunity against antigenically distinct influenza viruses and even neutralized existing infecting strains. The methods presented here may become a general approach for generating live virus vaccines that can be adapted to almost any virus.	[Si, Longlong; Xu, Huan; Zhou, Xueying; Zhang, Ziwei; Tian, Zhenyu; Wang, Yan; Wu, Yiming; Zhang, Bo; Niu, Zhenlan; Zhang, Chuanling; Fu, Ge; Xiao, Sulong; Xia, Qing; Zhang, Lihe; Zhou, Demin] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, 38 Xueyuan Rd, Beijing 100191, Peoples R China	Peking University	Zhou, DM (corresponding author), Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	deminzhou@bjmu.edu.cn	Hsia, Ching/HDM-0039-2022; Wu, Yiming/AAW-3339-2021; Zhang, Bo/GQH-1066-2022	Wu, Yiming/0000-0001-5083-8950	National Natural Science Foundation of China [81530090, 21572015]; National Key Research and Development Program of China [2016YFA0501500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	We thank Sinovac Biotech Ltd. (Beijing) for technical assistance with the animal work. Supported by National Natural Science Foundation of China grants 81530090 and 21572015 and by National Key Research and Development Program of China grant 2016YFA0501500. All authors declare no competing financial interests. D.Z. and L.S. are inventors on a patent application (PCT/CN2016/092778) held by Peking University that covers the preparation of PTC viruses through genetic codon expansion. Sharing of materials will be subject to standard material transfer agreements. The nucleotide sequences used in the study have been deposited in GenBank under accession numbers CY034139.1, CY034138.1, X17336.1, HE802059.1, CY034135.1, CY034134.1, D10598.1, and M12597.1; additional data are presented in the supplementary materials.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Cohen J, 2016, SCIENCE, V351, P16, DOI 10.1126/science.351.6268.16; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Jang YH, 2012, CLIN EXP VACCINE RES, V1, P35, DOI 10.7774/cevr.2012.1.1.35; Jin X, 2012, NUCLEIC ACIDS RES, V40, P1797, DOI 10.1093/nar/gkr927; Jung EJ, 2010, EXP MOL MED, V42, P116, DOI 10.3858/emm.2010.42.2.013; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Marzi A, 2015, SCIENCE, V348, P439, DOI 10.1126/science.aaa4919; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nogales A, 2014, J VIROL, V88, P10525, DOI 10.1128/JVI.01565-14; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Sun SB, 2014, CHEMBIOCHEM, V15, P1721, DOI 10.1002/cbic.201402154; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang NX, 2014, ANGEW CHEM INT EDIT, V53, P4867, DOI 10.1002/anie.201402092; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Xiao SL, 2016, BIOMATERIALS, V78, P74, DOI 10.1016/j.biomaterials.2015.11.034; Yu MR, 2014, J MED CHEM, V57, P10058, DOI 10.1021/jm5014067; Zhang CL, 2016, BIOMATERIALS, V80, P134, DOI 10.1016/j.biomaterials.2015.11.066; Zheng YX, 2015, NUCLEIC ACIDS RES, V43, pE73, DOI 10.1093/nar/gkv202	27	100	121	17	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1170	1173		10.1126/science.aah5869	http://dx.doi.org/10.1126/science.aah5869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934767				2022-12-28	WOS:000388916400047
J	Pool, MR				Pool, Martin R.			CELL BIOLOGY Sort of unexpected	NATURE			English	Editorial Material							ENDOPLASMIC-RETICULUM; SIGNAL SEQUENCES; MEMBRANE; PROTEINS; TRANSLOCATION; INSERTION; YEAST	To reach the cell surface, membrane proteins are first targeted to an organelle called the endoplasmic reticulum. Several targeting pathways are known, but it now emerges that there is yet another pathway. SEELETTER p.134	[Pool, Martin R.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Mol & Cellular Funct, Manchester M13 9PT, Lancs, England	University of Manchester	Pool, MR (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Mol & Cellular Funct, Manchester M13 9PT, Lancs, England.	martin.r.pool@manchester.ac.uk	Pool, Martin R./AAB-9181-2021	Pool, Martin R./0000-0003-3071-1535				Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Zhang X, 2014, ANNU REV BIOPHYS, V43, P381, DOI 10.1146/annurev-biophys-051013-022653	16	4	4	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					45	46		10.1038/540045a	http://dx.doi.org/10.1038/540045a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905422				2022-12-28	WOS:000388916600043
J	Wu, J; Greely, HT; Jaenisch, R; Nakauchi, H; Rossant, J; Belmonte, JCI				Wu, Jun; Greely, Henry T.; Jaenisch, Rudolf; Nakauchi, Hiromitsu; Rossant, Janet; Belmonte, Juan Carlos Izpisua			Stem cells and interspecies chimaeras	NATURE			English	Review							NEURAL CREST CELLS; HUMAN-NONHUMAN CHIMERAS; IN-VIVO; NAIVE PLURIPOTENCY; GROUND-STATE; MOUSE; EPIBLAST; LINES; GENERATION; RAT	Chimaeras are both monsters of the ancient imagination and a long-established research tool. Recent advances, particularly those dealing with the identification and generation of various kinds of stem cells, have broadened the repertoire and utility of mammalian interspecies chimaeras and carved out new paths towards understanding fundamental biology as well as potential clinical applications.	[Wu, Jun; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Wu, Jun] Univ Catolica San Antonio Murcia UCAM, Campus Jeronimos 135, Murcia 30107, Spain; [Greely, Henry T.] Stanford Law Sch, Ctr Law & Biosci, 559 Nathan Abbott Way Stanford, Stanford, CA 94305 USA; [Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA; [Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Tokyo 1088639, Japan; [Rossant, Janet] Hosp Sick Children Res Inst, Program Dev & Stem Cell Biol, 686 Bay St, Toronto, ON M5G 0A4, Canada; [Rossant, Janet] Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada	Salk Institute; Universidad Catolica de Murcia; Stanford University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Stanford University; University of Tokyo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Wu, Jun/AAF-1830-2019	Wu, Jun/0000-0001-9863-1668	California Institute of Regenerative Medicine (CIRM); Japan Agency for Medical Research and Development (AMED); Takeda Pharmaceuticals International, Inc.; G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; Fundacion Dr. Pedro Guillen; UCAM; NIH [HD 045022, R37-CA084198, 1R01NS088538-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Pharmaceuticals International, Inc.(Takeda Pharmaceutical Company Ltd); G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; Fundacion Dr. Pedro Guillen; UCAM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank all our laboratory members and collaborators, including the teams of J. M. Campistol, P. Guillen, E. Martinez and P. Ross for their comments and dedicated work that have greatly contributed to the ideas presented here. H.N. was supported by the California Institute of Regenerative Medicine (CIRM), Japan Agency for Medical Research and Development (AMED) and Takeda Pharmaceuticals International, Inc. J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, The Moxie Foundation, Fundacion Dr. Pedro Guillen and UCAM. R.J. was supported by grants from the NIH (HD 045022, R37-CA084198, 1R01NS088538-01).	Academy of Medical Sciences, 2011, AN CONT HUM MAT, V4; Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; [Anonymous], 2016, GUID STEM CELL SCI C; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen YC, 2015, CELL STEM CELL, V17, P116, DOI 10.1016/j.stem.2015.06.004; Chuma S, 2005, DEVELOPMENT, V132, P117, DOI 10.1242/dev.01555; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Cohen MA, 2016, P NATL ACAD SCI USA, V113, P1570, DOI 10.1073/pnas.1525518113; Dejosez M, 2013, SCIENCE, V341, P1511, DOI 10.1126/science.1241628; Douarin N. L., 1982, NEURAL CREST; Duggal G, 2015, STEM CELLS, V33, P2686, DOI 10.1002/stem.2071; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; FEHILLY CB, 1984, NATURE, V307, P634, DOI 10.1038/307634a0; Fujiki Y, 2003, TRANSPLANTATION, V75, P916, DOI 10.1097/01.TP.0000057243.12110.7C; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; GARDNER RL, 1973, NATURE-NEW BIOL, V246, P86, DOI 10.1038/newbio246086a0; Geiger H, 1998, CELL, V93, P1055, DOI 10.1016/S0092-8674(00)81210-6; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Greely H., 2011, OXFORD HDB ANIMAL ET; Greely HT, 2007, AM J BIOETHICS, V7, P27, DOI 10.1080/15265160701290371; Greene M, 2005, SCIENCE, V309, P385, DOI 10.1126/science.1112207; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Harder F, 2002, BLOOD, V99, P719, DOI 10.1182/blood.V99.2.719; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hermeren G, 2015, DEVELOPMENT, V142, P3, DOI 10.1242/dev.119024; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; HUSZAR D, 1991, DEVELOPMENT, V112, P131; Hyun I, 2007, CELL STEM CELL, V1, P367, DOI 10.1016/j.stem.2007.09.006; Hyun I, 2015, DEVELOPMENT, V142, P6, DOI 10.1242/dev.119206; Institute of Medicine and National Research Council, 2007, GUID HUM EMBR STEM C, DOI [10.17226/11870, DOI 10.17226/11153]; *INT SOC STEM CELL, 2006, GUID COND HUM EMBR S; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; JAENISCH R, 1985, NATURE, V318, P181, DOI 10.1038/318181a0; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnston J, 2003, AM J BIOETHICS, V3, pW6; Karpowicz P, 2005, KENNEDY INST ETHIC J, V15, P107, DOI 10.1353/ken.2005.0015; Karpowicz P, 2004, NAT MED, V10, P331, DOI 10.1038/nm0404-331; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Kobayashi T, 2015, STEM CELLS DEV, V24, P182, DOI 10.1089/scd.2014.0270; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LEDOUARIN NM, 1980, NATURE, V286, P663, DOI 10.1038/286663a0; Leitch HG, 2014, DEV BIOL, V385, P155, DOI 10.1016/j.ydbio.2013.11.014; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li ZW, 2016, CELL STEM CELL, V19, P516, DOI 10.1016/j.stem.2016.07.016; Masaki H, 2016, CELL STEM CELL, V19, P587, DOI 10.1016/j.stem.2016.10.013; Masaki H, 2015, DEVELOPMENT, V142, P3222, DOI 10.1242/dev.124016; Mascetti VL, 2016, CELL STEM CELL, V19, P163, DOI 10.1016/j.stem.2016.07.018; Mascetti VL, 2016, CELL STEM CELL, V18, P67, DOI 10.1016/j.stem.2015.11.017; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Palacios-Gonzalez C, 2015, MONASH BIOETH REV, V33, P181, DOI 10.1007/s40592-015-0031-1; Palacios-Gonzalez C, 2015, MED HEALTH CARE PHIL, V18, P487, DOI 10.1007/s11019-015-9644-7; Pera MF, 2014, CELL STEM CELL, V15, P543, DOI 10.1016/j.stem.2014.10.013; Rashid T, 2014, CELL STEM CELL, V15, P406, DOI 10.1016/j.stem.2014.09.013; Reardon S, 2016, NATURE, V536, P135, DOI 10.1038/nature.2016.20379; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Robert JS, 2003, AM J BIOETHICS, V3, P1, DOI 10.1162/15265160360706417; ROSSANT J, 1983, J EMBRYOL EXP MORPH, V73, P179; ROSSANT J, 1982, J ANIM SCI, V55, P1241, DOI 10.2527/jas1982.5551241x; ROSSANT J, 1980, SCIENCE, V208, P419, DOI 10.1126/science.7367871; ROSSANT J, 1982, J EMBRYOL EXP MORPH, V69, P141; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Simerly C, 2011, STEM CELL RES, V7, P28, DOI 10.1016/j.scr.2011.03.002; Simerly CR, 2009, STEM CELL RES, V2, P178, DOI 10.1016/j.scr.2009.02.004; Streiffer R., 2009, STANFORD ENCY PHILOS; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2016, CELL STEM CELL, V19, P502, DOI 10.1016/j.stem.2016.06.011; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1996, BIOL REPROD, V55, P254, DOI 10.1095/biolreprod55.2.254; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; United States National Institutes of Health, 2015, NIH RES INV INTR HUM; United States National Institutes of Health, 2016, NEXT STEPS RES US AN; United States National Institutes of Health, 1988, NIH GUID GRANTS CONT; United States National Institutes of Health Revitalization Act of, 1993, PUBLIC LAW, P103; Usui JI, 2012, AM J PATHOL, V180, P2417, DOI 10.1016/j.ajpath.2012.03.007; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; WILLIAMS TJ, 1990, REPROD FERT DEVELOP, V2, P385, DOI 10.1071/RD9900385; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wu J, 2016, CELL, V165, P1572, DOI 10.1016/j.cell.2016.05.043; Wu J, 2015, CELL STEM CELL, V17, P509, DOI 10.1016/j.stem.2015.10.009; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413; Xiang AP, 2008, HUM MOL GENET, V17, P27, DOI 10.1093/hmg/ddm282; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zanjani ED, 1998, EXP HEMATOL, V26, P353	104	105	106	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					51	59		10.1038/nature20573	http://dx.doi.org/10.1038/nature20573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905428	Green Published			2022-12-28	WOS:000388916600047
J	Rosenthal, DI; Verghese, A				Rosenthal, David I.; Verghese, Abraham			Meaning and the Nature of Physicians' Work	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PATIENT		[Rosenthal, David I.] Yale Univ, Sch Med, Gen Internal Med Sect, 333 Cedar St, New Haven, CT 06520 USA; [Verghese, Abraham] Stanford Univ, Dept Med, Sch Med, Program Bedside Med, Stanford, CA 94305 USA	Yale University; Stanford University	Rosenthal, DI (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, 333 Cedar St, New Haven, CT 06520 USA.							Chi J, 2014, JAMA-J AM MED ASSOC, V312, P2331, DOI 10.1001/jama.2014.12820; Czernik Z, 2016, JAMA-J AM MED ASSOC, V315, P2399, DOI 10.1001/jama.2016.1722; Friedberg M.W., 2013, FACTORS AFFECTING PH; Mata DA, 2015, JAMA-J AM MED ASSOC, V314, P2373, DOI 10.1001/jama.2015.15845; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461	5	44	44	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					1813	1815		10.1056/NEJMp1609055	http://dx.doi.org/10.1056/NEJMp1609055			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB6ZK	27959650				2022-12-28	WOS:000387534200002
J	Ataga, KI; Kutlar, A; Kanter, J; Liles, D; Cancado, R; Friedrisch, J; Guthrie, TH; Knight-Madden, J; Alvarez, OA; Gordeuk, VR; Gualandro, S; Colella, MP; Smith, WR; Rollins, SA; Stocker, JW; Rother, RP				Ataga, K. I.; Kutlar, A.; Kanter, J.; Liles, D.; Cancado, R.; Friedrisch, J.; Guthrie, T. H.; Knight-Madden, J.; Alvarez, O. A.; Gordeuk, V. R.; Gualandro, S.; Colella, M. P.; Smith, W. R.; Rollins, S. A.; Stocker, J. W.; Rother, R. P.			Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; P-SELECTIN; ADHESION; ANEMIA; FLOW; VASOOCCLUSION; ERYTHROCYTES; ENDOTHELIUM; HYDROXYUREA; LEUKOCYTES	BACKGROUND The up-regulation of P-selectin in endothelial cells and platelets contributes to the cell-cell interactions that are involved in the pathogenesis of vaso-occlusion and sickle cell-related pain crises. The safety and efficacy of crizanlizumab, an antibody against the adhesion molecule P-selectin, were evaluated in patients with sickle cell disease. METHODS In this double-blind, randomized, placebo-controlled, phase 2 trial, we assigned patients to receive low-dose crizanlizumab (2.5 mg per kilogram of body weight), high-dose crizanlizumab (5.0 mg per kilogram), or placebo, administered intravenously 14 times over a period of 52 weeks. Patients who were receiving concomitant hydroxyurea as well as those not receiving hydroxyurea were included in the study. The primary end point was the annual rate of sickle cell-related pain crises with high-dose crizanlizumab versus placebo. The annual rate of days hospitalized, the times to first and second crises, annual rates of uncomplicated crises (defined as crises other than the acute chest syndrome, hepatic sequestration, splenic sequestration, or priapism) and the acute chest syndrome, and patient-reported outcomes were also assessed. RESULTS A total of 198 patients underwent randomization at 60 sites. The median rate of crises per year was 1.63 with high-dose crizanlizumab versus 2.98 with placebo (indicating a 45.3% lower rate with high-dose crizanlizumab, P = 0.01). The median time to the first crisis was significantly longer with high-dose crizanlizumab than with placebo (4.07 vs. 1.38 months, P = 0.001), as was the median time to the second crisis (10.32 vs. 5.09 months, P = 0.02). The median rate of uncomplicated crises per year was 1.08 with high-dose crizanlizumab, as compared with 2.91 with placebo (indicating a 62.9% lower rate with high-dose crizanlizumab, P = 0.02). Adverse events that occurred in 10% or more of the patients in either active-treatment group and at a frequency that was at least twice as high as that in the placebo group were arthralgia, diarrhea, pruritus, vomiting, and chest pain. CONCLUSIONS In patients with sickle cell disease, crizanlizumab therapy resulted in a significantly lower rate of sickle cell-related pain crises than placebo and was associated with a low incidence of adverse events.	[Ataga, K. I.] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC USA; [Liles, D.] East Carolina Univ, Div Hematol Oncol, Greenville, NC USA; [Kutlar, A.] Augusta Univ, Med Coll Georgia, Sickle Cell Ctr, Augusta, GA USA; [Kanter, J.] Med Univ South Carolina, Div Pediat, Charleston, SC USA; [Cancado, R.] Santa Casa Med Sch Sao Paulo, Dept Hematol Oncol, Sao Paulo, Brazil; [Gualandro, S.] Univ Sao Paulo, Div Hematol, Sao Paulo, Brazil; [Friedrisch, J.] Hosp Clin Porto Alegre, Hematol & Bone Marrow Transplantat Serv, Porto Alegre, RS, Brazil; [Colella, M. P.] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Guthrie, T. H.] Baptist Med Ctr, Baptist Canc Inst, Jacksonville, FL USA; [Knight-Madden, J.] Univ West Indies, Sickle Cell Unit, Jamaica, NY USA; [Alvarez, O. A.] Univ Miami, Div Pediat Hematol Oncol, Miami, FL USA; [Gordeuk, V. R.] Univ Illinois, Dept Med, Chicago, IL USA; [Smith, W. R.] Virginia Commonwealth Univ, Div Gen Internal Med, Richmond, VA USA; [Rollins, S. A.; Stocker, J. W.; Rother, R. P.] Selexys Pharmaceut, Oklahoma City, OK USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; East Carolina University; University System of Georgia; Augusta University; Medical University of South Carolina; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Miami; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Virginia Commonwealth University	Ataga, KI (corresponding author), Univ North Carolina Chapel Hill, Div Hematol Oncol, Comprehens Sickle Cell Program, 3rd Fl,Phys Off Bldg, Chapel Hill, NC 27599 USA.	kataga@med.unc.edu	Gordeuk, Victor/AAG-6577-2019	Liles, Darla/0000-0003-1480-7887	Selexys Pharmaceuticals; National Heart, Lung, and Blood Institute of the National Institutes of Health [5R44HL093893]; Orphan Products Grant Program of the Food and Drug Administration [R01FD004805]; Pfizer; Emmaus Life Sciences; Mast Therapeutics; GlycoMimetics; Hema-Quest Pharmaceuticals; ApoPharma; FOOD AND DRUG ADMINISTRATION [R01FD004805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL093893] Funding Source: NIH RePORTER	Selexys Pharmaceuticals; National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Orphan Products Grant Program of the Food and Drug Administration; Pfizer(Pfizer); Emmaus Life Sciences; Mast Therapeutics; GlycoMimetics; Hema-Quest Pharmaceuticals; ApoPharma; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by Selexys Pharmaceuticals and by grants to Selexys Pharmaceuticals from the National Heart, Lung, and Blood Institute of the National Institutes of Health (award number, 5R44HL093893) and the Orphan Products Grant Program of the Food and Drug Administration (award number, R01FD004805).; Dr. Gordeuk reports receiving grant support from Pfizer, Emmaus Life Sciences, Mast Therapeutics, GlycoMimetics, Hema-Quest Pharmaceuticals, and ApoPharma; and Drs. Rollins, Stocker, and Rother, being employees of and owning stock in Selexys Pharmaceuticals at the time of the study; Drs. Rollins and Rother also report holding patents related to methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies (U.S. patent number, 8945565) and anti-P-selectin antibodies (U.S. patent number, 9068001), both assigned to Selexys Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Ataga KI, 2011, BRIT J HAEMATOL, V153, P92, DOI 10.1111/j.1365-2141.2010.08520.x; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; Ballas SK, 2005, AM J HEMATOL, V79, P17, DOI 10.1002/ajh.20336; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Candrilli SD, 2011, AM J HEMATOL, V86, P273, DOI 10.1002/ajh.21968; Chang CH, 2010, STROKE, V41, P1884, DOI 10.1161/STROKEAHA.110.585828; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Chuang SY, 2015, STROKE, V46, P996, DOI 10.1161/STROKEAHA.114.007932; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; Frenette PS, 2004, MICROCIRCULATION, V11, P167, DOI 10.1080/10739680490278556; Gutsaeva DR, 2011, BLOOD, V117, P727, DOI 10.1182/blood-2010-05-285718; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; Heeney MM, 2016, NEW ENGL J MED, V374, P625, DOI 10.1056/NEJMoa1512021; Kutlar A, 2012, AM J HEMATOL, V87, P536, DOI 10.1002/ajh.23147; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Manwani D, 2013, BLOOD, V122, P3892, DOI 10.1182/blood-2013-05-498311; Matsui NM, 2002, BLOOD, V100, P3790, DOI 10.1182/blood-2002-02-0626; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Polanowska-Grabowska R, 2010, ARTERIOSCL THROM VAS, V30, P2392, DOI 10.1161/ATVBAHA.110.211615; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; van Tuijn CFJ, 2010, AM J HEMATOL, V85, P532, DOI 10.1002/ajh.21731; Wun T, 1997, J LAB CLIN MED, V129, P507, DOI 10.1016/S0022-2143(97)90005-6; Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001	26	410	420	4	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					429	439		10.1056/NEJMoa1611770	http://dx.doi.org/10.1056/NEJMoa1611770			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8WH	27959701	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000393507200006
J	Dansinger, M				Dansinger, Michael			Dear Plagiarist: A Letter to a Peer Reviewer Who Stole and Published Our Manuscript as His Own	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dansinger, Michael] Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA	Tufts Medical Center	Dansinger, M (corresponding author), Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA.	mdansinger@tuftsmedicalcenter.org						Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Finelli C, 2016, EXCLI J, V15, P166, DOI 10.17179/excli2015-642	2	18	18	4	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					143	+		10.7326/M16-2551	http://dx.doi.org/10.7326/M16-2551			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	27951597				2022-12-28	WOS:000391842600021
J	Gulshan, V; Peng, L; Coram, M; Stumpe, MC; Wu, D; Narayanaswamy, A; Venugopalan, S; Widner, K; Madams, T; Cuadros, J; Kim, R; Raman, R; Nelson, PC; Mega, JL; Webster, R				Gulshan, Varun; Peng, Lily; Coram, Marc; Stumpe, Martin C.; Wu, Derek; Narayanaswamy, Arunachalam; Venugopalan, Subhashini; Widner, Kasumi; Madams, Tom; Cuadros, Jorge; Kim, Ramasamy; Raman, Rajiv; Nelson, Philip C.; Mega, Jessica L.; Webster, R.			Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMAGES	IMPORTANCE Deep learning is a family of computational methods that allow an algorithm to program itself by learning from a large set of examples that demonstrate the desired behavior, removing the need to specify rules explicitly. Application of these methods to medical imaging requires further assessment and validation. OBJECTIVE To apply deep learning to create an algorithm for automated detection of diabetic retinopathy and diabetic macular edema in retinal fundus photographs. DESIGN AND SETTING A specific type of neural network optimized for image classification called a deep convolutional neural network was trained using a retrospective development data set of 128 175 retinal images, which were graded 3 to 7 times for diabetic retinopathy, diabetic macular edema, and image gradability by a panel of 54 US licensed ophthalmologists and ophthalmology senior residents between May and December 2015. The resultant algorithm was validated in January and February 2016 using 2 separate data sets, both graded by at least 7 US board-certified ophthalmologists with high intragrader consistency. EXPOSURE Deep learning-trained algorithm. MAIN OUTCOMES AND MEASURES The sensitivity and specificity of the algorithm for detecting referable diabetic retinopathy (RDR), defined as moderate and worse diabetic retinopathy, referable diabetic macular edema, or both, were generated based on the reference standard of the majority decision of the ophthalmologist panel. The algorithm was evaluated at 2 operating points selected from the development set, one selected for high specificity and another for high sensitivity. RESULTS The EyePACS-1 data set consisted of 9963 images from 4997 patients (mean age, 54.4 years; 62.2% women; prevalence of RDR, 683/8878 fully gradable images [7.8%]); the Messidor-2 data set had 1748 images from 874 patients (mean age, 57.6 years; 42.6% women; prevalence of RDR, 254/1745 fully gradable images [14.6%]). For detecting RDR, the algorithm had an area under the receiver operating curve of 0.991 (95% CI, 0.988-0.993) for EyePACS-1 and 0.990(95% CI, 0.986-0.995) for Messidor-2. Using the first operating cut point with high specificity, for EyePACS-1, the sensitivity was 90.3%(95% CI, 87.5%-92.7%) and the specificity was 98.1%(95% CI, 97.8%-98.5%). For Messidor-2, the sensitivity was 87.0%(95% CI, 81.1%-91.0%) and the specificity was 98.5%(95% CI, 97.7%-99.1%). Using a second operating point with high sensitivity in the development set, for EyePACS-1 the sensitivity was 97.5% and specificity was 93.4% and for Messidor-2 the sensitivity was 96.1% and specificity was 93.9%. CONCLUSIONS AND RELEVANCE In this evaluation of retinal fundus photographs from adults with diabetes, an algorithm based on deep machine learning had high sensitivity and specificity for detecting referable diabetic retinopathy. Further research is necessary to determine the feasibility of applying this algorithm in the clinical setting and to determine whether use of the algorithm could lead to improved care and outcomes compared with current ophthalmologic assessment.	[Gulshan, Varun; Peng, Lily; Coram, Marc; Stumpe, Martin C.; Wu, Derek; Narayanaswamy, Arunachalam; Venugopalan, Subhashini; Widner, Kasumi; Madams, Tom; Nelson, Philip C.; Webster, R.] Google Res, 1600 Amphitheatre Way, Mountain View, CA 94043 USA; [Venugopalan, Subhashini] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Cuadros, Jorge] EyePACS LLC, San Jose, CA USA; [Cuadros, Jorge] Univ Calif Berkeley, Sch Optometry, Vis Sci Grad Grp, Berkeley, CA 94720 USA; [Kim, Ramasamy] Aravind Eye Care Syst, Aravind Med Res Fdn, Madurai, Tamil Nadu, India; [Raman, Rajiv] Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India; [Mega, Jessica L.] Verily Life Sci, Mountain View, CA USA; [Mega, Jessica L.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Mega, Jessica L.] Harvard Med Sch, Boston, MA USA	Google Incorporated; University of Texas System; University of Texas Austin; University of California System; University of California Berkeley; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Peng, L (corresponding author), Google Res, 1600 Amphitheatre Way, Mountain View, CA 94043 USA.	lhpeng@google.com	Raman, Rajiv/A-7234-2009; van Os, Jim/C-2113-2014	Raman, Rajiv/0000-0001-5842-0233; Coram, Marc/0000-0002-8877-2501	Google Inc; Google	Google Inc(Google Incorporated); Google(Google Incorporated)	Google Inc sponsored the study. Aravind, Sankara, and EyePACS received funding from Google to support extraction, deidentification, and transfer of images for the study (Dr Kim is affiliated with Aravind, Dr Raman is affiliated with Sankara, and Dr Cuadros is affiliated with EyePACS).	Abramoff MD, 2013, JAMA OPHTHALMOL, V131, P351, DOI 10.1001/jamaophthalmol.2013.1743; Bresnick GH, 2000, OPHTHALMOLOGY, V107, P19, DOI 10.1016/S0161-6420(99)00010-X; Caruana R, 2001, ADV NEUR IN, V13, P402; Chakrabarti R, 2012, EXPERT REV OPHTHALMO, V7, P417, DOI 10.1586/EOP.12.52; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Dean J., 2012, ADV NEURAL INFORM PR, P1223, DOI DOI 10.5555/2999134.2999271; Decenciere E, 2014, IMAGE ANAL STEREOL, V33, P231, DOI 10.5566/ias.1155; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; Elmore JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI 10.1001/jama.2015.1405; Giancardo L, 2012, MED IMAGE ANAL, V16, P216, DOI 10.1016/j.media.2011.07.004; IOFFE S, 2015, ARXIV 1502 03167, V1502, P3167, DOI DOI 10.1007/S13398-014-0173-7.2; Krizhevsky A., P 25 INT C NEUR INF, P1097; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Philip S, 2007, BRIT J OPHTHALMOL, V91, P1512, DOI 10.1136/bjo.2007.119453; Quellec G, 2008, IEEE T MED IMAGING, V27, P1230, DOI 10.1109/TMI.2008.920619; Quellec G, 2012, MED IMAGE ANAL, V16, P1228, DOI 10.1016/j.media.2012.06.003; Raman R, 2009, OPHTHALMOLOGY, V116, P311, DOI 10.1016/j.ophtha.2008.09.010; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Solanki K, 2015, INVEST OPHTH VIS SCI, V56; Szegedy C, 2016, P IEEE C COMP VIS PA, P2818; Verma L, 2003, ACTA OPHTHALMOL SCAN, V81, P373, DOI 10.1034/j.1600-0420.2003.00004.x; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	23	2926	3086	70	773	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2402	2410		10.1001/jama.2016.17216	http://dx.doi.org/10.1001/jama.2016.17216			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27898976				2022-12-28	WOS:000389884600021
J	Simen, P; Matell, M				Simen, Patrick; Matell, Matthew			Why does time seem to fly when we're having fun?	SCIENCE			English	Editorial Material							DOPAMINE NEURONS; INTERVAL; REWARD; PREDICTION; MECHANISM; STRIATUM; CORTEX; CLOCK; SPEED		[Simen, Patrick] Oberlin Coll, Dept Neurosci, Oberlin, OH 44074 USA; [Matell, Matthew] Villanova Univ, Dept Psychol, Villanova, PA 19085 USA	Oberlin College; Villanova University	Simen, P (corresponding author), Oberlin Coll, Dept Neurosci, Oberlin, OH 44074 USA.	psimen@oberlin.edu			NIDA NIH HHS [R15 DA029809, R15 DA039405] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA039405] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Howe MW, 2013, NATURE, V500, P575, DOI 10.1038/nature12475; Jazayeri M, 2015, CURR BIOL, V25, P2599, DOI 10.1016/j.cub.2015.08.038; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; Lake JI, 2013, NEUROPSYCHOLOGIA, V51, P284, DOI 10.1016/j.neuropsychologia.2012.09.014; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P171, DOI 10.1037/0097-7403.9.2.171; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Parker KL, 2014, J NEUROSCI, V34, P16774, DOI 10.1523/JNEUROSCI.2772-14.2014; Simen P., 2013, TIMING TIME PERCEPT, V1, P159, DOI [10.1163/22134468-00002018, DOI 10.1163/22134468-00002018]; Soares S, 2016, SCIENCE, V354, P1273, DOI 10.1126/science.aah5234; Takahashi YK, 2016, NEURON, V91, P182, DOI 10.1016/j.neuron.2016.05.015; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064	15	9	9	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1231	1232		10.1126/science.aal4021	http://dx.doi.org/10.1126/science.aal4021			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940832	Green Accepted			2022-12-28	WOS:000389598800039
J	Acin, A; Masanes, L				Acin, Antonio; Masanes, Lluis			Certified randomness in quantum physics	NATURE			English	Review							BELLS-INEQUALITY; PROPOSED EXPERIMENT; KEY DISTRIBUTION; ELECTRON SPINS; VIOLATION; LOOPHOLE; ENTANGLEMENT; LOCALITY	The concept of randomness plays an important part in many disciplines. On the one hand, the question of whether random processes exist is fundamental for our understanding of nature. On the other, randomness is a resource for cryptography, algorithms and simulations. Standard methods for generating randomness rely on assumptions about the devices that are often not valid in practice. However, quantum technologies enable new methods for generating certified randomness, based on the violation of Bell inequalities. These methods are referred to as device-independent because they do not rely on any modelling of the devices. Here we review efforts to design device-independent randomness generators and the associated challenges.	[Acin, Antonio] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona 08860, Spain; [Acin, Antonio] ICREA, Barcelona 08010, Spain; [Masanes, Lluis] UCL, Dept Phys & Astron, London WC1E 6BT, England	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); ICREA; University of London; University College London	Acin, A (corresponding author), Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona 08860, Spain.; Acin, A (corresponding author), ICREA, Barcelona 08010, Spain.	antonio.acin@icfo.es		Masanes, Lluis/0000-0002-1476-2327	ERC CoG QITBOX; AXA Chair in Quantum Information Science; Spanish MINECO [FOQUS FIS2013-46768-P, SEV-2015-0522]; Fundacion Cellex; Generalitat de Catalunya [SGR 875]; John Templeton Foundation; EPSRC; ICREA Funding Source: Custom	ERC CoG QITBOX; AXA Chair in Quantum Information Science(AXA Research Fund); Spanish MINECO(Spanish Government); Fundacion Cellex(Foundation CELLEX); Generalitat de Catalunya(Generalitat de Catalunya); John Templeton Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ICREA(ICREA)	We thank S. Pironio, V. Scarani. F. G. S. L. Brandao, R. Arnon Friedman and A Wallraff for discussions. A.A. acknowledges support from the ERC CoG QITBOX, the AXA Chair in Quantum Information Science, Spanish MINECO (FOQUS FIS2013-46768-P and SEV-2015-0522), Fundacion Cellex, the Generalitat de Catalunya (SGR 875) and The John Templeton Foundation. L.M. is supported by EPSRC.	Acin A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230501; Acin A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120405; Acin A, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.040102; Acin A, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.012319; Acin A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.100402; Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; Arnon-Friedman R., 2016, SIMPLE TIGHT DEVICE; ASPECT A, 1975, PHYS LETT A, V54, P117, DOI 10.1016/0375-9601(75)90831-2; Barrett J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010503; Barrett J, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022101; Barrett J, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.042111; Barrett J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170409; Barrett J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.010503; Barrett J, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.062326; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bennet AJ, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031003; Bouda J, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.032313; Bowles J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.140407; Branciard C, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.010301; Brandao FGSL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11345; Canetti R, 2001, ANN IEEE SYMP FOUND, P136, DOI 10.1109/sfcs.2001.959888; Christensen BG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130406; Chung K. M., 2015, PHYS RANDOMNESS EXTR; Colbeck R., 2006, THESIS; Colbeck R, 2012, NAT PHYS, V8, P450, DOI [10.1038/nphys2300, 10.1038/NPHYS2300]; Colbeck R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.150402; Colbeck R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1416; Colbeck R, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/9/095305; Coudron M, 2014, STOC'14: PROCEEDINGS OF THE 46TH ANNUAL 2014 ACM SYMPOSIUM ON THEORY OF COMPUTING, P427, DOI 10.1145/2591796.2591873; Curchod F. J., 2015, UNBOUNDED RANDOMNESS; de la Torre G, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.160502; Dehollain JP, 2016, NAT NANOTECHNOL, V11, P242, DOI [10.1038/nnano.2015.262, 10.1038/NNANO.2015.262]; Dhara C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.100402; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Gallego R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3654; Gallego R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.230501; Giustina M, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.250401; Giustina M, 2013, NATURE, V497, P227, DOI 10.1038/nature12012; Hall MJW, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.062117; Hanggi E., 2010, DEVICE INDEPENDENT Q; Hensen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30289; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Hofmann J, 2012, SCIENCE, V337, P72, DOI 10.1126/science.1221856; Kent A, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.012107; Khalfin L., 1985, S FDN MOD PHYS, P441; Thinh LP, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/3/035007; Li HW, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.052308; Lunghi T, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.150501; Markowsky G., 2014, J CYBER SECUR MOBIL, V3, P1; Masanes L, 2006, PHYS REV A, V73, DOI [10.1103/PhysRevA.73.012112, 10.1103/PhysREvA.73.012112]; Masanes L, 2014, IEEE T INFORM THEORY, V60, P4973, DOI 10.1109/TIT.2014.2329417; Masanes L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1244; Masanes L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.140501; Massar S, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.062109; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; Mattar A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/2/022003; Mayers D, 2004, QUANTUM INFORM COMPU, V4, P273; Miller C. A., 2015, UNIVERSAL SECURITY R; Miller CA, 2014, STOC'14: PROCEEDINGS OF THE 46TH ANNUAL 2014 ACM SYMPOSIUM ON THEORY OF COMPUTING, P417, DOI 10.1145/2591796.2591843; Navascues M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.010401; Navascues M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073013; Neeley M, 2010, NATURE, V467, P570, DOI 10.1038/nature09418; Nieto-Silleras O, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/013035; Nisan N, 1999, J COMPUT SYST SCI, V58, P148, DOI 10.1006/jcss.1997.1546; Pawlowski M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.010302; PEARLE PM, 1970, PHYS REV D, V2, P1418, DOI 10.1103/PhysRevD.2.1418; Pironio S, 2010, NATURE, V464, P1021, DOI 10.1038/nature09008; Pironio S., 2015, RANDOM CHOICES LOCAL; Pironio S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045021; POPESCU S, 1994, FOUND PHYS, V24, P379, DOI 10.1007/BF02058098; Ramanathan R., 2015, RANDOMNESS AMPLIFICA; Reichardt BW, 2013, NATURE, V496, P456, DOI 10.1038/nature12035; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Rukhin A., 2010, NIST SPECIAL PUBLICA, P1, DOI DOI 10.6028/NIST.SP.800-22R1A; Santha M., 1984, 25th Annual Symposium on Foundations of Computer Science (Cat. No. 84CH2085-9), P434, DOI 10.1109/SFCS.1984.715945; Shalm LK, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.250402; Silman J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.100504; Simon C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.110405; Smith DH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1628; Tomamichel M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/10/103002; Trevisan L, 2001, J ACM, V48, P860, DOI 10.1145/502090.502099; Tsirelson B., 1993, HADRONIC J S, V8, P329; Valentini A, 2002, PHYS LETT A, V297, P273, DOI 10.1016/S0375-9601(02)00438-3; Vazirani U, 2012, PHILOS T R SOC A, V370, P3432, DOI 10.1098/rsta.2011.0336; von Neumann J., 1951, MONTE CARLO METHODS, V12, P36; Wiseman HM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.140402; Wittmann B, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053030; Wojewodka H., 2016, AMPLIFYING RANDOMNES; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	93	113	114	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					213	219		10.1038/nature20119	http://dx.doi.org/10.1038/nature20119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27929003	Green Submitted			2022-12-28	WOS:000389548700047
J	Mueller, AA; van Velthoven, CT; Fukumoto, KD; Cheung, TH; Rando, TA				Mueller, Alisa A.; van Velthoven, Cindy T.; Fukumoto, Kathryn D.; Cheung, Tom H.; Rando, Thomas A.			Intronic polyadenylation of PDGFR alpha in resident stem cells attenuates muscle fibrosis	NATURE			English	Article							ALTERNATIVE POLYADENYLATION; GROWTH-FACTOR; EXPRESSION; RECEPTOR; DYSTROPHY; FIBROGENESIS; PROGENITORS; REPAIR	Platelet-derived growth factor receptor a (PDGFR alpha) exhibits divergent effects in skeletal muscle. At physiological levels, signalling through this receptor promotes muscle development in growing embryos and angiogenesis in regenerating adult muscle(1,2). However, both increased PDGF ligand abundance and enhanced PDGFRa pathway activity cause pathological fibrosis(3,4). This excessive collagen deposition, which is seen in aged and diseased muscle(5-7), interferes with muscle function and limits the effectiveness of gene-and cell-based therapies for muscle disorders(8,9). Although compelling evidence exists for the role of PDGFRa in fibrosis, little is known about the cells through which this pathway acts. Here we show in mice that PDGFRa signalling regulates a population of muscle-resident fibro/adipogenic progenitors (FAPs) that play a supportive role in muscle regeneration but may also cause fibrosis when aberrantly regulated 10(-13). We found that FAPs produce multiple transcriptional variants of Pdgfra with different polyadenylation sites, including an intronic variant that codes for a protein isoform containing a truncated kinase domain. This variant, upregulated during regeneration, acts as a decoy to inhibit PDGF signalling and to prevent FAP over-activation. Moreover, increasing the expression of this isoform limits fibrosis in vivo in mice, suggesting both biological relevance and therapeutic potential of modulating polyadenylation patterns in stem-cell populations.	[Mueller, Alisa A.; van Velthoven, Cindy T.; Fukumoto, Kathryn D.; Cheung, Tom H.; Rando, Thomas A.] Stanford Univ, Paul F Glenn Ctr Biol Aging, Sch Med, Stanford, CA 94305 USA; [Mueller, Alisa A.; van Velthoven, Cindy T.; Fukumoto, Kathryn D.; Cheung, Tom H.; Rando, Thomas A.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Mueller, Alisa A.] Stanford Univ, Program Canc Biol, Sch Med, Stanford, CA 94305 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev REAP, Palo Alto, CA 94304 USA; [Mueller, Alisa A.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Cheung, Tom H.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Harvard University; Brigham & Women's Hospital; Hong Kong University of Science & Technology	Rando, TA (corresponding author), Stanford Univ, Paul F Glenn Ctr Biol Aging, Sch Med, Stanford, CA 94305 USA.; Rando, TA (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.; Rando, TA (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA.; Rando, TA (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev REAP, Palo Alto, CA 94304 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564; van Velthoven, Cindy/0000-0001-5120-4546; Mueller, Alisa/0000-0002-1342-6962	Glenn Foundation for Medical Research; National Institutes of Health [F30 AG043235]; California Institute for Regenerative Medicine [TG2-01159]; Department of Veterans Affairs; NIH [P01 AG036695, R01 AG23806, R01 AR062185, TR01 AG47820]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG043235, R01AG023806, R37AG023806, R01AG047820, P01AG036695] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002324, I21RX002234] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We would like to thank members of the Rando laboratory, especially A. de Morree, M. Quarta, J. Shih, B. Yoo, V. Garcia and I. Akimenko for discussions and experimental assistance as well as L. Rott for guidance with FACS. This work was supported by the Glenn Foundation for Medical Research, by grants from the National Institutes of Health (F30 AG043235) and the California Institute for Regenerative Medicine (TG2-01159) to A.A.M., and by grants from the Department of Veterans Affairs and the NIH (P01 AG036695, R01 AG23806, R01 AR062185, and TR01 AG47820) to T.A.R.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bansal R, 2011, HEPATOLOGY, V54, P586, DOI 10.1002/hep.24395; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Du LT, 2011, J IMMUNOL METHODS, V365, P1, DOI 10.1016/j.jim.2010.12.001; Fiore D, 2016, STEM CELL RES, V17, P161, DOI 10.1016/j.scr.2016.06.007; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Ito T, 2013, NEUROMUSCULAR DISORD, V23, P349, DOI 10.1016/j.nmd.2012.10.025; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Mueller AA, 2013, CURR OPIN CELL BIOL, V25, P222, DOI 10.1016/j.ceb.2012.12.008; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; Soriano P, 1997, DEVELOPMENT, V124, P2691; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TIDBALL JG, 1992, EXP CELL RES, V203, P141, DOI 10.1016/0014-4827(92)90049-E; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vorlova S, 2011, MOL CELL, V43, P927, DOI 10.1016/j.molcel.2011.08.009; Zhao YJ, 2003, J PATHOL, V201, P149, DOI 10.1002/path.1414	33	83	84	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					276	279		10.1038/nature20160	http://dx.doi.org/10.1038/nature20160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27894125	Green Accepted			2022-12-28	WOS:000389548700058
J	Ladejobi, A; Schelbert, EB				Ladejobi, Adetola; Schelbert, Erik B.			Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Suspected Coronary Heart Disease	ANNALS OF INTERNAL MEDICINE			English	Letter									[Ladejobi, Adetola] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA; UPMC Cardiovasc Magnet Resonance Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ladejobi, A (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA.							Bruder O, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-9; Bruder O, 2009, J AM COLL CARDIOL, V54, P1457, DOI 10.1016/j.jacc.2009.07.003; Greenwood JP, 2016, ANN INTERN MED, V165, P1, DOI 10.7326/M15-1801; Schelbert EB, 2008, HEART, V94, DOI 10.1136/hrt.2006.111674; Schelbert EB, 2012, JAMA-J AM MED ASSOC, V308, P890, DOI 10.1001/2012.jama.11089	5	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					829	830		10.7326/L16-0479	http://dx.doi.org/10.7326/L16-0479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27919090				2022-12-28	WOS:000389263900022
J	Bahri, C				Bahri, Charu			India's changing clinical trials scene	LANCET			English	Editorial Material																			0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2727	2728		10.1016/S0140-6736(16)32461-8	http://dx.doi.org/10.1016/S0140-6736(16)32461-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FB	27924767				2022-12-28	WOS:000389629800011
J	Popkin, G				Popkin, Gabriel			QUEST FOR QUBITS	SCIENCE			English	Editorial Material																			0	34	34	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1091	1093		10.1126/science.354.6316.1090	http://dx.doi.org/10.1126/science.354.6316.1090			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934716				2022-12-28	WOS:000388916400014
J	Aviram, N; Ast, T; Costa, EA; Arakel, EC; Chuartzman, SG; Jan, CH; Hassenteufel, S; Dudek, J; Jung, M; Schorr, S; Zimmermann, R; Schwappach, B; Weissman, JS; Schuldiner, M				Aviram, Naama; Ast, Tslil; Costa, Elizabeth A.; Arakel, Eric C.; Chuartzman, Silvia G.; Jan, Calvin H.; Hassenteufel, Sarah; Dudek, Johanna; Jung, Martin; Schorr, Stefan; Zimmermann, Richard; Schwappach, Blanche; Weissman, Jonathan S.; Schuldiner, Maya			The SND proteins constitute an alternative targeting route to the endoplasmic reticulum	NATURE			English	Article							SIGNAL RECOGNITION PARTICLE; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; GENE DISRUPTION; YEAST; TRANSLOCATION; INSERTION; IDENTIFICATION; TRANSFORMATION; DELETION	In eukaryotes, up to one-third of cellular proteins are targeted to the endoplasmic reticulum, where they undergo folding, processing, sorting and trafficking to subsequent endomembrane compartments(1). Targeting to the endoplasmic reticulum has been shown to occur co-translationally by the signal recognition particle (SRP) pathway(2) or post-translationally by the mammalian transmembrane recognition complex of 40 kDa (TRC40)(3,4) and homologous yeast guided entry of tail-anchored proteins (GET)(5,6) pathways. Despite the range of proteins that can be catered for by these two pathways, many proteins are still known to be independent of both SRP and GET, so there seems to be a critical need for an additional dedicated pathway for endoplasmic reticulum relay(7,8). We set out to uncover additional targeting proteins using unbiased high-content screening approaches. To this end, we performed a systematic visual screen using the yeast Saccharomyces cerevisiae(9,10), and uncovered three uncharacterized proteins whose loss affected targeting. We suggest that these proteins work together and demonstrate that they function in parallel with SRP and GET to target a broad range of substrates to the endoplasmic reticulum. The three proteins, which we name Snd1, Snd2 and Snd3 (for SRP-independent targeting), can synthetically compensate for the loss of both the SRP and GET pathways, and act as a backup targeting system. This explains why it has previously been difficult to demonstrate complete loss of targeting for some substrates. Our discovery thus puts in place an essential piece of the endoplasmic reticulum targeting puzzle, highlighting how the targeting apparatus of the eukaryotic cell is robust, interlinked and flexible.	[Aviram, Naama; Ast, Tslil; Chuartzman, Silvia G.; Schuldiner, Maya] Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel; [Costa, Elizabeth A.; Jan, Calvin H.; Weissman, Jonathan S.] UCSF, Calif Inst Quantitat Biomed Res, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Costa, Elizabeth A.; Jan, Calvin H.; Weissman, Jonathan S.] Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Arakel, Eric C.; Schwappach, Blanche] Univ Med Ctr Gottingen, Dept Mol Biol, D-37073 Gottingen, Germany; [Hassenteufel, Sarah; Dudek, Johanna; Jung, Martin; Schorr, Stefan; Zimmermann, Richard] Univ Saarland, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Schwappach, Blanche] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Ast, Tslil] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02114 USA	Weizmann Institute of Science; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of Gottingen; Saarland University; Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ast, T; Schuldiner, M (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel.; Ast, T (corresponding author), Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02114 USA.	tast@broadinstitute.org; maya.schuldiner@weizmann.ac.il	Jung, Martin/D-2207-2012; Schuldiner, Maya/C-9488-2009; Ast, Tslil/ABF-5110-2021; Jung, Martin/AAM-4547-2021	Jung, Martin/0000-0002-1482-7020; Jung, Martin/0000-0002-1482-7020; Costa, Elizabeth/0000-0001-8365-0436; Aviram, Naama/0000-0002-0581-958X; Ast, Tslil/0000-0002-6927-6238; Schuldiner, Maya/0000-0001-9947-115X; Arakel, Eric Clement/0000-0001-7716-7149; Weissman, Jonathan/0000-0003-2445-670X	Israel Academy of Sciences and Humanities; DFG [IRTG 1830, ZI 234/13-1]; HOMFOR; Deutsche Forschungsgemeinschaft [SFB 1190 P04]; NIH/NGMS (Center for RNA Systems Biology) [P50 GM102706]; National Science Foundation [1144247]; Minerva foundation; Israel Science Foundation [791/14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810, P50GM102706] Funding Source: NIH RePORTER	Israel Academy of Sciences and Humanities; DFG(German Research Foundation (DFG)); HOMFOR; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH/NGMS (Center for RNA Systems Biology); National Science Foundation(National Science Foundation (NSF)); Minerva foundation; Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Schuldiner laboratory members for discussions and comments on the manuscript; D. Kaganovich, T. Ravid, J. Gerst, S. High and H. Riezman for plasmids; P. Walter and M. Seedorf for antibodies; and I. Yofe and U. Weill for the N-terminal tagging plasmid and primers. T.A. was supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. The work on human cells was supported by a DFG grant (IRTG 1830 and ZI 234/13-1) to R.Z. and the generation of anti-hSnd2 antibodies was funded by HOMFOR (HOMFOR2015). Supercomplex analysis by E.C.A. and B.S. was funded by the Deutsche Forschungsgemeinschaft (SFB 1190 P04). J.S.W. is supported by the NIH/NGMS (Center for RNA Systems Biology P50 GM102706 (Cate)). E.A.C. is supported by the National Science Foundation under grant 1144247. This work was funded by the Minerva foundation and Israel Science Foundation grant number 791/14 support to M.S. M.S is an incumbent of the Dr. Gilbert Omenn and Martha Darling Professorial Chair in Molecular Genetics.	Ast T, 2013, CRIT REV BIOCHEM MOL, V48, P273, DOI 10.3109/10409238.2013.782999; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Aviram N, 2014, CURR OPIN CELL BIOL, V29, P8, DOI 10.1016/j.ceb.2014.02.004; Brachmann CB, 1998, YEAST, V14, P115; Breker M, 2013, J CELL BIOL, V200, P839, DOI 10.1083/jcb.201301120; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cohen Y, 2011, METHODS MOL BIOL, V781, P127, DOI 10.1007/978-1-61779-276-2_8; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham T. R., 2001, CURR PROTOC CELL BIO, V7, P76; Harada Y, 2011, J BIOL CHEM, V286, P2956, DOI 10.1074/jbc.M110.159517; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mandon E. C., 2013, COLD SPRING HARB PER, V5, P1; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Noriega TR, 2014, J BIOL CHEM, V289, P19294, DOI 10.1074/jbc.M114.563239; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ricarte F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023696; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Yofe I, 2014, YEAST, V31, P77, DOI 10.1002/yea.2998; Yompakdee C, 1996, MOL GEN GENET, V251, P580, DOI 10.1007/s004380050205; Zhao YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064228	40	127	130	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					134	+		10.1038/nature20169	http://dx.doi.org/10.1038/nature20169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905431	Green Submitted, Green Accepted			2022-12-28	WOS:000388916600063
J	Kho, JSB; Howlett, DC				Kho, James S. B.; Howlett, David C.			Hip pain in a middle aged woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LESSER TROCHANTER; FRACTURES; AVULSION		[Kho, James S. B.] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Howlett, David C.] East Sussex Healthcare NHS Trust, Hastings, England	Brighton and Sussex University Hospitals NHS Trust; University of Brighton	Kho, JSB (corresponding author), Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England.	jamesksb@gmail.com		Kho, James Swee Beng/0000-0002-4839-1632				FERNBACH SK, 1981, AM J ROENTGENOL, V137, P581, DOI 10.2214/ajr.137.3.581; PHILLIPS CD, 1988, SKELETAL RADIOL, V17, P106; Rouvillain JL, 2011, ORTHOP TRAUMATOL-SUR, V97, P217, DOI 10.1016/j.otsr.2010.11.005; Sheehan SE, 2015, RADIOGRAPHICS, V35, P1563, DOI 10.1148/rg.2015140301; Theologis TN, 1997, INJURY, V28, P363, DOI 10.1016/S0020-1383(97)00017-X	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2016	355								i6129	10.1136/bmj.i6129	http://dx.doi.org/10.1136/bmj.i6129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZD	27903504				2022-12-28	WOS:000389308600004
J	Ward, B; Zee, D				Ward, Bryan; Zee, David			Dizziness and Vertigo during MRI	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ward, Bryan; Zee, David] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Ward, B (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	bward15@jhmi.edu	Ward, Bryan/AAM-7721-2020; Ward, Bryan/M-2306-2018	Ward, Bryan/0000-0001-5201-6117					0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					E44	E44		10.1056/NEJMicm1514075	http://dx.doi.org/10.1056/NEJMicm1514075			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC9KU	27959734				2022-12-28	WOS:000388464300011
J	Kaplan, RS; Haas, DA; Warsh, J				Kaplan, Robert S.; Haas, Derek A.; Warsh, Jonathan			Adding Value by Talking More	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXPECTATIONS		[Kaplan, Robert S.; Haas, Derek A.; Warsh, Jonathan] Harvard Sch Business, Boston, MA 02163 USA	Harvard University	Kaplan, RS (corresponding author), Harvard Sch Business, Boston, MA 02163 USA.		Kaplan, Robert/AAB-9571-2021					Haas DA, 2014, HARVARD BUSINESS REV; Henn RF, 2007, J BONE JOINT SURG AM, V89A, P1913, DOI 10.2106/JBJS.F.00358; James J., 2013, HLTH AFFAIRS; Myers SS, 2008, J GEN INTERN MED, V23, P148, DOI 10.1007/s11606-007-0460-5; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	5	24	25	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1918	1920		10.1056/NEJMp1607079	http://dx.doi.org/10.1056/NEJMp1607079			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC1HS	27959597				2022-12-28	WOS:000387856100003
J	Wilensky, GR				Wilensky, Gail R.			The Future of the ACA and Health Care Policy in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wilensky, Gail R.] Project HOPE, 7500 Old Georgetown Rd,Ste 600, Bethesda, MD 20814 USA		Wilensky, GR (corresponding author), Project HOPE, 7500 Old Georgetown Rd,Ste 600, Bethesda, MD 20814 USA.	gwilensky@projecthope.org						Ryan Paul, SPEAKER OF THE HOUSE	1	4	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					21	22		10.1001/jama.2016.18762	http://dx.doi.org/10.1001/jama.2016.18762			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	27893882				2022-12-28	WOS:000391009100010
J	Schardon, K; Hohl, M; Graff, L; Pfannstiel, J; Schulze, W; Stintzi, A; Schaller, A				Schardon, Katharina; Hohl, Mathias; Graff, Lucile; Pfannstiel, Jens; Schulze, Waltraud; Stintzi, Annick; Schaller, Andreas			Precursor processing for plant peptide hormone maturation by subtilisin-like serine proteinases	SCIENCE			English	Article							FLORAL ORGAN ABSCISSION; INFLORESCENCE-DEFICIENT; CELL-SEPARATION; ARABIDOPSIS; PROTEASE; STRATEGIES; SIGNALS; KINASE; TOOLS; HAESA	Peptide hormones that regulate plant growth and development are derived from larger precursor proteins by proteolytic processing. Our study addressed the role of subtilisin-like proteinases (SBTs) in this process. Using tissue-specific expression of proteinase inhibitors as a tool to overcome functional redundancy, we found that SBT activity was required for the maturation of IDA (INFLORESCENCE DEFICIENT IN ABSCISSION), a peptide signal for the abscission of floral organs in Arabidopsis. We identified three SBTs that process the IDA precursor in vitro, and this processing was shown to be required for the formation of mIDA (the mature and bioactive form of IDA) as the endogenous signaling peptide in vivo. Hence, SBTs act as prohormone convertases in plants, and several functionally redundant SBTs contribute to signal biogenesis.	[Schardon, Katharina; Hohl, Mathias; Graff, Lucile; Stintzi, Annick; Schaller, Andreas] Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany; [Pfannstiel, Jens] Core Facil Hohenheim, Mass Spectrometry Unit, D-70593 Stuttgart, Germany; [Schulze, Waltraud] Univ Hohenheim, Dept Plant Syst Biol, D-70593 Stuttgart, Germany	University Hohenheim; University Hohenheim	Schaller, A (corresponding author), Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany.	andreas.schaller@uni-hohenheim.de	Schaller, Andreas/AAC-1940-2020; Schulze, Waltraud X/E-9800-2011	Schaller, Andreas/0000-0001-6872-9576; Schulze, Waltraud X/0000-0001-9957-7245; Hohl, Mathias/0000-0003-3676-6705	German Research Foundation (Deutsche Forschungsgemeinschaft) [SCHA 591/3-2, SCHA 591/4-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	We thank S. Kamoun (The Sainsbury Laboratory) for EPI1a and EPI10 expression constructs and R. Aalen (University of Oslo) for seeds of the ida mutant and the PGAZAT reporter line. We also thank them for fruitful discussions, as well as U. Gluck-Behrens and J. Babo for technical assistance. This work was supported in part by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft) to A.Sc. (SCHA 591/3-2 and SCHA 591/4-1). The supplementary materials contain additional data.	Aalen RB, 2013, J EXP BOT, V64, P5253, DOI 10.1093/jxb/ert338; Butenko MA, 2003, PLANT CELL, V15, P2296, DOI 10.1105/tpc.014365; Butenko MA, 2014, PLANT CELL, V26, P1838, DOI 10.1105/tpc.113.120071; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; Engineer CB, 2014, NATURE, V513, P246, DOI 10.1038/nature13452; Ghorbani S, 2016, J EXP BOT, V67, P4877, DOI 10.1093/jxb/erw241; Gonzalez-Carranza ZH, 2012, PLANT PHYSIOL, V160, P1342, DOI 10.1104/pp.112.205955; Jinn TL, 2000, GENE DEV, V14, P108; Liljegren SJ, 2012, CURR OPIN PLANT BIOL, V15, P670, DOI 10.1016/j.pbi.2012.09.012; Matsubayashi Y, 2014, ANNU REV PLANT BIOL, V65, P385, DOI 10.1146/annurev-arplant-050312-120122; Meng XZ, 2016, CELL REP, V14, P1330, DOI 10.1016/j.celrep.2016.01.023; Niederhuth CE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-37; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Santiago J, 2016, ELIFE, V5, DOI 10.7554/eLife.15075; Schaller A, 1998, PHYTOCHEMISTRY, V47, P605, DOI 10.1016/S0031-9422(97)00523-2; Schaller A, 2012, PHYSIOL PLANTARUM, V145, P52, DOI 10.1111/j.1399-3054.2011.01529.x; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Srivastava R, 2009, PLANT J, V59, P930, DOI 10.1111/j.1365-313X.2009.03926.x; Stenvik GE, 2008, PLANT CELL, V20, P1805, DOI 10.1105/tpc.108.059139; Tavormina P, 2015, PLANT CELL, V27, P2095, DOI 10.1105/tpc.15.00440; Tian Miaoying, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-15; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226	24	79	79	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1594	1597		10.1126/science.aai8550	http://dx.doi.org/10.1126/science.aai8550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	27940581				2022-12-28	WOS:000390254300055
J	Karki, R; Man, SM; Malireddi, RKS; Kesavardhana, S; Zhu, QF; Burton, AR; Sharma, BR; Qi, XP; Pelletier, S; Vogel, P; Rosenstiel, P; Kanneganti, TD				Karki, Rajendra; Man, Si Ming; Malireddi, R. K. Subbarao; Kesavardhana, Sannula; Zhu, Qifan; Burton, Amanda R.; Sharma, Bhesh Raj; Qi, Xiaopeng; Pelletier, Stephane; Vogel, Peter; Rosenstiel, Philip; Kanneganti, Thirumala-Devi			NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer	NATURE			English	Article							PROTEIN-KINASE B; NOD-LIKE RECEPTOR; NF-KAPPA-B; COLON INFLAMMATION; CUTTING EDGE; AMINO-ACIDS; CELL-DEATH; ACTIVATION; AIM2; TUMORIGENESIS	NLRs (nucleotide-binding domain and leucine-rich repeats) belong to a large family of cytoplasmic sensors that regulate an extraordinarily diverse range of biological functions. One of these functions is to contribute to immunity against infectious diseases, but dysregulation of their functional activity leads to the development of inflammatory and autoimmune diseases(1). Cytoplasmic innate immune sensors, including NLRs, are central regulators of intestinal homeostasis(2-9). NLRC3 (also known as CLR16.2 or NOD3) is a poorly characterized member of the NLR family and was identified in a genomic screen for genes encoding proteins bearing leucine-rich repeats (LRRs) and nucleotide-binding domains(10,1)1. Expression of NLRC3 is drastically reduced in the tumour tissue of patients with colorectal cancer compared to healthy tissues(12), highlighting an undefined potential function for this sensor in the development of cancer. Here we show that mice lacking NLRC3 are hyper-susceptible to colitis and colorectal tumorigenesis. The effect of NLRC3 is most dominant in enterocytes, in which it suppresses activation of the mTOR signalling pathways and inhibits cellular proliferation and stem-cell-derived organoid formation. NLRC3 associates with PI3Ks and blocks activation of the PI3K-dependent kinase AKT following binding of growth factor receptors or Toll-like receptor 4. These findings reveal a key role for NLRC3 as an inhibitor of the mTOR pathways, mediating protection against colorectal cancer.	[Karki, Rajendra; Man, Si Ming; Malireddi, R. K. Subbarao; Kesavardhana, Sannula; Zhu, Qifan; Burton, Amanda R.; Sharma, Bhesh Raj; Qi, Xiaopeng; Pelletier, Stephane; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zhu, Qifan] Univ Tennessee, Integrated Biomed Sci Program, Hlth Sci Ctr, Memphis, TN 38163 USA; [Pelletier, Stephane] St Jude Childrens Res Hosp, Embryon Stem Cell Lab, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, 332 N Lauderdale St, Memphis, TN 38105 USA; [Rosenstiel, Philip] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Kiel	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/M-9435-2018; Malireddi, RKSubbarao/C-5804-2013; Rosenstiel, Philip/A-5137-2009; Karki, Rajendra/H-6647-2019; Vogel, Peter/N-2490-2018; Man, Si Ming/AAE-9168-2019; Kanneganti, Thirumala-Devi/Y-2503-2019; Sharma, Bhesh/AAJ-5150-2020; Sharma, Bhesh Raj/H-3782-2014	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447; Rosenstiel, Philip/0000-0002-9692-8828; Karki, Rajendra/0000-0003-4436-9128; Vogel, Peter/0000-0002-7535-0545; Man, Si Ming/0000-0002-5079-2857; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Sharma, Bhesh/0000-0003-3609-833X; Sharma, Bhesh Raj/0000-0003-3609-833X	SJCRH; NCI [P30 CA021765-35]; US National Institutes of Health [AI101935, AI124346, AR056296, CA163507]; ALSAC; ExC306 Inflammation at Interfaces; DFG [SFB 877 B9, SFB1182 C2]; R. G. Menzies Early Career Fellowship from the National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI101935, R01AI101935, R01AI124346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	SJCRH; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); ExC306 Inflammation at Interfaces; DFG(German Research Foundation (DFG)); R. G. Menzies Early Career Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the Transgenic Gene Knockout Shared Resource at St. Jude Children's Research Hospital (SJCRH) for assistance with knockout mouse generation. Images were acquired at the SJCRH Cell & Tissue Imaging Center, which is supported by SJCRH and NCI grant P30 CA021765-35. Work from our laboratory is supported by the US National Institutes of Health (grants AI101935, AI124346, AR056296 and CA163507 to T.-D.K.), ALSAC (to T.-D.K.), and the ExC306 Inflammation at Interfaces, the DFG SFB 877 B9 and DFG SFB1182 C2 projects (to P.R.). S.M.M. is supported by the R. G. Menzies Early Career Fellowship from the National Health and Medical Research Council of Australia.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Boussemart L, 2014, NATURE, V513, P105, DOI 10.1038/nature13572; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Jones BW, 2001, ANN RHEUM DIS, V60, pIII6; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Laudien M, 2011, MUCOSAL IMMUNOL, V4, P564, DOI 10.1038/mi.2011.9; Liu RR, 2015, ONCOTARGET, V6, P33456, DOI 10.18632/oncotarget.5587; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Pelletier S, 2015, IMMUNITY, V42, P18, DOI 10.1016/j.immuni.2015.01.004; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Shiau CE, 2013, CELL REP, V5, P1342, DOI 10.1016/j.celrep.2013.11.004; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	32	105	110	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					583	+		10.1038/nature20597	http://dx.doi.org/10.1038/nature20597			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27951586	Green Accepted			2022-12-28	WOS:000391190500052
J	Schworer, S; Becker, F; Feller, C; Baig, AH; Kober, U; Henze, H; Kraus, JM; Xin, BB; Lechel, A; Lipka, DB; Varghese, CS; Schmidt, M; Rohs, R; Aebersold, R; Medina, KL; Kestler, HA; Neri, F; von Maltzahn, J; Tumpel, S; Rudolph, KL				Schwoerer, Simon; Becker, Friedrich; Feller, Christian; Baig, Ali H.; Koeber, Ute; Henze, Henriette; Kraus, Johann M.; Xin, Beibei; Lechel, Andre; Lipka, Daniel B. .; Varghese, Christy S.; Schmidt, Manuel; Rohs, Remo; Aebersold, Ruedi; Medina, Kay L.; Kestler, Hans A.; Neri, Francesco; von Maltzahn, Julia; Tumpel, Stefan; Rudolph, K. Lenhard			Epigenetic stress responses induce muscle stem-cell ageing by Hoxa9 developmental signals	NATURE			English	Article							SKELETAL-MUSCLE; SELF-RENEWAL; GENES; MOUSE; BROMODOMAIN; INHIBITION; QUIESCENCE; DEFECTS; DESIGN; FATE	The functionality of stem cells declines during ageing, and this decline contributes to ageing-associated impairments in tissue regeneration and function(1). Alterations in developmental pathways have been associated with declines in stem-cell function during ageing(2-6), but the nature of this process remains poorly understood. Hox genes are key regulators of stem cells and tissue patterning during embryogenesis with an unknown role in ageing(7,8). Here we show that the epigenetic stress response in muscle stem cells (also known as satellite cells) differs between aged and young mice. The alteration includes aberrant global and site-specific induction of active chromatin marks in activated satellite cells from aged mice, resulting in the specific induction of Hoxa9 but not other Hox genes. Hoxa9 in turn activates several developmental pathways and represents a decisive factor that separates satellite cell gene expression in aged mice from that in young mice. The activated pathways include most of the currently known inhibitors of satellite cell function in ageing muscle, including Wnt, TGF beta, JAK/STAT and senescence signalling(2-4,6). Inhibition of aberrant chromatin activation or deletion of Hoxa9 improves satellite cell function and muscle regeneration in aged mice, whereas overexpression of Hoxa9 mimics ageing-associated defects in satellite cells from young mice, which can be rescued by the inhibition of Hoxa9-targeted developmental pathways. Together, these data delineate an altered epigenetic stress response in activated satellite cells from aged mice, which limits satellite cell function and muscle regeneration by Hoxa9-dependent activation of developmental pathways.	[Schwoerer, Simon; Becker, Friedrich; Baig, Ali H.; Koeber, Ute; Henze, Henriette; Varghese, Christy S.; Schmidt, Manuel; Kestler, Hans A.; Neri, Francesco; von Maltzahn, Julia; Tumpel, Stefan; Rudolph, K. Lenhard] FLI, Leibniz Inst Aging, Beutenbergstr 11, D-07745 Jena, Germany; [Feller, Christian; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, Auguste Piccard Hof 1, CH-8093 Zurich, Switzerland; [Kraus, Johann M.; Kestler, Hans A.] Univ Ulm, Inst Med Syst Biol, D-89081 Ulm, Germany; [Xin, Beibei; Rohs, Remo] Univ Southern Calif, Mol & Computat Biol Program, 1050 Childs Way, Los Angeles, CA 90089 USA; [Lechel, Andre] Univ Ulm, Dept Internal Med 1, Albert Einstein Allee 23, D-89081 Ulm, Germany; [Lipka, Daniel B. .] DKFZ, Div Epigen & Canc Risk Factors, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland; [Medina, Kay L.] Mayo Clin, Dept Immunol, 200 First St SW, Rochester, MN 55905 USA; [Rudolph, K. Lenhard] Friedrich Schiller Univ, Fac Med, Jena, Germany	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Swiss Federal Institutes of Technology Domain; ETH Zurich; Ulm University; University of Southern California; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zurich; Mayo Clinic; Friedrich Schiller University of Jena	von Maltzahn, J; Tumpel, S; Rudolph, KL (corresponding author), FLI, Leibniz Inst Aging, Beutenbergstr 11, D-07745 Jena, Germany.; Rudolph, KL (corresponding author), Friedrich Schiller Univ, Fac Med, Jena, Germany.	julia.vonmaltzahn@leibniz-fli.de; stefan.tuempel@leibniz-fli.de; lenhard.rudolph@leibniz-fli.de	Kestler, Hans A./D-5799-2012; von Maltzahn, Julia/A-6689-2017; Neri, Francesco/A-3321-2014; von Maltzahn, Julia/AFP-2284-2022; Lechel, André/AAQ-2041-2021	Kestler, Hans A./0000-0002-4759-5254; von Maltzahn, Julia/0000-0001-7674-1487; Neri, Francesco/0000-0003-3903-1974; von Maltzahn, Julia/0000-0001-7674-1487; Lechel, André/0000-0003-0221-6959; Varghese, Christy Susan/0000-0003-3312-0159; Rudolph, Karl Lenhard/0000-0002-4839-2862	DGF [RU-745/10, RU-745/12]; ERC [2012-AdG 323136, AdvGr 670821]; state of Thuringia; Leibniz association; DFG [MA-3975/2-1, FE-1544/1-1, SFB 1074]; EMBO [ALTF 55-2015]; NIH [HL096108, R01GM106056]; BMBF [0315894A]; European Community [602783]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106056] Funding Source: NIH RePORTER	DGF(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); state of Thuringia; Leibniz association; DFG(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BMBF(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Morita and A. Illing for providing guidance regarding FACS analysis. We are thankful to the FLI Core Facilities Functional Genomics (T. Kroll A Ploubidou) and DNA Sequencing (M. Groth) for their services. We express our thanks to M. Burkhalter, T Sperka and A. Illing for discussions and suggestions. We are grateful to B. Wollscheid and S. Goetze for providing support for proteomic measurements. We thank V. Sakk and M. Kettering for mouse husbandry as well as S. Eichwald. K. Tramm and A. Abou Self for experimental assistance. We are grateful to M. Kessel, M. Kyba, G. Sauvageau and D. Wellik for sharing plasmids with Hox cDNAs. We thank the Structural Genomics Consortium and S. Ackloo for providing access to the epigenetic probe library. We further thank M. Cerletti for providing protocols on SC isolation and E. Perdiguero for advice on infection of SCs before transplantation. Work on this project in K.L.R.'s laboratory was supported by the DGF (RU-745/10, RU-745/12), the ERC (2012-AdG 323136), the state of Thuringia, and intramural funds from the Leibniz association. J.V.M. was supported by a grant from the DFG (MA-3975/2-1). C.F. acknowledges support by the DFG (FE-1544/1-1) and EMBO (long-term postdoctoral fellowship ALTF 55-2015). R.A. was supported by the ERC (AdvGr 670821 (Proteomics 4D)). The funding for the Hoxa9<SUP>-/-</SUP> mice to K.L.M. was provided by a grant of the NIH (HL096108). R.R. was supported by a grant from the NIH (R01GM106056). This work was further supported by grants to H.A.K. from the DFG (SFB 1074 project Z1), the BMBF (Gerontosys II, Forschungskern SyStaR, project ID 0315894A), and the European Community's Seventh Framework Programme 390 (FP7/2007-2013, grant agreement 602783).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Barsyte-Lovejoy D, 2016, METHOD ENZYMOL, V574, P79, DOI 10.1016/bs.mie.2016.01.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Blagosklonny MV, 2013, CELL CYCLE, V12, P3736, DOI 10.4161/cc.27188; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brown PJ, 2015, FUTURE MED CHEM, V7, P1901, DOI 10.4155/fmc.15.127; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen PL, 2016, J MED CHEM, V59, P1410, DOI 10.1021/acs.jmedchem.5b00209; Clark P. G., 2015, ANGEW CHEM, V127, P6315, DOI DOI 10.1002/ANGE.201501394; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Drouin L, 2015, J MED CHEM, V58, P2553, DOI 10.1021/jm501963e; Feller C, 2015, MOL CELL, V57, P559, DOI 10.1016/j.molcel.2014.12.008; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Hay DA, 2014, J AM CHEM SOC, V136, P9308, DOI 10.1021/ja412434f; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lawrence HJ, 1996, STEM CELLS, V14, P281, DOI 10.1002/stem.140281; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LYONS KM, 1990, DEVELOPMENT, V109, P833; Martin LJ, 2016, J MED CHEM, V59, P4462, DOI 10.1021/acs.jmedchem.5b01865; Martin N, 2014, TRENDS MOL MED, V20, P667, DOI 10.1016/j.molmed.2014.09.008; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Picaud S, 2015, CANCER RES, V75, P5106, DOI 10.1158/0008-5472.CAN-15-0236; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Schambach A, 2006, EXP HEMATOL, V34, P588, DOI 10.1016/j.exphem.2006.02.005; Sehgal P.B., 2003, SIGNAL TRANSDUCERS A; Shen WF, 1999, MOL CELL BIOL, V19, P3051; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Theodoulou NH, 2016, J MED CHEM, V59, P1425, DOI 10.1021/acs.jmedchem.5b00256; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	53	67	72	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					428	+		10.1038/nature20603	http://dx.doi.org/10.1038/nature20603			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27919074	Green Accepted			2022-12-28	WOS:000389716800041
J	Zheng, Y; Qin, L; Zacarias, NVO; de Vries, H; Han, GW; Gustavsson, M; Dabros, M; Zhao, CX; Cherney, RJ; Carter, P; Stamos, D; Abagyan, R; Cherezov, V; Stevens, RC; Ijzerman, AP; Heitman, LH; Tebben, A; Kufareva, I; Handel, TM				Zheng, Yi; Qin, Ling; Zacarias, Natalia V. Ortiz; de Vries, Henk; Han, Gye Won; Gustavsson, Martin; Dabros, Marta; Zhao, Chunxia; Cherney, Robert J.; Carter, Percy; Stamos, Dean; Abagyan, Ruben; Cherezov, Vadim; Stevens, Raymond C.; Ijzerman, Adriaan P.; Heitman, Laura H.; Tebben, Andrew; Kufareva, Irina; Handel, Tracy M.			Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists	NATURE			English	Article							CRYSTAL-STRUCTURE; SMALL-MOLECULE; BINDING-SITE; MEMBRANE-PROTEINS; DISCOVERY; POTENT; ACTIVATION; COMPLEX; REVEAL; CXCR4	CC chemokine receptor 2 (CCR2) is one of 19 members of the chemokine receptor subfamily of human class A G-protein-coupled receptors. CCR2 is expressed on monocytes, immature dendritic cells, and T-cell subpopulations, and mediates their migration towards endogenous CC chemokine ligands such as CCL2 (ref. 1). CCR2 and its ligands are implicated in numerous inflammatory and neurodegenerative diseases(2) including atherosclerosis, multiple sclerosis, asthma, neuropathic pain, and diabetic nephropathy, as well as cancer(3). These disease associations have motivated numerous preclinical studies and clinical trials(4) (see http://www.clinicaltrials.gov) in search of therapies that target the CCR2-chemokine axis. To aid drug discovery efforts(5), here we solve a structure of CCR2 in a ternary complex with an orthosteric (BMS-681 (ref. 6)) and allosteric (CCR2-RA-[R](7)) antagonist. BMS-681 inhibits chemokine binding by occupying the orthosteric pocket of the receptor in a previously unseen binding mode. CCR2-RA-[R] binds in a novel, highly druggable pocket that is the most intracellular allosteric site observed in class A G-protein-coupled receptors so far; this site spatially overlaps the G-protein-binding site in homologous receptors. CCR2-RA-[R] inhibits CCR2 non-competitively by blocking activation-associated conformational changes and formation of the G-protein-binding interface. The conformational signature of the conserved microswitch residues observed in double-antagonist-bound CCR2 resembles the most inactive G-protein-coupled receptor structures solved so far. Like other protein-protein interactions, receptor-chemokine complexes are considered challenging therapeutic targets for small molecules, and the present structure suggests diverse pocket epitopes that can be exploited to overcome obstacles in drug design.	[Zheng, Yi; Qin, Ling; Gustavsson, Martin; Zhao, Chunxia; Abagyan, Ruben; Kufareva, Irina; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Zacarias, Natalia V. Ortiz; de Vries, Henk; Ijzerman, Adriaan P.; Heitman, Laura H.] Leiden Univ, LACDR, Div Med Chem, NL-2333 CC Leiden, Netherlands; [Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Univ Southern Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Han, Gye Won; Cherezov, Vadim] Univ Southern Calif, Bridge Inst, Dept Phys & Astron, Los Angeles, CA 90089 USA; [Dabros, Marta; Cherney, Robert J.; Carter, Percy; Tebben, Andrew] Bristol Myers Squibb Co, Princeton, NJ 08543 USA; [Stamos, Dean] Vertex Pharmaceut Inc, 11010 Torreyana Rd, San Diego, CA 92121 USA; [Stevens, Raymond C.] Univ Southern Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA	University of California System; University of California San Diego; Leiden University; Leiden University - Excl LUMC; University of Southern California; University of Southern California; Bristol-Myers Squibb; Vertex Pharmaceuticals; University of Southern California	Kufareva, I; Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Heitman, LH (corresponding author), Leiden Univ, LACDR, Div Med Chem, NL-2333 CC Leiden, Netherlands.	l.h.heitman@lacdr.leidenuniv.nl; ikufareva@ucsd.edu; thandel@ucsd.edu	Han, Gye Won/GLT-1531-2022; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022; Gustavsson, Martin/S-9370-2018; Stevens, Raymond/K-7272-2015; IJzerman, Ad/ABG-1353-2020; zheng, yi/G-1917-2016; Heitman, Laura/H-9019-2017	Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Gustavsson, Martin/0000-0002-3015-2043; Stevens, Raymond/0000-0002-4522-8725; IJzerman, Ad/0000-0002-1182-2259; zheng, yi/0000-0002-4871-0779; Ortiz Zacarias, Natalia V./0000-0002-2012-5519; Heitman, Laura/0000-0002-1381-8464; Kufareva, Irina/0000-0001-9083-7039	National Institutes of Health [R01 GM071872, U54 GM094618, R01 AI118985, R21 AI121918, R21 AI122211]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118985, R21AI121918, R21AI122211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071872, R01GM117424, U54GM094618, U01GM094612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Ishchenko and H. Zhang for help with X-ray data collection, C. Wang and H. X. Wu for suggestions on construct design, F. Li for help with data processing, and M. Galella for assistance with BMS compound data and statistics. We thank C. Ogata, R. Sanishvili, N. Venugopalan, M. Becker, and S. Corcoran at beamline 23ID at GM/CA CAT Advanced Photon Source. Funding for this research was provided by National Institutes of Health grants R01 GM071872, U54 GM094618, R01 AI118985, R21 AI121918, and R21 AI122211. GM/CA@APS has been funded in whole or in part with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract number DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Andrews G, 2008, MOL PHARMACOL, V73, P855, DOI 10.1124/mol.107.039321; Berkhout TA, 2003, J MED CHEM, V46, P4070, DOI 10.1021/jm030862l; Blankenship E, 2015, STRUCTURE, V23, P2358, DOI 10.1016/j.str.2015.09.015; Brodmerkel CM, 2005, J IMMUNOL, V175, P5370, DOI 10.4049/jimmunol.175.8.5370; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Carter PH, 2015, ACS MED CHEM LETT, V6, P439, DOI 10.1021/ml500505q; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Cherney RJ, 2008, BIOORG MED CHEM LETT, V18, P5063, DOI 10.1016/j.bmcl.2008.07.123; Cherney RJ, 2008, J MED CHEM, V51, P721, DOI 10.1021/jm701488f; Cooke RM, 2015, DRUG DISCOV TODAY, V20, P1355, DOI 10.1016/j.drudis.2015.08.003; Dasse OA, 2007, LETT DRUG DES DISCOV, V4, P263, DOI 10.2174/157018007784619989; Doyon J, 2008, CHEMMEDCHEM, V3, P660, DOI 10.1002/cmdc.200700276; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hall SE, 2009, MOL PHARMACOL, V75, P1325, DOI 10.1124/mol.108.053470; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Lim SY, 2016, ONCOTARGET, V7, P28697, DOI 10.18632/oncotarget.7376; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monteclaro FS, 1997, J BIOL CHEM, V272, P23186, DOI 10.1074/jbc.272.37.23186; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; O'Connor T, 2015, ENDOCR METAB IMMUNE, V15, P105, DOI 10.2174/1871530315666150316120920; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pease J, 2012, J MED CHEM, V55, P9363, DOI 10.1021/jm300682j; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Solari R, 2015, EUR J PHARMACOL, V746, P363, DOI 10.1016/j.ejphar.2014.06.060; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083; Zweemer AJM, 2014, MOL PHARMACOL, V86, P358, DOI 10.1124/mol.114.093328; Zweemer AJM, 2013, MOL PHARMACOL, V84, P551, DOI 10.1124/mol.113.086850	42	170	172	6	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					458	+		10.1038/nature20605	http://dx.doi.org/10.1038/nature20605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27926736	Green Accepted, Green Submitted			2022-12-28	WOS:000389716800047
J	Keylor, MH; Matsuura, BS; Griesser, M; Chauvin, JPR; Harding, RA; Kirillova, MS; Zhu, X; Fischer, OJ; Pratt, DA; Stephenson, CRJ				Keylor, Mitchell H.; Matsuura, Bryan S.; Griesser, Markus; Chauvin, Jean-Philippe R.; Harding, Ryan A.; Kirillova, Mariia S.; Zhu, Xu; Fischer, Oliver J.; Pratt, Derek A.; Stephenson, Corey R. J.			Synthesis of resveratrol tetramers via a stereoconvergent radical equilibrium	SCIENCE			English	Article							NATURAL-PRODUCTS; HOPEAHAINOL; CHEMISTRY; HOPEANOL; PLANTS	Persistent free radicals have become indispensable in the synthesis of organic materials through living radical polymerization. However, examples of their use in the synthesis of small molecules are rare. Here, we report the application of persistent radical and quinone methide intermediates to the synthesis of the resveratrol tetramers nepalensinol B and vateriaphenol C. The spontaneous cleavage and reconstitution of exceptionally weak carbon-carbon bonds has enabled a stereoconvergent oxidative dimerization of racemic materials in a transformation that likely coincides with the biogenesis of these natural products. The efficient synthesis of higher-order oligomers of resveratrol will facilitate the biological studies necessary to elucidate their mechanism(s) of action.	[Keylor, Mitchell H.; Matsuura, Bryan S.; Harding, Ryan A.; Kirillova, Mariia S.; Zhu, Xu; Fischer, Oliver J.; Stephenson, Corey R. J.] Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA; [Griesser, Markus; Chauvin, Jean-Philippe R.; Pratt, Derek A.] Univ Ottawa, Dept Chem & Biomol Sci, 10 Marie Curie Private, Ottawa, ON K1N 6N5, Canada	University of Michigan System; University of Michigan; University of Ottawa	Stephenson, CRJ (corresponding author), Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA.; Pratt, DA (corresponding author), Univ Ottawa, Dept Chem & Biomol Sci, 10 Marie Curie Private, Ottawa, ON K1N 6N5, Canada.	dpratt@uottawa.ca; crjsteph@umich.edu	Stephenson, Corey/Y-3069-2019; Zhu, Xu/A-5575-2017; Pratt, Derek A/A-1453-2011; Stephenson, Corey/G-1457-2016	Stephenson, Corey/0000-0002-2443-5514; Zhu, Xu/0000-0002-8856-2045; Stephenson, Corey/0000-0002-2443-5514; Kirillova, Mariia/0000-0003-1628-4186; Fischer, Oliver/0000-0002-2101-6939; Griesser, Markus/0000-0002-7810-1560; Chauvin, Jean-Philippe/0000-0001-8771-7968; Keylor, Mitchell/0000-0002-9842-7234	NIH-National Institute of General Medical Sciences [R01-GM096129]; Camille Dreyfus Teacher Scholar Award Program; University of Michigan; National Sciences and Research Council of Canada; Canara Research Chairs program; University of Ottawa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096129] Funding Source: NIH RePORTER	NIH-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Camille Dreyfus Teacher Scholar Award Program; University of Michigan(University of Michigan System); National Sciences and Research Council of Canada; Canara Research Chairs program; University of Ottawa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support is gratefully acknowledged from the NIH-National Institute of General Medical Sciences (grant R01-GM096129), the Camille Dreyfus Teacher Scholar Award Program, and the University of Michigan to C.R.J.S., and the National Sciences and Research Council of Canada, the Canara Research Chairs program, and the University of Ottawa to D.A.P. J-P.R.C. acknowledges the support of Ontario Graduate Scholarships. We thank J. W. Karrpf for conducting x-ray diffraction experiments and solving the structures of compounds 4b and 9. Atomic coordinates and structure factors for the crystal structures reported are available free of charge tram the Cambridge Crystallographic Database under accession nos. CCDC 1499423 and CCDC 1485815, respectively. Additional characterization data am available in the supplementary materials. Reprints and permissions information is available at www.sciencemag.org/help/reprints-and-permissions. The authors declare no competing financial interests. Readers are welcome to comment on the online version of the paper. Correspondence and requests for materials should be addressed to C.R.J.S. (crjsteph@umich.edu) or D.A.P. (dpratt@uottawa.ca).	Amorati R, 2004, J ORG CHEM, V69, P7101, DOI 10.1021/jo0497860; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKER HD, 1969, J ORG CHEM, V34, P1211, DOI 10.1021/jo01257a006; Brown PD, 2012, ORG LETT, V14, P4537, DOI 10.1021/ol302042u; COGGON P, 1966, CHEM COMMUN, P439, DOI 10.1039/c19660000439; Gagnepain J, 2008, ANGEW CHEM INT EDIT, V47, P628, DOI 10.1002/anie.200890007; Gomberg M, 1900, J AM CHEM SOC, V22, P757, DOI 10.1021/ja02049a006; GRILLER D, 1976, ACCOUNTS CHEM RES, V9, P13, DOI 10.1021/ar50097a003; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Harvey RS, 2015, ANGEW CHEM INT EDIT, V54, P1795, DOI 10.1002/anie.201409818; He YH, 2006, HETEROCYCLES, V68, P93; Ito T, 2008, HELV CHIM ACTA, V91, P1989, DOI 10.1002/hlca.200890214; Jeandet P, 2014, MOLECULES, V19, P18033, DOI 10.3390/molecules191118033; Jeffrey JL, 2009, ORG LETT, V11, P5450, DOI 10.1021/ol902141z; Jepsen TH, 2014, ANGEW CHEM INT EDIT, V53, P6747, DOI 10.1002/anie.201402858; Jiang LY, 2012, PHYTOCHEMISTRY, V77, P294, DOI 10.1016/j.phytochem.2012.01.021; Keylor MH, 2015, CHEM REV, V115, P8976, DOI 10.1021/cr500689b; Klotter F, 2014, ANGEW CHEM INT EDIT, V53, P2473, DOI 10.1002/anie.201310676; Lucarini M, 1996, J ORG CHEM, V61, P9259, DOI 10.1021/jo961039i; Matsuura BS, 2015, ANGEW CHEM INT EDIT, V54, P3754, DOI 10.1002/anie.201409773; MONTGOMERY JA, 1994, J CHEM PHYS, V101, P5900, DOI 10.1063/1.467306; Mulder P, 2005, J PHYS CHEM A, V109, P2647, DOI 10.1021/jp047148f; Nicolaou KC, 2009, ANGEW CHEM INT EDIT, V48, P3440, DOI 10.1002/anie.200900438; Ohyama M, 1998, CHEM PHARM BULL, V46, P663; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Sako M, 2004, J ORG CHEM, V69, P2598, DOI 10.1021/jo035791c; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Snyder SA, 2007, ANGEW CHEM INT EDIT, V46, P8186, DOI 10.1002/anie.200703333; Snyder SA, 2012, ANGEW CHEM INT EDIT, V51, P4080, DOI 10.1002/anie.201107730; Snyder SA, 2011, ANGEW CHEM INT EDIT, V50, P8629, DOI 10.1002/anie.201103575; Snyder SA, 2011, NATURE, V474, P461, DOI 10.1038/nature10197; Soldi C, 2014, J AM CHEM SOC, V136, P15142, DOI 10.1021/ja508586t; Takaya Y, 2002, TETRAHEDRON, V58, P9265, DOI 10.1016/S0040-4020(02)01191-2; Wittman JM, 2013, J AM CHEM SOC, V135, P12956, DOI 10.1021/ja406500h; World Health Organization, 2015, WHO MOD LIST ESS MED; Wright NE, 2014, ANGEW CHEM INT EDIT, V53, P3409, DOI 10.1002/anie.201311299; Yamada M, 2006, PHYTOCHEMISTRY, V67, P307, DOI 10.1016/j.phytochem.2005.11.001	37	51	51	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1260	1265		10.1126/science.aaj1597	http://dx.doi.org/10.1126/science.aaj1597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940867	Green Accepted			2022-12-28	WOS:000389598800054
J	Matsumura, S; Kun, A; Ryckelynck, M; Coldren, F; Szilagyi, A; Jossinet, F; Rick, C; Nghe, P; Szathmary, E; Griffiths, AD				Matsumura, Shigeyoshi; Kun, Adam; Ryckelynck, Michael; Coldren, Faith; Szilagyi, Andrs; Jossinet, Fabrice; Rick, Christian; Nghe, Philippe; Szathmary, Eors; Griffiths, Andrew D.			Transient compartmentalization of RNA replicators prevents extinction due to parasites	SCIENCE			English	Article							GROUP SELECTION; ORIGIN; LIFE; EVOLUTION; DYNAMICS; SYSTEM; TRANSITIONS; HYPERCYCLES; MOLECULE; WORLD	The appearance of molecular replicators (molecules that can be copied) was probably a critical step in the origin of life. However, parasitic replicators would take over and would have prevented life from taking off unless the replicators were compartmentalized in reproducing protocells. Paradoxically, control of protocell reproduction would seem to require evolved replicators. We show here that a simpler population structure, based on cycles of transient compartmentalization (TC) and mixing of RNA replicators, is sufficient to prevent takeover by parasitic mutants. TC tends to select for ensembles of replicators that replicate at a similar rate, including a diversity of parasites that could serve as a source of opportunistic functionality. Thus, TC in natural, abiological compartments could have allowed life to take hold.	[Matsumura, Shigeyoshi; Nghe, Philippe; Griffiths, Andrew D.] Ecole Super Phys & Chim Ind Ville Paris ESPCI Par, CNRS, UMR 8231, 10 Rue Vauquelin, F-75231 Paris 05, France; [Matsumura, Shigeyoshi; Ryckelynck, Michael; Coldren, Faith; Rick, Christian; Griffiths, Andrew D.] Univ Strasbourg, CNRS, ISIS, UMR 7006, 8 Allee Gaspard Monge,BP 70028, F-67083 Strasbourg, France; [Matsumura, Shigeyoshi] Toyama Univ, Grad Sch Sci & Engn, 3190 Gotuku, Toyama 9308555, Japan; [Kun, Adam; Szilagyi, Andrs; Szathmary, Eors] Parmenides Ctr Conceptual Fdn Sci, Munich, Germany; [Kun, Adam; Szathmary, Eors] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary; [Ryckelynck, Michael; Jossinet, Fabrice; Rick, Christian] Univ Strasbourg, CNRS, UPR 9002, Architecture & React ARN, F-67084 Strasbourg, France; [Szilagyi, Andrs] Dept Plant Systemat Ecol & Theoret Biol, MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Budapest, Hungary; [Szathmary, Eors] Eotvos Lorand Univ, Inst Biology, Dept Plant Systemat Ecol & Theoret Biol, Budapest, Hungary; [Szathmary, Eors] Inst Adv Studies, Conflict & Cooperat Evolutionary Syst Program, Koszeg, Hungary	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Toyama; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Eotvos Lorand University	Griffiths, AD (corresponding author), Ecole Super Phys & Chim Ind Ville Paris ESPCI Par, CNRS, UMR 8231, 10 Rue Vauquelin, F-75231 Paris 05, France.; Griffiths, AD (corresponding author), Univ Strasbourg, CNRS, ISIS, UMR 7006, 8 Allee Gaspard Monge,BP 70028, F-67083 Strasbourg, France.; Szathmary, E (corresponding author), Parmenides Ctr Conceptual Fdn Sci, Munich, Germany.; Szathmary, E (corresponding author), MTA ELTE MTM Ecol Res Grp, Budapest, Hungary.; Szathmary, E (corresponding author), Eotvos Lorand Univ, Inst Biology, Dept Plant Systemat Ecol & Theoret Biol, Budapest, Hungary.; Szathmary, E (corresponding author), Inst Adv Studies, Conflict & Cooperat Evolutionary Syst Program, Koszeg, Hungary.	szathmary.eors@gmail.com; andrew.griffiths@espci.fr	Nghe, Philippe/AAB-3575-2019; Ryckelynck, Michael/AAM-1024-2020; Matsumura, Shigeyoshi/GWV-0171-2022; Szathmary, Eors/AAS-1202-2021; Griffiths, Andrew D/A-1370-2010; Kun, Adam/A-5571-2011	Nghe, Philippe/0000-0003-3690-4610; Ryckelynck, Michael/0000-0002-2225-3733; Szathmary, Eors/0000-0001-5227-2997; Griffiths, Andrew D/0000-0002-0808-3539; Matsumura, Shigeyoshi/0000-0003-1666-0065; Szilagyi, Andras/0000-0002-6894-4652; Kun, Adam/0000-0002-8409-8521	European Union [225167, 294332]	European Union(European Commission)	Comments by M. Santos and H. de Vladar are gatefully acknowledged. This work was supported by the European Union Seventh Framework Program (FP7/2007-2013) under grant agreements 225167 (eFlux) and 294332 (EvoEvo).	Bansho Y, 2016, P NATL ACAD SCI USA, V113, P4045, DOI 10.1073/pnas.1524404113; Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; BRESCH C, 1980, J THEOR BIOL, V85, P399, DOI 10.1016/0022-5193(80)90314-8; Czaran T, 2000, GEOMETRY ECOLOGICAL, P116, DOI 10.1613/jair.301; Dobson CM, 2000, P NATL ACAD SCI USA, V97, P11864, DOI 10.1073/pnas.200366897; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GUO HCT, 1995, EMBO J, V14, P368, DOI 10.1002/j.1460-2075.1995.tb07011.x; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Ichihashi N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3494; Kanavarioti A, 2001, ASTROBIOLOGY, V1, P271, DOI 10.1089/15311070152757465; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; Koonin EV, 2005, TRENDS GENET, V21, P647, DOI 10.1016/j.tig.2005.09.006; Kun A, 2015, ANN NY ACAD SCI, V1341, P75, DOI 10.1111/nyas.12700; Luisi PL, 1999, CURR OPIN COLLOID IN, V4, P33, DOI 10.1016/S1359-0294(99)00012-6; MICHOD RE, 1983, AM ZOOL, V23, P5; MILLS DR, 1973, SCIENCE, V180, P916, DOI 10.1126/science.180.4089.916; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; Ohno S., 1970, EVOLUTION GENE DUPLI; ORGEL LE, 1992, NATURE, V358, P203, DOI 10.1038/358203a0; SMITH JM, 1979, NATURE, V280, P445, DOI 10.1038/280445a0; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; SZATHMARY E, 1992, J THEOR BIOL, V159, P99, DOI 10.1016/S0022-5193(05)80770-2; Szathmary E, 1997, J THEOR BIOL, V187, P555, DOI 10.1006/jtbi.1996.0389; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Traulsen A, 2005, J THEOR BIOL, V235, P393, DOI 10.1016/j.jtbi.2005.01.019; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	30	77	77	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1293	1296		10.1126/science.aag1582	http://dx.doi.org/10.1126/science.aag1582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940874	Green Accepted			2022-12-28	WOS:000389598800061
J	Kalra, A; Suri, K				Kalra, Ankur; Suri, Kunal			Alienated	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							J-1		[Kalra, Ankur] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Kalra, Ankur] Houston Methodist Hosp, Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA; [Kalra, Ankur] Weill Cornell Med Coll, New York, NY USA; [Kalra, Ankur] Harvard Med Sch, Safety Qual Informat & Leadership, Boston, MA USA; [Suri, Kunal] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Cornell University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Kalra, A (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.; Kalra, A (corresponding author), Houston Methodist Hosp, Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA.; Kalra, A (corresponding author), Weill Cornell Med Coll, New York, NY USA.; Kalra, A (corresponding author), Harvard Med Sch, Safety Qual Informat & Leadership, Boston, MA USA.	kalramd.ankur@gmail.com		Kalra, MD, FACP, FACC, FSCAI, Ankur/0000-0003-0080-1660				Albrecht CA, 2003, J AM COLL CARDIOL, V42, P1716, DOI 10.1016/j.jacc.2003.07.001; Hallock JA, 2006, ACAD MED, V81, pS7, DOI 10.1097/01.ACM.0000243344.55996.1e; Kahn TR, 2010, ACAD MED, V85, P614, DOI 10.1097/ACM.0b013e3181d2ad1d; US Government Accountability Office, 2016, FOR PHYS DAT US J 1	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2016	316	21					2191	2192		10.1001/jama.2016.10319	http://dx.doi.org/10.1001/jama.2016.10319			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YV	27923094				2022-12-28	WOS:000389307400003
J	Mpindi, JP; Yadav, B; Ostling, P; Gautam, P; Malani, D; Murumagi, A; Hirasawa, A; Kangaspeska, S; Wennerberg, K; Kallioniemi, O; Aittokallio, T				Mpindi, John Patrick; Yadav, Bhagwan; Ostling, Paivi; Gautam, Prson; Malani, Disha; Murumagi, Astrid; Hirasawa, Akira; Kangaspeska, Sara; Wennerberg, Krister; Kallioniemi, Olli; Aittokallio, Tero			Consistency in drug response profiling	NATURE			English	Letter							SENSITIVITY		[Mpindi, John Patrick; Yadav, Bhagwan; Ostling, Paivi; Gautam, Prson; Malani, Disha; Murumagi, Astrid; Hirasawa, Akira; Kangaspeska, Sara; Wennerberg, Krister; Kallioniemi, Olli; Aittokallio, Tero] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland; [Ostling, Paivi; Kallioniemi, Olli] Karolinska Inst, Dept Pathol & Oncol, Sci Life Lab, S-17165 Solna, Sweden; [Hirasawa, Akira] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1608582, Japan; [Aittokallio, Tero] Univ Turku, Dept Math & Stat, Turku 20014, Finland	University of Helsinki; Karolinska Institutet; Keio University; University of Turku	Aittokallio, T (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland.; Aittokallio, T (corresponding author), Univ Turku, Dept Math & Stat, Turku 20014, Finland.	tero.aittokallio@fimm.fi	Malani, Disha/AAP-1060-2021; Aittokallio, Tero/B-6583-2009; Wennerberg, Krister/AFM-0539-2022; Wennerberg, Krister/AAH-2919-2022; He, Liye/C-8843-2015; Kallioniemi, Olli P/H-5111-2011; Yadav, Bhagwan/M-2921-2015	Malani, Disha/0000-0001-9614-3281; Aittokallio, Tero/0000-0002-0886-9769; Wennerberg, Krister/0000-0002-1352-4220; Wennerberg, Krister/0000-0002-1352-4220; He, Liye/0000-0002-6632-2112; Kallioniemi, Olli P/0000-0002-3231-0332; Yadav, Bhagwan/0000-0002-3502-9335; Gautam, Prson/0000-0002-1154-8501; Ostling, Paivi/0000-0001-5501-466X	Cancer Foundation Finland sr [140114, 160080, 140175] Funding Source: researchfish	Cancer Foundation Finland sr		Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI 10.1090/qam/10666; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Nicola G, 2012, J MED CHEM, V55, P6987, DOI 10.1021/jm300501t; Pemovska T, 2013, CANCER DISCOV, V3, P1416, DOI 10.1158/2159-8290.CD-13-0350; Weinstein JN, 2013, NATURE, V504, P381, DOI 10.1038/nature12839; Yadav B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05193	10	44	44	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					E5	E6		10.1038/nature20171	http://dx.doi.org/10.1038/nature20171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905421				2022-12-28	WOS:000388916600010
J	Caskey, M; Klein, F; Nussenzweig, MC				Caskey, Marina; Klein, Florian; Nussenzweig, Michel C.			FOCUS ON RESEARCH Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							3BNC117; HUMANS		[Caskey, Marina; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Klein, Florian] Univ Cologne, Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Dept Internal Med 1,Lab Expt Immunol,CMMC, Cologne, Germany; [Klein, Florian] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Cologne; German Center for Infection Research; University of Cologne	Caskey, M (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019					Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012	5	49	50	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2019	2021		10.1056/NEJMp1613362	http://dx.doi.org/10.1056/NEJMp1613362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC9KU	27959740				2022-12-28	WOS:000388464300004
J	Kwak, EL; Hong, TS; Forcione, DG; Kambadakone, A; Lennerz, JK				Kwak, Eunice L.; Hong, Theodore S.; Forcione, David G.; Kambadakone, Avinash; Lennerz, Jochen K.			Case 35-2016: A 62-Year-Old Man with Dysphagia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; ESOPHAGEAL CANCER; ESOPHAGOGASTRIC CANCER; PIK3CA MUTATIONS; IN-VIVO; ADENOCARCINOMA; MET; CHEMORADIOTHERAPY; PLUS; AMPLIFICATION		[Kwak, Eunice L.; Forcione, David G.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hong, Theodore S.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Kambadakone, Avinash] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Lennerz, Jochen K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kwak, Eunice L.; Forcione, David G.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Hong, Theodore S.] Harvard Med Sch, Dept Radiat Oncol, Boston, MA USA; [Kambadakone, Avinash] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Lennerz, Jochen K.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kwak, EL (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Kwak, EL (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Cizkova M, 2013, BRIT J CANCER, V108, P1807, DOI 10.1038/bjc.2013.164; Conroy T, 2014, LANCET ONCOL, V15, P305, DOI 10.1016/S1470-2045(14)70028-2; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Enzinger PC, 2016, J CLIN ONCOL, V34, P2736, DOI 10.1200/JCO.2015.65.5092; Harada K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2422-y; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kwak EL, 2015, CANCER DISCOV, V5, P1271, DOI 10.1158/2159-8290.CD-15-0748; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Li VSW, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-29; Lopez S, 2014, GYNECOL ONCOL, V135, P312, DOI 10.1016/j.ygyno.2014.08.024; Maeng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041655; Mariette C, 2014, J CLIN ONCOL, V32, P2416, DOI 10.1200/JCO.2013.53.6532; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Pogue-Geile KL, 2015, J CLIN ONCOL, V33, P1340, DOI 10.1200/JCO.2014.56.2439; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6	27	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1983	1991		10.1056/NEJMcpc1610714	http://dx.doi.org/10.1056/NEJMcpc1610714			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC1HS	27959609				2022-12-28	WOS:000387856100012
J	Liu, WW; Chen, A				Liu, Wendy W.; Chen, Adam			Diagnosing Myasthenia Gravis with an Ice Pack	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liu, Wendy W.] Harvard Med Sch, Boston, MA 02115 USA; [Chen, Adam] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Liu, WW (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	wwliu@alumni.harvard.edu		Liu, Wendy/0000-0002-1648-4068					0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					E39	E39		10.1056/NEJMicm1509523	http://dx.doi.org/10.1056/NEJMicm1509523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB6ZK	27959645				2022-12-28	WOS:000387534200001
J	Denkert, C; Liedtke, C; Tutt, A; von Minckwitz, G				Denkert, Carsten; Liedtke, Cornelia; Tutt, Andrew; von Minckwitz, Gunter			Molecular alterations in triple-negative breast cancer-the road to new treatment strategies	LANCET			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ADENOID CYSTIC CARCINOMAS; DOSE-DENSE DOXORUBICIN; NEOADJUVANT CHEMOTHERAPY; BASAL-LIKE; PHASE-II; GENE-EXPRESSION; OPEN-LABEL; ADJUVANT BEVACIZUMAB; SYNTHETIC LETHALITY	Triple-negative breast cancer is a heterogeneous disease and specific therapies have not been available for a long time. Therefore, conventional chemotherapy is still considered the clinical state of the art. Different subgroups of triple-negative breast cancer have been identified on the basis of protein expression, mRNA signatures, and genomic alterations. Important elements of triple-negative breast cancer biology include high proliferative activity, an increased immunological infiltrate, a basal-like and a mesenchymal phenotype, and deficiency in homologous recombination, which is in part associated with loss of BRCA1 or BRCA2 function. A minority of triple-negative tumours express luminal markers, such as androgen receptors, and have a lower proliferative activity. These biological subgroups are overlapping and currently cannot be combined into a unified model of triple-negative breast cancer biology. Nevertheless, the molecular analysis of this disease has identified potential options for targeted therapeutic intervention. This has led to promising clinical strategies, including modified chemotherapy approaches targeting the DNA damage response, angiogenesis inhibitors, immune checkpoint inhibitors, or even anti-androgens, all of which are being evaluated in phase 1-3 clinical studies. This Series paper focuses on the most relevant clinical questions, summarises the results of recent clinical trials, and gives an overview of ongoing studies and trial concepts that will lead to a more refined therapy for this tumour type.	[Denkert, Carsten] Charite, Inst Pathol, D-10117 Berlin, Germany; [Denkert, Carsten] German Canc Consortium DKTK, Partner Site Berlin, Berlin, Germany; [Liedtke, Cornelia] Univ Hosp Schleswig Holstein, Campus Lubeck, Lubeck, Germany; [Tutt, Andrew] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England; [Tutt, Andrew] Kings Coll London, Breast Canc Now Res Unit, London, England; [von Minckwitz, Gunter] German Breast Grp, Neu Isenburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); University of Kiel; Schleswig Holstein University Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; German Breast Group	Denkert, C (corresponding author), Charite, Inst Pathol, D-10117 Berlin, Germany.	carsten.denkert@charite.de	Denkert, Carsten/AHE-2675-2022	Tutt, Andrew/0000-0001-8715-2901; Denkert, Carsten/0000-0002-2249-0982	TRANSCAN-I grant [BMBF-01KT1314 (TRANSCAN-I UGI1)]; German Cancer Consortium (DKTK); Sividon Diagnostics; AstraZeneca; Tesaro; Myrad Genetics; Nanostring	TRANSCAN-I grant; German Cancer Consortium (DKTK); Sividon Diagnostics; AstraZeneca(AstraZeneca); Tesaro; Myrad Genetics; Nanostring	CD had full access to all data in the study and had final responsibility for the decision to submit for publication. The study is funded partially by TRANSCAN-I, grant BMBF-01KT1314 (TRANSCAN-I UGI1) and a grant from the German Cancer Consortium (DKTK), with a focus on triple-negative breast cancer, both to CD. CD reports other funding from Sividon Diagnostics, personal fees from Celgene, AstraZeneca, Teva, Myriad, and Roche, outside of the submitted work. AT reports other fees from AstraZeneca, Tesaro, Myrad Genetics, and Nanostring during the study; and other fees from Vertex and Celgene outside of the submitted work. In addition, AT has a patent with the Institute of Cancer Research (with paid royalties), and a patent pending with King's College London. GvM reports grants and personal fees from Pfizer, GSK, Sanofi-Aventis, Amgen, Roche, Novartis, Celgene, Teva, AstraZeneca, and Myriad, outside the submitted work. CL declares no competing interests.	Adams S, 2016, 2016 ASCO ANN M CHIC; Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Alba E, BREAST CANC RES TREA, V136, P487; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Andre F, 2015, LANCET ONCOL, V16, P600, DOI 10.1016/S1470-2045(15)70201-9; Andre F, 2015, BREAST CANCER RES TR, V150, P1, DOI 10.1007/s10549-015-3301-y; Anestis A, 2015, CANCER TREAT REV, V41, P547, DOI 10.1016/j.ctrv.2015.04.009; [Anonymous], 2015, WHO IARC CLASSIFICAT; Bear HD, 2015, LANCET ONCOL, V16, P1037, DOI 10.1016/S1470-2045(15)00041-8; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Bonilla L, 2010, JNCI-J NATL CANCER I, V102, P1845, DOI 10.1093/jnci/djq409; Bonnefoi H, 2016, ANN ONCOL, V27, P812, DOI 10.1093/annonc/mdw067; Budczies J, 2015, J PATHOL CLIN RES, V1, P225, DOI 10.1002/cjp2.25; Bulut N, 2008, CANCER CHEMOTH PHARM, V63, P189, DOI 10.1007/s00280-008-0717-7; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Byrski T, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3231; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Colleoni M, 2016, J CLIN ONCOL, V34, P3400, DOI 10.1200/JCO.2015.65.6595; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Curigliano G, 2015, 2015 ASCO ANN M CHIC; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Denkert C, 2015, J CLIN ONCOL, V33, P983, DOI 10.1200/JCO.2014.58.1967; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Earl HM, 2015, LANCET ONCOL, V16, P656, DOI 10.1016/S1470-2045(15)70137-3; Emens LA, 2015, 2015 AACR ANN M PHIL; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gucalp A, 2011, 2011 ASCO ANN M CHIC; Gucalp A, 2016, 2016 ASCO ANN M CHIC; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Harrison H, 2010, CANCER RES, V70, P8973, DOI 10.1158/0008-5472.CAN-10-1559; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Hu XC, 2015, LANCET ONCOL, V16, P436, DOI 10.1016/S1470-2045(15)70064-1; Huober J, 2012, ANN ONCOL, V23, P2843, DOI 10.1093/annonc/mds105; Isakoff SJ, 2015, J CLIN ONCOL, V33, P1902, DOI 10.1200/JCO.2014.57.6660; Iwamoto T, 2012, J CLIN ONCOL, V30, P729, DOI 10.1200/JCO.2011.36.2574; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Lehmann BD, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0406-x; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li DL, 2012, MODERN PATHOL, V25, P567, DOI 10.1038/modpathol.2011.190; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Lord CJ, 2015, ANNU REV MED, V66, P455, DOI 10.1146/annurev-med-050913-022545; Marchio C, 2010, J CLIN PATHOL, V63, P220, DOI 10.1136/jcp.2009.073908; Marquard AM, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0033-4; Marra P, 2014, CANCER RES, V74, P4908, DOI 10.1158/0008-5472.CAN-14-0637; Martelotto LG, 2015, J PATHOL, V237, P179, DOI 10.1002/path.4573; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Moebus V, 2010, J CLIN ONCOL, V28, P2874, DOI 10.1200/JCO.2009.24.7643; Montagna E, 2013, CLIN BREAST CANCER, V13, P31, DOI 10.1016/j.clbc.2012.09.002; Nahleh ZA, 2016, BREAST CANCER RES TR, V158, P485, DOI 10.1007/s10549-016-3889-6; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Parker JS, 2015, 2015 ASCO ANN M CHIC; Pearson A, 2016, CANCER DISCOV, V6, P838, DOI 10.1158/2159-8290.CD-15-1246; PEDERSEN L, 1989, BREAST CANCER RES TR, V14, P91, DOI 10.1007/BF01805979; Podetta M, 2009, TUMORI, V95, P264; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Provenzano E, 2015, MODERN PATHOL, V28, P1185, DOI 10.1038/modpathol.2015.74; Rakha EA, 2009, EUR J CANCER, V45, P1780, DOI 10.1016/j.ejca.2009.02.014; Ring BZ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2198-0; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Rugo HS, 2016, NEW ENGL J MED, V375, P23, DOI 10.1056/NEJMoa1513749; Savas P, 2016, NAT REV CLIN ONCOL, V13, P228, DOI 10.1038/nrclinonc.2015.215; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Sikov WM, 2015, 2015 SAN ANT BREAST; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stanton SE, 2016, JAMA ONCOL, V2, P1354, DOI 10.1001/jamaoncol.2016.1061; Stoeck A, 2014, CANCER DISCOV, V4, P1154, DOI 10.1158/2159-8290.CD-13-0830; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Telli ML, 2016, CLIN CANCER RES, V22, P3764, DOI 10.1158/1078-0432.CCR-15-2477; Telli ML, 2015, J CLIN ONCOL, V33, P1895, DOI 10.1200/JCO.2014.57.0085; Timms KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0475-x; Toi M, 2015, 2015 SAN ANT BREAST; Traina TA, 2015, 2015 ASCO ANN M CHIC; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Tutt A, 2014, SAN ANTONIO BREAST C, V2014, pS3; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Tutt ANJ, 2015, 2015 ASCO ANN M CHIC; VANHOEVEN KH, 1993, AM J SURG PATHOL, V17, P248; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; von Minckwitz G, 2014, ANN ONCOL, V25, P2363, DOI 10.1093/annonc/mdu455; von Minckwitz G, 2014, 2014 ASCO ANN M CHIC; Von Minckwitz G, 2015, 2015 SAN ANT BREAST; von Minckwitz G, 2015, 2015 ASCO ANN M CHIC; von Minckwitz G, 2014, LANCET ONCOL, V15, P747, DOI 10.1016/S1470-2045(14)70160-3; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Wang CJ, 2016, ONCOTARGET, V7, P46482, DOI 10.18632/oncotarget.10208; Wang K, 2015, CLIN CANCER RES, V21, P1487, DOI 10.1158/1078-0432.CCR-14-1348; Wetterskog D, 2012, J PATHOL, V226, P84, DOI 10.1002/path.2974; Zardavas D, 2014, BRIT J CANCER, V111, P1881, DOI 10.1038/bjc.2014.341	108	428	447	17	177	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2430	2442		10.1016/S0140-6736(16)32454-0	http://dx.doi.org/10.1016/S0140-6736(16)32454-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX6ED	27939063	Green Submitted			2022-12-28	WOS:000403334400028
J	van Adrichem, RA; Nemeth, B; Algra, A; le Cessie, S; Rosendaal, FR; Schipper, IB; Nelissen, RGHH; Cannegieter, SC				van Adrichem, Raymond A.; Nemeth, Banne; Algra, Ale; le Cessie, Saskia; Rosendaal, Frits R.; Schipper, Inger B.; Nelissen, Rob G. H. H.; Cannegieter, Suzanne C.		POT-KAST POT-CAST Grp	Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; PROLONGED THROMBOPROPHYLAXIS; ORTHOPEDIC-SURGERY; PLASTER-CAST; THROMBOSIS; IMMOBILIZATION; EFFICACY; OUTPATIENTS; DALTEPARIN	BACKGROUND The use of thromboprophylaxis to prevent clinically apparent venous thromboembolism after knee arthroscopy or casting of the lower leg is disputed. We compared the incidence of symptomatic venous thromboembolism after these procedures between patients who received anticoagulant therapy and those who received no anticoagulant therapy. METHODS We conducted two parallel, pragmatic, multicenter, randomized, controlled, open-label trials with blinded outcome evaluation: the POT-KAST trial, which included patients undergoing knee arthroscopy, and the POT-CAST trial, which included patients treated with casting of the lower leg. Patients were assigned to receive either a prophylactic dose of low-molecular-weight heparin (for the 8 days after arthroscopy in the POT-KAST trial or during the full period of immobilization due to casting in the POT-CAST trial) or no anticoagulant therapy. The primary outcomes were the cumulative incidences of symptomatic venous thromboembolism and major bleeding within 3 months after the procedure. RESULTS In the POT-KAST trial, 1543 patients underwent randomization, of whom 1451 were included in the intention-to-treat population. Venous thromboembolism occurred in 5 of the 731 patients (0.7%) in the treatment group and in 3 of the 720 patients (0.4%) in the control group (relative risk, 1.6; 95% confidence interval [CI], 0.4 to 6.8; absolute difference in risk, 0.3 percentage points; 95% CI, -0.6 to 1.2). Major bleeding occurred in 1 patient (0.1%) in the treatment group and in 1 (0.1%) in the control group (absolute difference in risk, 0 percentage points; 95% CI, -0.6 to 0.7). In the POT-CAST trial, 1519 patients underwent randomization, of whom 1435 were included in the intention-to-treat population. Venous thromboembolism occurred in 10 of the 719 patients (1.4%) in the treatment group and in 13 of the 716 patients (1.8%) in the control group (relative risk, 0.8; 95% CI, 0.3 to 1.7; absolute difference in risk, -0.4 percentage points; 95% CI, -1.8 to 1.0). No major bleeding events occurred. In both trials, the most common adverse event was infection. CONCLUSIONS The results of our trials showed that prophylaxis with low-molecular-weight heparin for the 8 days after knee arthroscopy or during the full period of immobilization due to casting was not effective for the prevention of symptomatic venous thromboembolism.	[van Adrichem, Raymond A.; Nemeth, Banne; Algra, Ale; le Cessie, Saskia; Rosendaal, Frits R.; Cannegieter, Suzanne C.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands; [van Adrichem, Raymond A.; Nemeth, Banne; Nelissen, Rob G. H. H.] Leiden Univ, Med Ctr, Dept Orthoped Surg, Leiden, Netherlands; [Cannegieter, Suzanne C.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Schipper, Inger B.] Leiden Univ, Med Ctr, Dept Trauma Surg, Leiden, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Patient Care, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Cannegieter, SC (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.	s.c.cannegieter@lumc.nl	Cannegieter, Suzanne/W-3696-2019; Rosendaal, Frits/Q-3842-2017; le+Cessie, Saskia/HGC-8966-2022; Schipper, Inger/ABE-7796-2021; Nelissen, Rob/AAD-8134-2020; Nemeth, Banne/AAA-3701-2019; Nemeth, Banne/AAP-8022-2020	Cannegieter, Suzanne/0000-0003-4707-2303; Rosendaal, Frits/0000-0003-2558-7496; Schipper, Inger/0000-0001-9952-3079; Nelissen, Rob/0000-0003-1228-4162; Nemeth, Banne/0000-0002-1214-5923; Nemeth, Banne/0000-0002-1214-5923; le Cessie, Saskia/0000-0003-2154-4923; van Kampen, Paulien/0000-0002-6169-7265	Netherlands Organization for Health Research and Development [171102001]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	Supported by the Netherlands Organization for Health Research and Development (project number 171102001).	American Academy of Orthopaedic Surgeons, KNEE ARTHR; American Academy of Orthopedic Surgeons, PREV VEN THROMB DIS; Ashrani AA, 2009, J THROMB THROMBOLYS, V28, P465, DOI 10.1007/s11239-009-0309-3; Bergqvist D, 2012, THROMB HAEMOSTASIS, V107, P280, DOI 10.1160/TH11-07-0464; Bushnell BD, 2008, ARTHROSCOPY, V24, P604, DOI 10.1016/j.arthro.2007.11.010; Camporese G, 2008, ANN INTERN MED, V149, P73, DOI 10.7326/0003-4819-149-2-200807150-00003; Camporese G, 2016, THROMB HAEMOSTASIS, V116, P349, DOI 10.1160/TH16-02-0118; Comp PC, 2001, J BONE JOINT SURG AM, V83A, P336, DOI 10.2106/00004623-200103000-00004; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Forster R, 2016, COCHRANE DB SYST REV, V3; Jorgensen PS, 2002, THROMB RES, V105, P477, DOI 10.1016/S0049-3848(02)00059-2; KOCK HJ, 1995, LANCET, V346, P459, DOI 10.1016/S0140-6736(95)91320-3; Krych AJ, 2015, ARTHROSCOPY, V31, P2112, DOI 10.1016/j.arthro.2015.04.091; Lapidus LJ, 2007, ACTA ORTHOP, V78, P528, DOI 10.1080/17453670710014185; Lassen MR, 1998, THROMB RES, V89, P281, DOI 10.1016/S0049-3848(98)00018-8; Lassen MR, 2002, NEW ENGL J MED, V347, P726, DOI 10.1056/NEJMoa011327; Mauck KF, 2013, J THROMB HAEMOST, V11, P1279, DOI 10.1111/jth.12283; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; National Institiute for Health and Care Excellence, 2010, VEN THROMB RED RISK; Nemeth B, 2015, INT SOC THROMB HAEM; Nemeth B, 2016, THROMB HAEMOSTASIS, V116, P1001, DOI 10.1160/TH16-05-0396; Nemeth B, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001899; Ramos J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005259.pub3; Raskob GE, 2014, J THROMB HAEMOST, V12, P1580, DOI 10.1111/jth.12698; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Sobieraj DM, 2012, ANN INTERN MED, V156, P720, DOI 10.7326/0003-4819-156-10-201205150-00423; Testroote M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD006681.PUB2; Testroote M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006681.pub3; Thorlund JB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2747; Van Adrichem RA, 2015, J THROMB HAEMOST, V13, P1441, DOI 10.1111/jth.12996; van Adrichem RA, 2014, J THROMB HAEMOST, V12, P1461, DOI 10.1111/jth.12655	32	78	78	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					515	525		10.1056/NEJMoa1613303	http://dx.doi.org/10.1056/NEJMoa1613303			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8XL	27959702				2022-12-28	WOS:000393510500006
J	Kiselev, A; Bachmann, F; Pedevilla, P; Cox, SJ; Michaelides, A; Gerthsen, D; Leisner, T				Kiselev, Alexei; Bachmann, Felix; Pedevilla, Philipp; Cox, Stephen J.; Michaelides, Angelos; Gerthsen, Dagmar; Leisner, Thomas			Active sites in heterogeneous ice nucleation-the example of K-rich feldspars	SCIENCE			English	Article							EPITAXIAL-GROWTH; WATER-ADSORPTION; KAOLINITE; DEPOSITION; DUST; MORPHOLOGY; PARTICLES; MINERALS; SURFACES	Ice formation on aerosol particles is a process of crucial importance to Earth's climate and the environmental sciences, but it is not understood at the molecular level. This is partly because the nature of active sites, local surface features where ice growth commences, is still unclear. Here we report direct electron-microscopic observations of deposition growth of aligned ice crystals on feldspar, an atmospherically important component of mineral dust. Our molecular-scale computer simulations indicate that this alignment arises from the preferential nucleation of prismatic crystal planes of ice on high-energy (100) surface planes of feldspar. The microscopic patches of (100) surface, exposed at surface defects such as steps, cracks, and cavities, are thought to be responsible for the high ice nucleation efficacy of potassium (K)-feldspar particles.	[Kiselev, Alexei; Bachmann, Felix; Leisner, Thomas] Karlsruhe Inst Technol KIT, Inst Meteorol & Climate Res IMK AAF, Atmospher Aerosol Res Dept, Hermann Helmholtz Platz, Karlsruhe, Germany; [Bachmann, Felix; Gerthsen, Dagmar] KIT, Lab Elect Microscopy LEM, Engesserstrasse 7, D-76131 Karlsruhe, Germany; [Pedevilla, Philipp; Cox, Stephen J.; Michaelides, Angelos] Univ Coll London UCL, Thomas Young Ctr, London Ctr Nanotechnol, 17-19 Gordon St, London, ON WC1H 0AH, Canada; [Pedevilla, Philipp; Cox, Stephen J.] Univ Coll London UCL, Dept Phys & Astron, 17-19 Gordon St, London, ON WC1H 0AH, Canada; [Leisner, Thomas] Heidelberg Univ, Inst Umweltphys, Im Neuenheimer Feld 229, Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg	Kiselev, A (corresponding author), Karlsruhe Inst Technol KIT, Inst Meteorol & Climate Res IMK AAF, Atmospher Aerosol Res Dept, Hermann Helmholtz Platz, Karlsruhe, Germany.	alexei.kiselev@kit.edu	Kiselev, Alexei/A-3036-2013; Leisner, Thomas K/A-2391-2013; Gerthsen, Dagmar/N-6245-2019; Gerthsen, Dagmar/I-4448-2012	Kiselev, Alexei/0000-0003-0136-2428; Leisner, Thomas K/0000-0001-9693-7671; Michaelides, Angelos/0000-0002-9169-169X; Cox, Stephen/0000-0003-2708-8711; Bachmann, Felix/0000-0002-7153-7441	Deutsche Forschungsgemeinschaft (DFG) [DFG-FOR-1525-6343]; KIT Startup Budget [2066992441-Start-Up-Eisbildung-ESEM GG 507]; European Research Council under the European Union's Seventh Framework Programme (FP)-European Research Council [616121]; Royal Society through a Royal Society Wolfson Research Merit Award; Materials Chemistry Consortium through the Engineering and Physical Sciences Research Council [EP/L000202]; UCL Research Computing; London Centre for Nanotechnology; Helmholtz Association under Atmosphere and Climate Programme (ATMO); Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); KIT Startup Budget; European Research Council under the European Union's Seventh Framework Programme (FP)-European Research Council; Royal Society through a Royal Society Wolfson Research Merit Award; Materials Chemistry Consortium through the Engineering and Physical Sciences Research Council; UCL Research Computing; London Centre for Nanotechnology; Helmholtz Association under Atmosphere and Climate Programme (ATMO); Karlsruhe Institute of Technology(Helmholtz Association)	The preparation and x-ray diffraction characterization of feldspar samples at the Institute of Applied Geosciences of TU Darmstadt (M. Ebert) as a part of cooperation within the Deutsche Forschungsgemeinschaft (DFG)-funded research unit INUIT (DFG-FOR-1525-6343) is greatly acknowledged. This work was also partly supported by KIT Startup Budget 2011 (2066992441-Start-Up-Eisbildung-ESEM GG 507). A.K and F.B. thank V. Zibat (KIT LEM) and J. Nadolny (KIT IMK-AAF) for technical and programming support. A.M. is supported by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)-European Research Council Grant Agreement no. 616121 (HeteroIce project). A.M. is also supported by the Royal Society through a Royal Society Wolfson Research Merit Award. P.P. and A.M. are grateful for computational resources provided by the Materials Chemistry Consortium through the Engineering and Physical Sciences Research Council grant no. EP/L000202, UCL Research Computing, and the London Centre for Nanotechnology. A.K. and T.L. are supported by the Helmholtz Association under Atmosphere and Climate Programme (ATMO). D.G. and F.B. were supported by the Karlsruhe Institute of Technology. The experimental and computational data sets used in this work are available as supplementary materials.	ANDERSON BJ, 1976, J ATMOS SCI, V33, P822, DOI 10.1175/1520-0469(1976)033<0822:SATDOI>2.0.CO;2; Atkinson JD, 2013, NATURE, V498, P355, DOI 10.1038/nature12278; BEHRENS H, 1995, MINERAL MAG, V59, P15, DOI 10.1180/minmag.1995.59.394.02; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bryant G. W., 1960, J PHYS CHEM SOLIDS, V12, DOI DOI 10.1016/0022-3697(60)90036-6; Cantrell W, 2005, B AM METEOROL SOC, V86, P795, DOI 10.1175/BAMS-86-6-795; Carrasco J, 2012, NAT MATER, V11, P667, DOI [10.1038/NMAT3354, 10.1038/nmat3354]; CASLAVSKY JL, 1971, J APPL PHYS, V42, P516, DOI 10.1063/1.1660054; CHO N, 1984, J CRYST GROWTH, V69, P317, DOI 10.1016/0022-0248(84)90338-5; Christenson HK, 2013, CRYSTENGCOMM, V15, P2030, DOI 10.1039/c3ce26887j; Connolly PJ, 2009, ATMOS CHEM PHYS, V9, P2805, DOI 10.5194/acp-9-2805-2009; Cox SJ, 2013, FARADAY DISCUSS, V167, P389, DOI 10.1039/c3fd00059a; Cox SJ, 2012, PHYS CHEM CHEM PHYS, V14, P7944, DOI 10.1039/c2cp23438f; Croteau T, 2008, J PHYS CHEM A, V112, P10708, DOI 10.1021/jp805615q; Croteau T, 2009, J PHYS CHEM A, V113, P7826, DOI 10.1021/jp902453f; Cygan RT, 2004, J PHYS CHEM B, V108, P1255, DOI 10.1021/jp0363287; FEDERER B, 1968, Z ANGEW MATH PHYS, V19, P637, DOI 10.1007/BF01594971; Fitzner M, 2015, J AM CHEM SOC, V137, P13658, DOI 10.1021/jacs.5b08748; Fletcher N. H., 1960, AUST J PHYS, V13, P408; FLETCHER NH, 1969, J ATMOS SCI, V26, P1266, DOI 10.1175/1520-0469(1969)026<1266:ASAICN>2.0.CO;2; Freedman MA, 2015, J PHYS CHEM LETT, V6, P3850, DOI 10.1021/acs.jpclett.5b01326; FUKUTA N, 1963, J PHYS CHEM SOLIDS, V24, P715, DOI 10.1016/0022-3697(63)90217-8; Hallett J., 1973, J RECH ATMOS, V5, P223; Harrison AD, 2016, ATMOS CHEM PHYS, V16, P10927, DOI 10.5194/acp-16-10927-2016; Hiranuma N, 2015, NAT GEOSCI, V8, P273, DOI 10.1038/NGEO2374; Hiranuma N, 2014, ATMOS CHEM PHYS, V14, P13145, DOI 10.5194/acp-14-13145-2014; Hodgson A, 2009, SURF SCI REP, V64, P381, DOI 10.1016/j.surfrep.2009.07.001; Hoose C, 2012, ATMOS CHEM PHYS, V12, P9817, DOI 10.5194/acp-12-9817-2012; Hu XL, 2008, SURF SCI, V602, P960, DOI 10.1016/j.susc.2007.12.032; Hu XL, 2007, SURF SCI, V601, P5378, DOI 10.1016/j.susc.2007.09.012; Kobayashi T., 1965, CONT I TEMP SCI    A, V20, P1; Libbrecht K. G., 2012, P R SOC LONDON, V49, P323; Lupi L, 2014, J PHYS CHEM A, V118, P7330, DOI 10.1021/jp4118375; Lupi L, 2014, J AM CHEM SOC, V136, P3156, DOI 10.1021/ja411507a; Marcolli C, 2014, ATMOS CHEM PHYS, V14, P2071, DOI 10.5194/acp-14-2071-2014; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Parsons I., 1994, FELDSPARS THEIR RE C, V421; Peckhaus A, 2016, ATMOS CHEM PHYS, V16, P11477, DOI 10.5194/acp-16-11477-2016; Pedevilla P, 2016, J PHYS CHEM C, V120, P6704, DOI 10.1021/acs.jpcc.6b01155; Pruppacher H. R., 2004, MICROPHYSICS CLOUDS; Schill GP, 2015, ATMOS CHEM PHYS, V15, P7523, DOI 10.5194/acp-15-7523-2015; Smith J.V., 1974, FELDSPAR MINERALS CH, P447, DOI 10.1007/978-3-642-65743-6; Smith JV, 1998, P NATL ACAD SCI USA, V95, P3366, DOI 10.1073/pnas.95.7.3366; TURNBULL D, 1952, IND ENG CHEM, V44, P1292, DOI 10.1021/ie50510a031; Vali G., 1999, MOLECULES, V1999, P1; VONNEGUT B, 1947, J APPL PHYS, V18, P593, DOI 10.1063/1.1697813; Wilson TW, 2015, NATURE, V525, P234, DOI 10.1038/nature14986; Yakobi-Hancock JD, 2013, ATMOS CHEM PHYS, V13, P11175, DOI 10.5194/acp-13-11175-2013; Zielke SA, 2016, J PHYS CHEM B, V120, P1726, DOI 10.1021/acs.jpcb.5b09052	49	174	175	19	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2017	355	6323					367	371		10.1126/science.aai8034	http://dx.doi.org/10.1126/science.aai8034			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ4FR	27940582	Green Submitted			2022-12-28	WOS:000393172800031
J	Ivers, LC				Ivers, Louise C.			Eliminating Cholera Transmission in Haiti	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINATION		[Ivers, Louise C.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Ivers, LC (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.		Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230	NIAID NIH HHS [UM1 AI069421] Funding Source: Medline; Intramural CDC HHS [CC999999] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069421] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural CDC HHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barzilay EJ, 2013, NEW ENGL J MED, V368, P599, DOI 10.1056/NEJMoa1204927; Gavi: The Vaccine Alliance, 2016, GAV PROV SUPP EM CHO; Ivers LC, 2015, LANCET GLOB HEALTH, V3, pE162, DOI 10.1016/S2214-109X(14)70368-7; Severe K, 2016, AM J TROP MED HYG, V94, P1136, DOI 10.4269/ajtmh.15-0700; Tohme RA, 2015, EMERG INFECT DIS, V21, P984, DOI 10.3201/eid2106.141797	5	16	16	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2017	376	2					101	103		10.1056/NEJMp1614104	http://dx.doi.org/10.1056/NEJMp1614104			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI0XI	27959699	Green Accepted, Bronze			2022-12-28	WOS:000392198400001
J	Schuurhuis, GJ				Schuurhuis, Gerrit J.			CANCER A gene-expression profile for leukaemia	NATURE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; CLONAL EVOLUTION; PROGNOSIS; CELLS; AML	Can simple genetic risk profiles be identified for complex diseases? The development of a gene-expression profile for acute myeloid leukaemia suggests that they can, and that they may improve prognosis prediction. See Letter p.433	[Schuurhuis, Gerrit J.] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Schuurhuis, GJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Hematol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	gj.schuurhuis@vumc.nl						Cornelissen JJ, 2012, NAT REV CLIN ONCOL, V9, P579, DOI 10.1038/nrclinonc.2012.150; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hokland P, 2015, SEMIN HEMATOL, V52, P184, DOI 10.1053/j.seminhematol.2015.04.001; Jan M, 2013, ONCOGENE, V32, P135, DOI 10.1038/onc.2012.48; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Ng SWK, 2016, NATURE, V540, P433, DOI 10.1038/nature20598; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Shivarov V, 2014, EXP HEMATOL, V42, P651, DOI 10.1016/j.exphem.2014.04.006; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299	12	2	2	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					346	348		10.1038/nature20488	http://dx.doi.org/10.1038/nature20488			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE6JR	27926735				2022-12-28	WOS:000389716800024
J	Wever, PC				Wever, Peter C.			CHRISTMAS 2016: IN LOVE AND WAR No 10 Stationary Hospital and the chapel ward at Saint-Omer, France, 1914-18	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wever, Peter C.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Wever, Peter C.] Mil Med Hist Res Soc, Rosmalen, Netherlands	Jeroen Bosch Ziekenhuis	Wever, PC (corresponding author), Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands.; Wever, PC (corresponding author), Mil Med Hist Res Soc, Rosmalen, Netherlands.	p.wever@jbz.nl						[Anonymous], 1917, WAR DIAR MATR CHIEF; [Anonymous], 1916, LINES UNOFFICIAL AUG; [Anonymous], 1918, EDINBURGH GAZETTE, P2778; [Anonymous], 2014, ROADS GREAT WAR WAR; [Anonymous], 1918, WAR DIAR MATR CHIEF; Appleton EE, EARLY LETT 1914 1915; Guillen JS, 1916, ILLUSTRATED LONDON N, P592; Imperial War Museums, FILM IWM; Macpherson WG, 1924, MED SERVICES GEN HIS, VIII; Newman V, 2014, NURSING SHOT SHELL G; Power J., 2015, CLARE GREAT WAR; Queen Alexandras Royal Army Nursing Corps, MIL MED AW QA NURS; Symons FA, 1917, TALE CASUALTY CLEARI	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2016	355								i6509	10.1136/bmj.i6509	http://dx.doi.org/10.1136/bmj.i6509			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JI	27956438				2022-12-28	WOS:000390150300003
J	Ortiz-Catalan, M; Gudmundsdottir, RA; Kristoffersen, MB; Zepeda-Echavarria, A; Caine-Winterberger, K; Kulbacka-Ortiz, K; Widehammar, C; Eriksson, K; Stockselius, A; Ragno, C; Pihlar, Z; Burger, H; Hermansson, L				Ortiz-Catalan, Max; Gudmundsdottir, Rannveig A.; Kristoffersen, Morten B.; Zepeda-Echavarria, Alejandra; Caine-Winterberger, Kerstin; Kulbacka-Ortiz, Katarzyna; Widehammar, Cathrine; Eriksson, Karin; Stockselius, Anita; Ragno, Christina; Pihlar, Zdenka; Burger, Helena; Hermansson, Liselotte			Phantom motor execution facilitated by machine learning and augmented reality as treatment for phantom limb pain: a single group, clinical trial in patients with chronic intractable phantom limb pain	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; COMPLEX REGIONAL PAIN; CORTICAL REORGANIZATION; PATTERN-RECOGNITION; PATHOLOGICAL PAIN; MIRROR THERAPY; IMAGERY; ANALGESIA; QUESTIONNAIRE; AMPUTATION	Background Phantom limb pain is a debilitating condition for which no eff ective treatment has been found. We hypothesised that re-engagement of central and peripheral circuitry involved in motor execution could reduce phantom limb pain via competitive plasticity and reversal of cortical reorganisation. Methods Patients with upper limb amputation and known chronic intractable phantom limb pain were recruited at three clinics in Sweden and one in Slovenia. Patients received 12 sessions of phantom motor execution using machine learning, augmented and virtual reality, and serious gaming. Changes in intensity, frequency, duration, quality, and intrusion of phantom limb pain were assessed by the use of the numeric rating scale, the pain rating index, the weighted pain distribution scale, and a study-specifi c frequency scale before each session and at follow-up interviews 1, 3, and 6 months after the last session. Changes in medication and prostheses were also monitored. Results are reported using descriptive statistics and analysed by non-parametric tests. The trial is registered at ClinicalTrials. gov, number NCT02281539. Findings Between Sept 15, 2014, and April 10, 2015, 14 patients with intractable chronic phantom limb pain, for whom conventional treatments failed, were enrolled. After 12 sessions, patients showed statistically and clinically signifi cant improvements in all metrics of phantom limb pain. Phantom limb pain decreased from pre-treatment to the last treatment session by 47% (SD 39; absolute mean change 1 . 0 [0 . 8]; p= 0 . 001) for weighted pain distribution, 32% (38; absolute mean change 1 . 6 [1 . 8]; p= 0 . 007) for the numeric rating scale, and 51% (33; absolute mean change 9 . 6 [8 . 1]; p= 0 . 0001) for the pain rating index. The numeric rating scale score for intrusion of phantom limb pain in activities of daily living and sleep was reduced by 43% (SD 37; absolute mean change 2 . 4 [2 . 3]; p= 0 . 004) and 61% (39; absolute mean change 2 . 3 [1 . 8]; p= 0 . 001), respectively. Two of four patients who were on medication reduced their intake by 81% (absolute reduction 1300 mg, gabapentin) and 33% (absolute reduction 75 mg, pregabalin). Improvements remained 6 months after the last treatment. Interpretation Our fi ndings suggest potential value in motor execution of the phantom limb as a treatment for phantom limb pain. Promotion of phantom motor execution aided by machine learning, augmented and virtual reality, and gaming is a non-invasive, non-pharmacological, and engaging treatment with no identifi ed side-eff ects at present.	[Ortiz-Catalan, Max; Gudmundsdottir, Rannveig A.; Kristoffersen, Morten B.; Zepeda-Echavarria, Alejandra] Chalmers Univ Technol, Dept Signals & Syst, Horsalsvagen 11, SE-41296 Gothenburg, Sweden; [Ortiz-Catalan, Max; Caine-Winterberger, Kerstin; Kulbacka-Ortiz, Katarzyna] Sahlgrens Univ Hosp, Ctr Adv Reconstruct Extrem, Molndal, Sweden; [Ortiz-Catalan, Max; Gudmundsdottir, Rannveig A.; Kristoffersen, Morten B.; Zepeda-Echavarria, Alejandra] Integrum AB, Molndal, Sweden; [Widehammar, Cathrine; Hermansson, Liselotte] Univ Orebro, Fac Med & Hlth, Univ Hlth Care Res Ctr, Orebro, Sweden; [Widehammar, Cathrine; Eriksson, Karin] Univ Orebro, Fac Med & Hlth, Dept Pediat, Orebro, Sweden; [Hermansson, Liselotte] Univ Orebro, Fac Med & Hlth, Dept Prosthet & Orthot, Orebro, Sweden; [Stockselius, Anita; Ragno, Christina] BrackeDiakoni Rehabctr Sfaren, Solna, Sweden; [Pihlar, Zdenka; Burger, Helena] Univ Rehabil Inst, Ljubljana, Slovenia	Chalmers University of Technology; Sahlgrenska University Hospital; Orebro University; Orebro University; Orebro University; University of Ljubljana	Ortiz-Catalan, M (corresponding author), Chalmers Univ Technol, Dept Signals & Syst, Horsalsvagen 11, SE-41296 Gothenburg, Sweden.	maxo@chalmers.se	Hermansson, Liselotte/W-8579-2019; Kristoffersen, Morten Bak/AAD-5127-2020	Hermansson, Liselotte/0000-0003-4247-2236; Kristoffersen, Morten Bak/0000-0002-3901-2856	Promobilia Foundation; VINNOVA; Jimmy Dahlstens Fond; PicoSolve; Innovationskontor Vast	Promobilia Foundation; VINNOVA(Vinnova); Jimmy Dahlstens Fond; PicoSolve; Innovationskontor Vast	Promobilia Foundation, VINNOVA, Jimmy Dahlstens Fond, PicoSolve, and Innovationskontor Vast.; This study was funded by Promobilia Foundation, VINNOVA, Jimmy Dahlstens Fond, PicoSolve, and Innovationskontor Vast. We acknowledge the patients who participated in this study for their time and effort. AS and CR thank Bracke Diakoni for allowing them to participate in this study. We thank Bo Hakansson and Rickard Branemark for their support during this research.	ARENA JG, 1990, J PSYCHOSOM RES, V34, P71, DOI 10.1016/0022-3999(90)90009-S; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Bowering KJ, 2013, J PAIN, V14, P3, DOI 10.1016/j.jpain.2012.09.007; Brodie EE, 2007, EUR J PAIN, V11, P428, DOI 10.1016/j.ejpain.2006.06.002; Cacchio A, 2009, NEW ENGL J MED, V361, P634, DOI 10.1056/NEJMc0902799; Chan BL, 2007, NEW ENGL J MED, V357, P2206, DOI 10.1056/NEJMc071927; Cole J, 2009, DISABIL REHABIL, V31, P846, DOI 10.1080/09638280802355197; Desmond DM, 2006, J PROSTHET ORTHOT, V18, P74, DOI [10.1097/00008526-200607000-00005, DOI 10.1097/00008526-200607000-00005]; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fernandez-Espejo D, 2015, JAMA NEUROL, V72, P1442, DOI 10.1001/jamaneurol.2015.2614; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Harris AJ, 1999, LANCET, V354, P1464, DOI 10.1016/S0140-6736(99)05003-5; Johnson S, 2012, EUR J PAIN, V16, P550, DOI 10.1002/j.1532-2149.2011.00064.x; Knecht S, 1998, BRAIN, V121, P717, DOI 10.1093/brain/121.4.717; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Maclver K, 2008, BRAIN, V131, P2181, DOI 10.1093/brain/awn124; Makin TR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2571; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mercier C, 2009, NEUROREHAB NEURAL RE, V23, P587, DOI 10.1177/1545968308328717; Moseley GL, 2006, NEUROLOGY, V67, P2129, DOI 10.1212/01.wnl.0000249112.56935.32; Murray C.D., 2006, INT J DISABIL HUM DE, V5, P227, DOI [10.1515/IJDHD.2006.5.3.227, DOI 10.1515/IJDHD.2006.5.3.227]; Nikolajsen L, 2001, BRIT J ANAESTH, V87, P107, DOI 10.1093/bja/87.1.107; Ortiz-Catalan M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008933; Ortiz-Catalan M, 2014, IEEE T NEUR SYS REH, V22, P756, DOI 10.1109/TNSRE.2014.2305097; Ortiz-Catalan M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00024; Ortiz-Catalan M, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-11; Pollo A, 2001, PAIN, V93, P77, DOI 10.1016/S0304-3959(01)00296-2; Tan DW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008669; Taub E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00396	36	97	99	3	104	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2885	2894		10.1016/S0140-6736(16)31598-7	http://dx.doi.org/10.1016/S0140-6736(16)31598-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FU	27916234	Green Published			2022-12-28	WOS:000389631700033
J	Reid, NM; Proestou, DA; Clark, BW; Warren, WC; Colbourne, JK; Shaw, JR; Karchner, SI; Hahn, ME; Nacci, D; Oleksiak, MF; Crawford, DL; Whitehead, A				Reid, Noah M.; Proestou, Dina A.; Clark, Bryan W.; Warren, Wesley C.; Colbourne, John K.; Shaw, Joseph R.; Karchner, Sibel I.; Hahn, Mark E.; Nacci, Diane; Oleksiak, Marjorie F.; Crawford, Douglas L.; Whitehead, Andrew			The genomic landscape of rapid repeated evolutionary adaptation to toxic pollution in wild fish	SCIENCE			English	Article							KILLIFISH FUNDULUS-HETEROCLITUS; ATLANTIC KILLIFISH; GENETIC-VARIATION; CRUDE-OIL; RECEPTOR; POPULATIONS; TOLERANCE; GROWTH; PCBS; LOCI	Atlantic killifish populations have rapidly adapted to normally lethal levels of pollution in four urban estuaries. Through analysis of 384 whole killifish genome sequences and comparative transcriptomics in four pairs of sensitive and tolerant populations, we identify the aryl hydrocarbon receptor-based signaling pathway as a shared target of selection. This suggests evolutionary constraint on adaptive solutions to complex toxicant mixtures at each site. However, distinct molecular variants apparently contribute to adaptive pathway modification among tolerant populations. Selection also targets other toxicity-mediating genes and genes of connected signaling pathways; this indicates complex tolerance phenotypes and potentially compensatory adaptations. Molecular changes are consistent with selection on standing genetic variation. In killifish, high nucleotide diversity has likely been a crucial substrate for selective sweeps to propel rapid adaptation.	[Reid, Noah M.; Whitehead, Andrew] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Proestou, Dina A.] USDA ARS, Kingston, RI 02881 USA; [Clark, Bryan W.] US EPA, Oak Ridge Inst Sci & Educ, Off Res & Dev, Narragansett, RI 02882 USA; [Warren, Wesley C.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63108 USA; [Colbourne, John K.; Shaw, Joseph R.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Shaw, Joseph R.] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Karchner, Sibel I.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Karchner, Sibel I.; Hahn, Mark E.] Boston Univ, Superfund Res Program, Boston, MA 02118 USA; [Nacci, Diane] US EPA, Off Res & Dev, Narragansett, RI 02882 USA; [Oleksiak, Marjorie F.; Crawford, Douglas L.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; Washington University (WUSTL); University of Birmingham; Indiana University System; Indiana University Bloomington; Woods Hole Oceanographic Institution; Boston University; United States Environmental Protection Agency; University of Miami	Whitehead, A (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.	awhitehead@ucdavis.edu	Hahn, Mark/AAV-7516-2020; Colbourne, John K/L-7748-2014	Hahn, Mark/0000-0003-4358-2082; Colbourne, John K/0000-0002-6966-2972; Crawford, Douglas/0000-0002-6239-4012	National Center for Biotechnology Information [PRJNA323589]; NSF [DEB-1265282, DEB-112052, DEB-1120013, DEB-1120263, DEB-1120333, DEB-1120398]; National Institutes of Environmental Health Sciences [1R01ES021934-01, P42ES007381, R01ES019324]; National Science Foundation [OCE-1314567]; Postdoctoral Research Program at the U.S. Environmental Protection Agency (EPA) [DW92429801]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021934, P42ES007381, R01ES019324] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011198] Funding Source: NIH RePORTER	National Center for Biotechnology Information; NSF(National Science Foundation (NSF)); National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); Postdoctoral Research Program at the U.S. Environmental Protection Agency (EPA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Sequence data are archived at the National Center for Biotechnology Information (BioProject PRJNA323589). Phylogenetic tree data are archived at Dryad (doi: 10.5061/dryad.68n87). We thank G. Coop, B. Counterman, D. Champlin, I. Kirby, and A. Bertrand for their valuable input. Primary support was from the NSF (collaborative research grants DEB-1265282, DEB-112052, DEB-1120013, DEB-1120263, DEB-1120333, DEB-1120398 to J.K.C., D.L.C., M.E.H., S.I.K., M.F.O., J.R.S., W.C.W. and A.W.). Further support was provided by the National Institutes of Environmental Health Sciences (1R01ES021934-01 to A.W.; P42ES007381 to M.E.H.; R01ES019324 to J.R.S.), and the National Science Foundation (OCE-1314567 to A.W.). B.W.C. as supported by the Postdoctoral Research Program at the U.S. Environmental Protection Agency (EPA) administered by the Oak Ridge Institute for Science and Education (agreement DW92429801). The views expressed in this article are those of the authors and do not necessarily represent the views or policies of the EPA.	Amores A, 2014, GENETICS, V197, P625, DOI 10.1534/genetics.114.164293; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bell G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0080; Berg JJ, 2015, GENETICS, V201, P707, DOI 10.1534/genetics.115.178962; Brette F, 2014, SCIENCE, V343, P772, DOI 10.1126/science.1242747; Clark BW, 2010, AQUAT TOXICOL, V99, P232, DOI 10.1016/j.aquatox.2010.05.004; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Duvernell DD, 2008, MOL ECOL, V17, P1344, DOI 10.1111/j.1365-294X.2007.03648.x; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Greytak SR, 2010, AQUAT TOXICOL, V99, P291, DOI 10.1016/j.aquatox.2010.05.009; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Nacci D, 1999, MAR BIOL, V134, P9, DOI 10.1007/s002270050520; Nacci D, 2016, MOL ECOL, V25, P5467, DOI 10.1111/mec.13848; Nacci DE, 2010, ESTUAR COAST, V33, P853, DOI 10.1007/s12237-009-9257-6; Nukaya M, 2010, J BIOL CHEM, V285, P35599, DOI 10.1074/jbc.M110.132043; Pohjanvirta R, 2012, AH RECEPTOR BIOL TOX; Proestou DA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-7; Reitzel AM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-6; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; VALIELA I, 1977, MAR BIOL, V40, P135, DOI 10.1007/BF00396259; Whitehead A, 2012, P ROY SOC B-BIOL SCI, V279, P427, DOI 10.1098/rspb.2011.0847; Wilson B., 2016, BIORXIV, DOI [10.1101/052993, DOI 10.1101/052993]; Wirgin I, 2011, SCIENCE, V331, P1322, DOI 10.1126/science.1197296	25	232	234	8	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1305	1308		10.1126/science.aah4993	http://dx.doi.org/10.1126/science.aah4993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940876	Green Accepted, Green Published			2022-12-28	WOS:000389598800064
J	Tchernichovski, O; Lipkind, D				Tchernichovski, Ofer; Lipkind, Dina			Encoding vocal culture	SCIENCE			English	Editorial Material							SONG; BIRDSONG		[Tchernichovski, Ofer; Lipkind, Dina] CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Tchernichovski, O (corresponding author), CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10021 USA.	tchernichovski@gmail.com	Tchernichovski, Ofer/AAC-5678-2019	Tchernichovski, Ofer/0000-0001-6788-614X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004722] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ali F, 2013, NEURON, V80, P494, DOI 10.1016/j.neuron.2013.07.049; Araki M, 2016, SCIENCE, V354, P1282, DOI 10.1126/science.aah6799; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Carr JW, 2017, COGNITIVE SCI, V41, P892, DOI 10.1111/cogs.12371; Centola D, 2015, P NATL ACAD SCI USA, V112, P1989, DOI 10.1073/pnas.1418838112; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Gadagkar V, 2016, SCIENCE, V354, P1278, DOI 10.1126/science.aah6837; Marler T., 1962, CONDOR, V64, P368; Tchernichovski O, 2014, CURR OPIN NEUROBIOL, V28, P42, DOI 10.1016/j.conb.2014.06.002; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204	10	1	1	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1234	1235		10.1126/science.aal3205	http://dx.doi.org/10.1126/science.aal3205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940834				2022-12-28	WOS:000389598800041
J	Gupta, S				Gupta, Sujata			Unlock your inner salamander	NATURE			English	Editorial Material							REGENERATION											Haubner BJ, 2016, CIRC RES, V118, P216, DOI 10.1161/CIRCRESAHA.115.307017; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Yu L, 2012, DEV BIOL, V372, P263, DOI 10.1016/j.ydbio.2012.09.021	3	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					S58	S59		10.1038/540S58a	http://dx.doi.org/10.1038/540S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27926702	Bronze			2022-12-28	WOS:000389548700005
J	Kobayashi, C				Kobayashi, Chiaki			Elemental abundances across cosmic time	NATURE			English	Editorial Material							UNIVERSE; GALAXY; ENRICHMENT	The chemical composition of a massive galaxy in the early Universe reveals an extremely short period of star formation. This result could challenge our ideas about the evolution of galaxies and of the Universe itself. SEE LETTER p.248	[Kobayashi, Chiaki] Univ Hertfordshire, Sch Phys Astron & Math, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Kobayashi, C (corresponding author), Univ Hertfordshire, Sch Phys Astron & Math, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England.	c.kobayashi@herts.ac.uk		Kobayashi, Chiaki/0000-0002-4343-0487	STFC [ST/M001008/1, ST/M000958/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Heckman TM, 2014, ANNU REV ASTRON ASTR, V52, P589, DOI 10.1146/annurev-astro-081913-035722; Hoyle F., 1954, ASTROPHYS J SUPPL S, V1, P121, DOI 10.1086/190005; Ji AP, 2016, NATURE, V531, P610, DOI 10.1038/nature17425; Johnson CI, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/4/67; Kriek M, 2016, NATURE, V540, P248, DOI 10.1038/nature20570; Maraston C, 2005, MON NOT R ASTRON SOC, V362, P799, DOI 10.1111/j.1365-2966.2005.09270.x; Nomoto K, 2013, ANNU REV ASTRON ASTR, V51, P457, DOI 10.1146/annurev-astro-082812-140956; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Taylor P, 2015, MON NOT R ASTRON SOC, V448, P1835, DOI 10.1093/mnras/stv139	11	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					205	207		10.1038/540205a	http://dx.doi.org/10.1038/540205a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27929026				2022-12-28	WOS:000389548700042
J	Lee, P				Lee, Paul			Wasting Energy to Treat Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Paul] St Vincents Hosp, Diabet & Metab Div, Garvan Inst Med Res, Sydney, NSW, Australia; [Lee, Paul] St Vincents Hosp, Dept Endocrinol, Sydney, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; St Vincents Hospital Sydney	Lee, P (corresponding author), St Vincents Hosp, Diabet & Metab Div, Garvan Inst Med Res, Sydney, NSW, Australia.; Lee, P (corresponding author), St Vincents Hosp, Dept Endocrinol, Sydney, NSW, Australia.							[Anonymous], 1879, DTSCH ARCH KLIN MED, V24, P539; DEDUVE C, 1964, FED PROC, V23, P1045; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Long JZ, 2016, CELL, V166, P424, DOI 10.1016/j.cell.2016.05.071; Tainter ML, 1935, J AMER MED ASSOC, V105, P0332, DOI 10.1001/jama.1935.02760310006002	5	7	7	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2298	2300		10.1056/NEJMcibr1610015	http://dx.doi.org/10.1056/NEJMcibr1610015			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0ZQ	27959675				2022-12-28	WOS:000389310000017
J	[Anonymous]				[Anonymous]			Association Between Gun Law Reforms and Intentional Firearm Deaths in Australia, 1979-2013 (vol 316, pg 291, 2016)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Correction																		Chapman S, 2016, JAMA-J AM MED ASSOC, V316, P291, DOI 10.1001/jama.2016.8752	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2016	316	21					2277	2277		10.1001/jama.2016.18002	http://dx.doi.org/10.1001/jama.2016.18002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YV	27923075	Bronze			2022-12-28	WOS:000389307400019
J	Tuthill, M				Tuthill, Matthew			Making a difference, differently	SCIENCE			English	Editorial Material									[Tuthill, Matthew] Kapiolani Community Coll, Honolulu, HI 96816 USA	University of Hawaii System	Tuthill, M (corresponding author), Kapiolani Community Coll, Honolulu, HI 96816 USA.	SciCareerEditor@aaas.org							0	0	0	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1194	1194		10.1126/science.354.6316.1194	http://dx.doi.org/10.1126/science.354.6316.1194			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934769				2022-12-28	WOS:000388916400048
J	Lawrence, PA				Lawrence, Peter A.			Francis Crick: A Singular Approach to Scientific Discovery	CELL			English	Editorial Material									[Lawrence, Peter A.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Lawrence, PA (corresponding author), Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England.	pal38@cam.ac.uk		Lawrence, Peter/0000-0002-9554-8268				Brenner S., 2001, MY LIFE SCI SYDNEY B; Cobb M., 2015, LIFES GREATEST SECRE; Crick F, 1988, WHAT MAD PURSUIT PER; Crick F., 1973, THE DNA STORY; Crick F., 1993, THE TRIPLET CODE; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; CRICK FHC, 1975, SCIENCE, V189, P340, DOI 10.1126/science.806966; Darwin F., 1903, MORE LETT C DARWIN; Jacob F., 1995, STATUE WITHIN AUTOBI; LAWRENCE PA, 1972, J CELL SCI, V11, P815; Mitchison G, 2004, J GENET, V83, P221, DOI 10.1007/BF02729901; Olby RC, 2009, F CRICK HUNTER LIFES; Ridley M., 2006, F CRICK DISCOVERER G	14	1	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1436	1439		10.1016/j.cell.2016.11.008	http://dx.doi.org/10.1016/j.cell.2016.11.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912050	Green Submitted, Bronze			2022-12-28	WOS:000389470500003
J	Shorter, J; Gitler, AD				Shorter, James; Gitler, Aaron D.			Susan Lee Lindquist (1949-2016) OBITUARY	NATURE			English	Biographical-Item									[Shorter, James] Univ Penn, Biochem & Biophys, Philadelphia, PA 19104 USA; [Gitler, Aaron D.] Stanford Univ, Genet, Stanford, CA 94305 USA; [Gitler, Aaron D.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA	University of Pennsylvania; Stanford University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Shorter, J (corresponding author), Univ Penn, Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu; agitler@stanford.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Gitler, Aaron/0000-0001-8603-1526				LINDQUIST SL, PUBLICATION LIST	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					40	40		10.1038/540040a	http://dx.doi.org/10.1038/540040a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905439				2022-12-28	WOS:000388916600039
J	Gustavsson, S; Yan, F; Catelani, G; Bylander, J; Kamal, A; Birenbaum, J; Hover, D; Rosenberg, D; Samach, G; Sears, AP; Weber, SJ; Yoder, JL; Clarke, J; Kerman, AJ; Yoshihara, F; Nakamura, Y; Orlando, TP; Oliver, WD				Gustavsson, Simon; Yan, Fei; Catelani, Gianluigi; Bylander, Jonas; Kamal, Archana; Birenbaum, Jeffrey; Hover, David; Rosenberg, Danna; Samach, Gabriel; Sears, Adam P.; Weber, Steven J.; Yoder, Jonilyn L.; Clarke, John; Kerman, Andrew J.; Yoshihara, Fumiki; Nakamura, Yasunobu; Orlando, Terry P.; Oliver, William D.			Suppressing relaxation in superconducting qubits by quasiparticle pumping	SCIENCE			English	Article							COHERENCE	Dynamical error suppression techniques are commonly used to improve coherence in quantum systems. They reduce dephasing errors by applying control pulses designed to reverse erroneous coherent evolution driven by environmental noise. However, such methods cannot correct for irreversible processes such as energy relaxation. We investigate a complementary, stochastic approach to reducing errors: Instead of deterministically reversing the unwanted qubit evolution, we use control pulses to shape the noise environment dynamically. In the context of superconducting qubits, we implement a pumping sequence to reduce the number of unpaired electrons (quasiparticles) in close proximity to the device. A 70% reduction in the quasiparticle density results in a threefold enhancement in qubit relaxation times and a comparable reduction in coherence variability.	[Gustavsson, Simon; Yan, Fei; Kamal, Archana; Orlando, Terry P.; Oliver, William D.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Catelani, Gianluigi] Forschungszentrum Julich, Peter Grunberg Inst PGI 2, D-52425 Julich, Germany; [Bylander, Jonas] Chalmers, Microtechnol & Nanosci, SE-41296 Gothenburg, Sweden; [Birenbaum, Jeffrey; Hover, David; Rosenberg, Danna; Samach, Gabriel; Sears, Adam P.; Weber, Steven J.; Yoder, Jonilyn L.; Kerman, Andrew J.; Oliver, William D.] MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02420 USA; [Clarke, John] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Yoshihara, Fumiki] RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; [Nakamura, Yasunobu] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Nakamura, Yasunobu] Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan; [Oliver, William D.] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Helmholtz Association; Research Center Julich; Chalmers University of Technology; Lincoln Laboratory; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; RIKEN; RIKEN; University of Tokyo; Massachusetts Institute of Technology (MIT)	Gustavsson, S (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	simongus@mit.edu	Catelani, Gianluigi/E-7134-2011; Bylander, Jonas/A-4636-2011; Gustavsson, Simon/B-5391-2012; Nakamura, Yasunobu/H-1300-2012	Catelani, Gianluigi/0000-0002-0421-7325; Bylander, Jonas/0000-0003-4521-710X; Gustavsson, Simon/0000-0002-7069-1025; Nakamura, Yasunobu/0000-0003-0424-630X; Kamal, Archana/0000-0001-5430-9837; Samach, Gabriel/0000-0001-8032-5267; Kerman, Andrew/0000-0002-4718-7621	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA); MIT Lincoln Laboratory under Air Force [FA8721-05-C-0002]; U.S. Army Research Office [W911NF-14-1-0682]; NSF [PHY-1415514]; European Union (EU) under Research Executive Agency (REA) [CIG-618258]; EU under REA [CIG-618353]; Direct For Mathematical & Physical Scien [1415514] Funding Source: National Science Foundation	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA); MIT Lincoln Laboratory under Air Force; U.S. Army Research Office; NSF(National Science Foundation (NSF)); European Union (EU) under Research Executive Agency (REA); EU under REA; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank M. Blencowe, D. Campbell, M. Devoret, J. Grover, P. Krantz, and I. Pop for useful discussions and P. Baldo, V. Bolkhovsky, G. Fitch, J. Miloshi, P. Murphy, B. Osadchy, K. Parrillo, R. Slattery, and T. Weir at MIT Lincoln Laboratory for technical assistance. This research was funded in part by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), and the Assistant Secretary of Defense for Research and Engineering via MIT Lincoln Laboratory under Air Force contract no. FA8721-05-C-0002; by the U.S. Army Research Office grant no. W911NF-14-1-0682; and by NSF grant no. PHY-1415514. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of ODNI, IARPA, or the U.S. government. G.C. acknowledges partial support by the European Union (EU) under Research Executive Agency (REA) grant agreement no. CIG-618258. J.By. acknowledges partial support by the EU under REA grant agreement no. CIG-618353.	Aumentado J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.066802; Catelani G, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.184514; Catelani G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.077002; de Graaf SE, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.137002; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; HAPPER W, 1972, REV MOD PHYS, V44, P169, DOI 10.1103/RevModPhys.44.169; Leppakangas J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.144503; Levenson-Falk EM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.047002; Lutchyn R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014517; Maisi VF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.147001; Murch KW, 2013, NATURE, V499, P62, DOI 10.1038/nature12264; Nsanzineza I, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.117002; Pop IM, 2014, NATURE, V508, P369, DOI 10.1038/nature13017; Rainis D, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.174533; Riste D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2936; Schreier JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180502; Stern M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.123601; Sun L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.230509; Taupin M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10977; Valenzuela SO, 2006, SCIENCE, V314, P1589, DOI 10.1126/science.1134008; Visser P. J. D., 2011, PHYS REV LETT, V106; Vool U, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.247001; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6836; Wenner J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.150502; WINELAND DJ, 1978, PHYS REV LETT, V40, P1639, DOI 10.1103/PhysRevLett.40.1639; Yan F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12964	30	60	61	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1573	1577		10.1126/science.aah5844	http://dx.doi.org/10.1126/science.aah5844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	27940578	Green Submitted			2022-12-28	WOS:000390254300049
J	James, NR; Brown, A; Gordiyenko, Y; Ramakrishnan, V				James, Nathan R.; Brown, Alan; Gordiyenko, Yuliya; Ramakrishnan, V.			Translational termination without a stop codon	SCIENCE			English	Article							RIBOSOME-RESCUE FACTOR; RELEASE FACTOR RF2; ESCHERICHIA-COLI; STALLED RIBOSOMES; TRANS-TRANSLATION; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; MESSENGER-RNA; ARFA; FACTOR-2	Ribosomes stall when they encounter the end of messenger RNA (mRNA) without an in-frame stop codon. In bacteria, these "nonstop" complexes can be rescued by alternative ribosome-rescue factor A (ArfA). We used electron cryomicroscopy to determine structures of ArfA bound to the ribosome with 3'-truncated mRNA, at resolutions ranging from 3.0 to 3.4 angstroms. ArfA binds within the ribosomal mRNA channel and substitutes for the absent stop codon in the A site by specifically recruiting release factor 2 (RF2), initially in a compact preaccommodated state. A similar conformation of RF2 may occur on stop codons, suggesting a general mechanism for release-factor-mediated translational termination in which a conformational switch leads to peptide release only when the appropriate signal is present in the A site.	[James, Nathan R.; Brown, Alan; Gordiyenko, Yuliya; Ramakrishnan, V.] MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk		Brown, Alan/0000-0002-0021-0476; James, Nathan/0000-0003-1147-6285; Ramakrishnan, V/0000-0002-4699-2194	UK MRC [MC_U105184332]; Wellcome Trust [WT096570]; Agouron Institute; Louis-Jeantet Foundation; Medical Research Council [MC_U105184332, 1352328] Funding Source: researchfish; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish; MRC [MC_U105184332] Funding Source: UKRI	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Y. Shimizu for providing the arfA clone, A. G. Kelley for providing tRNA. R. S. Hegde for providing E. coli RF2, S. H. W. Scheres for help with RELION-2.0: J. Grimmett and T. Darling for computing support, and C. D. Rae and S. Shao for comments. The work was supported by grants to V.R. from the UK MRC (MC_U105184332; the Wellcome Trust (WT096570): the Agouron Institute, and the Louis-Jeantet Foundation. The maps have been deposited with the Electron Microscopy Data Bank under the accession codes EMD-3489, EMD-3490: EMD-3492, and EMD-3193. Atomic coordinates have been deposited with the Protein Data Bane under IDs 5MDV, 5MDW, 5MDY, and 5MDZ.	Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Chadani Y, 2011, GENES GENET SYST, V86, P151; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Gagnon MG, 2012, SCIENCE, V335, P1370, DOI 10.1126/science.1217443; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Giudice E, 2013, TRENDS BIOCHEM SCI, V38, P403, DOI 10.1016/j.tibs.2013.06.002; He SL, 2010, NAT STRUCT MOL BIOL, V17, P465, DOI 10.1038/nsmb.1766; Hetrick B, 2009, BIOCHEMISTRY-US, V48, P11178, DOI 10.1021/bi901577d; Ito K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028413; Keiler KC, 2015, NAT REV MICROBIOL, V13, P285, DOI 10.1038/nrmicro3438; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Kurita D, 2014, NUCLEIC ACIDS RES, V42, P13339, DOI 10.1093/nar/gku1069; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Neubauer C, 2012, SCIENCE, V335, P1366, DOI 10.1126/science.1217039; Ramadoss NS, 2013, P NATL ACAD SCI USA, V110, P10282, DOI 10.1073/pnas.1302816110; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Schaub RE, 2012, J BIOL CHEM, V287, P29765, DOI 10.1074/jbc.M112.374074; Shao SC, 2016, CELL, V167, P1229, DOI 10.1016/j.cell.2016.10.046; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Trappl K, 2016, J MOL BIOL, V428, P1333, DOI 10.1016/j.jmb.2016.01.021; Vestergaard B, 2005, MOL CELL, V20, P929, DOI 10.1016/j.molcel.2005.11.022; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Zeng FX, 2016, RNA, V22, P49, DOI 10.1261/rna.053082.115; Zoldak G, 2007, NUCLEIC ACIDS RES, V35, P1343, DOI 10.1093/nar/gkl696	30	48	78	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1437	1440		10.1126/science.aai9127	http://dx.doi.org/10.1126/science.aai9127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27934701	Green Accepted			2022-12-28	WOS:000390261300047
J	Kaspi, VM				Kaspi, Victoria M.			A fast radio boom	SCIENCE			English	Editorial Material							BURST		[Kaspi, Victoria M.] McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada; [Kaspi, Victoria M.] McGill Space Inst, 3550 Univ St, Montreal, PQ H3A 2A7, Canada	McGill University	Kaspi, VM (corresponding author), McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.; Kaspi, VM (corresponding author), McGill Space Inst, 3550 Univ St, Montreal, PQ H3A 2A7, Canada.	vkaspi@physics.mcgill.ca						Lorimer DR, 2007, SCIENCE, V318, P777, DOI 10.1126/science.1147532; Oppermann N, 2016, MON NOT R ASTRON SOC, V461, P984, DOI 10.1093/mnras/stw1401; Ravi V, 2016, SCIENCE, V354, P1249, DOI 10.1126/science.aaf6807; Spitler LG, 2016, NATURE, V531, P202, DOI 10.1038/nature17168	4	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1230	1231		10.1126/science.aag1600	http://dx.doi.org/10.1126/science.aag1600			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940831				2022-12-28	WOS:000389598800038
J	Xie, M; Ye, H; Wang, H; Hamri, GCE; Lormeau, C; Saxena, P; Stelling, J; Fussenegger, M				Xie, Mingqi; Ye, Haifeng; Wang, Hui; Hamri, Ghislaine Charpin-El; Lormeau, Claude; Saxena, Pratik; Stelling, Jorg; Fussenegger, Martin			beta-cell-mimetic designer cells provide closed-loop glycemic control	SCIENCE			English	Article							TYPE-1 DIABETES-MELLITUS; GLUCAGON-LIKE PEPTIDE-1; INSULIN-RESISTANCE; METABOLIC SYNDROME; IN-VITRO; GLUCOSE; MICE; COMPETENT; SECRETION; CHANNELS	Chronically deregulated blood-glucose concentrations in diabetes mellitus result from a loss of pancreatic insulin-producing beta cells (type 1 diabetes, T1D) or from impaired insulin sensitivity of body cells and glucose-stimulated insulin release (type 2 diabetes, T2D). Here, we show that therapeutically applicable beta-cell-mimetic designer cells can be established by minimal engineering of human cells. We achieved glucose responsiveness by a synthetic circuit that couples glycolysis-mediated calcium entry to an excitation-transcription system controlling therapeutic transgene expression. Implanted circuit-carrying cells corrected insulin deficiency and self-sufficiently abolished persistent hyperglycemia in T1D mice. Similarly, glucose-inducible glucagon-like peptide 1 transcription improved endogenous glucose-stimulated insulin release and glucose tolerance in T2D mice. These systems may enable a combination of diagnosis and treatment for diabetes mellitus therapy.	[Xie, Mingqi; Wang, Hui; Lormeau, Claude; Saxena, Pratik; Stelling, Jorg; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland; [Ye, Haifeng] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Dongchuan Rd 500, Shanghai 200241, Peoples R China; [Ye, Haifeng] East China Normal Univ, Sch Life Sci, Dongchuan Rd 500, Shanghai 200241, Peoples R China; [Hamri, Ghislaine Charpin-El] IUT, Dept Genie Biol, F-69622 Villeurbanne, France; [Lormeau, Claude; Stelling, Jorg] Swiss Fed Inst Technol, SIB, Mattenstr 26, CH-4058 Basel, Switzerland; [Fussenegger, Martin] Univ Basel, Fac Sci, Mattenstr 26, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; East China Normal University; East China Normal University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Basel	Stelling, J; Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.; Stelling, J (corresponding author), Swiss Fed Inst Technol, SIB, Mattenstr 26, CH-4058 Basel, Switzerland.; Fussenegger, M (corresponding author), Univ Basel, Fac Sci, Mattenstr 26, CH-4058 Basel, Switzerland.	joerg.stelling@bsse.ethz.ch; fussenegger@bsse.ethz.ch	Stelling, Joerg/F-7499-2010	Stelling, Joerg/0000-0002-1145-891X; Magnard (Lormeau), Claude/0000-0002-8141-0532; Ye, Haifeng/0000-0002-5482-8116	European Research Council [321381]; Natural Science Foundation of China [31522017]; National Centre of Competence in Research Molecular Systems Engineering	European Research Council(European Research Council (ERC)European Commission); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Centre of Competence in Research Molecular Systems Engineering	We thank V. Haellman and H. Zulewski for critical comments on the manuscript. This work was supported by a European Research Council advanced grant (ProNet no. 321381) and in part by the Natural Science Foundation of China (no. 31522017) and the National Centre of Competence in Research Molecular Systems Engineering. All data supporting the findings of this study are presented in the main paper and supplementary materials. Plasmids are available from M.F. on request. M.X. and. M.F. are inventors on a patent application filed by the ETH Zurich on the beta-cell mimetic designer cells (application nos. EP16180000.8 and EP16200258.8). M.X., H.Y., H.W., P.S. and G.C. conducted the experiments; C.L., M.X., and J.S. developed the mathematical model; M.X., C.L., J.S., and M.F. designed the experiments and wrote the manuscript.	Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Auslander D, 2014, MOL CELL, V55, P397, DOI 10.1016/j.molcel.2014.06.007; Bruin JE, 2015, STEM CELL REP, V4, P605, DOI 10.1016/j.stemcr.2015.02.011; Church GM, 2014, NAT REV MOL CELL BIO, V15, P289, DOI 10.1038/nrm3767; Cleland SJ, 2012, NAT REV ENDOCRINOL, V8, P476, DOI 10.1038/nrendo.2012.47; Cornell S, 2015, THER CLIN RISK MANAG, V11, P621, DOI 10.2147/TCRM.S67387; D'Arco M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003355; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Elsner M, 2002, DIABETOLOGIA, V45, P1542, DOI 10.1007/s00125-002-0955-x; Grundy SM, 2006, NAT REV DRUG DISCOV, V5, P294, DOI 10.1038/nrd2005; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kastellorizios M, 2015, ADV EXP MED BIOL, V865, P93, DOI 10.1007/978-3-319-18603-0_6; Kieffer TJ, 2016, CELL STEM CELL, V18, P699, DOI 10.1016/j.stem.2016.05.014; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marzban L, 2006, DIABETES, V55, P2192, DOI 10.2337/db05-1566; McCluskey JT, 2011, J BIOL CHEM, V286, P21982, DOI 10.1074/jbc.M111.226795; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pickup JC, 2012, NEW ENGL J MED, V366, P1616, DOI 10.1056/NEJMct1113948; Polonsky KS, 2012, NEW ENGL J MED, V367, P1332, DOI 10.1056/NEJMra1110560; Rao PM, 2013, NAT REV ENDOCRINOL, V9, P479, DOI 10.1038/nrendo.2013.122; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Saxena P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11247; Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; Tuch BE, 2003, GENE THER, V10, P490, DOI 10.1038/sj.gt.3301911; Tuomilehto J, 2016, NAT REV ENDOCRINOL, V12, P127, DOI 10.1038/nrendo.2015.227; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Ye HF, 2013, P NATL ACAD SCI USA, V110, P141, DOI 10.1073/pnas.1216801110; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Zaykov AN, 2016, NAT REV DRUG DISCOV, V15, P425, DOI 10.1038/nrd.2015.36	37	130	139	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1296	1301		10.1126/science.aaf4006	http://dx.doi.org/10.1126/science.aaf4006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940875				2022-12-28	WOS:000389598800062
J	Tapp, R				Tapp, Ruth			What it feels like to be an interesting teaching opportunity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rsnow@bmj.com							0	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2016	355								i6190	10.1136/bmj.i6190	http://dx.doi.org/10.1136/bmj.i6190			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SX	27927671	Green Published, Bronze			2022-12-28	WOS:000390037400004
J	DeCamp, M; Riggs, KR				DeCamp, Matthew; Riggs, Kevin R.			Navigating Ethical Tensions in High-Value Care Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[DeCamp, Matthew] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, 1809 Ashland Ave,Deering Hall, Baltimore, MD 21205 USA; [DeCamp, Matthew] Johns Hopkins Univ, Div Gen Internal Med, 1809 Ashland Ave,Deering Hall, Baltimore, MD 21205 USA; [Riggs, Kevin R.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA	Johns Hopkins University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham	DeCamp, M (corresponding author), Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, 1809 Ashland Ave,Deering Hall, Baltimore, MD 21205 USA.; DeCamp, M (corresponding author), Johns Hopkins Univ, Div Gen Internal Med, 1809 Ashland Ave,Deering Hall, Baltimore, MD 21205 USA.	mdecamp1@jhmi.edu		DeCamp, Matthew/0000-0002-9371-8729; Riggs, Kevin/0000-0002-0015-5809	NHLBI NIH HHS [T32 HL007180] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007180] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bloche MG, 2016, NEW ENGL J MED, V374, P1001, DOI 10.1056/NEJMp1502629; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; Cruess RL, 2015, ACAD MED, V90, P718, DOI 10.1097/ACM.0000000000000700; Korenstein D, 2015, JAMA-J AM MED ASSOC, V314, P2359, DOI 10.1001/jama.2015.15406; Lynn J, 2015, JAMA-J AM MED ASSOC, V314, P1445, DOI 10.1001/jama.2015.8909; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; Riggs KR, 2014, JAMA-J AM MED ASSOC, V312, P1631, DOI 10.1001/jama.2014.7105; Tilburt JC, 2014, AM J BIOETHICS, V14, P29, DOI 10.1080/15265161.2014.935878; Tilburt JC, 2013, JAMA-J AM MED ASSOC, V310, P380, DOI 10.1001/jama.2013.8278	9	8	9	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2016	316	21					2189	2190		10.1001/jama.2016.17488	http://dx.doi.org/10.1001/jama.2016.17488			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YV	27923098	Green Accepted			2022-12-28	WOS:000389307400002
J	Jones, JDG; Vance, RE; Dangl, JL				Jones, Jonathan D. G.; Vance, Russell E.; Dangl, Jeffery L.			Intracellular innate immune surveillance devices in plants and animals	SCIENCE			English	Review							DISEASE RESISTANCE PROTEIN; WRKY TRANSCRIPTION FACTORS; NB-LRR PROTEIN; INFLAMMASOME ACTIVATION; PATHOGEN EFFECTORS; NLR PROTEINS; III EFFECTOR; CELL-DEATH; BACTERIAL PEPTIDOGLYCAN; DEFENSE RESPONSES	Multicellular eukaryotes coevolve with microbial pathogens, which exert strong selective pressure on the immune systems of their hosts. Plants and animals use intracellular proteins of the nucleotide-binding domain, leucine-rich repeat (NLR) superfamily to detect many types of microbial pathogens. The NLR domain architecture likely evolved independently and convergently in each kingdom, and the molecular mechanisms of pathogen detection by plant and animal NLRs have long been considered to be distinct. However, microbial recognition mechanisms overlap, and it is now possible to discern important key trans-kingdom principles of NLR-dependent immune function. Here, we attempt to articulate these principles. We propose that the NLR architecture has evolved for pathogen-sensing in diverse organisms because of its utility as a tightly folded "hair trigger" device into which a virtually limitless number of microbial detection platforms can be integrated. Recent findings suggest means to rationally design novel recognition capabilities to counter disease.	[Jones, Jonathan D. G.] Sainsbury Lab, Norwich Res Pk,Colney Lane, Norwich NR4 7UH, Norfolk, England; [Vance, Russell E.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Vance, Russell E.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Dangl, Jeffery L.] Univ North Carolina Chapel Hill, Howard Hughes Med Inst, Dept Biol, Chapel Hill, NC 27599 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jones, JDG (corresponding author), Sainsbury Lab, Norwich Res Pk,Colney Lane, Norwich NR4 7UH, Norfolk, England.; Vance, RE (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA.; Dangl, JL (corresponding author), Univ North Carolina Chapel Hill, Howard Hughes Med Inst, Dept Biol, Chapel Hill, NC 27599 USA.	jonathan.jones@sainsbury-laboratory.ac.uk; rvance@berkeley.edu; dangl@email.unc.edu	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X	Biotechnology and Biological Sciences Research Council; European Resdearch Council; Gordon and Betty Moore Foundation (GBMF); Gatsby Foundation; NSF, NIH; GMBF; HHMI; BBSRC [BB/M008193/1, BB/M003809/1, BB/K003550/1] Funding Source: UKRI; Division Of Integrative Organismal Systems [1257373] Funding Source: National Science Foundation	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Resdearch Council; Gordon and Betty Moore Foundation (GBMF)(Gordon and Betty Moore Foundation); Gatsby Foundation; NSF, NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GMBF; HHMI(Howard Hughes Medical Institute); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NLR and effector research in the laboratories of the authors is funded by the Biotechnology and Biological Sciences Research Council, European Resdearch Council, Gordon and Betty Moore Foundation (GBMF), and the Gatsby Foundation (J.D.G.J.) and the NSF, NIH (J.L.D. and R.E.V.), GMBF (J.L.D.), and HHMI (J.L.D. and R.E.V.). J.D.G.J. thanks B. Staskawicz for hosting a brief sabbatical visit, during which conversations leading to this review were initiated, and we thank A. Daskalov and O. Furzer for helpful discussion. We thank V. Maltez, E. Miao, I. Rauch, K. Witek, and J. Parker for providing unpublished images for Fig. 1 and J. Tenthorey for help with Fig. 2.	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Albrecht M, 2006, BIOCHEM BIOPH RES CO, V339, P459, DOI 10.1016/j.bbrc.2005.10.074; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bentham A, 2017, ANN BOT-LONDON, V119, P689, DOI 10.1093/aob/mcw171; Bernoux M, 2016, PLANT CELL, V28, P146, DOI 10.1105/tpc.15.00303; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bonardi V, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00237; Bonardi V, 2012, CURR OPIN IMMUNOL, V24, P41, DOI 10.1016/j.coi.2011.12.006; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Chae E, 2014, CELL, V159, P1341, DOI 10.1016/j.cell.2014.10.049; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chavarria-Smith J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003452; Chung EH, 2014, CELL HOST MICROBE, V16, P484, DOI 10.1016/j.chom.2014.09.004; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Collier SM, 2011, MOL PLANT MICROBE IN, V24, P918, DOI 10.1094/MPMI-03-11-0050; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; Daskalov A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002059; Duxbury Z, 2016, BIOESSAYS, V38, P769, DOI 10.1002/bies.201600046; Dyrka W, 2014, GENOME BIOL EVOL, V6, P3137, DOI 10.1093/gbe/evu251; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hamada M, 2013, MOL BIOL EVOL, V30, P167, DOI 10.1093/molbev/mss213; Hayashi N, 2010, PLANT J, V64, P498, DOI 10.1111/j.1365-313X.2010.04348.x; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Howe K, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160009; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Jacob F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00297; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Kim SH, 2016, SCIENCE, V351, P684, DOI 10.1126/science.aad3436; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Kroj T, 2016, NEW PHYTOL, V210, P618, DOI 10.1111/nph.13869; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lee D, 2015, PLANT CELL, V27, P2042, DOI 10.1105/tpc.114.132308; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu JB, 2011, ELSEV INSIGHT, P213, DOI 10.1016/B978-0-12-385144-4.00007-2; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Nandety RS, 2013, PLANT PHYSIOL, V162, P1459, DOI 10.1104/pp.113.219162; Narusaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055954; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Ntoukakis V, 2014, CURR OPIN PLANT BIOL, V20, P69, DOI 10.1016/j.pbi.2014.04.002; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013; Sarris PF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0228-7; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Schreiber KJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005769; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Steuernage B, 2016, NAT BIOTECHNOL, V34, P652, DOI 10.1038/nbt.3543; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang GX, 2015, CELL HOST MICROBE, V18, P285, DOI 10.1016/j.chom.2015.08.004; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Witek K, 2016, NAT BIOTECHNOL, V34, P656, DOI 10.1038/nbt.3540; Wu CH, 2016, NEW PHYTOL, V209, P1344, DOI 10.1111/nph.13764; Yang HB, 2010, PLANT J, V63, P283, DOI 10.1111/j.1365-313X.2010.04241.x; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	99	501	516	34	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316							aaf6395	10.1126/science.aaf6395	http://dx.doi.org/10.1126/science.aaf6395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934708	Green Submitted			2022-12-28	WOS:000388916400033
J	Park, S; Oh, CM; Cho, H; Lee, JY; Jung, KW; Jun, JK; Won, YJ; Kong, HJ; Choi, KS; Lee, YJ; Lee, JS				Park, Sohee; Oh, Chang-Mo; Cho, Hyunsoon; Lee, Joo Young; Jung, Kyu-Won; Jun, Jae Kwan; Won, Young-Joo; Kong, Hyun-Joo; Choi, Kui Son; Lee, You Jin; Lee, Jin Soo			Association between screening and the thyroid cancer "epidemic" in South Korea: evidence from a nationwide study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INCREASING INCIDENCE; PAPILLARY MICROCARCINOMA; ACTIVE SURVEILLANCE; MORTALITY; SURVIVAL; PREVALENCE; STATISTICS; CARCINOMA; BURDEN	OBJECTIVE To investigate whether screening for thyroid cancer led to the current "epidemic"in South Korea. DESIGN Review of the medical records of nationally representative samples of patients with a diagnosis of thyroid cancer in 1999, 2005, and 2008. SETTING Sample cases were randomly selected from South Korea's nationwide cancer registry, using a systematic sampling method after stratification by region. PARTICIPANTS 5796 patients with thyroid cancer were included (891 in 1999, 2355 in 2005, and 2550 in 2008). MAIN OUTCOME MEASURES The primary outcome was age standardised incidence of thyroid cancer and the changes in incidence between 1999 and 2008 according to the methods used to detect tumours (screen detection versus clinical detection versus unspecified). RESULTS Between 1999 and 2008, the incidence of thyroid cancer increased 6.4-fold (95% confidence interval 4.9-fold to 8.4-fold), from 6.4 (95% confidence interval 6.2 to 6.6) per 100 000 population to 40.7 (40.2 to 41.2) per 100 000 population. Of the increase, 94.4% (34.4 per 100 000 population) were for tumours less than 20 mm, which were detected mainly by screening. 97.1% of the total increase was localised and regional tumours according to the Surveillance, Epidemiology, and End Results (SEER) summary stage. Where cases were clinically detected, 99.9% of the increased incidences (6.4 per 100 000 population) over the same period were tumours less than 20 mm. CONCLUSION The current "epidemic"of thyroid cancer in South Korea is due to an increase in the detection of small tumours, most likely as a result of overdetection. Concerted efforts are needed at a national level to reduce unnecessary thyroid ultrasound examinations in the asymptomatic general population.	[Park, Sohee; Oh, Chang-Mo; Cho, Hyunsoon; Lee, Joo Young; Jung, Kyu-Won; Jun, Jae Kwan; Won, Young-Joo; Kong, Hyun-Joo; Choi, Kui Son] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Park, Sohee] Yonsei Univ, Grad Sch Publ Hlth, Dept Biostat, Seoul, South Korea; [Cho, Hyunsoon; Jun, Jae Kwan; Won, Young-Joo; Choi, Kui Son; Lee, Jin Soo] Natl Canc Ctr, Dept Canc Control & Policy, Grad Sch Canc Sci & Policy, Goyang, South Korea; [Lee, Joo Young] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Lee, You Jin] Natl Canc Ctr, Ctr Thyroid Canc, Goyang, South Korea; [Lee, Jin Soo] Natl Canc Ctr, Res Inst & Hosp, 111 Jungbalsan Ro, Goyang 410769, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Lee, JS (corresponding author), Natl Canc Ctr, Res Inst & Hosp, 111 Jungbalsan Ro, Goyang 410769, Gyeonggi Do, South Korea.	jslee@ncc.re.kr		Park, Sohee/0000-0001-8513-5163	National Cancer Center [NCC-1310223, NCC-1032020]; NCC [NCC-1032020]	National Cancer Center; NCC	This work was supported by a grant from the National Cancer Center (NCC-1310223 and NCC-1032020). The views expressed in this article are those of the authors and do not necessarily represent the views of the NCC, Goyang, Korea. The NEST survey was conducted with funding support from the NCC (NCC-1032020). The funders had no role in coordinating the study or writing the manuscript.	Ahn HS, 2015, NEW ENGL J MED, V373, P2389, DOI 10.1056/NEJMc1507622; Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; Bahl M, 2014, WORLD J SURG, V38, P1312, DOI 10.1007/s00268-013-2407-9; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Castro MR, 2015, CANCER-AM CANCER SOC, V121, P3364, DOI 10.1002/cncr.29468; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Davies L, 2015, ENDOCR PRACT, V21, P686, DOI 10.4158/EP14466.DSCR; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Ferlay J, 2013, GLOBOCAN 2012 V10 CA; Forman D, 2013, CANC INCIDENCE 5 CON, VXIARC; Fritz AG., 2000, INT CLASSIFICATION D, V3rd; Greene F.L., 2002, MELANOMA SKIN, Vsixth, P209, DOI [10.1007/978-1-4757-3656-4_24, DOI 10.1007/978-1-4757-3656-4_24, 10.1007/978-1-4757-3656-4, DOI 10.1007/978-1-4757-3656-125]; Grodski S, 2008, SURGERY, V144, P1038, DOI 10.1016/j.surg.2008.08.023; Han MA, 2011, ASIAN PAC J CANCER P, V12, P1657; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hay ID, 2016, SURGERY, V159, P11, DOI 10.1016/j.surg.2015.05.046; Ito Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Jung KW, 2013, CANCER RES TREAT, V45, P162, DOI 10.4143/crt.2013.45.3.162; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Kim SH, 2009, J KOREAN THYROID ASS, V2, P33; Kweon SS, 2013, JPN J CLIN ONCOL, V43, P1039, DOI 10.1093/jjco/hyt102; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Lee KS, 2015, CANCER RES TREAT, V47, P387, DOI 10.4143/crt.2014.001; Lubitz CC, 2014, CANCER-AM CANCER SOC, V120, P1345, DOI 10.1002/cncr.28562; Malone MK, 2014, THYROID, V24, P314, DOI 10.1089/thy.2012.0651; Miyauchi A, 2016, WORLD J SURG, V40, P516, DOI 10.1007/s00268-015-3392-y; Morris LGT, 2010, AM J SURG, V200, P454, DOI 10.1016/j.amjsurg.2009.11.008; Oda H, 2016, THYROID, V26, P150, DOI 10.1089/thy.2015.0313; Oh CM, 2015, CANCER RES TREAT, V47, P362, DOI 10.4143/crt.2014.110; Oh CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099054; Pandeya N, 2016, CLIN ENDOCRINOL, V84, P257, DOI 10.1111/cen.12724; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Segi M., 1960, CANC MORTALITY SELEC; Veiga LHS, 2016, RADIAT RES, V185, P473, DOI 10.1667/RR14213.1; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Won YJ, 2009, CANCER RES TREAT, V41, P122, DOI 10.4143/crt.2009.41.3.122; Yi KH, 2015, J KOREAN MED ASSOC, V58, P302, DOI 10.5124/jkma.2015.58.4.302; Yi KH, 2010, ENDOCRINOL METAB, V25, P270, DOI 10.3803/EnM.2010.25.4.270; Yoo F, 2013, JAMA OTOLARYNGOL, V139, P1181, DOI 10.1001/jamaoto.2013.5050; Young JL, 2001, NIH PUB	42	85	90	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2016	355								i5745	10.1136/bmj.i5745	http://dx.doi.org/10.1136/bmj.i5745			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZD	27903497	Green Published, hybrid			2022-12-28	WOS:000389308600001
J	Kirby, T				Kirby, Tony			Targeting HIV prevention to young women in Africa	LANCET			English	Editorial Material																			0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2579	2579		10.1016/S0140-6736(16)32385-6	http://dx.doi.org/10.1016/S0140-6736(16)32385-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27894653				2022-12-28	WOS:000388516800012
J	Anders, HJ; Davis, JM; Thurau, K				Anders, Hans-Joachim; Davis, John M.; Thurau, Klaus			Nephron Protection in Diabetic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EMPAGLIFLOZIN		[Anders, Hans-Joachim] Klinikum Ludwig Maximilians Univ Munchen, Nephrol Zentrum, Med Klin & Poliklin 4, Munich, Germany; [Davis, John M.; Thurau, Klaus] Ludwig Maximilians Univ Munchen, Dept Physiol, Munich, Germany	University of Munich; University of Munich	Anders, HJ (corresponding author), Klinikum Ludwig Maximilians Univ Munchen, Nephrol Zentrum, Med Klin & Poliklin 4, Munich, Germany.		Anders, Hans-Joachim/ABD-6247-2021	Anders, Hans-Joachim/0000-0003-2434-2956				Carlstrom M, 2015, PHYSIOL REV, V95, P405, DOI 10.1152/physrev.00042.2012; THURAU KWC, 1972, CIRC RES, V31, pI182; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	5	66	67	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2096	2098		10.1056/NEJMcibr1608564	http://dx.doi.org/10.1056/NEJMcibr1608564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC9KU	27959742				2022-12-28	WOS:000388464300014
J	Forsmark, CE; Vege, SS; Wilcox, CM				Forsmark, Chris E.; Vege, Santhi Swaroop; Wilcox, C. Mel			Acute Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ALCOHOL-ASSOCIATED PANCREATITIS; MILD ACUTE-PANCREATITIS; POST-ERCP PANCREATITIS; NECROTIZING PANCREATITIS; RISK-FACTORS; FLUID RESUSCITATION; ANTIBIOTIC-TREATMENT; RANDOMIZED-TRIAL; PRIMARY-CARE; DOUBLE-BLIND		[Forsmark, Chris E.] Univ Florida, Div Gastroenterol Hepatol & Nutr, 1329 SW 16th St,Suite 5251,POB 100214, Gainesville, FL 32610 USA; [Vege, Santhi Swaroop] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Wilcox, C. Mel] Univ Alabama Birmingham, Div Gastroenterol & Hepatol, Birmingham, AL USA	State University System of Florida; University of Florida; Mayo Clinic; University of Alabama System; University of Alabama Birmingham	Forsmark, CE (corresponding author), Univ Florida, Div Gastroenterol Hepatol & Nutr, 1329 SW 16th St,Suite 5251,POB 100214, Gainesville, FL 32610 USA.	chris.forsmark@medicine.ufl.edu			Calci-Medica; Takeda; Bharat Serums and Vaccines; Teva; BCH Mumbai; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK108320] Funding Source: NIH RePORTER	Calci-Medica; Takeda(Takeda Pharmaceutical Company Ltd); Bharat Serums and Vaccines; Teva(Teva Pharmaceutical Industries); BCH Mumbai; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Swaroop Vege reports receiving consulting fees from Calci-Medica, Takeda, Bharat Serums and Vaccines, and Teva and fees for educational activities for residents and fellows from BCH Mumbai. No other potential conflict of interest relevant to this article was reported.	Al-Omran M, 2010, COCHRANE DB SYST REV, V1; Andersen DK, 2013, PANCREAS, V42, P1227, DOI 10.1097/MPA.0b013e3182a9ad9d; Apte MV, 2010, J GASTROEN HEPATOL, V25, P1816, DOI 10.1111/j.1440-1746.2010.06445.x; Bakker OJ, 2014, NEW ENGL J MED, V371, P1983, DOI 10.1056/NEJMoa1404393; Bakker OJ, 2013, GUT, V62, P1475, DOI 10.1136/gutjnl-2012-302870; Bakker OJ, 2012, JAMA-J AM MED ASSOC, V307, P1053, DOI 10.1001/jama.2012.276; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bertilsson S, 2015, PANCREAS, V44, P1096, DOI 10.1097/MPA.0000000000000406; Bertin C, 2012, AM J GASTROENTEROL, V107, P311, DOI 10.1038/ajg.2011.424; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Chang YS, 2013, CRIT CARE, V17, DOI 10.1186/cc12790; Cote GA, 2012, GASTROENTEROLOGY, V143, P1502, DOI 10.1053/j.gastro.2012.09.006; Cote GA, 2011, CLIN GASTROENTEROL H, V9, P266, DOI 10.1016/j.cgh.2010.10.015; Cotton PB, 2014, JAMA-J AM MED ASSOC, V311, P2101, DOI 10.1001/jama.2014.5220; da Costa DW, 2015, LANCET, V386, P1261, DOI 10.1016/S0140-6736(15)00274-3; Dellinger EP, 2007, ANN SURG, V245, P674, DOI 10.1097/01.sla.0000250414.09255.84; Dellinger EP, 2012, ANN SURG, V256, P875, DOI 10.1097/SLA.0b013e318256f778; DiMagno MJ, 2012, AM J GASTROENTEROL, V107, P318, DOI 10.1038/ajg.2011.430; Ding X, 2015, SURG-J R COLL SURG E, V13, P218, DOI 10.1016/j.surge.2014.11.005; Eckerwall GE, 2007, CLIN NUTR, V26, P758, DOI 10.1016/j.clnu.2007.04.007; Elmunzer BJ, 2012, NEW ENGL J MED, V366, P1414, DOI 10.1056/NEJMoa1111103; En-Qiang M, 2009, CHINESE MED J-PEKING, V122, P169, DOI 10.3760/cma.j.issn.0366-6999.2009.02.011; Forsmark CE, 2016, PANCREATOLOGY, V16, P10, DOI 10.1016/j.pan.2015.11.009; Freeman ML, 2012, PANCREAS, V41, P1176, DOI 10.1097/MPA.0b013e318269c660; Gardner TB, 2008, CLIN GASTROENTEROL H, V6, P1070, DOI 10.1016/j.cgh.2008.05.005; Gardner TB, 2009, PANCREATOLOGY, V9, P770, DOI 10.1159/000210022; Gurusamy KS, 2013, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD010326.PUB2; Haydock MD, 2013, ANN SURG, V257, P182, DOI 10.1097/SLA.0b013e31827773ff; Hazra N, 2014, BRIT J GEN PRACT, V64, pE295, DOI 10.3399/bjgp14X679732; Isenmann R, 2004, GASTROENTEROLOGY, V126, P997, DOI 10.1053/j.gastro.2003.12.050; Jacobson BC, 2007, CLIN GASTROENTEROL H, V5, P946, DOI 10.1016/j.cgh.2007.04.012; Krishna SG, 2015, AM J GASTROENTEROL, V110, P1607, DOI 10.1038/ajg.2015.343; Law R, 2015, EXPERT REV GASTROENT, V9, P167, DOI 10.1586/17474124.2014.943186; Lim CLL, 2015, J GASTROINTEST SURG, V19, P480, DOI 10.1007/s11605-014-2662-6; Lindkvist B, 2004, CLIN GASTROENTEROL H, V2, P831, DOI 10.1016/S1542-3565(04)00355-6; Mazaki T, 2014, J GASTROENTEROL, V49, P343, DOI 10.1007/s00535-013-0806-1; McAlister VC, 2007, COCHRANE DB SYST REV, V4; Mole DJ, 2011, HPB, V13, P51, DOI 10.1111/j.1477-2574.2010.00241.x; Mouli VP, 2013, GASTROENTEROLOGY, V144, P333, DOI 10.1053/j.gastro.2012.10.004; Mounzer R, 2012, GASTROENTEROLOGY, V142, P1476, DOI 10.1053/j.gastro.2012.03.005; Nitsche Claudia, 2012, Curr Gastroenterol Rep, V14, P131, DOI 10.1007/s11894-012-0245-9; Nordback I, 2009, GASTROENTEROLOGY, V136, P848, DOI 10.1053/j.gastro.2008.11.044; Pant C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095552; Peery AF, 2015, GASTROENTEROLOGY, V149, P1731, DOI 10.1053/j.gastro.2015.08.045; Pelli H, 2008, SCAND J GASTROENTERO, V43, P614, DOI 10.1080/00365520701843027; Phillip V, 2011, CLIN GASTROENTEROL H, V9, P995, DOI 10.1016/j.cgh.2011.06.016; Sadr-Azodi O, 2013, AM J GASTROENTEROL, V108, P133, DOI 10.1038/ajg.2012.381; Sand J, 2007, PANCREATOLOGY, V7, P147, DOI 10.1159/000104251; Sankaran SJ, 2015, GASTROENTEROLOGY, V149, P1490, DOI 10.1053/j.gastro.2015.07.066; Shen H, 2011, EUR J GASTROEN HEPAT, V23, P1136, DOI 10.1097/MEG.0b013e32834b0e0e; Spanier BWM, 2013, WORLD J GASTROENTERO, V19, P3018, DOI 10.3748/wjg.v19.i20.3018; Sun E, 2013, J PANCREAS, V14, P221, DOI 10.6092/1590-8577/871; Teich N, 2010, PANCREAS, V39, P1088, DOI 10.1097/MPA.0b013e3181d3ce05; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Tse F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009779.pub2; Valdivielso P, 2014, EUR J INTERN MED, V25, P689, DOI 10.1016/j.ejim.2014.08.008; van Baal MC, 2012, ANN SURG, V255, P860, DOI 10.1097/SLA.0b013e3182507646; van Santvoort HC, 2011, GASTROENTEROLOGY, V141, P1254, DOI 10.1053/j.gastro.2011.06.073; Varadarajulu S, 2013, GASTROENTEROLOGY, V145, P583, DOI 10.1053/j.gastro.2013.05.046; Villatoro E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002941.pub3; Vlada AC, 2013, HPB, V15, P822, DOI 10.1111/hpb.12140; Whitcomb DC, 2013, GASTROENTEROLOGY, V144, P1292, DOI 10.1053/j.gastro.2013.01.069; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Wu BU, 2008, GASTROENTEROLOGY, V135, P816, DOI 10.1053/j.gastro.2008.05.053; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026; Yadav D, 2003, J CLIN GASTROENTEROL, V36, P54, DOI 10.1097/00004836-200301000-00016; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Yadav D, 2014, PANCREAS, V43, P630, DOI 10.1097/MPA.0000000000000078; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yang CJ, 2014, DIGEST LIVER DIS, V46, P446, DOI 10.1016/j.dld.2014.01.158; Yi FM, 2012, INTERNAL MED, V51, P523, DOI 10.2169/internalmedicine.51.6685	71	366	438	11	160	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1972	1981		10.1056/NEJMra1505202	http://dx.doi.org/10.1056/NEJMra1505202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC1HS	27959604				2022-12-28	WOS:000387856100009
J	Korthuis, PT; McCarty, D; Weimer, M; Bougatsos, C; Blazina, I; Zakher, B; Grusing, S; Devine, B; Chou, R				Korthuis, P. Todd; McCarty, Dennis; Weimer, Melissa; Bougatsos, Christina; Blazina, Ian; Zakher, Bernadette; Grusing, Sara; Devine, Beth; Chou, Roger			Primary Care-Based Models for the Treatment of Opioid Use Disorder A Scoping Review	ANNALS OF INTERNAL MEDICINE			English	Review							PATIENTS RECEIVING BUPRENORPHINE/NALOXONE; HIV CLINICAL CARE; NEONATAL ABSTINENCE SYNDROME; DEPENDENT PATIENTS; INTEGRATED BUPRENORPHINE/NALOXONE; RELEASE NALTREXONE; COLLABORATIVE CARE; TREATMENT OUTCOMES; INFECTED PATIENTS; RANDOMIZED-TRIAL	Greater integration of medication-assisted treatment (MAT) for opioid use disorder (OUD) in U.S. primary care settings would expand access to treatment for this condition. Models for integrating MAT into primary care vary in structure. This article summarizes findings of a technical report for the Agency for Healthcare Research and Quality describing MAT models of care for OUD, based on a literature review and interviews with key informants in the field. The report describes 12 representative models of care for integrating MAT into primary care settings that could be considered for adaptation across diverse health care settings. Common components of existing care models include pharmacotherapy with buprenorphine or naltrexone, provider and community education, coordination and integration of OUD treatment with other medical and psychological needs, and psychosocial services and interventions. Models vary in how each component is implemented. Decisions about adopting MAT models of care should be individualized to address the unique milieu of each implementation setting.	[Korthuis, P. Todd; Weimer, Melissa] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code L-475, Portland, OR 97239 USA; [Devine, Beth] Univ Washington, Box 357630, Seattle, WA 98195 USA; [McCarty, Dennis] OHSU PSU Sch Publ Hlth, CB669,3186 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Bougatsos, Christina; Blazina, Ian; Zakher, Bernadette; Grusing, Sara; Chou, Roger] Oregon Hlth & Sci Univ, Mail Code BICC, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle; Oregon Health & Science University	Korthuis, PT (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code L-475, Portland, OR 97239 USA.	korthuis@ohsu.edu	Weimer, Melissa/M-5599-2019	Korthuis, Philip/0000-0001-5556-3597; Weimer, Melissa/0000-0002-5624-2434; Blazina, Ian/0000-0003-0164-6674; Chou, Roger/0000-0001-9889-8610	AHRQ, U.S. Department of Health and Human Services [HHSA290201500009I]; NATIONAL INSTITUTE ON DRUG ABUSE [UG1DA015815, R01DA037441, P50DA010233] Funding Source: NIH RePORTER	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was funded under contract HHSA290201500009I, Task Order 4, from the AHRQ, U.S. Department of Health and Human Services.	Alford DP, 2007, J GEN INTERN MED, V22, P171, DOI 10.1007/s11606-006-0023-1; Alford DP, 2011, ARCH INTERN MED, V171, P425, DOI 10.1001/archinternmed.2010.541; Alliance of Community Health Plans, 2013, VERM HLTH HOM OP ADD; Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; [Anonymous], 2011, J ACQUIR IMMUNE D S1, V56, pS46, DOI [10.1097/QAI.0b013e3182097561, DOI 10.1097/QAI.0B013E3182097561]; Carrieri MP, 2003, DRUG ALCOHOL DEPEN, V72, P13, DOI 10.1016/S0376-8716(03)00189-3; Center for Behavioral Health Statistics and Quality, 2015, HHS PUBL; Center for Substance Abuse Treatment. Substance Abuse Treatment: Group Therapy, 2005, SUBSTANCE ABUSE TREA, V41; Chaudhry AA, 2011, JAIDS-J ACQ IMM DEF, V56, pS14, DOI 10.1097/QAI.0b013e318209d3b9; Cheever LW, 2011, JAIDS-J ACQ IMM DEF, V56, pS3, DOI 10.1097/QAI.0b013e318209740f; Chen H., 2014, REPORT VERMONT LEGIS; Chou R, 2016, 290201500009I AG HEA; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Commonwealth of Massachusetts Executive Office of Health and Human Services, 2015, GET HELP TYP TREATM; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; D'Onofrio G, 2015, JAMA-J AM MED ASSOC, V313, P1636, DOI 10.1001/jama.2015.3474; Fiellin DA, 2002, AM J DRUG ALCOHOL AB, V28, P231, DOI 10.1081/ADA-120002972; Fiellin DA, 2008, AM J ADDICTION, V17, P116, DOI 10.1080/10550490701860971; Fiellin DA, 2006, NEW ENGL J MED, V355, P365, DOI 10.1056/NEJMoa055255; Fiellin DA, 2011, JAIDS-J ACQ IMM DEF, V56, pS33, DOI 10.1097/QAI.0b013e3182097537; Finkelstein R, 2011, JAIDS-J ACQ IMM DEF, V56, pS98, DOI 10.1097/QAI.0b013e31820a9a97; Friedland G, 2011, JAIDS-J ACQ IMM DEF, V56, pS1, DOI 10.1097/QAI.0b013e31820bc9ba; Health Resources and Services Administration, 2016, RYAN WHIT HIV AIDS P; HIV/AIDS Bureau, 2011, INT BUPR THER HIV PR; Jones CM, 2015, AM J PUBLIC HEALTH, V105, pE55, DOI 10.2105/AJPH.2015.302664; Jones HE, 2005, DRUG ALCOHOL DEPEN, V79, P1, DOI 10.1016/j.drugalcdep.2004.11.013; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Komaromy M, 2016, SUBST ABUS, V37, P20, DOI 10.1080/08897077.2015.1129388; Korthuis PT, 2011, JAIDS-J ACQ IMM DEF, V56, pS39, DOI 10.1097/QAI.0b013e318209754c; Korthuis PT, 2011, JAIDS-J ACQ IMM DEF, V56, pS83, DOI 10.1097/QAI.0b013e31820bc9a5; Korthuis PT, 2010, J ADDICT MED, V4, P204, DOI 10.1097/ADM.0b013e3181cc9610; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; LaBelle CT, 2016, J SUBST ABUSE TREAT, V60, P6, DOI 10.1016/j.jsat.2015.06.010; Liebschutz JM, 2014, JAMA INTERN MED, V174, P1369, DOI 10.1001/jamainternmed.2014.2556; LifeSpring Health Systems, 2016, US LOC; Lucas GM, 2010, ANN INTERN MED, V152, P704, DOI 10.7326/0003-4819-152-11-201006010-00003; Lum PJ, 2011, JAIDS-J ACQ IMM DEF, V56, pS91, DOI 10.1097/QAI.0b013e31820a9a82; Macrae J, 2015, HHS BLOG        0727; Mann C, 2014, MEDICATION ASSISTED; Mattick RP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub4; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; McConnell KJ, 2016, JAMA-J AM MED ASSOC, V315, P869, DOI 10.1001/jama.2016.0206; Moses K., 2015, DESIGNING MEDICAID H; National Institute on Drug Abuse, 2015, OV DEATH RAT; National Institute on Drug Abuse, 2012, TOP BRIEF MED ASS TR; Oregon Pain Guidance, 2016, PAIN MAN GUID TOOLS; Patient-Centered Primary Care Collaborative, 2015, VERM HUB SPOK HLTH H; Pecoraro A, 2012, SUBST USE MISUSE, V47, P1026, DOI 10.3109/10826084.2012.663292; Project ECHO, 2014, ECHO ACC OP US DIS T; Pupillo J., 2014, PROJECT ECHO TRAINS; Raymond SC, 2012, INTEGRATING BUPRENOR; Schackman BR, 2011, JAIDS-J ACQ IMM DEF, V56, pS76, DOI 10.1097/QAI.0b013e31820a9a66; Shanahan CW, 2010, J GEN INTERN MED, V25, P803, DOI 10.1007/s11606-010-1311-3; Stoller K., 2015, INNOVATIVE PRACTICES; Stoller K.B., 2015, ADDICT SCI CLIN PRAC, V10, pA63, DOI [10.1186/1940-0640-10-S1-A63, DOI 10.1186/1940-0640-10-S1-A63, 10.1186/1940-0640-10-s1-a63.]; Sullivan LE, 2006, CLIN INFECT DIS, V43, pS184, DOI 10.1086/508182; Sullivan LE, 2011, JAIDS-J ACQ IMM DEF, V56, pS54, DOI 10.1097/QAI.0b013e3182097576; TARGET Center, 2009, BEEHIVE BUPR PROGR T; The White House, 2015, PRES MEM ADDR PRESCR; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Vergara-Rodriguez P, 2011, JAIDS-J ACQ IMM DEF, V56, pS62, DOI 10.1097/QAI.0b013e31820a820f; Vermont Agency of Human Services, 2012, INT TREATM CONT SUBS; Weiss L, 2011, JAIDS-J ACQ IMM DEF, V56, pS7, DOI 10.1097/QAI.0b013e3182097426; Weiss L, 2011, JAIDS-J ACQ IMM DEF, V56, pS68, DOI 10.1097/QAI.0b013e31820a8226	66	166	167	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					268	+		10.7326/M16-2149	http://dx.doi.org/10.7326/M16-2149			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL7FO	27919103	Green Accepted			2022-12-28	WOS:000394786700016
J	Mehra, MR; Naka, Y; Uriel, N; Goldstein, DJ; Cleveland, JC; Colombo, PC; Walsh, MN; Milano, CA; Patel, CB; Jorde, UP; Pagani, FD; Aaronson, KD; Dean, DA; McCants, K; Itoh, A; Ewald, GA; Horstmanshof, D; Long, JW; Salerno, C				Mehra, Mandeep R.; Naka, Yoshifumi; Uriel, Nir; Goldstein, Daniel J.; Cleveland, Joseph C., Jr.; Colombo, Paolo C.; Walsh, Mary N.; Milano, Carmelo A.; Patel, Chetan B.; Jorde, Ulrich P.; Pagani, Francis D.; Aaronson, Keith D.; Dean, David A.; McCants, Kelly; Itoh, Akinobu; Ewald, Gregory A.; Horstmanshof, Douglas; Long, James W.; Salerno, Christopher		MOMENTUM 3 Investigators	A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR ASSIST DEVICE; THROMBOSIS; SUPPORT; MULTICENTER; DIAGNOSIS; PROTOCOL; OUTCOMES; THERAPY; TRIAL	BACKGROUND Continuous-flow left ventricular assist systems increase the rate of survival among patients with advanced heart failure but are associated with the development of pump thrombosis. We investigated the effects of a new magnetically levitated centrifugal continuous-flow pump that was engineered to avert thrombosis. METHODS We randomly assigned patients with advanced heart failure to receive either the new centrifugal continuous-flow pump or a commercially available axial continuous-flow pump. Patients could be enrolled irrespective of the intended goal of pump support (bridge to transplantation or destination therapy). The primary end point was a composite of survival free of disabling stroke (with disabling stroke indicated by a modified Rankin score >3; scores range from 0 to 6, with higher scores indicating more severe disability) or survival free of reoperation to replace or remove the device at 6 months after implantation. The trial was powered for noninferiority testing of the primary end point (noninferiority margin, -10 percentage points). RESULTS Of 294 patients, 152 were assigned to the centrifugal-flow pump group and 142 to the axial-flow pump group. In the intention-to-treat population, the primary end point occurred in 131 patients (86.2%) in the centrifugal-flow pump group and in 109 (76.8%) in the axial-flow pump group (absolute difference, 9.4 percentage points; 95% lower confidence boundary, -2.1 [P<0.001 for noninferiority]; hazard ratio, 0.55; 95% confidence interval [CI], 0.32 to 0.95 [two-tailed P = 0.04 for superiority]). There were no significant between-group differences in the rates of death or disabling stroke, but reoperation for pump malfunction was less frequent in the centrifugal-flow pump group than in the axial-flow pump group (1 [0.7%] vs. 11 [7.7%]; hazard ratio, 0.08; 95% CI, 0.01 to 0.60; P = 0.002). Suspected or confirmed pump thrombosis occurred in no patients in the centrifugal-flow pump group and in 14 patients (10.1%) in the axial-flow pump group. CONCLUSIONS Among patients with advanced heart failure, implantation of a fully magnetically levitated centrifugal-flow pump was associated with better outcomes at 6 months than was implantation of an axial-flow pump, primarily because of the lower rate of reoperation for pump malfunction.	[Mehra, Mandeep R.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Mehra, Mandeep R.] Harvard Med Sch, Boston, MA USA; [Naka, Yoshifumi; Colombo, Paolo C.] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA; [Naka, Yoshifumi; Colombo, Paolo C.] New York Presbyterian Hosp, New York, NY USA; [Goldstein, Daniel J.; Jorde, Ulrich P.] Montefiore Einstein Ctr Heart & Vasc Care, New York, NY USA; [Uriel, Nir] Univ Chicago, Sch Med, Chicago, IL 60637 USA; [Uriel, Nir] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Cleveland, Joseph C., Jr.] Univ Colorado, Sch Med, Denver, CO USA; [Walsh, Mary N.; Salerno, Christopher] St Vincent Heart Ctr, Indianapolis, IN USA; [Milano, Carmelo A.; Patel, Chetan B.] Duke Univ, Duke Heart Ctr, Durham, NC USA; [Pagani, Francis D.; Aaronson, Keith D.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Dean, David A.; McCants, Kelly] Piedmont Hosp, Atlanta, GA USA; [Itoh, Akinobu; Ewald, Gregory A.] Washington Univ, Sch Med, St Louis, MO USA; [Horstmanshof, Douglas; Long, James W.] Integris Baptist Med Ctr, Oklahoma City, OK USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Columbia University; NewYork-Presbyterian Hospital; University of Chicago; University of Chicago; University of Chicago Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Duke University; University of Michigan System; University of Michigan; Washington University (WUSTL)	Mehra, MR (corresponding author), Brigham & Womens Hosp, Heart & Vasc Ctr, Ctr Adv Heart Dis, 75 Francis St, Boston, MA 02115 USA.	mmehra@bwh.harvard.edu	Mehra, Mandeep R/O-7273-2019; Mehra, Mandeep R/G-3484-2013; Goldstein, Daniel J/I-5723-2019	Mehra, Mandeep R/0000-0001-8683-7044; Mehra, Mandeep R/0000-0001-8683-7044; Lima, Brian/0000-0002-2555-2229; Entwistle, John/0000-0002-1492-6483; Pagani, Francis/0000-0003-4430-9969	St. Jude Medical	St. Jude Medical(St. Jude Medical)	Supported by St. Jude Medical.	Heatley G, 2016, J HEART LUNG TRANSPL, V35, P528, DOI 10.1016/j.healun.2016.01.021; Kirklin JK, 2015, J HEART LUNG TRANSPL, V34, P1495, DOI 10.1016/j.healun.2015.10.003; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P12, DOI 10.1016/j.healun.2013.11.001; Mehra MR, 2014, J HEART LUNG TRANSPL, V33, P1, DOI 10.1016/j.healun.2013.12.002; Najjar SS, 2014, J HEART LUNG TRANSPL, V33, P23, DOI 10.1016/j.healun.2013.12.001; Netuka I, 2016, J HEART LUNG TRANSPL, V35, P860, DOI 10.1016/j.healun.2016.05.019; Netuka I, 2015, J AM COLL CARDIOL, V66, P2579, DOI 10.1016/j.jacc.2015.09.083; Pagani FD, 2016, J HEART LUNG TRANSPL, V35, P1277, DOI 10.1016/j.healun.2016.09.002; Patel CB, 2014, J HEART LUNG TRANSPL, V33, P667, DOI 10.1016/j.healun.2014.02.014; Schmitto JD, 2015, J HEART LUNG TRANSPL, V34, P858, DOI 10.1016/j.healun.2015.03.001; Shah P, 2014, J HEART LUNG TRANSPL, V33, P102, DOI 10.1016/j.healun.2013.07.013; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Starling RC, 2014, NEW ENGL J MED, V370, P33, DOI 10.1056/NEJMoa1313385; Stewart GC, 2015, J HEART LUNG TRANSPL, V34, P1511, DOI 10.1016/j.healun.2015.10.038; Stulak JM, 2015, J HEART LUNG TRANSPL, V34, P1535, DOI 10.1016/j.healun.2015.10.020; Teuteberg JJ, 2013, JACC-HEART FAIL, V1, P369, DOI 10.1016/j.jchf.2013.05.006; Uriel N, 2014, J HEART LUNG TRANSPL, V33, P51, DOI 10.1016/j.healun.2013.10.005; Willey JZ, 2014, J HEART LUNG TRANSPL, V33, P878, DOI 10.1016/j.healun.2014.05.005	18	471	479	3	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					440	450		10.1056/NEJMoa1610426	http://dx.doi.org/10.1056/NEJMoa1610426			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ8WH	27959709	Bronze			2022-12-28	WOS:000393507200007
J	Ma, CY; Kurita, D; Li, NN; Chen, Y; Himeno, H; Gao, N				Ma, Chengying; Kurita, Daisuke; Li, Ningning; Chen, Yan; Himeno, Hyouta; Gao, Ning			Mechanistic insights into the alternative translation termination by ArfA and RF2	NATURE			English	Article							PEPTIDYL-TRANSFER-RNA; RIBOSOME-RESCUE; ESCHERICHIA-COLI; STALLED RIBOSOMES; NONSTOP TRANSLATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MESSENGER-RNA; RELEASE; TMRNA	During cellular translation of messenger RNAs by ribosomes, the translation apparatus sometimes pauses or stalls at the elongation and termination steps(1-6). With the exception of programmed stalling, which is usually used by cells for regulatory purposes(5,7,8), ribosomes stalled on mRNAs need to be terminated and recycled to maintain adequate translation capacity(9). Much ribosome stalling originates in aberrant mRNAs that lack a stop codon. Transcriptional errors, misprocessing of primary transcripts, and undesired mRNA cleavage all contribute to the formation of nonstop mRNAs. Ribosomes stalled at the 3' end of non-stop mRNAs do not undergo normal termination owing to the lack of specific stop-codon recognition by canonical peptide release factors at the A-site decoding centre. In bacteria, the transfer-messenger RNA (tmRNA)-SmpB-mediated trans-translation rescue system reroutes stalled ribosomes to the normal elongation cycle and translation termination(3,4,10-12). Two additional rescue systems, ArfA-RF2 (refs 13-16) and ArfB (formerly known as YaeJ)(17,18), are also present in many bacterial species, but their mechanisms are not fully understood. Here, using cryo-electron microscopy, we characterize the structure of the Escherichia coli 70S ribosome bound with ArfA, the release factor RF2, a short non-stop mRNA and a cognate P-site tRNA. The C-terminal loop of ArfA occupies the mRNA entry channel on the 30S subunit, whereas its N terminus is sandwiched between the decoding centre and the switch loop of RF2, leading to marked conformational changes in both the decoding centre and RF2. Despite the distinct conformation of RF2, its conserved catalytic GGQ motif is precisely positioned next to the CCA-end of the P-site tRNA. These data illustrate a stop-codon surrogate mechanism for ArfA in facilitating the termination of non-stop ribosomal complexes by RF2.	[Ma, Chengying; Chen, Yan; Gao, Ning] Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Kurita, Daisuke; Himeno, Hyouta] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori 0368561, Japan; [Li, Ningning] Peking Univ, Sch Life Sci, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Tsinghua University; Hirosaki University; Peking University	Gao, N (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China.; Himeno, H (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori 0368561, Japan.	himeno@hirosaki-u.ac.jp; ninggao@tsinghua.edu.cn	Gao, Ning/AAK-2214-2020; Gao, Ning/J-9623-2012; Kurita, Daisuke/E-9135-2013	Gao, Ning/0000-0003-3067-9993; Gao, Ning/0000-0003-3067-9993; Kurita, Daisuke/0000-0003-3426-3864; Li, Ningning/0000-0001-8601-5171	National Natural Science Foundation of China [31422016, 31470722, 31630087]; Ministry of Science and Technology of China [2016YFA0500700, 2013CB910404]; Japan Society for the Promotion of Science [16K18684]; Peking-Tsinghua Center for Life Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Peking-Tsinghua Center for Life Sciences	We thank the National Center for Protein Sciences (Beijing, China) for providing resources for data collection and computation. Part of the computation was performed on the Computing Platform of the Center for Life Science, Peking Univesity. We also thank S. Goto for providing expression vectors and the staff of Gene Research Center of Hirosaki University for the use of the facility. This work was supported by the National Natural Science Foundation of China (31422016, 31470722 and 31630087 to N.G.), the Ministry of Science and Technology of China (2016YFA0500700 and 2013CB910404 to N.G.) and by the Japan Society for the Promotion of Science (16K18684 to D.K.). N.L. is supported by a postdoctoral fellowship from the Peking-Tsinghua Center for Life Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Chadani Y, 2011, GENES GENET SYST, V86, P151; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gagnon MG, 2012, SCIENCE, V335, P1370, DOI 10.1126/science.1217443; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Giudice E, 2013, TRENDS BIOCHEM SCI, V38, P403, DOI 10.1016/j.tibs.2013.06.002; Guo Q, 2011, P NATL ACAD SCI USA, V108, P13100, DOI 10.1073/pnas.1104645108; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Himeno H, 2015, BIOCHIMIE, V114, P102, DOI 10.1016/j.biochi.2014.11.014; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Jin H, 2010, P NATL ACAD SCI USA, V107, P8593, DOI 10.1073/pnas.1003995107; Keiler KC, 2015, NAT REV MICROBIOL, V13, P285, DOI 10.1038/nrmicro3438; Keiler KC, 2014, J BACTERIOL, V196, P2123, DOI 10.1128/JB.01490-14; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kurita D, 2014, NUCLEIC ACIDS RES, V42, P13339, DOI 10.1093/nar/gku1069; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neubauer C, 2012, SCIENCE, V335, P1366, DOI 10.1126/science.1217039; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierson WE, 2016, CELL REP, V17, P11, DOI 10.1016/j.celrep.2016.08.085; Ramrath DJF, 2012, NATURE, V485, P526, DOI 10.1038/nature11006; Richter JD, 2015, CELL, V163, P292, DOI 10.1016/j.cell.2015.09.041; Santos N, 2013, STRUCTURE, V21, P1258, DOI 10.1016/j.str.2013.04.028; Schaub RE, 2012, J BIOL CHEM, V287, P29765, DOI 10.1074/jbc.M112.374074; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Simms CL, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1366; Starosta AL, 2014, FEMS MICROBIOL REV, V38, P1172, DOI 10.1111/1574-6976.12083; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Wilson DN, 2016, CURR OPIN STRUC BIOL, V37, P123, DOI 10.1016/j.sbi.2016.01.008; Zeng FX, 2016, RNA, V22, P49, DOI 10.1261/rna.053082.115; Zhang YQ, 2015, NAT STRUCT MOL BIOL, V22, P906, DOI 10.1038/nsmb.3103	47	27	59	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					550	553		10.1038/nature20822	http://dx.doi.org/10.1038/nature20822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6LX	27906160				2022-12-28	WOS:000396116600055
J	Rugo, HS; Barve, A; Waller, CF; Hernandez-Bronchud, M; Herson, J; Yuan, JY; Sharma, R; Baczkowski, M; Kothekar, M; Loganathan, S; Manikhas, A; Bondarenko, I; Mukhametshina, G; Nemsadze, G; Parra, JD; Abesamis-Tiambeng, MLT; Baramidze, K; Akewanlop, C; Vynnychenko, I; Sriuranpong, V; Mamillapalli, G; Ray, S; Ruiz, EPY; Pennella, E				Rugo, Hope S.; Barve, Abhijit; Waller, Cornelius F.; Hernandez-Bronchud, Miguel; Herson, Jay; Yuan, Jinyu; Sharma, Rajiv; Baczkowski, Mark; Kothekar, Mudgal; Loganathan, Subramanian; Manikhas, Alexey; Bondarenko, Igor; Mukhametshina, Guzel; Nemsadze, Gia; Parra, Joseph D.; Abesamis-Tiambeng, Maria Luisa T.; Baramidze, Kakhaber; Akewanlop, Charuwan; Vynnychenko, Ihor; Sriuranpong, Virote; Mamillapalli, Gopichand; Ray, Sirshendu; Yanez Ruiz, Eduardo P.; Pennella, Eduardo		Heritage Study Investigators	Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHASE-II TRIAL; ADJUVANT CHEMOTHERAPY; PLUS; THERAPY; DOCETAXEL	IMPORTANCE Treatment with the anti-ERBB2 humanized monoclonal antibody trastuzumab and chemotherapy significantly improves outcome in patients with ERBB2 (HER2)-positive metastatic breast cancer; a clinically effective biosimilar may help increase access to this therapy. OBJECTIVE To compare the overall response rate and assess the safety of a proposed trastuzumab biosimilar plus a taxane or trastuzumab plus a taxane in patients without prior treatment for ERBB2-positivemetastatic breast cancer. DESIGN, SETTING, AND PARTICIPANTS Multicenter, double-blind, randomized, parallel-group, phase 3 equivalence study in patients with metastatic breast cancer. From December 2012 to August 2015, 500 patients were randomized 1: 1 to receive a proposed biosimilar or trastuzumab plus a taxane. Chemotherapy was administered for at least 24 weeks followed by antibody alone until unacceptable toxic effects or disease progression occurred. INTERVENTIONS Proposed biosimilar (n = 230) or trastuzumab (n = 228) with a taxane. MAIN OUTCOMES AND MEASURES The primary outcome was week 24 overall response rate (ORR) defined as complete or partial response. Equivalence boundaries were 0.81 to 1.24 with a 90% CI for ORR ratio (proposed biosimilar/trastuzumab) and -15% to 15% with a 95% CI for ORR difference. Secondary outcome measures included time to tumor progression, progression-free and overall survival at week 48, and adverse events. RESULTS Among 500 women randomized, the intention-to-treat population included 458 women (mean [SD] age, 53.6 [11.11] years) and the safety population included 493 women. The ORR was 69.6%(95% CI, 63.62%-75.51%) for the proposed biosimilar vs 64.0%(95% CI, 57.81%-70.26%) for trastuzumab. The ORR ratio (1.09; 90% CI, 0.974-1.211) and ORR difference (5.53; 95% CI, -3.08 to 14.04) were within the equivalence boundaries. At week 48, there was no statistically significant difference with the proposed biosimilar vs trastuzumab for time to tumor progression (41.3% vs 43.0%; -1.7%; 95% CI, -11.1% to 6.9%), progression-free survival (44.3% vs 44.7%; -0.4%; 95% CI, -9.4% to 8.7%), or overall survival (89.1% vs 85.1%; 4.0%; 95% CI, -2.1% to 10.3%). In the proposed biosimilar and trastuzumab groups, 239 (98.6%) and 233 (94.7%) had at least 1 adverse event, the most common including neutropenia (57.5% vs 53.3%), peripheral neuropathy (23.1% vs 24.8%), and diarrhea (20.6% vs 20.7%). CONCLUSIONS AND RELEVANCE Among women with ERBB2-positivemetastatic breast cancer receiving taxanes, the use of a proposed trastuzumab biosimilar compared with trastuzumab resulted in an equivalent overall response rate at 24 weeks. Further study is needed to assess safety and long-term clinical outcome.	[Rugo, Hope S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 1600 Divisadero St, San Francisco, CA 94127 USA; [Barve, Abhijit; Kothekar, Mudgal; Loganathan, Subramanian] Biocon Res Ltd, Bangalore, Karnataka, India; [Barve, Abhijit; Yuan, Jinyu; Sharma, Rajiv; Baczkowski, Mark; Pennella, Eduardo] Mylan Inc, Canonsburg, PA USA; [Waller, Cornelius F.] Univ Med Ctr Freiburg, Dept Haematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Waller, Cornelius F.] Univ Freiburg, Fac Med, Freiburg, Germany; [Hernandez-Bronchud, Miguel] Quiron Dexeus, Barcelona, Spain; [Herson, Jay] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Yuan, Jinyu; Baczkowski, Mark; Pennella, Eduardo] Mylan Inc, Canonsburg, PA USA; [Manikhas, Alexey] City Clin Oncol Dispensary, St Petersburg, Russia; [Bondarenko, Igor] Dnipropetrovsk State Med Acad, Dnepropetrovsk, Ukraine; [Mukhametshina, Guzel] Reg Clin Oncol Ctr, Kazan, Russia; [Nemsadze, Gia] Inst Clin Oncol, Tbilisi, Georgia; [Parra, Joseph D.] St Lukes Med Ctr Global City, Taguig City, Philippines; [Abesamis-Tiambeng, Maria Luisa T.] Cardinal Santos Med Ctr, Manila, Philippines; [Baramidze, Kakhaber] Golden Fleece 21 Century Hlth House Ltd, Tbilisi, Georgia; [Akewanlop, Charuwan] Siriraj Hosp, Bangkok, Thailand; [Vynnychenko, Ihor] Sumy State Univ, Sumy, Ukraine; [Sriuranpong, Virote] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Mamillapalli, Gopichand] City Canc Ctr, Vijayawada, India; [Ray, Sirshendu] Curie Manavata Canc Ctr, Nasik, India; [Yanez Ruiz, Eduardo P.] Inst Clin Oncolo Sur, Temuco, Chile	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Biocon Limited; University of Freiburg; University of Freiburg; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Dnipro State Medical University; Mahidol University; Ministry of Education & Science of Ukraine; Sumy State University; Chulalongkorn University	Rugo, HS (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 1600 Divisadero St, San Francisco, CA 94127 USA.	hope.rugo@ucsf.edu	Vynnychenko, Ihor O/E-1684-2012; Manikhas, Alexey/ABI-7193-2020; Akewanlop, Charuwan/AFU-5176-2022; Bondarenko, Igor N/GQP-1497-2022; Bondarenko, Igor/U-5156-2017; Bondarenko, Igor/W-9412-2019	Vynnychenko, Ihor O/0000-0002-2339-6509; Akewanlop, Charuwan/0000-0003-1022-3745; Bondarenko, Igor N/0000-0002-7071-2471; Bondarenko, Igor/0000-0002-7071-2471; Bondarenko, Igor/0000-0002-7071-2471; Manikhas, Alexey/0000-0001-9616-6635; Waller, Cornelius/0000-0002-5777-0212	Mylan Inc; Biocon Research Limited	Mylan Inc; Biocon Research Limited	The Heritage Study was funded and sponsored by Mylan Inc and Biocon Research Limited.	Baer WH, 2014, PHARMACEUTICALS, V7, P530, DOI 10.3390/ph7050530; Bang YJ, 2010, LANCET, V376, P1302; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Bellati F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/890758; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellis PG, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.29_suppl.20; European Medicines Agency, 2014, GUID SIM BIOL MED PR; Expert Committee on Biological Standardization, 2009, GUID EV SIM BIOTH PR; Gasparini G, 2007, BREAST CANCER RES TR, V101, P355, DOI 10.1007/s10549-006-9306-9; Gelmon KA, 2015, J CLIN ONCOL, V33, P1574, DOI 10.1200/JCO.2014.56.9590; Hegg R, 2012, ESMO C 2012 EUR SOC; Ismael G, 2012, LANCET ONCOL, V13, P869, DOI 10.1016/S1470-2045(12)70329-7; Lammers P, 2014, PHARMACEUTICALS-BASE, V7, P943, DOI 10.3390/ph7090943; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; McCamish M, 2011, MABS-AUSTIN, V3, P209, DOI 10.4161/mabs.3.2.15005; Mulcahy MW, 2014, COST SAVINGS POTENTI; Mylan Inc, 2015, PHARM 2015 M BRIT PH; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Rugo HS, 2016, CANCER TREAT REV, V46, P73, DOI 10.1016/j.ctrv.2016.04.003; Sharkey RM, 2006, CA-CANCER J CLIN, V56, P226, DOI 10.3322/canjclin.56.4.226; Singh SC, 2015, AM J MANAG CARE, V21, pS331; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; US Department of Health and Human Services; US Food and Drug Administration; Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research, 2015, SCI CONS DEM BIOS RE	25	110	115	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					37	47		10.1001/jama.2016.18305	http://dx.doi.org/10.1001/jama.2016.18305			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	27918780	Bronze			2022-12-28	WOS:000391009100018
J	Grayling, AC				Grayling, A. C.			CHRISTMAS 2016: BEING WELL Morality and non-medical drug use	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Grayling, A. C.] New Coll Humanities, London WC1B 3HH, England		Grayling, AC (corresponding author), New Coll Humanities, London WC1B 3HH, England.	acgrayling@yahoo.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2016	355								i5850	10.1136/bmj.i5850	http://dx.doi.org/10.1136/bmj.i5850			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SZ	27940433				2022-12-28	WOS:000390037600001
J	Roman, NG				Roman, Nancy Grace			Following my lucky star	SCIENCE			English	Editorial Material									[Roman, Nancy Grace] NASA, Astron Program, Washington, DC 20024 USA; [Roman, Nancy Grace] NASA, Relat Program, Washington, DC 20024 USA	National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA)	Roman, NG (corresponding author), NASA, Astron Program, Washington, DC 20024 USA.								0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1346	1346		10.1126/science.354.6317.1346	http://dx.doi.org/10.1126/science.354.6317.1346			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940878				2022-12-28	WOS:000389598800065
J	Savage, N				Savage, Neil			The promise of printing	NATURE			English	Editorial Material							BIOINK											Armstrong JPK, 2016, ADV HEALTHC MATER, V5, P1724, DOI 10.1002/adhm.201600022; Kador KE, 2016, TISSUE ENG PT A, V22, P286, DOI [10.1089/ten.tea.2015.0373, 10.1089/ten.TEA.2015.0373]; Kolesky DB, 2016, P NATL ACAD SCI USA, V113, P3179, DOI 10.1073/pnas.1521342113; Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935; Yu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep28714	5	9	9	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					S56	S57		10.1038/540S56a	http://dx.doi.org/10.1038/540S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27926696	Bronze			2022-12-28	WOS:000389548700004
J	Wasson, LT; Cusmano, A; Meli, L; Louh, I; Falzon, L; Hampsey, M; Young, G; Shaffer, J; Davidson, KW				Wasson, Lauren T.; Cusmano, Amberle; Meli, Laura; Louh, Irene; Falzon, Louise; Hampsey, Meghan; Young, Geoffrey; Shaffer, Jonathan; Davidson, Karina W.			Association Between Learning Environment Interventions and Medical Student Well-being	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MENTAL-HEALTH-SERVICES; EDUCATION RESEARCH; SUICIDAL IDEATION; PSYCHOLOGICAL DISTRESS; STRESS-MANAGEMENT; SCHOOL; DEPRESSION; PROGRAM; SCALE; MINDFULNESS	IMPORTANCE Concerns exist about the current quality of undergraduate medical education and its effect on students' well-being. OBJECTIVE To identify best practices for undergraduate medical education learning environment interventions that are associated with improved emotional well-being of students. DATA SOURCES Learning environment interventions were identified by searching the biomedical electronic databases Ovid MEDLINE, EMBASE, the Cochrane Library, and ERIC from database inception dates to October 2016. Studies examined any intervention designed to promote medical students' emotional well-being in the setting of a US academic medical school, with an outcome defined as students' reports of well-being as assessed by surveys, semistructured interviews, or other quantitative methods. DATA EXTRACTION AND SYNTHESIS Two investigators independently reviewed abstracts and full-text articles. Data were extracted into tables to summarize results. Study quality was assessed by the Medical Education Research Study Quality Instrument (MERQSI), which has a possible range of 5 to 18; higher scores indicate higher design and methods quality and a score of 14 or higher indicates a high-quality study. FINDINGS Twenty-eight articles including at least 8224 participants met eligibility criteria. Study designs included single-group cross-sectional or posttest only (n = 10), single-group pretest/posttest (n = 2), nonrandomized 2-group (n = 13), and randomized clinical trial (n = 3); 89.2% were conducted at a single site, and the mean MERSQI score for all studies was 10.3 (SD, 2.11; range, 5-13). Studies encompassed a variety of interventions, including those focused on pass/fail grading systems (n = 3; mean MERSQI score, 12.0), mental health programs (n = 4; mean MERSQI score, 11.9), mind-body skills programs (n = 7; mean MERSQI score, 11.3), curriculum structure (n = 3; mean MERSQI score, 9.5), multicomponent program reform (n = 5; mean MERSQI score, 9.4), wellness programs (n = 4; mean MERSQI score, 9.0), and advising/mentoring programs (n = 3; mean MERSQI score, 8.2). CONCLUSIONS AND RELEVANCE In this systematic review, limited evidence suggested that some specific learning environment interventions were associated with improved emotional well-being among medical students. However, the overall quality of the evidence was low, highlighting the need for high-quality medical education research.	[Wasson, Lauren T.; Cusmano, Amberle; Meli, Laura; Louh, Irene; Falzon, Louise; Davidson, Karina W.] Columbia Univ Med Ctr, Ctr Behav Cardiovasc Hlth, 622 W 168th St,PH 9-314, New York, NY 10032 USA; [Hampsey, Meghan] George Washington Univ, Washington, DC USA; [Young, Geoffrey] Assoc Amer Med Colleges, Washington, DC USA; [Shaffer, Jonathan] Univ Colorado Denver, Dept Psychol, Coll Liberal Arts & Sci, Denver, CO USA; [Davidson, Karina W.] NewYork Presbyterian Hosp, New York, NY USA	Columbia University; George Washington University; Association of American Medical Colleges; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; NewYork-Presbyterian Hospital	Davidson, KW (corresponding author), Columbia Univ Med Ctr, Ctr Behav Cardiovasc Hlth, 622 W 168th St,PH 9-314, New York, NY 10032 USA.	kd2124@cumc.columbia.edu	Falzon, Louise/HCI-2175-2022; Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Falzon, Louise/AAG-2404-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Falzon, Louise/0000-0002-9449-6056	National Heart, Lung, and Blood Institute [K24 HL084034]; Agency for Healthcare Research and Quality [K08 HS024598]; National Institutes of Health [U24AG052175, 515-0142]; Columbia University Medical Center; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS024158, K08HS024598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343, K24HL084034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG052175] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University Medical Center; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Davidson was supported by research grant K24 HL084034 from the National Heart, Lung, and Blood Institute. Dr Wasson was supported by research grant K08 HS024598 from the Agency for Healthcare Research and Quality. Ms Falzon was supported by research grant U24AG052175 and contract 515-0142, both from the National Institutes of Health, and by Columbia University Medical Center.	Association of American Medical Colleges, 2004, ED DOCT PROV HIGH QU; Bloodgood RA, 2009, ACAD MED, V84, P655, DOI 10.1097/ACM.0b013e31819f6d78; BOLLEN KA, 1990, SOC FORCES, V69, P479, DOI 10.2307/2579670; Bond AR, 2013, MED EDUC ONLINE, V18, DOI 10.3402/meo.v18i0.20699; Brazeau CMLR, 2014, ACAD MED, V89, P1520, DOI 10.1097/ACM.0000000000000482; BROOK RH, 1979, CONCEPTUALIZATION ME, V8; CAMP DL, 1994, ACAD MED, V69, pS25, DOI 10.1097/00001888-199410000-00031; Coates WC, 2008, ACAD MED, V83, P754, DOI 10.1097/ACM.0b013e31817eb7dc; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Cook DA, 2015, ACAD MED, V90, P1067, DOI 10.1097/ACM.0000000000000786; Cote L, 2005, MED TEACH, V27, P71, DOI 10.1080/01421590400016308; Derogatis L.R, 1983, SCL 90 R ADM SCORING, VII; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Dezee KJ, 2012, MED TEACH, V34, P521, DOI 10.3109/0142159X.2012.668248; Downs N, 2014, ACAD PSYCHIATR, V38, P547, DOI 10.1007/s40596-014-0115-x; Drolet BC, 2010, ACAD MED, V85, P103, DOI 10.1097/ACM.0b013e3181c46963; Dupuy H.J., 1978, AM PUBL HLTH ASS M; Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008; Dyrbye LN, 2015, ACAD MED, V90, P961, DOI 10.1097/ACM.0000000000000655; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Erogul M, 2014, TEACH LEARN MED, V26, P350, DOI 10.1080/10401334.2014.945025; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; FICKLIN FL, 1983, J MED EDUC, V58, P817; Finkelstein C, 2007, MED EDUC, V41, P258, DOI 10.1111/j.1365-2929.2007.02685.x; Fleming A, 2013, ACAD MED, V88, P1246, DOI 10.1097/ACM.0b013e31829f8e2a; Gelfand J., 2000, GL C SERIES, V4, P1; Gentile Julie P, 2009, Psychiatry (Edgmont), V6, P38; Givens JL, 2002, ACAD MED, V77, P918, DOI 10.1097/00001888-200209000-00024; GOETZEL RZ, 1984, J MED EDUC, V59, P331; Green JL, 2006, HANDBOOK OF COMPLEMENTARY METHODS IN EDUCATION RESEARCH, pXV; Greeson JM, 2015, EXPLORE-NY, V11, P186, DOI 10.1016/j.explore.2015.02.003; Hojat M, 2001, EDUC PSYCHOL MEAS, V61, P349, DOI 10.1177/00131640121971158; HOLTZWORTHMUNROE A, 1985, J MED EDUC, V60, P417; Johansson AC, 2011, ACAD MED, V86, P809, DOI 10.1097/ACM.0b013e31821d6c4c; Jones KG, 2003, FASEB J, V17, pA385; Keune JD, 2013, ACAD MED, V88, P449, DOI 10.1097/ACM.0b013e3182854bef; Kornitzer B, 2005, MT SINAI J MED, V72, P317; Kraemer KM, 2016, TEACH LEARN MED, V28, P219, DOI 10.1080/10401334.2016.1146605; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kushner RF, 2011, ACAD MED, V86, P901, DOI 10.1097/ACM.0b013e31821da193; Lee J, 2001, MED EDUC, V35, P652, DOI 10.1046/j.1365-2923.2001.00956.x; Lin H, 2016, ACAD MED, V91, P140, DOI 10.1097/ACM.0000000000000937; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; McNair D.M., 1992, POMS MANUAL PROFILE; Moos R.H., 1974, PRELIMINARY MANUAL F; MOOS RH, 1968, J RES CRIME DELINQ, V5, P174, DOI 10.1177/002242786800500207; MOOS RH, 1968, J ABNORM PSYCHOL, V73, P595, DOI 10.1037/h0026600; Mosteller F., 2002, EVIDENCE MATTERS RAN; Moutier C, 2012, ACAD MED, V87, P320, DOI 10.1097/ACM.0b013e31824451ad; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; PLAUT SM, 1993, ACAD MED, V68, P360, DOI 10.1097/00001888-199305000-00019; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reed DA, 2007, JAMA-J AM MED ASSOC, V298, P1002, DOI 10.1001/jama.298.9.1002; Reed DA, 2011, ACAD MED, V86, P1367, DOI 10.1097/ACM.0b013e3182305d81; ROBINS LS, 1995, ACAD MED, V70, P327, DOI 10.1097/00001888-199504000-00019; Rohe DE, 2006, MAYO CLIN PROC, V81, P1443, DOI 10.4065/81.11.1443; Rose GL, 2005, ACAD MED, V80, P344, DOI 10.1097/00001888-200504000-00007; Rosenzweig S, 2003, TEACH LEARN MED, V15, P88, DOI 10.1207/S15328015TLM1502_03; ROTHMAN AI, 1970, J MED EDUC, V45, P754; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Sastre EA, 2010, MED TEACH, V32, pE429, DOI 10.3109/0142159X.2010.498486; Schwenk TL, 2010, JAMA-J AM MED ASSOC, V304, P1181, DOI 10.1001/jama.2010.1300; Seritan AL, 2015, ACAD PSYCHIATR, V39, P80, DOI 10.1007/s40596-014-0152-5; Simons JS, 2005, MOTIV EMOTION, V29, P83, DOI 10.1007/s11031-005-7955-3; Slavin SJ, 2014, ACAD MED, V89, P573, DOI 10.1097/ACM.0000000000000166; Spielberger C. D., 1973, MANUAL STATE TRAIT I; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stacy R, 2000, MED EDUC, V34, P498; Stewart AL, 1992, MEASURING FUNCTIONIN; STRAYHORN G, 1989, ACAD MED, V64, P25, DOI 10.1097/00001888-198901000-00012; TARLOV AR, 1989, JAMA-J AM MED ASSOC, V262, P925, DOI 10.1001/jama.262.7.925; Thompson D, 2010, ACAD MED, V85, P1635, DOI 10.1097/ACM.0b013e3181f0b49c; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; VITALIANO PP, 1984, J NERV MENT DIS, V172, P730, DOI 10.1097/00005053-198412000-00006; Vosti KL, 1999, ACAD MED, V74, P547, DOI 10.1097/00001888-199905000-00023; Whitehouse WG, 1996, PSYCHOSOM MED, V58, P249, DOI 10.1097/00006842-199605000-00009; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Yakes, 2015, MED SCI ED, V25, P397, DOI DOI 10.1007/S40670-015-0156-0; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	83	102	106	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2016	316	21					2237	2252		10.1001/jama.2016.17573	http://dx.doi.org/10.1001/jama.2016.17573			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0YV	27923091	Green Accepted, Bronze			2022-12-28	WOS:000389307400010
J	Hyde, R				Hyde, Rob			Mixed diagnosis for Serbian health system	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2729	2730		10.1016/S0140-6736(16)32460-6	http://dx.doi.org/10.1016/S0140-6736(16)32460-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FB	27924768				2022-12-28	WOS:000389629800012
J	Deroy, O				Deroy, Ophelia			Other Minds The Octopus, the Sea, and the Deep Origins of Consciousness	SCIENCE			English	Book Review									[Deroy, Ophelia] Univ London, Inst Philosophy, Sch Adv Study, London WC1E 7HU, England	University of London; University of London School of Advanced Study	Deroy, O (corresponding author), Univ London, Inst Philosophy, Sch Adv Study, London WC1E 7HU, England.	ophelia.deroy@sas.ac.uk		Deroy, Ophelia/0000-0001-9431-3136				Godfrey-Smith P, 2016, OTHER MINDS OCTOPUS	1	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1110	1110		10.1126/science.aak9976	http://dx.doi.org/10.1126/science.aak9976			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934730				2022-12-28	WOS:000388916400028
J	Seekell, D				Seekell, David			ECOLOGY AND ENVIRONMENT Passing the point of no return	SCIENCE			English	Editorial Material							WHOLE-ECOSYSTEM EXPERIMENT; REGIME SHIFTS; EARLY WARNINGS		[Seekell, David] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden	Umea University	Seekell, D (corresponding author), Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden.	david.seekell@umu.se						Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Cline TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00398.1; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Kramer MA, 2012, P NATL ACAD SCI USA, V109, P21116, DOI 10.1073/pnas.1210047110; Kuehn C, 2014, J COMPLEX NETW, V2, P141, DOI 10.1093/comnet/cnt022; Pace ML, 2013, LIMNOL OCEANOGR, V58, P525, DOI 10.4319/lo.2013.58.2.0525; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seekell DA, 2013, THEOR ECOL-NETH, V6, P385, DOI 10.1007/s12080-013-0183-7; Seekell DA, 2012, ECOSYSTEMS, V15, P741, DOI 10.1007/s10021-012-9542-2; Seekell DA, 2011, AM NAT, V178, P442, DOI 10.1086/661898; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Tan JPL, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-41038-1	12	2	2	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316								10.1126/science.aal2188	http://dx.doi.org/10.1126/science.aal2188			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934729				2022-12-28	WOS:000388916400027
J	Zinshteyn, B; Green, R				Zinshteyn, Boris; Green, Rachel			When stop makes sense	SCIENCE			English	Editorial Material							TRANSLATION TERMINATION; GENETIC-CODE		[Zinshteyn, Boris; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu		Zinshteyn, Boris/0000-0003-0103-3501	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059425] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Ge ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.11155; Heaphy SM, 2016, MOL BIOL EVOL, V33, P2885, DOI 10.1093/molbev/msw166; Ivanov A, 2016, NUCLEIC ACIDS RES, V44, P7766, DOI 10.1093/nar/gkw635; Klobutcher LA, 2002, CELL, V111, P763, DOI 10.1016/S0092-8674(02)01138-8; Lobanov AV, 2017, NAT STRUCT MOL BIOL, V24, P61, DOI 10.1038/nsmb.3330; Sengupta S, 2015, J MOL EVOL, V80, P229, DOI 10.1007/s00239-015-9686-8; Swart EC, 2016, CELL, V166, P691, DOI 10.1016/j.cell.2016.06.020; Wang RL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21139; Zahonova K, 2016, CURR BIOL, V26, P2364, DOI 10.1016/j.cub.2016.06.064	11	1	2	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1106	1106		10.1126/science.aai9060	http://dx.doi.org/10.1126/science.aai9060			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934724				2022-12-28	WOS:000388916400022
J	Day, J				Day, Jody			Commentary: Selling unproved fertility treatments to women desperate for a baby may be unethical	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jody@gateway-women.com						Heneghan C, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6295; Hepburn J., 2014, DAILY MAIL; Human Fertilisation and Embryology Authority, 2016, FERT TREATM 2014 TRE	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2016	355								i6434	10.1136/bmj.i6434	http://dx.doi.org/10.1136/bmj.i6434			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZO	27908888				2022-12-28	WOS:000389309800007
J	van Leersum, F; Hamid, MA; Steijlen, P				van Leersum, Frank; Hamid, Myrurgia Abdul; Steijlen, Peter			Scleromyxoedema	LANCET			English	Editorial Material									[van Leersum, Frank; Steijlen, Peter] Maastricht Univ Med Ctr, Dept Dermatol, NL-6229 HX Maastricht, Netherlands; [Hamid, Myrurgia Abdul] Maastricht Univ Med Ctr, Dept Pathol, Maastricht, Netherlands; [Steijlen, Peter] Maastricht Univ Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	van Leersum, F (corresponding author), Maastricht Univ Med Ctr, Dept Dermatol, NL-6229 HX Maastricht, Netherlands.	frank.van.leersum@mumc.nl	Steijlen, Peter/X-2729-2019						0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2017	389	10078					1549	1549		10.1016/S0140-6736(16)31401-5	http://dx.doi.org/10.1016/S0140-6736(16)31401-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER7OP	27894593				2022-12-28	WOS:000399002900028
J	Watts, NB; Manson, JE				Watts, Nelson B.; Manson, JoAnn E.			Osteoporosis and Fracture Risk Evaluation and Management Shared Decision Making in Clinical Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Watts, Nelson B.] Mercy Hlth, Osteoporosis & Bone Hlth Serv, Cincinnati, OH USA; [Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA; [Manson, JoAnn E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Manson, JE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 900 Commonwealth Ave,Third Floor, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu			Amgen; Merck; Radius	Amgen(Amgen); Merck(Merck & Company); Radius	Conflict of Interest Disclosures: Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Watts reported receiving honoraria for lectures from Amgen and Merck and consulting fees from Amgen, Merck, and Radius. No other disclosures were reported.	Adler RA, 2016, J BONE MINER RES, V31, P16, DOI 10.1002/jbmr.2708; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Camacho PM, 2016, ENDOCR PRACT, V22, P1, DOI 10.4158/EP161435.GL; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Khosla S, 2016, J BONE MINER RES, V31, P1485, DOI 10.1002/jbmr.2888; McClung MR, 2016, OSTEOPOROSIS INT, V27, P1677, DOI 10.1007/s00198-016-3553-3; Singer A, 2015, MAYO CLIN PROC, V90, P53, DOI 10.1016/j.mayocp.2014.09.011; Wozniak LA, 2017, OSTEOPOROSIS INT, V28, P219, DOI 10.1007/s00198-016-3693-5	8	25	28	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2017	317	3					253	254		10.1001/jama.2016.19087	http://dx.doi.org/10.1001/jama.2016.19087			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9KC	27942715				2022-12-28	WOS:000392089200006
J	Nissen, SE; Yeomans, ND; Solomon, DH; Luscher, TF; Libby, P; Husni, ME; Graham, DY; Borer, JS; Wisniewski, LM; Wolski, KE; Wang, QQ; Menon, V; Ruschitzka, F; Gaffney, M; Beckerman, B; Berger, MF; Bao, WH; Lincoff, AM				Nissen, Steven E.; Yeomans, Neville D.; Solomon, Daniel H.; Luescher, Thomas F.; Libby, Peter; Husni, M. Elaine; Graham, David Y.; Borer, Jeffrey S.; Wisniewski, Lisa M.; Wolski, Katherine E.; Wang, Qiuqing; Menon, Venu; Ruschitzka, Frank; Gaffney, Michael; Beckerman, Bruce; Berger, Manuela F.; Bao, Weihang; Lincoff, A. Michael		PRECISION Trial Investigators	Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CLINICAL-TRIAL; OSTEOARTHRITIS; PAIN; METAANALYSIS	BACKGROUND The cardiovascular safety of celecoxib, as compared with nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), remains uncertain. METHODS Patients who required NSAIDs for osteoarthritis or rheumatoid arthritis and were at increased cardiovascular risk were randomly assigned to receive celecoxib, ibuprofen, or naproxen. The goal of the trial was to assess the noninferiority of celecoxib with regard to the primary composite outcome of cardiovascular death (including hemorrhagic death), nonfatal myocardial infarction, or nonfatal stroke. Noninferiority required a hazard ratio of 1.12 or lower, as well as an upper 97.5% confidence limit of 1.33 or lower in the intention-to-treat population and of 1.40 or lower in the on-treatment population. Gastrointestinal and renal outcomes were also adjudicated. RESULTS A total of 24,081 patients were randomly assigned to the celecoxib group (mean [+/-SD] daily dose, 209+/-37 mg), the naproxen group (852+/-103 mg), or the ibuprofen group (2045+/-246 mg) for a mean treatment duration of 20.3+/-16.0 months and a mean follow-up period of 34.1+/-13.4 months. During the trial, 68.8% of the patients stopped taking the study drug, and 27.4% of the patients discontinued follow-up. In the intention-to-treat analyses, a primary outcome event occurred in 188 patients in the celecoxib group (2.3%), 201 patients in the naproxen group (2.5%), and 218 patients in the ibuprofen group (2.7%) (hazard ratio for celecoxib vs. naproxen, 0.93; 95% confidence interval [CI], 0.76 to 1.13; hazard ratio for celecoxib vs. ibuprofen, 0.85; 95% CI, 0.70 to 1.04; P<0.001 for noninferiority in both comparisons). In the on-treatment analysis, a primary outcome event occurred in 134 patients in the celecoxib group (1.7%), 144 patients in the naproxen group (1.8%), and 155 patients in the ibuprofen group (1.9%) (hazard ratio for celecoxib vs. naproxen, 0.90; 95% CI, 0.71 to 1.15; hazard ratio for celecoxib vs. ibuprofen, 0.81; 95% CI, 0.65 to 1.02; P<0.001 for noninferiority in both comparisons). The risk of gastrointestinal events was significantly lower with celecoxib than with naproxen (P=0.01) or ibuprofen (P=0.002); the risk of renal events was significantly lower with celecoxib than with ibuprofen (P=0.004) but was not significantly lower with celecoxib than with naproxen (P=0.19). CONCLUSIONS At moderate doses, celecoxib was found to be noninferior to ibuprofen or naproxen with regard to cardiovascular safety. (Funded by Pfizer; ClinicalTrials.gov number, NCT00346216.)	[Nissen, Steven E.; Husni, M. Elaine; Wisniewski, Lisa M.; Wolski, Katherine E.; Wang, Qiuqing; Menon, Venu; Lincoff, A. Michael] Cleveland Clin, Cleveland, OH 44106 USA; [Yeomans, Neville D.] Univ Western Sydney, Campbelltown, NSW, Australia; [Solomon, Daniel H.; Libby, Peter] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Luescher, Thomas F.; Ruschitzka, Frank] Univ Zurich Hosp, Zurich, Switzerland; Vet Affairs Med Ctr, Baylor Coll Med, 2002 Holcombe Blvd, Houston, TX 77030 USA; [Borer, Jeffrey S.] SUNY Downstate Hlth Sci Ctr, Brooklyn, NY USA; [Gaffney, Michael; Beckerman, Bruce; Berger, Manuela F.; Bao, Weihang] Pfizer, New York, NY USA	Cleveland Clinic Foundation; Western Sydney University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Zurich; University Zurich Hospital; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Pfizer	Nissen, SE (corresponding author), Cleveland Clin J2 230, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org	Graham, David/AAL-2165-2021; Khraishi, Majed/HDN-4826-2022; Menon, Venu/AAF-1871-2019; Garcia-De La Torre, Ignacio/O-7533-2019; Ignatenko, Grigoriy G. A./Q-2716-2017; Deane, Peter Michael/J-3141-2019; Brenol, João Carlos Tavares/V-7062-2019; Libby, Peter/AAY-6404-2021; Kuryata, Olexandr/J-1005-2017	Khraishi, Majed/0000-0003-0293-5128; Garcia-De La Torre, Ignacio/0000-0002-9261-678X; Ignatenko, Grigoriy G. A./0000-0003-3611-1186; Deane, Peter Michael/0000-0002-3735-0317; Brenol, João Carlos Tavares/0000-0002-8745-566X; Libby, Peter/0000-0002-1502-502X; Yeomans, Neville/0000-0001-9870-832X; Abud-Mendoza, Carlos/0000-0002-3749-5831; Lipko, Nancy/0000-0001-9267-4587; Kuryata, Olexandr/0000-0001-7642-0077	Pfizer	Pfizer(Pfizer)	Funded by Pfizer	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Becker MC, 2009, AM HEART J, V157, P606, DOI 10.1016/j.ahj.2008.12.014; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Food and Drug Administration, 2004, FDA PUBL HLTH ADV SA; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Moore RA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2422; Patrono C, 2014, CIRCULATION, V129, P907, DOI 10.1161/CIRCULATIONAHA.113.004480; Pfizer, 2014, ADV COMM BRIEF DOC A; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Whittle BJR, 2000, GUT, V47, P320, DOI 10.1136/gut.47.3.320	13	436	465	4	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2519	2529		10.1056/NEJMoa1611593	http://dx.doi.org/10.1056/NEJMoa1611593			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SC	27959716	Green Published, Bronze			2022-12-28	WOS:000391175300005
J	Parikshak, NN; Swarup, V; Belgard, TG; Irimia, M; Ramaswami, G; Gandal, MJ; Hartl, C; Leppa, V; Ubieta, LD; Huang, J; Lowe, JK; Blencowe, BJ; Horvath, S; Geschwind, DH				Parikshak, Neelroop N.; Swarup, Vivek; Belgard, T. Grant; Irimia, Manuel; Ramaswami, Gokul; Gandal, Michael J.; Hartl, Christopher; Leppa, Virpi; Ubieta, Luis de la Torre; Huang, Jerry; Lowe, Jennifer K.; Blencowe, Benjamin J.; Horvath, Steve; Geschwind, Daniel H.			Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism	NATURE			English	Article							SPECTRUM DISORDERS; CODING MUTATIONS; NETWORK; TRANSCRIPTOME; RISK; CORTEX; ARCHITECTURE; INSIGHTS; NEURONS; DISEASE	Autism spectrum disorder (ASD) involves substantial genetic contributions. These contributions are profoundly heterogeneous but may converge on common pathways that are not yet well understood(1-3). Here, through post-mortem genome-wide transcriptome analysis of the largest cohort of samples analysed so far, to our knowledge(4-7), we interrogate the noncoding transcriptome, alternative splicing, and upstream molecular regulators to broaden our understanding of molecular convergence in ASD. Our analysis reveals ASD-associated dysregulation of primate-specific long noncoding RNAs (lncRNAs), downregulation of the alternative splicing of activity-dependent neuron-specific exons, and attenuation of normal differences in gene expression between the frontal and temporal lobes. Our data suggest that SOX5, a transcription factor involved in neuron fate specification, contributes to this reduction in regional differences. We further demonstrate that a genetically defined subtype of ASD, chromosome 15q11.2-13.1 duplication syndrome (dup15q), shares the core transcriptomic signature observed in idiopathic ASD. Co-expression network analysis reveals that individuals with ASD show age-related changes in the trajectory of microglial and synaptic function over the first two decades, and suggests that genetic risk for ASD may influence changes in regional cortical gene expression. Our findings illustrate how diverse genetic perturbations can lead to phenotypic convergence at multiple biological levels in a complex neuropsychiatric disorder.	[Parikshak, Neelroop N.; Swarup, Vivek; Belgard, T. Grant; Ramaswami, Gokul; Gandal, Michael J.; Hartl, Christopher; Leppa, Virpi; Ubieta, Luis de la Torre; Huang, Jerry; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Parikshak, Neelroop N.; Swarup, Vivek; Belgard, T. Grant; Ramaswami, Gokul; Gandal, Michael J.; Hartl, Christopher; Leppa, Virpi; Ubieta, Luis de la Torre; Huang, Jerry; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA; [Parikshak, Neelroop N.; Swarup, Vivek; Belgard, T. Grant; Ramaswami, Gokul; Gandal, Michael J.; Hartl, Christopher; Ubieta, Luis de la Torre; Huang, Jerry; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 695 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Irimia, Manuel] BIST, Ctr Genom Regulat, 88 Dr Aiguader, Barcelona 08003, Spain; [Irimia, Manuel] UPF, Barcelona, Spain; [Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S IA8, Canada; [Horvath, Steve; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Belgard, T. Grant] Verge Genom, 42A Dore St, San Francisco, CA 94103 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Toronto; University of Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 695 Charles E Young Dr South, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu	Gandal, Michael/AAE-4282-2020; Irimia, Manuel/E-3040-2010	Gandal, Michael/0000-0001-5800-5128; Irimia, Manuel/0000-0002-2179-2567; Leppa, Virpi/0000-0003-2942-2656; de la Torre-Ubieta, Luis/0000-0001-8059-6243; Hartl, Christopher/0000-0003-3352-4356; Belgard, Tildon/0000-0002-6962-7894; Parikshak, Neel/0000-0003-2027-1871	Simons Foundation; University of Maryland Brain and Tissue Bank; NIMH [5R37 MH060233, 5R01 MH09714, 5R01 MH100027]; NRSA [F30 MH099886]; CIHR; Alzheimer's Research Foundation; University of Toronto McLaughlin Centre;  [5T32 MH073526];  [ERC-StG-LS2-637591]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100027, T32MH073526, R37MH060233, F30MH099886] Funding Source: NIH RePORTER	Simons Foundation; University of Maryland Brain and Tissue Bank; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Alzheimer's Research Foundation; University of Toronto McLaughlin Centre; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Tissue, biological specimens or data used in this research were obtained from the Autism BrainNet (formerly the Autism Tissue Program), which is sponsored by the Simons Foundation, and the University of Maryland Brain and Tissue Bank, which is a component of the NIH NeuroBioBank. We are grateful to the patients and families who participate in the tissue donation programs. The authors acknowledge R. Zielke, J. Cottrell and R. Johnson, who assisted with sample acquisition from the latter brain bank. Funding for this work was provided by grants to D.H.G. (NIMH 5R37 MH060233, 5R01 MH09714 and 5R01 MH100027), N.N.P. (NRSA F30 MH099886, UCLA Medical Scientist Training Program), V.L. (Sigrid Juselius Fellowship) and T.G.B. (training grant 5T32 MH073526). Additional grants supporting this work include those to B.J.B. (CIHR, Alzheimer's Research Foundation and University of Toronto McLaughlin Centre) and M.I. (ERC-StG-LS2-637591). We also thank D. Polioudakis for assistance with data management and V. Chandran for discussion of transcription factor binding site analysis and providing software.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumenthal I, 2014, AM J HUM GENET, V94, P870, DOI 10.1016/j.ajhg.2014.05.004; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chow ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002592; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; Dittmar KA, 2012, MOL CELL BIOL, V32, P1468, DOI 10.1128/MCB.06536-11; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; Gueroussov S, 2015, SCIENCE, V349, P868, DOI 10.1126/science.aaa8381; Gupta S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6748; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Khundrakpam BS, 2016, NEUROIMAGE, V134, P192, DOI 10.1016/j.neuroimage.2016.03.062; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lamb AN, 2012, HUM MUTAT, V33, P728, DOI 10.1002/humu.22037; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maze I, 2015, NEURON, V87, P77, DOI 10.1016/j.neuron.2015.06.014; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mullins C, 2016, NEURON, V89, P1131, DOI 10.1016/j.neuron.2016.02.017; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Raj B, 2014, MOL CELL, V56, P90, DOI 10.1016/j.molcel.2014.08.011; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Scoles HA, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-19; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Wu J, 2013, NUCLEIC ACIDS RES, V41, P5149, DOI 10.1093/nar/gkt216; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179	58	343	351	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					423	+		10.1038/nature20612	http://dx.doi.org/10.1038/nature20612			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27919067	Green Accepted, Green Published			2022-12-28	WOS:000389716800040
J	Bierman, PR; Shakun, JD; Corbett, LB; Zimmerman, SR; Rood, DH				Bierman, Paul R.; Shakun, Jeremy D.; Corbett, Lee B.; Zimmerman, Susan R.; Rood, Dylan H.			A persistent and dynamic East Greenland Ice Sheet over the past 7.5 million years	NATURE			English	Article							NUCLIDE PRODUCTION-RATES; LATE PLIOCENE GREENLAND; SITU COSMOGENIC BE-10; DEEP-SEA-TEMPERATURE; HALF-LIFE; SOUTHERN GREENLAND; RAFTED DETRITUS; HEAT-FLUX; GLACIATION; CLIMATE	Climate models show that ice-sheet melt will dominate sea-level rise over the coming centuries, but our understanding of ice-sheet variations before the last interglacial 125,000 years ago remains fragmentary. This is because terrestrial deposits of ancient glacial and interglacial periods(1-3) are overrun and eroded by more recent glacial advances, and are therefore usually rare, isolated and poorly dated(4). In contrast, material shed almost continuously from continents is preserved as marine sediment that can be analysed to infer the time-varying state of major ice sheets. Here we show that the East Greenland Ice Sheet existed over the past 7.5 million years, as indicated by beryllium and aluminium isotopes (Be-10 and Al-26) in quartz sand removed by deep, ongoing glacial erosion on land and deposited offshore in the marine sedimentary record(5,6.) During the early Pleistocene epoch, ice cover in East Greenland was dynamic; in contrast, East Greenland was mostly ice-covered during the mid-to-late Pleistocene. The isotope record we present is consistent with distinct signatures of changes in ice sheet behaviour coincident with major climate transitions. Although our data are continuous, they are from low-deposition-rate sites and sourced only from East Greenland. Consequently, the signal of extensive deglaciation during short, intense interglacials could be missed or blurred, and we cannot distinguish between a remnant ice sheet in the East Greenland highlands and a diminished continent-wide ice sheet. A clearer constraint on the behaviour of the ice sheet during past and, ultimately, future interglacial warmth could be produced by Be-10 and Al-26 records from a coring site with a higher deposition rate. Nonetheless, our analysis challenges the possibility of complete and extended deglaciation over the past several million years.	[Bierman, Paul R.; Corbett, Lee B.] Univ Vermont, Dept Geol, Burlington, VT 05405 USA; [Bierman, Paul R.; Corbett, Lee B.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA; [Shakun, Jeremy D.] Boston Coll, Dept Earth & Environm Sci, Chestnut Hill, MA 02467 USA; [Zimmerman, Susan R.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA; [Rood, Dylan H.] Imperial Coll London, Dept Earth Sci & Engn, South Kensington Campus, London SW7 2AZ, England; [Rood, Dylan H.] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland	University of Vermont; University of Vermont; Boston College; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Imperial College London; Scottish Universities Research & Reactor Center	Bierman, PR (corresponding author), Univ Vermont, Dept Geol, Burlington, VT 05405 USA.; Bierman, PR (corresponding author), Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA.	pbierman@uvm.edu	Bierman, Paul/AAA-9466-2020	Bierman, Paul/0000-0001-9627-4601; Zimmerman, Susan/0000-0002-1320-1878	NSF [ARC-1023191]; Office of Polar Programs (OPP) [1023191] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Research supported by NSF ARC-1023191. A. Nelson prepared some samples. W. Hale and the Bremen Core Repository facilitated core sampling. G. Balco provided input on muon production. We thank K. St John for providing ODP site 918 mass accumulation rate data, B. de Boer for ice sheet model output W. Huang for running foraminifer stable isotope samples, and S. Xu and the staff of the SUERC AMS laboratory for support during <SUP>26</SUP>Al measurements. This is LLNL-JRNL-701099.	Argento DC, 2015, QUAT GEOCHRONOL, V26, P44, DOI 10.1016/j.quageo.2014.09.005; Argento DC, 2013, NUCL INSTRUM METH B, V294, P464, DOI 10.1016/j.nimb.2012.05.022; Balco G, 2008, QUAT GEOCHRONOL, V3, P174, DOI 10.1016/j.quageo.2007.12.001; Bell RE, 2014, NAT GEOSCI, V7, P497, DOI [10.1038/NGEO2179, 10.1038/ngeo2179]; Bennike O, 2002, PALAEOGEOGR PALAEOCL, V186, P1, DOI 10.1016/S0031-0182(02)00439-X; Bennike O, 2010, BOREAS, V39, P603, DOI 10.1111/j.1502-3885.2010.00147.x; Bierman PR, 2015, GEOLOGY, V43, P1059, DOI 10.1130/G37225.1; Bierman PR, 2014, SCIENCE, V344, P402, DOI 10.1126/science.1249047; Bierman PR, 1999, GEOMORPHOLOGY, V27, P25, DOI 10.1016/S0169-555X(98)00088-9; Borchers B, 2016, QUAT GEOCHRONOL, V31, P188, DOI 10.1016/j.quageo.2015.01.009; Bridgewater D., 1976, GEOLOGY GREENLAND, P304; Butt FA, 2001, NORSK GEOL TIDSSKR, V81, P3; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Carlson AE, 2014, GEOPHYS RES LETT, V41, P5514, DOI 10.1002/2014GL060800; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; Clark PU, 2002, QUATERNARY SCI REV, V21, P1, DOI 10.1016/S0277-3791(01)00118-4; Corbett L. B., 2016, EOS, pC53C; Corbett LB, 2016, QUAT GEOCHRONOL, V33, P24, DOI 10.1016/j.quageo.2016.02.001; Corbett LB, 2016, EARTH PLANET SC LETT, V440, P147, DOI 10.1016/j.epsl.2016.02.004; de Boer B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3999; De Schepper S, 2014, EARTH-SCI REV, V135, P83, DOI 10.1016/j.earscirev.2014.04.003; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; DePaolo DJ, 2006, EARTH PLANET SC LETT, V248, P394, DOI 10.1016/j.epsl.2006.06.004; Dolan AM, 2015, CLIM PAST, V11, P403, DOI 10.5194/cp-11-403-2015; Dowdeswell J. A., 2001, EOS, V82, P382; Dutton A, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4019; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Eldrett JS, 2007, NATURE, V446, P176, DOI 10.1038/nature05591; Elverhoi A, 1998, QUATERNARY SCI REV, V17, P209, DOI 10.1016/S0277-3791(97)00070-X; FEYLING-HANSSEN R W, 1983, Bulletin of the Geological Society of Denmark, V31, P81; FUKUMA K, 1998, P OCEAN DRILLING PRO, V152, P265; Funder S, 2001, B GEOL SOC DENMARK, V48, P117; Fyke JG, 2014, GEOSCI MODEL DEV, V7, P1183, DOI 10.5194/gmd-7-1183-2014; GIBBONS AB, 1984, GEOLOGY, V12, P327, DOI 10.1130/0091-7613(1984)12<327:POMSIA>2.0.CO;2; Goehring B. M., 2010, J QUATERNARY SCI, V25, P1; Granger DE, 2006, GEOL SOC AM SPEC PAP, V415, P1, DOI 10.1130/2006.2415(01); Greve R, 2005, ANN GLACIOL-SER, V42, P424, DOI 10.3189/172756405781812510; Hansen J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0294; Heisinger B, 2002, GEOCHIM COSMOCHIM AC, V66, pA558; Helland PE, 1997, PALAEOGEOGR PALAEOCL, V135, P109, DOI 10.1016/S0031-0182(97)00025-4; Hemming SR, 2000, QUATERNARY RES, V54, P372, DOI 10.1006/qres.2000.2181; Hill DJ, 2010, STRATIGRAPHY, V7, P111; Kaus BJP, 2013, NAT GEOSCI, V6, P683, DOI 10.1038/ngeo1919; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; Knutz PC, 2015, GEOLOGY, V43, P907, DOI 10.1130/G36927.1; Koenig SJ, 2015, CLIM PAST, V11, P369, DOI 10.5194/cp-11-369-2015; KOHL CP, 1992, GEOCHIM COSMOCHIM AC, V56, P3583, DOI 10.1016/0016-7037(92)90401-4; Korschinek G, 2010, NUCL INSTRUM METH B, V268, P187, DOI 10.1016/j.nimb.2009.09.020; LAL D, 1991, EARTH PLANET SC LETT, V104, P424, DOI 10.1016/0012-821X(91)90220-C; LARSEN HC, 1994, SCIENCE, V264, P952, DOI 10.1126/science.264.5161.952; LARSEN HC, 1980, B GEOLOGICAL SOC DEN, V29, P77; Larsen NK, 2015, GEOLOGY, V43, P291, DOI 10.1130/G36476.1; Lifton N, 2014, EARTH PLANET SC LETT, V386, P149, DOI 10.1016/j.epsl.2013.10.052; Linthout K, 2000, GEOL MIJNBOUW-N J G, V79, P109; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; MacGregor JA, 2016, J GEOPHYS RES-EARTH, V121, P1328, DOI 10.1002/2015JF003803; Martin T, 1999, DEEP-SEA RES PT II, V46, P1063, DOI 10.1016/S0967-0645(99)00016-8; Molnia B. F., 1983, GLACIAL MARINE SEDIM, P593; Nelson AH, 2014, EARTH SURF PROC LAND, V39, P1087, DOI 10.1002/esp.3565; Nielsen T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01875; Nishiizumi K, 2004, NUCL INSTRUM METH B, V223, P388, DOI 10.1016/j.nimb.2004.04.075; Nishiizumi K., 1996, EOS, V77; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; NORRIS TL, 1983, J GEOPHYS RES, V88, pB331, DOI 10.1029/JB088iS01p0B331; Party S. S., 1996, P OC DRILL PROGR, P345; Party S. S., 1994, P ODP INIT REP, V152, P177; Petrunin AG, 2013, NAT GEOSCI, V6, P746, DOI [10.1038/ngeo1898, 10.1038/NGEO1898]; Reyes AV, 2014, NATURE, V510, P525, DOI 10.1038/nature13456; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Rood DH, 2013, NUCL INSTRUM METH B, V294, P426, DOI 10.1016/j.nimb.2012.08.039; Rood DH, 2010, NUCL INSTRUM METH B, V268, P730, DOI 10.1016/j.nimb.2009.10.016; Solgaard AM, 2011, J GLACIOL, V57, P871, DOI 10.3189/002214311798043816; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Spezzaferri Silvia, 1998, Proceedings of the Ocean Drilling Program Scientific Results, V152, P161; Spratt R.M., 2015, CLIM DISCUSS, V11, P3699; St John KEK, 2002, BOREAS, V31, P28; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; Storms JEA, 2012, QUATERNARY SCI REV, V35, P29, DOI 10.1016/j.quascirev.2011.12.014; SUGDEN DE, 1977, CAN J EARTH SCI, V14, P2817, DOI 10.1139/e77-248; Tripati AK, 2008, EARTH PLANET SC LETT, V265, P112, DOI 10.1016/j.epsl.2007.09.045; Wei Wuchang, 1998, Proceedings of the Ocean Drilling Program Scientific Results, V152, P147; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Xu S, 2015, NUCL INSTRUM METH B, V361, P39, DOI 10.1016/j.nimb.2015.03.064; Yau AM, 2016, EARTH PLANET SC LETT, V451, P1, DOI 10.1016/j.epsl.2016.06.053; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	87	56	57	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					256	+		10.1038/nature20147	http://dx.doi.org/10.1038/nature20147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27929005	Green Accepted, Green Submitted			2022-12-28	WOS:000389548700054
J	Zhang, XL; Xu, B				Zhang, Xin-Lin; Xu, Biao			Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							VASCULAR SCAFFOLDS		[Zhang, Xin-Lin] Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China	Nanjing University	Zhang, XL (corresponding author), Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.			Xu, Biao/0000-0001-5351-2630				Costa JD, 2016, J AM COLL CARDIOL, V67, P430; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; Kereiakes DJ, 2016, CIRCULATION, V134, P168, DOI 10.1161/CIRCULATIONAHA.116.021539; Puricel S, 2016, J AM COLL CARDIOL, V67, P921, DOI 10.1016/j.jacc.2015.12.019	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					829	829		10.7326/L16-0419	http://dx.doi.org/10.7326/L16-0419			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27919088				2022-12-28	WOS:000389263900021
J	Eshel, N				Eshel, Neir			CELL AND MOLECULAR BIOLOGY Trial and error	SCIENCE			English	Editorial Material							REWARD; PREDICTION		[Eshel, Neir] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA	Stanford University	Eshel, N (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA.	neshel@stanford.edu	Eshel, Neir/AAV-5548-2021	Eshel, Neir/0000-0002-5976-2013				BUSH RR, 1951, PSYCHOL REV, V58, P313, DOI 10.1037/h0054388; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Eshel N, 2016, NAT NEUROSCI, V19, P479, DOI 10.1038/nn.4239; Eshel N, 2015, NATURE, V525, P243, DOI 10.1038/nature14855; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; Kamin L. J., 1969, FUNDAMENTAL ISSUES A, P42; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Sutton R. S., 1998, REINFORCEMENT LEARNI, V1	12	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1108	1109		10.1126/science.aal2187	http://dx.doi.org/10.1126/science.aal2187			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934726				2022-12-28	WOS:000388916400024
J	Govindu, RR; Kelley, M				Govindu, Rukma R.; Kelley, Michelle			Neurogenic Megacolon in Spinal Cord Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Govindu, Rukma R.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Kelley, Michelle] McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Kelley, M (corresponding author), McGovern Med Sch, Houston, TX 77030 USA.	michelle.d.kelley@uth.tmc.edu							0	2	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					E45	E45		10.1056/NEJMicm1604013	http://dx.doi.org/10.1056/NEJMicm1604013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED7GN	27959751				2022-12-28	WOS:000389030400011
J	Wan, Z; Chen, JH; El Makhloufi, A; Sperling, D; Chen, Y				Wan, Zheng; Chen, Jihong; El Makhloufi, Abdel; Sperling, Daniel; Chen, Yang			Four routes to better maritime governance	NATURE			English	Editorial Material									[Wan, Zheng] Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China; [Chen, Jihong] Shanghai Municipal Transport Commiss, Sci & Technol Comm, Shanghai, Peoples R China; [El Makhloufi, Abdel] Amsterdam Univ Appl Sci, Amsterdam, Netherlands; [Sperling, Daniel] Univ Calif Davis, Civil Engn & Environm Sci & Policy, Davis, CA 95616 USA; [Sperling, Daniel] Univ Calif Davis, Inst Transportat Studies, Davis, CA 95616 USA; [Chen, Yang] Shanghai Int Shipping Inst, Shanghai, Peoples R China	Shanghai Maritime University; University of California System; University of California Davis; University of California System; University of California Davis	Wan, Z (corresponding author), Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China.	mrwan@ucdavis.edu	Makhloufi, Abdel El/B-5798-2011	Makhloufi, Abdel El/0000-0001-8639-4781				Albert RJ, 2013, ECOL APPL, V23, P289, DOI 10.1890/12-0669.1; Lloyd's Register, 2016, NAT BALL WAT MAN REQ; McCauley DJ, 2016, SCIENCE, V351, P1148, DOI 10.1126/science.aad5686; Miller AW, 2014, NAT CLIM CHANGE, V4, P413, DOI 10.1038/nclimate2244; Smayda TJ, 2007, HARMFUL ALGAE, V6, P601, DOI 10.1016/j.hal.2007.02.003; Tamelander J., 2010, GUIDELINES DEV NATL; Tan A. K.-J, 2005, VESSEL SOURCE MARINE; Wan Z, 2016, NATURE, V530, P275, DOI 10.1038/530275a; Xu J, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1699, DOI 10.1145/2623330.2623364	9	19	21	2	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					27	29		10.1038/540027a	http://dx.doi.org/10.1038/540027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905465	Bronze			2022-12-28	WOS:000388916600026
J	Mahmood, SS; Wroe, E; Fuller, A; Leaning, J				Mahmood, Syed S.; Wroe, Emily; Fuller, Arlan; Leaning, Jennifer			The Rohingya people of Myanmar: health, human rights, and identity	LANCET			English	Review							BANGLADESH; REFUGEES; VIOLENCE	The Rohingya people of Myanmar (known as Burma before 1989) were stripped of citizenship in 1982, because they could not meet the requirement of proving their forefathers settled in Burma before 1823, and now account for one in seven of the global population of stateless people. Of the total 1.5 million Rohingya people living in Myanmar and across southeast Asia, only 82 000 have any legal protection obtained through UN-designated refugee status. Since 2012, more than 159 000 people, most of whom are Rohingya, have fled Myanmar in poorly constructed boats for journeys lasting several weeks to neighbouring nations, causing hundreds of deaths. We outline historical events preceding this complex emergency in health and human rights. The Rohingya people face a cycle of poor infant and child health, malnutrition, waterborne illness, and lack of obstetric care. In December, 2014, a UN resolution called for an end to the crisis. We discuss the Myanmar Government's ongoing treatment of Rohingya through the lens of international law, and the steps that the newly elected parliament must pursue for a durable solution.	[Mahmood, Syed S.; Wroe, Emily] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA USA; [Mahmood, Syed S.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiol Div, Boston, MA USA; [Wroe, Emily] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Global Hlth Equity, Boston, MA USA; [Wroe, Emily] Partners Hlth, Boston, MA USA; [Fuller, Arlan; Leaning, Jennifer] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, FXB Ctr Hlth & Human Rights, Boston, MA USA; [Leaning, Jennifer] Phys Human Rights, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Mahmood, SS (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	mahmood.saad@mgh.harvard.edu						AALL C, 1979, DISASTERS, V3, P429, DOI 10.1111/j.1467-7717.1979.tb00181.x; Adams B., 2015, COMMUNICATION; Agency CI, 2016, WORLD FACTB BURM; Akhter S, 2014, INDIAN J GEND STUD, V21, P225, DOI 10.1177/0971521514525088; [Anonymous], 2015, NY TIMES; [Anonymous], 2014, MYANM POP HOUS CENS, VI; [Anonymous], 2012, BURM NEW VIOL AR STA; [Anonymous], 2010, MYANM GDP PER CAP PP; Bennison J.J., 1933, RANGOON OFFICE SUPER, V11; Buchanan F., 1799, ASIATIC RESEARCHES H, V5, P219; Chan A., 2005, SOAS B BURMA RES, V3, P396; Clark J., 2015, BMJ, DOI 10.1136/bmj.h2728; European Commission's Humanitarian Aid and Civil Protection Department, 2014, ROH CRIS; Fortify Rights, 2014, POL PERS END AB STAT; Fuller Thomas, 2016, NY TIMES; Gurpreet K, 2011, J HEALTH POPUL NUTR, V29, P103; Hickox K, 2009, MYANMAR DELIVERING C; Human Rights Watch, 2015, SE AS ROH BOAT PUSHB; International Court of Justice, 1989, DECL RES CONV PREV P; KHAN MU, 1983, INT J EPIDEMIOL, V12, P460, DOI 10.1093/ije/12.4.460; Lee Y, 2014, A69398 UN GEN ASS; Lindblom A, 2015, PERSECUATION ROHINGY; McGovern J. H., RES 418 URGING GOVT; Medecins Sans Frontieres, 2002, 10 YEAR ROH REF BANG; Medecins Sans Frontieres, 2014, MYANM ENC DIAL RAKH; Medecins Sans Frontieres, 2013, ONG HUM EM MYANM RAK; Medecins Sans Frontieres, 2013, MYANM VIOL INT LEAV; Medicins Sans Frontieres, 2013, MYANM RESTR SEV IMP; Myo M, 2013, FINAL REPORT INQUIRY; Nieburg P, 2005, NEW ENGL J MED, V353, P1547, DOI 10.1056/NEJMp058237; OCHA, 2013, HUM B MYANM; Office SC, 2016, EST ADV COMM RAKH ST; Paddock R., 2016, NY TIMES; PAHO/WHO, 2022, TECHN NOT AC SEV HEP; [Philippines Go Employment DoLa], 2016, COMP WAG SEL COUNTR, P2; phr [Physicians for Human Rights], 2013, PATT ANTIMUSLIM VIOL; Ramzy A., 2015, NY TIMES; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Sen A, 2008, J PEACE RES, V45, P5, DOI 10.1177/0022343307084920; Shank J., 2015, HIGH COUNTRY NEWS; Shwe Man TR, 2013, NAY PYI TAW MYANMAR, P30; Simpson I, 2013, HUFFINGTON POST; Sollom R, 2010, STATELESS STARVING P; Teng TS., 2011, MALAYS J MED HLTH SC, V7, P41; The Sphere Project, 2011, HUM CHART MIN STAND; Transnational Institute, 2014, ETHN MEAN DAT CONT 2; UN, 2009, NONDR EC SOC CULT RI; UN, ARES69248 UN; UN General Assembly, 1951, CONV REL STAT REF 28; UN Human Rights Council, 2014, S E AS IRR MAR MOV J, P1; UNICEF, 2012, RAKH STAT SNAPSH CHI; UNICEF, 2013, BANGL NEON CHILD HLT; UNICEF, 2012, MAL MAT NEW B CHILD; UNICEF (The United Nations Children's Fund), 2009, CHILD MAT NUTR BANGL; United Healthcare letter to providers, 2015, SIT SERV PRIOR AUTH, P1; United Nations, 2016, MILL DEV GOALS IND; United Nations High Commission for Refugees, 2014, 2014 UNHCR COUNTR OP; United Nations High Commissioner for Refugees, 2013, WARS HUM COST UNHCR; United Nations High Commissioner for Refugees, 2015, STAT PART 1951 CONV; United Nations High Commissioner on Refugees, 2014, REP COMM INQ HUM RIG, P1; United Nations High Commissioner on Refugees, 2012, UNHCR WFP PRE BANGL, P35; United Nations High Commissionier on Refugees, 2014, UN REF AG LAUNCH CAM; US Department of State, 2014, THAIL 2014 TRAFF PER; WHO, 2013, MORT BURD DIS MAL; WIJNROKS M, 1993, DISASTERS, V17, P348, DOI 10.1111/j.1467-7717.1993.tb00507.x	65	58	57	2	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1841	1850		10.1016/S0140-6736(16)00646-2	http://dx.doi.org/10.1016/S0140-6736(16)00646-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	27916235				2022-12-28	WOS:000400549300033
J	Cheung, A; Stukel, TA; Alter, DA; Glazier, RH; Ling, V; Wang, XS; Shah, BR				Cheung, Andrew; Stukel, Therese A.; Alter, David A.; Glazier, Richard H.; Ling, Vicki; Wang, Xuesong; Shah, Baiju R.			Primary Care Physician Volume and Quality of Diabetes Care A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITAL VOLUME; HEALTH-CARE; PANEL SIZE; ONTARIO; MORTALITY; OUTCOMES	Background: A relationship between higher patient volume and both better quality of care and better outcomes has been shown for many acute care conditions. Whether a volume-quality relationship exists for the outpatient management of chronic diseases is uncertain. Objective: To explore the association between primary care physician volume and quality of diabetes care. Design: Cohort study. Setting: The study was conducted using linked population-based health care administrative data in Ontario, Canada. Patients: 1 018 647 adults with diabetes in 2011 who received care from 9014 primary care physicians. Two measures of volume were ascertained for each physician: overall ambulatory volume (representing time available to devote to chronic disease management during patient encounters) and diabetes-specific volume (representing disease-specific expertise). Measurements: Quality of care was measured over a 2-year period using 6 indicators: disease monitoring (eye examination, hemoglobin A(1c) testing, and low-density lipoprotein cholesterol testing), prescribing appropriate medications (angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers and statins), and adverse clinical outcomes (emergency department visits for hypoglycemia or hyperglycemia). Results: Higher overall ambulatory volume was associated with lower rates of appropriate disease monitoring and medication prescription. In contrast, higher diabetes-specific volume was associated with better quality of care across all 6 indicators. Limitation: Only a select set of quality indicators and potential confounders could be ascertained from available data. Conclusion: Primary care physicians with busier ambulatory patient practices delivered lower-quality diabetes care, but those with greater diabetes-specific experience delivered higher-quality care. These findings show that relationships between physician volume and quality can be extended from acute care to outpatient chronic disease care. Health policies or programs to support physicians with a low volume of patients with diabetes may improve care.	Univ Toronto, St Michaels Hosp, Toronto Rehabil Inst, Inst Clin Evaluat Sci, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Stukel, Therese A.; Alter, David A.; Glazier, Richard H.; Ling, Vicki; Wang, Xuesong; Shah, Baiju R.] Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Cheung, Andrew] McMaster Univ, Dept Med, Hlth Sci Ctr, 3W10,1200 Main St West, Hamilton, ON L8N 3Z5, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Shah, BR (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	baiju.shah@ices.on.ca		Stukel, Therese/0000-0002-2951-1360; Cheung, Andrew/0000-0002-5876-3487	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research.	Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Dahrouge S, 2016, ANN FAM MED, V14, P26, DOI 10.1370/afm.1864; Gidengil CA, 2015, INQUIRY-J HEALTH CAR, V52, P1, DOI 10.1177/0046958015571130; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hansen LJ, 2003, BRIT J GEN PRACT, V53, P47; Homboe ES, 2006, MED CARE, V44, P1073, DOI 10.1097/01.mlr.0000233685.22497.cf; Hutchison B, 2013, HEALTH AFFAIR, V32, P695, DOI 10.1377/hlthaff.2012.1087; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Kiran Tara, 2016, CMAJ Open, V4, pE80, DOI 10.9778/cmajo.20150065; Kralj B, 2000, ONTARIO MED REV, V67, P33; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Nguyen YL, 2015, CHEST, V148, P79, DOI 10.1378/chest.14-2195; Shah BR, 2007, J GEN INTERN MED, V22, P275, DOI 10.1007/s11606-006-0027-x; Stefos T, 2011, HEALTH SERV MANAG RE, V24, P96, DOI 10.1258/hsmr.2011.011001; Stukel Therese A, 2013, Open Med, V7, pe40; Turchin A, 2007, DIABETES CARE, V30, P1442, DOI 10.2337/dc07-0029; Wang Jun-Sing, 2009, Diabetes Res Clin Pract, V84, pe27, DOI 10.1016/j.diabres.2009.02.010	19	22	22	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					240	+		10.7326/M16-1056	http://dx.doi.org/10.7326/M16-1056			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	27951589				2022-12-28	WOS:000394786700013
J	Blumenthal, DM; Goldman, DP; Jena, AB				Blumenthal, Daniel M.; Goldman, Dana P.; Jena, Anupam B.			Outcomes-Based Pricing as a Tool to Ensure Access to Novel but Expensive Biopharmaceuticals	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK-SHARING ARRANGEMENTS; FAMILIAL HYPERCHOLESTEROLEMIA; DRUGS		Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA USA; Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Southern California	Jena, AB (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396	Office of the Director, National Institutes of Health (NIH Early Independence Award) [1DP5OD017897-01]; National Institute on Aging [5P01AG033559]; NATIONAL INSTITUTE ON AGING [P01AG033559] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health (NIH Early Independence Award); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By the Office of the Director, National Institutes of Health (NIH Early Independence Award, grant 1DP5OD017897-01; Dr. Jena), and the National Institute on Aging (grant 5P01AG033559; Dr. Goldman).	Adamski J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-153; Everett BM, 2015, NEW ENGL J MED, V373, P1588, DOI 10.1056/NEJMp1508120; Humer C, 2016, T REUTERS       0212; Jena AB, 2016, AM J MANAG CARE, V22, pE199; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Neumann PJ, 2011, HEALTH AFFAIR, V30, P2329, DOI 10.1377/hlthaff.2010.1147; Shrank W, 2015, HLTH AFFAIRS BL 0217; Weisman R., 2015, BOSTON GLOBE	10	8	8	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					219	+		10.7326/M16-1847	http://dx.doi.org/10.7326/M16-1847			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	27951598				2022-12-28	WOS:000394781200011
J	Papi, A; Fabbri, LM				Papi, Alberto; Fabbri, Leonardo M.			Management of patients with early mild asthma and infrequent symptoms	LANCET			English	Editorial Material							EARLY INTERVENTION; PERSISTENT ASTHMA; CHILDHOOD ASTHMA; BUDESONIDE		[Papi, Alberto] Univ Ferrara, Res Ctr Asthma, I-44121 Ferrara, Italy; [Papi, Alberto] Univ Ferrara, COPD, Dept Med Sci, I-44121 Ferrara, Italy; [Fabbri, Leonardo M.] Univ Modena & Reggio Emilia, St Agostino Estense Hosp, Dept Metab Med, Modena, Italy	University of Ferrara; University of Ferrara; Universita di Modena e Reggio Emilia	Papi, A (corresponding author), Univ Ferrara, Res Ctr Asthma, I-44121 Ferrara, Italy.; Papi, A (corresponding author), Univ Ferrara, COPD, Dept Med Sci, I-44121 Ferrara, Italy.	ppa@unife.it	Papi, alberto/AAC-1888-2019; Fabbri, Leonardo/I-4055-2012	Fabbri, Leonardo/0000-0001-8894-1689				[Anonymous], 2014, THORAX, V69, P1; Busse WW, 2008, J ALLERGY CLIN IMMUN, V121, P1167, DOI 10.1016/j.jaci.2008.02.029; Global Initiative For Asthma, 2016, GLOB STRAT ASTHM MAN; Lange P, 2016, LANCET RESP MED, V4, P454, DOI 10.1016/S2213-2600(16)00098-9; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Reddel H, 2016, LANCET; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Tagiyeva N, 2016, AM J RESP CRIT CARE, V193, P23, DOI 10.1164/rccm.201505-0870OC	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					129	130		10.1016/S0140-6736(16)32111-0	http://dx.doi.org/10.1016/S0140-6736(16)32111-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EH9UT	27912984				2022-12-28	WOS:000392117600004
J	Jha, S; Topol, EJ				Jha, Saurabh; Topol, Eric J.			Adapting to Artificial Intelligence Radiologists and Pathologists as Information Specialists	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jha, Saurabh] Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Topol, Eric J.] Scripps Res Inst, La Jolla, CA 92037 USA	University of Pennsylvania; Scripps Research Institute	Jha, S (corresponding author), Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA.	saurabh.jha@uphs.upenn.edu						[Anonymous], 2014, LUNG RADS VERSION 1; [Anonymous], 2016, ECONOMIST; Chockley K, 2016, J AM COLL RADIOL, V13, P1415, DOI 10.1016/j.jacr.2016.07.010; Dwoskin E., 2015, WALL STREET J; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Jha S, 2016, MEDSCAPE; Levenson RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141357; LUSTED LB, 1960, RADIOLOGY, V74, P178, DOI 10.1148/74.2.178; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474	9	259	274	3	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2353	2354		10.1001/jama.2016.17438	http://dx.doi.org/10.1001/jama.2016.17438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27898975				2022-12-28	WOS:000389884600010
J	Badylak, S				Badylak, Stephen			Work with, not against, biology	NATURE			English	Editorial Material									[Badylak, Stephen] McGowan Inst Regenerat Med, Surg, Pittsburgh, PA 15219 USA		Badylak, S (corresponding author), McGowan Inst Regenerat Med, Surg, Pittsburgh, PA 15219 USA.	badylaks@upmc.edu		Badylak, Stephen/0000-0003-3555-0689				Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Horst M, 2013, J TISSUE ENG REGEN M, V7, P515, DOI 10.1002/term.547; King BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157106; Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g; Ren X, 2015, NAT BIOTECHNOL, V33, P1097, DOI 10.1038/nbt.3354; Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0	6	15	16	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					S55	S55		10.1038/540S55a	http://dx.doi.org/10.1038/540S55a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27926701	Bronze			2022-12-28	WOS:000389548700003
J	Cook, S				Cook, Sophie			In search of a good nanny	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												scook@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2016	355								i6565	10.1136/bmj.i6565	http://dx.doi.org/10.1136/bmj.i6565			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SY	27932537	Green Published, Bronze			2022-12-28	WOS:000390037500007
J	Cohn, SL				Cohn, Steven L.			Preoperative Evaluation for Noncardiac Surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLINICAL-PRACTICE GUIDELINES; PERIOPERATIVE CARDIOVASCULAR EVALUATION; PATIENTS ANTITHROMBOTIC THERAPY; QUALITY IMPROVEMENT PROGRAM; MAJOR VASCULAR-SURGERY; ED AMERICAN-COLLEGE; 8 COMMON OPERATIONS; POSTOPERATIVE COMPLICATIONS; ACC/AHA GUIDELINE; CARDIAC RISK											Bamgbade OA, 2007, WORLD J SURG, V31, P556, DOI 10.1007/s00268-006-0305-0; Bhave PD, 2012, AM HEART J, V164, P918, DOI 10.1016/j.ahj.2012.09.004; Bilimoria KY, 2013, J AM COLL SURGEONS, V217, P833, DOI 10.1016/j.jamcollsurg.2013.07.385; Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999; CHARPAK Y, 1988, MED CARE, V26, P95, DOI 10.1097/00005650-198802000-00001; Chung F, 2009, CURR OPIN ANESTHESIO, V22, P405, DOI 10.1097/ACO.0b013e32832a96e2; Cohen-Kerem R, 2005, AM J SURG, V190, P467, DOI 10.1016/j.amjsurg.2005.03.033; Creswell L L, 1999, Semin Thorac Cardiovasc Surg, V11, P303; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1504, DOI 10.1056/NEJMoa1401106; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261, DOI 10.1001/jama.1961.03040420001001; Eagle KA, 2002, J AM COLL CARDIOL, V39, P542, DOI 10.1016/S0735-1097(01)01788-0; Eliasen M, 2013, ANN SURG, V258, P930, DOI 10.1097/SLA.0b013e3182988d59; Erasmus MC, 2012, REP 2012 FOLL INV PO; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Feely MA, 2013, AM FAM PHYSICIAN, V87, P414; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944; Flu WJ, 2010, ANESTHESIOLOGY, V112, P1316, DOI 10.1097/ALN.0b013e3181da89ca; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Girish M, 2001, CHEST, V120, P1147, DOI 10.1378/chest.120.4.1147; Glance LG, 2012, ANN SURG, V255, P696, DOI 10.1097/SLA.0b013e31824b45af; Goodman SM, 2015, DRUG AGING, V32, P361, DOI 10.1007/s40266-015-0262-0; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Gupta PK, 2011, CIRCULATION, V124, P381, DOI 10.1161/CIRCULATIONAHA.110.015701; Hoetzel A, 2012, CURR OPIN ANESTHESIO, V25, P340, DOI 10.1097/ACO.0b013e3283532b02; Howell SJ, 2004, BRIT J ANAESTH, V92, P570, DOI 10.1093/bja/aeh091; Joshi GP, 2013, ANESTH ANALG, V117, P1082, DOI 10.1213/ANE.0b013e3182a823f4; Keyes GR, 2008, PLAST RECONSTR SURG, V122, P245, DOI 10.1097/PRS.0b013e31817747fd; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Khuri SF, 1999, ANN SURG, V230, P429; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282; Le Manach Y, 2007, ANESTH ANALG, V104, P1326, DOI 10.1213/01.ane.0000263029.72643.10; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Li G, 2009, ANESTHESIOLOGY, V110, P759, DOI 10.1097/ALN.0b013e31819b5bdc; Lopez-Olivo MA, 2012, JCR-J CLIN RHEUMATOL, V18, P61, DOI 10.1097/RHU.0b013e318247bb0d; MACPHERSON DS, 1990, ANN INTERN MED, V113, P969, DOI 10.7326/0003-4819-113-12-969; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; Mills E, 2011, AM J MED, V124, P144, DOI 10.1016/j.amjmed.2010.09.013; Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008; Reilly DF, 1999, ARCH INTERN MED, V159, P2185, DOI 10.1001/archinte.159.18.2185; Rosenberg H, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0310-1; Schein OD, 2000, NEW ENGL J MED, V342, P168, DOI 10.1056/NEJM200001203420304; Schouten O, 2009, AM J CARDIOL, V103, P897, DOI 10.1016/j.amjcard.2008.12.018; Smetana GW, 1999, NEW ENGL J MED, V340, P937, DOI 10.1056/NEJM199903253401207; Smetana GW, 2003, MED CLIN N AM, V87, P7, DOI 10.1016/S0025-7125(02)00147-5; Thomsen T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002294.pub4; Wijeysundera DN, 2014, J AM COLL CARDIOL, V64, P2406, DOI 10.1016/j.jacc.2014.07.939	51	10	10	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					ITC81	ITC96		10.7326/AITC201612060	http://dx.doi.org/10.7326/AITC201612060			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27919097				2022-12-28	WOS:000389263900001
J	Wolke, CT; Fournier, JA; Dzugan, LC; Fagiani, MR; Odbadrakh, TT; Knorke, H; Jordan, KD; McCoy, AB; Asmis, KR; Johnson, MA				Wolke, Conrad T.; Fournier, Joseph A.; Dzugan, Laura C.; Fagiani, Matias R.; Odbadrakh, Tuguldur T.; Knorke, Harald; Jordan, Kenneth D.; McCoy, Anne B.; Asmis, Knut R.; Johnson, Mark A.			Spectroscopic snapshots of the proton-transfer mechanism in water	SCIENCE			English	Article							HYDRATED EXCESS PROTON; HYDROGEN-BONDS; LIQUID WATER; SPECTRAL SIGNATURES; INFRARED-SPECTRA; IR SPECTROSCOPY; CLUSTERS; TRANSPORT; ENERGY; VIBRATIONS	The Grotthuss mechanism explains the anomalously high proton mobility in water as a sequence of proton transfers along a hydrogen-bonded (H-bonded) network. However, the vibrational spectroscopic signatures of this process are masked by the diffuse nature of the key bands in bulk water. Here we report how the much simpler vibrational spectra of cold, composition-selected heavy water clusters, D+(D2O)(n), can be exploited to capture clear markers that encode the collective reaction coordinate along the proton-transfer event. By complexing the solvated hydronium "Eigen" cluster [D3O+(D2O)(3)] with increasingly strong H-bond acceptor molecules (D-2, N-2, CO, and D2O), we are able to track the frequency of every O-D stretch vibration in the complex as the transferring hydron is incrementally pulled from the central hydronium to a neighboring water molecule.	[Wolke, Conrad T.; Fournier, Joseph A.; Johnson, Mark A.] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA; [Fournier, Joseph A.] Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Fournier, Joseph A.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Dzugan, Laura C.; McCoy, Anne B.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Fagiani, Matias R.; Knorke, Harald; Asmis, Knut R.] Univ Leipzig, Wilhelm Ostwald Inst Phys & Theoret Chem, D-04103 Leipzig, Germany; [Fagiani, Matias R.] Fritz Haber Inst Max Planck Gesell, D-14195 Berlin, Germany; [Odbadrakh, Tuguldur T.; Jordan, Kenneth D.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15620 USA; [McCoy, Anne B.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	Yale University; University of Chicago; University of Chicago; University System of Ohio; Ohio State University; Leipzig University; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle	Johnson, MA (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.; McCoy, AB (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.; Asmis, KR (corresponding author), Univ Leipzig, Wilhelm Ostwald Inst Phys & Theoret Chem, D-04103 Leipzig, Germany.; Jordan, KD (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15620 USA.; McCoy, AB (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	jordan@pitt.edu; abmccoy@uw.edu; knut.asmis@uni-leipzig.de; mark.johnson@yale.edu	Asmis, Knut R./N-5408-2014; Odbadrakh, Tuguldur T/P-4316-2018	Asmis, Knut R./0000-0001-6297-5856; 	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-FG02-06ER15800, DE-FG02-06ER15066]; U.S. NSF [CHE-1619660]; Collaborative Research Center 1109 of the German Research Foundation (Deutsche Forschungsgemeinschaft); Direct For Mathematical & Physical Scien [1619660] Funding Source: National Science Foundation	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. NSF(National Science Foundation (NSF)); Collaborative Research Center 1109 of the German Research Foundation (Deutsche Forschungsgemeinschaft); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	M.A.J. and K.D.J. acknowledge financial support from the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Award Numbers DE-FG02-06ER15800 and DE-FG02-06ER15066. K.D.J. acknowledges the use of resources in the University of Pittsburgh's Center for Simulation and Modeling. A.B.M. thanks the U.S. NSF (grant CHE-1619660) and the Ohio Supercomputing Center for resources on the Oakley Cluster. M.R.F. and K.R.A. acknowledge financial support from Collaborative Research Center 1109 of the German Research Foundation (Deutsche Forschungsgemeinschaft). Additional data supporting the conclusions are available in supplementary materials.	Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634; Barone V, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1824881; Berkelbach TC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238302; Bian HT, 2011, P NATL ACAD SCI USA, V108, P4737, DOI 10.1073/pnas.1019565108; Chaudhuri C, 2001, MOL PHYS, V99, P1161, DOI 10.1080/00268970110046312; Dahms F, 2016, ANGEW CHEM INT EDIT, V55, P10600, DOI 10.1002/anie.201602523; Douberly GE, 2010, J PHYS CHEM A, V114, P4570, DOI 10.1021/jp100778s; EIGEN M, 1958, PROC R SOC LON SER-A, V247, P505, DOI 10.1098/rspa.1958.0208; Fagiani MR, 2016, PHYS CHEM CHEM PHYS, V18, P26743, DOI 10.1039/c6cp05217g; Fournier JA, 2015, J PHYS CHEM A, V119, P9425, DOI 10.1021/acs.jpca.5b04355; Fournier JA, 2014, SCIENCE, V344, P1009, DOI 10.1126/science.1253788; Grotthuss C.J.T., 1806, ANN CHIM, VLVIII, P54; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Heine N, 2013, J AM CHEM SOC, V135, P8266, DOI 10.1021/ja401359t; Heyden M, 2010, P NATL ACAD SCI USA, V107, P12068, DOI 10.1073/pnas.0914885107; Horvath S, 2010, J PHYS CHEM A, V114, P1556, DOI 10.1021/jp9088782; JANOSCHE.R, 1972, J AM CHEM SOC, V94, P2387, DOI 10.1021/ja00762a032; Kulig W, 2014, J PHYS CHEM B, V118, P278, DOI 10.1021/jp410446d; Libowitzky E, 1999, MONATSH CHEM, V130, P1047, DOI 10.1007/s007060050263; Markovitch O, 2008, J PHYS CHEM B, V112, P9456, DOI 10.1021/jp804018y; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Marx D, 2006, CHEMPHYSCHEM, V7, P1848, DOI 10.1002/cphc.200600128; McCoy AB, 2012, PHYS CHEM CHEM PHYS, V14, P7205, DOI 10.1039/c2cp24110b; McCunn LR, 2008, J PHYS CHEM B, V112, P321, DOI 10.1021/jp075289m; MIKENDA W, 1986, J MOL STRUCT, V147, P1, DOI 10.1016/0022-2860(86)87054-5; Mizuse K, 2012, J PHYS CHEM A, V116, P4868, DOI 10.1021/jp302030d; Mizuse K, 2011, PHYS CHEM CHEM PHYS, V13, P7129, DOI 10.1039/c1cp20207c; Novak A., 1974, LARGE MOL, P177; OKUMURA M, 1986, J CHEM PHYS, V85, P2328, DOI 10.1063/1.451079; Thamer M, 2015, SCIENCE, V350, P78, DOI 10.1126/science.aab3908; TUCKERMAN M, 1995, J CHEM PHYS, V103, P150, DOI 10.1063/1.469654; Tuckerman ME, 1997, SCIENCE, V275, P817, DOI 10.1126/science.275.5301.817; Vendrell O, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2787596; ZUNDEL G, 1968, Z PHYS CHEM NEUE FOL, V58, P225	34	154	153	11	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1131	1135		10.1126/science.aaf8425	http://dx.doi.org/10.1126/science.aaf8425			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934761				2022-12-28	WOS:000388916400038
J	Glausiusz, J				Glausiusz, Josie			The ghosts of old computers	NATURE			English	Editorial Material							EXPOSURE											Balde C.P., 2015, GLOBAL E WASTE MONIT; Davis JM., 2016, TECHNIQUES CULTURE, V65, P390, DOI [10. 4000/tc. 8150, DOI 10.4000/TC.8150]; Grant K, 2013, LANCET GLOB HEALTH, V1, pE350, DOI 10.1016/S2214-109X(13)70101-3; Safi J, 2006, ENVIRON HEALTH PERSP, V114, P917, DOI 10.1289/ehp.8339	4	3	3	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					22	25		10.1038/540022a	http://dx.doi.org/10.1038/540022a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905451	Bronze			2022-12-28	WOS:000388916600025
J	Safikhani, Z; El-Hachem, N; Smirnov, P; Freeman, M; Goldenberg, A; Birkbak, NJ; Beck, AH; Aerts, HJWL; Quackenbush, J; Haibe-Kains, B				Safikhani, Zhaleh; El-Hachem, Nehme; Smirnov, Petr; Freeman, Mark; Goldenberg, Anna; Birkbak, Nicolai J.; Beck, Andrew H.; Aerts, Hugo J. W. L.; Quackenbush, John; Haibe-Kains, Benjamin			Consistency in drug response profiling Reply	NATURE			English	Letter									[Safikhani, Zhaleh; Smirnov, Petr; Freeman, Mark; Haibe-Kains, Benjamin] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Safikhani, Zhaleh; Haibe-Kains, Benjamin] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [El-Hachem, Nehme] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Goldenberg, Anna] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Goldenberg, Anna; Haibe-Kains, Benjamin] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; [Birkbak, Nicolai J.] Francis Crick Inst, London NW1 1AT, England; [Birkbak, Nicolai J.] UCL, Inst Canc, London WC1E 6BT, England; [Beck, Andrew H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Beck, Andrew H.; Aerts, Hugo J. W. L.] Harvard Med Sch, Boston, MA 02115 USA; [Aerts, Hugo J. W. L.; Quackenbush, John] Dana Farber Canc Inst, Boston, MA 02115 USA; [Aerts, Hugo J. W. L.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Quackenbush, John] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Haibe-Kains, Benjamin] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Francis Crick Institute; University of London; University College London; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Haibe-Kains, B (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Haibe-Kains, B (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.; Haibe-Kains, B (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada.; Haibe-Kains, B (corresponding author), Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada.	bhaibeka@uhnresearch.ca	Aerts, Hugo/ABF-2821-2020; Aerts, Hugo/P-6350-2015; Smirnov, Petr A/N-9652-2015; Haibe-Kains, Benjamin/D-3702-2011	Aerts, Hugo/0000-0002-2122-2003; Aerts, Hugo/0000-0002-2122-2003; Birkbak, Nicolai/0000-0003-1613-9587; El-Hachem, Nehme/0000-0002-5778-5342; Haibe-Kains, Benjamin/0000-0002-7684-0079				Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bouhaddou M, 2016, NATURE, V540, pE9, DOI 10.1038/nature20580; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Mpindi JP, 2016, NATURE, V540, pE5, DOI 10.1038/nature20171; Pemovska T, 2013, CANCER DISCOV, V3, P1416, DOI 10.1158/2159-8290.CD-13-0350; Pozdeyev N., 2016, ONCOTARGET; Safikhani Z, F1000RESEARCH; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Smirnov P, 2016, BIOINFORMATICS, V32, P1244, DOI 10.1093/bioinformatics/btv723	11	6	6	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					E6	E8		10.1038/nature20172	http://dx.doi.org/10.1038/nature20172			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905416				2022-12-28	WOS:000388916600011
J	Giles, C				Giles, Ceinwen			Coping with self management	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ceinwen.giles@gmail.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2016	355								i6442	10.1136/bmj.i6442	http://dx.doi.org/10.1136/bmj.i6442			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZD	27903523				2022-12-28	WOS:000389308600011
J	Coates, L; Helliwell, P				Coates, Laura; Helliwell, Philip			More than meets the eye?	LANCET			English	Editorial Material									[Coates, Laura; Helliwell, Philip] Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England		Helliwell, P (corresponding author), Univ Leeds, Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, 2nd Floor,Harehills Lane, Leeds LS7 4SA, W Yorkshire, England.	p.helliwell@leeds.ac.uk			National Institute for Health Research [CL-2011-02-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					E15	E15		10.1016/S0140-6736(16)32188-2	http://dx.doi.org/10.1016/S0140-6736(16)32188-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27894663				2022-12-28	WOS:000388516800001
J	Zellweger, M				Zellweger, Matthieu			Picturing health: stories of stillbirths	LANCET			English	Editorial Material									[Zellweger, Matthieu] Haytham REA, Paris, France		Zellweger, M (corresponding author), Haytham REA, Paris, France.			Zellweger, Matthieu/0000-0002-0590-3175					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2588	2599		10.1016/S0140-6736(16)32231-0	http://dx.doi.org/10.1016/S0140-6736(16)32231-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27894656				2022-12-28	WOS:000388516800018
J	Sousa, CC; Duarte, J				Sousa, Carolina C.; Duarte, Joana			Large Hiatal Hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sousa, Carolina C.; Duarte, Joana] Hosp Prof Doutor Fernando Fonseca, Amadora, Portugal	Hospital Professor Doutor Fernando Fonseca, EPE	Sousa, CC (corresponding author), Hosp Prof Doutor Fernando Fonseca, Amadora, Portugal.	carolinacastrosousa@gmail.com		Azevedo Duarte, Joana/0000-0001-9201-6859					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2081	2081		10.1056/NEJMicm1515408	http://dx.doi.org/10.1056/NEJMicm1515408			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC9KU	27959726	Green Published			2022-12-28	WOS:000388464300010
J	Gaudry, S; Hajage, D; Dreyfuss, D				Gaudry, Stephane; Hajage, David; Dreyfuss, Didier			Initiation of Renal-Replacement Therapy in the Intensive Care Unit REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Gaudry, Stephane; Hajage, David; Dreyfuss, Didier] Assistance Publ Hop Paris, Paris, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Dreyfuss, D (corresponding author), Assistance Publ Hop Paris, Paris, France.	didier.dreyfuss@aphp.fr	Hajage, David/D-5226-2014	Hajage, David/0000-0002-8475-4090				Pocock SJ, 2016, NEW ENGL J MED, V375, P971, DOI 10.1056/NEJMra1601511; Ridgeon EE, 2016, CRIT CARE MED, V44, P1278, DOI 10.1097/CCM.0000000000001670; Wald R, 2015, KIDNEY INT, V88, P897, DOI 10.1038/ki.2015.184; Zarbock A, 2016, JAMA-J AM MED ASSOC, V315, P2190, DOI 10.1001/jama.2016.5828	4	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					1901	1902						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB6ZK	27959653				2022-12-28	WOS:000387534200021
J	Spanuchart, I; Gallacher, S				Spanuchart, Ittikorn; Gallacher, Scott			Hemothorax after Thoracentesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Spanuchart, Ittikorn; Gallacher, Scott] Univ Hawaii, Honolulu, HI 96822 USA	University of Hawaii System	Gallacher, S (corresponding author), Univ Hawaii, Honolulu, HI 96822 USA.	sgallacher@queens.org							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					1878	1878		10.1056/NEJMicm1507029	http://dx.doi.org/10.1056/NEJMicm1507029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB6ZK	27959649				2022-12-28	WOS:000387534200011
J	Marks, PW; Witten, CM; Califf, RM				Marks, Peter W.; Witten, Celia M.; Califf, Robert M.			Clarifying Stem-Cell Therapy's Benefits and Risks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marks, Peter W.; Witten, Celia M.; Califf, Robert M.] US FDA, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Marks, PW (corresponding author), US FDA, Silver Spring, MD 20993 USA.							Albini T, 2015, AM AC OPHTH ANN M LA; Berkowitz AL, 2016, NEW ENGL J MED, V375, P196, DOI 10.1056/NEJMc1600188; Locatelli F, 2016, EXPERT REV CLIN IMMU, V29, P1; Nguyen PK, 2016, JAMA CARDIOL, V1, P831, DOI 10.1001/jamacardio.2016.2225; Thirabanjasak D, 2010, J AM SOC NEPHROL, V21, P1218, DOI 10.1681/ASN.2009111156	5	150	152	4	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1007	1009		10.1056/NEJMp1613723	http://dx.doi.org/10.1056/NEJMp1613723			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QT	27959704				2022-12-28	WOS:000396403700003
J	Service, RF				Service, Robert F.			MATERIALS SCIENCE Perovskite solar cells gear up to go commercial	SCIENCE			English	News Item																			0	49	50	3	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1214	1215		10.1126/science.354.6317.1214	http://dx.doi.org/10.1126/science.354.6317.1214			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940825				2022-12-28	WOS:000389598800012
J	Suri, T; Jack, W				Suri, Tavneet; Jack, William			The long-run poverty and gender impacts of mobile money	SCIENCE			English	Article							MICROCREDIT EVIDENCE; FIELD EXPERIMENT; MICROENTERPRISES; RETURNS; PHONES	Mobile money, a service that allows monetary value to be stored on a mobile phone and sent to other users via text messages, has been adopted by the vast majority of Kenyan households. We estimate that access to the Kenyan mobile money system M-PESA increased per capita consumption levels and lifted 194,000 households, or 2% of Kenyan households, out of poverty. The impacts, which are more pronounced for female-headed households, appear to be driven by changes in financial behavior-in particular, increased financial resilience and saving-and labor market outcomes, such as occupational choice, especially for women, who moved out of agriculture and into business. Mobile money has therefore increased the efficiency of the allocation of consumption over time while allowing a more efficient allocation of labor, resulting in a meaningful reduction of poverty in Kenya.	[Suri, Tavneet] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Suri, Tavneet] MIT, Abdul Latif Jameel Poverty Act Lab J PAL, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Suri, Tavneet] Kenya Lead Acad, Int Growth Ctr, London, England; [Suri, Tavneet] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Suri, Tavneet] Innovat Poverty Act, New Haven, CT 06510 USA; [Jack, William] Georgetown Univ, Dept Econ, Washington, DC USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Bureau of Economic Research; Innovations for Poverty Action (IPA); Georgetown University	Suri, T (corresponding author), MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Suri, T (corresponding author), MIT, Abdul Latif Jameel Poverty Act Lab J PAL, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Suri, T (corresponding author), Kenya Lead Acad, Int Growth Ctr, London, England.; Suri, T (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.; Suri, T (corresponding author), Innovat Poverty Act, New Haven, CT 06510 USA.	tavneet@mit.edu			Gates Foundation	Gates Foundation(Bill & Melinda Gates Foundation)	We thank S. Asman and G. Romani for management of the 2014 data collection, and Financial Sector Deepening Kenya and the Gates Foundation for financial support for the data collection. The study received institutional review board approval from the MIT Committee on Use of Humans as Experimental Subjects, IRB 1403006291. T.S. is on the board of directors of Innovations for Poverty Action; which participated in some of the rounds of data collection. The DOI for round 5 of the data is 10.7910/DVN/L1DVIH (https://dataverse.harvard.edu/dataverse/mobilemoney).	Aker JC, 2017, REV ECON STAT, V99, P185, DOI 10.1162/REST_a_00611; Aker JC, 2012, AM ECON J-APPL ECON, V4, P94, DOI 10.1257/app.4.4.94; Aker JC, 2010, J ECON PERSPECT, V24, P207, DOI 10.1257/jep.24.3.207; Angelucci M, 2015, AM ECON J-APPL ECON, V7, P151, DOI 10.1257/app.20130537; ATTANASIO O, AM EC J APPL EC, V7, P90; Augsburg B, 2015, AM ECON J-APPL ECON, V7, P183, DOI 10.1257/app.20130272; Banerjee A, 2015, AM ECON J-APPL ECON, V7, P22, DOI 10.1257/app.20130533; Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420; Communications Commission of Kenya, ANN REP FIN YEAR 201; Crepon B, 2015, AM ECON J-APPL ECON, V7, P123, DOI 10.1257/app.20130535; de Mel S, 2008, Q J ECON, V123, P1329, DOI 10.1162/qjec.2008.123.4.1329; de Mel S, 2012, SCIENCE, V335, P962, DOI 10.1126/science.1212973; de Mel S, 2009, AM ECON J-APPL ECON, V1, P1, DOI 10.1257/app.1.3.1; Fitzgerald J, 1998, J HUM RESOUR, V33, P251, DOI 10.2307/146433; GSMA, 2015, STAT IND REP MOB MON; Jack W., 2011, NATL BUREAU EC RES; Jack W, 2014, AM ECON REV, V104, P183, DOI 10.1257/aer.104.1.183; Jack W, 2013, AM ECON REV, V103, P356, DOI 10.1257/aer.103.3.356; Karlan D, 2011, SCIENCE, V332, P1278, DOI 10.1126/science.1200138; Mas I., 2010, J PAYMENTS STRATEGY, V4, P352; Suri T, 2012, P NATL ACAD SCI USA, V109, P10257, DOI 10.1073/pnas.1115843109; Tarozzi A, 2015, AM ECON J-APPL ECON, V7, P54, DOI 10.1257/app.20130475	23	243	244	16	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1288	1292		10.1126/science.aah5309	http://dx.doi.org/10.1126/science.aah5309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940873				2022-12-28	WOS:000389598800060
J	Tobler, M; Culumber, ZW				Tobler, Michael; Culumber, Zachary W.			Swimming in polluted waters	SCIENCE			English	Editorial Material							ADAPTATION; SUBSTITUTIONS; EVOLUTION		[Tobler, Michael; Culumber, Zachary W.] Kansas State Univ, Div Biol, 116 Ackert Hall, Manhattan, KS 66506 USA	Kansas State University	Tobler, M (corresponding author), Kansas State Univ, Div Biol, 116 Ackert Hall, Manhattan, KS 66506 USA.	tobler@ksu.edu		Tobler, Michael/0000-0002-0326-0890				Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Dobler S, 2012, P NATL ACAD SCI USA, V109, P13040, DOI 10.1073/pnas.1202111109; Juan D, 2008, FEBS LETT, V582, P1225, DOI 10.1016/j.febslet.2008.02.017; Kelley JL, 2016, MOL BIOL EVOL, V33, P1419, DOI 10.1093/molbev/msw020; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Natarajan C, 2016, SCIENCE, V354, P336, DOI 10.1126/science.aaf9070; Reid NM, 2016, SCIENCE, V354, P1305, DOI 10.1126/science.aah4993; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Tarvin RD, 2016, MOL BIOL EVOL, V33, P1068, DOI 10.1093/molbev/msv350; Tobler M., 2015, EXTREMOPHILE FISHES, P279	10	4	4	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1232	1233		10.1126/science.aal3211	http://dx.doi.org/10.1126/science.aal3211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940833				2022-12-28	WOS:000389598800040
J	Fischer, MG; Hackl, T				Fischer, Matthias G.; Hackl, Thomas			Host genome integration and giant virus-induced reactivation of the virophage mavirus	NATURE			English	Article							DNA VIRUSES; TRANSPOSONS; EUKARYOTES; PROVIROPHAGES; ASSEMBLIES; PARTICLES; EVOLUTION; MIMIVIRUS; BROWSER; VIRION	Endogenous viral elements are increasingly found in eukaryotic genomes(1), yet little is known about their origins, dynamics, or function. Here we provide a compelling example of a DNA virus that readily integrates into a eukaryotic genome where it acts as an inducible antiviral defence system. We found that the virophage mavirus(2), a parasite of the giant Cafeteria roenbergensis virus (CroV)(3), integrates at multiple sites within the nuclear genome of the marine protozoan Cafeteria roenbergensis(4). The endogenous mavirus is structurally and genetically similar to eukaryotic DNA transposons and endogenous viruses of the Maverick/Polinton family(5-7). Provirophage genes are not constitutively expressed, but are specifically activated by superinfection with CroV, which induces the production of infectious mavirus particles. Virophages can inhibit the replication of mimivirus-like giant viruses and an anti-viral protective effect of provirophages on their hosts has been hypothesized(2,8). We find that provirophage-carrying cells are not directly protected from CroV; however, lysis of these cells releases infectious mavirus particles that are then able to suppress CroV replication and enhance host survival during subsequent rounds of infection. The microbial host-parasite interaction described here involves an altruistic aspect and suggests that giant-virus-induced activation of provirophages might be ecologically relevant in natural protist populations.	[Fischer, Matthias G.; Hackl, Thomas] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [Hackl, Thomas] MIT, 15 Vassar St, Cambridge, MA 02139 USA	Max Planck Society; Massachusetts Institute of Technology (MIT)	Fischer, MG (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany.	mfischer@mpimf-heidelberg.mpg.de	Fischer, Matthias G/Q-2738-2017	Fischer, Matthias G/0000-0002-4014-3626; Hackl, Thomas/0000-0002-0022-320X	Max Planck Society	Max Planck Society(Max Planck Society)	This research was supported by the Max Planck Society. We are grateful to C. Suttle for access to host and virus strains, and to the Roscoff team for maintaining and distributing protist strains. We thank K-A. Seifert, K. Fenzl and K. Barenhoff for technical assistance, U. Mersdorf for electron microscopy, C. Roome for IT support, L. Czaja and the Max Planck Genome Centre in Cologne for bioinformatic assistance, S. Higgins for suggestions, K. Haslinger and J. Reinstein for comments on the manuscript, and I. Schlichting for mentoring and support.	Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Blanc G, 2015, P NATL ACAD SCI USA, V112, pE5318, DOI 10.1073/pnas.1506469112; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Campbell Michael S, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0411s48; Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109; FENCHEL T, 1988, Marine Microbial Food Webs, V3, P9; Fischer MG, 2014, VIROLOGY, V466, P82, DOI 10.1016/j.virol.2014.05.029; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Garza DR, 1995, AQUAT MICROB ECOL, V9, P203, DOI 10.3354/ame009203; GONZALEZ JM, 1993, MAR ECOL PROG SER, V94, P1, DOI 10.3354/meps094001; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Kapitonov VV, 2006, P NATL ACAD SCI USA, V103, P4540, DOI 10.1073/pnas.0600833103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krupovic M, 2016, CURR OPIN MICROBIOL, V31, P25, DOI 10.1016/j.mib.2016.01.006; Krupovic M, 2016, ARCH VIROL, V161, P233, DOI 10.1007/s00705-015-2622-9; Krupovic M, 2015, NAT REV MICROBIOL, V13, P105, DOI 10.1038/nrmicro3389; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renesto P, 2006, J VIROL, V80, P11678, DOI 10.1128/JVI.00940-06; Resch W, 2007, VIROLOGY, V358, P233, DOI 10.1016/j.virol.2006.08.025; Santini S, 2013, P NATL ACAD SCI USA, V110, P10800, DOI 10.1073/pnas.1303251110; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Yutin N, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0207-4	35	74	74	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					288	+		10.1038/nature20593	http://dx.doi.org/10.1038/nature20593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27929021	Green Submitted			2022-12-28	WOS:000389548700061
J	Gupta, R; Shah, ND; Ross, JS				Gupta, Ravi; Shah, Nilay D.; Ross, Joseph S.			The Rising Price of Naloxone - Risks to Efforts to Stem Overdose Deaths	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gupta, Ravi; Ross, Joseph S.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Dept Hlth Policy & Management, Sch Publ Hlth, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Shah, Nilay D.] Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Rochester, MN USA	Yale University; Yale University; Mayo Clinic; Mayo Clinic	Gupta, R (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.			Ross, Joseph/0000-0002-9218-3320				[Anonymous], 2015, EXPL NAL UPT US PUBL; Beletsky L, 2012, JAMA-J AM MED ASSOC, V308, P1863, DOI 10.1001/jama.2012.14205; Kapczynski A, 2016, HEALTH AFFAIR, V35, P791, DOI 10.1377/hlthaff.2015.1120; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Wheeler E, 2015, MMWR-MORBID MORTAL W, V64, P631	5	84	84	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2213	2215		10.1056/NEJMp1609578	http://dx.doi.org/10.1056/NEJMp1609578			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0ZQ	27959694	Bronze			2022-12-28	WOS:000389310000001
J	Kronschlager, MT; Drdla-Schutting, R; Gassner, M; Honsek, SD; Teuchmann, HL; Sandkuhler, J				Kronschlaeger, M. T.; Drdla-Schutting, R.; Gassner, M.; Honsek, S. D.; Teuchmann, H. L.; Sandkuehler, J.			Gliogenic LTP spreads widely in nociceptive pathways	SCIENCE			English	Article							LONG-TERM POTENTIATION; SPINAL DORSAL-HORN; NEUROPATHIC PAIN; PATHOLOGICAL PAIN; P2X7 RECEPTOR; ATP RELEASE; LAMINA-I; MICROGLIA; ACTIVATION; INDUCTION	Learning and memory formation involve long-term potentiation (LTP) of synaptic strength. A fundamental feature of LTP induction in the brain is the need for coincident pre- and postsynaptic activity. This restricts LTP expression to activated synapses only (homosynaptic LTP) and leads to its input specificity. In the spinal cord, we discovered a fundamentally different form of LTP that is induced by glial cell activation and mediated by diffusible, extracellular messengers, including D-serine and tumor necrosis factor (TNF), and that travel long distances via the cerebrospinal fluid, thereby affecting susceptible synapses at remote sites. The properties of this gliogenic LTP resolve unexplained findings of memory traces in nociceptive pathways and may underlie forms of widespread pain hypersensitivity.	[Kronschlaeger, M. T.; Drdla-Schutting, R.; Gassner, M.; Honsek, S. D.; Teuchmann, H. L.; Sandkuehler, J.] Med Univ Vienna, Dept Neurophysiol, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria	Medical University of Vienna	Sandkuhler, J (corresponding author), Med Univ Vienna, Dept Neurophysiol, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria.	juergen.sandkuehler@meduniwien.ac.at	Sandkühler, Jürgen/B-6648-2012; Kronschlager, Mira/G-6711-2019	Sandkühler, Jürgen/0000-0002-5209-485X; Drdla-Schutting, Ruth/0000-0003-0645-986X; Kronschlager, Mira/0000-0002-3216-5243	Austrian Science Fund (FWF) [P 29206-B27, W1205]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants P 29206-B27 and W1205 from the Austrian Science Fund (FWF) to J.S. We thank L. Czarnecki for laboratory support and B. Heinke and G. Janeselli for technical support. All of the data are archived on servers of the Center for Brain Research, Medical University of Vienna. The authors declare no conflicts of interest. M.T.K., R.D.-S., and J.S. designed the research. M.T.K., R.D.-S., M.G., S.D.H., and H.L.T. generated and analyzed the data. M.T.K., R.D.-S., and J.S. wrote the paper, with input from the other authors.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Aoyama R, 2011, PAIN, V152, P2085, DOI 10.1016/j.pain.2011.05.014; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Chu YX, 2010, BRAIN BEHAV IMMUN, V24, P1176, DOI 10.1016/j.bbi.2010.06.001; Clark AK, 2015, J NEUROSCI, V35, P4552, DOI 10.1523/JNEUROSCI.2061-14.2015; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Ficker C, 2014, GLIA, V62, P1671, DOI 10.1002/glia.22707; Fields RD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001128; Gong QJ, 2009, GLIA, V57, P583, DOI 10.1002/glia.20786; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Gruber-Schoffnegger D, 2013, J NEUROSCI, V33, P6540, DOI 10.1523/JNEUROSCI.5087-12.2013; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; He WJ, 2012, BEHAV BRAIN RES, V226, P163, DOI 10.1016/j.bbr.2011.09.015; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Jung J, 2013, BIOCHEM BIOPH RES CO, V430, P488, DOI 10.1016/j.bbrc.2012.12.009; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kobayashi K, 2011, NEUROSCI LETT, V504, P57, DOI 10.1016/j.neulet.2011.08.058; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Martineau M, 2013, J NEUROSCI, V33, P3413, DOI 10.1523/JNEUROSCI.3497-12.2013; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Sekiguchi KJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11450; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Wei XH, 2013, J NEUROSCI, V33, P1540, DOI 10.1523/JNEUROSCI.0324-12.2013; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617	30	88	88	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1144	1148		10.1126/science.aah5715	http://dx.doi.org/10.1126/science.aah5715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934764	Green Accepted			2022-12-28	WOS:000388916400041
J	Taylor-Weiner, A; Zack, T; O'Donnell, E; Guerriero, JL; Bernard, B; Reddy, A; Han, GC; AlDubayan, S; Amin-Mansour, A; Schumacher, SE; Litchfield, K; Turnbull, C; Gabriel, S; Beroukhim, R; Getz, G; Carter, SL; Hirsch, MS; Letai, A; Sweeney, C; Van Allen, EM				Taylor-Weiner, Amaro; Zack, Travis; O'Donnell, Elizabeth; Guerriero, Jennifer L.; Bernard, Brandon; Reddy, Anita; Han, G. Celine; AlDubayan, Saud; Amin-Mansour, Ali; Schumacher, Steven E.; Litchfield, Kevin; Turnbull, Clare; Gabriel, Stacey; Beroukhim, Rameen; Getz, Gad; Carter, Scott L.; Hirsch, Michelle S.; Letai, Anthony; Sweeney, Christopher; Van Allen, Eliezer M. .			Genomic evolution and chemoresistance in germ-cell tumours	NATURE			English	Article							DNA-DAMAGE; CANCER; MUTATIONS; REVEALS; QUANTIFICATION; ASSOCIATION; DISCOVERY; CULTURE; SAMPLES	Germ-cell tumours (GCTs) are derived from germ cells and occur most frequently in the testes(1,2). GCTs are histologically heterogeneous and distinctly curable with chemotherapy(3). Gains of chromosome arm 12p and aneuploidy are nearly universal in GCTs(4-6), but specific somatic genomic features driving tumour initiation, chemosensitivity and progression are incompletely characterized. Here, using clinical whole-exome and transcriptome sequencing of precursor, primary (testicular and mediastinal) and chemoresistant metastatic human GCTs, we show that the primary somatic feature of GCTs is highly recurrent chromosome arm level amplifications and reciprocal deletions (reciprocal loss of heterozygosity), variations that are significantly enriched in GCTs compared to 19 other cancer types. These tumours also acquire KRAS mutations during the development from precursor to primary disease, and primary testicular GCTs (TGCTs) are uniformly wild type for TP53. In addition, by functional measurement of apoptotic signalling (BH3 profiling) of fresh tumour and adjacent tissue(7), we find that primary TGCTs have high mitochondrial priming that facilitates chemotherapy-induced apoptosis. Finally, by phylogenetic analysis of serial TGCTs that emerge with chemotherapy resistance, we show how TGCTs gain additional reciprocal loss of heterozygosity and that this is associated with loss of pluripotency markers (NANOG and POU5F1)(8,9) in chemoresistant teratomas or transformed carcinomas. Our results demonstrate the distinct genomic features underlying the origins of this disease and associated with the chemosensitivity phenotype, as well as the rare progression to chemoresistance. These results identify the convergence of cancer genomics, mitochondrial priming and GCT evolution, and may provide insights into chemosensitivity and resistance in other cancers.	[Taylor-Weiner, Amaro; Zack, Travis] Harvard Univ, Div Med Sci, Boston, MA 02115 USA; [Taylor-Weiner, Amaro; Han, G. Celine; Amin-Mansour, Ali; Schumacher, Steven E.; Gabriel, Stacey; Beroukhim, Rameen; Getz, Gad; Carter, Scott L.; Van Allen, Eliezer M. .] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Zack, Travis] Harvard Med Sch, Hlth Sci & Technol, Boston, MA 02115 USA; [O'Donnell, Elizabeth; Guerriero, Jennifer L.; Bernard, Brandon; Han, G. Celine; Beroukhim, Rameen; Letai, Anthony; Sweeney, Christopher; Van Allen, Eliezer M. .] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [O'Donnell, Elizabeth] Massachusetts Gen Hosp, Dept Med Oncol, Boston, MA 02114 USA; [Reddy, Anita] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [AlDubayan, Saud] Boston Childrens Hosp, Div Genet & Genom, Dept Med, Boston, MA 02115 USA; [AlDubayan, Saud] King Saud bin Abdulaziz Univ Hlth Sci, Dept Med, Riyadh, Saudi Arabia; [Schumacher, Steven E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Litchfield, Kevin; Turnbull, Clare] Inst Canc Res, Div Genet & Epidemiol, Fulham Rd, London SW3 6JB, England; [Litchfield, Kevin; Turnbull, Clare] Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England; [Getz, Gad] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Carter, Scott L.; Van Allen, Eliezer M. .] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02215 USA; [Carter, Scott L.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Carter, Scott L.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Hirsch, Michelle S.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; King Saud Bin Abdulaziz University for Health Sciences; Harvard University; Dana-Farber Cancer Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Queen Mary University London; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA.; Van Allen, EM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Van Allen, EM (corresponding author), Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02215 USA.	eliezerm_vanallen@dfci.harvard.edu	Turnbull, Clare/AAA-6596-2019	Litchfield, Kevin/0000-0002-3725-0914; Han, Celine/0000-0003-2004-8186; AlDubayan, MD, Saud H/0000-0001-9062-3399; Turnbull, Clare/0000-0002-1734-5772	NIH [U54 HG003067, 1K08 CA188615]; Damon Runyon Clinical Investigator Award; Shawmut Design and Construction Pan Mass Challenge Team; Giovino Jimmy Fund Golf Tournament; NATIONAL CANCER INSTITUTE [K08CA188615] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, U54HG003067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Clinical Investigator Award; Shawmut Design and Construction Pan Mass Challenge Team; Giovino Jimmy Fund Golf Tournament; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the patients for contributing to this study, and H. Taylor-Weiner for feedback on ES cells. This work was supported by NIH U54 HG003067, NIH 1K08 CA188615 (E.M.V.), Damon Runyon Clinical Investigator Award (E.M.V.), Shawmut Design and Construction Pan Mass Challenge Team (C.S.), and Giovino Jimmy Fund Golf Tournament (C.S.).	Abada PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087444; [Anonymous], 2015, VIOLIN M SIMPLE VIOL; ATKIN NB, 1982, LANCET, V2, P1349; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Feldman DR, 2014, CLIN CANCER RES, V20, P3712, DOI 10.1158/1078-0432.CCR-13-2868; Goudarzi KM, 2016, INT J ONCOL, V48, P1313, DOI 10.3892/ijo.2016.3387; Gutekunst M, 2013, CANCER RES, V73, P1460, DOI 10.1158/0008-5472.CAN-12-2876; Hanna NH, 2014, NEW ENGL J MED, V371, P2005, DOI 10.1056/NEJMra1407550; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Jacobsen C, 2015, ANDROLOGY-US, V3, P111, DOI 10.1111/andr.299; Jorgensen A, 2013, J PATHOL, V229, P588, DOI 10.1002/path.4154; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6973; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Moch H, 2016, EUR UROL, V70, P93, DOI 10.1016/j.eururo.2016.02.029; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; OOSTERHUIS JW, 1989, LAB INVEST, V60, P14; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rijlaarsdam MA, 2014, SEMIN CANCER BIOL, V29, P59, DOI 10.1016/j.semcancer.2014.07.003; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Sonne SB, 2009, CANCER RES, V69, P5241, DOI 10.1158/0008-5472.CAN-08-4554; Stachler MD, 2015, NAT GENET, V47, P1047, DOI 10.1038/ng.3343; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Touzeau C, 2016, LEUKEMIA, V30, P761, DOI 10.1038/leu.2015.184; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Wang LH, 2014, NATURE, V511, P241, DOI 10.1038/nature13296; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	43	101	103	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					114	+		10.1038/nature20596	http://dx.doi.org/10.1038/nature20596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905446	Green Accepted			2022-12-28	WOS:000388916600059
J	Vampa, G; Hammond, TJ; Thire, N; Schmidt, BE; Legare, F; McDonald, CR; Brabec, T; Corkum, PB				Vampa, G.; Hammond, T. J.; Thire, N.; Schmidt, B. E.; Legare, F.; McDonald, C. R.; Brabec, T.; Corkum, P. B.			Linking high harmonics from gases and solids (vol 522, pg 462, 2015)	NATURE			English	Correction																		Luu TT, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.115164; Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517	2	1	1	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					260	260		10.1038/nature20809	http://dx.doi.org/10.1038/nature20809			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	27926739	Bronze			2022-12-28	WOS:000393737500047
J	Balar, AV; Balar, AV; Rosenberg, JE; Powles, T; Petrylak, DP; Bellmunt, J; Loriot, Y; Necchi, A; Hoffman-Censits, J; Perez-Gracia, JL; Dawson, NA; van der Heijden, MS; Dreicer, R; Srinivas, S; Retz, MM; Joseph, RW; Drakaki, A; Vaishampayan, UN; Sridhar, SS; Quinn, DI; Duran, I; Shaffer, DR; Eigl, BJ; Grivas, PD; Yu, EY; Li, S; Kadel, EE; Boyd, Z; Bourgon, R; Hegde, PS; Mariathasan, S; Thastrom, A; Abidoye, OO; Fine, GD; Bajorin, DF				Balar, Arjun V.; Galsky, Matthew D.; Rosenberg, Jonathan E.; Powles, Thomas; Petrylak, Daniel P.; Bellmunt, Joaquim; Loriot, Yohann; Necchi, Andrea; Hoffman-Censits, Jean; Perez-Gracia, Jose Luis; Dawson, Nancy A.; van der Heijden, Michiel S.; Dreicer, Robert; Srinivas, Sandy; Retz, Margitta M.; Joseph, Richard W.; Drakaki, Alexandra; Vaishampayan, Ulka N.; Sridhar, Srikala S.; Quinn, David I.; Duran, Ignacio; Shaffer, David R.; Eigl, Bernhard J.; Grivas, Petros D.; Yu, Evan Y.; Li, Shi; Kadel, Edward E., III; Boyd, Zachary; Bourgon, Richard; Hegde, Priti S.; Mariathasan, Sanjeev; Thastrom, AnnChristine; Abidoye, Oyewale O.; Fine, Gregg D.; Bajorin, Dean F.		IMvigor210 Study Grp	Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial	LANCET			English	Article							LONG-TERM-SURVIVAL; BLADDER-CANCER; CLINICAL ACTIVITY; CELL CARCINOMA; CHEMOTHERAPY; UNFIT; METHOTREXATE; GEMCITABINE; VINBLASTINE; DOXORUBICIN	Background First-line chemotherapy for patients with cisplatin-ineligible locally advanced or metastatic urothelial carcinoma is associated with short response duration, poor survival, and high toxicity. This study assessed atezolizumab (anti-programmed death-ligand 1 [PD-L1]) as treatment for metastatic urothelial cancer in cisplatin-ineligible patients. Methods For this single-arm, multicentre, phase 2 study, in 47 academic medical centres and community oncology practices in seven countries in North America and Europe, we recruited previously untreated patients with locally advanced or metastatic urothelial cancer who were cisplatin ineligible. Patients were given 1200 mg intravenous atezolizumab every 21 days until progression. The primary endpoint was independently confirmed objective response rate per Response Evaluation Criteria in Solid Tumors version 1.1 (central review), assessed in prespecified subgroups based on PD-L1 expression and in all patients. All participants who received one or more doses of atezolizumab were included in the primary and safety analyses. This study was registered with ClinicalTrials.gov, number NCT02108652. Findings Between June 9, 2014, and March 30, 2015, we enrolled 123 patients, of whom 119 received one or more doses of atezolizumab. At 17.2 months' median follow-up, the objective response rate was 23% (95% CI 16 to 31), the complete response rate was 9% (n=11), and 19 of 27 responses were ongoing. Median response duration was not reached. Responses occurred across all PD-L1 and poor prognostic factor subgroups. Median progression-free survival was 2.7 months (2.1 to 4.2). Median overall survival was 15.9 months (10.4 to not estimable). Tumour mutation load was associated with response. Treatment-related adverse events that occurred in 10% or more of patients were fatigue (36 [30%] patients), diarrhoea (14 [12%] patients), and pruritus (13 [11%] patients). One treatment-related death (sepsis) occurred. Nine (8%) patients had an adverse event leading to treatment discontinuation. Immune-mediated events occurred in 14 (12%) patients. Interpretation Atezolizumab showed encouraging durable response rates, survival, and tolerability, supporting its therapeutic use in untreated metastatic urothelial cancer. Funding F Hoff mann-La Roche, Genentech.	[Balar, Arjun V.] NYU, Perlmutter Canc Ctr, Langone Med Ctr, Genitourinary Cancers Program, New York, NY USA; [Galsky, Matthew D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Rosenberg, Jonathan E.; Bajorin, Dean F.] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Powles, Thomas] Queen Mary Univ London, Barts Hlth & Royal Free NHS Trust, Barts Canc Inst ECMC, London, England; [Petrylak, Daniel P.] Yale Univ, Smilow Canc Ctr, New Haven, CT USA; [Bellmunt, Joaquim] Harvard Med Sch, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA; [Loriot, Yohann] Univ Paris Saclay, Dept Med Oncol, Villejuif, France; [Loriot, Yohann] Gustave Roussy, Villejuif, France; [Necchi, Andrea] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy; [Hoffman-Censits, Jean] Sidney Kimmel Canc Ctr Jefferson, Philadelphia, PA USA; [Perez-Gracia, Jose Luis] Univ Navarra, Clin Univ Navarra, Dept Oncol, Pamplona, Navarre, Spain; [Dawson, Nancy A.] Medstar Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC USA; [van der Heijden, Michiel S.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Dreicer, Robert] Univ Virginia, Sch Med, Div Hematol Oncol, Charlottesville, VA 22908 USA; [Srinivas, Sandy] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Retz, Margitta M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, Munich, Germany; [Joseph, Richard W.] Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA; [Drakaki, Alexandra] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Dept Med, Los Angeles, CA 90095 USA; [Drakaki, Alexandra] Univ Calif Los Angeles, David Geffen Sch Med, Inst Urol Oncol, Los Angeles, CA 90095 USA; [Vaishampayan, Ulka N.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Sridhar, Srikala S.] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada; [Quinn, David I.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Duran, Ignacio] Hosp Univ Virgen Rocio, Dept Med Oncol, Seville, Spain; [Duran, Ignacio] Inst Biomed Seville, Seville, Spain; [Shaffer, David R.] New York Oncol Hematol, Albany, NY USA; [Eigl, Bernhard J.] British Columbia Canc Agcy, Vancouver, BC, Canada; [Grivas, Petros D.] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA; [Yu, Evan Y.] Univ Washington, Dept Med, Div Oncol, Seattle, WA USA; [Yu, Evan Y.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Li, Shi; Kadel, Edward E., III; Boyd, Zachary; Bourgon, Richard; Hegde, Priti S.; Mariathasan, Sanjeev; Thastrom, AnnChristine; Abidoye, Oyewale O.; Fine, Gregg D.] Genentech Inc, San Francisco, CA USA	New York University; NYU Langone Medical Center; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Barts Health NHS Trust; University of London; Queen Mary University London; Yale University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Fondazione IRCCS Istituto Nazionale Tumori Milan; Jefferson University; University of Navarra; Georgetown University; Netherlands Cancer Institute; University of Virginia; Stanford University; Technical University of Munich; Mayo Clinic; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Southern California; Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); British Columbia Cancer Agency; Cleveland Clinic Foundation; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Roche Holding; Genentech	Balar, AV (corresponding author), NYU, Perlmutter Canc Ctr, New York, NY 10016 USA.	arjun.balar@nyumc.org	Necchi, Andrea/L-6021-2017; Quinn, David/N-3730-2019; Loriot, Yohann/W-5572-2019; Bellmunt, Joaquim/B-8151-2019; Perez-Gracia, Jose Luis/I-8372-2017; Eigl, Bernhard/T-7276-2019	Necchi, Andrea/0000-0002-3007-2756; Quinn, David/0000-0002-1411-0417; Bellmunt, Joaquim/0000-0003-2328-3421; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Eigl, Bernhard/0000-0003-1653-6929; Joseph, Richard/0000-0001-6102-4661; DURAN, IGNACIO/0000-0001-8571-7163; Bourgon, Richard/0000-0002-5890-4374; Vaishampayan, Ulka/0000-0001-5800-4571; Balar, Arjun/0000-0003-3949-5656	F Hoffmann-La Roche, Genentech; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA015083] Funding Source: NIH RePORTER	F Hoffmann-La Roche, Genentech(Hoffmann-La RocheRoche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	F Hoffmann-La Roche, Genentech.	Bajorin DF, 1999, J CLIN ONCOL, V17, P3173, DOI 10.1200/JCO.1999.17.10.3173; Bellmunt J, 2014, ANN ONCOL, V25, P40, DOI 10.1093/annonc/mdu223; Bellmunt J, 2012, J CLIN ONCOL, V30, P1107, DOI 10.1200/JCO.2011.38.6979; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; De Santis M, 2016, ANN ONCOL, V27, P449, DOI 10.1093/annonc/mdv609; De Santis M, 2012, J CLIN ONCOL, V30, P191, DOI 10.1200/JCO.2011.37.3571; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Ferlay J, GLOBOCAN 2012 V1 0 C; Galsky MD, 2015, EUR J CANCER, V51, pS520, DOI 10.1016/S0959-8049(16)31442-3; Galsky MD, 2011, J CLIN ONCOL, V29, P2432, DOI 10.1200/JCO.2011.34.8433; Galsky MD, 2011, LANCET ONCOL, V12, P211, DOI 10.1016/S1470-2045(10)70275-8; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hutchinson R, 2016, CLIN ADV HEMATOL ONC, V14, P101; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; LOEHRER PJ, 1992, J CLIN ONCOL, V10, P1066, DOI 10.1200/JCO.1992.10.7.1066; McDermott DF, 2016, J CLIN ONCOL, V34, P833, DOI 10.1200/JCO.2015.63.7421; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; National Cancer Institute Surveillance Spidemiology and End Results Program, SEER CANC STAT FACTS; National Comprehensive Cancer Network, 2016, CLIN PRACT GUID ONC; Necchi A, 2017, CLIN GENITOURIN CANC, V15, P23, DOI 10.1016/j.clgc.2016.05.003; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P71, DOI 10.1016/j.clgc.2013.11.016; Taylor JA, 2009, NAT CLIN PRACT UROL, V6, P135, DOI 10.1038/ncpuro1315; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965	30	1230	1264	4	130	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2017	389	10064					67	76		10.1016/S0140-6736(16)32455-2	http://dx.doi.org/10.1016/S0140-6736(16)32455-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7VH	27939400	Green Accepted			2022-12-28	WOS:000391264000039
J	Boland, CS; Khan, U; Ryan, G; Barwich, S; Charifou, R; Harvey, A; Backes, C; Li, Z; Ferreira, MS; Mobius, ME; Young, RJ; Coleman, JN				Boland, Conor S.; Khan, Umar; Ryan, Gavin; Barwich, Sebastian; Charifou, Romina; Harvey, Andrew; Backes, Claudia; Li, Zheling; Ferreira, Mauro S.; Mobius, Matthias E.; Young, Robert J.; Coleman, Jonathan N.			Sensitive electromechanical sensors using viscoelastic graphene-polymer nanocomposites	SCIENCE			English	Article							MELT RHEOLOGY; BEHAVIOR	Despite its widespread use in nanocomposites, the effect of embedding graphene in highly viscoelastic polymer matrices is not well understood. We added graphene to a lightly crosslinked polysilicone, often encountered as Silly Putty, changing its electromechanical properties substantially. The resulting nanocomposites display unusual electromechanical behavior, such as postdeformation temporal relaxation of electrical resistance and nonmonotonic changes in resistivity with strain. These phenomena are associated with the mobility of the nanosheets in the low-viscosity polymer matrix. By considering both the connectivity and mobility of the nanosheets, we developed a quantitative model that completely describes the electromechanical properties. These nanocomposites are sensitive electromechanical sensors with gauge factors >500 that can measure pulse, blood pressure, and even the impact associated with the footsteps of a small spider.	[Boland, Conor S.; Khan, Umar; Ryan, Gavin; Barwich, Sebastian; Charifou, Romina; Harvey, Andrew; Backes, Claudia; Ferreira, Mauro S.; Mobius, Matthias E.; Coleman, Jonathan N.] Trinity Coll Dublin, Sch Phys, CRANN, Dublin 2, Ireland; [Boland, Conor S.; Khan, Umar; Ryan, Gavin; Barwich, Sebastian; Charifou, Romina; Harvey, Andrew; Backes, Claudia; Ferreira, Mauro S.; Mobius, Matthias E.; Coleman, Jonathan N.] Trinity Coll Dublin, Adv Mat & Bioengn Res AMBER Res Ctr, Dublin 2, Ireland; [Li, Zheling; Young, Robert J.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England; [Li, Zheling; Young, Robert J.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England	Trinity College Dublin; Trinity College Dublin; University of Manchester; University of Manchester	Coleman, JN (corresponding author), Trinity Coll Dublin, Sch Phys, CRANN, Dublin 2, Ireland.; Coleman, JN (corresponding author), Trinity Coll Dublin, Adv Mat & Bioengn Res AMBER Res Ctr, Dublin 2, Ireland.	colemaj@tcd.ie	Mobius, Matthias/HDM-3517-2022; Khan, Umar/ABG-7594-2020; Boland, Conor S/ABF-3324-2020; Möbius, Matthias/D-3140-2013; Boland, Conor/ABF-9258-2020; Coleman, Jonathan N/B-8403-2011; Ferreira, Mauro/A-9101-2010	Möbius, Matthias/0000-0002-5509-8725; Coleman, Jonathan N/0000-0001-9659-9721; Ferreira, Mauro/0000-0002-0856-9811; Young, Robert/0000-0001-6073-9489; Khan, Umar/0000-0002-2587-3604; Boland, Conor S./0000-0003-4376-6770	Science Foundation Ireland [SFI/12/RC/2278]; European Union [604391, 696656, G22226/RFP-1/MTR/3135]; COST action [MP1305]; EPSRC [EP/K005014/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K005014/1] Funding Source: researchfish	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union(European Commission); COST action(European Cooperation in Science and Technology (COST)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge the Science Foundation Ireland-funded AMBER research center (SFI/12/RC/2278). J.N.C. and R.J.Y. acknowledge funding from the European Union Seventh Framework Program under grant agreements 604391 and 696656, Graphene Flagship. G.R. and M.E.M. acknowledge funding, from Science Foundation Ireland (G22226/RFP-1/MTR/3135) and support from COST action MP1305. "Graphene Polymer Nanocomposites" was filed at the European Patent Organisation (EP161827498) on 4 August 2016; inventors, J.N.C. U.K., and C.B.; assignee, Trinity College Dublin.	Boland CS, 2014, ACS NANO, V8, P8819, DOI 10.1021/nn503454h; Cross R, 2012, AM J PHYS, V80, P870, DOI 10.1119/1.4732086; Heinrich G, 2002, ADV POLYM SCI, V160, P1; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Khan U, 2011, LANGMUIR, V27, P9077, DOI 10.1021/la201797h; KOGUT PM, 1979, J PHYS C SOLID STATE, V12, P2151, DOI 10.1088/0022-3719/12/11/023; KRAUS G, 1984, APPL POLYM SYMP, P75; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Payne A.R., 1962, J APPL POLYM SCI, V6, P57, DOI 10.1002/app.1962.070061906; SHIH WH, 1990, PHYS REV A, V42, P4772, DOI 10.1103/PhysRevA.42.4772; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; STAUFFER D, 1994, INTRO PERCOLATION TH; Tripathi SN, 2015, POLYM ADVAN TECHNOL, V26, P1558, DOI 10.1002/pat.3581; Vermant J, 2007, J RHEOL, V51, P429, DOI 10.1122/1.2516399; Winter HH, 1997, ADV POLYM SCI, V134, P165; Young R.J., 2011, INTRO POLYM, DOI DOI 10.1201/9781439894156; Young RJ, 2012, COMPOS SCI TECHNOL, V72, P1459, DOI 10.1016/j.compscitech.2012.05.005; Zhao J, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/5/057701	18	543	567	40	957	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1257	1260		10.1126/science.aag2879	http://dx.doi.org/10.1126/science.aag2879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940866	Green Submitted			2022-12-28	WOS:000389598800053
J	Kaiser, J				Kaiser, Jocelyn			WHEN DNA AND CULTURE CLASH	SCIENCE			English	Editorial Material																			0	7	7	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1217	1221		10.1126/science.354.6317.1217	http://dx.doi.org/10.1126/science.354.6317.1217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940828				2022-12-28	WOS:000389598800015
J	Priscott, P				Priscott, Philip			Robin Priscott OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		PRISCOTT R, PUBLICATION LIST	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2016	355								i6574	10.1136/bmj.i6574	http://dx.doi.org/10.1136/bmj.i6574			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SZ	27940574				2022-12-28	WOS:000390037600008
J	Lence, T; Akhtar, J; Bayer, M; Schmid, K; Spindler, L; Ho, CH; Kreim, N; Andrade-Navarro, MA; Poeck, B; Helm, M; Roignant, JY				Lence, Tina; Akhtar, Junaid; Bayer, Marc; Schmid, Katharina; Spindler, Laura; Ho, Cheuk Hei; Kreim, Nastasja; Andrade-Navarro, Miguel A.; Poeck, Burkhard; Helm, Mark; Roignant, Jean-Yves			m(6)A modulates neuronal functions and sex determination in Drosophila	NATURE			English	Article							MESSENGER-RNA METHYLATION; EMBRYONIC STEM-CELLS; NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; CENTRAL COMPLEX; MAMMALIAN RNA; GENE; N-6-METHYLADENOSINE; REVEALS; EXPRESSION	N-6-methyladenosine RNA (m(6)A) is a prevalent messenger RNA modification in vertebrates. Although its functions in the regulation of post-transcriptional gene expression are beginning to be unveiled, the precise roles of m(6)A during development of complex organisms remain unclear. Here we carry out a comprehensive molecular and physiological characterization of the individual components of the methyltransferase complex, as well as of the YTH domain-containing nuclear reader protein in Drosophila melanogaster. We identify the member of the split ends protein family, Spenito, as a novel bona fide subunit of the methyltransferase complex. We further demonstrate important roles of this complex in neuronal functions and sex determination, and implicate the nuclear YT521-B protein as a main m(6)A effector in these processes. Altogether, our work substantially extends our knowledge of m(6)A biology, demonstrating the crucial functions of this modification in fundamental processes within the context of the whole animal.	[Lence, Tina; Akhtar, Junaid; Bayer, Marc; Kreim, Nastasja; Andrade-Navarro, Miguel A.; Roignant, Jean-Yves] Inst Mol Biol, D-55128 Mainz, Germany; [Schmid, Katharina; Helm, Mark] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55128 Mainz, Germany; [Spindler, Laura; Poeck, Burkhard] Johannes Gutenberg Univ Mainz, Inst Zool Neurobiol 3, D-55128 Mainz, Germany; [Ho, Cheuk Hei] NYU, Skirball Inst, Dept Cell Biol, Kimmel Ctr Biol & Med,Sch Med, 540 First Ave, New York, NY 10016 USA; [Andrade-Navarro, Miguel A.] Johannes Gutenberg Univ Mainz, Fac Biol, D-55128 Mainz, Germany	Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; New York University; Johannes Gutenberg University of Mainz	Roignant, JY (corresponding author), Inst Mol Biol, D-55128 Mainz, Germany.	j.roignant@imb-mainz.de	Helm, Mark/AAD-5433-2022	Helm, Mark/0000-0002-0154-0928; Lence, Tina/0000-0001-9377-546X; Akhtar, Junaid/0000-0002-2561-686X; Roignant, Jean-Yves/0000-0003-1395-2150	Marie Curie CIG [334288]; Deutsche Forschungsgemeinschaft (DFG) [RO 4681/4-1]; Rhineland-Palatinate program Gene RED; DFG [HE 3397/13-1]	Marie Curie CIG; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Rhineland-Palatinate program Gene RED; DFG(German Research Foundation (DFG))	We would like to thank the Bloomington Drosophila Stock Center for fly reagents; the Drosophila Genomics Resource Center at Indiana University for plasmids; The Developmental Studies Hybridoma Bank and the Lehmann laboratory for antibodies; M. Soller for sharing unpublished data; members of the J.-Y.R. laboratory for helpful discussion; A. Dold and V. Morin for experimental help; the IMB Genomics; the IMB Genomics, Proteomics and Bioinformatics Core facilities for support; and Bioinformatics Core facilities for support; and R. Ketting, N. Soshnikova, R. Strauss, J. Treisman and K. Zarnack for critical reading of the manuscript. Research in the laboratory of J.-Y.R. is supported by the Marie Curie CIG 334288 and the Deutsche Forschungsgemeinschaft (DFG) SPP1935 grant RO 4681/4-1. L.S. is funded by the Rhineland-Palatinate program Gene RED. The project was also supported by a DFG grant (HE 3397/13-1, SPP1784) to M.H.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Astigarraga S, 2010, J NEUROSCI, V30, P15358, DOI 10.1523/JNEUROSCI.1862-10.2010; Bahadorani S, 2008, NUTR RES, V28, P377, DOI 10.1016/j.nutres.2008.03.018; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bluhm A, 2016, PROTEOMICS, V16, P427, DOI 10.1002/pmic.201500217; Bodi Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00048; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Clough E, 2012, BRIEF FUNCT GENOMICS, V11, P387, DOI 10.1093/bfgp/els019; Deng X, 2015, NUCLEIC ACIDS RES, V43, P6557, DOI 10.1093/nar/gkv596; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gotz K G, 1980, Basic Life Sci, V16, P391; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Hilfiker A, 1995, DEVELOPMENT, V121, P4017; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kellner S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku733; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YL, 2014, RNA BIOL, V11, P1180, DOI 10.4161/rna.36281; Lin SB, 2014, NAT CELL BIOL, V16, P129, DOI 10.1038/ncb2914; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Motorin Y., WILEY INTERDISCIP RE; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Poeck B, 2008, DEV NEUROBIOL, V68, P1046, DOI 10.1002/dneu.20643; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; STRAUSS R, 1992, J NEUROGENET, V8, P125, DOI 10.3109/01677069209083444; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, RNA BIOL, V11, P669, DOI 10.4161/rna.28829; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	54	293	316	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					242	+		10.1038/nature20568	http://dx.doi.org/10.1038/nature20568			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27919077				2022-12-28	WOS:000389548700051
J	Roehr, B				Roehr, Bob			Denton Cooley OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												BobRoehr@aol.com						COOLEY D, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2016	355								i6606	10.1136/bmj.i6606	http://dx.doi.org/10.1136/bmj.i6606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SY	27932372				2022-12-28	WOS:000390037500009
J	Taya, Y; Ota, Y; Wilkinson, AC; Kanazawa, A; Watarai, H; Kasai, M; Nakauchi, H; Yamazaki, S				Taya, Yuki; Ota, Yasunori; Wilkinson, Adam C.; Kanazawa, Ayano; Watarai, Hiroshi; Kasai, Masataka; Nakauchi, Hiromitsu; Yamazaki, Satoshi			Depleting dietary valine permits nonmyeloablative mouse hematopoietic stem cell transplantation	SCIENCE			English	Article							AMINO-ACIDS; L-SERINE; PROGENITOR; NEURONS; NICHES	A specialized bone marrow microenvironment (niche) regulates hematopoietic stem cell (HSC) self-renewal and commitment. For successful donor-HSC engraftment, the niche must be emptied via myeloablative irradiation or chemotherapy. However, myeloablation can cause severe complications and even mortality. Here we report that the essential amino acid valine is indispensable for the proliferation and maintenance of HSCs. Both mouse and human HSCs failed to proliferate when cultured in valine-depleted conditions. In mice fed a valine-restricted diet, HSC frequency fell dramatically within 1 week. Furthermore, dietary valine restriction emptied the mouse bone marrow niche and afforded donor-HSC engraftment without chemoirradiative myeloablation. These findings indicate a critical role for valine in HSC maintenance and suggest that dietary valine restriction may reduce iatrogenic complications in HSC transplantation.	[Taya, Yuki; Wilkinson, Adam C.; Kanazawa, Ayano; Kasai, Masataka; Nakauchi, Hiromitsu; Yamazaki, Satoshi] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo 1088639, Japan; [Ota, Yasunori] Univ Tokyo, Inst Med Sci, Res Hosp, Dept Pathol, Tokyo 1088639, Japan; [Wilkinson, Adam C.; Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Lorry I Lokey Stem Cell Res Bldg,265 Campus Dr, Stanford, CA 94305 USA; [Watarai, Hiroshi] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Cell, Tokyo 1088639, Japan; [Watarai, Hiroshi] Japan Sci & Technol Agcy JST, Impulsing Paradigm Change Disrupt Technol Program, Tokyo 1020076, Japan	University of Tokyo; University of Tokyo; Stanford University; University of Tokyo; Japan Science & Technology Agency (JST)	Nakauchi, H; Yamazaki, S (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo 1088639, Japan.; Nakauchi, H (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Lorry I Lokey Stem Cell Res Bldg,265 Campus Dr, Stanford, CA 94305 USA.	nakauchi@stanford.edu; y-sato4@ims.u-tokyo.ac.jp			JST; Ministry of Education, Culture, Sport, Science and Technology (Japan); Japan Society for the Promotion of Science; California Institute of Regenerative Medicine; Siebel Foundation; Ludwig Foundation; Grants-in-Aid for Scientific Research [16K15501, 16H02661] Funding Source: KAKEN	JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Siebel Foundation; Ludwig Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Endo, Y. Yamazaki, Y. Ishii, and K. Chan for technical support; J. E. Dick, R. Yamamoto, and A. Knisely for critical manuscript reading; and S. Satomi, M. Chin, T. Kobayashi, K. Sudo, P. van Galen. N. Mbong, G. Karlsson, A. Reinisch, D. Thomas, K. Takubo, A. Iwama, K. Miharada, M. Otsu, H. Ema, L. Zon, and N. Chandel for advice. This work was supported by grants from JST; the Ministry of Education, Culture, Sport, Science and Technology (Japan); the Japan Society for the Promotion of Science; California Institute of Regenerative Medicine; the Siebel Foundation; and the Ludwig Foundation. H.N., S.Y., and Y.T. are inventors on a patent application (PCT/JP2015/083088) submitted by the University of Tokyo that covers the composition for decreasing HSCs and methods for producing these cells.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Gyurkocza B, 2014, BLOOD, V124, P344, DOI 10.1182/blood-2014-02-514778; HARPER AE, 1958, ANN NY ACAD SCI, V69, P1025, DOI 10.1111/j.1749-6632.1958.tb49733.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KORNBERG A, 1946, J BIOL CHEM, V164, P203; KORNBERG A, 1946, SCIENCE, V103, P646, DOI 10.1126/science.103.2682.646; KREHL WA, 1945, SCIENCE, V101, P489, DOI 10.1126/science.101.2628.489; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Mehanna HM, 2008, BRIT MED J, V336, P1495, DOI 10.1136/bmj.a301; Mitoma J, 1998, NEUROSCI RES, V30, P195, DOI 10.1016/S0168-0102(97)00113-2; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; STIPANUK MH, 1986, ANNU REV NUTR, V6, P179, DOI 10.1146/annurev.nu.06.070186.001143	16	103	108	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1152	1155		10.1126/science.aag3145	http://dx.doi.org/10.1126/science.aag3145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934766				2022-12-28	WOS:000388916400043
J	Crowther, TW; Todd-Brown, KEO; Rowe, CW; Wieder, WR; Carey, JC; Machmuller, MB; Snoek, BL; Fang, S; Zhou, G; Allison, SD; Blair, JM; Bridgham, SD; Burton, AJ; Carrillo, Y; Reich, PB; Clark, JS; Classen, AT; Dijkstra, FA; Elberling, B; Emmett, BA; Estiarte, M; Frey, SD; Guo, J; Harte, J; Jiang, L; Johnson, BR; Kroel-Dulay, G; Larsen, KS; Laudon, H; Lavallee, JM; Luo, Y; Lupascu, M; Ma, LN; Marhan, S; Michelsen, A; Mohan, J; Niu, S; Pendall, E; Penuelas, J; Pfeifer-Meister, L; Poll, C; Reinsch, S; Reynolds, LL; Schmidt, IK; Sistla, S; Sokol, NW; Templer, PH; Treseder, KK; Welker, JM; Bradford, MA				Crowther, T. W.; Todd-Brown, K. E. O.; Rowe, C. W.; Wieder, W. R.; Carey, J. C.; Machmuller, M. B.; Snoek, B. L.; Fang, S.; Zhou, G.; Allison, S. D.; Blair, J. M.; Bridgham, S. D.; Burton, A. J.; Carrillo, Y.; Reich, P. B.; Clark, J. S.; Classen, A. T.; Dijkstra, F. A.; Elberling, B.; Emmett, B. A.; Estiarte, M.; Frey, S. D.; Guo, J.; Harte, J.; Jiang, L.; Johnson, B. R.; Kroel-Dulay, G.; Larsen, K. S.; Laudon, H.; Lavallee, J. M.; Luo, Y.; Lupascu, M.; Ma, L. N.; Marhan, S.; Michelsen, A.; Mohan, J.; Niu, S.; Pendall, E.; Penuelas, J.; Pfeifer-Meister, L.; Poll, C.; Reinsch, S.; Reynolds, L. L.; Schmidt, I. K.; Sistla, S.; Sokol, N. W.; Templer, P. H.; Treseder, K. K.; Welker, J. M.; Bradford, M. A.			Quantifying global soil carbon losses in response to warming	NATURE			English	Article							EARTH SYSTEM MODELS; CLIMATE-CHANGE; TEMPERATURE SENSITIVITY; ORGANIC-CARBON; FEEDBACKS; TUNDRA; DECOMPOSITION; UNCERTAINTY; PROJECTIONS; ECOSYSTEMS	The majority of the Earth's terrestrial carbon is stored in the soil. If anthropogenic warming stimulates the loss of this carbon to the atmosphere, it could drive further planetary warming(1-4). Despite evidence that warming enhances carbon fluxes to and from the soil(5,6), the net global balance between these responses remains uncertain. Here we present a comprehensive analysis of warming-induced changes in soil carbon stocks by assembling data from 49 field experiments located across North America, Europe and Asia. We find that the effects of warming are contingent on the size of the initial soil carbon stock, with considerable losses occurring in high-latitude areas. By extrapolating this empirical relationship to the global scale, we provide estimates of soil carbon sensitivity to warming that may help to constrain Earth system model projections. Our empirical relationship suggests that global soil carbon stocks in the upper soil horizons will fall by 30 +/- 30 petagrams of carbon to 203 +/- 161 petagrams of carbon under one degree of warming, depending on the rate at which the effects of warming are realized. Under the conservative assumption that the response of soil carbon to warming occurs within a year, a business-as-usual climate scenario would drive the loss of 55 +/- 50 petagrams of carbon from the upper soil horizons by 2050. This value is around 12-17 per cent of the expected anthropogenic emissions over this period(7,8). Despite the considerable uncertainty in our estimates, the direction of the global soil carbon response is consistent across all scenarios. This provides strong empirical support for the idea that rising temperatures will stimulate the net loss of soil carbon to the atmosphere, driving a positive land carbon-climate feedback that could accelerate climate change.	[Crowther, T. W.; Snoek, B. L.; Bradford, M. A.] Netherlands Inst Ecol, Droevendaalsesteeg 10, NL-6708 PB Wageningen, Netherlands; [Crowther, T. W.; Rowe, C. W.; Bradford, M. A.] Yale Univ, Yale Sch Forestry & Environm Studies, 370 Prospect St, New Haven, CT 06511 USA; [Todd-Brown, K. E. O.; Sokol, N. W.] Pacific Northwest Natl Lab, Richland, WA 99354 USA; [Wieder, W. R.] Natl Ctr Atmospher Res, Climate & Global Dynam Lab, Boulder, CO 80307 USA; [Wieder, W. R.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80303 USA; [Carey, J. C.] Marine Biol Lab, 7 MBL St, Woods Hole, MA 02543 USA; [Machmuller, M. B.; Lavallee, J. M.] Colorado State Univ, Nat Resource Ecol Lab, 1499 Campus Delivery, Ft Collins, CO 80523 USA; [Snoek, B. L.] Wageningen Univ, Lab Nematol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [Fang, S.; Zhou, G.] Chinese Acad Meteorol Sci, 46 Zhongguancun South St, Beijing 100081, Peoples R China; [Fang, S.] Nanjing Univ Informat Sci & Technol, Collaborat Innovat Ctr Forecast Meteorol Disast, Nanjing 210044, Jiangsu, Peoples R China; [Allison, S. D.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Allison, S. D.; Treseder, K. K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Blair, J. M.] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Bridgham, S. D.; Pfeifer-Meister, L.; Reynolds, L. L.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Burton, A. J.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Carrillo, Y.; Reich, P. B.; Pendall, E.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2570, Australia; [Reich, P. B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Clark, J. S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Classen, A. T.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Univ Pk 15, DK-2100 Copenhagen O, Denmark; [Classen, A. T.] Univ Tennessee, Dept Ecol & Evolutionary Biol, 569 Dabney Hall,1416 Circle Dr, Knoxville, TN 37996 USA; [Dijkstra, F. A.] Univ Sydney, Ctr Carbon Water & Food, Camden, NSW 2570, Australia; [Elberling, B.; Michelsen, A.] Univ Copenhagen, Dept Geosci & Nat Resource Management, Ctr Permafrost CENPERM, Oster Voldgade 10, DK-1350 Copenhagen K, Denmark; [Emmett, B. A.; Reinsch, S.] Environm Ctr Wales, Ctr Ecol & Hydrol, Bangor LL57 2UW, Gwynedd, Wales; [Estiarte, M.; Penuelas, J.] CSIC, Global Ecol Unit CREAF CSIC, Cerdanyola Del Valles 08193, Catalonia, Spain; [Estiarte, M.; Penuelas, J.] CREAF, Cerdanyola Del Valles 08193, Catalonia, Spain; [Frey, S. D.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Guo, J.] Northeast Normal Univ, Minist Educ, Key Lab Vegetat Ecol, Changchun 130024, Jilin, Peoples R China; [Harte, J.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Jiang, L.; Luo, Y.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Johnson, B. R.] Univ Oregon, Dept Landscape Architecture, Eugene, OR 97403 USA; [Kroel-Dulay, G.] Magyar Tud Akad Ctr Ecol Res, Inst Ecol & Bot, 2-4 Alkotmany Utcakereso, H-2163 Vacratot, Hungary; [Larsen, K. S.; Schmidt, I. K.] Univ Copenhagen, Dept Geosci & Nat Resource Management, Rolighedsvej 23, DK-1958 Frederiksberg C, Denmark; [Laudon, H.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Lavallee, J. M.] Univ Manchester, Fac Life Sci, Dover St, Manchester M13 9PT, Lancs, England; [Luo, Y.] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Lupascu, M.] Natl Univ Singapore, Dept Geog, 1 Arts Link, Singapore 117570, Singapore; [Ma, L. N.] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Marhan, S.; Poll, C.] Univ Hohenheim, Inst Soil Sci & Land Evaluat, D-70593 Stuttgart, Germany; [Michelsen, A.] Univ Copenhagen, Dept Biol, Univ Pk 15, DK-2100 Copenhagen, Denmark; [Mohan, J.] Univ Georgia, Odum Sch Ecol, Athens, GA 30601 USA; [Niu, S.] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China; [Sistla, S.] Hampshire Coll, Sch Nat Sci, 893 West St, Amherst, MA 01002 USA; [Templer, P. H.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Welker, J. M.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Yale University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; National Center Atmospheric Research (NCAR) - USA; University of Colorado System; University of Colorado Boulder; Marine Biological Laboratory - Woods Hole; Colorado State University; Wageningen University & Research; Chinese Academy of Meteorological Sciences (CAMS); Nanjing University of Information Science & Technology; University of California System; University of California Irvine; University of California System; University of California Irvine; Kansas State University; University of Oregon; Michigan Technological University; Western Sydney University; University of Minnesota System; University of Minnesota Twin Cities; Duke University; University of Copenhagen; University of Tennessee System; University of Tennessee Knoxville; University of Sydney; University of Copenhagen; UK Centre for Ecology & Hydrology (UKCEH); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University System Of New Hampshire; University of New Hampshire; Northeast Normal University - China; University of California System; University of California Berkeley; University of Oklahoma System; University of Oklahoma - Norman; University of Oregon; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Copenhagen; Swedish University of Agricultural Sciences; University of Manchester; Tsinghua University; National University of Singapore; Chinese Academy of Sciences; Institute of Botany, CAS; University Hohenheim; University of Copenhagen; University System of Georgia; University of Georgia; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Boston University; University of Alaska System; University of Alaska Anchorage	Crowther, TW (corresponding author), Netherlands Inst Ecol, Droevendaalsesteeg 10, NL-6708 PB Wageningen, Netherlands.; Crowther, TW (corresponding author), Yale Univ, Yale Sch Forestry & Environm Studies, 370 Prospect St, New Haven, CT 06511 USA.	thomas.crowther11@gmail.com	Bradford, Mark A/G-3850-2012; Treseder, Kathleen K/E-5148-2011; Allison, Steven D./E-2978-2010; Pendall, Elise/AAF-5667-2020; Larsen, Klaus S/C-7549-2015; Lupascu, Massimo/AAD-8686-2021; Michelsen, Anders/L-5279-2014; Dijkstra, Feike A/H-2182-2012; Classen, Aimee/AAM-5671-2021; Emmett, Bridget A/D-6199-2011; Schmidt, Inger K/A-6230-2015; Reinsch, Sabine/J-6731-2017; Lupascu, Massimo/AAA-3051-2021; Estiarte, Marc/G-2001-2016; Classen, Aimee T/C-4035-2008; Penuelas, Josep/D-9704-2011; Wieder, William R./AAY-3338-2020; Laudon, Hjalmar/J-3074-2013; Classen, Aimee/X-2984-2019; Blair, John M/I-4082-2014; Lavallee, Jocelyn M/I-7658-2014; Bridgham, Scott/R-1557-2017; Frey, Serita D/Y-3397-2019; Snoek, Basten L/E-4713-2014; KNAW, NIOO-KNAW/A-4320-2012; Elberling, Bo/M-4000-2014	Bradford, Mark A/0000-0002-2022-8331; Treseder, Kathleen K/0000-0003-2847-6935; Allison, Steven D./0000-0003-4629-7842; Larsen, Klaus S/0000-0002-1421-6182; Lupascu, Massimo/0000-0002-0416-629X; Michelsen, Anders/0000-0002-9541-8658; Dijkstra, Feike A/0000-0002-6191-6018; Emmett, Bridget A/0000-0002-2713-4389; Schmidt, Inger K/0000-0003-3880-2060; Reinsch, Sabine/0000-0003-4649-0677; Estiarte, Marc/0000-0003-1176-8480; Classen, Aimee T/0000-0002-6741-3470; Penuelas, Josep/0000-0002-7215-0150; Wieder, William R./0000-0001-7116-1985; Laudon, Hjalmar/0000-0001-6058-1466; Blair, John M/0000-0003-0072-0721; Lavallee, Jocelyn M/0000-0002-3028-7087; Bridgham, Scott/0000-0003-0614-2678; Frey, Serita D/0000-0002-9221-5919; Snoek, Basten L/0000-0001-5321-2996; Pendall, Elise/0000-0002-1651-8969; Poll, Christian/0000-0002-9674-4447; KNAW, NIOO-KNAW/0000-0002-3835-159X; Reich, Peter/0000-0003-4424-662X; Niu, Shuli/0000-0002-2394-2864; Machmuller, Megan/0000-0002-0204-3712; fang, shibo/0000-0003-1516-1360; Elberling, Bo/0000-0002-6023-885X; Burton, Andrew/0000-0002-3068-0997; Sokol, Noah/0000-0003-0239-1976; Crowther, Thomas/0000-0001-5674-8913	Global Soil Biodiversity Initiative (GSBI); Marie Sklodowska-Curie actions; British Ecological Society; Yale Climate and Energy Institute; US National Science Foundation; US Department of Energy; Linus Pauling Distinguished Postdoctoral Fellowship programme; NERC [ceh020008] Funding Source: UKRI; Natural Environment Research Council [ceh020008] Funding Source: researchfish; Direct For Biological Sciences [1457614] Funding Source: National Science Foundation; Division Of Environmental Biology [1242531, 1340847, 1234162, 1120064] Funding Source: National Science Foundation	Global Soil Biodiversity Initiative (GSBI); Marie Sklodowska-Curie actions; British Ecological Society; Yale Climate and Energy Institute; US National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Linus Pauling Distinguished Postdoctoral Fellowship programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to thank the Global Soil Biodiversity Initiative (GSBI) for support during this project. This project was largely funded by grants to T.W.C. from Marie Sklodowska-Curie actions, the British Ecological Society and the Yale Climate and Energy Institute. M.A.B. and W.R.W. were supported by grants from the US National Science Foundation and W.R.W. from the US Department of Energy and K.E.O.T.-B. by the Linus Pauling Distinguished Postdoctoral Fellowship programme. The experiments that produced the data were funded by grants too numerous to list here.	Arora VK, 2013, J CLIMATE, V26, P5289, DOI 10.1175/JCLI-D-12-00494.1; Ballantyne AP, 2015, BIOGEOSCIENCES, V12, P2565, DOI 10.5194/bg-12-2565-2015; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; BILLINGS WD, 1987, QUATERNARY SCI REV, V6, P165, DOI 10.1016/0277-3791(87)90032-1; Bradford MA, 2016, NAT CLIM CHANGE, V6, P751, DOI [10.1038/nclimate3071, 10.1038/NCLIMATE3071]; Ciais P., 2013, CLIM CHANG 2013 PHYS; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Crowther TW, 2015, NATURE, V525, P201, DOI 10.1038/nature14967; Crowther TW, 2015, P NATL ACAD SCI USA, V112, P7033, DOI 10.1073/pnas.1502956112; Crowther TW, 2013, ECOL LETT, V16, P469, DOI 10.1111/ele.12069; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Day TA, 2008, GLOBAL CHANGE BIOL, V14, P1827, DOI 10.1111/j.1365-2486.2008.01623.x; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Georgiou K, 2015, GLOBAL CHANGE BIOL, V21, P4298, DOI 10.1111/gcb.13039; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jones C, 2013, J CLIMATE, V26, P4398, DOI 10.1175/JCLI-D-12-00554.1; Koven CD, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0423; Koven CD, 2015, BIOGEOSCIENCES, V12, P5211, DOI 10.5194/bg-12-5211-2015; Lu M, 2013, ECOLOGY, V94, P726, DOI 10.1890/12-0279.1; Macias-Fauria M, 2012, NAT CLIM CHANGE, V2, P613, DOI 10.1038/NCLIMATE1558; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Meehl GA, 2013, J CLIMATE, V26, P6287, DOI 10.1175/JCLI-D-12-00572.1; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Sistla SA, 2013, NATURE, V497, P615, DOI 10.1038/nature12129; Todd-Brown KEO, 2014, BIOGEOSCIENCES, V11, P2341, DOI 10.5194/bg-11-2341-2014; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]	30	568	592	89	1234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					104	+		10.1038/nature20150	http://dx.doi.org/10.1038/nature20150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905442	Green Submitted, Green Accepted			2022-12-28	WOS:000388916600057
J	Alegre-Diaz, J; Herrington, W; Lopez-Cervantes, M; Gnatiuc, L; Ramirez, R; Hill, M; Baigent, C; McCarthy, MI; Lewington, S; Collins, R; Whitlock, G; Tapia-Conyer, R; Peto, R; Kuri-Morales, P; Emberson, JR				Alegre-Diaz, Jesus; Herrington, William; Lopez-Cervantes, Malaquias; Gnatiuc, Louisa; Ramirez, Raul; Hill, Michael; Baigent, Colin; McCarthy, Mark I.; Lewington, Sarah; Collins, Rory; Whitlock, Gary; Tapia-Conyer, Roberto; Peto, Richard; Kuri-Morales, Pablo; Emberson, Jonathan R.			Diabetes and Cause-Specific Mortality in Mexico City	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCOSE; PREVALENCE; QUALITY; COUNTRY; TRENDS; DEATH	BACKGROUND Most large, prospective studies of the effects of diabetes on mortality have focused on high-income countries where patients have access to reasonably good medical care and can receive treatments to establish and maintain good glycemic control. In those countries, diabetes less than doubles the rate of death from any cause. Few large, prospective studies have been conducted in middle-income countries where obesity and diabetes have become common and glycemic control may be poor. METHODS From 1998 through 2004, we recruited approximately 50,000 men and 100,000 women 35 years of age or older into a prospective study in Mexico City, Mexico. We recorded the presence or absence of previously diagnosed diabetes, obtained and stored blood samples, and tracked 12-year disease-specific deaths through January 1, 2014. We accepted diabetes as the underlying cause of death only for deaths that were due to acute diabetic crises. We estimated rate ratios for death among participants who had diabetes at recruitment versus those who did not have diabetes at recruitment; data from participants who had chronic diseases other than diabetes were excluded from the main analysis. RESULTS At the time of recruitment, obesity was common and the prevalence of diabetes rose steeply with age (3% at 35 to 39 years of age and >20% by 60 years of age). Participants who had diabetes had poor glycemic control (mean [+/- SD] glycated hemoglobin level, 9.0 +/- 2.4%), and the rates of use of other vasoprotective medications were low (e.g., 30% of participants with diabetes were receiving antihypertensive medication at recruitment and 1% were receiving lipid-lowering medication). Previously diagnosed diabetes was associated with rate ratios for death from any cause of 5.4 (95% confidence interval [CI], 5.0 to 6.0) at 35 to 59 years of age, 3.1 (95% CI, 2.9 to 3.3) at 60 to 74 years of age, and 1.9 (95% CI, 1.8 to 2.1) at 75 to 84 years of age. Between 35 and 74 years of age, the excess mortality associated with previously diagnosed diabetes accounted for one third of all deaths; the largest absolute excess risks of death were from renal disease (rate ratio, 20.1; 95% CI, 17.2 to 23.4), cardiac disease (rate ratio, 3.7; 95% CI, 3.2 to 4.2), infection (rate ratio, 4.7; 95% CI, 4.0 to 5.5), acute diabetic crises (8% of all deaths among participants who had previously diagnosed diabetes), and other vascular disease (mainly stroke). Little association was observed between diabetes and mortality from cirrhosis, cancer, or chronic obstructive pulmonary disease. CONCLUSIONS In this study in Mexico, a middle-income country with high levels of obesity, diabetes was common, glycemic control was poor, and diabetes was associated with a far worse prognosis than that seen in high-income countries; it accounted for at least one third of all deaths between 35 and 74 years of age. (Funded by the Wellcome Trust and others.)	[Alegre-Diaz, Jesus; Lopez-Cervantes, Malaquias; Ramirez, Raul; Tapia-Conyer, Roberto; Kuri-Morales, Pablo] Univ Nacl Autonoma Mexico, Sch Med, Mexico City, DF, Mexico; [Herrington, William; Gnatiuc, Louisa; Hill, Michael; Baigent, Colin; Lewington, Sarah; Collins, Rory; Whitlock, Gary; Peto, Richard; Emberson, Jonathan R.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Herrington, William; Gnatiuc, Louisa; Hill, Michael; Baigent, Colin; Lewington, Sarah; Collins, Rory; Whitlock, Gary; Peto, Richard; Emberson, Jonathan R.] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Hill, Michael; Baigent, Colin; Lewington, Sarah; Emberson, Jonathan R.] Univ Oxford, MRC, Populat Hlth Res Unit, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [McCarthy, Mark I.] Univ Oxford, OCDEM, Nuffield Dept Med, Oxford, England	Universidad Nacional Autonoma de Mexico; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Emberson, JR (corresponding author), CTSU, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	jonathan.emberson@ndph.ox.ac.uk	; McCarthy, Mark/M-3763-2015	Lewington, Sarah/0000-0002-4496-4771; Gnatiuc Friedrichs, Louisa/0000-0002-0641-2220; Tapia-Conyer, Roberto/0000-0001-9425-7322; Herrington, William/0000-0003-1172-8243; McCarthy, Mark/0000-0002-4393-0510; ALEGRE - DIAZ, JESUS/0000-0001-9390-3871; Emberson, Jonathan/0000-0001-7792-9422	Wellcome Trust; MRC [MC_U137686855, MC_UU_12026/3, MC_U137686857] Funding Source: UKRI; Cancer Research UK [16896] Funding Source: researchfish; Medical Research Council [MC_U137686857, MC_UU_12026/3, MC_U137686855] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by the Wellcome Trust and others.	Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Astudillo O, 2014, LANCET DIABETES ENDO, V2, P15, DOI 10.1016/S2213-8587(13)70160-8; Bonilla-Chacin M.E., 2013, UNIVERSAL HLTH COVER, V1; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Flores-Hernandez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133958; Garcia-Garcia G, 2007, J AM SOC NEPHROL, V18, P1922, DOI 10.1681/ASN.2006121388; Hernandez B, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-38; Hippisley-Cox J, 2007, DIABETES UK ANAL QRE; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2015, INT DIAB FED DIAB AT; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; National Glycohemoglobin Standardization Program, INT FED CLIN CHEM IF; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Tapia-Conyer R, 2006, INT J EPIDEMIOL, V35, P243, DOI 10.1093/ije/dyl042; The World Bank, MEX DAT; Vazquez-Martinez Jose Luis, 2006, Rev Med Inst Mex Seguro Soc, V44, P13; World Health Organization, 2004, INT STAT CLASS DIS R, V2; World Health Organization, GLOB DAT BOD MASS IN; World Health Organization, GLOB HLTH OBS DAT RE; Youngman LD, 2002, CLIN CHEM, V48, P1627; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	34	147	153	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1961	1971		10.1056/NEJMoa1605368	http://dx.doi.org/10.1056/NEJMoa1605368			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC1HS	27959614	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000387856100008
J	Doherty, R				Doherty, Robert			The Demise of the Affordable Care Act? Not So Fast	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Doherty, Robert] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA	American College of Physicians	Doherty, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	rdoherty@mail.acponline.org						Abelson R, 2016, NY TIMES; [Anonymous], 2016, LIST GOV EXPR REP AF; Cancryn A, 2016, OBAMACARE REPEAL PLA; Holler D, 2015, MEMO REPEAL ALL OBAM; Kliff S, 2016, I READ 7 REPUBLICAN; Meyer H, 2016, ACA REPEAL REPLACEME; Reynolds ME, 2016, KEEPING TABS POTENTI; Sanger-Katz Margot, 2016, NY TIMES; Spiro T, 2016, REPUBLICAN ACA REPEA	9	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					144	+		10.7326/M16-2728	http://dx.doi.org/10.7326/M16-2728			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	27951588				2022-12-28	WOS:000391842600022
J	McKenzie, C				McKenzie, Colin			Alfred Wilson McKenzie OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		MCKENZIE AW, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2016	355								i6566	10.1136/bmj.i6566	http://dx.doi.org/10.1136/bmj.i6566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SZ	27940886				2022-12-28	WOS:000390037600005
J	Bierman, AS; Tinetti, ME				Bierman, Arlene S.; Tinetti, Mary E.			Precision medicine to precision care: managing multimorbidity	LANCET			English	Editorial Material							CLINICAL-PRACTICE GUIDELINES; DISEASE		[Bierman, Arlene S.] Agcy Healthcare Res & Qual, Ctr Evidence & Practice Improvement, Rockville, MD 20857 USA; [Tinetti, Mary E.] Yale Sch Med, Dept Med, New Haven, CT USA; [Tinetti, Mary E.] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA	Agency for Healthcare Research & Quality; Yale University; Yale University	Bierman, AS (corresponding author), Agcy Healthcare Res & Qual, Ctr Evidence & Practice Improvement, Rockville, MD 20857 USA.	arlene.bierman@ahrq.hhs.gov						Arnett DK, 2014, J AM COLL CARDIOL, V64, P1851, DOI 10.1016/j.jacc.2014.07.012; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Korsen NBA, 2016, INTEGRATION PLAYBOOK; Moreno G, 2013, J AM GERIATR SOC, V61, P2027, DOI 10.1111/jgs.12513; Muth C, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0223-1; National Guideline Clearinghouse, 2016, MULT CHRON COND MCC; National Institute for Health and Care Excellence, 2016, MULTIMORBIDITY CLIN; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Tinetti ME, 2016, CLIN GERIATR MED, V32, P261, DOI 10.1016/j.cger.2016.01.012; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203; Wyatt KD, 2014, MED CARE, V52, pS92, DOI 10.1097/MLR.0b013e3182a51b3d	13	46	47	2	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2721	2723		10.1016/S0140-6736(16)32232-2	http://dx.doi.org/10.1016/S0140-6736(16)32232-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FB	27924764				2022-12-28	WOS:000389629800008
J	Gibney, E				Gibney, Elizabeth			Bonus funds excite UK scientists	NATURE			English	News Item																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					16	17		10.1038/nature.2016.21038	http://dx.doi.org/10.1038/nature.2016.21038			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905461	Bronze			2022-12-28	WOS:000388916600019
J	Hollingsworth, JM; Canales, BK; Rogers, MAM; Sukumar, S; Yan, P; Kuntz, GM; Dahm, P				Hollingsworth, John M.; Canales, Benjamin K.; Rogers, Mary A. M.; Sukumar, Shyam; Yan, Phyllis; Kuntz, Gretchen M.; Dahm, Philipp			Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MEDICAL EXPULSIVE THERAPY; DOUBLE-BLIND; FACILITATE PASSAGE; DOSE TAMSULOSIN; EFFICACY; MANAGEMENT; CALCULI; ALFUZOSIN; SILODOSIN; DOXAZOSIN	OBJECTIVE To investigate the efficacy and safety of alpha blockers in the treatment of patients with ureteric stones. DESIGN Systematic review and meta-analysis. DATA SOURCES Cochrane Central Register of Controlled Trials, Web of Science, Embase, LILACS, and Medline databases and scientific meeting abstracts to July 2016. REVIEW METHODS Randomized controlled trials of alpha blockers compared with placebo or control for treatment of ureteric stones were eligible. Two team members independently extracted data from each included study. The primary outcome was the proportion of patients who passed their stone. Secondary outcomes were the time to passage; the number of pain episodes; and the proportions of patients who underwent surgery, required admission to hospital, and experienced an adverse event. Pooled risk ratios and 95% confidence intervals were calculated for the primary outcome with profile likelihood random effects models. Cochrane Collaboration's tool for assessing risk of bias and the GRADE approach were used to evaluate the quality of evidence and summarize conclusions. RESULTS 55 randomized controlled trials were included. There was moderate quality evidence that alpha blockers facilitate passage of ureteric stones (risk ratio 1.49, 95% confidence interval 1.39 to 1.61). Based on a priori subgroup analysis, there seemed to be no benefit to treatment with alpha blocker among patients with smaller ureteric stones (1.19, 1.00 to 1.48). Patients with larger stones treated with an alpha blocker, however, had a 57% higher risk of stone passage compared with controls (1.57, 1.17 to 2.27). The effect of alpha blockers was independent of stone location (1.48 (1.05 to 2.10) for upper or middle stones; 1.49 (1.38 to 1.63) for lower stones). Compared with controls, patients who received alpha blockers had significantly shorter times to stone passage (mean difference -3.79 days, -4.45 to -3.14; moderate quality evidence), fewer episodes of pain (-0.74 episodes, -1.28 to -0.21; low quality evidence), lower risks of surgical intervention (risk ratio 0.44, 0.37 to 0.52; moderate quality evidence), and lower risks of admission to hospital (0.37, 0.22 to 0.64; moderate quality evidence). The risk of a serious adverse event was similar between treatment and control groups (1.49, 0.24 to 9.35; low quality evidence). CONCLUSIONS Alpha blockers seem efficacious in the treatment of patients with ureteric stones who are amenable to conservative management. The greatest benefit might be among those with larger stones. These results support current guideline recommendations advocating a role for alpha blockers in patients with ureteric stones. SYSTEMATIC REVIEW REGISTRATION PROSPERO registration No CRD42015024169.	[Hollingsworth, John M.; Yan, Phyllis] Univ Michigan, Dept Urol, 2800 Plymouth Rd,Bldg 16,1st Floor, Ann Arbor, MI 48109 USA; [Canales, Benjamin K.] Univ Florida, Dept Urol, 1600 SW Archer Rd, Gainesville, FL 32610 USA; [Rogers, Mary A. M.] Univ Michigan, Div Gen Med, Dept Internal Med, 2800 Plymouth Rd,Bldg 16,4th Floor, Ann Arbor, MI 48109 USA; [Sukumar, Shyam; Dahm, Philipp] Univ Minnesota, Minneapolis Vet Adm Hlth Care Syst, Mayo Mem Bldg,420 Delaware St SE,MMC 394, Minneapolis, MN 55455 USA; [Sukumar, Shyam; Dahm, Philipp] Univ Minnesota, Dept Urol, Mayo Mem Bldg,420 Delaware St SE,MMC 394, Minneapolis, MN 55455 USA; [Kuntz, Gretchen M.] Univ Florida, Borland Lib, 653-1 W 8th St, Jacksonville, FL 32209 USA	University of Michigan System; University of Michigan; State University System of Florida; University of Florida; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida	Hollingsworth, JM (corresponding author), Univ Michigan, Dept Urol, 2800 Plymouth Rd,Bldg 16,1st Floor, Ann Arbor, MI 48109 USA.	kinks@med.umich.edu	Dahm, Philipp/I-1614-2019	Dahm, Philipp/0000-0003-2819-2553; Rogers, Mary/0000-0001-5519-3223	Agency for Healthcare Research and Quality; Urology Care Foundation; Blue Cross Blue Shield of Michigan	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Urology Care Foundation; Blue Cross Blue Shield of Michigan	All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi disclosure.pdf and declare: JMH received research grants from the Agency for Healthcare Research and Quality, the Urology Care Foundation, and Blue Cross Blue Shield of Michigan during the conduct of this study.	Abdel-Meguid TA, 2010, CAN J UROL, V17, P5178; Abhishek L, 2015, INDIAN J UROL, V31; Agrawal M, 2009, UROLOGY, V73, P706, DOI 10.1016/j.urology.2008.11.013; Ahmad Hussain, 2015, J Ayub Med Coll Abbottabad, V27, P48; Ahmed AFAM, 2010, KOREAN J UROL, V51, P193, DOI 10.4111/kju.2010.51.3.193; Al-Ansari A, 2010, UROLOGY, V75, P4, DOI 10.1016/j.urology.2009.09.073; Alizadeh M, 2014, Glob J Health Sci, V6, P44, DOI 10.5539/gjhs.v6n7p44; Ambani SN, 2016, NAT REV UROL, V13, DOI 10.1038/nrurol.2015.290; Aravinthan T, 2012, INT J UROL, V19, P64; Ayubov B, 2007, EUR UROL SUPPL, V6, P114, DOI 10.1016/S1569-9056(07)60367-4; Bajwa MSA, 2013, PAK J MED HEALTH SCI, V7, P769; Bak CW, 2007, KOREAN J UROL, V48, P517, DOI DOI 10.4111/KJU.2007.48.5.517; Balci M, 2014, RENAL FAILURE, V36, P1541, DOI 10.3109/0886022X.2014.959023; Bannakij L, 2012, INT J UROL, V19, P64; Berger DA, 2015, AM J EMERG MED, V33, P1721, DOI 10.1016/j.ajem.2015.08.006; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Bultitude M., 2015, DRUGS DONT WORK; Campschroer T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008509.pub2; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; De Sio M, 2006, J ENDOUROL, V20, P12; Desai A, 2014, INDIAN J UROL, V30, pS61; El Said NO, 2015, PHARMACOTHERAPY, V35, P470, DOI 10.1002/phar.1593; El-Gamal O, 2012, UROL RES, V40, P219, DOI 10.1007/s00240-011-0406-6; Erturhan S, 2007, UROLOGY, V69, P633, DOI 10.1016/j.urology.2007.01.009; Eryildirim B, 2015, INT UROL NEPHROL, V47, P1271, DOI 10.1007/s11255-015-1036-7; Ferre RM, 2009, ANN EMERG MED, V54, P432, DOI 10.1016/j.annemergmed.2008.12.026; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Furyk JS, 2016, ANN EMERG MED, V67, P86, DOI 10.1016/j.annemergmed.2015.06.001; Georgescu D, 2015, FARMACIA, V63, P184; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Hartung J, 2001, STAT MED, V20, P3875, DOI 10.1002/sim.1009; Hartung J, 2001, STAT MED, V20, P1771, DOI 10.1002/sim.791; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hollingsworth JM, 2006, LANCET, V368, P1171, DOI 10.1016/S0140-6736(06)69474-9; Huang W, 2016, BRIT J CLIN PHARMACO, V81, P13, DOI 10.1111/bcp.12737; HUBNER WA, 1993, EUR UROL, V24, P172; Ibrahim AK, 2013, ARAB J UROL, V11, P142, DOI 10.1016/j.aju.2013.02.003; IntHout J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010247; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Itoh Y, 2007, INT J UROL, V14, P749, DOI 10.1111/j.1442-2042.2007.01812.x; Itoh Y, 2013, INT UROL NEPHROL, V45, P675, DOI 10.1007/s11255-013-0429-8; Kaneko T, 2010, INT J UROL, V17, P462, DOI 10.1111/j.1442-2042.2010.02499.x; Kim JW, 2007, KOREAN J UROL, V48, P724, DOI [10.4111/kju.2007.48.7.724., DOI 10.4111/KJU.2007.48.7.724]; Kumar S, 2013, KOREAN J UROL, V54, P311, DOI 10.4111/kju.2013.54.5.311; Kupeli B, 2004, UROLOGY, V64, P1111, DOI 10.1016/j.urology.2004.07.020; Lee SW, 2014, INT J CLIN PRACT, V68, P216, DOI 10.1111/ijcp.12271; Liatsikos EN, 2007, J ENDOUROL, V21, P538, DOI 10.1089/end.2006.0107; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134589; Lojanapiwat B, 2008, J INT MED RES, V36, P529, DOI 10.1177/147323000803600318; Lu ZP, 2012, UROL INT, V89, P107, DOI 10.1159/000338909; Lv JL, 2014, UROLITHIASIS, V42, P541, DOI 10.1007/s00240-014-0708-6; Mohseni MG, 2006, SAUDI MED J, V27, P838; Mukhtarov S, 2007, EUR UROL SUPPL, V6, P216, DOI 10.1016/S1569-9056(07)60769-6; Ochoa-Gomez R, 2011, UROL RES, V39, P491, DOI 10.1007/s00240-011-0380-z; Ozsoy M, 2016, UROLITHIASIS, V44, P491, DOI 10.1007/s00240-016-0872-y; Park HK, 2007, UROL RES, V35, P325, DOI 10.1007/s00240-007-0118-0; Park J, 2012, J ENDOUROL, V26, pA105; Pedro RN, 2008, J UROLOGY, V179, P2244, DOI 10.1016/j.juro.2008.01.141; Pickard R, 2015, LANCET, V386, P341, DOI 10.1016/S0140-6736(15)60933-3; Porpiglia F, 2004, J UROLOGY, V172, P568, DOI 10.1097/01.ju.0000132390.61756.ff; Preminger GM, 2007, J UROLOGY, V178, P2418, DOI 10.1016/j.juro.2007.09.107; Preminger GM, 2016, J UROLOGY, V195, P554, DOI 10.1016/j.juro.2015.12.066; Rahim J, 2012, PAK J MED HEALTH SCI, V6, P191; Rathi S, 2014, INDIAN J UROLOGY S1, V30, pS83; Resim S, 2005, INT J UROL, V12, P615, DOI 10.1111/j.1442-2042.2005.01116.x; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Sameer, 2014, INDIAN J UROL, V30, P387, DOI 10.4103/0970-1591.139572; Sayed MAB, 2008, SCAND J UROL NEPHROL, V42, P59, DOI 10.1080/00365590701571076; Sigala S, 2005, NEUROUROL URODYNAM, V24, P142, DOI 10.1002/nau.20097; Singh A, 2007, ANN EMERG MED, V50, P552, DOI 10.1016/j.annemergmed.2007.05.015; Sun XH, 2009, J UROLOGY, V181, P1716, DOI 10.1016/j.juro.2008.11.118; Sur RL, 2015, EUR UROL, V67, P959, DOI 10.1016/j.eururo.2014.10.049; Taghavi R., 2005, Journal of Endourology, V19, pA9; Tekin A, 2004, J UROL, V171; Turk C, 2016, EUR UROL, V69, P468, DOI 10.1016/j.eururo.2015.07.040; UENO A, 1977, Urology, V10, P544, DOI 10.1016/0090-4295(77)90097-8; Van Asseldonk B, 2015, UROLOGY, V86, P649, DOI 10.1016/j.urology.2015.06.030; Wang CJ, 2008, J ENDOUROL, V22, P41, DOI 10.1089/end.2007.0133; Wang CJ, 2016, UROL J, V13, P2666; Wimpissinger F, 2007, J UROLOGY, V178, P1341, DOI 10.1016/j.juro.2007.05.128; 강동일, 2009, Investigative and Clinical Urology, V50, P586; Yilmaz E, 2005, J UROLOGY, V173, P2010, DOI 10.1097/01.ju.0000158453.60029.0a; Yuksel M, 2015, INT J CLIN EXP MED, V8, P19086; Zehri AA, 2010, UROLOGY, V75, P1285, DOI 10.1016/j.urology.2009.10.069	88	76	79	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2016	355								i6112	10.1136/bmj.i6112	http://dx.doi.org/10.1136/bmj.i6112			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZO	27908918	hybrid, Green Published			2022-12-28	WOS:000389309800001
J	Zhang, Z; Chen, J				Zhang, Zhe; Chen, Jue			Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator	CELL			English	Article							NUCLEOTIDE-BINDING DOMAIN; PORE-LINING RESIDUES; CHLORIDE CHANNEL; MOLECULAR-BASIS; CONFORMATIONAL-CHANGES; ABC TRANSPORTER; R-DOMAIN; STRUCTURE VALIDATION; DELTA-F508 MUTATION; ANION SELECTIVITY	The cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel evolved from the ATP-binding cassette (ABC) transporter family. In this study, we determined the structure of zebrafish CFTR in the absence of ATP by electron cryo-microscopy to 3.7 angstrom resolution. Human and zebrafish CFTR share 55% sequence identity, and 42 of the 46 cystic-fibrosis-causing missense mutational sites are identical. In CFTR, we observe a large anion conduction pathway lined by numerous positively charged residues. A single gate near the extracellular surface closes the channel. The regulatory domain, dephosphorylated, is located in the intracellular opening between the two nucleotide-binding domains (NBDs), preventing NBD dimerization and channel opening. The structure also reveals why many cystic-fibrosis-causing mutations would lead to defects either in folding, ion conduction, or gating and suggests new avenues for therapeutic intervention.	[Zhang, Zhe; Chen, Jue] Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA; [Zhang, Zhe; Chen, Jue] Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	Chen, J (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.; Chen, J (corresponding author), Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	juechen@rockefeller.edu			Rockefeller University; Howard Hughes Medical Institute	Rockefeller University; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank David Gadsby and Roderick MacKinnon for discussions and critical comments on the manuscript; Eric Gouaux for reagents of the mammalian expression system; Mark Ebrahim and Johanna Sotiris at the Rockefeller Evelyn Gruss Lipper Cryo-Electron Microscopy Resource Center and Zhiheng Yu, Chuan Hong, and Rick Huang at the Janelia Farms Howard Hughes Medical Institute cryo-EM facility for assistance in data collection; and Sarah McCarry for editing this manuscript. We also thank the Rockefeller University and the Howard Hughes Medical Institute for financial support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bagnat M, 2010, CURR BIOL, V20, P1840, DOI 10.1016/j.cub.2010.09.012; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; Bilan F, 2004, J CELL SCI, V117, P1923, DOI 10.1242/jcs.01070; Billet A, 2013, J CYST FIBROS, V12, P737, DOI 10.1016/j.jcf.2013.02.002; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chaves LAP, 2015, J GEN PHYSIOL, V145, P261, DOI 10.1085/jgp.201411347; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Csanady L, 2013, J GEN PHYSIOL, V142, P61, DOI 10.1085/jgp.201210954; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Decaestecker K, 2004, EUR RESPIR J, V23, P679, DOI 10.1183/09031936.04.00014804; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; El Hiani Y, 2014, BIOCHEM CELL BIOL, V92, P481, DOI 10.1139/bcb-2014-0038; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Elborn J. S., 2016, LANCET; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Fu J, 2001, J PHYSIOL-LONDON, V536, P459, DOI 10.1111/j.1469-7793.2001.0459c.xd; Gao XL, 2016, J GEN PHYSIOL, V147, P407, DOI 10.1085/jgp.201511557; Gao X, 2013, BIOPHYS J, V104, P786, DOI 10.1016/j.bpj.2012.12.048; Gene GG, 2008, HUM MUTAT, V29, P738, DOI 10.1002/humu.20721; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Guinamard R, 1999, BIOCHEMISTRY-US, V38, P5528, DOI 10.1021/bi990155n; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Jurkuvenaite A, 2006, J BIOL CHEM, V281, P3329, DOI 10.1074/jbc.M508131200; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Linsdell P, 2000, BIOPHYS J, V78, P2973, DOI 10.1016/S0006-3495(00)76836-6; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell P, 2001, J PHYSIOL-LONDON, V531, P51, DOI 10.1111/j.1469-7793.2001.0051j.x; Linsdell P., 2016, CELL MOL LIFE SCI; Linsdell P, 2016, BBA-BIOMEMBRANES, V1858, P740, DOI 10.1016/j.bbamem.2016.01.009; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCDONOUGH S, 1994, NEURON, V13, P623, DOI 10.1016/0896-6273(94)90030-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Navis A, 2015, DEV BIOL, V399, P237, DOI 10.1016/j.ydbio.2014.12.034; Oldham ML, 2016, NATURE, V529, P537, DOI 10.1038/nature16506; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Peters KW, 2001, PFLUG ARCH EUR J PHY, V443, pS65, DOI 10.1007/s004240100647; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; RIORDAN JR, 1993, ANNU REV PHYSIOL, V55, P609, DOI 10.1146/annurev.ph.55.030193.003141; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seibert FS, 1999, BBA-BIOMEMBRANES, V1461, P275, DOI 10.1016/S0005-2736(99)00163-7; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Smart O. S., 1996, J MOL GRAPHICS, V14, P376, DOI [DOI 10.1016/S0263-7855(97)00009-X, 10.1016/S0263-7855119000009-21]; Smith SS, 1999, J GEN PHYSIOL, V114, P799, DOI 10.1085/jgp.114.6.799; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; TENEYCK LF, 1977, ACTA CRYSTALLOGR A, V33, P486, DOI 10.1107/S0567739477001211; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Wang WY, 2014, PFLUG ARCH EUR J PHY, V466, P477, DOI 10.1007/s00424-013-1317-x; Wang WY, 2012, J BIOL CHEM, V287, P32136, DOI 10.1074/jbc.M112.385096; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Wang YT, 2014, INT J BIOCHEM CELL B, V52, P47, DOI 10.1016/j.biocel.2014.04.001; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5808; Webb B., 2014, CURR PROTOC BIOINFOR; Wei SP, 2016, FASEB J, V30, P1247, DOI 10.1096/fj.15-278382; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; YANG YP, 1993, HUM MOL GENET, V2, P1253, DOI 10.1093/hmg/2.8.1253; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Zhang JY, 2015, BIOCHEMISTRY-US, V54, P3839, DOI 10.1021/acs.biochem.5b00427; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	103	196	201	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1586	+		10.1016/j.cell.2016.11.014	http://dx.doi.org/10.1016/j.cell.2016.11.014			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912062	Bronze			2022-12-28	WOS:000389470500019
J	Weeks, A; Temmerman, M				Weeks, Andrew; Temmerman, Marleen			New WHO antenatal care model-quality worth paying for?	LANCET			English	Editorial Material									[Weeks, Andrew] Univ Liverpool, Dept Womens & Childrens Hlth, Sanyu Res Unit, Liverpool L69 3BX, Merseyside, England; [Weeks, Andrew] Liverpool Womens Hosp, Matern Div, Liverpool, Merseyside, England; [Temmerman, Marleen] Aga Khan Univ, Dept Obstet & Gynaecol, Nairobi, Kenya; [Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	University of Liverpool; University of Liverpool; Aga Khan University; Ghent University	Temmerman, M (corresponding author), Aga Khan Univ, Dept Obstet & Gynaecol, Nairobi, Kenya.; Temmerman, M (corresponding author), Univ Ghent, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	marleen.temmerman@aku.edu		Weeks, Andrew/0000-0002-1909-337X	MRC [G1100686, MR/M017990/1] Funding Source: UKRI; Medical Research Council [G1100686, MR/K007408/1, MR/M017990/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dowswell T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000934.pub2; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; National Institute for Health and Clinical Excellence (NICE), 2008, ANT CAR UNC PREGN; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; WHO, 2022, WHO RECOMMENDATIONS; World Health Organization, 2001, WHO ANT CAR RAND TRI	6	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2574	2575		10.1016/S0140-6736(16)32233-4	http://dx.doi.org/10.1016/S0140-6736(16)32233-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27894650				2022-12-28	WOS:000388516800009
J	Roberts, G				Roberts, Graham			Another step towards prevention of food allergy	LANCET			English	Editorial Material							METAANALYSIS; INFANTS; TRIAL; RISK		[Roberts, Graham] Univ Southampton, Fac Med, Paediat Allergy & Resp Med Unit, Southampton SO17 1BJ, Hants, England; [Roberts, Graham] Univ Southampton, Fac Med, Clin & Expt Sci Unit, Southampton SO17 1BJ, Hants, England; [Roberts, Graham] Univ Southampton, Fac Med, Human Dev Hlth Acad Unit, Southampton SO17 1BJ, Hants, England; [Roberts, Graham] Southampton Univ Hosp, Southampton SO17 1BJ, Hants, England; [Roberts, Graham] NHS Fdn Trust, Univ Hosp Southampton, Natl Inst Hlth Res, Southampton Resp Biomed Res Unit, Southampton, Hants, England; [Roberts, Graham] St Marys Hosp, David Hide Asthma & Allergy Res Ctr, Isle Of Wight, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Roberts, G (corresponding author), Univ Southampton, Fac Med, Paediat Allergy & Resp Med Unit, Southampton SO17 1BJ, Hants, England.; Roberts, G (corresponding author), Univ Southampton, Fac Med, Clin & Expt Sci Unit, Southampton SO17 1BJ, Hants, England.; Roberts, G (corresponding author), Univ Southampton, Fac Med, Human Dev Hlth Acad Unit, Southampton SO17 1BJ, Hants, England.; Roberts, G (corresponding author), Southampton Univ Hosp, Southampton SO17 1BJ, Hants, England.; Roberts, G (corresponding author), NHS Fdn Trust, Univ Hosp Southampton, Natl Inst Hlth Res, Southampton Resp Biomed Res Unit, Southampton, Hants, England.; Roberts, G (corresponding author), St Marys Hosp, David Hide Asthma & Allergy Res Ctr, Isle Of Wight, England.	g.c.roberts@soton.ac.uk		Roberts, Graham/0000-0003-2252-1248				Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bellach J, 2017, J ALLERGY CLIN IMMUN, V139, P1591, DOI 10.1016/j.jaci.2016.06.045; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Natsume O, 2016, LANCET; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210	9	1	1	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					230	231		10.1016/S0140-6736(16)31661-0	http://dx.doi.org/10.1016/S0140-6736(16)31661-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	27939036				2022-12-28	WOS:000392801200006
J	Hughes, B				Hughes, Bronwyn			Marian Hughes OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		HUGHES M, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2016	355								i6577	10.1136/bmj.i6577	http://dx.doi.org/10.1136/bmj.i6577			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SZ	27940432				2022-12-28	WOS:000390037600009
J	Gray, M; Wallace, A; Aldridge, S				Gray, Matthew; Wallace, Alasdair; Aldridge, Stephen			Assessment of shoulder pain for non-specialists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ROTATOR CUFF; DIAGNOSIS; MANAGEMENT; INJECTIONS; DISORDERS; REPAIR		[Gray, Matthew; Aldridge, Stephen] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [Wallace, Alasdair] Village Green Surg, Wallsend, Tyne & Wear, England	Newcastle University - UK	Gray, M (corresponding author), Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England.	matthew.gray@doctors.org.uk						Bateman Marcus, 2015, Shoulder Elbow, V7, P282, DOI 10.1177/1758573215592266; Bull Damian, 2016, Shoulder Elbow, V8, P77, DOI 10.1177/1758573215622385; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; Denard PJ, 2015, AM J SPORT MED, V43, P2373, DOI 10.1177/0363546515597486; Dias R, 2005, BMJ-BRIT MED J, V331, P1453, DOI 10.1136/bmj.331.7530.1453; Diercks R, 2014, ACTA ORTHOP, V85, P314, DOI 10.3109/17453674.2014.920991; Gaujoux-Viala C, 2009, ANN RHEUM DIS, V68, P1843, DOI 10.1136/ard.2008.099572; Goud A, 2008, EUR J RADIOL, V68, P2, DOI 10.1016/j.ejrad.2008.02.023; Hossain S, 2008, J SHOULDER ELB SURG, V17, P535, DOI 10.1016/j.jse.2007.12.001; Jacob A K, 1997, Biomed Sci Instrum, V34, P380; Jakobsen BW, 2007, ARTHROSCOPY, V23, P118, DOI 10.1016/j.arthro.2006.11.004; Kuhn JE, 2009, J SHOULDER ELB SURG, V18, P138, DOI 10.1016/j.jse.2008.06.004; Kulkarni Rohit, 2015, Shoulder Elbow, V7, P135, DOI 10.1177/1758573215576456; Kwaees TA, 2015, MUSCLES LIGAMENTS TE, V4, P420, DOI [10.11138/mltj/2014.4.4.420, DOI 10.11138/MLTJ/2014.4.4.420]; Laslett M, 2014, J REHABIL MED, V46, P898, DOI 10.2340/16501977-1860; Le Goff B, 2010, JOINT BONE SPINE, V77, P258, DOI 10.1016/j.jbspin.2010.01.012; Lenza M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009020.pub2; Luime JJ, 2004, SCAND J RHEUMATOL, V33, P73, DOI 10.1080/03009740310004667; Mitchell C, 2005, BMJ-BRIT MED J, V331, P1124, DOI 10.1136/bmj.331.7525.1124; National Institute for Health and Care Excellence, 2006, CLIN KNOWL SUMM SHOU; Ostor AJK, 2005, RHEUMATOLOGY, V44, P800, DOI 10.1093/rheumatology/keh598; Ottenheijm RPG, 2015, ANN FAM MED, V13, P53, DOI 10.1370/afm.1734; Page MJ, 2015, J CLIN EPIDEMIOL, V68, P1270, DOI 10.1016/j.jclinepi.2015.06.006; Petrera M, 2010, KNEE SURG SPORT TR A, V18, P1742, DOI 10.1007/s00167-010-1093-5; Rangan A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4162; Sciascia AD, 2012, J ATHL TRAINING, V47, P457, DOI 10.4085/1062-6050-47.4.09; Thangarajah T, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2537; Uppal HS, 2015, WORLD J ORTHOP, V6, P263, DOI 10.5312/wjo.v6.i2.263; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959	29	3	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2016	355								i5783	10.1136/bmj.i5783	http://dx.doi.org/10.1136/bmj.i5783			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SX	27927638				2022-12-28	WOS:000390037400002
J	Boddy, J				Boddy, Jessica			NEUROSCIENCE Energy pulses reveal possible new state of memory	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1089	1089		10.1126/science.354.6316.1089	http://dx.doi.org/10.1126/science.354.6316.1089			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934715				2022-12-28	WOS:000388916400013
J	Hatch, N				Hatch, Nina			Galaxy formation through cosmic recycling	SCIENCE			English	Editorial Material									[Hatch, Nina] Univ Nottingham, Sch Phys & Astron, Univ Pk, Nottingham NG7 2RD, England	University of Nottingham	Hatch, N (corresponding author), Univ Nottingham, Sch Phys & Astron, Univ Pk, Nottingham NG7 2RD, England.	nina.hatch@nottingham.ac.uk		Hatch, Nina/0000-0001-5600-0534	STFC [ST/J002844/1, ST/G004994/1, ST/L000695/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Collins CA, 2009, NATURE, V458, P603, DOI 10.1038/nature07865; Daddi E, 2008, ASTROPHYS J LETT, V673, pL21, DOI 10.1086/527377; De Lucia G, 2007, MON NOT R ASTRON SOC, V375, P2, DOI 10.1111/j.1365-2966.2006.11287.x; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Emonts BHC, 2016, SCIENCE, V354, P1128, DOI 10.1126/science.aag0512; FABIAN AC, 1994, ANNU REV ASTRON ASTR, V32, P277, DOI 10.1146/annurev.aa.32.090194.001425; Hatch NA, 2008, MON NOT R ASTRON SOC, V383, P931, DOI 10.1111/j.1365-2966.2007.12626.x; Miley GK, 2006, ASTROPHYS J, V650, pL29, DOI 10.1086/508534; Narayanan D, 2015, NATURE, V525, P496, DOI 10.1038/nature15383; Oser L, 2010, ASTROPHYS J, V725, P2312, DOI 10.1088/0004-637X/725/2/2312; Pentericci L, 1997, ASTRON ASTROPHYS, V326, P580	11	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1102	1103		10.1126/science.aah6255	http://dx.doi.org/10.1126/science.aah6255			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934721				2022-12-28	WOS:000388916400019
J	Gupta, S				Gupta, Sujata			DIET Changing the recipe	NATURE			English	Editorial Material							MULTIPLE-SCLEROSIS; FAT											Farinotti M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004192.pub3; Muris A.-H., 2016, ECTRIMS ONLINE LIB; SWANK RL, 1990, LANCET, V336, P37, DOI 10.1016/0140-6736(90)91533-G; Torkildsen O, 2012, ARCH NEUROL-CHICAGO, V69, P1044, DOI 10.1001/archneurol.2012.283; Yadav V, 2016, MULT SCLER RELAT DIS, V9, P80, DOI 10.1016/j.msard.2016.07.001	5	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					S13	S14		10.1038/540S13a	http://dx.doi.org/10.1038/540S13a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27902680				2022-12-28	WOS:000388916600007
J	Johannes, L; Wunder, C				Johannes, Ludger; Wunder, Christian			Retromer Sets a Trap for Endosomal Cargo Sorting	CELL			English	Editorial Material							COMPLEX; PROTEIN; SUPERCOMPLEX; MECHANISM; ARCHITECTURE	Membrane trafficking from endosomes to the trans-Golgi network or the plasma membrane is driven by the retromer complex. Through structural analysis of the cargo-bound complex, Lucas et al. describe a mechanism by which endosomal membrane recruitment and cargo recognition are integrated through cooperative interactions between retromer subunits.	[Johannes, Ludger; Wunder, Christian] PSL Res Univ, Inst Curie, Chem Biol Membranes & Therapeut Delivery Unit, INSERM U1143,CNRS UMR 3666, 26 Rue Ulm, F-75248 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Johannes, L (corresponding author), PSL Res Univ, Inst Curie, Chem Biol Membranes & Therapeut Delivery Unit, INSERM U1143,CNRS UMR 3666, 26 Rue Ulm, F-75248 Paris 05, France.	ludger.johannes@curie.fr	Johannes, Ludger/M-9778-2017; Johannes, Ludger/W-8593-2019; Wunder, Christian/K-8542-2017	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Wunder, Christian/0000-0001-9091-0080				Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Bragoszewski P, 2015, P NATL ACAD SCI USA, V112, P7713, DOI 10.1073/pnas.1504615112; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Harrison MS, 2014, P NATL ACAD SCI USA, V111, P267, DOI 10.1073/pnas.1316482111; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Johannes L, 2011, NAT CELL BIOL, V13, P884, DOI 10.1038/ncb2300; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Lucas M, 2016, CELL, V167, P1623, DOI 10.1016/j.cell.2016.10.056; Perez-Perez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Seaman MNJ, 2013, TRENDS CELL BIOL, V23, P522, DOI 10.1016/j.tcb.2013.04.010; Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	22	5	5	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1452	1454		10.1016/j.cell.2016.11.026	http://dx.doi.org/10.1016/j.cell.2016.11.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912055	Bronze			2022-12-28	WOS:000389470500009
J	Renkawitz, J; Sixt, M				Renkawitz, Joerg; Sixt, Michael			Formin' a Nuclear Protection	CELL			English	Editorial Material							ENVELOPE RUPTURE; CELL-MIGRATION; ACTIN; DEFORMATION	In this issue of Cell, Skau et al. show that the formin FMN2 organizes a perinuclear actin cytoskeleton that protects the nucleus and its genomic content of migrating cells squeezing through small spaces.	[Renkawitz, Joerg; Sixt, Michael] Inst Sci & Technol Austria IST Austria, Campus 1, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Sixt, M (corresponding author), Inst Sci & Technol Austria IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	sixt@ist.ac.at	Renkawitz, Jörg/AAD-5932-2022	Renkawitz, Jörg/0000-0003-2856-3369; Sixt, Michael/0000-0002-6620-9179				Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; Hatch EM, 2016, J CELL BIOL, V215, P27, DOI 10.1083/jcb.201603053; Irianto J, 2016, MOL BIOL CELL, V27; Jayo A, 2016, DEV CELL, V38, P371, DOI 10.1016/j.devcel.2016.07.021; McGregor AL, 2016, CURR OPIN CELL BIOL, V40, P32, DOI 10.1016/j.ceb.2016.01.011; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Skau CT, 2016, CELL, V167, P1571, DOI 10.1016/j.cell.2016.10.023; Thiam HR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10997; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006	10	0	0	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1448	1449		10.1016/j.cell.2016.11.024	http://dx.doi.org/10.1016/j.cell.2016.11.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912053	Bronze			2022-12-28	WOS:000389470500007
J	Wu, M; Gu, JK; Guo, RY; Huang, YS; Yang, MJ				Wu, Meng; Gu, Jinke; Guo, Runyu; Huang, Yushen; Yang, Maojun			Structure of Mammalian Respiratory Supercomplex I1III2IV1	CELL			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL ELECTRON-TRANSPORT; COMPLEX-I; CRYSTAL-STRUCTURE; CHAIN; ORGANIZATION; ARCHITECTURE; MECHANISM; DEFICIENCY; SYSTEM	The mammalian respiratory chain complexes assemble into supercomplexes (SCs) and reside in the inner mitochondrial membrane to transfer electrons and establish the proton gradient for complex V to synthesize ATP. The precise arrangement of SCs is largely unknown. Here, we report a 4.0-angstrom cryoelectron microscopy (cryo-EM) structure of the major SC in porcine heart, the 1.7-MDa SCI1III2IV1. The complex III (CIII) dimer and complex IV (CIV) bind at the same side of the L-shaped complex I (CI). Several accessory or supernumerary subunits of CI, such as NDUFA11, NDUFB4, NDUFB8, and NDUFB9, directly contribute to the oligomerization of CI, CIII, and CIV. COX7C and COX7A of CIV attach CIV to the concave surface formed by CIII and the distal end of membrane arm of CI. The structure suggests a possible mechanism by which electrons are transferred from NADH to cytochrome c and provides a platform for future functional dissection of respiration.	[Wu, Meng; Gu, Jinke; Guo, Runyu; Huang, Yushen; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Key Lab Prot Sci,Minist Educ, Tsinghua Peking Joint Ctr Life Sci,Beijing Adv In, Beijing 100084, Peoples R China	Tsinghua University	Yang, MJ (corresponding author), Tsinghua Univ, Sch Life Sci, Key Lab Prot Sci,Minist Educ, Tsinghua Peking Joint Ctr Life Sci,Beijing Adv In, Beijing 100084, Peoples R China.	maojunyang@tsinghua.edu.cn		Gu, Jinke/0000-0001-5942-480X; Yang, Maojun/0000-0002-6798-3094	Ministry of Science and Technology of China [2016YFA0501100, 2012CB911101]; National Science Fund for Distinguished Young Scholars [31625008]; National Natural Science Foundation of China [31030020, 31170679]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We would like to thank Dr. Mengqiu Dong and Dan Tan (National Institute of Biological Sciences, Beijing) for the mass spectrometry analyses, Dr. Jianlin Lei for cryo-EM data collection, and the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the facility support. This work was supported by grants from the Ministry of Science and Technology of China (2016YFA0501100 and 2012CB911101), the National Science Fund for Distinguished Young Scholars (31625008), and the National Natural Science Foundation of China (31030020 and 31170679).	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Andrews B, 2013, P NATL ACAD SCI USA, V110, P18934, DOI 10.1073/pnas.1319247110; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Enriquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bavi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11984; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; Benard G, 2008, INT J BIOCHEM CELL B, V40, P1543, DOI 10.1016/j.biocel.2007.11.023; Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332; Berrisford JM, 2016, BBA-BIOENERGETICS, V1857, P892, DOI 10.1016/j.bbabio.2016.01.012; Blaza JN, 2014, P NATL ACAD SCI USA, V111, P15735, DOI 10.1073/pnas.1413855111; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Bultema JB, 2009, BBA-BIOENERGETICS, V1787, P60, DOI 10.1016/j.bbabio.2008.10.010; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Drose S, 2002, BBA-BIOENERGETICS, V1556, P65, DOI 10.1016/S0005-2728(02)00307-9; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng Y, 2012, NATURE, V491, P478, DOI 10.1038/nature11541; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Genova ML, 2014, ADV PHOTOSYNTH RESP, V39, P401, DOI 10.1007/978-94-017-8742-0_21; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Guo R., 2016, PROTEIN CELL; Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Ikeda K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3147; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; KUONEN DR, 1986, ANAL BIOCHEM, V153, P221, DOI 10.1016/0003-2697(86)90084-9; Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mourier A, 2014, CELL METAB, V20, P1069, DOI 10.1016/j.cmet.2014.11.005; Nicastro D, 2000, J STRUCT BIOL, V129, P48, DOI 10.1006/jsbi.1999.4204; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pietras R, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0133; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Shinzawa-Itoh K, 2016, J BIOL CHEM, V291, P4178, DOI 10.1074/jbc.M115.680553; Smirnov AY, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016011; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Swierczek M, 2010, SCIENCE, V329, P451, DOI 10.1126/science.1190899; Tan AS, 2014, BBA-GEN SUBJECTS, V1840, P1454, DOI 10.1016/j.bbagen.2013.10.016; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Williams EG, 2016, SCIENCE, V352, DOI 10.1126/science.aad0189; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	79	231	241	2	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1598	+		10.1016/j.cell.2016.11.012	http://dx.doi.org/10.1016/j.cell.2016.11.012			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912063	Bronze			2022-12-28	WOS:000389470500020
J	Marra, A; Bottero, N; Leoncini, G; Murialdo, G				Marra, Alessio; Bottero, Nicoletta; Leoncini, Giovanna; Murialdo, Giovanni			Dyspnoea after home improvement work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FIRE-EATERS PNEUMONIA; LIPOID PNEUMONIA; KEROSENE; INTOXICATION; MANAGEMENT; ASPIRATION; PARAFFIN; CHILDREN; LUNG		[Marra, Alessio; Bottero, Nicoletta; Leoncini, Giovanna; Murialdo, Giovanni] Univ Genoa, Dept Internal Med, IRCCS AOU San Martino IST, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST	Marra, A (corresponding author), Univ Genoa, Dept Internal Med, IRCCS AOU San Martino IST, Genoa, Italy.	dott.alessio.marra@gmail.com		Marra, Alessio/0000-0002-8220-3113				BAGHDASS.OM, 1965, AMER J ROENTGENOL RA, V95, P104, DOI 10.2214/ajr.95.1.104; Balme KH, 2015, CLIN TOXICOL, V53, P789, DOI 10.3109/15563650.2015.1059943; Bond GR, 2008, CLIN TOXICOL, V46, P222, DOI 10.1080/15563650701801218; CACHIA EA, 1964, ARCH DIS CHILD, V39, P502, DOI 10.1136/adc.39.207.502; Carolissen G, 2004, CRIME VIOLENCE INJUR, P158; Chibishev A, 2014, J FORENSIC LEG MED, V26, P1, DOI 10.1016/j.jflm.2014.04.023; Chilcott RP, 2012, CHEM HAZARD COMPENDI; DICE WH, 1982, ANN EMERG MED, V11, P138, DOI 10.1016/S0196-0644(82)80239-4; Farrow C, 2000, CHEM INCIDENT MANAGE; Franquet T, 2000, J COMPUT ASSIST TOMO, V24, P448, DOI 10.1097/00004728-200005000-00017; Franzen D, 2014, RESPIRATION, V87, P98, DOI 10.1159/000350443; Gentina T, 2001, MEDICINE, V80, P291, DOI 10.1097/00005792-200109000-00002; Hadda Vijay, 2010, Expert Rev Respir Med, V4, P799, DOI 10.1586/ers.10.74; Kanat F, 2004, INT J TUBERC LUNG D, V8, P271; LITOVITZ T, 1988, OCCUP MED, V3, P555; Marchiori E, 2011, RESP MED, V105, P659, DOI 10.1016/j.rmed.2010.12.001; Matzopoulos R, 2006, AFRICAN SAFETY PROMO, V3, P4; Mowry JB, 2015, CLIN TOXICOL, V53, P962, DOI 10.3109/15563650.2015.1102927; Nakashima S, 2015, RESP CARE, V60, pE1, DOI 10.4187/respcare.03225; Ritchie GD, 2001, J TOXICOL ENV HEAL B, V4, P223, DOI 10.1080/109374001301419728; Robledo RF, 1999, TOXICOL SCI, V51, P119, DOI 10.1093/toxsci/51.1.119; Sachdev A, 2015, INDIAN PEDIATR, V52, P63, DOI 10.1007/s13312-015-0569-2; SCHARF SM, 1981, AM REV RESPIR DIS, V124, P625; Sen V, 2013, EUR REV MED PHARMACO, V17, P9; Seymour FK, 2001, HUM EXP TOXICOL, V20, P551, DOI 10.1191/096032701718620918; WOLFSDORF J, 1976, J PEDIATR-US, V88, P1037; Yigit O, 2012, J EMERG MED, V42, P417, DOI 10.1016/j.jemermed.2010.11.025	27	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2016	355								i5957	10.1136/bmj.i5957	http://dx.doi.org/10.1136/bmj.i5957			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZD	27903491	Green Published			2022-12-28	WOS:000389308600002
J	Dewey, M				Dewey, Marc			Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial (vol 355, i5441, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Dewey M, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5441	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2016	355								i6420	10.1136/bmj.i6420	http://dx.doi.org/10.1136/bmj.i6420			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZA	27899352	hybrid, Green Published			2022-12-28	WOS:000389308200007
J	Darzi, A; Evans, T				Darzi, Ara; Evans, Tim			The global shortage of health workers-an opportunity to transform care	LANCET			English	Editorial Material									[Darzi, Ara] Imperial Coll London, Inst Global Hlth Innovat, London SW7 2AZ, England; [Evans, Tim] World Bank Grp, Washington, DC USA	Imperial College London; The World Bank	Darzi, A (corresponding author), Imperial Coll London, Inst Global Hlth Innovat, London SW7 2AZ, England.	a.darzi@imperial.ac.uk						Evans T, 2016, WORLD INN S IN PRESS; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Nicholson S, 2012, HBK ECON, P873, DOI 10.1016/B978-0-444-53592-4.00014-1; Organisation for Economic Co-operation and Development, 2015, GROWTH REM GPS SPEC; Organization for Economic Co operation and Development, 2016, HLTH WORKF POL OECD; Shehnaz SI, 2011, S E ASIAN J MEDICAL, V5, P18; Vaughn BT, 2010, HEALTH AFFAIR, V29, P933, DOI 10.1377/hlthaff.2009.0675; [World Bank Health professional education quality project], 2015, IMPL COMPL RES REP; World Health Organization, 2016, DRAFT GLOB STRAT HUM; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	10	37	39	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2576	2577		10.1016/S0140-6736(16)32235-8	http://dx.doi.org/10.1016/S0140-6736(16)32235-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27894651	Green Submitted			2022-12-28	WOS:000388516800010
J	Devi, S				Devi, Sharmila			Government purge continues in Turkey after failed coup	LANCET			English	Editorial Material																			0	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2580	2581		10.1016/S0140-6736(16)32386-8	http://dx.doi.org/10.1016/S0140-6736(16)32386-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27894654				2022-12-28	WOS:000388516800013
J	Horton, R				Horton, Richard			Offline: The case against (and for) public health	LANCET			English	Editorial Material												richard.horton@lancet.com							0	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2578	2578		10.1016/S0140-6736(16)32387-X	http://dx.doi.org/10.1016/S0140-6736(16)32387-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27894652	Bronze			2022-12-28	WOS:000388516800011
J	Schwartz, JL				Schwartz, Jason L.			HISTORY OF MEDICINE Fifty Years of Expert Advice - Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schwartz, Jason L.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Schwartz, Jason L.] Yale Sch Med, Sect Hist Med, New Haven, CT 06510 USA	Yale University; Yale University	Schwartz, JL (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.; Schwartz, JL (corresponding author), Yale Sch Med, Sect Hist Med, New Haven, CT 06510 USA.		Schwartz, Jason L./ABA-8718-2020					[Anonymous], 1966, DRUG EFFICACY STUDY, V1; [Anonymous], 1969, DRUG EFF STUD FIN RE; Carpenter D, 2010, PRINC STUD AM POLIT, P1; LANGER E, 1966, SCIENCE, V152, P1487, DOI 10.1126/science.152.3728.1487; Podolsky SH, 2015, ANTIBIOTIC ERA: REFORM, RESISTANCE, AND THE PURSUIT OF A RATIONAL THERAPEUTICS, P1	5	4	4	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2015	2017		10.1056/NEJMp1609763	http://dx.doi.org/10.1056/NEJMp1609763			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC9KU	27959733				2022-12-28	WOS:000388464300002
J	Cooper, Z; Morton, FS				Cooper, Zack; Morton, Fiona Scott			Out-of-Network Emergency-Physician Bills - An Unwelcome Surprise	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cooper, Zack] Yale Univ, Dept Publ Hlth, New Haven, CT 06520 USA; [Cooper, Zack] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Morton, Fiona Scott] Yale Univ, Sch Management, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Cooper, Z (corresponding author), Yale Univ, Dept Publ Hlth, New Haven, CT 06520 USA.; Cooper, Z (corresponding author), Yale Univ, Dept Econ, New Haven, CT 06520 USA.							Board of Governors of the Federal Reserve System, 2014, REPORT EC WELL BEING; Hamel L., 2016, BURDEN MED DEBT RESU; Hoadley J, 2015, BALANCE BILLING ARE; Pogue S, 2014, SURPRISE MED BILS TA; Rosenthal E., 2014, NY TIMES	5	52	52	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1915	1918		10.1056/NEJMp1608571	http://dx.doi.org/10.1056/NEJMp1608571			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC1HS	27959612				2022-12-28	WOS:000387856100002
J	Chinnery, PF; Zeviani, M				Chinnery, Patrick F.; Zeviani, Massimo			Mitochondrial Matchmaking	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chinnery, Patrick F.; Zeviani, Massimo] Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England; [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England	University of Cambridge; University of Cambridge	Chinnery, PF (corresponding author), Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.; Chinnery, PF (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England.		Zeviani, Massimo/AAU-2632-2021	Zeviani, Massimo/0000-0002-9067-5508; Chinnery, Patrick/0000-0002-7065-6617	MRC [MC_UP_1002/1] Funding Source: UKRI; Medical Research Council [MC_UP_1501/2, MC_UP_1002/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature18303, 10.1038/nature183030]; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230	5	7	7	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					1894	1896		10.1056/NEJMcibr1608715	http://dx.doi.org/10.1056/NEJMcibr1608715			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB6ZK	27959648				2022-12-28	WOS:000387534200014
J	Burton, R; Henn, C; Lavoie, D; O'Connor, R; Perkins, C; Sweeney, K; Greaves, F; Ferguson, B; Beynon, C; Belloni, A; Musto, V; Marsden, J; Sheron, N				Burton, Robyn; Henn, Clive; Lavoie, Don; O'Connor, Rosanna; Perkins, Clare; Sweeney, Kate; Greaves, Felix; Ferguson, Brian; Beynon, Caryl; Belloni, Annalisa; Musto, Virginia; Marsden, John; Sheron, Nick			A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective	LANCET			English	Review							MASS-MEDIA CAMPAIGNS; OFF-TRADE ALCOHOL; BRIEF INTERVENTIONS; EMERGENCY-DEPARTMENTS; POTENTIAL BENEFITS; PRICE ELASTICITIES; NATURAL EXPERIMENT; LICENSED PREMISES; OUTLET DENSITY; GREAT-BRITAIN	This paper reviews the evidence for the effectiveness and cost-effectiveness of policies to reduce alcohol-related harm. Policies focus on price, marketing, availability, information and education, the drinking environment, drink-driving, and brief interventions and treatment. Although there is variability in research design and measured outcomes, evidence supports the effectiveness and cost-effectiveness of policies that address affordability and marketing. An adequate reduction in temporal availability, particularly late night on-sale availability, is effective and cost-effective. Individually-directed interventions delivered to at-risk drinkers and enforced legislative measures are also effective. Providing information and education increases awareness, but is not sufficient to produce long-lasting changes in behaviour. At best, interventions enacted in and around the drinking environment lead to small reductions in acute alcohol-related harm. Overall, there is a rich evidence base to support the decisions of policy makers in implementing the most effective and cost-effective policies to reduce alcohol-related harm.	[Burton, Robyn; Henn, Clive; Lavoie, Don; O'Connor, Rosanna; Perkins, Clare; Sweeney, Kate; Greaves, Felix; Ferguson, Brian; Beynon, Caryl; Belloni, Annalisa; Musto, Virginia; Marsden, John; Sheron, Nick] Publ Hlth England, Skipton House, London SE1 6LH, England; [Greaves, Felix] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Ferguson, Brian] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Burton, Robyn; Marsden, John] Kings Coll London, Inst Psychiat Psychol Neurosci, Addict Dept, London, England; [Sheron, Nick] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	Public Health England; Imperial College London; University of York - UK; University of London; King's College London; University of Southampton	Henn, C (corresponding author), Publ Hlth England, Skipton House, London SE1 6LH, England.	clive.henn@phe.gov.uk	Greaves, Felix/A-1324-2012; Wright, Virginia Musto/ABE-4156-2021; Greaves, Felix/AAL-5891-2021	Greaves, Felix/0000-0001-9393-3122; Greaves, Felix/0000-0001-9393-3122; Sheron, Nick/0000-0002-6156-8367; Sheron, Nick/0000-0001-5232-8292; Belloni, Annalisa/0000-0001-6214-0285	Department of Health; Institute for Health Research (NIHR); Medical Research Council; NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Mental Health Foundation Trust; British Liver Trust; Alcohol Education Research Council; Pabrinex; Norgine	Department of Health; Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Mental Health Foundation Trust; British Liver Trust; Alcohol Education Research Council; Pabrinex; Norgine	All authors are employed by Public Health England. FG holds an honorary senior lecturer position at Imperial College London. BF holds an honorary Chair at the University of York, UK. CB is employed part-time at the University of Liverpool/Laurate Education, UK. RB holds a visiting research associate post at King's College London. VM is studying a part-time PhD at Sheffield University. JM is supported by research grants from the Department of Health, the Institute for Health Research (NIHR), Medical Research Council, and the NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Mental Health Foundation Trust. He has received honoraria from Merck Serono (2013, 2015; clinical oncology medicine) and Indivior (via PCM Scientific) as a faculty member and conference (2012-13), and co-chair (2015-16) for Improving Outcomes in Treatment of Opioid Dependence conference. NS has received research grants from British Liver Trust, Alcohol Education Research Council, and various other funding bodies. He has undertaken paid consultancy work and received travelling expenses from Pabrinex and Norgine for developing drugs for the treatment of inflammatory bowel disease, liver disease, and viral hepatitis and been paid for medicolegal work in the area of hepatitis C and alcohol-related liver disease. He is a clinical adviser to Public Health England, a scientific adviser to European Public Health Alliance, and Royal College of Physicians representative on EU Alcohol Policies, EU Alcohol Forum. He has advised for the Alcohol Health Alliance UK, UK Department of Health, Home Office, Department of Transport, Southampton City Council, British Liver Trust, European Association for the Study of the Liver (EASL), British Association for the Study of the Liver (BASL), and British Society of Gastroenterology (BSG). All other authors declare no competing interests.	Adams J, 2012, ALCOHOL ALCOHOLISM, V47, P187, DOI 10.1093/alcalc/agr159; Al-hamdani M, 2014, J PUBLIC HEALTH POL, V35, P65, DOI 10.1057/jphp.2013.47; Alcohol Concern, 2015, DRINK RESP PLEAS KEE; Alcohol Concern UK, 2010, OV ALC MARK WORLD CU; Allsop R, 2015, SAVING LIVES LOWERIN; Ally AK, 2014, ADDICTION, V109, P1994, DOI 10.1111/add.12590; Alvarez-Bueno C, PREV MED S, V76, pS33; Anderson P, 2007, ADDICTION, V102, P1515, DOI 10.1111/j.1360-0443.2007.02000.x; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Anderson Z, 2007, EXPLORATION YOUNG PE; Angus C, 2015, MODELLING POTENTIAL; Angus C, 2015, MODELLING IMPACT MIN; Angus C., 2016, MODEL BASED APPRAISA; Angus C, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00114; [Anonymous], 2009, INFL DAM EFF ALC MAR; Asbridge M, 2009, DRUG-EDUC PREV POLIC, V16, P140, DOI 10.1080/09687630701804507; Ayyagari P, 2013, HEALTH ECON, V22, P89, DOI 10.1002/hec.1817; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Bellis MA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-380; Bergen G, 2014, AM J PREV MED, V46, P529, DOI 10.1016/j.amepre.2014.01.018; Best D, 2006, ADDICT BEHAV, V31, P1424, DOI 10.1016/j.addbeh.2005.12.002; Blomberg RD, 2005, CRASH RISK ALCOHOL I; Booth A., 2008, INDEPENDENT REV EFFE; Brannstrom L, 2016, J EPIDEMIOL COMMUN H, V70, P226, DOI 10.1136/jech-2015-206124; Brennan A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5452; Brennan I, 2011, ADDICTION, V106, P706, DOI 10.1111/j.1360-0443.2010.03297.x; Brown K, 2016, ALCOHOL ALCOHOLISM, V51, P747, DOI 10.1093/alcalc/agw006; Burns L, 2014, MANCHESTER CITY CTR; Buykx P, 2016, INVESTIGATION PUBLIC; Buykx P, 2015, INT J DRUG POLICY, V26, P371, DOI 10.1016/j.drugpo.2014.08.006; Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028; Campos S, 2011, PUBLIC HEALTH NUTR, V14, P1496, DOI 10.1017/S1368980010003290; Chick J, 2015, ALCOHOL PRICING PURC; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Cobiac L, 2009, ADDICTION, V104, P1646, DOI 10.1111/j.1360-0443.2009.02708.x; Coomaraswamy KS, 2003, INJ PREV, V9, P81, DOI 10.1136/ip.9.1.81; Coomber K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2160-0; Crawford MJ, 2015, SEX TRANSM INFECT, V91, P37, DOI 10.1136/sextrans-2014-051561; Crawford MJ, 2012, ALCOHOL ALCOHOLISM, V47, P738, DOI 10.1093/alcalc/ags091; Danaher BG, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-41; Darvishi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126870; de Visser RO, 2016, HEALTH PSYCHOL, V35, P281, DOI 10.1037/hea0000297; de Vocht F, 2015, LANCET, V386, pS33, DOI 10.1016/S0140-6736(15)00871-5; Department of Health, 2011, PUBL HLTH RESP DEAL; Dhalwani N, 2011, J PIONEER MED SCI, V1, P23; Dhital R, 2015, ADDICTION, V110, P1586, DOI 10.1111/add.12994; Diageo, 2015, DIAG ANN REP 2015; Ditter SM, 2005, AM J PREV MED, V28, P280, DOI 10.1016/j.amepre.2005.02.013; Dixon HG, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006511; Donoghue K, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3193; Drummond C, 2005, ALCOHOL CLIN EXP RES, V29, p36A; Drummond C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099463; Durnford AJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-379; El-Maaytah M, 2008, BRIT J ORAL MAX SURG, V46, P460, DOI 10.1016/j.bjoms.2008.01.018; Elder RW, 2011, AM J PREV MED, V40, P362, DOI 10.1016/j.amepre.2010.11.012; Elder RW, 2010, AM J PREV MED, V38, P217, DOI 10.1016/j.amepre.2009.11.005; Elder RW, 2004, AM J PREV MED, V27, P57, DOI 10.1016/j.amepre.2004.03.002; Elzerbi C, 2015, ADDICTION, V110, P1082, DOI 10.1111/add.12960; Erke A, 2009, ACCIDENT ANAL PREV, V41, P914, DOI 10.1016/j.aap.2009.05.005; Fell JC, 2006, J SAFETY RES, V37, P233, DOI 10.1016/j.jsr.2005.07.006; Fogarty J, 2008, DEMAND BEER WINE SPI; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Forsyth AJM, 2008, ALCOHOL ALCOHOLISM, V43, P111, DOI 10.1093/alcalc/agm142; Forsyth AJM, 2014, ALCOHOL ALCOHOLISM, V49, P96, DOI 10.1093/alcalc/agt175; Foss RD, 1999, AM J PREV MED, V16, P47, DOI 10.1016/S0749-3797(98)00112-3; Foxcroft DR, 2015, COCHRANE DB SYST REV, V12; Foxcroft DR, 2011, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD009113; Gallet CA, 2007, AUST J AGR RESOUR EC, V51, P121, DOI 10.1111/j.1467-8489.2007.00365.x; Gmel G, 2016, DRUG ALCOHOL REV, V35, P40, DOI 10.1111/dar.12304; Gruenewald PJ, 2010, ALCOHOL CLIN EXP RES, V34, P519, DOI 10.1111/j.1530-0277.2009.01117.x; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hadland SE, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150200; Hahn RA, 2010, AM J PREV MED, V39, P590, DOI 10.1016/j.amepre.2010.09.016; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Harris F, 2006, TOB CONTROL, V15, P26, DOI 10.1136/tc.2005.013110; Hart Carole L, 2010, BMJ, V340, pc1240, DOI 10.1136/bmj.c1240; Hartling L, 2004, COCHRANE DB SYST REV, V2; Hastings G, 2009, THEYLL DRINK BUCKET; Healey C, 2014, INT J DRUG POLICY, V25, P124, DOI 10.1016/j.drugpo.2013.07.008; Health and Social Care Information Centre. Health Survey for England, 2014, HLTH SURV ENGL 2014; Health & Social Care Information Centre, STAT ALC ENGL; Henkel Dieter, 2011, Curr Drug Abuse Rev, V4, P4; Henriksen L, 2012, TOB CONTROL, V21, P147, DOI 10.1136/tobaccocontrol-2011-050416; HM Government, 2015, BUDG 2015 POL COST; HM Government, 2013, BUDG 2013 POL COST; HM Government, 2014, BUDG 2014 POL COST; Hollingworth W, 2006, J STUD ALCOHOL, V67, P300, DOI 10.15288/jsa.2006.67.300; Holm AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088041; Holmes J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1301; Holmes J, 2014, DRUG ALCOHOL REV, V33, P515, DOI 10.1111/dar.12191; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; Home Office, 2012, SUPP GUID POOLS COND; House of Commons Health Committee, 2010, ALC 1 REP SESS 2009, V1; House of Commons Health Committee. Government's Alcohol Strategy, 3 HOUS COMM HLTH COM; HRUBEC Z, 1981, ALCOHOL CLIN EXP RES, V5, P207, DOI 10.1111/j.1530-0277.1981.tb04890.x; Hughes K, 2008, ADDICTION, V103, P60, DOI 10.1111/j.1360-0443.2007.02030.x; Hughes K, 2012, INT J ENV RES PUB HE, V9, P4068, DOI 10.3390/ijerph9114068; Humphreys DK, 2014, SOC SCI MED, V102, P1, DOI 10.1016/j.socscimed.2013.11.038; Humphreys DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055581; Institute of Alcohol Studies, 2014, HLTH IN HARM PAR WHY; Janssen MM, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-18; Jernigan D, 2017, ADDICTION, V112, P7, DOI 10.1111/add.13591; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Jones L., 2015, UNDERSTANDING ALCOHO; Jones L, 2011, HEALTH PLACE, V17, P508, DOI 10.1016/j.healthplace.2010.12.006; Jones LA, 2010, EMERG MED J, V27, P688, DOI 10.1136/emj.2009.077487; Jones S, 2010, CONTEMP DRUG PROBL, V37, P109, DOI DOI 10.1177/009145091003700106; Jones SC, 2014, J PUBLIC HEALTH POL, V35, P75, DOI 10.1057/jphp.2013.46; Jones SJ, 2013, INT J INJ CONTROL SA, V20, P321, DOI 10.1080/17457300.2012.726631; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kaner E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8501; Knai C, 2015, ADDICTION, V110, P1217, DOI 10.1111/add.12892; Kypri K, 2014, DRUG ALCOHOL REV, V33, P323, DOI 10.1111/dar.12123; Lahausse JA, 2009, TRAFFIC INJ PREV, V10, P528, DOI 10.1080/15389580903173706; Lhachimi SK, 2012, PREV MED, V55, P237, DOI 10.1016/j.ypmed.2012.06.006; Liang WB, 2015, INT J DRUG POLICY, V26, P131, DOI 10.1016/j.drugpo.2014.07.001; Liverpool John Moores University, 2009, EV LANC POL GLASS PI; Livingston M, 2007, DRUG ALCOHOL REV, V26, P557, DOI 10.1080/09595230701499191; Lobstein T, 2017, ADDICTION, V112, P21, DOI 10.1111/add.13493; Lynch S, 2015, RANDOMISED TRIAL EVA; Ma T, 2015, ACCIDENT ANAL PREV, V85, P248, DOI 10.1016/j.aap.2015.09.017; Mann RE, 2001, ACCIDENT ANAL PREV, V33, P569, DOI 10.1016/S0001-4575(00)00077-4; Mansdotter AM, 2007, EUR J PUBLIC HEALTH, V17, P618, DOI 10.1093/eurpub/ckm017; Martin-Moreno JM, 2013, EUR J PUBLIC HEALTH, V23, P1082, DOI 10.1093/eurpub/ckt046; Martineau F, 2013, PREV MED, V57, P278, DOI 10.1016/j.ypmed.2013.06.019; Meier P, 2009, INDEPENDENT REV EFFE; Meier PS, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001963; Meier PS, 2010, ADDICTION, V105, P383, DOI 10.1111/j.1360-0443.2009.02721.x; Meng Y, 2014, J HEALTH ECON, V34, P96, DOI 10.1016/j.jhealeco.2013.12.006; Meng Y, 2014, ADDICTION, V109, P206, DOI 10.1111/add.12330; Middleton JC, 2010, AM J PREV MED, V39, P575, DOI 10.1016/j.amepre.2010.09.015; Miller P, 2011, DRUG ALCOHOL REV, V30, P546, DOI 10.1111/j.1465-3362.2011.00337.x; Miller PG, 2015, AM J DRUG ALCOHOL AB, V41, P16, DOI 10.3109/00952990.2014.966199; Moore SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-21; Moss AC, 2015, ADDICT BEHAV, V44, P94, DOI 10.1016/j.addbeh.2014.11.035; Naimi TS, 2014, AM J PREV MED, V46, P10, DOI 10.1016/j.amepre.2013.07.015; Nakamura R, 2014, ADDICTION, V109, P558, DOI 10.1111/add.12419; Nash V, 2012, EFFECTIVE AGE VERIFI; National Institute for Health and Care Excellence, 2014, NALM RED ALC CONS PE; National Obesity Observatory, 2012, OB ALC OV; Navarro HJ, 2011, DRUG ALCOHOL DEPEN, V114, P87, DOI 10.1016/j.drugalcdep.2010.11.009; Newbury-Birch D, 2014, ALCOHOL ALCOHOLISM, V49, P540, DOI 10.1093/alcalc/agu046; Newton A, 2007, EMERG MED J, V24, P532, DOI 10.1136/emj.2007.046094; Nicholls J, 2012, ALCOHOL ALCOHOLISM, V47, P486, DOI 10.1093/alcalc/ags043; Noel JK, 2017, ADDICTION, V112, P28, DOI 10.1111/add.13410; North P, 2010, REPORT REV DRINK DRU; Ofcom, 2013, CHILDR YOUNG PEOPL E; Office for National Statistics, 2015, INT US 2015; Organisation for Economic Co-operation and Development, 2015, TACKL HAU; Parackal SM, 2010, INT J DRUG POLICY, V21, P302, DOI 10.1016/j.drugpo.2009.10.006; Patil S, 2014, EUR J PUBLIC HEALTH, V24, P561, DOI 10.1093/eurpub/cku060; Patton R, 2014, ALCOHOL ALCOHOLISM, V49, P207, DOI 10.1093/alcalc/agt165; Peirce BH, 2011, EUR J EMERG MED, V18, P351, DOI 10.1097/MEJ.0b013e3283468ee0; Pennay A, 2012, DRUG-EDUC PREV POLIC, V19, P91, DOI 10.3109/09687637.2011.640719; Petticrew M, 2016, ADDICTION, V111, P51, DOI 10.1111/add.13094; Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054; Public Health England, 2015, LOC ALC PROF ENGL 20; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Quigg Z, 2016, EVALUATION LIVERPOOL; Rabinovich L, 2012, FURTHER STUDY AFFORD; Rammohan V, 2011, AM J PREV MED, V41, P334, DOI 10.1016/j.amepre.2011.06.027; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Richardson E, 2014, ALCOHOL RELATED ILLN; Richardson EA, 2015, HEALTH PLACE, V33, P172, DOI 10.1016/j.healthplace.2015.02.014; Robinson M, 2014, ADDICTION, V109, P2035, DOI 10.1111/add.12701; ROSE G, 1990, BRIT MED J, V301, P1031, DOI 10.1136/bmj.301.6759.1031; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Ross CS, 2013, J PUBLIC AFF, V13, P123, DOI 10.1002/pa.1452; Russell KF, 2011, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD003300.PUB3; Sassi F, 2013, 66 OECD; Schmidt CS, 2016, ADDICTION, V111, P783, DOI 10.1111/add.13263; Scholes-Balog KE, 2012, AUST NZ J PUBL HEAL, V36, P524, DOI 10.1111/j.1753-6405.2012.00934.x; Schulte B, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00131; Sharma A, 2016, HEALTH ECON, V25, P1182, DOI 10.1002/hec.3388; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080936; Sheron N, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1860; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Siegfried N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010704.pub2; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51; Stockwell T., 2006, REV RES IMPACTS ALCO; Stockwell T, 2015, J STUD ALCOHOL DRUGS, V76, P628, DOI 10.15288/jsad.2015.76.628; Stockwell T, 2013, AM J PUBLIC HEALTH, V103, P2014, DOI 10.2105/AJPH.2013.301289; Stockwell Tim, 2012, Am J Public Health, V102, pe103, DOI 10.2105/AJPH.2012.301094; Strom HK, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-48; Tam TW, 2010, HUM FACTOR ERGON MAN, V20, P538, DOI 10.1002/hfm.20239; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; The Academy of Medical Sciences, CALL TIM NAT DRINK M; The British Psychological Society The Royal College of Psychiatrists, 2011, ALC US DIS NICE GUID; Tippetts AS, 2005, ACCIDENT ANAL PREV, V37, P149, DOI 10.1016/j.aap.2004.02.006; Traeen B, 1996, ADDICTION, V91, P995, DOI 10.1046/j.1360-0443.1996.9179956.x; Treno AJ, 2007, ACCIDENT ANAL PREV, V39, P894, DOI 10.1016/j.aap.2006.12.011; Trolldal B, 2013, ADDICTION, V108, P89, DOI 10.1111/j.1360-0443.2012.04004.x; Wagenaar AC, 2007, ALCOHOL CLIN EXP RES, V31, P1399, DOI 10.1111/j.1530-0277.2007.00441.x; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Warpenius K, 2010, ADDICTION, V105, P1032, DOI 10.1111/j.1360-0443.2009.02873.x; Watson Margaret C, 2009, Int J Pharm Pract, V17, P199; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, 1 GLOB MIN C HLTH LI; Wilkinson C, 2016, PUBLIC HEALTH RES PR, V26, DOI 10.17061/phrp2641644; Wilkinson C, 2009, DRUG ALCOHOL REV, V28, P696, DOI 10.1111/j.1465-3362.2009.00129_7.x; Wilkinson C, 2009, DRUG ALCOHOL REV, V28, P426, DOI 10.1111/j.1465-3362.2009.00055.x; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; Willis C, 2004, COCHRANE DB SYST REV, V4; Winpenny E, 2012, ASSESSMENT YOUNG PEO; World Health Organization, 2007, INT CLASS DIS REL HL; Xu X, 2011, ALCOHOL RES HEALTH, V34, P236; Yadav RP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2088-4; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	214	158	159	3	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2017	389	10078					1558	1580		10.1016/S0140-6736(16)32420-5	http://dx.doi.org/10.1016/S0140-6736(16)32420-5			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER7OP	27919442	Green Accepted, Green Submitted			2022-12-28	WOS:000399002900030
J	Li, J; Casteels, T; Frogne, T; Ingvorsen, C; Honore, C; Courtney, M; Huber, KVM; Schmitner, N; Kimmel, RA; Romanov, RA; Sturtzel, C; Lardeau, CH; Klughammer, J; Farlik, M; Sdelci, S; Vieira, A; Avolio, F; Briand, F; Baburin, I; Majek, P; Pauler, FM; Penz, T; Stukalov, A; Gridling, M; Parapatics, K; Barbieux, C; Berishvili, E; Spittler, A; Colinge, J; Bennett, KL; Hering, S; Sulpice, T; Bock, C; Distel, M; Harkany, T; Meyer, D; Superti-Furga, G; Collombat, P; Hecksher-Sorensen, J; Kubicek, S				Li, Jin; Casteels, Tamara; Frogne, Thomas; Ingvorsen, Camilla; Honore, Christian; Courtney, Monica; Huber, Kilian V. M.; Schmitner, Nicole; Kimmel, Robin A.; Romanov, Roman A.; Sturtzel, Caterina; Lardeau, Charles-Hugues; Klughammer, Johanna; Farlik, Matthias; Sdelci, Sara; Vieira, Andhira; Avolio, Fabio; Briand, Francois; Baburin, Igor; Majek, Peter; Pauler, Florian M.; Penz, Thomas; Stukalov, Alexey; Gridling, Manuela; Parapatics, Katja; Barbieux, Charlotte; Berishvili, Ekaterine; Spittler, Andreas; Colinge, Jacques; Bennett, Keiryn L.; Hering, Steffen; Sulpice, Thierry; Bock, Christoph; Distel, Martin; Harkany, Tibor; Meyer, Dirk; Superti-Furga, Giulio; Collombat, Patrick; Hecksher-Sorensen, Jacob; Kubicek, Stefan			Artemisinins Target GABA(A) Receptor Signaling and Impair alpha Cell Identity	CELL			English	Article							GLUCAGON-SECRETION; ENDOCRINE PANCREAS; SAMPLE PREPARATION; BETA-CELLS; GLUCOSE-INHIBITION; SMALL MOLECULES; INSULIN; EXPRESSION; CONVERSION; GEPHYRIN	Type 1 diabetes is characterized by the destruction of pancreatic beta cells, and generating new insulin-producing cells from other cell types is a major aim of regenerative medicine. One promising approach is transdifferentiation of developmentally related pancreatic cell types, including glucagon-producing a cells. In a genetic model, loss of the master regulatory transcription factor Arx is sufficient to induce the conversion of a cells to functional beta-like cells. Here, we identify artemisinins as small molecules that functionally repress Arx by causing its translocation to the cytoplasm. We show that the protein gephyrin is the mammalian target of these antimalarial drugs and that the mechanism of action of these molecules depends on the enhancement of GABA(A) receptor signaling. Our results in zebrafish, rodents, and primary human pancreatic islets identify gephyrin as a druggable target for the regeneration of pancreatic b cell mass from alpha cells.	[Casteels, Tamara; Ingvorsen, Camilla; Kimmel, Robin A.; Gridling, Manuela; Distel, Martin; Kubicek, Stefan] Austrian Acad Sci Lazarettgasse, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Kimmel, Robin A.; Sturtzel, Caterina; Klughammer, Johanna; Briand, Francois; Penz, Thomas; Gridling, Manuela] Novo Nordisk AS, Novo Nordisk Pk, DK-2760 Malov, Denmark; [Li, Jin; Honore, Christian; Schmitner, Nicole; Sturtzel, Caterina; Klughammer, Johanna; Sdelci, Sara; Vieira, Andhira; Avolio, Fabio; Briand, Francois; Baburin, Igor; Majek, Peter] Univ Co dAzur, CNRS, INSERM, IBV, F-06108 Nice, France; [Kimmel, Robin A.; Baburin, Igor; Spittler, Andreas; Bennett, Keiryn L.; Hecksher-Sorensen, Jacob; Kubicek, Stefan] Leopold Franzens Univ Innsbruck, Mol Biol, Technikerstr 25, A-6020 Innsbruck, Austria; [Schmitner, Nicole; Penz, Thomas; Spittler, Andreas; Colinge, Jacques; Harkany, Tibor; Collombat, Patrick] Med Univ Vienna, Dept Mol Neurosci, Ctr Brain Res, A-1090 Vienna, Austria; [Ingvorsen, Camilla] Childrens Canc Res Inst, Innovat Canc Models, Zimmermannplatz 10, A-1090 Vienna, Austria; [Courtney, Monica; Klughammer, Johanna; Baburin, Igor] Austrian Acad Sci, CeMM Res Ctr Mol Med, Christian Doppler Lab Chem Epigenet & Antunfect, Lazarettgasse 14, A-1090 Vienna, Austria; [Sturtzel, Caterina; Farlik, Matthias; Distel, Martin; Collombat, Patrick] Physiogenex SAS, Prologue Biotech, Rue Pierre & Marie Curie, F-31670 Labege, France; [Frogne, Thomas; Kimmel, Robin A.; Penz, Thomas] Univ Vienna, Inst Pharmacol & Toxicol, Althanstrasse 14, A-1090 Vienna, Austria; [Romanov, Roman A.; Penz, Thomas] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, CH-1211 Geneva, Switzerland; [Li, Jin; Huber, Kilian V. M.; Romanov, Roman A.; Klughammer, Johanna; Sdelci, Sara] Univ Geneva, CH-1211 Geneva, Switzerland; [Frogne, Thomas; Courtney, Monica; Farlik, Matthias; Berishvili, Ekaterine; Colinge, Jacques] Med Univ Vienna, Core Facil Flow Cytometry & Dept Surg, Res Labs, A-1090 Vienna, Austria; [Kimmel, Robin A.; Sturtzel, Caterina; Sdelci, Sara; Stukalov, Alexey; Collombat, Patrick; Kubicek, Stefan] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Huber, Kilian V. M.; Schmitner, Nicole; Baburin, Igor; Parapatics, Katja; Superti-Furga, Giulio] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Courtney, Monica; Huber, Kilian V. M.; Sturtzel, Caterina; Bock, Christoph] Karolinska Inst, Dept Neuroscience, S-17177 Stockholm, Sweden; [Sdelci, Sara; Vieira, Andhira; Penz, Thomas; Parapatics, Katja; Kubicek, Stefan] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Schmitner, Nicole; Penz, Thomas; Barbieux, Charlotte] Ilia State Univ, Inst Med Res, Tbilisi 0162, Georgia; [Avolio, Fabio; Penz, Thomas; Berishvili, Ekaterine; Colinge, Jacques] Harvard Med Sch, Div Endocrinol, Beth Israel Deaconess Med Ctr & Dept Genet, Boston, MA 02215 USA; [Li, Jin; Frogne, Thomas; Courtney, Monica; Kimmel, Robin A.; Romanov, Roman A.] Evotec GmbH, D-37079 Gottingen, Germany; [Casteels, Tamara; Honore, Christian; Huber, Kilian V. M.; Romanov, Roman A.; Sturtzel, Caterina] Univ Oxford, Struct Genom Consortium & Target Discovery Inst, Nuffield Dept Med, Oxford OX1 3PA, England	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Novo Nordisk; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Innsbruck; Medical University of Vienna; Saint Anna Children's Hospital; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Vienna; University of Geneva; University of Geneva; Medical University of Vienna; Medical University of Vienna; Max Planck Society; Karolinska Institutet; Medical University of Vienna; Ilia State University; Harvard University; Harvard Medical School; Evotec; University of Oxford	Kubicek, S (corresponding author), Austrian Acad Sci Lazarettgasse, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.	skubicek@cemm.oeaw.ac.at	Hua, QX/HGE-3640-2022; Berishvili, Ekaterine/AAL-9758-2020; Stukalov, Alexey/AAS-3208-2021; Bock, Christoph/AAE-7618-2019; collombat, patrick/F-4495-2015; sdelci, sara/S-2243-2018; Colinge, Jacques/Z-2613-2019; collombat, patrick/P-3741-2019; Kubicek, Stefan/C-2089-2017; Kimmel, Robin/AAP-5821-2020; Colinge, Jacques/D-1578-2017; Distel, Martin/AAN-6408-2020; Superti-Furga, Giulio/AAE-5681-2019; Huber, Kilian V. M./L-6921-2015; BRIAND, FRANCOIS/AAS-3030-2020; Romanov, Roman/J-2349-2015; Hecksher-Sørensen, Jacob/AAB-3424-2021	Berishvili, Ekaterine/0000-0002-7969-1937; Stukalov, Alexey/0000-0002-4981-8124; Bock, Christoph/0000-0001-6091-3088; collombat, patrick/0000-0001-8232-1438; sdelci, sara/0000-0003-1330-4364; Colinge, Jacques/0000-0003-2466-4824; collombat, patrick/0000-0001-8232-1438; Kubicek, Stefan/0000-0003-0855-8343; Colinge, Jacques/0000-0003-2466-4824; Distel, Martin/0000-0001-5942-0817; Huber, Kilian V. M./0000-0002-1103-5300; Romanov, Roman/0000-0002-3937-518X; Sturtzel, Caterina/0000-0003-1002-5634; Li, Jin/0000-0002-7957-1476; Avolio, Fabio/0000-0003-2067-5315; Honore, Christian/0000-0003-4846-1319; Spittler, Andreas/0000-0003-2657-6836; Kimmel, Robin/0000-0002-9283-1252; Meyer, Dirk/0000-0002-4020-4484; Bennett, Keiryn L./0000-0001-9356-7708; Harkany, Tibor/0000-0002-6637-5900	JDRF award [31-2012-783, 1-RSC-2014-100-I-X, 3-SRA-2015-20-Q-R, 17-2011-258]; NIDDK [1UC4DK098085]; European Research Council [ERC-2015-AdG-695136, StG-2011-281265]; Medical University of Vienna; EMBO long-term research fellowship [ALTF 596-2014]; NovoNordisk Foundation; European Commission [GA-2012-600394]; Austrian Science Fund [FWF P25659-B19]; DOC Fellowship of the Austrian Academy of Sciences; INSERM AVENIR program; INSERM; FMR [DRC20091217179]; ANR/BMBF [2009 GENO 105 01/01KU0906]; "Investments for the Future'' LABEX SIGNALIFE [ANR-11-LABX-0028-01]; Max-Planck Society; Club Isatis; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche; New Frontiers Research Infrastructure grant from the Austrian Academy of Sciences; Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology, and Development; GW Pharmaceuticals;  [17-2011-16];  [2-2010-567];  [26-2008-639];  [17-2013-426];  [3-PDF-2014-206-A-N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK098085] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-EG2009A-1] Funding Source: researchfish; Novo Nordisk Fonden [NNF17OC0027294, NNF15OC0015964, NNF14OC0010695] Funding Source: researchfish	JDRF award; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Research Council(European Research Council (ERC)European Commission); Medical University of Vienna; EMBO long-term research fellowship; NovoNordisk Foundation(Novo Nordisk Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund(Austrian Science Fund (FWF)); DOC Fellowship of the Austrian Academy of Sciences; INSERM AVENIR program(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FMR; ANR/BMBF(French National Research Agency (ANR)); "Investments for the Future'' LABEX SIGNALIFE; Max-Planck Society(Max Planck SocietyFoundation CELLEX); Club Isatis; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche; New Frontiers Research Infrastructure grant from the Austrian Academy of Sciences; Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology, and Development; GW Pharmaceuticals; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Freya Klepsch and Patrick Markt (CeMM) for their input in the design of the drug library. Human islets were provided through the JDRF awards 31-2012-783 and 1-RSC-2014-100-I-X (ECIT Islet for Basic Research Program) and the NIDDK-funded Integrated Islet Distribution Program (IIDP) at City of Hope (NIH grant #1UC4DK098085). Next-generation sequencing was performed by the Biomedical Sequencing Facility at CeMM. This work was funded by JDRF grants 3-SRA-2015-20-Q-R, 17-2011-258 (generation of beta cells from alternative pancreatic subtypes; P.C., J.H.-S., and S.K.), 17-2011-16, 2-2010-567, 26-2008-639, 17-2013-426 (P.C.), and 3-PDF-2014-206-A-N (S.S.); the European Research Council (ERC-2015-AdG-695136 Secret-Cells to T.H.; and StG-2011-281265 to P.C.); intramural funds of the Medical University of Vienna (to T.H.); an EMBO long-term research fellowship (ALTF 596-2014 to R.A.R.); the NovoNordisk Foundation (to T.H.); European Commission FP7 Marie Curie Actions (EMBOCOFUND2012 and GA-2012-600394 to R.A.R.); the Austrian Science Fund (FWF P25659-B19 to R.A.K.); a DOC Fellowship of the Austrian Academy of Sciences (to J.K.); the INSERM AVENIR program (to P.C.); the INSERM (to P.C.); the FMR (DRC20091217179 to P.C.); the ANR/BMBF (2009 GENO 105 01/01KU0906 to P.C.); the "Investments for the Future'' LABEX SIGNALIFE (ANR-11-LABX-0028-01 to P.C.); the Max-Planck Society (to P.C.); Club Isatis (to P.C.); Mr. and Mrs. Dorato (to P.C.); Mr. and Mrs. Peter de Marffy-Mantuano (to P.C.); the Fondation Generale de Sante (to P.C.); and the Foundation Schlumberger pour l'Education et la Recherche (to P.C.). The single-cell sequencing infrastructure at CeMM was supported by a New Frontiers Research Infrastructure grant from the Austrian Academy of Sciences. Research in the S.K. lab is supported by the Austrian Federal Ministry of Science, Research and Economy and the National Foundation for Research, Technology, and Development. J.L. and S.K. have filed a patent application based on the findings described in this manuscript (WO/2015/155303). T.F., C.I., C.H., and J.H.-S. are employees of Novo NordiskA/S and may also own shares in in the company. F.B. and T.S. are employees of Physiogenex S.A.S. T.H. is supported by GW Pharmaceuticals on projects unrelated in scope to the content of the present report.	Ahmad W, 2014, J ETHNOPHARMACOL, V151, P618, DOI 10.1016/j.jep.2013.11.012; Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; ALWAILI NS, 1988, CLIN EXP PHARMACOL P, V15, P497, DOI 10.1111/j.1440-1681.1988.tb01106.x; Arreesrisom P, 2007, PARASITOL INT, V56, P221, DOI 10.1016/j.parint.2007.04.004; Ben-Othman N, 2017, CELL, V168, P73, DOI 10.1016/j.cell.2016.11.002; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; DENAULT JB, 1995, J CARDIOVASC PHARM, V26, pS47; Distel M., 2007, CSH PROTOCOLS, V2007; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ericsson T, 2014, EUR J CLIN PHARMACOL, V70, P1453, DOI 10.1007/s00228-014-1754-2; Fernbach NV, 2009, J PROTEOME RES, V8, P4753, DOI 10.1021/pr900455x; Fomina-Yadlin D, 2010, P NATL ACAD SCI USA, V107, P15099, DOI 10.1073/pnas.1010018107; Franklin IK, 2004, J GEN PHYSIOL, V123, P185, DOI 10.1085/jgp.200409016; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Ho WE, 2014, PHARMACOL THERAPEUT, V142, P126, DOI 10.1016/j.pharmthera.2013.12.001; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Kersey P, 2000, BIOINFORMATICS, V16, P1048, DOI 10.1093/bioinformatics/16.11.1048; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimmel RA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14241; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubicek S, 2012, P NATL ACAD SCI USA, V109, P5364, DOI 10.1073/pnas.1201079109; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Li CH, 2013, J BIOL CHEM, V288, P3938, DOI 10.1074/jbc.M112.385682; Li J, 2016, EMBO REP, V17, P178, DOI 10.15252/embr.201540946; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; Maurer M, 2013, J PROTEOME RES, V12, P1040, DOI 10.1021/pr301009u; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakashima K, 2009, ENDOCR J, V56, P45, DOI 10.1507/endocrj.K08E-172; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Pennarossa G, 2013, P NATL ACAD SCI USA, V110, P8948, DOI 10.1073/pnas.1220637110; Purwana I, 2014, DIABETES, V63, P4197, DOI 10.2337/db14-0153; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Sangan CB, 2015, MOL CELL ENDOCRINOL, V399, P50, DOI 10.1016/j.mce.2014.09.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; SHUKLA KL, 1995, J MOL GRAPHICS, V13, P215, DOI 10.1016/0263-7855(94)00001-9; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; STAGNER JI, 1992, DIABETES, V41, P93, DOI 10.2337/diabetes.41.1.93; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; Thorel F, 2011, DIABETES, V60, P2872, DOI 10.2337/db11-0876; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Walpita D, 2012, J BIOMOL SCREEN, V17, P509, DOI 10.1177/1087057111430253; Wan Y, 2015, DIABET METAB SYND OB, V8, P79, DOI 10.2147/DMSO.S50642; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10111; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xie S, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-47; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Ye LH, 2015, DEVELOPMENT, V142, P1407, DOI 10.1242/dev.117911; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	75	245	270	5	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2017	168	1-2					86	+		10.1016/j.cell.2016.11.010	http://dx.doi.org/10.1016/j.cell.2016.11.010			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8JM	27916275	hybrid, Green Published			2022-12-28	WOS:000396246700013
J	Thaiss, CA; Tav, SI; Rothschild, D; Eijer, MTM; Levy, M; Moresi, C; Dohnalova, L; Braverman, S; Rozin, S; Malitsky, S; Dori-Bachash, M; Kuperman, Y; Biton, I; Gertler, A; Harmelin, A; Shapiro, H; Halpern, Z; Aharoni, A; Segal, E; Elinav, E				Thaiss, Christoph A.; Tav, Shlomik I.; Rothschild, Daphna; Eijer, Mariska T. M.; Levy, Maayan; Moresi, Claudia; Dohnalova, Lenka; Braverman, Sofia; Rozin, Shachar; Malitsky, Sergey; Dori-Bachash, Mally; Kuperman, Yael; Biton, Inbal; Gertler, Arieh; Harmelin, Alon; Shapiro, Hagit; Halpern, Zamir; Aharoni, Asaph; Segal, Eran; Elinav, Eran			Persistent microbiome alterations modulate the rate of post-dieting weight regain	NATURE			English	Article							GUT MICROBIOTA; OBESITY; APIGENIN; FAT; FLAVONOIDS; QUERCETIN; HEALTH; GENES; RISK	In tackling the obesity pandemic, considerable efforts are devoted to the development of effective weight reduction strategies, yet many dieting individuals fail to maintain a long-term weight reduction, and instead undergo excessive weight regain cycles. The mechanisms driving recurrent post-dieting obesity remain largely elusive. Here we identify an intestinal microbiome signature that persists after successful dieting of obese mice and contributes to faster weight regain and metabolic aberrations upon re-exposure to obesity-promoting conditions. Faecal transfer experiments show that the accelerated weight regain phenotype can be transmitted to germ-free mice. We develop a machine-learning algorithm that enables personalized microbiome-based prediction of the extent of post-dieting weight regain. Additionally, we find that the microbiome contributes to diminished post-dieting flavonoid levels and reduced energy expenditure, and demonstrate that flavonoid-based 'post-biotic' intervention ameliorates excessive secondary weight gain. Together, our data highlight a possible microbiome contribution to accelerated post-dieting weight regain, and suggest that microbiome-targeting approaches may help to diagnose and treat this common disorder.	[Thaiss, Christoph A.; Tav, Shlomik I.; Eijer, Mariska T. M.; Levy, Maayan; Moresi, Claudia; Dohnalova, Lenka; Braverman, Sofia; Rozin, Shachar; Dori-Bachash, Mally; Shapiro, Hagit; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Rothschild, Daphna; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Rothschild, Daphna; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Malitsky, Sergey; Aharoni, Asaph] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel; [Kuperman, Yael; Biton, Inbal; Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Gertler, Arieh] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Halpern, Zamir] Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Digest Ctr, IL-64239 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Elinav, E (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il; eran.elinav@weizmann.ac.il	Segal, Eran/AAF-4855-2019; aharoni, asaph/W-6670-2019; Malitsky, Sergey/ABC-2545-2020; Meijer, Mariska T/I-5473-2016; Shapiro, Hagit/F-8648-2015; Elinav, Eran/ABE-8881-2020	Malitsky, Sergey/0000-0003-4619-7219; Meijer, Mariska T/0000-0002-4146-3947; Elinav, Eran/0000-0002-5775-2110; Segal, Eran/0000-0002-6859-1164; Moresi, Claudia/0000-0002-0990-2137; Rothschild, Daphna/0000-0002-0872-8624; Dohnalova, Lenka/0000-0002-2761-2547	Boehringer Ingelheim Fonds PhD Fellowship; Levi Eshkol PhD Scholarship for Personalized Medicine by the Israeli Ministry of Science; Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council; National Institute of Health; Israel Science Foundation; Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS); Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development; Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation; European Foundation for the Study of Diabetes; European Foundation for the Study of Diabetes [Lilly 2015_7] Funding Source: researchfish	Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Levi Eshkol PhD Scholarship for Personalized Medicine by the Israeli Ministry of Science; Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council(European Research Council (ERC)European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation(Helmholtz Association); European Foundation for the Study of Diabetes; European Foundation for the Study of Diabetes	We thank the members of the Elinav and Segal laboratories for discussions and C. Bar-Nathan for germ-free mouse work. C.A.T. received a Boehringer Ingelheim Fonds PhD Fellowship. D.R. received a Levi Eshkol PhD Scholarship for Personalized Medicine by the Israeli Ministry of Science. Y.K. is the incumbent of the Sarah and Rolando Uziel Research Associate Chair. E.S. is supported by the Crown Human Genome Center; the Else Kroener Fresenius Foundation; D.L. Schwarz; J.N. Halpern; L. Steinberg; and grants funded by the European Research Council, the National Institute of Health, and the Israel Science Foundation. E.E. is supported by Y. and R. Ungar; the Abisch Frenkel Foundation for the Promotion of Life Sciences; the Gurwin Family Fund for Scientific Research; the Leona M. and Harry B. Helmsley Charitable Trust; the Crown Endowment Fund for Immunological Research; the estate of J. Gitlitz; the estate of L. Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; the Adelis Foundation; J. L. and V. Schwartz; A. and G. Markovitz; A. and C. Adelson; the French National Center for Scientific Research (CNRS); D. L. Schwarz; the V. R. Schwartz Research Fellow Chair; L. Steinberg; J. N. Halpern; A. Edelheit; and by grants funded by the European Research Council; a Marie Curie Integration grant; the German-Israeli Foundation for Scientific Research and Development; the Israel Science Foundation; the Minerva Foundation; the Rising Tide Foundation; the Helmholtz Foundation; and the European Foundation for the Study of Diabetes. E. E. is the incumbent of the Rina Gudinski Career Development Chair and a senior fellow of the Canadian Institute for Advanced Research (CIFAR).	Anastasiou CA, 2015, METABOLISM, V64, P1395, DOI 10.1016/j.metabol.2015.08.006; Assini JM, 2015, ENDOCRINOLOGY, V156, P2087, DOI 10.1210/en.2014-2003; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braune A, 2016, GUT MICROBES, V7, P216, DOI 10.1080/19490976.2016.1158395; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Choi JH, 2016, NUTRITION, V32, P1002, DOI 10.1016/j.nut.2016.02.007; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dulloo AG, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12250; Elinav E, 2009, ENDOCRINOLOGY, V150, P3083, DOI 10.1210/en.2008-1706; Goldwasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012399; Guo XX, 2016, OBES RES CLIN PRACT, V10, P327, DOI 10.1016/j.orcp.2015.08.004; Hoek-van den Hil EF, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0469-z; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812; Kudo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137809; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Mehta T, 2014, OBES REV, V15, P870, DOI 10.1111/obr.12222; Montani JP, 2015, OBES REV, V16, P7, DOI 10.1111/obr.12251; Myoung HJ, 2010, ARCH PHARM RES, V33, P1741, DOI 10.1007/s12272-010-1105-5; Neumark-Sztainer D, 2006, J AM DIET ASSOC, V106, P559, DOI 10.1016/j.jada.2006.01.003; Pietilainen KH, 2012, INT J OBESITY, V36, P456, DOI 10.1038/ijo.2011.160; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Saarni SE, 2006, INT J OBESITY, V30, P1639, DOI 10.1038/sj.ijo.0803325; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Stevens J, 2015, OBESITY, V23, P527, DOI 10.1002/oby.20985; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414	34	262	267	5	193	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					544	+		10.1038/nature20796	http://dx.doi.org/10.1038/nature20796			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27906159				2022-12-28	WOS:000391190500044
J	Berger, RE; Ellenbogen, KA; Stevenson, WG				Berger, Rebecca E.; Ellenbogen, Kenneth A.; Stevenson, William G.			Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEART-FAILURE; CLINICAL-TRIALS		[Berger, Rebecca E.] Brigham & Womens Hosp, Cardiac Arrhythmia Program, Dept Med, 75 Francis St, Boston, MA 02115 USA; Brigham & Womens Hosp, Cardiovasc Div, Dept Med, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Berger, RE (corresponding author), Brigham & Womens Hosp, Cardiac Arrhythmia Program, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Ellenbogen, Kenneth/AAJ-3992-2021					Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Colquitt JL, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18560; Hess PL, 2015, CIRC-CARDIOVASC QUAL, V8, P179, DOI 10.1161/CIRCOUTCOMES.114.001306; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029; Packer DL, 2009, CIRCULATION, V120, P2170, DOI 10.1161/CIRCULATIONAHA.109.853689; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Steinberg BA, 2014, JACC-HEART FAIL, V2, P623, DOI 10.1016/j.jchf.2014.06.007; Woods B, 2015, HEART, V101, P1800, DOI 10.1136/heartjnl-2015-307634	9	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2290	2292		10.1056/NEJMclde1611988	http://dx.doi.org/10.1056/NEJMclde1611988			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0ZQ	27959679				2022-12-28	WOS:000389310000015
J	Eisenstein, M				Eisenstein, Michael			REWRITING THE REGENERATIVE RULEBOOK	NATURE			English	Editorial Material																			0	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					S64	S67		10.1038/540S63a	http://dx.doi.org/10.1038/540S63a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27926695	Bronze			2022-12-28	WOS:000389548700007
J	Votteler, J; Ogohara, C; Yi, S; Hsia, Y; Nattermann, U; Belnap, DM; King, NP; Sundquist, WI				Votteler, Jorg; Ogohara, Cassandra; Yi, Sue; Hsia, Yang; Nattermann, Una; Belnap, David M.; King, Neil P.; Sundquist, Wesley I.			Designed proteins induce the formation of nanocage-containing extracellular vesicles	NATURE			English	Article							COMPUTATIONAL DESIGN; VIRUS; DNA; FUSION; IMAGE; VISUALIZATION	Complex biological processes are often performed by self-organizing nanostructures comprising multiple classes of macromolecules, such as ribosomes (proteins and RNA) or enveloped viruses (proteins, nucleic acids and lipids). Approaches have been developed for designing self-assembling structures consisting of either nucleic acids(1,2) or proteins(3-5), but strategies for engineering hybrid biological materials are only beginning to emerge(6,7). Here we describe the design of self-assembling protein nanocages that direct their own release from human cells inside small vesicles in a manner that resembles some viruses. We refer to these hybrid biomaterials as 'enveloped protein nanocages' (EPNs). Robust EPN biogenesis requires protein sequence elements that encode three distinct functions: membrane binding, self-assembly, and recruitment of the endosomal sorting complexes required for transport (ESCRT) machinery(8). A variety of synthetic proteins with these functional elements induce EPN biogenesis, highlighting the modularity and generality of the design strategy. Biochemical analyses and cryo-electron microscopy reveal that one design, EPN-01, comprises small (similar to 100 nm) vesicles containing multiple protein nanocages that closely match the structure of the designed 60-subunit self-assembling scaffold(9). EPNs that incorporate the vesicular stomatitis viral glycoprotein can fuse with target cells and deliver their contents, thereby transferring cargoes from one cell to another. These results show how proteins can be programmed to direct the formation of hybrid biological materials that perform complex tasks, and establish EPNs as a class of designed, modular, genetically-encoded nanomaterials that can transfer molecules between cells.	[Votteler, Jorg; Belnap, David M.; Sundquist, Wesley I.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Ogohara, Cassandra; Yi, Sue; Hsia, Yang; Nattermann, Una; King, Neil P.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ogohara, Cassandra; Yi, Sue; Hsia, Yang; Nattermann, Una; King, Neil P.] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Hsia, Yang; Nattermann, Una] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Belnap, David M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah	Sundquist, WI (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.; King, NP (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; King, NP (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.	neilking@uw.edu; wes@biochem.utah.edu			Deutsche Forschungsgemeinschaft (DFG) Fellowship [VO 1836/1-1]; NIH Molecular Biology Training Grant [T32GM008268]; PHS National Research Service Award from NIGMS [T32GM007270]; Bill & Melinda Gates Foundation [OPP1118840]; Defense Advanced Research Projects Agency [W911NF-14-1-0162, W911NF-15-1-0645]; NIH [RO1 AI 51174, P50 082545]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045405, R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, T32GM007270, T32GM008268] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG) Fellowship(German Research Foundation (DFG)); NIH Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS National Research Service Award from NIGMS; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Fellowship VO 1836/1-1 (to J.V.), an NIH Molecular Biology Training Grant (T32GM008268)(Y.H.), a PHS National Research Service Award (T32GM007270) from NIGMS (U.N.), grants from the Bill & Melinda Gates Foundation (OPP1118840) and Defense Advanced Research Projects Agency (W911NF-14-1-0162 and W911NF-15-1-0645) (N.P.K.), and NIH grants RO1 AI 51174 and P50 082545 (W.I.S.). We thank P Shen and J. McCullough for assistance and advice on cryo-EM experiments, M. Kay and D. Eckert and J. Marvin (University of Utah FACS Core) for help with BIaM assays, S. Carter and S. Magesrawan (Caltech) for assistance with Amira Software, L. Nikolova (University of Utah EM Core) for assistance with immunogold labelling experiments, M. Redd (University of Utah Cell Imaging Core) for assistance with confocal microscopy, A. Wargacki for cloning assistance, S. Hauschka for tissue culture assistance, and M. Lajoie, L Stewart and D. Baker for helpful discussions.	Abrishami V, 2013, BIOINFORMATICS, V29, P2460, DOI 10.1093/bioinformatics/btt429; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Frank GA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6854; FREDERICKSEN BL, 1995, J VIROL, V69, P1435, DOI 10.1128/JVI.69.3.1435-1443.1995; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; Griffiths JS, 2002, BIOORGAN MED CHEM, V10, P545, DOI 10.1016/S0968-0896(01)00307-8; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Hsia Y, 2016, NATURE, V535, P136, DOI 10.1038/nature18010; Hu CMJ, 2015, NATURE, V526, P118, DOI 10.1038/nature15373; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Kondo E, 1996, J VIROL, V70, P159, DOI 10.1128/JVI.70.1.159-164.1996; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lai YT, 2014, NAT CHEM, V6, P1065, DOI [10.1038/NCHEM.2107, 10.1038/nchem.2107]; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Monroe N, 2016, J MOL BIOL, V428, P1897, DOI 10.1016/j.jmb.2015.11.004; Morita Eiji, 2012, Biotechniques, V0, P1, DOI 10.2144/000113909; Mou Y, 2015, NATURE, V525, P230, DOI 10.1038/nature14874; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Penczek PA, 2010, METHOD ENZYMOL, V482, P73, DOI 10.1016/S0076-6879(10)82003-8; Perrault SD, 2014, ACS NANO, V8, P5132, DOI 10.1021/nn5011914; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Vargas J, 2014, BIOINFORMATICS, V30, P2891, DOI 10.1093/bioinformatics/btu404; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wang XX, 2015, NATURE, V517, P85, DOI 10.1038/nature13806; Weissenhorn W, 2013, CURR OPIN VIROL, V3, P159, DOI 10.1016/j.coviro.2013.03.011; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; ZHENG S., 2016, PREPRINT	46	70	76	5	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					292	+		10.1038/nature20607	http://dx.doi.org/10.1038/nature20607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27919066	Green Accepted			2022-12-28	WOS:000389548700062
J	Whayne, TF				Whayne, Thomas F., Jr.			New Studies Do Not Challenge the American College of Cardiology/American Heart Association Lipid Guidelines	ANNALS OF INTERNAL MEDICINE			English	Letter							DENSITY-LIPOPROTEIN TARGETS		[Whayne, Thomas F., Jr.] Univ Kentucky, Gill Heart Inst, Lexington, KY 40506 USA	University of Kentucky	Whayne, TF (corresponding author), Univ Kentucky, Gill Heart Inst, Lexington, KY 40506 USA.							Buchwald H, 1998, ARCH INTERN MED, V158, P1253, DOI 10.1001/archinte.158.11.1253; Hayward RA, 2012, CIRC-CARDIOVASC QUAL, V5, P2, DOI 10.1161/CIRCOUTCOMES.111.964676; Hofer TP, 2016, ANN INTERN MED, V164, P683, DOI 10.7326/M15-2428; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Whayne TF, 2013, ANGIOLOGY, V64, P411, DOI 10.1177/0003319712451115	5	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					827	827		10.7326/L16-0418	http://dx.doi.org/10.7326/L16-0418			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27919087				2022-12-28	WOS:000389263900018
J	Sultan, AA; West, J; Grainge, MJ; Riley, RD; Tata, LJ; Stephansson, O; Fleming, KM; Nelson-Piercy, C; Ludvigsson, JF				Sultan, Alyshah Abdul; West, Joe; Grainge, Matthew J.; Riley, Richard D.; Tata, Laila J.; Stephansson, Olof; Fleming, Kate M.; Nelson-Piercy, Catherine; Ludvigsson, Jonas F.			Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POPULATION-BASED COHORT; ANTITHROMBOTIC THERAPY; PREGNANCY; THROMBOSIS; DIAGNOSIS; PROGNOSIS; EVENTS	OBJECTIVE To develop and validate a risk prediction model for venous thromboembolism in the first six weeks after delivery (early postpartum). DESIGN Cohort study. SETTING Records from England based Clinical Practice Research Datalink (CPRD) linked to Hospital Episode Statistics (HES) and data from Sweden based registry. PARTICIPANTS All pregnant women registered with CPRD-HES linked data between 1997 and 2014 and Swedish medical birth registry between 2005 and 2011 with postpartum follow-up. MAIN OUTCOM E MEASURE Multivariable logistic regression analysis was used to develop a risk prediction model for postpartum venous thromboembolism based on the English data, which was externally validated in the Swedish data. RESULTS 433 353 deliveries were identified in the English cohort and 662 387 in the Swedish cohort. The absolute rate of venous thromboembolism was 7.2 per 10 000 deliveries in the English cohort and 7.9 per 10 000 in the Swedish cohort. Emergency caesarean delivery, stillbirth, varicose veins, pre-eclampsia/eclampsia, postpartum infection, and comorbidities were the strongest predictors of venous thromboembolism in the final multivariable model. Discrimination of the model was similar in both cohorts, with a C statistic above 0.70, with excellent calibration of observed and predicted risks. The model identified more venous thromboembolism events than the existing national English (sensitivity 68% v 63%) and Swedish guidelines (30% v 21%) at similar thresholds. CONCLUSION A new prediction model that quantifies absolute risk of postpartum venous thromboembolism has been developed and externally validated. It is based on clinical variables that are available in many developed countries at the point of delivery and could serve as the basis for real time decisions on obstetric thromboprophylaxis.	[Sultan, Alyshah Abdul; Riley, Richard D.] Keele Univ, Res Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England; [Sultan, Alyshah Abdul; West, Joe; Grainge, Matthew J.; Tata, Laila J.; Fleming, Kate M.; Ludvigsson, Jonas F.] Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, Nottingham NG5, England; [Sultan, Alyshah Abdul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Stephansson, Olof] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Stephansson, Olof] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Fleming, Kate M.] Liverpool John Moores Univ, Publ Hlth Inst, Liverpool L3 2ET, Merseyside, England; [Nelson-Piercy, Catherine] Guys & St Thomas Fdn Trust, Womens Hlth Acad Ctr, St Thomas Hosp, London SE1 7EH, England; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Paediat, Orebro, Sweden	Keele University; University of Nottingham; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Liverpool John Moores University; Guy's & St Thomas' NHS Foundation Trust; Orebro University	Sultan, AA (corresponding author), Keele Univ, Res Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England.; Sultan, AA (corresponding author), Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, Nottingham NG5, England.; Sultan, AA (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	alyshah.sultan@hotmail.com	West, Joe/I-6637-2012; Riley, Richard David/ABE-5877-2020; Fleming, Kate M/A-6475-2010; Ludvigsson, Jonas F/A-8560-2012; West, Joe/M-3867-2019; Tata, Laila/J-5227-2012	West, Joe/0000-0002-1135-9356; Riley, Richard David/0000-0001-8699-0735; Fleming, Kate M/0000-0002-6572-5016; Ludvigsson, Jonas F/0000-0003-1024-5602; West, Joe/0000-0002-1135-9356; Grainge, Matthew/0000-0001-7181-4042; Tata, Laila/0000-0002-6404-8658; Stephansson, Olof/0000-0003-1528-4563	JW's University of Nottingham/Nottingham University Hospital's NHS Trust senior clinical research fellowship; Swedish Research Council [2013-2429]	JW's University of Nottingham/Nottingham University Hospital's NHS Trust senior clinical research fellowship; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project was funded by JW's University of Nottingham/Nottingham University Hospital's NHS Trust senior clinical research fellowship. OS was supported by the Swedish Research Council (project No 2013-2429).	Bates Shannon M, 2012, Chest, V141, pe691S, DOI 10.1378/chest.11-2300; Blondon M, 2015, CIRCULATION, V131, P1471, DOI 10.1161/CIRCULATIONAHA.114.012749; Centre for Epidemiology National Board of Health and Welfare, 2003, SWED MED BIRTH REG S; Chan WS, 2014, J OBSTET GYNAECOL CA, V36, P527, DOI 10.1016/S1701-2163(15)30569-7; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Drife J, 2003, BRIT MED BULL, V67, P177, DOI 10.1093/bmb/ldg010; Friedman AM, 2013, OBSTET GYNECOL, V122, P1197, DOI 10.1097/AOG.0000000000000007; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Hippisley-Cox J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4656; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Knight M, 2008, BJOG-INT J OBSTET GY, V115, P453, DOI 10.1111/j.1471-0528.2007.01622.x; Knight M, 2014, SAVING LIVES IMPROVI, P2014; Kurinczuk Jennifer J., 2015, SAVING LIVES IMPROVI; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lindqvist Pelle G, 2011, Adv Hematol, V2011, P157483, DOI 10.1155/2011/157483; Lindqvist PG, 2008, VASC HEALTH RISK MAN, V4, P1081, DOI 10.2147/VHRM.S2831; Lindqvist PG, 2002, ACTA OBSTET GYN SCAN, V81, P412, DOI 10.1034/j.1600-0412.2002.810507.x; Liu SL, 2009, J OBSTET GYNAECOL CA, V31, P611, DOI 10.1016/S1701-2163(16)34240-2; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Riley RD, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3140; Royal College of Obstetricians and Gynaecologists, 2009, RED RISK THROMB EMB; Royal College of Obstetricians & Gynaecologists, 2015, GREEN TOP GUIDELINE; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Sultan AA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008864; Sultan AA, 2014, BLOOD, V124, P2872, DOI 10.1182/blood-2014-05-572834; Sultan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070310; Sultan AA, 2013, BLOOD, V121, P3953, DOI 10.1182/blood-2012-11-469551; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i6	34	76	82	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2016	355								i6253	10.1136/bmj.i6253	http://dx.doi.org/10.1136/bmj.i6253			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SU	27919934	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000390037100003
J	Horton, R				Horton, Richard			Offline: Looking forward to Donald Trump	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2726	2726		10.1016/S0140-6736(16)32462-X	http://dx.doi.org/10.1016/S0140-6736(16)32462-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FB	27924766	Bronze			2022-12-28	WOS:000389629800010
J	McLaughlin, K				McLaughlin, Kathleen			BRINGING LEGENDS TO LIFE	SCIENCE			English	Editorial Material																			0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1094	1095		10.1126/science.354.6316.1094	http://dx.doi.org/10.1126/science.354.6316.1094			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934717				2022-12-28	WOS:000388916400015
J	Geeleher, P; Gamazon, ER; Seoighe, C; Cox, NJ; Huang, S				Geeleher, Paul; Gamazon, Eric R.; Seoighe, Cathal; Cox, Nancy J.; Huang, Stephanie			Consistency in large pharmacogenomic studies	NATURE			English	Letter							DRUG-SENSITIVITY; CANCER-CELLS; INHIBITOR; EXPRESSION; KINASE		[Geeleher, Paul; Gamazon, Eric R.; Cox, Nancy J.; Huang, Stephanie] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Gamazon, Eric R.; Cox, Nancy J.] Vanderbilt Univ, Div Med Genet, Nashville, TN 37232 USA; [Gamazon, Eric R.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Seoighe, Cathal] Natl Univ Ireland, Dept Math Stat & Appl Math, Galway, Ireland	University of Chicago; Vanderbilt University; University of Amsterdam; Academic Medical Center Amsterdam; Ollscoil na Gaillimhe-University of Galway	Cox, NJ (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	nancy.j.cox@vanderbilt.edu; rhuang@medicine.bsd.uchicago.edu	Gamazon, Eric/I-6873-2018; Geeleher, Paul/C-7040-2019	Gamazon, Eric/0000-0003-4204-8734; Seoighe, Cathal/0000-0003-0496-4029; Huang, R. Stephanie/0000-0002-9862-0368	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM089941] Funding Source: NIH RePORTER; NIGMS NIH HHS [K08 GM089941] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Falgreen S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1237-6; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Geeleher P, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r47; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Timm A, 2013, AM J HEALTH-SYST PH, V70, P943, DOI 10.2146/ajhp120261; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105	12	27	27	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					E1	E2		10.1038/nature19838	http://dx.doi.org/10.1038/nature19838			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905415	Green Accepted			2022-12-28	WOS:000388916600008
J	Higgins, K				Higgins, Kathleen			Post-truth: a guide for the perplexed	NATURE			English	Editorial Material									[Higgins, Kathleen] Univ Texas Austin, Nietzsche Aesthet & Philosophy Emot, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Higgins, K (corresponding author), Univ Texas Austin, Nietzsche Aesthet & Philosophy Emot, Austin, TX 78712 USA.	kmhiggins@austin.utexas.edu							0	75	76	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					9	9		10.1038/540009a	http://dx.doi.org/10.1038/540009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905459	Bronze			2022-12-28	WOS:000388916600017
J	Mullard, A				Mullard, Asher			STEM CELLS Stemming the tide	NATURE			English	Editorial Material							AGGRESSIVE MULTIPLE-SCLEROSIS; PROOF-OF-CONCEPT; TRANSPLANTATION; TRIAL											Atkins HL, 2016, LANCET, V388, P576, DOI 10.1016/S0140-6736(16)30169-6; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Freedman M, 2016, MULT SCLER J, V22, P1258, DOI 10.1177/1352458516654311; Mullard A, 2016, NAT REV DRUG DISCOV, V15, P519, DOI 10.1038/nrd.2016.158; Saccardi R, 2012, MULT SCLER J, V18, P825, DOI 10.1177/1352458512438454; Sormani M. P., 2016, ECTRIMS ONLINE LIB; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1	7	0	0	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					S11	S12		10.1038/540S11a	http://dx.doi.org/10.1038/540S11a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27902679				2022-12-28	WOS:000388916600006
J	Oliver, D				Oliver, David			David Oliver: Time for an honest patient's charter?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Appleby J, 2015, PUBLIC SATISFACTION; Ball JE, 2014, BMJ QUAL SAF, V23, P116, DOI 10.1136/bmjqs-2012-001767; Blunt I., 2014, QUALITYWATCH FOC A E; Campbell D, 2016, GUARDIAN; Data. parliament, 2016, FIN0003 CEO NHS; Department of Health, 2013, FLOR GOV INTH SUNSH; Dunhill L, 2016, HLTH SERV J; Healthwatch England, 2015, SAF HOM WHAT HAPP PE; Hubbard RE, 2004, AGE AGEING, V33, P479, DOI 10.1093/ageing/afh164; King's Fund, 2016, Q MON REP; King's Fund, 2010, HAV TARG IMPR NHS PE; NHS England, 2015, NHS CONST NHS BEL US; Nuffield Trust, SPOTL 7 DAY NHS; Oliver D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2948; Patient's charter blamed for attacks on NHS staff, 1998, BBC HEALTH      1028; Quigley A., 2014, MAINTAINING PRIDE NH; Rimmer A, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6069; The UK National Health Service Act of, 1946, PITTSBURGH POST 0429	18	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2016	355								i6388	10.1136/bmj.i6388	http://dx.doi.org/10.1136/bmj.i6388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZD	27903498	Bronze			2022-12-28	WOS:000389308600009
J	Redfield, MM				Redfield, Margaret M.			Heart Failure with Preserved Ejection Fraction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATRIURETIC PEPTIDE; EXERCISE INTOLERANCE; ATRIAL-FIBRILLATION; CARDIAC STRUCTURE; ARTERY-DISEASE; WEDGE PRESSURE; DYSFUNCTION; MANAGEMENT; DIAGNOSIS; COMMUNITY	A 73-year-old woman with a history of dyspnea on exertion presents for a follow-up visit after hospitalization for acute worsening of dyspnea and orthopnea. On admission to the hospital, the patient had atrial fibrillation with a ventricular rate of 120 beats per minute, and chest radiography revealed pulmonary venous hypertension. Despite anticoagulation, rate control with a beta-blocker, and administration of loop diuretics during the hospitalization, she continues to have fatigue and exertional dyspnea. On physical examination, the body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) is 39, pulse 76 beats per minute, and blood pressure 160/70 mm Hg. There is jugular venous distention and lower-extremity edema but no third heart sound, murmurs, or rales. The serum creatinine level is 1.4 mg per deciliter (124 mu mol per liter), estimated glomerular filtration rate (GFR) 37 ml per minute per 1.73 m(2) of body-surface area, and N-terminal pro-brain natriuretic peptide (NT-proBNP) level 300 pg per milliliter (age-specific and sex-specific normal range, 10 to 218 pg per milliliter). Echocardiography reveals an ejection fraction of 70%, a normal left ventricular cavity dimension and wall thickness, and left atrial enlargement. Doppler echocardiography shows elevated left atrial pressure (E/e' ratio, 22) and an estimated pulmonary-artery systolic pressure of 52 mm Hg. How should this patient's condition be managed?	[Redfield, Margaret M.] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA	Mayo Clinic	Redfield, MM (corresponding author), Mayo Clin, Guggenheim 9,200 First St SW, Rochester, MN 55905 USA.	redfield.margaret@mayo.edu			Merck; Eli Lilly; Actelion; St. Jude Medical; Medtronic	Merck(Merck & Company); Eli Lilly(Eli Lilly); Actelion; St. Jude Medical(St. Jude Medical); Medtronic(Medtronic)	Dr. Redfield reports serving as a member of a scientific committee for Novartis (unpaid) and receiving consulting fees from Merck, Eli Lilly, and Actelion, fees for serving on a data and safety monitoring board for Covaria, and grant support from St. Jude Medical and Medtronic. No other potential conflict of interest relevant to this article was reported.	Adamson PB, 2014, CIRC-HEART FAIL, V7, P935, DOI 10.1161/CIRCHEARTFAILURE.113.001229; Alehagen U, 2015, CIRC-HEART FAIL, V8, P862, DOI 10.1161/CIRCHEARTFAILURE.115.002143; Anjan VY, 2012, AM J CARDIOL, V110, P870, DOI 10.1016/j.amjcard.2012.05.014; Bishu K, 2012, AM HEART J, V164, P763, DOI 10.1016/j.ahj.2012.08.014; Borlaug BA, 2014, CIRC J, V78, P20, DOI 10.1253/circj.CJ-13-1103; Borlaug BA, 2011, HEART, V97, P964, DOI 10.1136/hrt.2010.212787; Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701; Borlaug BA, 2009, J AM COLL CARDIOL, V54, P410, DOI 10.1016/j.jacc.2009.05.013; Campbell RT, 2012, J AM COLL CARDIOL, V60, P2349, DOI 10.1016/j.jacc.2012.04.064; Chan MMY, 2013, EUR J HEART FAIL, V15, P604, DOI 10.1093/eurjhf/hft062; Chatterjee NA, 2014, CIRCULATION, V130, P2272, DOI 10.1161/CIRCULATIONAHA.114.013536; Conraads VM, 2012, EUR J HEART FAIL, V14, P219, DOI 10.1093/eurjhf/hfr161; Costello-Boerrigter LC, 2006, J AM COLL CARDIOL, V47, P345, DOI 10.1016/j.jacc.2005.09.025; Dalzell JR, 2014, NEW ENGL J MED, V371, P179, DOI 10.1056/NEJMc1405715; Dhakal BP, 2015, CIRC-HEART FAIL, V8, P286, DOI 10.1161/CIRCHEARTFAILURE.114.001825; Franssen C, 2015, EUR J HEART FAIL, V17, P132, DOI 10.1002/ejhf.225; Gillmore JD, 2016, CIRCULATION, V133, P2404, DOI 10.1161/CIRCULATIONAHA.116.021612; Gladden JD, 2014, PFLUG ARCH EUR J PHY, V466, P1037, DOI 10.1007/s00424-014-1480-8; Gonzalez-Lopez E, 2015, EUR HEART J, V36, P2585, DOI 10.1093/eurheartj/ehv338; Haykowsky MJ, 2015, J APPL PHYSIOL, V119, P739, DOI 10.1152/japplphysiol.00049.2015; Hwang SJ, 2014, J AM COLL CARDIOL, V63, P2817, DOI 10.1016/j.jacc.2014.03.034; Iwanaga Y, 2006, J AM COLL CARDIOL, V47, P742, DOI 10.1016/j.jacc.2005.11.030; JAMES PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Kitzman DW, 2016, JAMA-J AM MED ASSOC, V315, P36, DOI 10.1001/jama.2015.17346; Lam CSP, 2007, CIRCULATION, V115, P1982, DOI 10.1161/CIRCULATIONAHA.106.659763; Lee DS, 2011, CIRC-HEART FAIL, V4, P36, DOI 10.1161/CIRCHEARTFAILURE.110.957480; Liu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090555; Mohammed SF, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003272; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Muhlestein JB, 2013, J AM COLL CARDIOL, V61, pE1155, DOI 10.1016/j.jacc.2013.01.004; Nanayakkara S, 2015, CLIN THER, V37, P2186, DOI 10.1016/j.clinthera.2015.08.005; Ohman EM, 2016, NEW ENGL J MED, V374, P1167, DOI 10.1056/NEJMcp1502240; Pandey A, 2015, CIRC-HEART FAIL, V8, P33, DOI 10.1161/CIRCHEARTFAILURE.114.001615; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Pfeffer MA, 2015, CIRCULATION, V131, P34, DOI 10.1161/CIRCULATIONAHA.114.013255; PICHARD AD, 1983, CLIN CARDIOL, V6, P534, DOI 10.1002/clc.4960061104; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Redfield MM, 2015, NEW ENGL J MED, V373, P2314, DOI 10.1056/NEJMoa1510774; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Richards M, 2013, JACC-HEART FAIL, V1, P192, DOI 10.1016/j.jchf.2013.02.004; Rossi A, 2014, CIRC-HEART FAIL, V7, P1042, DOI 10.1161/CIRCHEARTFAILURE.114.001276; Shah RV, 2010, J CARD FAIL, V16, P260, DOI 10.1016/j.cardfail.2009.11.007; Shah SJ, 2016, CIRCULATION, V134, P73, DOI 10.1161/CIRCULATIONAHA.116.021884; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Thenappan T, 2015, CAN J CARDIOL, V31, P430, DOI 10.1016/j.cjca.2014.12.028; van Veldhuisen DJ, 2009, J AM COLL CARDIOL, V53, P2150, DOI 10.1016/j.jacc.2009.02.046; Yamamoto K, 2013, EUR J HEART FAIL, V15, P110, DOI 10.1093/eurjhf/hfs141; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Zakeri R, 2013, CIRCULATION, V128, P1085, DOI 10.1161/CIRCULATIONAHA.113.001475; Zile MR, 2011, CIRCULATION, V124, P2491, DOI 10.1161/CIRCULATIONAHA.110.011031; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	54	282	295	6	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					1868	1877		10.1056/NEJMcp1511175	http://dx.doi.org/10.1056/NEJMcp1511175			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB6ZK	27959663				2022-12-28	WOS:000387534200010
J	McQuade, CN; Mizus, M; Wald, JW; Goldberg, L; Jessup, M; Umscheid, CA				McQuade, Casey N.; Mizus, Marisa; Wald, Joyce W.; Goldberg, Lee; Jessup, Mariell; Umscheid, Craig A.			Brain-Type Natriuretic Peptide and Amino-Terminal Pro-Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Review							TISSUE DOPPLER-ECHOCARDIOGRAPHY; BLOOD UREA NITROGEN; NT-PROBNP; 6-MONTH MORTALITY; RISK STRATIFICATION; HOSPITAL DISCHARGE; GUIDED TREATMENT; ELDERLY-PATIENTS; PREDISCHARGE; BNP	Background: Acute decompensated heart failure (ADHF) requiring hospitalization is associated with high postdischarge mortality and readmission rates. Purpose: To examine the association between achieving predischarge natriuretic peptide (NP) thresholds and mortality and readmission rates in adults hospitalized for ADHF. Data Sources: Multiple databases from 1947 to October 2016 (English-language studies only). Study Selection: Trials and observational studies that compared mortality and readmission outcomes between patients with ADHF achieving a specific predischarge NP goal and those not achieving the goal. Data Extraction: Two investigators independently extracted study characteristics and assessed study risk of bias. One author graded the overall strength of evidence, with review by a second author. Data Synthesis: One randomized trial, 3 quasi-experimental studies, and 40 observational studies were identified. The most commonly used thresholds were a brain-type NP (BNP) level of 250 pg/mL or less or an amino-terminal pro-brain-type NP (NT-proBNP) decrease of at least 30%. Achievement of absolute BNP thresholds reduced postdischarge all-cause mortality (7 of 8 studies) and the composite outcome of mortality and readmission (12 of 14 studies). Achievement of percentage-change BNP thresholds reduced the composite outcome (5 of 6 studies), and achievement of percentage-change NT-proBNP thresholds reduced all-cause and cardiovascular mortality (2 of 4 studies) and the composite outcome (9 of 9 studies). All findings were low-strength. The randomized trial, assessed as having high risk of bias, suggested that a predischarge decrease in NT-proBNP level was associated with lower risk for the composite outcome. Two quasi-experimental studies and 5 observational studies had low risk of bias. Low-risk-of-bias studies had outcome estimates similar in magnitude and direction to estimates from high-risk-of-bias studies. Limitation: Most studies failed to adjust for critical confounders and had inadequate definition or assessment of exposures and outcomes. Conclusion: Low-strength evidence suggests an association between achieving NP predischarge thresholds and reduced ADHF mortality and readmission.	Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [McQuade, Casey N.; Umscheid, Craig A.] Univ Penn Hlth Syst, Penn Med Ctr Evidence Based Practice, 3535 Market St,Mezzanine 9,Suite 50, Philadelphia, PA 19104 USA; [McQuade, Casey N.] UPMC, Montefiore Hosp, N-715,200 Lothrop St, Pittsburgh, PA 15213 USA; [Mizus, Marisa] Lankenau Med Ctr, 100 East Lancaster Ave, Wynnewood, PA 19096 USA; [Wald, Joyce W.; Goldberg, Lee; Jessup, Mariell] Perelman Ctr Adv Med, 3400 Civ Ctr Blvd,East Pavil,2nd Floor, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Lankenau Medical Center; University of Pennsylvania; Pennsylvania Medicine	Umscheid, CA (corresponding author), Univ Penn Hlth Syst, Penn Med Ctr Evidence Based Practice, 3535 Market St,Mezzanine 9,Suite 50, Philadelphia, PA 19104 USA.	mcquadec@upmc.edu; craig.umscheid@uphs.upenn.edu		Jessup, Mariell/0000-0002-3010-0112; Umscheid, Craig/0000-0003-1853-1013; Goldberg, Lee/0000-0002-7906-9638	Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania; Medtronic	Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania; Medtronic(Medtronic)	Dr. Mizus reports grants from the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania and from the National Institutes of Health during the conduct of the study. Dr. Goldberg reports personal fees from Medtronic and a grant from Respicardia outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-1468.	Aspromonte N, 2007, DIABETIC MED, V24, P124, DOI 10.1111/j.1464-5491.2007.02070.x; Balion C, 2006, Evid Rep Technol Assess (Full Rep), P1; Bettencourt P, 2002, AM J MED, V113, P215, DOI 10.1016/S0002-9343(02)01184-1; Bettencourt P, 2004, CIRCULATION, V110, P2168, DOI 10.1161/01.CIR.0000144310.04433.BE; Bettencourt P, 2007, INT J CARDIOL, V117, P75, DOI 10.1016/j.ijcard.2006.06.004; Carubelli V, 2016, J CARDIOVASC MED, V17, P828, DOI 10.2459/JCM.0000000000000419; Chen CY, 2012, CIRC J, V76, P2372, DOI 10.1253/circj.CJ-12-0040; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P630, DOI 10.1001/jama.275.8.630; Cournot M, 2008, AM HEART J, V155, P986, DOI 10.1016/j.ahj.2008.01.011; Cournot M, 2007, AM J GERIATR CARDIOL, V16, P8, DOI 10.1111/j.1076-7460.2007.05297.x; De Vecchis R, 2013, MINERVA CARDIOANGIOL, V61, P437; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Di Somma S, 2010, CRIT CARE, V14, DOI 10.1186/cc9067; Dokainish H, 2005, J AM COLL CARDIOL, V45, P1223, DOI 10.1016/j.jacc.2005.01.025; Eurlings LW, 2014, J CARD FAIL, V20, P881, DOI 10.1016/j.cardfail.2014.08.014; Faggiano P, 2010, INT J CARDIOL, V140, P88, DOI 10.1016/j.ijcard.2008.11.020; Feola M, 2008, J CARD FAIL, V14, P420, DOI 10.1016/j.cardfail.2008.01.013; Feola M, 2012, ARCH MED SCI, V8, P462, DOI 10.5114/aoms.2012.29401; Ferreira Susana, 2007, Rev Port Cardiol, V26, P535; Gackowski A, 2004, EUR HEART J, V25, P1788, DOI 10.1016/j.ehj.2004.07.038; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hamada Y, 2005, J CARD FAIL, V11, P43, DOI 10.1016/j.cardfail.2004.05.001; Hartling L, 2015, J CLIN EPIDEMIOL, V68, P1451, DOI 10.1016/j.jclinepi.2015.05.036; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Ho SJ, 2011, ECHOCARDIOGR-J CARD, V28, P303, DOI 10.1111/j.1540-8175.2010.01322.x; Ito K, 2012, EUR HEART J-ACUTE CA, V1, P240, DOI 10.1177/2048872612458580; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kociol RD, 2013, CIRC-HEART FAIL, V6, P240, DOI 10.1161/CIRCHEARTFAILURE.112.969246; Koitabashi T, 2005, INT HEART J, V46, P453, DOI 10.1536/ihj.46.453; Kubler P, 2008, INT J CARDIOL, V129, P373, DOI 10.1016/j.ijcard.2007.07.126; Lindenfeld J, 2010, J CARD FAIL, V16, pe1, DOI DOI 10.1016/J.CARDFAIL.2010.04.004; Logeart D, 2004, J AM COLL CARDIOL, V43, P635, DOI 10.1016/j.jacc.2003.09.044; Lourenco P, 2015, AM J CARDIOL, V116, P744, DOI 10.1016/j.amjcard.2015.05.046; Ludka O, 2013, COR VASA, V55, pE286, DOI 10.1016/j.crvasa.2013.03.007; Metra M, 2007, EUR J HEART FAIL, V9, P776, DOI 10.1016/j.ejheart.2007.05.007; Michtalik HJ, 2011, AM J CARDIOL, V107, P1191, DOI 10.1016/j.amjcard.2010.12.018; Mitchell MD, 2011, INT J TECHNOL ASSESS, V27, P127, DOI 10.1017/S0266462311000031; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Naffaa M, 2014, AM J EMERG MED, V32, P44, DOI 10.1016/j.ajem.2013.10.002; Nakada Y, 2016, AM J PHYSIOL-HEART C, V310, pH813, DOI 10.1152/ajpheart.00602.2015; Noveanu M, 2011, CRIT CARE, V15, DOI 10.1186/cc9398; O'Brien RJ, 2003, EUR J HEART FAIL, V5, P499, DOI 10.1016/S1388-9842(03)00098-9; Omar HR, 2016, INT J CARDIOL, V221, P1116, DOI 10.1016/j.ijcard.2016.07.117; Pimenta JM, 2007, J CARD FAIL, V13, P275, DOI 10.1016/j.cardfail.2007.01.001; Ruocco G, 2016, J CARDIOVASC MED, V17, P818, DOI 10.2459/JCM.0000000000000350; Santaguida PL, 2014, HEART FAIL REV, V19, P453, DOI 10.1007/s10741-014-9442-y; Savarese G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058287; Seo Y, 2008, J CARDIOL, V52, P224, DOI 10.1016/j.jjcc.2008.07.008; Shah MR, 2007, AM J CARDIOL, V100, P1427, DOI 10.1016/j.amjcard.2007.06.035; Siswanto BB, 2006, CRIT CARE SHOCK, V9, P61; Stienen S, 2015, EUR J HEART FAIL, V17, P936, DOI 10.1002/ejhf.320; The Cochrane Collaboration, 2008, COCHR HDB REV INT; Troughton RW, 2014, EUR HEART J, V35, P1559, DOI 10.1093/eurheartj/ehu090; Valle R, 2008, INT J CARDIOL, V126, P400, DOI 10.1016/j.ijcard.2006.03.097; Valle R, 2008, J CARD FAIL, V14, P219, DOI 10.1016/j.cardfail.2007.10.009; Valle Roberto, 2006, Am J Geriatr Cardiol, V15, P202, DOI 10.1111/j.1076-7460.2006.04830.x; Valle R, 2011, HEART FAIL REV, V16, P519, DOI 10.1007/s10741-011-9244-4; Verdiani V, 2005, EUR J HEART FAIL, V7, P566, DOI 10.1016/j.ejheart.2004.12.006; Verdiani V, 2008, J CARDIOVASC MED, V9, P694, DOI 10.2459/JCM.0b013e3282f447ae; Wells G., 2014, NEWCASTLE OTTAWA SCA; Yu CM, 1999, EUR J HEART FAIL, V1, P59, DOI 10.1016/S1388-9842(98)00010-5	61	34	36	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					180	+		10.7326/M16-1468	http://dx.doi.org/10.7326/M16-1468			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	27894126				2022-12-28	WOS:000394781200007
J	Mortimer, K; Ndamala, CB; Naunje, AW; Malava, J; Katundu, C; Weston, W; Havens, D; Pope, D; Bruce, NG; Nyirenda, M; Wang, DL; Crampin, A; Grigg, J; Balmes, J; Gordon, SB				Mortimer, Kevin; Ndamala, Chifundo B.; Naunje, Andrew W.; Malava, Jullita; Katundu, Cynthia; Weston, William; Havens, Deborah; Pope, Daniel; Bruce, Nigel G.; Nyirenda, Moffat; Wang, Duolao; Crampin, Amelia; Grigg, Jonathan; Balmes, John; Gordon, Stephen B.			A cleaner burning biomass-fuelled cookstove intervention to prevent pneumonia in children under 5 years old in rural Malawi (the Cooking and Pneumonia Study): a cluster randomised controlled trial	LANCET			English	Article							HOUSEHOLD AIR-POLLUTION; RISK-FACTOR; DISEASE	Background WHO estimates exposure to air pollution from cooking with solid fuels is associated with over 4 million premature deaths worldwide every year including half a million children under the age of 5 years from pneumonia. We hypothesised that replacing open fires with cleaner burning biomass-fuelled cookstoves would reduce pneumonia incidence in young children. Methods We did a community-level open cluster randomised controlled trial to compare the effects of a cleaner burning biomass-fuelled cookstove intervention to continuation of open fire cooking on pneumonia in children living in two rural districts, Chikhwawa and Karonga, of Malawi. Clusters were randomly allocated to intervention and control groups using a computer-generated randomisation schedule with stratification by site, distance from health centre, and size of cluster. Within clusters, households with a child under the age of 4.5 years were eligible. Intervention households received two biomass-fuelled cookstoves and a solar panel. The primary outcome was WHO Integrated Management of Childhood Illness (IMCI)-defined pneumonia episodes in children under 5 years of age. Efficacy and safety analyses were by intention to treat. The trial is registered with ISRCTN, number ISRCTN59448623. Findings We enrolled 10750 children from 8626 households across 150 clusters between Dec 9, 2013, and Feb 28, 2016. 10 543 children from 8470 households contributed 15 991 child-years of follow-up data to the intention-to-treat analysis. The IMCI pneumonia incidence rate in the intervention group was 15.76 (95% CI 14.89-16.63) per 100 child-years and in the control group 15.58 (95% CI 14.72-16.45) per 100 child-years, with an intervention versus control incidence rate ratio (IRR) of 1.01 (95% CI 0.91-1.13; p= 0.80). Cooking-related serious adverse events (burns) were seen in 19 children; nine in the intervention and ten (one death) in the control group (IRR 0.91 [ 95% CI 0.37-2.23]; p= 0.83). Interpretation We found no evidence that an intervention comprising cleaner burning biomass-fuelled cookstoves reduced the risk of pneumonia in young children in rural Malawi. Effective strategies to reduce the adverse health effects of household air pollution are needed. Copyright (C) The Author(s). Published by Elsevier Ltd.	[Mortimer, Kevin; Ndamala, Chifundo B.; Naunje, Andrew W.; Weston, William; Gordon, Stephen B.] Malawi Liverpool Wellcome Trust Programme, Blantyre, Malawi; [Mortimer, Kevin; Weston, William; Havens, Deborah; Wang, Duolao; Gordon, Stephen B.] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England; [Malava, Jullita; Katundu, Cynthia; Nyirenda, Moffat; Crampin, Amelia] Malawi Epidemiol & Intervent Res Unit, Chilumba, Malawi; [Pope, Daniel; Bruce, Nigel G.] Univ Liverpool, Liverpool, Merseyside, England; [Nyirenda, Moffat; Crampin, Amelia] London Sch Hyg & Trop Med, London, England; [Grigg, Jonathan] Queen Mary Univ London, London, England; [Balmes, John] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Balmes, John] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; Malawi Epidemiology and Intervention Research Unit; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of London; Queen Mary University London; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Mortimer, K (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	Kevin.mortimer@lstmed.ac.uk	Balmes, John/L-6281-2019	Mortimer, Kevin/0000-0002-8118-8871; Crampin, Amelia/0000-0002-1513-4330; Wang, Duolao/0000-0003-2788-2464; Pope, Daniel/0000-0003-2694-5478; Grigg, Jonathan/0000-0003-3109-6028; Gordon, Stephen/0000-0001-6576-1116	Medical Research Council [MR/L002515/1]; UK Department for International Development; Wellcome Trust [MR/K006533/1]; MRC Partnership Grant [MR/L009242/1]; North Thames Collaboration for Leadership in Applied Health Research and Care; Medical Research Council [MR/L009242/1, MR/K006533/1] Funding Source: researchfish; National Institute for Health Research [CL-2006-12-004] Funding Source: researchfish; MRC [MR/L009242/1, MR/L002515/1, MR/K006533/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Wellcome Trust(Wellcome Trust); MRC Partnership Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); North Thames Collaboration for Leadership in Applied Health Research and Care; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council, UK Department for International Development, and Wellcome Trust.; The trial was funded by a Joint Global Health Trials Grant from the Medical Research Council, UK Department for International Development, and Wellcome Trust (MR/K006533/1) and a New Investigator Research Grant from the Medical Research Council (MR/L002515/1). Additional support was provided by a MRC Partnership Grant (MR/L009242/1). JG is part-funded by the North Thames Collaboration for Leadership in Applied Health Research and Care. We thank the trial participants, village leaders and CAPS representatives, the study team in Chikhwawa (Patience Korea, Frank Mbalume, Emma T Nyirenda, Sarah Magombo Kamphandule, Aonenji Manyika, Yamikani Dickson, Bright Mnesa, Caroline Kumbuyo, Martha Chipeta, Gloria Banda, Ernest Mwangoka, Suzgo Mkandawire, Wezzie Nyapigoti, Fletcher Nangupeta, Kondawani C Munthali, Frank Jamestar, Steven Lanken, Nicholas Mwenda, James Chirambo, and others), the study team in Chilumba, Karonga (Alexander Nkosi, Andy Chisunda, Angellina Sakala, Bedgeman Chikwezya, Blessings Nyirenda, Calvin Mwalwanda, Desire Augustine, Dokiso Chihana, Donaria Zgambo, Grecium Nkhono, Hawkins Ndovie, Jimmy Mbalwa, Levie Gondwe, John Mughogho, Kelvin Gondwe, Louis Chavula, McDonald Kalua, Michael Nyirenda, Nathan Madise, Patrick Luhanga, Themba Chirwa, Timothy Mwaungulu, Tryness Kandonga, Tupiwe Sichali, and Wakisa Nyondo), the study team at Liverpool School of Tropical Medicine (Jane Ardrey, Debbie Jenkins, Rachael Lloyd, Andrew Bennett, James Smedley, Tao Chen, and Brian Faragher), the central support from Malawi Liverpool Wellcome Trust Programme (Moses Kamzati, Asimenye Kayuni, Owen Mwenefumbo, Tamara Chipasula Makawa, Elvis Moyo, Rodrick Sambukunsi, Neema Toto, Florence Shumba, Ethel Chilima, Chimwemwe Mateula Theu, Sitinga Kanzengo, Mary Kandeya, Elina Chomanika, Elestina Nyawenda, Yusuf Ronald, Rattibu Mavungire, Paul Lumbe, and Allan Brown), the central support from Malawi Epidemiology and Intervention Research Unit (Keith Branson, Jacky Saul, Steff en Geis, Yoryos Ponnighaus, Laurence Tembo, David Chilalika, Franklin Kondowe, Lydia Ngwira, Tiwonge Mdema, Jean Mwafulirwa, Lackson Kachiwanda, Olivier Koole, Chifundo Mpambira, Eliza Munthali, Martin Longwe, Oddie Mwiba, Samson Makwakwa, Orphan Chirwa, Alik Mwalwanda, and Mabvuto Luhanga), the Trial Steering Committee (Anne E Tattersfi eld, Norman Lufesi, William J Martin II, David Crosby, David G Lalloo, and Shabbar Jaffar), the Data Monitoring Committee (Stephen Holgate, Peter K Kimani, and Sundeep Salvi), the Malawi Ministry of Health, the Aprovecho Research Centre, and the African Clean Energy (ACE) company for their valued contributions to making the Cooking and Pneumonia Study a success.	Bruce N, WHO INDOOR AIR QUALI; Chihana ML, 2015, JAIDS-J ACQ IMM DEF, V68, P81, DOI 10.1097/QAI.0000000000000405; Fullerton DG, 2009, OCCUP ENVIRON MED, V66, P777, DOI 10.1136/oem.2008.045013; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; International Energy Agency, AFR EN OUTL; Jetter JJ, 2009, BIOMASS BIOENERG, V33, P294, DOI 10.1016/j.biombioe.2008.05.014; Kalu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155830; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malawi Ministry of Health and Population, 2005, HLTH MAN INF B; Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC; Mortimer K, LANCET; Mortimer K, 2012, CHEST, V142, P1308, DOI 10.1378/chest.12-1596; Puzzolo E, 2016, ENVIRON RES, V146, P218, DOI 10.1016/j.envres.2016.01.002; Romieu I, 2009, AM J RESP CRIT CARE, V180, P649, DOI 10.1164/rccm.200810-1556OC; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Weston W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155966; WHO, 2014, IND AIR QUAL GUILD H; WHO, HLTH SUST DEV BREATH; WHO, 2005, HDB IMCI INT MAN CHI	20	190	191	2	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					167	175		10.1016/S0140-6736(16)32507-7	http://dx.doi.org/10.1016/S0140-6736(16)32507-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9UT	27939058	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000392117600028
J	Fitzgerald, K; White, S; Borodovsky, A; Bettencourt, BR; Strahs, A; Clausen, V; Wijngaard, P; Horton, JD; Taubel, J; Brooks, A; Fernando, C; Kauffman, RS; Kallend, D; Vaishnaw, A; Simon, A				Fitzgerald, Kevin; White, Suellen; Borodovsky, Anna; Bettencourt, Brian R.; Strahs, Andrew; Clausen, Valerie; Wijngaard, Peter; Horton, Jay D.; Taubel, Jorg; Brooks, Ashley; Fernando, Chamikara; Kauffman, Robert S.; Kallend, David; Vaishnaw, Akshay; Simon, Amy			A Highly Durable RNAi Therapeutic Inhibitor of PCSK9	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUBTILISIN/KEXIN TYPE 9; DENSITY-LIPOPROTEIN-CHOLESTEROL; MONOCLONAL-ANTIBODY; LDL CHOLESTEROL; DOUBLE-BLIND; CARDIOVASCULAR EVENTS; HEALTHY-VOLUNTEERS; NONHUMAN-PRIMATES; REDUCING LIPIDS; HYPERCHOLESTEROLEMIA	BACKGROUND Inclisiran (ALN-PCSsc) is a long-acting RNA interference (RNAi) therapeutic agent that inhibits the synthesis of proprotein convertase subtilisin-kexin type 9 (PCSK9), a target for the lowering of low-density lipoprotein (LDL) cholesterol. METHODS In this phase 1 trial, we randomly assigned healthy volunteers with an LDL cholesterol level of at least 100 mg per deciliter in a 3: 1 ratio to receive a subcutaneous injection of inclisiran or placebo in either a single-ascending-dose phase (at a dose of 25, 100, 300, 500, or 800 mg) or a multiple-dose phase (125 mg weekly for four doses, 250 mg every other week for two doses, or 300 or 500 mg monthly for two doses, with or without concurrent statin therapy); each dose cohort included four to eight participants. Safety, the side-effect profile, and pharmacodynamic measures (PCSK9 level, LDL cholesterol level, and exploratory lipid variables) were evaluated. RESULTS The most common adverse events were cough, musculoskeletal pain, nasopharyngitis, headache, back pain, and diarrhea. All the adverse events were mild or moderate in severity. There were no serious adverse events or discontinuations due to adverse events. There was one grade 3 elevation in the.-glutamyltransferase level, which was considered by the investigator to be related to statin therapy. In the single-dose phase, inclisiran doses of 300 mg or more reduced the PCSK9 level (up to a least-squares mean reduction of 74.5% from baseline to day 84), and doses of 100 mg or more reduced the LDL cholesterol level (up to a least-squares mean reduction of 50.6% from baseline). Reductions in the levels of PCSK9 and LDL cholesterol were maintained at day 180 for doses of 300 mg or more. All multiple-dose regimens reduced the levels of PCSK9 (up to a least-squares mean reduction of 83.8% from baseline to day 84) and LDL cholesterol (up to a least-squares mean reduction of 59.7% from baseline to day 84). CONCLUSIONS In this phase 1 trial, no serious adverse events were observed with inclisiran. Doses of 300 mg or more (in single or multiple doses) significantly reduced levels of PCSK9 and LDL cholesterol for at least 6 months. (Funded by Alnylam Pharmaceuticals and the Medicines Company; ClinicalTrials.gov number, NCT02314442.)	[Fitzgerald, Kevin; White, Suellen; Borodovsky, Anna; Bettencourt, Brian R.; Strahs, Andrew; Clausen, Valerie; Kauffman, Robert S.; Vaishnaw, Akshay; Simon, Amy] Alnylam Pharmaceut, 300 Third St, Cambridge, MA 02142 USA; [Wijngaard, Peter; Kallend, David] Medicines Co, Parsippany, NJ USA; [Horton, Jay D.] Univ Texas Southwestern Med Ctr, Dallas, TX USA; [Taubel, Jorg] St Georges Univ London, Richmond Pharmacol, London, England; [Brooks, Ashley; Fernando, Chamikara] Covance Clin Res Unit, Leeds, W Yorkshire, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; St Georges University London	Fitzgerald, K (corresponding author), Alnylam Pharmaceut, 300 Third St, Cambridge, MA 02142 USA.	kfitzgerald@alnylam.com	Taubel, Jorg/I-1286-2019	Taubel, Jorg/0000-0002-0010-207X; Banerjee, Yajnavalka/0000-0002-7546-8893	Alnylam Pharmaceuticals; Medicines Company; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	Alnylam Pharmaceuticals; Medicines Company; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by Alnylam Pharmaceuticals and the Medicines Company.	Ballantyne CM, 2015, AM J CARDIOL, V115, P1212, DOI 10.1016/j.amjcard.2015.02.006; Barkas F, 2015, ANGIOLOGY, V66, P346, DOI 10.1177/0003319714535073; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; Egom EEA, 2016, ADV CLIN CHEM, V73, P127, DOI 10.1016/bs.acc.2015.10.005; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Henne KR, 2015, J PHARMACOL EXP THER, V353, P119, DOI 10.1124/jpet.114.221242; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Hooper AJ, 2013, EXPERT OPIN BIOL TH, V13, P429, DOI 10.1517/14712598.2012.748743; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Jameson K, 2014, CURR MED RES OPIN, V30, P655, DOI 10.1185/03007995.2014.890926; Jones PH, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001800; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Mousavi SA, 2009, J INTERN MED, V266, P507, DOI 10.1111/j.1365-2796.2009.02167.x; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Roth EM, 2014, INT J CARDIOL, V176, P55, DOI 10.1016/j.ijcard.2014.06.049; Rouleau J, 2005, AM J MED, V118, p28S, DOI 10.1016/j.amjmed.2005.09.014; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429; Zhang XL, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0358-8; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	27	402	419	7	126	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2017	376	1					41	51		10.1056/NEJMoa1609243	http://dx.doi.org/10.1056/NEJMoa1609243			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SS	27959715	Green Accepted			2022-12-28	WOS:000391177100007
J	Haussmann, IU; Bodi, Z; Sanchez-Moran, E; Mongan, NP; Archer, N; Fray, RG; Soller, M				Haussmann, Irmgard U.; Bodi, Zsuzsanna; Sanchez-Moran, Eugenio; Mongan, Nigel P.; Archer, Nathan; Fray, Rupert G.; Soller, Matthias			m(6)A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination	NATURE			English	Article							GENE; EXPRESSION; IDENTIFICATION; SPECIFICITY; METHYLASE; VIRILIZER; REVEALS; COMPLEX; PROTEIN	N-6-methyladenosine (m(6)A) is the most common internal modification of eukaryotic messenger RNA (mRNA) and is decoded by YTH domain proteins(1-7). The mammalian mRNA m(6)A methylosome is a complex of nuclear proteins that includes METTL3 (methyltransferase-like 3), METTL14, WTAP (Wilms tumour 1-associated protein) and KIAA1429. Drosophila has corresponding homologues named Ime4 and KAR4 (Inducer of meiosis 4 and Karyogamy protein 4), and Female-lethal (2) d (Fl(2) d) and Virilizer (Vir)(8-12). In Drosophila, fl(2) d and vir are required for sex-dependent regulation of alternative splicing of the sex determination factor Sex lethal (Sxl)(13). However, the functions of m(6)A in introns in the regulation of alternative splicing remain uncertain(3). Here we show that m6A is absent in the mRNA of Drosophila lacking Ime4. In contrast to mouse and plant knockout models(5,7,14), Drosophila Ime4-null mutants remain viable, though flightless, and show a sex bias towards maleness. This is because m6A is required for female-specific alternative splicing of Sxl, which determines female physiognomy, but also translationally represses male-specific lethal 2 (msl-2) to prevent dosage compensation in females. We further show that the m(6)A reader protein YT521-B decodes m(6)A in the sex-specifically spliced intron of Sxl, as its absence phenocopies Ime4 mutants. Loss of m(6)A also affects alternative splicing of additional genes, predominantly in the 5' untranslated region, and has global effects on the expression of metabolic genes. The requirement of m(6)A and its reader YT521-B for female-specific Sxl alternative splicing reveals that this hitherto enigmatic mRNA modification constitutes an ancient and specific mechanism to adjust levels of gene expression.	[Haussmann, Irmgard U.; Sanchez-Moran, Eugenio; Soller, Matthias] Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Haussmann, Irmgard U.] Coventry Univ, Sch Life Sci, Fac Hlth & Life Sci, Coventry CV1 5FB, W Midlands, England; [Bodi, Zsuzsanna; Archer, Nathan; Fray, Rupert G.] Univ Nottingham, Plant Sci Div, Sch Biosci, Loughborough LE12 5RD, Leics, England; [Mongan, Nigel P.] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England	University of Birmingham; Coventry University; University of Nottingham; University of Nottingham	Soller, M (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	m.soller@bham.ac.uk	Soller, Matthias/J-4844-2017; Fray, Rupert G/A-9059-2016; Archer, Nathan/T-7120-2019; Sanchez Moran, Eugenio/H-6356-2015	Soller, Matthias/0000-0003-3844-0258; Fray, Rupert G/0000-0002-3935-8945; Archer, Nathan/0000-0002-3356-6161; Haussmann, Irmgard/0000-0002-2764-694X; Sanchez Moran, Eugenio/0000-0002-7417-0024; Bodi, Zsuzsa/0000-0002-3219-9224; Mongan, Nigel/0000-0001-5438-1126	BBSRC [BB/M008606/1]; BBSRC [BB/M010066/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C513369/1, BB/M010066/1, 976176, BB/M008606/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Horabin, N. Perrimon and the Bloomington, Harvard and Kyoto stock centres for fly lines, BacPAc for DNA clones, E. Zaharieva and M. L. Li for help with imaging, W. Arlt and R. Michell for comments on the manuscript, and J.-Y. Roignant for communication of results before publication. We acknowledge funding from the BBSRC (BB/M008606/1) to R.F.	Bodi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132090; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Bokar JA, 1997, RNA, V3, P1233; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; HARPER JE, 1990, NUCLEIC ACIDS RES, V18, P5735, DOI 10.1093/nar/18.19.5735; Haussmann IU, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1938; Haussmann IU, 2011, GENETICS, V189, P97, DOI 10.1534/genetics.111.131383; Haussmann IU, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r73; Hilfiker A, 1995, DEVELOPMENT, V121, P4017; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Niessen M, 2001, GENETICS, V157, P679; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Penalva LOF, 2000, GENETICS, V155, P129; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salz HK, 2013, FLY, V7, DOI 10.4161/fly.22687; Schutt C, 2000, DEVELOPMENT, V127, P667; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; Soller M, 2005, MOL CELL BIOL, V25, P7580, DOI 10.1128/MCB.25.17.7580-7591.2005; Soller M, 2003, GENE DEV, V17, P2526, DOI 10.1101/gad.1106703; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Sturgill D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-320; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yan D, 2015, P NATL ACAD SCI USA, V112, P11606, DOI 10.1073/pnas.1515891112; Zaharieva E, 2015, MOL CELL BIOL, V35, P3104, DOI 10.1128/MCB.00473-15; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	42	336	362	10	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					301	+		10.1038/nature20577	http://dx.doi.org/10.1038/nature20577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27919081	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000389548700064
J	Potts, SG; Imperatriz-Fonseca, V; Ngo, HT; Aizen, MA; Biesmeijer, JC; Breeze, TD; Dicks, LV; Garibaldi, LA; Hill, R; Settele, J; Vanbergen, AJ				Potts, Simon G.; Imperatriz-Fonseca, Vera; Ngo, Hien T.; Aizen, Marcelo A.; Biesmeijer, Jacobus C.; Breeze, Thomas D.; Dicks, Lynn V.; Garibaldi, Lucas A.; Hill, Rosemary; Settele, Josef; Vanbergen, Adam J.			Safeguarding pollinators and their values to human well-being	NATURE			English	Review							WILD BEE ABUNDANCE; CLIMATE-CHANGE IMPACTS; PESTICIDE EXPOSURE; CROP YIELD; BUMBLE-BEE; BT COTTON; DECLINES; DIVERSITY; SERVICES; TRENDS	Wild and managed pollinators provide a wide range of benefits to society in terms of contributions to food security, farmer and beekeeper livelihoods, social and cultural values, as well as the maintenance of wider biodiversity and ecosystem stability. Pollinators face numerous threats, including changes in land-use and management intensity, climate change, pesticides and genetically modified crops, pollinator management and pathogens, and invasive alien species. There are well-documented declines in some wild and managed pollinators in several regions of the world. However, many effective policy and management responses can be implemented to safeguard pollinators and sustain pollination services.	[Potts, Simon G.; Breeze, Thomas D.] Univ Reading, Sch Agr Policy & Dev, Ctr Agri Environm Res, Reading RG6 6AR, Berks, England; [Imperatriz-Fonseca, Vera] S Paulo Univ, Biosci Inst, Dept Ecol, BR-05508090 Sao Paulo, Brazil; [Imperatriz-Fonseca, Vera] Vale Inst Technol Sustainable Dev, BR-66055090 Belem, Para, Brazil; [Ngo, Hien T.] IPBES Secretariat, Intergovt Sci Policy Platform Biodivers & Ecosyst, UN Campus,Pl Vereinten Nationen 1, D-53113 Bonn, Germany; [Aizen, Marcelo A.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, Quintral 1250, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Aizen, Marcelo A.] Univ Nacl Comahue, Ctr Reg Bariloche, Quintral 1250, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Biesmeijer, Jacobus C.] Nat Biodivers Ctr, POB 9517, NL-2300 RA Leiden, Netherlands; [Biesmeijer, Jacobus C.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, POB 94248, Amsterdam, Netherlands; [Dicks, Lynn V.] Univ East Anglia, Sch Biol Sci, Norwich NR4 7TL, Norfolk, England; [Garibaldi, Lucas A.] UNRN, Inst Invest Recursos Nat Agroecol & Desarrollo Ru, Sede Andina, Mitre 630, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Garibaldi, Lucas A.] Consejo Nacl Invest Cient & Tecn CONICET, Mitre 630, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Hill, Rosemary] CSIRO Land & Water, Box 12139, Cairns, Qld 4870, Australia; [Hill, Rosemary] James Cook Univ, Div Trop Environm & Soc, Box 12139, Cairns, Qld 4870, Australia; [Settele, Josef] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Theodor Lieser Str 4, D-06210 Halle, Germany; [Settele, Josef] German Ctr Integrat Biodivers Res iDiv, iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Vanbergen, Adam J.] NERC Ctr Ecol & Hydrol, Bush Estate, Edinburgh EH26 0QB, Midlothian, Scotland	University of Reading; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Nacional del Comahue; Naturalis Biodiversity Center; University of Amsterdam; University of East Anglia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); UK Centre for Ecology & Hydrology (UKCEH)	Potts, SG (corresponding author), Univ Reading, Sch Agr Policy & Dev, Ctr Agri Environm Res, Reading RG6 6AR, Berks, England.	s.g.potts@reading.ac.uk	Potts, Simon G/C-7250-2008; Potts, Simon/ABF-9221-2020; Breeze, Tom/ABC-6373-2021; Hill, Rosemary/A-6954-2011; Settele, Josef/A-6371-2009; Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; Garibaldi, Lucas A/D-7302-2013; Vanbergen, Adam J./I-6863-2012; Breeze, Tom/AAU-7068-2021; Dicks, Lynn V./AFH-5289-2022; Imperatriz-Fonseca, Vera Lucia/H-5582-2012	Potts, Simon G/0000-0002-2045-980X; Potts, Simon/0000-0002-2045-980X; Hill, Rosemary/0000-0002-7426-3132; Settele, Josef/0000-0002-8624-4983; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Vanbergen, Adam J./0000-0001-8320-5535; Breeze, Tom/0000-0002-8929-8354; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Biesmeijer, Koos/0000-0003-0328-0573; Dicks, Lynn/0000-0002-8304-4468; Garibaldi, Lucas Alejandro/0000-0003-0725-4049; Aizen, Marcelo/0000-0001-9079-9749	NERC [NE/K015419/1, NE/N014472/1, ceh020009] Funding Source: UKRI; Natural Environment Research Council [NE/K015419/1, ceh020009, NE/N014472/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Alteri MA, 2002, AGR ECOSYST ENVIRON, V93, P1, DOI 10.1016/S0167-8809(02)00085-3; Andersson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037411; Andow D.A., 2013, J BIOSAF, V22, P141; [Anonymous], 2014, CAMPBELL SYST REV, DOI [10.4073/CSR.2014.6, DOI 10.4073/CSR.2014.6]; Arias-Coyotl E, 2006, AM J BOT, V93, P1675, DOI 10.3732/ajb.93.11.1675; Ascher, 2014, DISCOVER LIFES BEE S; Aslan CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066993; Barfoot Peter, 2014, GM Crops Food, V5, P149, DOI 10.4161/gmcr.28449; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Barzman M, 2011, PEST MANAG SCI, V67, P1481, DOI 10.1002/ps.2283; Baude M, 2016, NATURE, V530, P85, DOI 10.1038/nature16532; Bauer DM, 2016, ECOL ECON, V126, P1, DOI 10.1016/j.ecolecon.2016.01.011; Berg A, 2013, INSECT CONSERV DIVER, V6, P639, DOI 10.1111/icad.12019; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blaauw BR, 2014, J APPL ECOL, V51, P890, DOI 10.1111/1365-2664.12257; Bohan DA, 2005, P ROY SOC B-BIOL SCI, V272, P463, DOI 10.1098/rspb.2004.3049; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Burton I, 2005, CLIMATIC CHANGE, V70, P191, DOI 10.1007/s10584-005-5942-z; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Carvell C, 2015, BASIC APPL ECOL, V16, P519, DOI 10.1016/j.baae.2015.05.006; Chaplin-Kramer R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1799; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Collison E, 2016, BIOL REV, V91, P1006, DOI 10.1111/brv.12206; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; Cross P, 2013, PEST MANAG SCI, V69, P768, DOI 10.1002/ps.3436; Dohzono I, 2010, APPL ENTOMOL ZOOL, V45, P37, DOI 10.1303/aez.2010.37; Ekstrom G., 2010, Outlooks on Pest Management, V21, P125, DOI 10.1564/21jun05; Ekstrom G, 2011, CRIT REV PLANT SCI, V30, P74, DOI 10.1080/07352689.2011.554354; Fischer D., 2014, PESTICIDE RISK ASSES; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Frimpong E.A., 2011, J POLLINATION ECOL, DOI [DOI 10.26786/1920-7603(2011)12, 10.26786/1920-7603%282011%2912, DOI 10.26786/1920-7603%282011%2912]; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gabriel D, 2007, AGR ECOSYST ENVIRON, V118, P43, DOI 10.1016/j.agee.2006.04.005; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2016, SCIENCE, V351, P388, DOI 10.1126/science.aac7287; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Gavin MC, 2015, TRENDS ECOL EVOL, V30, P140, DOI 10.1016/j.tree.2014.12.005; Giannini TC, 2013, AGR ECOSYST ENVIRON, V171, P39, DOI 10.1016/j.agee.2013.03.003; Gill RJ, 2016, ADV ECOL RES, V54, P135, DOI 10.1016/bs.aecr.2015.10.007; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; GODFRAY HCJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI DOI 10.1098/RSPB.2015.1821; Gomez-Baggethun Erik, 2013, Hum Ecol Interdiscip J, V41, DOI 10.1007/s10745-013-9577-9; Gupta R. K., 2014, BEEKEEPING POVERTY A, V1; Hanley N, 2015, ECOSYST SERV, V14, P124, DOI 10.1016/j.ecoser.2014.09.013; Hanna C, 2013, J APPL ECOL, V50, P147, DOI 10.1111/1365-2664.12027; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Hilmi M., 2011, BEEKEEPING SUSTAINAB; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; IPBES, 2016, SUMMARY POLICYMAKERS; Johansen E., 2013, REDUCE BEE POISONING; Jonsson AM, 2015, BIOL CONSERV, V184, P51, DOI 10.1016/j.biocon.2014.12.027; Jull AB, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005083.pub4; Junge X, 2015, LANDSCAPE URBAN PLAN, V133, P67, DOI 10.1016/j.landurbplan.2014.09.010; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koh I, 2016, P NATL ACAD SCI USA, V113, P140, DOI 10.1073/pnas.1517685113; Kormann U, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2347; Kremen C, 2012, ECOL SOC, V17, DOI 10.5751/ES-05103-170444; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; Lopes AV, 2009, BIOL CONSERV, V142, P1154, DOI 10.1016/j.biocon.2009.01.007; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lyver P., 2014, IND LOC KNOWL POLL P; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Mommaerts V, 2010, PEST MANAG SCI, V66, P520, DOI 10.1002/ps.1902; Morales CL, 2013, FRONT ECOL ENVIRON, V11, P529, DOI 10.1890/120321; Morandin LA, 2005, ECOL APPL, V15, P871, DOI 10.1890/03-5271; Moritz RFA, 2005, ECOSCIENCE, V12, P289, DOI 10.2980/i1195-6860-12-3-289.1; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nieto A., 2014, EUROPEAN RED LIST BE; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Padoch C, 2010, BIOTROPICA, V42, P550, DOI 10.1111/j.1744-7429.2010.00681.x; Park MG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0299; Pauw A, 2011, OIKOS, V120, P344, DOI 10.1111/j.1600-0706.2010.19039.x; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Polce C, 2014, GLOBAL CHANGE BIOL, V20, P2815, DOI 10.1111/gcb.12577; Ponisio LC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1396; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Pywell RF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1740; Quezada-Euan JJG, 2001, BEE WORLD, V82, P160, DOI 10.1080/0005772X.2001.11099523; Rehel S., 2009, CONSERV SOC, V7, P213, DOI DOI 10.4103/0972-4923.64732; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Saez A, 2014, J APPL ECOL, V51, P1603, DOI 10.1111/1365-2664.12325; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; Schnell M, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4499, 10.1038/ncomms5151]; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Senapathi D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0294; Settele J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.92, 10.1038/nplants.2016.92]; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271; Smith MR, 2015, LANCET, V386, P1964, DOI 10.1016/S0140-6736(15)61085-6; Stanley DA, 2015, NATURE, V528, P548, DOI 10.1038/nature16167; Steward PR., 2014, AGR FOOD SECURITY, V3, P1, DOI DOI 10.1186/2048-7010-3-5; Tehel A, 2016, CURR OPIN VIROL, V19, P16, DOI 10.1016/j.coviro.2016.06.006; The World Bank, 2015, AGR RUR DEV; Traveset A, 2014, ANNU REV ECOL EVOL S, V45, P89, DOI 10.1146/annurev-ecolsys-120213-091857; Tuck SL, 2014, J APPL ECOL, V51, P746, DOI 10.1111/1365-2664.12219; van der Ploeg JD, 2014, J PEASANT STUD, V41, P999, DOI 10.1080/03066150.2013.876997; van der Sluijs JP, 2015, ENVIRON SCI POLLUT R, V22, P148, DOI 10.1007/s11356-014-3229-5; Van Geert A, 2010, J ECOL, V98, P178, DOI 10.1111/j.1365-2745.2009.01600.x; van Swaay Chris, 2010, pi; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Woodcock BA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12459; Zizumbo-Villarreal D, 2013, GENET RESOUR CROP EV, V60, P33, DOI 10.1007/s10722-012-9812-z	119	761	799	76	1057	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					220	229		10.1038/nature20588	http://dx.doi.org/10.1038/nature20588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27894123	Green Accepted, Green Published			2022-12-28	WOS:000389548700048
J	Melvin, L; Cavalcanti, RB				Melvin, Lindsay; Cavalcanti, Rodrigo B.			The Oral Case Presentation A Key Tool for Assessment and Teaching in Competency-Based Medical Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Melvin, Lindsay] Univ Toronto, Wilson Ctr, Toronto, ON, Canada; [Melvin, Lindsay; Cavalcanti, Rodrigo B.] Univ Hlth Network, HoPingKong Ctr, Toronto, ON, Canada; [Cavalcanti, Rodrigo B.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Cavalcanti, RB (corresponding author), Toronto Western Hosp, Univ Hlth Network, HoPingKong Ctr, UHN-8E420,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	rodrigo.cavalcanti@uhn.ca		Cavalcanti, Rodrigo B/0000-0001-8980-159X				Bordage G, 1999, ACAD MED, V74, pS138, DOI 10.1097/00001888-199910000-00065; Green EH, 2011, TEACH LEARN MED, V23, P58, DOI 10.1080/10401334.2011.536894; Harber RJ, 2001, J GEN INTERN MED, V16, P308, DOI 10.1046/j.1525-1497.2001.00233.x; Hauer KE, 2014, ADV HEALTH SCI EDUC, V19, P435, DOI 10.1007/s10459-013-9474-4; Lingard L, 2003, MED EDUC, V37, P612, DOI 10.1046/j.1365-2923.2003.01553.x; Lingard LA, 1999, ACAD MED, V74, pS124, DOI 10.1097/00001888-199910000-00061; Sklar DP, 2015, ACAD MED, V90, P395, DOI 10.1097/ACM.0000000000000659; Sox CM, 2014, PEDIATRICS, V134, P965, DOI 10.1542/peds.2014-1209	8	19	19	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2016	316	21					2187	2188		10.1001/jama.2016.16415	http://dx.doi.org/10.1001/jama.2016.16415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YV	27923097				2022-12-28	WOS:000389307400001
J	Emonts, BHC; Lehnert, MD; Villar-Martin, M; Norris, RP; Ekers, RD; van Moorsel, GA; Dannerbauer, H; Pentericci, L; Miley, GK; Allison, JR; Sadler, EM; Guillard, P; Carilli, CL; Mao, MY; Rottgering, HJA; De Breuck, C; Seymour, N; Gullberg, B; Ceverino, D; Jagannathan, P; Vernet, J; Indermuehle, BT				Emonts, B. H. C.; Lehnert, M. D.; Villar-Martin, M.; Norris, R. P.; Ekers, R. D.; van Moorsel, G. A.; Dannerbauer, H.; Pentericci, L.; Miley, G. K.; Allison, J. R.; Sadler, E. M.; Guillard, P.; Carilli, C. L.; Mao, M. Y.; Rottgering, H. J. A.; De Breuck, C.; Seymour, N.; Gullberg, B.; Ceverino, D.; Jagannathan, P.; Vernet, J.; Indermuehle, B. T.			Molecular gas in the halo fuels the growth of a massive cluster galaxy at high redshift	SCIENCE			English	Article							SIMILAR-TO 2; STAR-FORMATION; SPIDERWEB GALAXY; ELLIPTIC GALAXIES; PROTO-CLUSTER; BILLION YEARS; STARBURSTS; FEEDBACK	The largest galaxies in the universe reside in galaxy clusters. Using sensitive observations of carbon monoxide, we show that the Spiderweb galaxy-a massive galaxy in a distant protocluster-is forming from a large reservoir of molecular gas. Most of this molecular gas lies between the protocluster galaxies and has low velocity dispersion, indicating that it is part of an enriched intergalactic medium. This may constitute the reservoir of gas that fuels the widespread star formation seen in earlier ultraviolet observations of the Spiderweb galaxy. Our results support the notion that giant galaxies in clusters formed from extended regions of recycled gas at high redshift.	[Emonts, B. H. C.; Villar-Martin, M.; Ceverino, D.] CSIC, Inst Nacl Tecn Aerosp, Ctr Astrobiol, Carretera Torrejon Ajalvir,Km 4, Madrid 28850, Spain; [Lehnert, M. D.; Guillard, P.] Univ Paris 06, Univ Pierre & Marie Curie, Sorbonne Univ, F-75014 Paris, France; [Lehnert, M. D.; Guillard, P.] CNRS, Unite Mixte Rech 7095, Inst Astrophys Paris, F-75014 Paris, France; [Villar-Martin, M.] Astrouniv Autonoma Madrid, Fac Ciencias, Unidad Asociada, CSIC, Campus Cantoblanco, Madrid 28049, Spain; [Norris, R. P.; Ekers, R. D.; Allison, J. R.; Indermuehle, B. T.] CSIRO, Astron & Space Sci, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Norris, R. P.] Univ Western Sydney, Penrith, NSW 1797, Australia; [van Moorsel, G. A.; Jagannathan, P.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Dannerbauer, H.] Inst Astrofis Canarias, E-38205 Tenerife, Spain; [Dannerbauer, H.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [van Moorsel, G. A.] Univ Vienna, Inst Astrophys, A-1180 Vienna, Austria; [Pentericci, L.] Osserv Astron Roma, Ist Nazl Astrofis, I-00040 Monte Porzio Catone, RM, Italy; [Miley, G. K.; Rottgering, H. J. A.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Sadler, E. M.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Carilli, C. L.] Cavendish Lab, Cambridge CB3 0HE, England; [Mao, M. Y.] European Res Infrastruct Consortium, Joint Inst Very Long Baseline Interferometry, NL-7990 AA Dwingeloo, Netherlands; [Mao, M. Y.] Univ Manchester, Jodrell Bank Observ, Macclesfield SK11 9DL, Cheshire, England; [De Breuck, C.; Vernet, J.] European Southern Observ, D-85748 Garching, Germany; [Seymour, N.] Curtin Univ, Int Ctr Radio Astron Res, Perth, WA, Australia; [Gullberg, B.] Univ Durham, Dept Phys, Ctr Extragalact Astron, Durham DH1 3LE, England; [Ceverino, D.] Heidelberg Univ, Zentrum Astron, Inst Theoret Astrophys, D-69120 Heidelberg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Sydney University; National Radio Astronomy Observatory (NRAO); Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Vienna; Istituto Nazionale Astrofisica (INAF); Leiden University; Leiden University - Excl LUMC; University of Sydney; University of Cambridge; University of Manchester; Jodrell Bank Centre for Astrophysics; European Southern Observatory; Curtin University; Durham University; Ruprecht Karls University Heidelberg	Emonts, BHC (corresponding author), CSIC, Inst Nacl Tecn Aerosp, Ctr Astrobiol, Carretera Torrejon Ajalvir,Km 4, Madrid 28850, Spain.	bjornemonts@gmail.com	Jagannathan, Preshanth/HHN-7171-2022; Sadler, Elaine M/A-5720-2008; Indermuehle, Balthasar/AAB-3527-2022; Seymour, Nicholas/M-4698-2017; Martin, Montserrat Villar/C-3126-2017; Ekers, Ron/AAY-6012-2020; Norris, Ray/A-1316-2008	Jagannathan, Preshanth/0000-0002-5825-9635; Sadler, Elaine M/0000-0002-1136-2555; Indermuehle, Balthasar/0000-0003-1479-7949; Seymour, Nicholas/0000-0003-3506-5536; Martin, Montserrat Villar/0000-0003-2566-2126; Ekers, Ron/0000-0002-3532-9928; Norris, Ray/0000-0002-4597-1906; Gullberg, Bitten/0000-0002-4671-3036; Vernet, Joel/0000-0002-8639-8560; Lehnert, Matthew/0000-0003-1939-5885; Allison, James/0000-0003-0436-4680	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 [624351]; Spanish Ministerio de Economia y Competitividad (MINECO) [AYA2012-32295]; MINECO under Ramon y Cajal program [RYC-2014-15686]; European Community [H2020-MSCA-IF-2014 660432]; European Research Council [DUSTYGAL 321334, STARLIGHT 33177]; Commonwealth of Australia	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7; Spanish Ministerio de Economia y Competitividad (MINECO); MINECO under Ramon y Cajal program; European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); Commonwealth of Australia(Australian Government)	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA grant agreement 624351. We thank L. Colina and S. Arribas for useful discussions. Supported by Spanish Ministerio de Economia y Competitividad (MINECO) grant AYA2012-32295 (B.H.C.E. and M.V.-M.), MINECO under Ramon y Cajal program RYC-2014-15686 (H.D.), European Community grant H2020-MSCA-IF-2014 660432 (M.Y.M.), and European Research Council advanced grants DUSTYGAL 321334 and STARLIGHT 33177 (B.G. and D.C.). The Australia Telescope is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities Inc. The data reported in this paper are tabulated in the supplementary materials and archived at http://atoa.atnf.csiro.au under project codes C2052 and C2717 (ATCA) and at https://archive.nrao.edu/archive/advquery.jsp under project code 14B-160 (VLA).	Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Collins CA, 2009, NATURE, V458, P603, DOI 10.1038/nature07865; Daddi E, 2010, ASTROPHYS J LETT, V714, pL118, DOI 10.1088/2041-8205/714/1/L118; Dannerbauer H, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201423771; De Lucia G, 2006, MON NOT R ASTRON SOC, V366, P499, DOI 10.1111/j.1365-2966.2005.09879.x; Emonts BHC, 2013, MON NOT R ASTRON SOC, V430, P3465, DOI 10.1093/mnras/stt147; Genzel R, 2010, MON NOT R ASTRON SOC, V407, P2091, DOI 10.1111/j.1365-2966.2010.16969.x; Gullberg B, 2016, ASTRON ASTROPHYS, V591, DOI 10.1051/0004-6361/201527647; Hatch NA, 2008, MON NOT R ASTRON SOC, V383, P931, DOI 10.1111/j.1365-2966.2007.12626.x; Hatch NA, 2009, MON NOT R ASTRON SOC, V395, P114, DOI 10.1111/j.1365-2966.2009.14525.x; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Kirkpatrick CC, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/2/L23; Koyama Y, 2013, MON NOT R ASTRON SOC, V428, P1551, DOI 10.1093/mnras/sts133; Kuiper E, 2011, MON NOT R ASTRON SOC, V415, P2245, DOI 10.1111/j.1365-2966.2011.18852.x; Li Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/54; Lidman C, 2012, MON NOT R ASTRON SOC, V427, P550, DOI 10.1111/j.1365-2966.2012.21984.x; Miley GK, 2006, ASTROPHYS J, V650, pL29, DOI 10.1086/508534; Narayanan D, 2015, NATURE, V525, P496, DOI 10.1038/nature15383; Oser L, 2010, ASTROPHYS J, V725, P2312, DOI 10.1088/0004-637X/725/2/2312; Pentericci L, 1997, ASTRON ASTROPHYS, V326, P580; Prochaska JX, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/140; Stevens JA, 2003, NATURE, V425, P264, DOI 10.1038/nature01976; Voit GM, 2015, NATURE, V519, P203, DOI 10.1038/nature14167	23	50	50	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1128	1130		10.1126/science.aag0512	http://dx.doi.org/10.1126/science.aag0512			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934760	Green Submitted			2022-12-28	WOS:000388916400037
J	Kaiser, J; Mervis, J; Servick, K				Kaiser, Jocelyn; Mervis, Jeffrey; Servick, Kelly			US POLICY Congress votes on sweeping biomedical bill	SCIENCE			English	News Item																			0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1085	1086		10.1126/science.354.6316.1085	http://dx.doi.org/10.1126/science.354.6316.1085			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934712				2022-12-28	WOS:000388916400010
J	Pin, JP; Bettler, B				Pin, Jean-Philippe; Bettler, Bernhard			Organization and functions of mGlu and GABA(B) receptor complexes	NATURE			English	Review							METABOTROPIC GLUTAMATE RECEPTORS; LIGAND-INDUCED REARRANGEMENT; PROTEIN-COUPLED RECEPTOR; ALLOSTERIC MODULATORS; HEPTAHELICAL DOMAIN; CONFORMATIONAL DYNAMICS; SUSHI DOMAINS; ACTIVATION; BINDING; PHOSPHORYLATION	The neurotransmitters glutamate and gamma-aminobutyric acid (GABA) transmit synaptic signals by activating fast-acting ligand-gated ion channels and more slowly acting G-protein-coupled receptors (GPCRs). The GPCRs for these neurotransmitters, metabotropic glutamate (mGlu) and GABA(B) receptors, are atypical GPCRs with a large extracellular domain and a mandatory dimeric structure. Recent studies have revealed how these receptors are activated through multiple allosteric interactions between subunit domains. It emerges that the molecular complexity of these receptors is further increased through association with trafficking, effector and regulatory proteins. The structure and composition of these receptors present opportunities for therapeutic intervention in mental health and neurological disorders.	[Pin, Jean-Philippe] Univ Montpellier, Inst Gonom Fonct, UMR 5203, CNRS, F-34094 Montpellier, France; [Pin, Jean-Philippe] INSERM, U1191, F-34094 Montpellier, France; [Bettler, Bernhard] Univ Basel, Pharmazentrum, Dept Biomed, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Basel	Pin, JP (corresponding author), Univ Montpellier, Inst Gonom Fonct, UMR 5203, CNRS, F-34094 Montpellier, France.; Pin, JP (corresponding author), INSERM, U1191, F-34094 Montpellier, France.	jppin@igf.cnrs.fr; bernhard.bettler@unibas.ch	Pin, Jean-Philippe/Y-6668-2019; bettler, bernhard/AAO-8018-2020	Pin, Jean-Philippe/0000-0002-1423-345X; Bettler, Bernhard/0000-0003-0842-8207	Swiss Science Foundation [3100A0-117816]; National Center for Competences in Research (NCCR); Agence National de la Recherche [ANR-12-BSV2-0015, ANR-13-RPIB-0009]; Fondation Recherche Medicale [FRM DEQ20130326522]; Fondation Bettencourt Schueller; Fond Unique Interministeriel of the French government (FUI)	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); National Center for Competences in Research (NCCR); Agence National de la Recherche(French National Research Agency (ANR)); Fondation Recherche Medicale; Fondation Bettencourt Schueller; Fond Unique Interministeriel of the French government (FUI)	We thank M. Gassmann, J. Kniazeff and X. Rovira for discussions and help with the figures. This work was supported by grants of the Swiss Science Foundation (3100A0-117816) the National Center for Competences in Research (NCCR) 'Synapsy, Synaptic Basis of Mental Health Disease' to B.B., and by grants from the Agence National de la Recherche (ANR-12-BSV2-0015; ANR-13-RPIB-0009), the Fondation Recherche Medicale (FRM DEQ20130326522), the Fondation Bettencourt Schueller, and the Fond Unique Interministeriel of the French government (FUI, Cell2Lead project) to J.-P.P.	Akgun Eyup, 2013, Proc Natl Acad Sci U S A, V110, P11595, DOI 10.1073/pnas.1305461110; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Beggiato S, 2016, J NEUROCHEM, V138, P254, DOI 10.1111/jnc.13652; Benke D, 2013, BIOCHEM PHARMACOL, V86, P1525, DOI 10.1016/j.bcp.2013.09.016; Bennett KA, 2015, CURR OPIN PHARMACOL, V20, P1, DOI 10.1016/j.coph.2014.09.022; Bessis AS, 2002, P NATL ACAD SCI USA, V99, P11097, DOI 10.1073/pnas.162138699; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Burmakina S, 2014, P NATL ACAD SCI USA, V111, P6958, DOI 10.1073/pnas.1400081111; Cabello N, 2009, J NEUROCHEM, V109, P1497, DOI 10.1111/j.1471-4159.2009.06078.x; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Chen Y, 2008, MOL PHARMACOL, V73, P909, DOI 10.1124/mol.107.040097; Choi KY, 2011, J NEUROSCI, V31, P5921, DOI 10.1523/JNEUROSCI.6253-10.2011; Christopher JA, 2015, J MED CHEM, V58, P6653, DOI 10.1021/acs.jmedchem.5b00892; Comps-Agrar L, 2012, FASEB J, V26, P3430, DOI 10.1096/fj.12-203646; Comps-Agrar L, 2011, EMBO J, V30, P2336, DOI 10.1038/emboj.2011.143; Doly S, 2016, MOL PSYCHIATR, V21, P480, DOI 10.1038/mp.2015.72; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Enz R, 2012, CURR DRUG TARGETS, V13, P145, DOI 10.2174/138945012798868452; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Ferraguti F, 2005, J NEUROSCI, V25, P10520, DOI 10.1523/JNEUROSCI.2547-05.2005; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Froestl W, 2010, ADV PHARMACOL, V58, P19, DOI 10.1016/S1054-3589(10)58002-5; Gaillard S, 2014, NEURON, V84, P123, DOI 10.1016/j.neuron.2014.08.056; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Gavalas A, 2013, MOL PHARMACOL, V84, P346, DOI 10.1124/mol.113.086868; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; Geng Y, 2012, NAT NEUROSCI, V15, P970, DOI 10.1038/nn.3133; Gentry PR, 2015, J BIOL CHEM, V290, P19478, DOI 10.1074/jbc.R115.662759; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Hanack C, 2015, CELL, V160, P759, DOI 10.1016/j.cell.2015.01.022; Hannan S, 2016, CELL REP, V16, P1962, DOI 10.1016/j.celrep.2016.07.021; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Hlavackova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002720; Hu JH, 2012, NAT NEUROSCI, V15, P836, DOI 10.1038/nn.3103; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Iacovelli L, 2013, NEUROPHARMACOLOGY, V66, P24, DOI 10.1016/j.neuropharm.2012.05.005; Jain A, 2016, HAND CLINIC, V133, P77, DOI 10.1016/B978-0-444-63432-0.00005-0; Kantamneni S, 2007, J NEUROCHEM, V100, P1003, DOI 10.1111/j.1471-4159.2006.04271.x; Kenakin T, 2015, MOL PHARMACOL, V88, P1055, DOI 10.1124/mol.115.099770; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Ko SJ, 2012, J NEUROSCI, V32, P16391, DOI 10.1523/JNEUROSCI.1964-12.2012; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Laffray S, 2012, EMBO J, V31, P3239, DOI 10.1038/emboj.2012.161; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lowder MA, 2011, CURR OPIN CHEM BIOL, V15, P781, DOI 10.1016/j.cbpa.2011.10.024; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Lujan R, 2012, CURR DRUG TARGETS, V13, P129, DOI 10.2174/138945012798868425; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nickols HH, 2014, NEUROBIOL DIS, V61, P55, DOI 10.1016/j.nbd.2013.09.013; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Olofsson L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6206; Pandya NJ, 2016, PROTEOMICS, V16, P2698, DOI 10.1002/pmic.201500400; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Rajalu M, 2015, NEUROPHARMACOLOGY, V88, P145, DOI 10.1016/j.neuropharm.2014.08.020; Rodriguez AL, 2005, MOL PHARMACOL, V68, P1793, DOI 10.1124/mol.105.016139; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Rook JM, 2015, NEURON, V86, P1029, DOI 10.1016/j.neuron.2015.03.063; Rovira X, 2015, FASEB J, V29, P116, DOI 10.1096/fj.14-257287; Schwenk J, 2016, NAT NEUROSCI, V19, P233, DOI 10.1038/nn.4198; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun B, 2016, BIOCHEM J, V473, P779, DOI 10.1042/BJ20150979; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Tiao JY, 2008, J BIOL CHEM, V283, P31005, DOI 10.1074/jbc.M804464200; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Turecek R, 2014, NEURON, V82, P1032, DOI 10.1016/j.neuron.2014.04.015; Vafabakhsh R, 2015, NATURE, V524, P497, DOI 10.1038/nature14679; Valdes V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044168; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vertkin I, 2015, P NATL ACAD SCI USA, V112, pE3291, DOI 10.1073/pnas.1424810112; Workman ER, 2015, MOL PSYCHIATR, V20, P298, DOI 10.1038/mp.2014.165; Wright SR, 2016, ADDICT BIOL, V21, P811, DOI 10.1111/adb.12259; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Xue L, 2015, NAT CHEM BIOL, V11, P134, DOI [10.1038/nchembio.1711, 10.1038/NCHEMBIO.1711]; Yin S, 2014, J NEUROSCI, V34, P79, DOI 10.1523/JNEUROSCI.1129-13.2014	99	139	141	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					60	68		10.1038/nature20566	http://dx.doi.org/10.1038/nature20566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905440				2022-12-28	WOS:000388916600048
J	Stewart, DE; Vigod, S				Stewart, Donna E.; Vigod, Simone			Postpartum Depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MENTAL-DISORDERS; POSTNATAL DEPRESSION; SERUM CONCENTRATIONS; RISK-FACTORS; ANTIDEPRESSANTS; PREGNANCY; MIRTAZAPINE; MANAGEMENT; WOMEN	A 28-year-old single mother of a 3-month-old son reports severe fatigue, general loss of interest, irritability, poor concentration, insomnia, low energy, and tearfulness that have lasted for 2 months. She had similar symptoms for several weeks when she was 18 years of age and again in mid-pregnancy, but her symptoms resolved spontaneously on those occasions. She is not suicidal or psychotic but feels that she cannot cope. What would you advise?	[Stewart, Donna E.] Univ Hlth Network, Ctr Mental Hlth, Toronto, ON, Canada; [Stewart, Donna E.] Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Vigod, Simone] Womens Mental Hlth Program, Reprod Life Stages Program, Toronto, ON, Canada; [Vigod, Simone] Womens Coll Hosp & Res Inst, Toronto, ON, Canada; [Stewart, Donna E.; Vigod, Simone] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto	Stewart, DE (corresponding author), Univ Toronto, Univ Hlth Network, Ctr Mental Hlth, Toronto Gen Hosp,Res Inst, 200 Elizabeth St,EN 7-229, Toronto, ON M5G 2C4, Canada.	donna.stewart@uhn.ca	Stewart, Donna Eileen E/J-2844-2016	Stewart, Donna Eileen E/0000-0002-8157-7746; Vigod, Simone/0000-0002-2736-9639	Eli Lilly	Eli Lilly(Eli Lilly)	Dr. Stewart reports receiving fees from Eli Lilly for serving on a scientific advisory committee for oversight of a duloxetine pregnancy registry. No other potential conflict of interest relevant to this article was reported.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2010, PRACTICE GUIDELINE T; [Anonymous], 2015, Obstet Gynecol, V125, P1268, DOI 10.1097/01.AOG.0000465192.34779.dc; [Anonymous], 2011, CLIN PRACT GUID DEPR; [Anonymous], 2014, ANT POSTN MENT HEALT; Ashford MT, 2016, J AFFECT DISORDERS, V197, P134, DOI 10.1016/j.jad.2016.02.057; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Bosanquet K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008913; Byatt N, 2015, OBSTET GYNECOL, V126, P1048, DOI 10.1097/AOG.0000000000001067; Couto TCE, 2015, WORLD J PSYCHIATR, V5, P103, DOI 10.5498/wjp.v5.i1.103; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Deligiannidis KM, 2014, BEST PRACT RES CL OB, V28, P85, DOI 10.1016/j.bpobgyn.2013.08.007; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; Dennis Cindy-Lee, 2013, Cochrane Database Syst Rev, pCD001134, DOI 10.1002/14651858.CD001134.pub3; Dennis CL, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001690.pub2; Earls MF, 2010, PEDIATRICS, V126, P1032, DOI 10.1542/peds.2010-2348; Esscher A, 2016, BRIT J PSYCHIAT, V208, P462, DOI 10.1192/bjp.bp.114.161711; Food and Drug Administration, 2008, REV 3 PHARM STUD AD; Gaynes B N, 2005, Evid Rep Technol Assess (Summ), P1; Gentile S, 2007, DRUG SAFETY, V30, P107, DOI 10.2165/00002018-200730020-00002; Gentile S, 2014, EXPERT OPIN DRUG SAF, V13, P207, DOI 10.1517/14740338.2014.869582; Goodman JH, 2004, JOGNN-J OBST GYN NEO, V33, P410, DOI 10.1177/0884217504266915; Guintivano J, 2014, MOL PSYCHIATR, V19, P560, DOI 10.1038/mp.2013.62; Hempel G, 2004, HANDB ANALYT SEPARAT, V5, P169; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lam RW, 2016, CAN J PSYCHIAT, V61, P506, DOI 10.1177/0706743716659061; Lam RW, 2013, BRIT J PSYCHIAT, V203, P358, DOI 10.1192/bjp.bp.112.125237; Lindahl V, 2005, ARCH WOMEN MENT HLTH, V8, P77, DOI 10.1007/s00737-005-0080-1; Mehta D, 2014, PSYCHOL MED, V44, P2309, DOI 10.1017/S0033291713003231; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Molyneaux E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002018.pub2; Munk-Olsen T, 2006, JAMA-J AM MED ASSOC, V296, P2582, DOI 10.1001/jama.296.21.2582; Myczkowski ML, 2012, NEUROPSYCH DIS TREAT, V8, P491, DOI 10.2147/NDT.S33851; Myers ER, 2013, AHRQ PUBLICATION, V13-EHC064-EF; Norhayati MN, 2015, J AFFECT DISORDERS, V175, P34, DOI 10.1016/j.jad.2014.12.041; Orsolini L, 2015, HUM PSYCHOPHARM CLIN, V30, P4, DOI 10.1002/hup.2451; Paulson JF, 2010, JAMA-J AM MED ASSOC, V303, P1961, DOI 10.1001/jama.2010.605; Putnam K, 2015, LANCET PSYCHIAT, V2, P59, DOI 10.1016/S2215-0366(14)00055-8; Scottish Intercollegiate Guidelines Network (SIGN), 2012, SIGN 127 MAN PER MO; Sigurdsson HP, 2015, J NEURAL TRANSM, V122, P721, DOI 10.1007/s00702-014-1317-9; Sirot EJ, 2012, J CLIN PSYCHOPHARM, V32, P622, DOI 10.1097/JCP.0b013e3182664d98; Smit M, 2016, EUR NEUROPSYCHOPHARM, V26, P126, DOI 10.1016/j.euroneuro.2015.06.014; Sriraman NK, 2015, BREASTFEED MED, V10, P290, DOI 10.1089/bfm.2015.29002; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Waldschmitt C, 2009, PHARMACOPSYCHIATRY, V42, P189, DOI 10.1055/s-0029-1220890; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87; Wisner KL, 2010, ARCH WOMEN MENT HLTH, V13, P37, DOI 10.1007/s00737-009-0119-9; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; Yazici E, 2015, NEUROPSYCH DIS TREAT, V11, P405, DOI 10.2147/NDT.S77194	51	177	193	3	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					2177	2186		10.1056/NEJMcp1607649	http://dx.doi.org/10.1056/NEJMcp1607649			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED7GN	27959754				2022-12-28	WOS:000389030400009
J	Saccone, G				Saccone, Gabriele			Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomised controlled trials (vol 355, i5044, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Saccone G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5044	1	2	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2016	355								i6416	10.1136/bmj.i6416	http://dx.doi.org/10.1136/bmj.i6416			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZA	27899362	Green Published			2022-12-28	WOS:000389308200004
J	Natsume, O; Kabashima, S; Nakazato, J; Yamamoto-Hanada, K; Narita, M; Kondo, M; Saito, M; Kishino, A; Takimoto, T; Inoue, E; Tang, JL; Kido, H; Wong, GWK; Matsumoto, K; Saito, H; Ohya, Y				Natsume, Osamu; Kabashima, Shigenori; Nakazato, Junko; Yamamoto-Hanada, Kiwako; Narita, Masami; Kondo, Mai; Saito, Mayako; Kishino, Ai; Takimoto, Tetsuya; Inoue, Eisuke; Tang, Julian; Kido, Hiroshi; Wong, Gary W. K.; Matsumoto, Kenji; Saito, Hirohisa; Ohya, Yukihiro		PETIT Study Team	Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							FOOD ALLERGY; ATOPIC-DERMATITIS; SENSITIZATION; CONSUMPTION; CHILDHOOD; SEVERITY; EXPOSURE; LIFE	Background Evidence is accumulating that early consumption is more beneficial than is delayed introduction as a strategy for primary prevention of food allergy. However, allergic reactions caused by early introduction of such solid foods have been a problematic issue. We investigated whether or not early stepwise introduction of eggs to infants with eczema combined with optimal eczema treatment would prevent egg allergy at 1 year of age. Methods In this randomised, double-blind, placebo-controlled trial, we enrolled infants 4-5 months of age with eczema from two centres in Japan. Exclusion criteria were being born before 37 weeks of gestational age, experience of ingestion of hen's eggs or egg products, history of immediate allergic reaction to hen's eggs, history of non-immediate allergic reaction to a particular type of food, and complications of any severe disease. Infants were randomly assigned (block size of four; stratified by institution and sex) to early introduction of egg or placebo (1:1). Participants in the egg group consumed orally 50 mg of heated egg powder per day from 6 months to 9 months of age and 250 mg per day thereafter until 12 months of age. We aggressively treated participants' eczema at entry and maintained control without exacerbations throughout the intervention period. Participants and physicians were masked to assignment, and allocation was concealed. The primary outcome was the proportion of participants with hen's egg allergy confirmed by open oral food challenges at 12 months of age, assessed blindly by standardised methods, in all randomly allocated participants who received the intervention. This trial is registered with the University Hospital Medical Information Network Clinical Trials Registry, number UMIN000008673. Findings Between Sept 18, 2012, and Feb 13, 2015, we randomly allocated 147 participants (73 [50%] to the egg group and 74 [50%] to the placebo group). This trial was terminated on the basis of the results of the scheduled interim analysis of 100 participants, which showed a significant difference between the two groups (four [9%] of 47 participants had an egg allergy in the egg group vs 18 [38%] of 47 in the placebo group; risk ratio 0.222 [95% CI 0.081-0.607]; p=0.0012). In the primary analysis population, five (8%) of 60 participants had an egg allergy in the egg group compared with 23 (38%) of 61 in the placebo group (risk ratio 0.221 [0.090-0.543]; p=0.0001). The only difference in adverse events between groups was admissions to hospital (six [10%] of 60 in the egg group vs none in the placebo group; p=0.022). 19 acute events occurred in nine (15%) participants in the egg group versus 14 events in 11 (18%) participants in the placebo group after intake of the trial powder. Interpretation Introduction of heated egg in a stepwise manner along with aggressive eczema treatment is a safe and efficacious way to prevent hen's egg allergy in high-risk infants. In this study, we developed a practical approach to overcome the second wave of the allergic epidemic caused by food allergy.	[Natsume, Osamu; Kabashima, Shigenori; Nakazato, Junko; Yamamoto-Hanada, Kiwako; Narita, Masami; Kondo, Mai; Saito, Mayako; Kishino, Ai; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Div Allergy, Dept Med Subspecialties, Setagaya Ku, 2-10-1 Okura, Tokyo, Japan; [Natsume, Osamu] Hamamatsu Univ, Sch Med, Div Pediat, Hamamatsu, Shizuoka, Japan; [Kabashima, Shigenori] Tachikawa Sougo Gen Hosp, Div Pediat, Nishiki Cho, Tachikawa, Tokyo, Japan; [Nakazato, Junko] Kanemura Ladies Clin, Div Pediat, Saitama, Japan; [Kondo, Mai] Oume Municipal Gen Hosp, Div Pediat, Tokyo, Japan; [Kishino, Ai] Tokyo Bay Urayasulchikawa Med Ctr, Div Pediat, Pediat, Chiba, Japan; [Takimoto, Tetsuya; Inoue, Eisuke; Tang, Julian] Natl Ctr Child Hlth & Dev, Ctr Clin Res & Dev, Setagaya Ku, Tokyo, Japan; [Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima, Japan; [Wong, Gary W. K.] Chinese Univ Hong Kong, Dept Pediat, Hong Kong, Hong Kong, Peoples R China; [Wong, Gary W. K.] Chinese Univ Hong Kong, Sch Publ Hlth, Prince Wales Hosp, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Matsumoto, Kenji; Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Setagaya Ku, Tokyo, Japan	National Center for Child Health & Development - Japan; Hamamatsu University School of Medicine; National Center for Child Health & Development - Japan; Tokushima University; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; National Center for Child Health & Development - Japan	Ohya, Y (corresponding author), Natl Ctr Child Hlth & Dev, Div Allergy, Dept Med Subspecialties, Setagaya Ku, 2-10-1 Okura, Tokyo, Japan.	ohya-y@ncchd.go.jp	Yamamoto-Hanada, Kiwako/AAR-3094-2020; Yamamoto-Hanada, Kiwako/GQH-6445-2022; Narita, Masami/AAF-1079-2019; Wong, Gary WK/AAY-9207-2020	Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Wong, Gary WK/0000-0001-5939-812X; Saito, Hirohisa/0000-0002-6630-8337; Narita, Masami/0000-0002-5862-679X; Saito-Abe, Mayako/0000-0002-8845-7034	Japanese Ministry of Health, Labour and Welfare [H23-Men'eki-Ippan-008]; National Centre for Child Health and Development, Japan [26-19]; Grants-in-Aid for Scientific Research [15H04866] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); National Centre for Child Health and Development, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This trial was supported by the Japanese Ministry of Health, Labour and Welfare (grant number H23-Men'eki-Ippan-008) and National Centre for Child Health and Development, Japan (grant number 26-19). We sincerely thank all participants in this trial. We particularly thank Masutaka Furue for his support of funding. For recruitment of participants, we are indebted to Rikako Sasaki, Manami Honda, Yoko Yagishita, Kuniko Takeuchi, Kazuko Nakamura, Shigeru Yanagaki, Hiroto Usui, Shigeru Furuhata, Masahiko Tsuda, Rin Nishi, and Kenta Horimukai. We also appreciate the kindness of the staff at public health centres who distributed leaflets about our clinical trial to caregivers of infants visiting the centres. We thank Aki Gen, Machiko Hanzawa, Mika Toyomura, Rina Okuno, Ichiro Nomura, Tomoko Suda, Masaki Futamura, Hiroshi Kitazawa, Yuki Tsumura, Motoki Yomase, Takahiro Kawaguchi, Kumiko Morita, Hisako Komuro, Takeshi Chiba, and Miyuki Hashimoto for their clinical support in outpatient units or provocation tests in hospitals. We are indebted to Hitomi Takahashi, Aki Washizuka, Takako Kimura, and Kazuko Hayase for their clinical assistance for follow-up. We thank Kazuko Okamoto for her support for randomisation and concealment of allocation. We particularly thank Mika Usuda and Mamoru Kimura for their dedicated work in hygienic control of trial powders. We thank Wakako Shinahara for laboratory projects to measure antigen-specific IgG and IgA concentrations. We thank Masayuki Akashi and Ayako Matsuda as members of the Independent Data and Safety Monitoring Committee. We thank Tetsuo Shoda for his help with the graphics.	Baker SS, 2000, PEDIATRICS, V106, P346; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Charman CR, 2004, ARCH DERMATOL, V140, P1513, DOI 10.1001/archderm.140.12.1513; Dean T, 2007, J ALLERGY CLIN IMMUN, V120, P1166, DOI 10.1016/j.jaci.2007.06.042; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Fiocchi A, 2006, ANN ALLERG ASTHMA IM, V97, P10, DOI 10.1016/S1081-1206(10)61364-6; Flohr C, 2014, J INVEST DERMATOL, V134, P345, DOI 10.1038/jid.2013.298; Fukuie T, 2010, BRIT J DERMATOL, V163, P1127, DOI 10.1111/j.1365-2133.2010.09904.x; Hamasaki Y, 2014, ALLERGOL INT, V63, P335, DOI 10.2332/allergolint.14-RAI-0767; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hill DJ, 2008, CLIN EXP ALLERGY, V38, P161, DOI 10.1111/j.1365-2222.2007.02861.x; Ito Komei, 2004, Arerugi, V53, P24; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Koplin JJ, 2010, J ALLERGY CLIN IMMUN, V126, P807, DOI 10.1016/j.jaci.2010.07.028; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000133.pub3; Kull I, 2006, ALLERGY, V61, P1009, DOI 10.1111/j.1398-9995.2006.01115.x; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Roduit C, 2014, J ALLERGY CLIN IMMUN, V133, P1056, DOI 10.1016/j.jaci.2013.12.1044; Schroeder A, 2009, CLIN EXP ALLERGY, V39, P261, DOI 10.1111/j.1365-2222.2008.03160.x; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Suzuki K, 2011, ANAL CHIM ACTA, V706, P321, DOI 10.1016/j.aca.2011.08.034; Wong GWK, 2015, CHEM IMMUNOL ALLERGY, V101, P30, DOI 10.1159/000371662	27	172	178	6	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					276	286		10.1016/S0140-6736(16)31418-0	http://dx.doi.org/10.1016/S0140-6736(16)31418-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI9BC	27939035	Green Submitted			2022-12-28	WOS:000392801200029
J	Faltas, BM; Tagawa, ST				Faltas, Bishoy M.; Tagawa, Scott T.			Immune-checkpoint blockade in cisplatin-ineligible patients with urothelial cancer	LANCET			English	Editorial Material							MULTICENTER		[Faltas, Bishoy M.; Tagawa, Scott T.] Weill Cornell Med, Meyer Canc Ctr, Div Hematol & Med Oncol, New York, NY 10065 USA	Cornell University	Tagawa, ST (corresponding author), Weill Cornell Med, Meyer Canc Ctr, Div Hematol & Med Oncol, New York, NY 10065 USA.	stt2007@med.cornell.edu	Faltas, Bishoy Morris/J-5739-2019	Faltas, Bishoy Morris/0000-0002-6432-1693; Tagawa, Scott/0000-0003-2777-8587				Balar A, 2016, ANN ONCOL S6, V27; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bamias A, 2016, ANN ONCOL S6, V27; De Santis M, 2009, J CLIN ONCOL, V27, P5634, DOI 10.1200/JCO.2008.21.4924; Faltas B, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.e15506; Faltas BM, 2016, NAT GENET, V48, P1490, DOI 10.1038/ng.3692; Galsky MD, 2011, J CLIN ONCOL, V29, P2432, DOI 10.1200/JCO.2011.34.8433; Galsky MD, 2016, ANN ONCOL S6, V27; LOEHRER PJ, 1992, J CLIN ONCOL, V10, P1066, DOI 10.1200/JCO.1992.10.7.1066; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068	11	3	3	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2017	389	10064					6	+		10.1016/S0140-6736(16)32516-8	http://dx.doi.org/10.1016/S0140-6736(16)32516-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG7VH	27939401				2022-12-28	WOS:000391264000013
J	Sparer, M				Sparer, Michael			Maintaining Insurance Access under Trump - A Strategy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sparer, Michael] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA	Columbia University	Sparer, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA.							Antonisse L., 2016, EFFECTS MEDICAID EXP; Mendelson D., 2016, EXPERTS PREDICT SHAR; Sparer M., 2012, MEDICAID MANAGED CAR	3	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2509	2511		10.1056/NEJMp1611202	http://dx.doi.org/10.1056/NEJMp1611202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG6SC	27959710				2022-12-28	WOS:000391175300001
J	Mehta, V; Tzima, E				Mehta, Vedanta; Tzima, Ellie			CARDIOVASCULAR DISEASE A turbulent path to plaque formation	NATURE			English	Editorial Material							DISTURBED FLOW; ATHEROSCLEROSIS; MEVALONATE; ACTIVATION; EXPRESSION; YAP/TAZ; STRESS; SHEAR; YAP	Plaque deposits often occur in curved arterial regions with turbulent blood flow. Endothelial cells have been found to respond to blood flow through a previously unidentified signalling pathway that affects plaque build-up. See Letter p.579	[Mehta, Vedanta; Tzima, Ellie] Univ Oxford, Radcliffe Dept Med, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Tzima, E (corresponding author), Univ Oxford, Radcliffe Dept Med, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	ellie@well.ox.ac.uk	Tzima, Ellie/L-9256-2017	Tzima, Ellie/0000-0002-3437-0902				CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chen J, 2015, AM J PATHOL, V185, P2575, DOI 10.1016/j.ajpath.2015.05.013; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; HOSHIGA M, 1995, CIRC RES, V77, P1129, DOI 10.1161/01.RES.77.6.1129; Maile LA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000476; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; ZHANG SH, 1994, J CLIN INVEST, V94, P937, DOI 10.1172/JCI117460; Zhou J, 2012, P NATL ACAD SCI USA, V109, P7770, DOI 10.1073/pnas.1205476109	16	14	15	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					531	532		10.1038/nature20489	http://dx.doi.org/10.1038/nature20489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	27926734				2022-12-28	WOS:000391190500039
J	Murthy, VH				Murthy, Vivek H.			Ending the Opioid Epidemic - A Call to Action	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Murthy, Vivek H.] Dept Hlth & Human Serv, Off Surg Gen, Washington, DC 20201 USA		Murthy, VH (corresponding author), Dept Hlth & Human Serv, Off Surg Gen, Washington, DC 20201 USA.							Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Jones CM, 2015, AM J PUBLIC HEALTH, V105, pE55, DOI 10.2105/AJPH.2015.302664; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3	4	162	166	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2413	2415		10.1056/NEJMp1612578	http://dx.doi.org/10.1056/NEJMp1612578			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1NL	27959718				2022-12-28	WOS:000390091500002
J	Zander, G; Hackmann, A; Bender, L; Becker, D; Lingner, T; Salinas, G; Krebber, H				Zander, Gesa; Hackmann, Alexandra; Bender, Lysann; Becker, Daniel; Lingner, Thomas; Salinas, Gabriela; Krebber, Heike			mRNA quality control is bypassed for immediate export of stress-responsive transcripts	NATURE			English	Article							HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; SACCHAROMYCES-CEREVISIAE; ARGININE METHYLATION; BINDING-PROTEINS; SHUTTLE VECTORS; POLY(A)(+) RNA; YEAST; COMPLEX; NPL3P; IDENTIFICATION	Cells grow well only in a narrow range of physiological conditions. Surviving extreme conditions requires the instantaneous expression of chaperones that help to overcome stressful situations. To ensure the preferential synthesis of these heat-shock proteins, cells inhibit transcription, pre-mRNA processing and nuclear export of non-heat-shock transcripts, while stress-specific mRNAs are exclusively exported and translated1. How cells manage the selective retention of regular transcripts and the simultaneous rapid export of heat-shock mRNAs is largely unknown. In Saccharomyces cerevisiae, the shuttling RNA adaptor proteins Npl3, Gbp2, Hrb1 and Nab2 are loaded co-transcriptionally onto growing pre-mRNAs. For nuclear export, they recruit the export-receptor heterodimer Mex67-Mtr2 (TAP-p15 in humans)(2). Here we show that cellular stress induces the dissociation of Mex67 and its adaptor proteins from regular mRNAs to prevent general mRNA export. At the same time, heat-shock mRNAs are rapidly exported in association with Mex67, without the need for adapters. The immediate co-transcriptional loading of Mex67 onto heat-shock mRNAs involves Hsf1, a heat-shock transcription factor that binds to heat-shock-promoter elements in stress-responsive genes. An important difference between the export modes is that adaptor-protein-bound mRNAs undergo quality control, whereas stress-specific transcripts do not. In fact, regular mRNAs are converted into uncontrolled stress-responsive transcripts if expressed under the control of a heat-shock promoter, suggesting that whether an mRNA undergoes quality control is encrypted therein. Under normal conditions, Mex67 adaptor proteins are recruited for RNA surveillance, with only quality-controlled mRNAs allowed to associate with Mex67 and leave the nucleus. Thus, at the cost of error-free mRNA formation, heat-shock mRNAs are exported and translated without delay, allowing cells to survive extreme situations.	[Zander, Gesa; Hackmann, Alexandra; Bender, Lysann; Becker, Daniel; Krebber, Heike] Georg August Univ Gottingen, Gottinger Zentrum Mol Biowissensch, Inst Mikrobiol & Genet, Abt Mol Genet, Gottingen, Germany; [Lingner, Thomas; Salinas, Gabriela] Georg August Univ Gottingen, Transkriptomanalyselab, Inst Entwicklungsbiochem, Gottingen, Germany	University of Gottingen; University of Gottingen	Krebber, H (corresponding author), Georg August Univ Gottingen, Gottinger Zentrum Mol Biowissensch, Inst Mikrobiol & Genet, Abt Mol Genet, Gottingen, Germany.	heike.krebber@biologie.uni-goettingen.de			Deutsche Forschungsgemeinschaft;  [SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	We thank H. Bastians for advice, L. Oldehaver for technical assistance, W. Kramer for discussion and R. Lill, P. A. Silver, C. Dargemont and E. Hurt for providing plasmids, strains or antibodies. This work was funded by grants from the Deutsche Forschungsgemeinschaft and the SFB860 to H.K.	Baejen C, 2014, MOL CELL, V55, P745, DOI 10.1016/j.molcel.2014.08.005; Baierlein C, 2013, MOL CELL BIOL, V33, P4811, DOI 10.1128/MCB.00873-13; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bond U, 2006, FEMS YEAST RES, V6, P160, DOI 10.1111/j.1567-1364.2006.00032.x; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Carmody SR, 2010, MOL CELL BIOL, V30, P5168, DOI 10.1128/MCB.00735-10; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Conrad NK, 2000, GENETICS, V154, P557; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Duncan K, 2000, CURR BIOL, V10, P687, DOI 10.1016/S0960-9822(00)00527-3; Faza MB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002915; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Hacker S, 2004, J BIOL CHEM, V279, P5049, DOI 10.1074/jbc.C300522200; Hackmann A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4123; Hackmann A, 2011, EMBO REP, V12, P1024, DOI 10.1038/embor.2011.155; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Kim S, 2013, J BIOL CHEM, V288, P12197, DOI 10.1074/jbc.M112.449553; Krebber H, 1999, GENE DEV, V13, P1994, DOI 10.1101/gad.13.15.1994; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Rollenhagen C, 2007, EUKARYOT CELL, V6, P505, DOI 10.1128/EC.00317-06; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Schmid M, 2015, CELL REP, V12, P128, DOI 10.1016/j.celrep.2015.06.008; Schmid M, 2012, MOL CELL, V47, P267, DOI 10.1016/j.molcel.2012.05.005; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shen EC, 2000, J BIOL CHEM, V275, P23718, DOI 10.1074/jbc.M002312200; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh H, 2006, GENETICS, V172, P2169, DOI 10.1534/genetics.105.052738; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; Thomsen R, 2003, RNA, V9, P1049, DOI 10.1261/rna.5170303; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Tutucci E, 2011, NAT REV MOL CELL BIO, V12, P376, DOI 10.1038/nrm3119; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Windgassen M, 2003, EMBO REP, V4, P278, DOI 10.1038/sj.embor.embor763; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001; Zid BM, 2014, NATURE, V514, P117, DOI 10.1038/nature13578	48	47	47	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					593	+		10.1038/nature20572	http://dx.doi.org/10.1038/nature20572			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27951587				2022-12-28	WOS:000391190500054
J	Eliazer, S; Brack, AS				Eliazer, Susan; Brack, Andrew S.			STEM CELLS Cause and consequence in aged-muscle decline	NATURE			English	Editorial Material							WNT	Activation of aged muscle stem cells induces changes in DNA packaging that lead to expression of the gene Hoxa9. This reactivates embryonic signalling pathways, restricting the cells' ability to repair injured muscle. See Letter p.428	[Eliazer, Susan; Brack, Andrew S.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Eliazer, Susan; Brack, Andrew S.] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Brack, AS (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Brack, AS (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA.	andrew.brack@ucsf.edu						Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Schworer S, 2016, NATURE, V540, P428, DOI 10.1038/nature20603; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	9	4	4	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					349	350		10.1038/nature20485	http://dx.doi.org/10.1038/nature20485			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE6JR	27919069				2022-12-28	WOS:000389716800026
J	Berger, KM				Berger, Kavita M.			What life scientists should know about security threats	SCIENCE			English	Editorial Material							PROGRAM		[Berger, Kavita M.] Gryphon Sci LLC, Takoma Pk, MD 20912 USA		Berger, KM (corresponding author), Gryphon Sci LLC, Takoma Pk, MD 20912 USA.	kberger@gryphonscientific.com						AAAS, DISC REG PERS SEC AC; Adcox W., COMMUNICATION; Berger K, 2013, BRIDGING SCI SECURIT; Berger K. M., 2010, COMPETING RESPONSIBI; Berger K. M., 2008, PROFESSIONAL GRADUAT; Berger K. M., 2013, BRIDGING SCI SECURIT; Berger KM, 2009, BIOL SAFETY TRAINING; Frankel M. S., 2009, SCIENCE, V326, P1193; Gryphon Scientific, 2015, RISK BEN AN GAIN FUN; Higgins JJ, 2013, BIOSECUR BIOTERROR, V11, P130, DOI 10.1089/bsp.2013.0024; Koninklijke Nederlandse Akademie Van Wetenschappen, 2009, COD COND BIOS; National Research Council, 2011, RES LIF SCI DUAL US, P54; National Research Council, 2013, DEV CAP TEACH RESP S, P137; National Research Council, 2009, RESP RES BIOL SEL AG; Office for Graduate Student Development and Diversity Yale University, 2016, 4 TIER MENT PROGR; Security Executive Council, 2016, DRIV RES COMM YOUR V; Skvorc C, 2011, BIOSECUR BIOTERROR, V9, P23, DOI 10.1089/bsp.2010.0048; University of Illinois Urbana-Champaign, 2016, FAC STAFF TOOLK MENT; World Health Organization,, 2010, RESP LIF SCI RES GLO	19	3	3	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1237	1239		10.1126/science.aaf9334	http://dx.doi.org/10.1126/science.aaf9334			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940836				2022-12-28	WOS:000389598800043
J	Ferris, J				Ferris, John			Robert Lockhart Johnston OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		JOHNSTON RL, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2016	355								i6567	10.1136/bmj.i6567	http://dx.doi.org/10.1136/bmj.i6567			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SZ	27940548				2022-12-28	WOS:000390037600006
J	Spires, R				Spires, Robert			Ulrich Erich Otto Schirrmacher OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		SCHIRRMACHER UEO, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2016	355								i6569	10.1136/bmj.i6569	http://dx.doi.org/10.1136/bmj.i6569			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SZ	27940502				2022-12-28	WOS:000390037600007
J	Yusuf, S; Wittes, J				Yusuf, Salim; Wittes, Janet			Interpreting Geographic Variations in Results of Randomized, Controlled Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SUBGROUP ANALYSES; HEART-FAILURE; FOLIC-ACID; THERAPY; HYPERTENSION		[Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Wittes, Janet] Stat Collaborat, Washington, DC USA	McMaster University; Population Health Research Institute	Yusuf, S (corresponding author), Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca		Yusuf, Salim/0000-0003-4776-5601				Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Anand S, 2007, NEW ENGL J MED, V357, P217; Bristow MR, 2010, CIRC-HEART FAIL, V3, P21, DOI 10.1161/CIRCHEARTFAILURE.109.885962; Center for Drug Evaluation and Research, 2009, 22387 FDA CTR DRUG E; Center for Drug Evaluation and Research, 2013, 204410ORIG1S000 FDA; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Columbia Laboratories, 2011, NDA 22 139 PROG GEL; FURBERG CD, 1983, CIRCULATION, V67, P98; Hjalmarson A, 1999, LANCET, V353, P2001; Huo Y, 2015, JAMA-J AM MED ASSOC, V313, P1325, DOI 10.1001/jama.2015.2274; Khandelwal M, 2012, INT J WOMENS HEALTH, V4, P481, DOI 10.2147/IJWH.S28944; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; Pfeffer MA, 2015, CIRCULATION, V131, P34, DOI 10.1161/CIRCULATIONAHA.114.013255; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Pocock S, 2013, EUR HEART J, V34, P1846, DOI 10.1093/eurheartj/eht071; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; ROSE G, 1986, LANCET, V1, P869; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wedel H, 2001, AM HEART J, V142, P502, DOI 10.1067/mhj.2001.117600; Wittes J., 2013, P 4 SEATTL S BIOST C, P95; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhang FR, 2013, NEW ENGL J MED, V369, P1620, DOI 10.1056/NEJMoa1213096	29	50	50	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2263	2271		10.1056/NEJMra1510065	http://dx.doi.org/10.1056/NEJMra1510065			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZQ	27959693	Bronze			2022-12-28	WOS:000389310000009
J	Mohammadi, D				Mohammadi, Dara			Joan Marston: don't forget the children	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2733	2733		10.1016/S0140-6736(16)32428-X	http://dx.doi.org/10.1016/S0140-6736(16)32428-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FB	27924769				2022-12-28	WOS:000389629800013
J	Sommerkamp, P; Trumpp, A				Sommerkamp, Pia; Trumpp, Andreas			Metabolic cues for hematopoietic stem cells	SCIENCE			English	Editorial Material							PLURIPOTENCY; MAINTENANCE; DORMANCY; NICHE		[Sommerkamp, Pia; Trumpp, Andreas] German Canc Res Ctr, Div Stem Cells & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Trumpp, A (corresponding author), German Canc Res Ctr, Div Stem Cells & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.; Trumpp, A (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med HI S, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.trumpp@dkfz.de	Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466; Sommerkamp, Pia/0000-0002-1148-2493				Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Chhabra A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aae0501; Cosgun KN, 2014, CELL STEM CELL, V15, P227, DOI 10.1016/j.stem.2014.06.001; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530; Mantel C, 2010, CELL CYCLE, V9, P2008, DOI 10.4161/cc.9.10.11733; Mehanna HM, 2008, BRIT MED J, V336, P1495, DOI 10.1136/bmj.a301; Taya Y, 2016, SCIENCE, V354, P1152, DOI 10.1126/science.aag3145; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	15	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1103	1104		10.1126/science.aal3466	http://dx.doi.org/10.1126/science.aal3466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934722				2022-12-28	WOS:000388916400020
J	Turner, SJ; Russ, BE				Turner, Stephen J.; Russ, Brendan E.			Can T cells be too exhausted to fight back?	SCIENCE			English	Editorial Material							BLOCKADE		[Turner, Stephen J.; Russ, Brendan E.] Monash Univ, Dept Microbiol, Biomed Discovery Inst, Clayton, Vic 3800, Australia	Monash University	Turner, SJ (corresponding author), Monash Univ, Dept Microbiol, Biomed Discovery Inst, Clayton, Vic 3800, Australia.	stephen.j.turner@monash.edu	Turner, Stephen/GXM-4654-2022	Russ, Brendan/0000-0001-6862-5283; Turner, Stephen/0000-0002-1002-0000				Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Ghoneim H. E., 2016, TRENDS MOL MED, DOI [10.1016/j.mol-med.2016.10.002, DOI 10.1016/J.MOL-MED.2016.10.002]; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zhang FQ, 2014, MOL THER, V22, P1698, DOI 10.1038/mt.2014.91	15	13	13	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1104	1105		10.1126/science.aal3204	http://dx.doi.org/10.1126/science.aal3204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934723				2022-12-28	WOS:000388916400021
J	Vogel, G				Vogel, Gretchen			INFECTIOUS DISEASE One year later, Zika scientists prepare for a long war	SCIENCE			English	News Item																			0	8	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1088	1089		10.1126/science.354.6316.1088	http://dx.doi.org/10.1126/science.354.6316.1088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934714				2022-12-28	WOS:000388916400012
J	Wu, L; Salehi, M; Koirala, N; Moon, J; Oh, S; Armitage, NP				Wu, Liang; Salehi, M.; Koirala, N.; Moon, J.; Oh, S.; Armitage, N. P.			Quantized Faraday and Kerr rotation and axion electrodynamics of a 3D topological insulator	SCIENCE			English	Article							POLARIZATION	Topological insulators have been proposed to be best characterized as bulk magnetoelectric materials that show response functions quantized in terms of fundamental physical constants. Here, we lower the chemical potential of three-dimensional (3D) Bi2Se3 films to similar to 30 meV above the Dirac point and probe their low-energy electrodynamic response in the presence of magnetic fields with high-precision time-domain terahertz polarimetry. For fields higher than 5 tesla, we observed quantized Faraday and Kerr rotations, whereas the dc transport is still semiclassical. A nontrivial Berry's phase offset to these values gives evidence for axion electrodynamics and the topological magnetoelectric effect. The time structure used in these measurements allows a direct measure of the fine-structure constant based on a topological invariant of a solid-state system.	[Wu, Liang; Armitage, N. P.] Johns Hopkins Univ, Dept Phys & Astron, Inst Quantum Matter, Baltimore, MD 21218 USA; [Salehi, M.] Rutgers State Univ, Dept Mat Sci & Engn, Piscataway, NJ 08854 USA; [Koirala, N.; Moon, J.; Oh, S.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Wu, Liang] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of California System; University of California Berkeley	Wu, L; Armitage, NP (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Inst Quantum Matter, Baltimore, MD 21218 USA.; Wu, L (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	liangwu@berkeley.edu; npa@jhu.edu	Wu, Liang/C-8715-2015	Wu, Liang/0000-0003-1696-7809	Army Research Office [W911NF-15-1-0560]; Gordon and Betty Moore Foundation [GBMF2628]; NSF [DMR-1308142, EFMA-1542798]; Gordon and Betty Moore Foundation EPiQS Initiative [GBMF4418]; Emerging Frontiers & Multidisciplinary Activities [1542798] Funding Source: National Science Foundation	Army Research Office; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation EPiQS Initiative; Emerging Frontiers & Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank M. Franz, T. Hughes, A. MacDonald, J. Maciejko, J. Moore, M. Orlita, V. Oganesyan, W.-K. Tse, A. Turner, R. Valdes Aguilar, X. L. Qi, and S.C. Zhang for helpful discussions. Experiments were supported by the Army Research Office Grant W911NF-15-1-0560, with additional support by the Gordon and Betty Moore Foundation through grant GBMF2628 to N.P.A. at Johns Hopkins University. Film growth for this work was supported by the NSF DMR-1308142, EFMA-1542798, and the Gordon and Betty Moore Foundation EPiQS Initiative Grant GBMF4418 to S.O. at Rutgers.	Aguilar RV, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.087403; ANDERSON PW, 1963, PHYS REV LETT, V10, P230, DOI 10.1103/PhysRevLett.10.230; DZYALOSHINSKII IE, 1960, SOV PHYS JETP-USSR, V10, P628; Essin AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146805; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Hancock JN, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.136803; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hehl FW, 2009, EUR PHYS J B, V71, P321, DOI 10.1140/epjb/e2009-00203-7; Hussain Z., 2011, J MATER RES, V16, P2695; Ikebe Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.256802; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Koirala N, 2015, NANO LETT, V15, P8245, DOI 10.1021/acs.nanolett.5b03770; Linder J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014513; Maciejko J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246809; Maciejko J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166803; Mohr PJ, 2000, REV MOD PHYS, V72, P351, DOI 10.1103/RevModPhys.72.351; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Morris CM, 2012, OPT EXPRESS, V20, P12303, DOI 10.1364/OE.20.012303; Pershoguba SS, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.165404; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2009, SCIENCE, V323, P1184, DOI 10.1126/science.1167747; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Shimano R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2866; Swingle B, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195139; Tse WK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.057401; Vafek O, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245417; VANDERBILT D, 1993, PHYS REV B, V48, P4442, DOI 10.1103/PhysRevB.48.4442; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; WILCZEK F, 1987, PHYS REV LETT, V58, P1799, DOI 10.1103/PhysRevLett.58.1799; Wojdel JC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267205; Wu L, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.217602; Wu L, 2013, NAT PHYS, V9, P410, DOI 10.1038/nphys2647; Xu Y, 2014, NAT PHYS, V10, P956, DOI [10.1038/NPHYS3140, 10.1038/nphys3140]; Yoshimi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7627; Zhang Y, 2010, NAT PHYS, V6, P584, DOI 10.1038/NPHYS1689	36	188	189	14	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1124	1127		10.1126/science.aaf5541	http://dx.doi.org/10.1126/science.aaf5541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934759	Green Submitted			2022-12-28	WOS:000388916400036
J	Melber, A; Winge, DR				Melber, Andrew; Winge, Dennis R.			Inner Secrets of the Respirasome	CELL			English	Editorial Material							MITOCHONDRIAL COMPLEX I; PROTEIN; SUPERCOMPLEX; ARCHITECTURE	Structure determination by cryo-electron microscopy has approached atomic resolution and helped solve structures of large membrane-protein complexes that resisted crystallography. The 4.0 angstrom cryo-EM structure of one of the most intricate enzyme systems, the respirasome, in the mitochondrial inner membrane is reported in this issue of Cell.	[Melber, Andrew; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110755] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK007115] Funding Source: Medline; NIGMS NIH HHS [R01 GM110755] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Bragoszewski P, 2015, P NATL ACAD SCI USA, V112, P7713, DOI 10.1073/pnas.1504615112; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Perez-Perez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	11	8	8	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1450	1452		10.1016/j.cell.2016.11.025	http://dx.doi.org/10.1016/j.cell.2016.11.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912054	Bronze, Green Accepted			2022-12-28	WOS:000389470500008
J	Oberlander, J				Oberlander, Jonathan			The End of Obamacare	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REFORM		[Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27514 USA.							Jost T, 2016, HLTH AFFAIRS BL 1109; McDonough JE, 2016, JAMA INTERN MED, V176, P1595, DOI 10.1001/jamainternmed.2016.6098; Oberlander J, 2016, J HEALTH POLIT POLIC, V41, P803, DOI 10.1215/03616878-3620953; ROY Avik, 2016, FORBES; Wilensky GR, 2016, NEW ENGL J MED, V375, P1312, DOI 10.1056/NEJMp1610716	5	19	19	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2017	376	1					1	3		10.1056/NEJMp1614438	http://dx.doi.org/10.1056/NEJMp1614438			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG6SS	27959711				2022-12-28	WOS:000391177100001
J	Pope, HG; Khalsa, JH; Bhasin, S				Pope, Harrison G., Jr.; Khalsa, Jag H.; Bhasin, Shalender			Body Image Disorders and Abuse of Anabolic-Androgenic Steroids Among Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MUSCLE DYSMORPHIA; USERS		[Pope, Harrison G., Jr.] Harvard Med Sch, McLean Hosp, Biol Psychiat Lab, Belmont, MA USA; [Khalsa, Jag H.] NIDA, Med Consequences Branch, Div Therapeut & Med Consequences, NIH, Bethesda, MD 20892 USA; [Bhasin, Shalender] Harvard Med Sch, Brigham & Womens Hosp, Res Program Mens Hlth Aging & Metab, 221 Longwood Ave, Boston, MA 02115 USA	Harvard University; McLean Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bhasin, S (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Res Program Mens Hlth Aging & Metab, 221 Longwood Ave, Boston, MA 02115 USA.	sbhasin@bwh.harvard.edu						Baggish AL, 2010, CIRC-HEART FAIL, V3, P472, DOI 10.1161/CIRCHEARTFAILURE.109.931063; Cafri G, 2008, COMPR PSYCHIAT, V49, P374, DOI 10.1016/j.comppsych.2008.01.003; Givens ML, 2016, MIL MED, V181, P680, DOI 10.7205/MILMED-D-15-00537; Ip EJ, 2016, AIDS CARE, V28, P294, DOI 10.1080/09540121.2015.1090539; Ip EJ, 2011, PHARMACOTHERAPY, V31, P757, DOI 10.1592/phco.31.8.757; Olivardia R, 2000, AM J PSYCHIAT, V157, P1291, DOI 10.1176/appi.ajp.157.8.1291; Phillips KA, 2010, DEPRESS ANXIETY, V27, P573, DOI 10.1002/da.20709; Pope HG, 2014, ENDOCR REV, V35, P341, DOI 10.1210/er.2013-1058; Rasmussen JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161208; Thiblin I, 2015, DRUG ALCOHOL DEPEN, V152, P87, DOI 10.1016/j.drugalcdep.2015.04.013	10	63	63	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					23	24		10.1001/jama.2016.17441	http://dx.doi.org/10.1001/jama.2016.17441			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG4JE	27930760				2022-12-28	WOS:000391009100011
J	Teerlink, JR; Felker, GM; McMurray, JJV; Solomon, SD; Adams, KF; Cleland, JGF; Ezekowitz, JA; Goudev, A; Macdonald, P; Metra, M; Mitrovic, V; Ponikowski, P; Serpytis, P; Spinar, J; Tomcsanyi, J; Vandekerckhove, HJ; Voors, AA; Monsalvo, ML; Johnston, J; Malik, FI; Honarpour, N				Teerlink, John R.; Felker, G. Michael; McMurray, John J. V.; Solomon, Scott D.; Adams, Kirkwood F., Jr.; Cleland, John G. F.; Ezekowitz, Justin A.; Goudev, Assen; Macdonald, Peter; Metra, Marco; Mitrovic, Veselin; Ponikowski, Piotr; Serpytis, Pranas; Spinar, Jindrich; Tomcsanyi, Janos; Vandekerckhove, Hans J.; Voors, Adriaan A.; Monsalvo, Maria Laura; Johnston, James; Malik, Fady I.; Honarpour, Narimon		COSMIC-HFf Investigators	Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial	LANCET			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; OMECAMTIV MECARBIL; TIME; MECHANISMS; PREDICTION; MORTALITY; EXERCISE; SAFETY	Background Impaired contractility is a feature of heart failure with reduced ejection fraction. We assessed the pharmacokinetics and eff ects on cardiac function and structure of the cardiac myosin activator, omecamtiv mecarbil. Methods In this randomised, double-blind study, done at 87 sites in 13 countries, we recruited patients with stable, symptomatic chronic heart failure and left ventricular ejection fraction 40% or lower. Patients were randomly assigned equally, via an interactive web response system, to receive 25 mg oral omecamtiv mecarbil twice daily (fixed-dose group), 25 mg twice daily titrated to 50 mg twice daily guided by pharmacokinetics (pharmacokinetic-titration group), or placebo for 20 weeks. We assessed the maximum concentration of omecamtiv mecarbil in plasma (primary endpoint) and changes in cardiac function and ventricular diameters. This trial is registered with ClinicalTrials. gov, number NCT01786512. Findings From March 17, 2014, to March 5, 2015, we enrolled 150 patients in the fi xed-dose omecamtiv mecarbil group and 149 in the pharmacokinetic-titration and placebo groups. Mean maximum concentration of omecamtiv mecarbil at 12 weeks was 200 (SD 71) ng/mL in the fi xed-dose group and 318 (129) ng/mL in the pharmacokinetic-titration group. For the pharmacokinetic-titration group versus placebo group at 20 weeks, least square mean diff erences were as follows: systolic ejection time 25 ms (95% CI 18-32, p< 0.0001), stroke volume 3.6 mL (0.5-6.7, p= 0.0217), left ventricular end-systolic diameter -1.8 mm (-2.9 to -0.6, p= 0.0027), left ventricular end-diastolic diameter -1.3 mm, (-2.3 to 0.3, p= 0.0128), heart rate -3.0 beats per min (-5.1 to -0.8, p= 0.0070), and N-terminal pro B-type natriuretic peptide concentration in plasma -970 pg/mL (-1672 to -268, p= 0.0069). The frequency of adverse clinical events did not diff er between groups. Interpretation Omecamtiv mecarbil dosing guided by pharmacokinetics achieved plasma concentrations associated with improved cardiac function and decreased ventricular diameter.	[Teerlink, John R.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Teerlink, John R.] San Francisco VA Med Ctr, Cardiol Sect, San Francisco, CA USA; [Felker, G. Michael] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA; [McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Solomon, Scott D.] Harvard Med Sch, Boston, MA USA; [Adams, Kirkwood F., Jr.] Univ North Carolina Chapel Hill, Div Cardiol, Chapel Hill, NC USA; [Cleland, John G. F.] Imperial Coll, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England; [Cleland, John G. F.] Imperial Coll, Harefield Hosp, London, England; [Cleland, John G. F.] Univ Glasgow, Robertson Ctr Biostat & Clin Trials, Glasgow, Lanark, Scotland; [Ezekowitz, Justin A.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Goudev, Assen] Queen Giovanna Univ Hosp, Dept Cardiol, Sofia, Bulgaria; [Goudev, Assen] Med Univ Sofia, Sofia, Bulgaria; [Macdonald, Peter] St Vincents Hosp, Heart Transplant Unit, Sydney, NSW, Australia; [Macdonald, Peter] Victor Chang Cardiac Res Inst, Transplantat Res Lab, Sydney, NSW, Australia; [Macdonald, Peter] Univ New South Wales, Sydney, NSW, Australia; [Metra, Marco] Univ Brescia, Div Cardiol, Brescia, Italy; [Mitrovic, Veselin] Kerckhoff Klin Forsch Gesell, Frankfurt, Germany; [Mitrovic, Veselin] Goethe Univ Frankfurt, Mainz, Germany; [Ponikowski, Piotr] Med Univ, Dept Heart Dis, Wroclaw, Poland; [Ponikowski, Piotr] Mil Hosp, Ctr Heart Dis, Wroclaw, Poland; [Serpytis, Pranas] Vilnius Univ Hosp Santariskiu Klin, Emergency Ctr, Vilnius, Lithuania; [Serpytis, Pranas] Vilnius Univ, Vilnius, Lithuania; [Spinar, Jindrich] Univ Hosp Brno, Brno, Czech Republic; [Spinar, Jindrich] Masaryk Univ, Fac Med, Brno, Czech Republic; [Tomcsanyi, Janos] St John God Hosp, Dept Cardiol, Budapest, Hungary; [Vandekerckhove, Hans J.] AZ St Lucas, Dept Cardiol, Ghent, Belgium; [Voors, Adriaan A.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Monsalvo, Maria Laura; Johnston, James; Honarpour, Narimon] Amgen Inc, Thousand Oaks, CA USA; [Malik, Fady I.] Cytokinetics, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Duke University; University of Glasgow; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Imperial College London; Royal Brompton Hospital; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; University of Glasgow; University of Alberta; Medical University Sofia; Medical University Sofia; St Vincents Hospital Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Brescia; Goethe University Frankfurt; Wroclaw Medical University; Vilnius University Hospital Santariskiu Klinikos; Vilnius University; University Hospital Brno; Masaryk University Brno; University of Groningen; Amgen	Teerlink, JR (corresponding author), San Francisco VA Med Ctr, Cardiol, 111C,4150 Clement St, San Francisco, CA 94121 USA.	john.teerlink@ucsf.edu	Metra, marco/E-7101-2010; Felker, Michael/AAX-2288-2021; Teerlink, John R/D-2986-2012; Voors, Adriaan/ABE-6784-2020; Cleland, John G./AAZ-4185-2020; mcmurray, John/B-2467-2013; Macdonald, Peter/Q-3188-2019; Ponikowski, Piotr/O-6454-2015; Ezekowitz, Justin/C-4579-2013	Cleland, John G./0000-0002-1471-7016; mcmurray, John/0000-0002-6317-3975; Ponikowski, Piotr/0000-0002-3391-7064; Ezekowitz, Justin/0000-0002-2724-4086	Amgen; Cytokinetics; National Institute for Health Research [NF-SI-0611-10227] Funding Source: researchfish	Amgen(Amgen); Cytokinetics; National Institute for Health Research(National Institute for Health Research (NIHR))	Amgen.; The COSMIC-HF study was funded and done by Amgen in collaboration with Cytokinetics.	Apple FS, 2009, CLIN CHEM, V55, P1303, DOI 10.1373/clinchem.2009.128363; Biering-Sorensen T, 2015, J CARD FAIL, V21, pS84, DOI 10.1016/j.cardfail.2015.06.254; BRAUWNAL.E, 1967, NEW ENGL J MED, V277, P1012, DOI 10.1056/NEJM196711092771907; Cleland J, 2008, J AM COLL CARDIOL, V52, P438, DOI 10.1016/j.jacc.2008.04.036; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; Cleland JGF, 2009, J AM COLL CARDIOL, V54, P1850, DOI 10.1016/j.jacc.2009.06.041; Greenberg BH, 2015, JACC-HEART FAIL, V3, P22, DOI 10.1016/j.jchf.2014.07.009; Hasenfuss G, 2011, EUR HEART J, V32, P1838, DOI 10.1093/eurheartj/ehr026; Klinkenberg LJJ, 2014, J AM COLL CARDIOL, V63, P1788, DOI 10.1016/j.jacc.2014.01.040; Kramer DG, 2010, J AM COLL CARDIOL, V56, P392, DOI 10.1016/j.jacc.2010.05.011; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; PACKER M, 1993, NEW ENGL J MED, V329, P201, DOI 10.1056/NEJM199307153290310; Palaparthy R, 2016, INT J CLIN PHARM TH, V54, P217, DOI 10.5414/CP202458; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Shave R, 2010, J AM COLL CARDIOL, V56, P169, DOI 10.1016/j.jacc.2010.03.037; Shen YT, 2010, CIRC-HEART FAIL, V3, P522, DOI 10.1161/CIRCHEARTFAILURE.109.930321; Solomon SD, 2010, CIRCULATION, V122, P985, DOI 10.1161/CIRCULATIONAHA.110.955039; Teerlink JR, 2016, J AM COLL CARDIOL, V67, P1444, DOI 10.1016/j.jacc.2016.01.031; Teerlink JR, 2011, LANCET, V378, P667, DOI 10.1016/S0140-6736(11)61219-1; Vu T, 2015, J CLIN PHARMACOL, V55, P1236, DOI 10.1002/jcph.538; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Waldenstrom A, 2014, CIRC RES, V114, P315, DOI 10.1161/CIRCRESAHA.114.300584; WEISSLER AM, 1968, CIRCULATION, V37, P149, DOI 10.1161/01.CIR.37.2.149	23	172	176	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2895	2903		10.1016/S0140-6736(16)32049-9	http://dx.doi.org/10.1016/S0140-6736(16)32049-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FU	27914656	Green Submitted, Green Accepted			2022-12-28	WOS:000389631700034
J	Hodell, DA				Hodell, David A.			The smoking gun of the ice ages	SCIENCE			English	Editorial Material							CLIMATE; TERMINATIONS; TEMPERATURE; OBLIQUITY; VOLUME		[Hodell, David A.] Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Downing St, Cambridge C82 3EQ, England	University of Cambridge	Hodell, DA (corresponding author), Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Downing St, Cambridge C82 3EQ, England.	dah73@cam.ac.uk		Hodell, David/0000-0001-8537-1588				BERGER AL, 1976, ASTRON ASTROPHYS, V51, P127; Crucifix M, 2012, PHILOS T R SOC A, V370, P1140, DOI 10.1098/rsta.2011.0315; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hughes T, 2011, QUATERNARY SCI REV, V30, P1829, DOI 10.1016/j.quascirev.2011.04.004; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; Milankovitch M., 1941, SECT MATH NAT SCI, V33; Paillard D, 2001, REV GEOPHYS, V39, P325, DOI 10.1029/2000RG000091; Raymo ME, 2006, SCIENCE, V313, P492, DOI 10.1126/science.1123296; Raymo ME, 2008, NATURE, V451, P284, DOI 10.1038/nature06589; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897	13	2	2	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1235	1236		10.1126/science.aal4111	http://dx.doi.org/10.1126/science.aal4111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940835				2022-12-28	WOS:000389598800042
J	Stone, R				Stone, Richard			CONSERVATION Dam-building threatens Mekong fisheries	SCIENCE			English	News Item																			0	37	39	5	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1084	1085		10.1126/science.354.6316.1084	http://dx.doi.org/10.1126/science.354.6316.1084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934711				2022-12-28	WOS:000388916400009
J	Abbott, A; Dolgin, E				Abbott, Alison; Dolgin, Elie			Leading Alzheimer's theory survives drug failure	NATURE			English	News Item																			0	96	102	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					15	16		10.1038/nature.2016.21045	http://dx.doi.org/10.1038/nature.2016.21045			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905452	Bronze			2022-12-28	WOS:000388916600018
J	Hawkes, N				Hawkes, Nigel			Sixty seconds on ... solanezumab	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							DRUG											Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Hawkes N, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6362; Hawkes N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4048; McCartney M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4064	4	7	7	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2016	355								i6389	10.1136/bmj.i6389	http://dx.doi.org/10.1136/bmj.i6389			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZA	27899350				2022-12-28	WOS:000389308200001
J	Dyer, MA				Dyer, Michael A.			BIOMEDICINE An eye on retinal recovery	NATURE			English	Editorial Material							PHOTORECEPTOR PRECURSORS; STEM-CELLS; TRANSPLANTATION; DONOR	Retinal-cell transplants restore vision in mouse models of retinal degeneration. It emerges that the transplant leads to an exchange of material between donor and host cells - not to donor-cell integration into the retina, as had been presumed.	[Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Dyer, Michael/N-8134-2018		NEI NIH HHS [R01 EY023619] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY023619] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Hiler D, 2015, CELL STEM CELL, V17, P101, DOI 10.1016/j.stem.2015.05.015; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Pearson RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13029; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Santos-Ferreira T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13028; Singh M. S., 2016, NATURE COMMUN; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053	10	5	5	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					350	351		10.1038/nature20487	http://dx.doi.org/10.1038/nature20487			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE6JR	27919071				2022-12-28	WOS:000389716800027
J	Ladstatter, S; Tachibana-Konwalski, K				Ladstaetter, Sabrina; Tachibana-Konwalski, Kikuee			A Surveillance Mechanism Ensures Repair of DNA Lesions during Zygotic Reprogramming	CELL			English	Article							REPLICATION STRESS; ACTIVE DEMETHYLATION; DAMAGE RESPONSE; PROTEIN-KINASE; COHESIN; CHECKPOINT; INHIBITION; EXCISION; IDENTIFICATION; EXPRESSION	Sexual reproduction culminates in a totipotent zygote with the potential to produce a whole organism. Sperm chromatin reorganization and epigenetic reprogramming that alter DNA and histone modifications generate a totipotent embryo. Active DNA demethylation of the paternal genome has been proposed to involve base excision and DNA repair-based mechanisms. The nature and consequence of DNA lesions generated during reprogramming are not known. Using mouse genetics and chemical biology, we discovered that Tet3-dependent zygotic reprogramming generates paternal DNA lesions that are monitored by a surveillance mechanism. In vivo structure-function rescue assays revealed that cohesin-dependent repair of paternal DNA lesions prevents activation of a Chk1-dependent checkpoint that delays mitotic entry. Culturing conditions affect checkpoint stringency, which has implications for human in vitro fertilization. We propose the zygotic checkpoint senses DNA lesions generated during paternal DNA demethylation and ensures reprogrammed loci are repaired before mitosis to prevent chromosome fragmentation, embryo loss, and infertility.	[Ladstaetter, Sabrina; Tachibana-Konwalski, Kikuee] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr, Dr Bohr Gasse 3, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Tachibana-Konwalski, K (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna Bioctr, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	kikue.tachibana@imba.oeaw.ac.at			FWF-DK Chromosome Dynamics doctoral program; Austrian Academy of Sciences; European Research Council [ERC-StG-336460]; VBC PhD programme in Molecular Life Sciences	FWF-DK Chromosome Dynamics doctoral program; Austrian Academy of Sciences; European Research Council(European Research Council (ERC)European Commission); VBC PhD programme in Molecular Life Sciences	We are grateful for the Xrcc1<SUP>fl</SUP> mice provided by Peter J. McKinnon (Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital). We thank Kerstin Klien and Johanna Gassler from the K.T.-K. lab for technical assistance; Hans-Christian Theussl and Jacek Rodegar Wojciechowski from the core Transgenics Facility for providing technical advice and assistance for zygote retrieval; the VBC PhD programme in Molecular Life Sciences and FWF-funded DK Chromosome Dynamics doctoral program for support; and the Life Science Editors for editorial assistance and scientific input. This research was funded by the Austrian Academy of Sciences and by the European Research Council (ERC-StG-336460 ChromHeritance) to K.T.-K.	Amouroux R, 2016, NAT CELL BIOL, V18, P225, DOI 10.1038/ncb3296; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Burton A, 2010, BRIEF FUNCT GENOMICS, V9, P444, DOI 10.1093/bfgp/elq027; Caron P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002460; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dietzel E, 2013, DEV CELL, V25, P106, DOI 10.1016/j.devcel.2013.03.001; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Gawecka JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056385; Gligoris TG, 2014, SCIENCE, V346, P963, DOI 10.1126/science.1256917; Goloborodko A, 2016, BIOPHYS J, V110, P2162, DOI 10.1016/j.bpj.2016.02.041; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jessberger R, 2009, EMBO J, V28, P2491, DOI 10.1038/emboj.2009.217; Jobson AG, 2007, MOL PHARMACOL, V72, P876, DOI 10.1124/mol.107.035832; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Landim-Alvarenga FC, 2002, ANIM REPROD SCI, V71, P181, DOI 10.1016/S0378-4320(02)00045-3; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Lundin C, 2003, J MOL BIOL, V328, P521, DOI 10.1016/S0022-2836(03)00313-9; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pacchierotti F, 2011, MUTAT RES-FUND MOL M, V714, P44, DOI 10.1016/j.mrfmmm.2011.06.010; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; RODMAN TC, 1981, J CELL BIOL, V90, P351, DOI 10.1083/jcb.90.2.351; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Sarkaria JN, 1999, CANCER RES, V59, P4375; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Shen L, 2014, CELL STEM CELL, V15, P459, DOI 10.1016/j.stem.2014.09.002; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077; Veuger SJ, 2003, CANCER RES, V63, P6008; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Watrin E, 2009, EMBO J, V28, P2625, DOI 10.1038/emboj.2009.202; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wohlschlegel JA, 2002, AM J PATHOL, V161, P267, DOI 10.1016/S0002-9440(10)64178-8; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu N, 2012, GENE DEV, V26, P1473, DOI 10.1101/gad.193615.112; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Yamamoto TM, 2013, BBA-GENE REGUL MECH, V1829, P1034, DOI 10.1016/j.bbagrm.2013.06.001; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhang H, 2012, Cold Spring Harb Symp Quant Biol, V77, P161, DOI 10.1101/sqb.2012.77.014936	69	42	45	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1774	+		10.1016/j.cell.2016.11.009	http://dx.doi.org/10.1016/j.cell.2016.11.009			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27916276	Green Published, hybrid			2022-12-28	WOS:000393114700016
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			CANCER IMMUNOTHERAPY Worries, confusion after cancer trial deaths	SCIENCE			English	News Item																			0	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1211	1211		10.1126/science.354.6317.1211	http://dx.doi.org/10.1126/science.354.6317.1211			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940822				2022-12-28	WOS:000389598800009
J	Iaccarino, HF; Singer, AC; Martorell, AJ; Rudenko, A; Gao, F; Gillingham, TZ; Mathys, H; Seo, J; Kritskiy, O; Abdurrob, F; Adaikkan, C; Canter, RG; Rueda, R; Brown, EN; Boyden, ES; Tsai, LH				Iaccarino, Hannah F.; Singer, Annabelle C.; Martorell, Anthony J.; Rudenko, Andrii; Gao, Fan; Gillingham, Tyler Z.; Mathys, Hansruedi; Seo, Jinsoo; Kritskiy, Oleg; Abdurrob, Fatema; Adaikkan, Chinnakkaruppan; Canter, Rebecca G.; Rueda, Richard; Brown, Emery N.; Boyden, Edward S.; Tsai, Li-Huei			Gamma frequency entrainment attenuates amyloid load and modifies microglia	NATURE			English	Article							HIPPOCAMPAL PLACE CELLS; ALZHEIMERS-DISEASE; NEURONAL-ACTIVITY; BETA DEPOSITION; NEURAL CIRCUITS; VISUAL-CORTEX; AWAKE STATE; MOUSE MODEL; OSCILLATIONS; ACTIVATION	Changes in gamma oscillations (20-50 Hz) have been observed in several neurological disorders. However, the relationship between gamma oscillations and cellular pathologies is unclear. Here we show reduced, behaviourally driven gamma oscillations before the onset of plaque formation or cognitive decline in a mouse model of Alzheimer's disease. Optogenetically driving fast-spiking parvalbumin-positive (FS-PV)-interneurons at gamma (40 Hz), but not other frequencies, reduces levels of amyloid-beta (A beta)(1-40) and A beta(1-42) isoforms. Gene expression profiling revealed induction of genes associated with morphological transformation of microglia, and histological analysis confirmed increased microglia co-localization with A beta. Subsequently, we designed a non-invasive 40 Hz light-flickering regime that reduced A beta(1-40) and A beta(1-42) levels in the visual cortex of pre-depositing mice and mitigated plaque load in aged, depositing mice. Our findings uncover a previously unappreciated function of gamma rhythms in recruiting both neuronal and glial responses to attenuate Alzheimer's-disease-associated pathology.	[Iaccarino, Hannah F.; Martorell, Anthony J.; Rudenko, Andrii; Gao, Fan; Gillingham, Tyler Z.; Mathys, Hansruedi; Seo, Jinsoo; Kritskiy, Oleg; Abdurrob, Fatema; Adaikkan, Chinnakkaruppan; Canter, Rebecca G.; Rueda, Richard; Brown, Emery N.; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Singer, Annabelle C.; Boyden, Edward S.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Iaccarino, Hannah F.; Singer, Annabelle C.; Martorell, Anthony J.; Rudenko, Andrii; Gao, Fan; Gillingham, Tyler Z.; Mathys, Hansruedi; Seo, Jinsoo; Kritskiy, Oleg; Abdurrob, Fatema; Adaikkan, Chinnakkaruppan; Canter, Rebecca G.; Rueda, Richard; Brown, Emery N.; Boyden, Edward S.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Singer, Annabelle C.; Boyden, Edward S.] MIT, Dept Biol Engn, MIT Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Singer, Annabelle C.; Boyden, Edward S.] MIT, Dept Brain & Cognit Sci, MIT Media Lab, E25-618, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Brown, Emery N.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tsai, Li-Huei] Broad Inst Harvard & MIT, Cambridge, MA 02139 USA; [Singer, Annabelle C.] Emory Univ, Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Rudenko, Andrii] CUNY, Dept Biol, New York, NY 10031 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Emory University; University System of Georgia; Georgia Institute of Technology; City University of New York (CUNY) System	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Rudenko, Andrey/AAG-4696-2020; Adaikkan, Chinnakkaruppan/Y-6415-2019; Seo, Jinsoo/AAD-4950-2019	Rudenko, Andrey/0000-0001-6858-3650; Adaikkan, Chinnakkaruppan/0000-0002-1027-1096; Seo, Jinsoo/0000-0001-6432-6964; Singer, Annabelle C./0000-0001-6003-0488; Rueda, Richard/0000-0002-0191-6921	Barbara J. Weedon Fellowship; National Institutes of Health (NIH) [1R01EY023173, 1DP1NS087724]; NATIONAL EYE INSTITUTE [R01EY023173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS087724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG047661] Funding Source: NIH RePORTER	Barbara J. Weedon Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to S. Tonegawa and D. Roy for APP/PS1 mice, and E. Demmons, W. Raja, E. Wu, and B. Arkhurst and the Boyden laboratory for technical assistance. We thank members of the Tsai and Boyden laboratories, C. Moore, C. Deister, D. Rei, J. Penney, R. Madabhushi, A. Mungenast, A. Bero, and J. Young for discussions and comments on the paper. H.F.I. acknowledges the Cameron Hayden Lord Foundation and Barbara J. Weedon Fellowship; E.S.B. acknowledges the New York Stem Cell Foundation-Robertson Award, National Institutes of Health (NIH) 1R01EY023173, and NIH 1DP1NS087724; L.H.T. acknowledges the JPB Foundation, Belfer Neurodegeneration Consortium, Halls Family Foundation. and NIH RF1 AG047661. E.S.B. and E.N.B. acknowledge NIH ROI GM104948.	Aronov D, 2014, NEURON, V84, P442, DOI 10.1016/j.neuron.2014.08.042; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carr MF, 2012, NEURON, V75, P700, DOI 10.1016/j.neuron.2012.06.014; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gillespie AK, 2016, NEURON, V90, P740, DOI 10.1016/j.neuron.2016.04.009; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Helwig M, 2013, J BIOL CHEM, V288, P1114, DOI 10.1074/jbc.M112.417071; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pericic D, 1997, EXP BRAIN RES, V115, P187, DOI 10.1007/PL00005681; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; Rossant C, 2016, NAT NEUROSCI, V19, P634, DOI 10.1038/nn.4268; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Stam CJ, 2002, J CLIN NEUROPHYSIOL, V19, P562, DOI 10.1097/00004691-200212000-00010; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yu HM, 2015, NAT NEUROSCI, V18, P836, DOI 10.1038/nn.4008; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	41	497	524	20	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					230	+		10.1038/nature20587	http://dx.doi.org/10.1038/nature20587			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27929004	Green Accepted, Green Published			2022-12-28	WOS:000389548700049
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Vocation, vocation, vocation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2016	355								i6526	10.1136/bmj.i6526	http://dx.doi.org/10.1136/bmj.i6526			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SY	27932404				2022-12-28	WOS:000390037500005
J	Shoubridge, EA				Shoubridge, Eric A.			Replacing the cell's power plants	NATURE			English	Editorial Material							MITOCHONDRIAL-DNA DISEASE; REPLACEMENT	Nuclear DNA from human eggs that harbour mutations in the DNA of organelles called mitochondria has been successfully transferred to donor eggs, bringing the prospect of therapy for mitochondrial diseases a step closer. SEE LETTER p.270	[Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Dept Human Genet, Montreal, PQ H3A 2B4, Canada	McGill University	Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Human Genet, Montreal, PQ H3A 2B4, Canada.	eric@ericpc.mni.mcgill.ca						Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature18303, 10.1038/nature183030]; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001	10	4	5	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					210	211		10.1038/nature20483	http://dx.doi.org/10.1038/nature20483			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27919076				2022-12-28	WOS:000389548700045
J	Cyranoski, D				Cyranoski, David			Gene-editing row escalates	NATURE			English	News Item																		Burgess S., 2016, PROTEIN CELL; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Lee S-H., 2016, NATURE BIOTECHNOL; Qi J, 2016, CELL RES	4	5	7	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					20	+		10.1038/nature.2016.21023	http://dx.doi.org/10.1038/nature.2016.21023			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905463	Bronze			2022-12-28	WOS:000388916600023
J	Kertesz, SG; Baggett, TP; O'Connell, JJ; Buck, DS; Kushel, MB				Kertesz, Stefan G.; Baggett, Travis P.; O'Connell, James J.; Buck, David S.; Kushel, Margot B.			Permanent Supportive Housing for Homeless People - Reframing the Debate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE; COSTS; 1ST		[Kertesz, Stefan G.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35233 USA; [Kertesz, Stefan G.] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA; [Baggett, Travis P.; O'Connell, James J.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Baggett, Travis P.; O'Connell, James J.] Boston Hlth Care Homeless Program, Boston, MA USA; [Buck, David S.] Baylor Coll Med, Houston, TX 77030 USA; [Buck, David S.] Healthcare Homeless Houston, Houston, TX USA; [Kushel, Margot B.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kushel, Margot B.] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard Medical School; Massachusetts General Hospital; Baylor College of Medicine; University of California System; University of California San Francisco	Kertesz, SG (corresponding author), Birmingham Vet Affairs Med Ctr, Birmingham, AL 35233 USA.; Kertesz, SG (corresponding author), Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA.			Kushel, Margot/0000-0002-1361-6889; Kertesz, Stefan/0000-0001-6101-8421				Aubry T, 2015, CAN J PSYCHIAT, V60, P467, DOI 10.1177/070674371506001102; Henry M, 2015, AHAR 1; Johnson TL, 2015, HEALTH AFFAIR, V34, P1312, DOI 10.1377/hlthaff.2014.1186; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Ly A, 2015, CAN J PSYCHIAT, V60, P475, DOI 10.1177/070674371506001103	5	28	28	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					2115	2117		10.1056/NEJMp1608326	http://dx.doi.org/10.1056/NEJMp1608326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED7GN	27959753				2022-12-28	WOS:000389030400002
J	Mayor, S				Mayor, Susan			Biological treatment is approved for severe eosinophilic asthma	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2016, FIN APPR DET MEP TRE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2016	355								i6472	10.1136/bmj.i6472	http://dx.doi.org/10.1136/bmj.i6472			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZO	27908911				2022-12-28	WOS:000389309800010
J	Nelson, KB; Sartwelle, TP; Rouse, DJ				Nelson, Karin B.; Sartwelle, Thomas P.; Rouse, Dwight J.			Electronic fetal monitoring, cerebral palsy, and caesarean section: assumptions versus evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEART-RATE; LITIGATION; DELIVERY; AUSCULTATION; TRIALS; HEALTH; TRENDS; BORN; RISK		[Nelson, Karin B.] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Sartwelle, Thomas P.] Deans & Lyons, Houston, TX USA; [Rouse, Dwight J.] Women & Infants Hosp Rhode Isl, Providence, RI 02908 USA; [Rouse, Dwight J.] Brown Univ, Providence, RI 02912 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Women & Infants Hospital Rhode Island; Brown University	Nelson, KB (corresponding author), NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	nelsonk@ninds.nih.gov						Alfirevic Z, 2013, COCHRANE DB SYST REV, V5; American College of Obstetricians and Gynecologists American Academy of Pediatrics, 2014, NEON ENC NEUR OUTC, P88; Ananth CV, 2013, OBSTET GYNECOL, V121, P927, DOI 10.1097/AOG.0b013e318289510d; Anderson A., 2013, CLIN RISK, V19, P24, DOI [10.1177/1356262213486434, DOI 10.1177/1356262213486434]; [Anonymous], 2015, NHS MATERNITY STAT E; Ayres-de-Campos D, 2011, BJOG-INT J OBSTET GY, V118, P978, DOI 10.1111/j.1471-0528.2011.03003.x; Barber EL, 2011, OBSTET GYNECOL, V118, P29, DOI 10.1097/AOG.0b013e31821e5f65; Bloom SL, 2016, SEMIN PERINATOL, V40, P307, DOI 10.1053/j.semperi.2016.03.008; Cahill AG, 2009, OBSTET GYNECOL, V114, P124, DOI [10.1097/AOG.0b013e3181a99def, 10.1097/AOG.0b013e3181aef106]; Carpentieri AM, 2015, OVERVIEW 2015 AM C O; Clark SL, 2003, AM J OBSTET GYNECOL, V188, P628, DOI 10.1067/mob.2003.204; Constantine MM, 2012, SEMIN PERINATOL, V36, P379, DOI DOI 10.1053/J.SEMPERI.2012.04.023; Curtin Sally C, 2015, Natl Vital Stat Rep, V64, P1; Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24; Donn SM, 2014, SEMIN FETAL NEONAT M, V19, P317, DOI 10.1016/j.siny.2014.08.005; EMOND A, 1989, ARCH DIS CHILD, V64, P848, DOI 10.1136/adc.64.6.848; Goodwin L, 2000, J PERINAT NEONAT NUR, V14, P53, DOI 10.1097/00005237-200012000-00005; Graham EM, 2006, OBSTET GYNECOL, V108, P656, DOI 10.1097/01.AOG.0000230533.62760.ef; GRANT A, 1989, LANCET, V2, P1233; Grimes DA, 2010, OBSTET GYNECOL, V116, P1397, DOI 10.1097/AOG.0b013e3181fae39f; Hankins GDV, 2006, OBSTET GYNECOL, V107, P1382, DOI 10.1097/01.AOG.0000220531.25707.27; Hornbuckle J, 2000, BRIT J OBSTET GYNAEC, V107, P3, DOI 10.1111/j.1471-0528.2000.tb11571.x; Lear CA, 2016, J PHYSIOL-LONDON, V594, P4711, DOI 10.1113/JP271205; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Minkoff H, 2012, SEMIN PERINATOL, V36, P390, DOI 10.1053/j.semperi.2012.04.025; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; Nelson KB, 2015, NEW ENGL J MED, V373, P946, DOI 10.1056/NEJMra1505261; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; NELSON KB, 1986, NEW ENGL J MED, V315, P81, DOI 10.1056/NEJM198607103150202; Reif P, 2016, BJOG-INT J OBSTET GY, V123, P2208, DOI 10.1111/1471-0528.13882; Sabiani L, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.066; Sachs BP, 1989, I MED US COMMITTEE S; Sartwelle TP, 2015, J CHILD NEUROL, V30, P828, DOI 10.1177/0883073814543306; SHY KK, 1990, NEW ENGL J MED, V322, P588, DOI 10.1056/NEJM199003013220904; Silver RM, 2012, SEMIN PERINATOL, V36, P315, DOI 10.1053/j.semperi.2012.04.013; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; WISE J, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6737; Xu X, 2015, HEALTH AFFAIR, V34, P1212, DOI 10.1377/hlthaff.2014.1088	38	24	25	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2016	355								i6405	10.1136/bmj.i6405	http://dx.doi.org/10.1136/bmj.i6405			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZO	27908902	Green Published			2022-12-28	WOS:000389309800004
J	Safikhani, Z; El-Hachem, N; Smirnov, P; Freeman, M; Goldenberg, A; Birkbak, NJ; Beck, AH; Aerts, HJWL; Quackenbush, J; Haibe-Kains, B				Safikhani, Zhaleh; El-Hachem, Nehme; Smirnov, Petr; Freeman, Mark; Goldenberg, Anna; Birkbak, Nicolai J.; Beck, Andrew H.; Aerts, Hugo J. W. L.; Quackenbush, John; Haibe-Kains, Benjamin			Drug response consistency in CCLE and CGP Reply	NATURE			English	Letter							SENSITIVITY		[Safikhani, Zhaleh; Smirnov, Petr; Freeman, Mark; Haibe-Kains, Benjamin] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Safikhani, Zhaleh; Haibe-Kains, Benjamin] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [El-Hachem, Nehme] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Goldenberg, Anna] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Goldenberg, Anna; Haibe-Kains, Benjamin] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; [Birkbak, Nicolai J.] UCL, Francis Crick Inst, London NW1 1AT, England; [Beck, Andrew H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Beck, Andrew H.; Aerts, Hugo J. W. L.] Harvard Med Sch, Boston, MA 02115 USA; [Aerts, Hugo J. W. L.; Quackenbush, John] Dana Farber Canc Inst, Boston, MA 02115 USA; [Aerts, Hugo J. W. L.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Quackenbush, John] Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Haibe-Kains, Benjamin] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Francis Crick Institute; University of London; University College London; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Haibe-Kains, B (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Haibe-Kains, B (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.; Haibe-Kains, B (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada.; Haibe-Kains, B (corresponding author), Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada.	benjamin.haibe.kains@utoronto.ca	Aerts, Hugo/ABF-2821-2020; Smirnov, Petr A/N-9652-2015; Haibe-Kains, Benjamin/D-3702-2011	Aerts, Hugo/0000-0002-2122-2003; El-Hachem, Nehme/0000-0002-5778-5342; Birkbak, Nicolai/0000-0003-1613-9587; Haibe-Kains, Benjamin/0000-0002-7684-0079				Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bouhaddou M, 2016, NATURE, V540, pE9, DOI 10.1038/nature20580; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mpindi JP, 2016, NATURE, V540, pE5, DOI 10.1038/nature20171; Pozdeyev N., 2016, ONCOTARGET; Safikhani Z., 2016, F1000RESEARCH; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Smirnov P, 2016, BIOINFORMATICS, V32, P1244, DOI 10.1093/bioinformatics/btv723	13	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					E11	E12		10.1038/nature20581	http://dx.doi.org/10.1038/nature20581			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905423				2022-12-28	WOS:000388916600013
J	Das, P				Das, Pamela			Deborah L Birx: on a mission to end the HIV/AIDS epidemic	LANCET			English	Biographical-Item																		BIRX DL, PUBLICATION LIST	1	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2583	2583		10.1016/S0140-6736(16)32227-9	http://dx.doi.org/10.1016/S0140-6736(16)32227-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED0EW	27894655				2022-12-28	WOS:000388516800015
J	Welch, JS; Petti, AA; Miller, CA; Fronick, CC; O'Laughlin, M; Fulton, RS; Wilson, RK; Baty, JD; Duncavage, EJ; Tandon, B; Lee, YS; Wartman, LD; Uy, GL; Ghobadi, A; Tomasson, MH; Pusic, I; Romee, R; Fehniger, TA; Stockerl-Goldstein, KE; Vij, R; Oh, ST; Abboud, CN; Cashen, AF; Schroeder, MA; Jacoby, MA; Heath, SE; Luber, K; Janke, MR; Hantel, A; Khan, N; Sukhanova, MJ; Knoebel, RW; Stock, W; Graubert, TA; Walter, MJ; Westervelt, P; Link, DC; DiPersio, JF; Ley, TJ				Welch, J. S.; Petti, A. A.; Miller, C. A.; Fronick, C. C.; O'Laughlin, M.; Fulton, R. S.; Wilson, R. K.; Baty, J. D.; Duncavage, E. J.; Tandon, B.; Lee, Y-S; Wartman, L. D.; Uy, G. L.; Ghobadi, A.; Tomasson, M. H.; Pusic, I.; Romee, R.; Fehniger, T. A.; Stockerl-Goldstein, K. E.; Vij, R.; Oh, S. T.; Abboud, C. N.; Cashen, A. F.; Schroeder, M. A.; Jacoby, M. A.; Heath, S. E.; Luber, K.; Janke, M. R.; Hantel, A.; Khan, N.; Sukhanova, M. J.; Knoebel, R. W.; Stock, W.; Graubert, T. A.; Walter, M. J.; Westervelt, P.; Link, D. C.; DiPersio, J. F.; Ley, T. J.			TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL WORKING GROUP; HYPOMETHYLATING AGENTS; CLONAL HEMATOPOIESIS; COMPLEX KARYOTYPE; RESPONSE CRITERIA; DNA METHYLATION; TET2 MUTATIONS; OLDER PATIENTS; IN-VIVO; THERAPY	BACKGROUND The molecular determinants of clinical responses to decitabine therapy in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) are unclear. METHODS We enrolled 84 adult patients with AML or MDS in a single-institution trial of decitabine to identify somatic mutations and their relationships to clinical responses. Decitabine was administered at a dose of 20 mg per square meter of body-surface area per day for 10 consecutive days in monthly cycles. We performed enhanced exome or gene-panel sequencing in 67 of these patients and serial sequencing at multiple time points to evaluate patterns of mutation clearance in 54 patients. An extension cohort included 32 additional patients who received decitabine in different protocols. RESULTS Of the 116 patients, 53 (46%) had bone marrow blast clearance (<5% blasts). Response rates were higher among patients with an unfavorable-risk cytogenetic profile than among patients with an intermediate-risk or favorable-risk cytogenetic profile (29 of 43 patients [67%] vs. 24 of 71 patients [34%], P<0.001) and among patients with TP53 mutations than among patients with wild-type TP53 (21 of 21 [100%] vs. 32 of 78 [41%], P<0.001). Previous studies have consistently shown that patients with an unfavorable-risk cytogenetic profile and TP53 mutations who receive conventional chemotherapy have poor outcomes. However, in this study of 10-day courses of decitabine, neither of these risk factors was associated with a lower rate of overall survival than the rate of survival among study patients with intermediate-risk cytogenetic profiles. CONCLUSIONS Patients with AML and MDS who had cytogenetic abnormalities associated with unfavorable risk, TP53 mutations, or both had favorable clinical responses and robust (but incomplete) mutation clearance after receiving serial 10-day courses of decitabine. Although these responses were not durable, they resulted in rates of overall survival that were similar to those among patients with AML who had an intermediate-risk cytogenetic profile and who also received serial 10-day courses of decitabine. (Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT01687400.)	[Welch, J. S.; Wartman, L. D.; Uy, G. L.; Ghobadi, A.; Tomasson, M. H.; Pusic, I.; Romee, R.; Fehniger, T. A.; Stockerl-Goldstein, K. E.; Vij, R.; Oh, S. T.; Abboud, C. N.; Cashen, A. F.; Schroeder, M. A.; Jacoby, M. A.; Heath, S. E.; Luber, K.; Janke, M. R.; Walter, M. J.; Westervelt, P.; Link, D. C.; DiPersio, J. F.; Ley, T. J.] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Baty, J. D.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Duncavage, E. J.; Tandon, B.; Lee, Y-S] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Petti, A. A.; Miller, C. A.; Fronick, C. C.; O'Laughlin, M.; Fulton, R. S.; Wilson, R. K.; Wartman, L. D.; Ley, T. J.] Washington Univ, McDonnell Genome Inst, St Louis, MO USA; [Hantel, A.; Khan, N.; Sukhanova, M. J.; Stock, W.] Univ Chicago, Dept Internal Med, Chicago, IL 60637 USA; [Knoebel, R. W.] Univ Chicago, Dept Pharm, Chicago, IL 60637 USA; [Graubert, T. A.] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Chicago; University of Chicago; Harvard University; Massachusetts General Hospital	Ley, TJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med, 660 S Euclid Ave,Box 8007, St Louis, MO 63110 USA.	timley@wustl.edu	Uy, Geoffrey/AAD-9815-2021; Miller, Christopher A./A-1060-2009; Knoebel, Randall/AAW-3319-2020; Walter, Matthew J/S-7758-2018; Wilson, Richard K./AAF-4139-2019; Hantel, Andrew/AAV-5385-2021	Miller, Christopher A./0000-0003-4266-6700; Knoebel, Randall/0000-0002-0166-4955; Wilson, Richard K./0000-0002-1992-1358; Hantel, Andrew/0000-0001-9612-3643; Uy, Geoffrey/0000-0002-7809-0996; Tomasson, Michael/0000-0003-4518-7123; Khan, Niloufer/0000-0002-8631-5710; Stockerl-Goldstein, Keith/0000-0002-7234-1715	Specialized Program of Research Excellence in AML of the National Cancer Institute [P50 CA171963]; Genomics of AML Program Project [P01 CA101937]; Novartis; Quintiles; Agios; NATIONAL CANCER INSTITUTE [P50CA171963, K12CA167540, K08CA166229, R35CA197561, P30CA086862, P01CA101937] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128447] Funding Source: NIH RePORTER	Specialized Program of Research Excellence in AML of the National Cancer Institute; Genomics of AML Program Project; Novartis(Novartis); Quintiles; Agios; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the Specialized Program of Research Excellence in AML of the National Cancer Institute (P50 CA171963, to Dr. Link) and the Genomics of AML Program Project (P01 CA101937, to Dr. Ley). Three patients received treatment in the LBH589 Plus Decitabine for Myelodysplastic Syndromes or Acute Myeloid Leukemia trial, which was supported by Novartis.; Dr. Uy reports receiving fees for serving on an advisory board and clinical-trial support from Novartis; Dr. Jacoby, receiving consulting fees and fees for end-point adjudication from Quintiles and clinical-trial support from Sunesis Pharmaceuticals; and Dr. Graubert, receiving consulting fees from Agios. No other potential conflict of interest relevant to this article was reported.	Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; Blum W, 2010, P NATL ACAD SCI USA, V107, P7473, DOI 10.1073/pnas.1002650107; Bowen D, 2009, LEUKEMIA, V23, P203, DOI 10.1038/leu.2008.173; Cabrero M, 2015, LEUKEMIA RES, V39, P520, DOI 10.1016/j.leukres.2015.03.006; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; DiNardo CD, 2014, LEUKEMIA LYMPHOMA, V55, P1925, DOI 10.3109/10428194.2013.855309; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Hou HA, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.59; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kim TK, 2015, SEMIN HEMATOL, V52, P172, DOI 10.1053/j.seminhematol.2015.04.003; Klco JM, 2015, JAMA-J AM MED ASSOC, V314, P811, DOI 10.1001/jama.2015.9643; Klco JM, 2013, BLOOD, V121, P1633, DOI 10.1182/blood-2012-09-459313; Klepin HD, 2016, CLIN GERIATR MED, V32, P155, DOI 10.1016/j.cger.2015.08.010; Lafouresse F, 2015, BLOOD, V126, P1336, DOI 10.1182/blood-2015-02-626291; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Lubbert M, 2016, ANN HEMATOL, V95, P191, DOI 10.1007/s00277-015-2547-0; Malik P, 2014, CANCER MANAG RES, V6, P53, DOI 10.2147/CMAR.S40600; Metzeler KH, 2012, LEUKEMIA, V26, P1106, DOI 10.1038/leu.2011.342; Middeke JM, 2016, BRIT J HAEMATOL, V172, P914, DOI 10.1111/bjh.13912; Ohgami RS, 2015, MODERN PATHOL, V28, P706, DOI 10.1038/modpathol.2014.160; Ravandi F, 2009, CANCER-AM CANCER SOC, V115, P5746, DOI 10.1002/cncr.24661; Ritchie EK, 2013, LEUKEMIA LYMPHOMA, V54, P2003, DOI 10.3109/10428194.2012.762093; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Sallman DA, 2016, LEUKEMIA, V30, P666, DOI 10.1038/leu.2015.304; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Song LX, 2012, ANN HEMATOL, V91, P1879, DOI 10.1007/s00277-012-1550-y; Wong TN, 2016, BLOOD, V127, P893, DOI 10.1182/blood-2015-10-677021; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yan P, 2012, BLOOD, V120, P2466, DOI 10.1182/blood-2012-05-429175	36	502	525	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2023	2036		10.1056/NEJMoa1605949	http://dx.doi.org/10.1056/NEJMoa1605949			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC9KU	27959731	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000388464300005
J	Ungaro, R; Mehandru, S; Allen, PB; Peyrin-Biroulet, L; Colombel, JF				Ungaro, Ryan; Mehandru, Saurabh; Allen, Patrick B.; Peyrin-Biroulet, Laurent; Colombel, Jean-Frederic			Ulcerative colitis	LANCET			English	Review							INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; POUCH-ANAL ANASTOMOSIS; C-REACTIVE PROTEIN; CLOSTRIDIUM-DIFFICILE INFECTION; VENOUS THROMBOEMBOLIC EVENTS; ENVIRONMENTAL RISK-FACTORS; INNATE LYMPHOID-CELLS; CROHNS-DISEASE; FECAL CALPROTECTIN	Ulcerative colitis is a chronic inflammatory disease affecting the colon, and its incidence is rising worldwide. The pathogenesis is multifactorial, involving genetic predisposition, epithelial barrier defects, dysregulated immune responses, and environmental factors. Patients with ulcerative colitis have mucosal inflammation starting in the rectum that can extend continuously to proximal segments of the colon. Ulcerative colitis usually presents with bloody diarrhoea and is diagnosed by colonoscopy and histological findings. The aim of management is to induce and then maintain remission, defined as resolution of symptoms and endoscopic healing. Treatments for ulcerative colitis include 5-aminosalicylic acid drugs, steroids, and immunosuppressants. Some patients can require colectomy for medically refractory disease or to treat colonic neoplasia. The therapeutic armamentarium for ulcerative colitis is expanding, and the number of drugs with new targets will rapidly increase in coming years.	[Ungaro, Ryan; Mehandru, Saurabh; Colombel, Jean-Frederic] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA; [Mehandru, Saurabh] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Allen, Patrick B.] Ulster Hosp, Div Gastroenterol, Belfast, Antrim, North Ireland; [Peyrin-Biroulet, Laurent] Univ Hosp Nancy Brabois, Dept Gastroenterol, Vandoeuvre Les Nancy, France	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; CHU de Nancy	Colombel, JF (corresponding author), Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA.	jean-frederic.colombel@mssm.edu		peyrin-biroulet, laurent/0000-0003-2536-6618	SUCCESS (Sinai Ulcerative Colitis Clinical, Experimental and System Studies) grant [GCO14-0560]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001435] Funding Source: NIH RePORTER	SUCCESS (Sinai Ulcerative Colitis Clinical, Experimental and System Studies) grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We would like to acknowledge and thank academic medical illustrator Jill Gregory for her wonderful help with figure conception and design. We would like to thank Jerome Waye, Mabel Ko, and Aude Marchal-Bressenot for their help in providing endoscopic and histological images. This Seminar was supported in part by the SUCCESS (Sinai Ulcerative Colitis Clinical, Experimental and System Studies) grant (GCO14-0560).	Abreu MT, 2007, CLIN GASTROENTEROL H, V5, P295, DOI 10.1016/j.cgh.2006.12.032; Adedokun OJ, 2014, GASTROENTEROLOGY, V147, P1296, DOI 10.1053/j.gastro.2014.08.035; Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Ananthakrishnan AN, 2008, GUT, V57, P205, DOI 10.1136/gut.2007.128231; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Ananthakrishnan AN, 2014, CLIN GASTROENTEROL H, V12, P1905, DOI 10.1016/j.cgh.2014.02.034; Ananthakrishnan AN, 2012, ANN INTERN MED, V156, P350, DOI 10.7326/0003-4819-156-5-201203060-00007; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Annese V, 2015, J CROHNS COLITIS, V9, P945, DOI 10.1093/ecco-jcc/jjv141; Annese V, 2013, J CROHNS COLITIS, V7, P982, DOI 10.1016/j.crohns.2013.09.016; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bartels SAL, 2012, ANN SURG, V256, P1045, DOI 10.1097/SLA.0b013e318250caa9; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Beaugerie L, 2001, AM J GASTROENTEROL, V96, P2113, DOI 10.1016/S0002-9270(01)02507-2; Beaugerie L, 2015, NEW ENGL J MED, V372, P1441, DOI 10.1056/NEJMra1403718; Ben-Horin S, 2014, AUTOIMMUN REV, V13, P24, DOI 10.1016/j.autrev.2013.06.002; Benchimol EI, 2015, AM J GASTROENTEROL, V110, P553, DOI 10.1038/ajg.2015.52; Benchimol EI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123599; Bengtson MB, 2009, J CROHNS COLITIS, V3, P92, DOI 10.1016/j.crohns.2008.11.002; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; BERNSTEIN CN, 1995, GASTROINTEST ENDOSC, V42, P232, DOI 10.1016/S0016-5107(95)70097-8; Beyer-Berjot L, 2013, ANN SURG, V258, P275, DOI 10.1097/SLA.0b013e3182813741; Biancone L, 2008, J CROHNS COLITIS, V2, P63, DOI 10.1016/j.crohns.2007.12.001; Birrenbach T, 2004, INFLAMM BOWEL DIS, V10, P848, DOI 10.1097/00054725-200411000-00019; Bressler B, 2015, GASTROENTEROLOGY, V148, P1035, DOI 10.1053/j.gastro.2015.03.001; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burisch J, 2014, GUT, V63, P588, DOI 10.1136/gutjnl-2013-304636; Burns EM, 2011, BRIT J SURG, V98, P408, DOI 10.1002/bjs.7312; Carbonnel F, 2016, GASTROENTEROLOGY, V150, P380, DOI 10.1053/j.gastro.2015.10.050; Carr I, 1999, AM J GASTROENTEROL, V94, P2918, DOI 10.1016/S0002-9270(99)00494-3; Chande N, 2014, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD007560.PUB3; Charpentier C, 2014, GUT, V63, P423, DOI 10.1136/gutjnl-2012-303864; Choi CHR, 2015, AM J GASTROENTEROL, V110, P1022, DOI 10.1038/ajg.2015.65; Cohen RD, 2010, ALIMENT PHARM THER, V31, P693, DOI 10.1111/j.1365-2036.2010.04234.x; Colombel JF, 2017, GUT, V66, P839, DOI 10.1136/gutjnl-2015-311079; Colombel JF, 2016, GASTROENTEROLOGY, V150, P389, DOI 10.1053/j.gastro.2015.10.016; Cornish JA, 2008, AM J GASTROENTEROL, V103, P2394, DOI 10.1111/j.1572-0241.2008.02064.x; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Danese S, 2014, ALIMENT PHARM THER, V39, P1095, DOI 10.1111/apt.12712; Danese S, 2013, J CROHNS COLITIS, V7, P586, DOI 10.1016/j.crohns.2013.03.011; DHaens G, 1997, AM J GASTROENTEROL, V92, P1275; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Duijvis NW, 2016, J CROHNS COLITIS, V10, P821, DOI 10.1093/ecco-jcc/jjw031; Farkas K, 2016, J CROHNS COLITIS, V10, P1273, DOI 10.1093/ecco-jcc/jjw085; Fazio VW, 2013, ANN SURG, V257, P679, DOI 10.1097/SLA.0b013e31827d99a2; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Feagan BG, 2013, INFLAMM BOWEL DIS, V19, P2031, DOI 10.1097/MIB.0b013e3182920108; Feagan BG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000544.pub3; Ford AC, 2011, AM J GASTROENTEROL, V106, P601, DOI 10.1038/ajg.2011.67; Ford AC, 2011, AM J GASTROENTEROL, V106, P590, DOI 10.1038/ajg.2011.70; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Geng X, 1998, GASTROENTEROLOGY, V114, P912, DOI 10.1016/S0016-5085(98)70310-5; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Gionchetti P, 1998, DIS COLON RECTUM, V41, P93, DOI 10.1007/BF02236902; Gower-Rousseau C, 2015, GUT, DOI [10.1136/gutjn1-2015-310151, DOI 10.1136/GUTJN1-2015-310151]; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Halme L, 2006, WORLD J GASTROENTERO, V12, P3668, DOI 10.3748/wjg.v12.i23.3668; Hanai H, 2004, DIGEST DIS SCI, V49, P1438, DOI 10.1023/B:DDAS.0000042243.47279.87; Harbord M, 2016, J CROHNS COLITIS, V10, P239, DOI 10.1093/ecco-jcc/jjv213; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Heikkila K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088711; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Higgins PDR, 2015, CLIN GASTROENTEROL H, V13, P316, DOI 10.1016/j.cgh.2014.07.017; Ho GT, 2004, ALIMENT PHARM THER, V19, P1079, DOI 10.1111/j.1365-2036.2004.01945.x; Hoivik ML, 2013, GUT, V62, P368, DOI 10.1136/gutjnl-2012-302311; Hviid A, 2011, GUT, V60, P49, DOI 10.1136/gut.2010.219683; Inoue S, 1999, AM J GASTROENTEROL, V94, P2441; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; Jharap B, 2015, ALIMENT PHARM THER, V42, P1082, DOI 10.1111/apt.13387; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Etchevers MJ, 2009, INFLAMM BOWEL DIS, V15, P1320, DOI 10.1002/ibd.20897; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kani HT, 2015, INFLAMM BOWEL DIS, V21, P716, DOI 10.1097/MIB.0000000000000226; Kaplan GG, 2008, GASTROENTEROLOGY, V134, P680, DOI 10.1053/j.gastro.2008.01.004; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kelly CR, 2014, AM J GASTROENTEROL, V109, P1065, DOI 10.1038/ajg.2014.133; Khalili H, 2012, GASTROENTEROLOGY, V143, P1199, DOI 10.1053/j.gastro.2012.07.096; Khanna R, 2016, GASTROENTEROLOGY, V150, P1056, DOI 10.1053/j.gastro.2016.03.013; Klement E, 2004, AM J CLIN NUTR, V80, P1342, DOI 10.1093/ajcn/80.5.1342; Ko Y, 2015, CLIN GASTROENTEROL H, V13, P1453, DOI 10.1016/j.cgh.2015.02.045; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; KOZAREK RA, 1989, ANN INTERN MED, V110, P353, DOI 10.7326/0003-4819-110-5-353; Laharie D, 2012, LANCET, V380, P1909, DOI 10.1016/S0140-6736(12)61084-8; Laine L, 2015, GASTROENTEROLOGY, V148, P639, DOI 10.1053/j.gastro.2015.01.031; Lang A, 2015, CLIN GASTROENTEROL H, V13, P1444, DOI 10.1016/j.cgh.2015.02.019; LENNARDJONES JE, 1975, GUT, V16, P579, DOI 10.1136/gut.16.8.579; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Lie MRKL, 2014, INFLAMM BOWEL DIS, V20, P2157, DOI 10.1097/MIB.0000000000000141; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Lynch RW, 2013, ALIMENT PHARM THER, V38, P935, DOI 10.1111/apt.12473; Magro F, 2013, J CROHNS COLITIS, V7, P827, DOI 10.1016/j.crohns.2013.06.001; Magro F, 2012, INFLAMM BOWEL DIS, V18, P573, DOI 10.1002/ibd.21815; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Marchal-Bressenot A, 2017, GUT, V66, P43, DOI 10.1136/gutjnl-2015-310187; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Menees SB, 2015, AM J GASTROENTEROL, V110, P444, DOI 10.1038/ajg.2015.6; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Moller FT, 2015, AM J GASTROENTEROL, V110, P564, DOI 10.1038/ajg.2015.50; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mosli MH, 2017, GUT, V66, P50, DOI 10.1136/gutjnl-2015-310393; Mosli MH, 2015, AM J GASTROENTEROL, V110, P802, DOI 10.1038/ajg.2015.120; Mulder CJJ, 1996, EUR J GASTROEN HEPAT, V8, P549, DOI 10.1097/00042737-199606000-00010; Ng SC, 2015, GUT, V64, P1063, DOI 10.1136/gutjnl-2014-307410; Ng SC, 2013, GASTROENTEROLOGY, V145, P158, DOI 10.1053/j.gastro.2013.04.007; Nguyen GC, 2008, AM J GASTROENTEROL, V103, P1443, DOI 10.1111/j.1572-0241.2007.01780.x; Nguyen GC, 2014, GASTROENTEROLOGY, V146, P835, DOI 10.1053/j.gastro.2014.01.042; Odes HS, 2001, DIGEST DIS SCI, V46, P1717, DOI 10.1023/A:1010609722315; Oresland T, 2015, J CROHNS COLITIS, V9, P4, DOI 10.1016/j.crohns.2014.08.012; Panaccione R, 2014, GASTROENTEROLOGY, V146, P392, DOI 10.1053/j.gastro.2013.10.052; Panes J, 2013, J CROHNS COLITIS, V7, P556, DOI 10.1016/j.crohns.2013.02.020; Paramsoth S, 2016, 11 C EUR CROHNS COL; Park SH, 2014, DIGEST DIS SCI, V59, P2050, DOI 10.1007/s10620-014-3129-z; Peter S, 2008, INFLAMM BOWEL DIS, V14, P1287, DOI 10.1002/ibd.20398; Peyrin-Biroulet L, 2015, AM J GASTROENTEROL, V110, P1324, DOI 10.1038/ajg.2015.233; Peyrin-Biroulet L, 2014, CLIN GASTROENTEROL H, V12, P929, DOI 10.1016/j.cgh.2013.07.022; Peyrin-Biroulet L, 2011, GASTROENTEROLOGY, V141, P1621, DOI 10.1053/j.gastro.2011.06.050; PODOLSKY DK, 1984, GASTROENTEROLOGY, V87, P991; Randall J, 2010, BRIT J SURG, V97, P404, DOI 10.1002/bjs.6874; Reese GE, 2006, AM J GASTROENTEROL, V101, P2410, DOI 10.1111/j.1572-0241.2006.00840.x; Regueiro M, 2011, INFLAMM BOWEL DIS, V17, P1008, DOI 10.1002/ibd.21445; Reinisch W, 2015, CLIN GASTROENTEROL H, V13, P635, DOI 10.1016/j.cgh.2014.03.037; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Roblin X, 2014, CLIN GASTROENTEROL H, V12, P80, DOI 10.1016/j.cgh.2013.07.010; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sahami S, 2016, AM J GASTROENTEROL, V111, P163, DOI 10.1038/ajg.2015.301; Sandborn WJ, 2015, ALIMENT PHARM THER, V41, P409, DOI 10.1111/apt.13076; Sandborn WJ, 2016, NEW ENGL J MED, V374, P1754, DOI 10.1056/NEJMoa1513248; Sandborn WJ, 2016, GASTROENTEROLOGY, V150, P96, DOI 10.1053/j.gastro.2015.09.001; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P85, DOI 10.1053/j.gastro.2013.05.048; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Sands BE, 2015, GASTROENTEROLOGY, V149, P1275, DOI 10.1053/j.gastro.2015.07.003; Schoepfer AM, 2013, INFLAMM BOWEL DIS, V19, P332, DOI 10.1097/MIB.0b013e3182810066; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Senhaji N, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0206-x; Shah SC, 2016, CLIN GASTROENTEROL H, V14, P1245, DOI 10.1016/j.cgh.2016.01.015; Shapiro JM, 2016, INFLAMM BOWEL DIS, V22, P1456, DOI 10.1097/MIB.0000000000000745; Shen B, 2001, INFLAMM BOWEL DIS, V7, P301, DOI 10.1097/00054725-200111000-00004; Shen B, 2013, CLIN GASTROENTEROL H, V11, P1538, DOI 10.1016/j.cgh.2013.03.033; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; Siebert U, 2013, INFLAMM BOWEL DIS, V19, P847, DOI 10.1097/MIB.0b013e31827f278e; Siegel CA, 2018, GUT, V67, P244, DOI 10.1136/gutjnl-2016-312648; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sinclair JA, 2012, GASTROENTEROL CLIN N, V41, P325, DOI 10.1016/j.gtc.2012.01.006; Singh S, 2014, CLIN GASTROENTEROL H, V12, P210, DOI 10.1016/j.cgh.2013.04.033; Soetikno RM, 2002, GASTROINTEST ENDOSC, V56, P48, DOI 10.1067/mge.2002.125367; Solberg IC, 2015, SCAND J GASTROENTERO, V50, P1456, DOI 10.3109/00365521.2015.1064991; Sood A, 2003, GUT, V52, P1587, DOI 10.1136/gut.52.11.1587; Soon IS, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-51; Torres J, 2012, INFLAMM BOWEL DIS, V18, P1356, DOI 10.1002/ibd.22839; Tozun N, 2009, J CLIN GASTROENTEROL, V43, P51, DOI 10.1097/MCG.0b013e3181574636; Travis SPL, 2012, GUT, V61, P535, DOI 10.1136/gutjnl-2011-300486; Turner D, 2007, CLIN GASTROENTEROL H, V5, P103, DOI 10.1016/j.cgh.2006.09.033; Ungaro R, 2014, AM J GASTROENTEROL, V109, P1728, DOI 10.1038/ajg.2014.246; Van Assche G, 2015, AM J GASTROENTEROL, V110, P708, DOI 10.1038/ajg.2015.114; Vande Casteele N, 2015, GASTROENTEROLOGY, V148, P1320, DOI 10.1053/j.gastro.2015.02.031; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1794, DOI 10.1097/MIB.0000000000000429; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343; Vermeire S, 2014, LANCET, V384, P309, DOI 10.1016/S0140-6736(14)60661-9; Victoria Carlos Roberto, 2009, Arq. Gastroenterol., V46, P20, DOI 10.1590/S0004-28032009000100009; Waljee A, 2006, GUT, V55, P1575, DOI 10.1136/gut.2005.090316; Walmsley RS, 1998, GUT, V43, P29, DOI 10.1136/gut.43.1.29; Yarur AJ, 2014, WORLD J GASTROENTERO, V20, P3475, DOI 10.3748/wjg.v20.i13.3475; Yoshimura N, 2015, GASTROENTEROLOGY, V149, P1775, DOI 10.1053/j.gastro.2015.08.044; Zenlea T, 2016, AM J GASTROENTEROL, V111, P685, DOI 10.1038/ajg.2016.50	183	1348	1430	127	670	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2017	389	10080					1756	1770		10.1016/S0140-6736(16)32126-2	http://dx.doi.org/10.1016/S0140-6736(16)32126-2			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET3BG	27914657	Green Accepted			2022-12-28	WOS:000400151000033
J	Kodati, S; Palmore, TN; Spellman, FA; Cunningham, D; Weistrop, B; Sen, HN				Kodati, Shilpa; Palmore, Tara N.; Spellman, Frank A.; Cunningham, Denise; Weistrop, Benjamin; Sen, H. Nida			Bilateral posterior uveitis associated with Zika virus infection	LANCET			English	Editorial Material									[Kodati, Shilpa; Cunningham, Denise; Sen, H. Nida] NEI, Immunol Lab, Bldg 10, Bethesda, MD 20892 USA; [Palmore, Tara N.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Spellman, Frank A.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Spellman, Frank A.] Retina Grp Washington, Washington, DC USA; [Weistrop, Benjamin] New York Med Coll, Valhalla, NY 10595 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; New York Medical College	Sen, HN (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	senh@nei.nih.gov			NATIONAL EYE INSTITUTE [ZIAEY000557] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267; Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618; Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079; Parke D Wilkin 3rd, 2016, Ophthalmology, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039; Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417	5	40	41	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2017	389	10064					125	126		10.1016/S0140-6736(16)32518-1	http://dx.doi.org/10.1016/S0140-6736(16)32518-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG7VH	27939402				2022-12-28	WOS:000391264000044
J	Baron, RJ; Braddock, CH				Baron, Richard J.; Braddock, Clarence H., III			Knowing What We Don't Know - Improving Maintenance of Certification	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baron, Richard J.] Amer Board Internal Med, Philadelphia, PA 19106 USA; [Baron, Richard J.] ABIM Fdn, Philadelphia, PA 19106 USA; [Braddock, Clarence H., III] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	American Board of Internal Medicine; American Board of Internal Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baron, RJ (corresponding author), Amer Board Internal Med, Philadelphia, PA 19106 USA.; Baron, RJ (corresponding author), ABIM Fdn, Philadelphia, PA 19106 USA.							Baron RJ, 2015, JAMA-J AM MED ASSOC, V313, P1807, DOI 10.1001/jama.2015.4060; Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; RELMAN AS, 1979, NEW ENGL J MED, V301, P778, DOI 10.1056/NEJM197910043011408; Young A, 2015, J MED REGUL, V101, P8	4	4	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2516	2517		10.1056/NEJMp1612106	http://dx.doi.org/10.1056/NEJMp1612106			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG6SC	27959703				2022-12-28	WOS:000391175300004
J	Gillingwater, TH				Gillingwater, Thomas H.			Dawn of a new therapeutic era for spinal muscular atrophy	LANCET			English	Editorial Material							RESCUE; GENE		[Gillingwater, Thomas H.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh EH8 9AG, Midlothian, Scotland; [Gillingwater, Thomas H.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh Med Sch Biomed Sci, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Gillingwater, TH (corresponding author), Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh EH8 9AG, Midlothian, Scotland.; Gillingwater, TH (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh Med Sch Biomed Sci, Edinburgh EH8 9AG, Midlothian, Scotland.	T.Gillingwater@ed.ac.uk		Gillingwater, Thomas/0000-0002-0306-5577				Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Finkel R. S, 2016, LANCET; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hosseinibarkooie S, 2016, AM J HUM GENET, V99, P647, DOI 10.1016/j.ajhg.2016.07.014; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kariya S, 2014, J CLIN INVEST, V124, P785, DOI 10.1172/JCI72017; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mercuri E, 2012, LANCET NEUROL, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Wishart TM, 2014, J CLIN INVEST, V124, P1821, DOI 10.1172/JCI71318	12	5	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2964	2965		10.1016/S0140-6736(16)32390-X	http://dx.doi.org/10.1016/S0140-6736(16)32390-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27939062	Green Accepted			2022-12-28	WOS:000390112300007
J	Robertson, JFR; Bondarenko, IM; Trishkina, E; Dvorkin, M; Panasci, L; Manikhas, A; Shparyk, Y; Cardona-Huerta, S; Cheung, KL; Philco-Salas, MJ; Ruiz-Borrego, M; Shao, Z; Noguchi, S; Rowbottom, J; Stuart, M; Grinsted, LM; Fazal, M; Ellis, MJ				Robertson, John F. R.; Bondarenko, Igor M.; Trishkina, Ekaterina; Dvorkin, Mikhail; Panasci, Lawrence; Manikhas, Alexey; Shparyk, Yaroslav; Cardona-Huerta, Servando; Cheung, Kwok-Leung; Philco-Salas, Manuel Jesus; Ruiz-Borrego, Manuel; Shao, Zhimin; Noguchi, Shinzaburo; Rowbottom, Jacqui; Stuart, Mary; Grinsted, Lynda M.; Fazal, Mehdi; Ellis, Matthew J.			Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial	LANCET			English	Article							FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; ENDOCRINE-THERAPY; 1ST-LINE THERAPY; TAMOXIFEN; LETROZOLE; SUPERIOR; SURVIVAL; EFFICACY	Background Aromatase inhibitors are a standard of care for hormone receptor-positive locally advanced or metastatic breast cancer. We investigated whether the selective oestrogen receptor degrader fulvestrant could improve progression-free survival compared with anastrozole in postmenopausal patients who had not received previous endocrine therapy. Methods In this phase 3, randomised, double-blind trial, we recruited eligible patients with histologically confi rmed oestrogen receptor-positive or progesterone receptor-positive, or both, locally advanced or metastatic breast cancer from 113 academic hospitals and community centres in 20 countries. Eligible patients were endocrine therapy-naive, with WHO performance status 0-2, and at least one measurable or non-measurable lesion. Patients were randomly assigned (1: 1) to fulvestrant (500 mg intramuscular injection; on days 0, 14, 28, then every 28 days thereafter) or anastrozole (1 mg orally daily) using a computer-generated randomisation scheme. The primary endpoint was progression-free survival, determined by Response Evaluation Criteria in Solid Tumors version 1 . 1, intervention by surgery or radiotherapy because of disease deterioration, or death from any cause, assessed in the intention-to-treat population. Safety outcomes were assessed in all patients who received at least one dose of randomised treatment (including placebo). This trial is registered with ClinicalTrials. gov, number NCT01602380. Findings Between Oct 17, 2012, and July 11, 2014, 524 patients were enrolled to this study. Of these, 462 patients were randomised (230 to receive fulvestrant and 232 to receive anastrozole). Progression-free survival was significantly longer in the fulvestrant group than in the anastrozole group (hazard ratio [HR] 0 . 797, 95% CI 0 . 637-0 . 999, p=0 . 0486). Median progression-free survival was 16 . 6 months (95% CI 13 . 83-20 . 99) in the fulvestrant group versus 13 . 8 months (11 . 99-16 . 59) in the anastrozole group. The most common adverse events were arthralgia (38 [17%] in the fulvestrant group vs 24 [10%] in the anastrozole group) and hot flushes (26 [11%] in the fulvestrant group vs 24 [10%] in the anastrozole group). 16 (7%) of 228 patients in in the fulvestrant group and 11 (5%) of 232 patients in the anastrozole group discontinued because of adverse events. Interpretation Fulvestrant has superior efficacy and is a preferred treatment option for patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not received previous endocrine therapy compared with a third-generation aromatase inhibitor, a standard of care for first-line treatment of these patients.	[Robertson, John F. R.; Cheung, Kwok-Leung] Univ Nottingham, Royal Derby Hosp, Sch Med, Div Med Sci & Grad Entry Med, Derby, England; [Bondarenko, Igor M.] Dnipropetrovsk State Med Acad, Dept Oncol, Dnepropetrovsk, Ukraine; [Trishkina, Ekaterina] Leningrad Reg Oncol Dispensary, St Petersburg, Russia; [Dvorkin, Mikhail] Clin Oncol Dispensary, Omsk, Russia; [Panasci, Lawrence] Jewish Gen Hosp, Dept Oncol, Montreal, PQ, Canada; [Manikhas, Alexey] City Clin Oncol Dispensary, St Petersburg, Russia; [Shparyk, Yaroslav] Lviv State Oncol Reg Treatment & Diagnost Ctr, Lvov, Ukraine; [Cardona-Huerta, Servando] Tecnol Monterrey, Breast Canc Ctr, Monterrey, Mexico; [Philco-Salas, Manuel Jesus] Inst Oncol Lima, Unidad Invest, Lima, Peru; [Ruiz-Borrego, Manuel] Hosp Univ Virgen Rocio, Seville, Spain; [Shao, Zhimin] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China; [Noguchi, Shinzaburo] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Osaka, Japan; [Rowbottom, Jacqui; Stuart, Mary] AstraZeneca, Alderley Pk, Macclesfield, Cheshire, England; [Grinsted, Lynda M.] AstraZeneca, Cambridge, England; [Fazal, Mehdi] AstraZeneca, Gaithersburg, MD USA; Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX USA	University of Nottingham; Dnipro State Medical University; McGill University; Tecnologico de Monterrey; Virgen del Rocio University Hospital; Fudan University; Osaka University; AstraZeneca; AstraZeneca; Baylor College of Medicine	Robertson, JFR (corresponding author), Univ Nottingham, Royal Derby Hosp Ctr, Fac Med & Hlth Sci, Sch Med,Div Med Sci Grad Entry Med, Derby DE22 3DT, England.	john.robertson@nottingham.ac.uk	Manikhas, Alexey/ABI-7193-2020; Bondarenko, Igor N/GQP-1497-2022; Bondarenko, Igor/U-5156-2017; Bondarenko, Igor/W-9412-2019	Bondarenko, Igor N/0000-0002-7071-2471; Bondarenko, Igor/0000-0002-7071-2471; Bondarenko, Igor/0000-0002-7071-2471; Cheung, Kwok-Leung/0000-0003-2973-0755; Manikhas, Alexey/0000-0001-9616-6635	AstraZeneca	AstraZeneca(AstraZeneca)	We thank the patients and investigators involved in this study. This study was sponsored by AstraZeneca. Medical writing support, funded by AstraZeneca, was provided by Simon Vass of Complete Medical Communications.	Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y; Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; Burman CF, 2009, STAT MED, V28, P739, DOI 10.1002/sim.3513; Cardoso F, 2014, BREAST, V23, P489, DOI 10.1016/j.breast.2014.08.009; Di Leo A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt337; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Ellis MJ, 2015, J CLIN ONCOL, V33, P3781, DOI 10.1200/JCO.2015.61.5831; Ellis S, 2008, CONTEMP CLIN TRIALS, V29, P456, DOI 10.1016/j.cct.2007.10.008; European Medicines Agency, 2015, FULV SUMM PROD CHAR; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Fribbens C, 2016, J CLIN ONCOL, V34, P2961, DOI 10.1200/JCO.2016.67.3061; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Martin M, 2016, BREAST, V28, P161, DOI 10.1016/j.breast.2016.05.015; Mouridsen H, 2001, J CLIN ONCOL, V19, P2596, DOI 10.1200/JCO.2001.19.10.2596; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Paridaens RJ, 2008, J CLIN ONCOL, V26, P4883, DOI 10.1200/JCO.2007.14.4659; Robertson JFR, 2007, ONCOLOGIST, V12, P774, DOI 10.1634/theoncologist.12-7-774; Robertson JFR, 2012, BREAST CANCER RES TR, V136, P503, DOI 10.1007/s10549-012-2192-4; Robertson JFR, 2009, J CLIN ONCOL, V27, P4530, DOI 10.1200/JCO.2008.21.1136; Rugo HS, 2016, J CLIN ONCOL, V34, P3069, DOI 10.1200/JCO.2016.67.1487; US Food and Drugs Administration, 2015, FULV PRESCR INF; Zafar SY, 2013, ONCOLOGIST, V18, P381, DOI 10.1634/theoncologist.2012-0279	25	321	346	1	68	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2997	3005		10.1016/S0140-6736(16)32389-3	http://dx.doi.org/10.1016/S0140-6736(16)32389-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27908454	Green Accepted			2022-12-28	WOS:000390112300032
J	Yamazaki, D; Trigg, MA				Yamazaki, Dai; Trigg, Mark A.			HYDROLOGY The dynamics of Earth's surface water	NATURE			English	Editorial Material							LAKES	High-resolution satellite mapping of Earth's surface water during the past 32 years reveals changes in the planet's water systems, including the influence of natural cycles and human activities. See Letter p.418	[Yamazaki, Dai] Japan Agcy Marine Earth Sci & Technol, Dept Integrated Climate Project Res, Yokohama, Kanagawa 2370061, Japan; [Trigg, Mark A.] Univ Leeds, Sch Civil Engn, Leeds LS2 9JT, W Yorkshire, England	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Leeds	Yamazaki, D (corresponding author), Japan Agcy Marine Earth Sci & Technol, Dept Integrated Climate Project Res, Yokohama, Kanagawa 2370061, Japan.	d-yamazaki@jamstec.go.jp; m.trigg@leeds.ac.uk	Yamazaki, Dai/J-3029-2012; Trigg, Mark A/A-5898-2010	Yamazaki, Dai/0000-0002-6478-1841; Trigg, Mark A/0000-0002-8412-9332				Carroll ML, 2009, INT J DIGIT EARTH, V2, P291, DOI 10.1080/17538940902951401; Donchyts G, 2016, NAT CLIM CHANGE, V6, P810, DOI 10.1038/nclimate3111; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Feng M, 2016, INT J DIGIT EARTH, V9, P113, DOI 10.1080/17538947.2015.1026420; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Verpoorter C, 2014, GEOPHYS RES LETT, V41, P6396, DOI 10.1002/2014GL060641; Wulder MA, 2016, REMOTE SENS ENVIRON, V185, P271, DOI 10.1016/j.rse.2015.11.032; Yamazaki D, 2015, REMOTE SENS ENVIRON, V171, P337, DOI 10.1016/j.rse.2015.10.014	8	28	29	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					348	349		10.1038/nature21100	http://dx.doi.org/10.1038/nature21100			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE6JR	27926737	Green Accepted			2022-12-28	WOS:000389716800025
J	Kang, EJ; Wu, J; Gutierrez, NM; Koski, A; Tippner-Hedges, R; Agaronyan, K; Platero-Luengo, A; Martinez-Redondo, P; Ma, H; Lee, Y; Hayama, T; Van Dyken, C; Wang, XJ; Luo, SY; Ahmed, R; Li, Y; Ji, DM; Kayali, R; Cinnioglu, C; Olson, S; Jensen, J; Battaglia, D; Lee, D; Wu, D; Huang, TS; Wolf, DP; Temiakov, D; Belmonte, JCI; Amato, P; Mitalipov, S				Kang, Eunju; Wu, Jun; Gutierrez, Nuria Marti; Koski, Amy; Tippner-Hedges, Rebecca; Agaronyan, Karen; Platero-Luengo, Aida; Martinez-Redondo, Paloma; Ma, Hong; Lee, Yeonmi; Hayama, Tomonari; Van Dyken, Crystal; Wang, Xinjian; Luo, Shiyu; Ahmed, Riffat; Li, Ying; Ji, Dongmei; Kayali, Refik; Cinnioglu, Cengiz; Olson, Susan; Jensen, Jeffrey; Battaglia, David; Lee, David; Wu, Diana; Huang, Taosheng; Wolf, Don P.; Temiakov, Dmitry; Belmonte, Juan Carlos Izpisua; Amato, Paula; Mitalipov, Shoukhrat			Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations	NATURE			English	Article							EMBRYONIC STEM-CELLS; PRONUCLEAR TRANSFER; PLURIPOTENT CELLS; NUCLEAR TRANSFER; OVARIAN RESERVE; GENETIC DRIFT; COPY NUMBER; DISEASE; TRANSMISSION; REPLICATION	Maternally inherited mitochondrial (mt) DNA mutations can cause fatal or severely debilitating syndromes in children(1-3), with disease severity dependent on the specific gene mutation and the ratio of mutant to wild-type mtDNA (heteroplasmy) in each cell and tissue(4). Pathogenic mtDNA mutations are relatively common, with an estimated 778 affected children born each year in the United States(5). Mitochondrial replacement therapies or techniques (MRT) circumventing mother-to-child mtDNA disease transmission involve replacement of oocyte maternal mtDNA(6-8). Here we report MRT outcomes in several families with common mtDNA syndromes. The mother's oocytes were of normal quality and mutation levels correlated with those in existing children. Efficient replacement of oocyte mutant mtDNA was performed by spindle transfer(8), resulting in embryos containing > 99% donor mtDNA. Donor mtDNA was stably maintained in embryonic stem cells (ES cells) derived from most embryos. However, some ES cell lines demonstrated gradual loss of donor mtDNA and reversal to the maternal haplotype. In evaluating donor-to-maternal mtDNA interactions, it seems that compatibility relates to mtDNA replication efficiency rather than to mismatch or oxidative phosphorylation dysfunction. We identify a polymorphism within the conserved sequence box II region of the D-loop as a plausible cause of preferential replication of specific mtDNA haplotypes. In addition, some haplotypes confer proliferative and growth advantages to cells. Hence, we propose a matching paradigm for selecting compatible donor mtDNA for MRT.	[Kang, Eunju; Gutierrez, Nuria Marti; Koski, Amy; Tippner-Hedges, Rebecca; Lee, Yeonmi; Hayama, Tomonari; Van Dyken, Crystal; Ahmed, Riffat; Li, Ying; Ji, Dongmei; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 SW Bond Ave, Portland, OR 97239 USA; [Kang, Eunju; Gutierrez, Nuria Marti; Koski, Amy; Tippner-Hedges, Rebecca; Ma, Hong; Lee, Yeonmi; Hayama, Tomonari; Van Dyken, Crystal; Ahmed, Riffat; Li, Ying; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA; [Wu, Jun; Platero-Luengo, Aida; Martinez-Redondo, Paloma; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Agaronyan, Karen; Temiakov, Dmitry] Rowan Univ, Dept Cell Biol, Sch Osteopath Med, 2 Med Ctr Dr, Stratford, NJ 08084 USA; [Wang, Xinjian; Luo, Shiyu; Huang, Taosheng] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Ji, Dongmei] Anhui Med Univ, Reprod Med Ctr, 218 Jixi Rd, Hefei 230022, Anhui, Peoples R China; [Kayali, Refik; Cinnioglu, Cengiz] IviGen Los Angeles, 406 Amapola Ave,Suite 215, Torrance, CA 90501 USA; [Olson, Susan] Oregon Hlth & Sci Univ, Res Cytogenet Lab, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Jensen, Jeffrey; Battaglia, David; Lee, David; Wu, Diana; Amato, Paula; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod Endocrinol, Dept Obstet & Gynecol, 3303 SW Bond Ave, Portland, OR 97239 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Biomed Engn, 3303 SW Bond Ave, Portland, OR 97239 USA; [Kang, Eunju] ASAN Med Ctr, ASAN Inst Life Sci, Stem Cell Ctr, Olymp Ro 43 Gil, Seoul 138736, South Korea	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Salk Institute; Rowan University; Rowan University School of Osteopathic Medicine; Cincinnati Children's Hospital Medical Center; Anhui Medical University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Ulsan; Asan Medical Center	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 SW Bond Ave, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.; Amato, P; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Div Reprod Endocrinol, Dept Obstet & Gynecol, 3303 SW Bond Ave, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, 3303 SW Bond Ave, Portland, OR 97239 USA.	amatop@ohsu.edu; mitalipo@ohsu.edu	Platero Luengo, Aida/GNW-5468-2022; Jensen, Jeffrey T/C-7421-2014; Luengo, Aida Platero/ABE-3282-2020; Platero-Luengo, Aida/A-6352-2017; Luo, Shiyu/AAD-7020-2020; Wu, Jun/AAF-1830-2019	Jensen, Jeffrey T/0000-0002-4733-1224; Luengo, Aida Platero/0000-0002-4693-7654; Platero-Luengo, Aida/0000-0002-4693-7654; Wu, Jun/0000-0001-9863-1668; MARTINEZ REDONDO, PALOMA/0000-0002-5722-8335; Luo, Shiyu/0000-0002-6965-8674; Huang, Taosheng/0000-0001-6601-6687	Leducq Foundation; OHSU institutional funds; Cincinnati Children's Hospital Research Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Moxie Foundation; Hewitt Foundation; Funciacion Alfonso Martin Escudero	Leducq Foundation(Leducq Foundation); OHSU institutional funds; Cincinnati Children's Hospital Research Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Moxie Foundation; Hewitt Foundation; Funciacion Alfonso Martin Escudero	The authors acknowledge the OHSU Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for oversight and guidance. We thank all study participants for tissue donations and the Women's Health Research Unit staff, University Fertility Consultants and the Reproductive Endocrinology and Infertility Division in the Department of Obstetrics and Gynecology, Oregon Health and Science University for support and procurement of human gametes. Studies were supported by the Leducq Foundation, OHSU institutional funds and Cincinnati Children's Hospital Research Foundation. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, the Leona M. and Harry B. Helmsley Charitable Trust and the Moxie Foundation. A.P.L. was partially supported by a fellowship from the Hewitt Foundation. P.M.R. was partially supported by a fellowship from Funciacion Alfonso Martin Escudero.	Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Boucret L, 2015, HUM REPROD, V30, P1653, DOI 10.1093/humrep/dev114; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Burgstaller JP, 2015, MOL HUM REPROD, V21, P11, DOI 10.1093/molehr/gau090; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960; Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature18303, 10.1038/nature183030]; Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804; Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Kelsey TW, 2012, MOL HUM REPROD, V18, P79, DOI 10.1093/molehr/gar059; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; KOEHLER CM, 1991, GENETICS, V129, P247; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; McClelland K., 2014, THESIS; Monnot S, 2013, HUM MOL GENET, V22, P1867, DOI 10.1093/hmg/ddt040; Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Smeets HJM, 2015, ANN NY ACAD SCI, V1350, P29, DOI 10.1111/nyas.12866; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398; Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413; Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001	35	164	170	4	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					270	+		10.1038/nature20592	http://dx.doi.org/10.1038/nature20592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27919073	Green Published			2022-12-28	WOS:000389548700057
J	Moritz, ED; Winton, CS; Tonnetti, L; Townsend, RL; Berardi, VP; Hewins, ME; Weeks, KE; Dodd, RY; Stramer, SL				Moritz, Erin D.; Winton, Colleen S.; Tonnetti, Laura; Townsend, Rebecca L.; Berardi, Victor P.; Hewins, Mary-Ellen; Weeks, Karen E.; Dodd, Roger Y.; Stramer, Susan L.			Screening for Babesia microti in the U. S. Blood Supply	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; APHERESIS PLATELETS; COST-EFFECTIVENESS; INFECTION; DONORS; VIRUS; RISK	BACKGROUND Babesia microti, a tickborne intraerythrocytic parasite that can be transmitted by means of blood transfusion, is responsible for the majority of cases of transfusiontransmitted babesiosis in the United States. However, no licensed test exists for screening for B. microti in donated blood. We assessed data from a large-scale, investigational product-release screening and donor follow-up program. METHODS From June 2012 through September 2014, we performed arrayed fluorescence immunoassays (AFIAs) for B. microti antibodies and real-time polymerase-chain-reaction (PCR) assays for B. microti DNA on blood-donation samples obtained in Connecticut, Massachusetts, Minnesota, and Wisconsin. We determined parasite loads with the use of quantitative PCR testing and assessed infectivity by means of the inoculation of hamsters and the subsequent examination for parasitemia. Donors with test-reactive samples were followed. Using data on cases of transfusiontransmitted babesiosis, we compared the proportions of screened versus unscreened donations that were infectious. RESULTS Of 89,153 blood-donation samples tested, 335 (0.38%) were confirmed to be positive, of which 67 (20%) were PCR-positive; 9 samples were antibody-negative (i.e., 1 antibody-negative sample per 9906 screened samples), representing 13% of all PCR-positive samples. PCR-positive samples were identified all through the year; antibody-negative infections occurred from June through September. Approximately one third of the red-cell samples from PCR-positive or high-titer AFIA-positive donations infected hamsters. Follow-up showed DNA clearance in 86% of the donors but antibody seroreversion in 8% after 1 year. In Connecticut and Massachusetts, no reported cases of transfusion-transmitted babesiosis were associated with screened donations (i.e., 0 cases per 75,331 screened donations), as compared with 14 cases per 253,031 unscreened donations (i.e., 1 case per 18,074 unscreened donations) (odds ratio, 8.6; 95% confidence interval, 0.51 to 144; P = 0.05). Overall, 29 cases of transfusion-transmitted babesiosis were linked to blood from infected donors, including blood obtained from 10 donors whose samples tested positive on the PCR assay 2 to 7 months after the implicated donation. CONCLUSIONS Blood-donation screening for antibodies to and DNA from B. microti was associated with a decrease in the risk of transfusion-transmitted babesiosis. (Funded by the American Red Cross and Imugen; ClinicalTrials. gov number, NCT01528449.)	[Moritz, Erin D.; Winton, Colleen S.; Tonnetti, Laura; Townsend, Rebecca L.; Dodd, Roger Y.; Stramer, Susan L.] Amer Red Cross, Sci Affairs, 9315 Gaither Rd, Gaithersburg, MD 20877 USA; [Berardi, Victor P.; Hewins, Mary-Ellen; Weeks, Karen E.] Imugen, Div Res, Norwood, MA USA	American Red Cross	Stramer, SL (corresponding author), Amer Red Cross, Sci Affairs, 9315 Gaither Rd, Gaithersburg, MD 20877 USA.	susan.stramer@redcross.org			American Red Cross; Imugen	American Red Cross; Imugen	Funded by the American Red Cross and Imugen	Acosta MEP, 2013, EMERG INFECT DIS, V19, P1105, DOI 10.3201/eid1907.121593; Adams Deborah, 2015, MMWR Morb Mortal Wkly Rep, V62, P1, DOI 10.15585/mmwr.mm6253a1; [Anonymous], 2015, TRANSCR M BLOOD PROD; Bish EK, 2015, TRANSFUSION, V55, P2256, DOI 10.1111/trf.13136; BRANDT F, 1977, J PARASITOL, V63, P934, DOI 10.2307/3279918; CULLEN JM, 1987, LAB ANIM SCI, V37, P640; Eder AF, 2016, TRANSFUSION, V56, P1608, DOI 10.1111/trf.13482; Eder AF, 2014, TRANSFUSION, V54, P857, DOI 10.1111/trf.12282; Fang DC, 2016, TRANSFUS MED REV, V30, P132, DOI 10.1016/j.tmrv.2016.04.002; Food and Drug Administration (FDA), FAT REP FDA FOLL BLO; GLEASON NN, 1970, J PARASITOL, V56, P1256, DOI 10.2307/3277582; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Johnson ST, 2009, TRANSFUSION, V49, P2574, DOI 10.1111/j.1537-2995.2009.02430.x; Kessler DA, 2012, TRANSFUSION, V52, p211A; Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10; Moritz ED, 2014, TRANSFUSION, V54, P2226, DOI 10.1111/trf.12693; Ness PM, 2001, TRANSFUSION, V41, P713, DOI 10.1046/j.1537-2995.2001.41050713.x; Simon MS, 2014, TRANSFUSION, V54, P889, DOI 10.1111/trf.12492; Stramer SL, 2013, TRANSFUSION, V53, P2449, DOI 10.1111/trf.12213; Tonnetti L, 2010, TRANSFUSION, V50, P1019, DOI 10.1111/j.1537-2995.2009.02538.x; Vannier EG, 2015, INFECT DIS CLIN N AM, V29, P357, DOI 10.1016/j.idc.2015.02.008; WESTERN KA, 1970, NEW ENGL J MED, V283, P854, DOI 10.1056/NEJM197010152831607; Young C, 2012, TRANSFUSION, V52, P1523, DOI 10.1111/j.1537-2995.2012.03612.x; Zou SM, 2010, TRANSFUSION, V50, P1495, DOI 10.1111/j.1537-2995.2010.02622.x	25	93	100	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2236	2245		10.1056/NEJMoa1600897	http://dx.doi.org/10.1056/NEJMoa1600897			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZQ	27959685				2022-12-28	WOS:000389310000006
J	Schaefer, JM; Finkel, RC; Balco, G; Alley, RB; Caffee, MW; Briner, JP; Young, NE; Gow, AJ; Schwartz, R				Schaefer, Joerg M.; Finkel, Robert C.; Balco, Greg; Alley, Richard B.; Caffee, Marc W.; Briner, Jason P.; Young, Nicolas E.; Gow, Anthony J.; Schwartz, Roseanne			Greenland was nearly ice-free for extended periods during the Pleistocene	NATURE			English	Article							ELASTIC RECOIL DETECTION; COSMOGENIC RADIONUCLIDES; HALF-LIFE; SHEET; BE-10; CLIMATE; AL-26; SENSITIVITY; BURIAL; MUONS	The Greenland Ice Sheet (GIS) contains the equivalent of 7.4 metres of global sea-level rise(1). Its stability in our warming climate is therefore a pressing concern. However, the sparse proxy evidence of the palaeo-stability of the GIS means that its history is controversial (compare refs 2 and 3 to ref. 4). Here we show that Greenland was deglaciated for extended periods during the Pleistocene epoch (from 2.6 million years ago to 11,700 years ago), based on new measurements of cosmic-ray-produced beryllium and aluminium isotopes (Be-10 and Al-26) in a bedrock core from beneath an ice core near the GIS summit. Models indicate that when this bedrock site is ice-free, any remaining ice is concentrated in the eastern Greenland highlands and the GIS is reduced to less than ten per cent of its current volume. Our results narrow the spectrum of possible GIS histories: the longest period of stability of the present ice sheet that is consistent with the measurements is 1.1 million years, assuming that this was preceded by more than 280,000 years of ice-free conditions. Other scenarios, in which Greenland was ice-free during any or all Pleistocene interglacials, may be more realistic. Our observations are incompatible with most existing model simulations that present a continuously existing Pleistocene GIS. Future simulations of the GIS should take into account that Greenland was nearly ice-free for extended periods under Pleistocene climate forcing.	[Schaefer, Joerg M.; Finkel, Robert C.; Young, Nicolas E.; Schwartz, Roseanne] Lamont Doherty Earth Observ, Geochem, Palisades, NY 10964 USA; [Schaefer, Joerg M.] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; [Finkel, Robert C.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 95064 USA; [Balco, Greg] Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA; [Alley, Richard B.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Caffee, Marc W.] Purdue Univ, Dept Phys & Astron, 525 Northwestern Ave, W Lafayette, IN 47907 USA; [Briner, Jason P.] SUNY Buffalo, Dept Otolaryngol, Buffalo, NY 14260 USA; [Gow, Anthony J.] US Army Cold Reg Res & Engn Lab, Hanover, NH 03755 USA	Columbia University; Columbia University; University of California System; University of California Berkeley; Berkeley Geochronolgy Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Purdue University System; Purdue University; Purdue University West Lafayette Campus; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL)	Schaefer, JM (corresponding author), Lamont Doherty Earth Observ, Geochem, Palisades, NY 10964 USA.; Schaefer, JM (corresponding author), Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA.	schaefer@ldeo.columbia.edu			Lamont Climate Center; Corner Family Foundation; NSF [AGS 1338832]; PLR Arctic System Science Program [1503959]; Ann and Gordon Getty Foundation; US National Science Foundation [EAR-1153689]; Division Of Earth Sciences [1560658] Funding Source: National Science Foundation	Lamont Climate Center; Corner Family Foundation; NSF(National Science Foundation (NSF)); PLR Arctic System Science Program; Ann and Gordon Getty Foundation; US National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We gratefully acknowledge help from the National Ice Core Laboratory (NICL) and thank the GISP2 steering committee for providing the bedrock core samples. J.M.S. acknowledges support by the Lamont Climate Center and the Corner Family Foundation. R.B.A. acknowledges support by the NSF (AGS 1338832). as do J.M.S., J.P.B. and N.E.Y. (PLR Arctic System Science Program number 1503959). We thank J. Fyke for assistance in producing Fig. 1b. G.B. acknowledges support from the Ann and Gordon Getty Foundation. M.W.C. acknowledges support from the US National Science Foundation, grant EAR-1153689. The pioneering cosmogenic-nuclide study of the GISP2 bedrock core under the lead of Kuni Nishiizumi in the late 1990s motivated our study. This is LDEO publication number 8068.	Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Alley RB, 2010, QUATERNARY SCI REV, V29, P1728, DOI 10.1016/j.quascirev.2010.02.007; Applegate PJ, 2015, CLIM DYNAM, V45, P2001, DOI 10.1007/s00382-014-2451-7; Balco G, 2008, QUAT GEOCHRONOL, V3, P174, DOI 10.1016/j.quageo.2007.12.001; Balco G, 2008, AM J SCI, V308, P1083, DOI 10.2475/10.2008.02; Bender ML, 2010, EARTH PLANET SC LETT, V299, P466, DOI 10.1016/j.epsl.2010.09.033; Bennike O, 2010, BOREAS, V39, P603, DOI 10.1111/j.1502-3885.2010.00147.x; Bierman PR, 2014, SCIENCE, V344, P402, DOI 10.1126/science.1249047; Bierman PR, 1999, GEOMORPHOLOGY, V27, P25, DOI 10.1016/S0169-555X(98)00088-9; Borchers B, 2016, QUAT GEOCHRONOL, V31, P188, DOI 10.1016/j.quageo.2015.01.009; Calov R, 2015, CRYOSPHERE, V9, P179, DOI 10.5194/tc-9-179-2015; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; Dahl-Jensen D, 2013, NATURE, V493, P489, DOI 10.1038/nature11789; DAVIS JC, 1990, NUCL INSTRUM METH B, V52, P269, DOI 10.1016/0168-583X(90)90419-U; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Dutton A, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4019; Fifield LK, 2007, NUCL INSTRUM METH B, V259, P178, DOI 10.1016/j.nimb.2007.01.156; Funder S, 2001, B GEOL SOC DENMARK, V48, P117; Fyke J, 2014, CLIM DYNAM, V43, P2249, DOI 10.1007/s00382-014-2050-7; Gow AJ, 1996, ANN GLACIOL, V22, P134, DOI 10.3189/1996AoG22-1-134-140; Granger DE, 2015, NATURE, V522, P85, DOI 10.1038/nature14268; Granger DE, 2006, GEOL SOC AM SPEC PAP, V415, P1, DOI 10.1130/2006.2415(01); Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; Heisinger B, 2002, EARTH PLANET SC LETT, V200, P357, DOI 10.1016/S0012-821X(02)00640-4; Heisinger B, 2002, EARTH PLANET SC LETT, V200, P345, DOI 10.1016/S0012-821X(02)00640-4; Houghton J. T., 2001, CLIMATE CHANGE 2001; Korschinek G, 2010, NUCL INSTRUM METH B, V268, P187, DOI 10.1016/j.nimb.2009.09.020; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Marrero SM, 2016, QUAT GEOCHRONOL, V31, P160, DOI 10.1016/j.quageo.2015.09.005; Nishiizumi K, 2004, NUCL INSTRUM METH B, V223, P388, DOI 10.1016/j.nimb.2004.04.075; Nishiizumi K., 1996, FALL M 1996, V77, pF428; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; Otto-Bliesner BL, 2010, QUATERNARY SCI REV, V29, P56, DOI 10.1016/j.quascirev.2009.07.004; PAUL M, 1990, NUCL INSTRUM METH B, V52, P315, DOI 10.1016/0168-583X(90)90429-X; Phillips FM, 2016, QUAT GEOCHRONOL, V31, P119, DOI 10.1016/j.quageo.2015.09.006; Reyes AV, 2014, NATURE, V510, P525, DOI 10.1038/nature13456; Rovey CW, 2015, PALAEOGEOGR PALAEOCL, V417, P44, DOI 10.1016/j.palaeo.2014.10.018; Schaefer JM, 2009, SCIENCE, V324, P622, DOI 10.1126/science.1169312; Stone EJ, 2010, CRYOSPHERE, V4, P397, DOI 10.5194/tc-4-397-2010; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; Timmers H, 2002, NUCL INSTRUM METH B, V190, P393, DOI 10.1016/S0168-583X(01)01281-2; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Yau AM, 2016, EARTH PLANET SC LETT, V451, P1, DOI 10.1016/j.epsl.2016.06.053	43	71	73	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					252	+		10.1038/nature20146	http://dx.doi.org/10.1038/nature20146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27929018				2022-12-28	WOS:000389548700053
J	Ghebrehewet, S; MacPherson, P; Ho, A				Ghebrehewet, Sam; MacPherson, Peter; Ho, Antonia			Influenza	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEMAGGLUTININ-STEM; VACCINE CANDIDATE; VIRUS-INFECTION; PHASE-III; SAFETY; ADULTS; IMMUNOGENICITY; QUADRIVALENT; TRIVALENT; CHILDREN		[Ghebrehewet, Sam; MacPherson, Peter] Publ Hlth England North West, Cheshire & Merseyside Hlth Protect Team, Liverpool, Merseyside, England; [MacPherson, Peter] Univ Liverpool, Farr Inst HeRC, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [MacPherson, Peter] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Res, Liverpool, Merseyside, England; [Ho, Antonia] Queen Elizabeth Univ Hosp, Dept Infect Dis, Glasgow, Lanark, Scotland; [Ho, Antonia] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England	Public Health England; University of Liverpool; Liverpool School of Tropical Medicine; Queen Elizabeth University Hospital (QEUH); University of Liverpool	Ghebrehewet, S (corresponding author), Publ Hlth England North West, Cheshire & Merseyside Hlth Protect Team, Liverpool, Merseyside, England.	sam.ghebrehewet@phe.gov.uk	Ho, Antonia/X-1751-2019	Ho, Antonia/0000-0003-1465-3785; MacPherson, Peter/0000-0002-0329-9613	MRC [MC_UU_12014/9] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ambrose CS, 2008, INFLUENZA OTHER RESP, V2, P193, DOI 10.1111/j.1750-2659.2008.00056.x; [Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; [Anonymous], 2010, WHO GUID PHARM MAN P; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Beran J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-224; Cromer D, 2014, J INFECTION, V68, P363, DOI 10.1016/j.jinf.2013.11.013; Demicheli V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub5; Department of Health, 2016, CHIEF MED OFF CHIEF; Department of Health, 2011, ROUT TRANSM INFL VIR; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; European Centre for Disease Prevention and Control (ECDC), 2014, TECHN DOC SAF US PER; Ferguson L, 2015, VIROLOGY, V486, P28, DOI 10.1016/j.virol.2015.08.030; Fleming DM, 2006, PEDIATR INFECT DIS J, V25, P860, DOI 10.1097/01.inf.0000237797.14283.cf; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Haffizulla J, 2014, LANCET INFECT DIS, V14, P609, DOI 10.1016/S1473-3099(14)70717-0; Hause BM, 2014, MBIO, V5, DOI 10.1128/mBio.00031-14; Health and Safety Executive, 2016, PAND FLU WORKPL GUID; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kawai S, 2011, CLIN INFECT DIS, V53, P130, DOI 10.1093/cid/cir336; Kieninger D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-343; Killingley B, 2016, J INFECT PUBLIC HEAL, V9, P278, DOI 10.1016/j.jiph.2015.10.009; Kliner M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012149; Lam PP, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1966-4; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Matsuzaki Y, 2016, J VIROL, V90, P8251, DOI 10.1128/JVI.00969-16; Minodier L, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0448-4; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Naleway AL, 2014, VACCINE, V32, P3122, DOI 10.1016/j.vaccine.2014.04.021; National Institute for Health and Care Excellence, 2015, CLIN KNOWL SUMM INFL; National Institute for Health and Care Excellence, 2008, OS AM ZAN PROPH INFL; National Institute for Health and Care Excellence, 2009, AM OS ZAN TREATM INF; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Pecheur EI, 2016, J VIROL, V90, P3086, DOI 10.1128/JVI.02077-15; Pepin S, 2013, VACCINE, V31, P5572, DOI 10.1016/j.vaccine.2013.08.069; Public Health England, 2016, PHE GUID US ANT AG T; Public Health England, 2012, MAN OUTBR AC RESP DI; Public Health England, 2014, INF CONTR PREC MIN T; Public Health England, 2016, PHE GUID MAN OUTBR I; Public Health England, 2013, IMMUNISATION INFECT; Rossignol JF, 2009, J BIOL CHEM, V284, P29798, DOI 10.1074/jbc.M109.029470; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tinoco JC, 2014, VACCINE, V32, P1480, DOI 10.1016/j.vaccine.2014.01.022; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization, 2010, PAND INFL PREP RESP; World Health Organization, 2016, GLOB INFL SURV RESP; World Health Organization, 2016, INFL VACC VIR REAG; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zambon M, 2014, CURR OPIN INFECT DIS, V27, P560, DOI 10.1097/QCO.0000000000000113	61	65	70	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2016	355								i6258	10.1136/bmj.i6258	http://dx.doi.org/10.1136/bmj.i6258			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SX	27927672	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000390037400006
J	Holdren, JP; McNutt, MK				Holdren, John P.; McNutt, Marcia K.			Ralph J. Cicerone (1943-2016)	SCIENCE			English	Biographical-Item									[Holdren, John P.] White House Off Sci & Technol Policy, Washington, DC 20504 USA; [McNutt, Marcia K.] US Natl Acad Sci, Washington, DC USA	National Academies of Sciences, Engineering & Medicine	Holdren, JP (corresponding author), White House Off Sci & Technol Policy, Washington, DC 20504 USA.	john_p._holdren@ostp.eop.gov; mmcnutt@nas.edu							0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1107	1107		10.1126/science.aal4054	http://dx.doi.org/10.1126/science.aal4054			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934725				2022-12-28	WOS:000388916400023
J	Schmidt, C				Schmidt, Charles			A DEGENERATIVE AFFLICTION	NATURE			English	Editorial Material																			0	11	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					S2	S3		10.1038/540S2a	http://dx.doi.org/10.1038/540S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27902683	Bronze			2022-12-28	WOS:000388916600002
J	Martinez, C; Suissa, S; Rietbrock, S; Katholing, A; Freedman, B; Cohen, AT; Handelsman, DJ				Martinez, Carlos; Suissa, Samy; Rietbrock, Stephan; Katholing, Anja; Freedman, Ben; Cohen, Alexander T.; Handelsman, David J.			Testosterone treatment and risk of venous thromboembolism: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR EVENTS; ORAL-CONTRACEPTIVES; EXOGENOUS TESTOSTERONE; ACTIVE SURVEILLANCE; THROMBOTIC EVENTS; MEN; THERAPY; ASSOCIATION; COHORT; WOMEN	Objective To determine the risk of venous thromboembolism associated with use of testosterone treatment in men, focusing particularly on the timing of the risk. Design Population based case- control study. Setting 370 general practices in UK primary care with linked hospital discharge diagnoses and in- hospital procedures and information on all cause mortality. Participants 19 215 patients with confirmed venous thromboembolism (comprising deep venous thrombosis and pulmonary embolism) and 909 530 age matched controls from source population including more than 2.22 million men between January 2001 and May 2013. Exposure of interest Three mutually exclusive testosterone exposure groups were identified: current treatment, recent (but not current) treatment, and no treatment in the previous two years. Current treatment was subdivided into duration of more or less than six months. Main outcome measure Rate ratios of venous thromboembolism in association with current testosterone treatment compared with no treatment were estimated using conditional logistic regression and adjusted for comorbidities and all matching factors. Results The adjusted rate ratio of venous thromboembolism was 1.25 (95% confidence interval 0.94 to 1.66) for current versus no testosterone treatment. In the first six months of testosterone treatment, the rate ratio of venous thromboembolism was 1.63 (1.12 to 2.37), corresponding to 10.0 (1.9 to 21.6) additional venous thromboembolisms above the base rate of 15.8 per 10 000 person years. The rate ratio after more than six months' treatment was 1.00 (0.68 to 1.47), and after treatment cessation it was 0.68 (0.43 to 1.07). Increased rate ratios within the first six months of treatment were observed in all strata: the rate ratio was 1.52 (0.94 to 2.46) for patients with pathological hypogonadism and 1.88 (1.02 to 3.45) for those without it, and 1.41 (0.82 to 2.41) for those with a known risk factor for venous thromboembolism and 1.91 (1.13 to 3.23) for those without one. Conclusions Starting testosterone treatment was associated with an increased risk of venous thromboembolism, which peaked within six months and declined thereafter.	[Martinez, Carlos; Rietbrock, Stephan; Katholing, Anja] Inst Epidemiol Stat & Informat GmbH, D-60388 Frankfurt, Germany; [Suissa, Samy] McGill Univ, Lady Davis Res Inst, Ctr Clin Epidemiol, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Freedman, Ben] Univ Sydney, ANZAC Res Inst, Concord Hosp, Concord, NSW 2139, Australia; [Freedman, Ben] Univ Sydney, Charles Perkins Ctr, Heart Res Inst, Sydney, NSW 2006, Australia; [Freedman, Ben] Univ Sydney, Sydney Med Sch, Concord Hosp, Dept Cardiol, Sydney, NSW 2006, Australia; [Cohen, Alexander T.] Kings Coll London, Dept Haematol, Guys & St Thomas NHS Fdn Trust, London, England	McGill University; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; Heart Research Institute; Concord Repatriation General Hospital; University of Sydney; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Martinez, C (corresponding author), Inst Epidemiol Stat & Informat GmbH, D-60388 Frankfurt, Germany.	carlos.martinez@pharmaepi.com	Handelsman, David/AAR-9580-2021; Freedman, Saul B/C-1625-2013; Research Institute, ANZAC/CAE-9030-2022	Freedman, Saul B/0000-0002-3809-2911; Handelsman, David/0000-0002-4200-7476; Martinez, Carlos/0000-0001-6498-6428	Boehringer Ingelheim; CSL Behring; Bayer Pharma AG; Bristol-Myers Squibb; Novartis; Boehringer-Ingelheim; AstraZeneca; Myers Squibb; Aspen; BMS/Pfizer; Servier; Gilead; Bayer HealthCare; Daiichi-Sankyo; Pfizer; Johnson and Johnson; Ono Pharmaceuticals; Portola; Sanofi; X01; Jannsen; Besins; Lawley	Boehringer Ingelheim(Boehringer Ingelheim); CSL Behring; Bayer Pharma AG; Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); Boehringer-Ingelheim(Boehringer Ingelheim); AstraZeneca(AstraZeneca); Myers Squibb; Aspen; BMS/Pfizer(Pfizer); Servier(Servier); Gilead(Gilead Sciences); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Pfizer(Pfizer); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Ono Pharmaceuticals; Portola; Sanofi; X01; Jannsen; Besins; Lawley	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; CM has received personal fees from Boehringer Ingelheim and grants from CSL Behring, Bayer Pharma AG, and Bristol-Myers Squibb; SS has received speaking fees from Novartis, Boehringer-Ingelheim, and AstraZeneca and research grants from Bayer Pharma AG, Boehringer-Ingelheim, Bristol-Myers Squibb, and Novartis; BF has received grants, personal fees, and non-financial support from Bayer Pharma AG, grants and non-financial support from Aspen, Boehringer Ingelheim, grants and personal fees from BMS/Pfizer, and personal fees from Servier, Astra-Zeneca, and Gilead. ATC has received grants and personal fees from Bayer HealthCare, Daiichi-Sankyo, Bristol-Myers Squibb, and Pfizer and personal fees from Boehringer Ingelheim, Johnson and Johnson, Ono Pharmaceuticals, Portola, Sanofi, X01, and Jannsen; DJH's institution received part funding from two companies (Besins, Lawley) in 2015 for investigator initiated clinical testosterone pharmacology research on which he is principal investigator, but he receives no personal funding; no other relationships or activities that could appear to have influenced the submitted work.	Albert SG, 2016, CLIN ENDOCRINOL, V85, P436, DOI 10.1111/cen.13084; Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; Baillargeon J, 2015, MAYO CLIN PROC, V90, P1038, DOI 10.1016/j.mayocp.2015.05.012; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Borst SE, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0211-5; Corona G, 2014, EXPERT OPIN DRUG SAF, V13, P1327, DOI 10.1517/14740338.2014.950653; Dinger J, 2014, CONTRACEPTION, V89, P253, DOI 10.1016/j.contraception.2014.01.023; Dinger JC, 2007, CONTRACEPTION, V75, P344, DOI 10.1016/j.contraception.2006.12.019; ESHRE Capri Workshop Grp, 2013, HUM REPROD UPDATE, V19, P471, DOI 10.1093/humupd/dmt028; Glueck CJ, 2016, CLIN APPL THROMB-HEM, V22, P548, DOI 10.1177/1076029615619486; Glueck CJ, 2011, TRANSL RES, V158, P225, DOI 10.1016/j.trsl.2011.06.003; Handelsman DJ, 2015, MED CARE, V53, P743, DOI 10.1097/MLR.0000000000000416; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548, DOI 10.5694/mja13.10111; Handelsman DJ, 2015, ENDOCRINOLOGY, P2368; Health Canada, 2014, SUMM SAF REV TEST RE; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Jasuja GK, 2015, MED CARE, V53, P746, DOI 10.1097/MLR.0000000000000398; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lidegaard Ojvind, 2011, BMJ, V343, pd6423, DOI 10.1136/bmj.d6423; Martinez C, 2014, THROMB HAEMOSTASIS, V112, P255, DOI 10.1160/TH13-09-0793; Middleton T, 2015, EUR J ENDOCRINOL, V172, P511, DOI 10.1530/EJE-14-0891; MIETTINEN OS, 1989, J CLIN EPIDEMIOL, V42, P325, DOI 10.1016/0895-4356(89)90037-1; Onasanya O, 2016, LANCET DIABETES ENDO, V4, P943, DOI 10.1016/S2213-8587(16)30215-7; Perls T, 2015, J AM GERIATR SOC, V63, P809, DOI 10.1111/jgs.13391; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Ruige JB, 2013, J CLIN ENDOCR METAB, V98, P4300, DOI 10.1210/jc.2013-1970; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Schoenfeld MJ, 2013, J SEX MED, V10, P1401, DOI 10.1111/jsm.12114; Sharma R, 2016, CHEST, V150, P563, DOI 10.1016/j.chest.2016.05.007; Snyder PJ, 2016, NEW ENGL J MED, V374, P611, DOI 10.1056/NEJMoa1506119; Spencer FA, 2009, J THROMB THROMBOLYS, V28, P401, DOI 10.1007/s11239-009-0378-3; Suissa S, 1997, CONTRACEPTION, V56, P141, DOI 10.1016/S0010-7824(97)00119-4; Suissa S, 2015, EPIDEMIOLOGY, V26, P242, DOI 10.1097/EDE.0000000000000221; US Food and Drug Administration, 2014, TEST PROD FDA CDER S; Winkler UH, 1996, MATURITAS, V24, P147, DOI 10.1016/S0378-5122(96)82004-4; Xu L, 2015, J THROMB HAEMOST, V13, P884, DOI 10.1111/jth.12862; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108	37	93	95	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2016	355								i5968	10.1136/bmj.i5968	http://dx.doi.org/10.1136/bmj.i5968			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZD	27903495	Green Published, hybrid			2022-12-28	WOS:000389308600003
J	Vansteensel, MJ; Pels, EGM; Bleichner, MG; Branco, MP; Denison, T; Freudenburg, ZV; Gosselaar, P; Leinders, S; Ottens, TH; Van den Boom, MA; Van Rijen, PC; Aarnoutse, EJ; Ramsey, NF				Vansteensel, Mariska J.; Pels, Elmar G. M.; Bleichner, Martin G.; Branco, Mariana P.; Denison, Timothy; Freudenburg, Zachary V.; Gosselaar, Peter; Leinders, Sacha; Ottens, Thomas H.; Van den Boom, Max A.; Van Rijen, Peter C.; Aarnoutse, Erik J.; Ramsey, Nick F.			Fully Implanted Brain-Computer Interface in a Locked-In Patient with ALS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; QUALITY-OF-LIFE; DEVICES; CORTEX; OUTPUT; SCALE; FMRI; BCI	Options for people with severe paralysis who have lost the ability to communicate orally are limited. We describe a method for communication in a patient with late-stage amyotrophic lateral sclerosis (ALS), involving a fully implanted brain-computer interface that consists of subdural electrodes placed over the motor cortex and a transmitter placed subcutaneously in the left side of the thorax. By attempting to move the hand on the side opposite the implanted electrodes, the patient accurately and independently controlled a computer typing program 28 weeks after electrode placement, at the equivalent of two letters per minute. The brain-computer interface offered autonomous communication that supplemented and at times supplanted the patient's eye-tracking device. (Funded by the Government of the Netherlands and the European Union; ClinicalTrials.gov number, NCT02224469.)	[Vansteensel, Mariska J.; Pels, Elmar G. M.; Branco, Mariana P.; Freudenburg, Zachary V.; Gosselaar, Peter; Leinders, Sacha; Van den Boom, Max A.; Van Rijen, Peter C.; Aarnoutse, Erik J.; Ramsey, Nick F.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [Ottens, Thomas H.] Univ Med Ctr Utrecht, Dept Anesthesiol, Utrecht, Netherlands; [Bleichner, Martin G.] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, European Med Sch, Neuropsychol Lab,Dept Psychol, Oldenburg, Germany; [Denison, Timothy] Medtronic, Neuromodulat Core Technol, Minneapolis, MN USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Carl von Ossietzky Universitat Oldenburg; Medtronic	Ramsey, NF (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	n.f.ramsey@umcutrecht.nl	Vansteensel, Mariska/K-8015-2019; Ottens, Thomas/AAF-5128-2019; Branco, Mariana Pedroso/J-9221-2019; Aarnoutse, Erik/S-4174-2019; Bleichner, Martin G/AAA-1383-2021; Bleichner, Martin G/AAV-2585-2021	Ottens, Thomas/0000-0001-6861-5755; Branco, Mariana Pedroso/0000-0002-7316-8846; Aarnoutse, Erik/0000-0001-7648-250X; Bleichner, Martin G/0000-0001-6933-9238; Bleichner, Martin G/0000-0001-6933-9238; Pels, Elmar/0000-0001-8997-9515; ramsey, nick/0000-0002-7136-259X; Denison, Timothy/0000-0002-5404-4004; van den Boom, Max/0000-0001-5481-1659; Vansteensel, Mariska/0000-0002-9252-5116	government grants from the Netherlands (Economic Affairs) [UGT7685, SSM06011, STW 12803]; Medtronic; European Union [ERC-Adv 320708]	government grants from the Netherlands (Economic Affairs); Medtronic(Medtronic); European Union(European Commission)	Supported by government grants from the Netherlands (UGT7685, Economic Affairs SSM06011 and STW 12803, cosponsored by Medtronic) and the European Union (ERC-Adv 320708). Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Bech P, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0529-3; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Bruno MA, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000039; Caligari M, 2013, AMYOTROPH LAT SCL FR, V14, P546, DOI 10.3109/21678421.2013.803576; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Day H., 1996, CAN J REHABIL, V9, P159; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Hermes D, 2012, HUM BRAIN MAPP, V33, P1689, DOI 10.1002/hbm.21314; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Huggins JE, 2011, AMYOTROPH LATERAL SC, V12, P318, DOI 10.3109/17482968.2011.572978; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Kleih S, 2011, INT J BIOELECTROMAGN, V13, P46; Kubler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112392; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Nijboer F, 2015, ANN PHYS REHABIL MED, V58, P35, DOI 10.1016/j.rehab.2014.11.001; Pfurtscheller G, 1995, MED PROG TECHNOL, V21, P111; Rousseau MC, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0304-z; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Siero JCW, 2014, NEUROIMAGE, V101, P177, DOI 10.1016/j.neuroimage.2014.07.002; Valderrama AT, 2012, CLIN NEUROPHYSIOL, V123, P2392, DOI 10.1016/j.clinph.2012.05.006; Vansteensel MJ, 2010, ANN NEUROL, V67, P809, DOI 10.1002/ana.21985; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948	24	250	252	17	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2060	2066		10.1056/NEJMoa1608085	http://dx.doi.org/10.1056/NEJMoa1608085			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC9KU	27959736	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000388464300008
J	Feagan, BG; Sandborn, WJ; Gasink, C; Jacobstein, D; Lang, Y; Friedman, JR; Blank, MA; Johanns, J; Gao, LL; Miao, Y; Adedokun, OJ; Sands, BE; Hanauer, SB; Vermeire, S; Targan, S; Ghosh, S; de Villiers, WJ; Colombel, JF; Tulassay, Z; Seidler, U; Salzberg, BA; Desreumaux, P; Lee, SD; Loftus, EV; Dieleman, LA; Katz, S; Rutgeerts, P				Feagan, B. G.; Sandborn, W. J.; Gasink, C.; Jacobstein, D.; Lang, Y.; Friedman, J. R.; Blank, M. A.; Johanns, J.; Gao, L. -L.; Miao, Y.; Adedokun, O. J.; Sands, B. E.; Hanauer, S. B.; Vermeire, S.; Targan, S.; Ghosh, S.; de Villiers, W. J.; Colombel, J. -F.; Tulassay, Z.; Seidler, U.; Salzberg, B. A.; Desreumaux, P.; Lee, S. D.; Loftus, E. V., Jr.; Dieleman, L. A.; Katz, S.; Rutgeerts, P.		UNITI-IM-UNITI Study Grp	Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MONOCLONAL-ANTIBODY; RANDOMIZED-TRIAL; INFLIXIMAB; ADALIMUMAB; INFECTIONS; EFFICACY; ARTICLE; SAFETY	BACKGROUND Ustekinumab, a monoclonal antibody to the p40 subunit of interleukin-12 and interleukin-23, was evaluated as an intravenous induction therapy in two populations with moderately to severely active Crohn's disease. Ustekinumab was also evaluated as subcutaneous maintenance therapy. METHODS We randomly assigned patients to receive a single intravenous dose of ustekinumab (either 130 mg or approximately 6 mg per kilogram of body weight) or placebo in two induction trials. The UNITI-1 trial included 741 patients who met the criteria for primary or secondary nonresponse to tumor necrosis factor (TNF) antagonists or had unacceptable side effects. The UNITI-2 trial included 628 patients in whom conventional therapy failed or unacceptable side effects occurred. Patients who completed these induction trials then participated in IM-UNITI, in which the 397 patients who had a response to ustekinumab were randomly assigned to receive subcutaneous maintenance injections of 90 mg of ustekinumab (either every 8 weeks or every 12 weeks) or placebo. The primary end point for the induction trials was a clinical response at week 6 (defined as a decrease from baseline in the Crohn's Disease Activity Index [CDAI] score of = 100 points or a CDAI score <150). The primary end point for the maintenance trial was remission at week 44 (CDAI score <150). RESULTS The rates of response at week 6 among patients receiving intravenous ustekinumab at a dose of either 130 mg or approximately 6 mg per kilogram were significantly higher than the rates among patients receiving placebo (in UNITI-1, 34.3%, 33.7%, and 21.5%, respectively, with P=0.003 for both comparisons with placebo; in UNITI-2, 51.7%, 55.5%, and 28.7%, respectively, with P<0.001 for both doses). In the groups receiving maintenance doses of ustekinumab every 8 weeks or every 12 weeks, 53.1% and 48.8%, respectively, were in remission at week 44, as compared with 35.9% of those receiving placebo (P = 0.005 and P = 0.04, respectively). Within each trial, adverse-event rates were similar among treatment groups. CONCLUSIONS Among patients with moderately to severely active Crohn's disease, those receiving intravenous ustekinumab had a significantly higher rate of response than did those receiving placebo. Subcutaneous ustekinumab maintained remission in patients who had a clinical response to induction therapy. (Funded by Janssen Research and Development; ClinicalTrials.gov numbers, NCT01369329, NCT01369342, and NCT01369355.)	[Feagan, B. G.] Univ Western Ontario, Robarts Clin Trials, Robarts Res Inst, 100 Perth Dr, London, ON N6A 5K8, Canada; [Ghosh, S.] Univ Calgary, Calgary, AB, Canada; [Dieleman, L. A.] Univ Alberta, Div Gastroenterol, Edmonton, AB, Canada; [Dieleman, L. A.] Univ Alberta, CEGIIR, Edmonton, AB, Canada; [Sandborn, W. J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Targan, S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Gasink, C.; Jacobstein, D.; Lang, Y.; Friedman, J. R.; Johanns, J.; Gao, L. -L.; Miao, Y.; Adedokun, O. J.] Janssen Res & Dev, Spring House, PA USA; [Blank, M. A.] Janssen Sci Affairs, Horsham, PA USA; [Sands, B. E.; Colombel, J. -F.] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA; [Katz, S.] NYU, Sch Med, New York, NY USA; [Hanauer, S. B.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Vermeire, S.; Rutgeerts, P.] Univ Hosp Leuven, Leuven, Belgium; [de Villiers, W. J.] Univ Stellenbosch, Stellenbosch, South Africa; [Tulassay, Z.] Semmelweis Univ, Budapest, Hungary; [Seidler, U.] Hannover Med Sch, Dept Gastroenterol, Hannover, Germany; [Salzberg, B. A.] Atlanta Gastroenterol Specialists, Atlanta, GA USA; [Desreumaux, P.] Hop Claude Huriez, Lille, France; [Lee, S. D.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Loftus, E. V., Jr.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA	Western University (University of Western Ontario); University of Calgary; University of Alberta; University of Alberta; University of California System; University of California San Diego; Cedars Sinai Medical Center; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Icahn School of Medicine at Mount Sinai; New York University; Northwestern University; Feinberg School of Medicine; KU Leuven; University Hospital Leuven; Stellenbosch University; Semmelweis University; Hannover Medical School; Universite de Lille - ISITE; CHU Lille; University of Washington; University of Washington Seattle; Mayo Clinic	Sandborn, WJ (corresponding author), Univ Calif San Diego, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Feagan, BG (corresponding author), Univ Western Ontario, Robarts Clin Trials, Robarts Res Inst, 100 Perth Dr, London, ON N6A 5K8, Canada.	brian.feagan@robartsinc.com; wsandborn@ucsd.edu	Sandborn, William/ABE-8342-2020; Loftus, Edward V/E-8304-2011; Dieleman, Levinus/AAT-8198-2021; Sorrentino, Dario/K-7253-2019; Glerup, Henning/R-2191-2019; Ghosh, Subrata/AAC-2676-2021; Friedman, Joshua/Q-9367-2019; Pavli, Paul/GZL-0607-2022; Seidler, Ursula/HII-8049-2022; Preiß, Jan/N-4976-2019; Sands, Bruce/R-7887-2019; Leong, Rupert WL/J-7839-2012; Desreumaux, Pierre F/R-6877-2018; Feagan, Brian/G-3292-2011; Stimac, Davor/S-7420-2018; Bossa, Fabrizio/B-3078-2017	Loftus, Edward V/0000-0001-7199-6851; Glerup, Henning/0000-0002-8247-8766; Ghosh, Subrata/0000-0002-1713-7797; Friedman, Joshua/0000-0001-9382-8429; Seidler, Ursula/0000-0002-9600-2769; Preiß, Jan/0000-0002-0901-1422; Sands, Bruce/0000-0001-5762-5042; Leong, Rupert WL/0000-0001-5944-3488; Desreumaux, Pierre F/0000-0002-6127-5281; Stimac, Davor/0000-0001-8243-2453; Allez, Matthieu/0000-0002-2012-7522; Annese, Vito/0000-0002-0082-892X; Travis, Simon/0000-0002-2690-4361; Rai, Rajesh Kumar/0000-0002-5249-9937; MARTIN ARRANZ, MARIA DOLORES/0000-0002-1872-0917; Sipahi, Aytan/0000-0002-9686-1627; Bossa, Fabrizio/0000-0002-4518-9949; Maria dos Santos, Fabiana/0000-0003-1785-7388; Savoye, Guillaume/0000-0002-9200-2067; van der Woude, C.Janneke/0000-0003-3875-6957; peyrin-biroulet, laurent/0000-0003-2536-6618; Pollok, Richard/0000-0001-6452-6763; Connor, Susan/0000-0001-5606-0270; Stein, Jurgen/0000-0003-3558-3341; Dieleman, Levinus/0000-0001-7852-2122; Isaacs, Kim/0000-0002-6433-876X; Glover, Sarah/0000-0002-9899-0473; katz, seymour/0000-0002-3492-9200; iqbal, tariq/0000-0002-6681-9882; Wnek, Aneta/0000-0003-4177-0514; Vermeire, Severine/0000-0001-9942-3019; Yamamoto, Takayuki/0000-0001-7551-5568; Marshall, John/0000-0002-0523-9032; Danese, Silvio/0000-0001-7341-1351; Parkes, Miles/0000-0002-6467-0631; Penchev, Plamen/0000-0001-5042-5216; Ehehalt, Robert/0000-0003-4252-5801	Janssen Research and Development	Janssen Research and Development	Funded by Janssen Research and Development; ClinicalTrials.gov numbers, NCT01369329, NCT01369342, and NCT01369355.	[Anonymous], 2014, STEL UST SUBC US; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Biancone L, 2003, ALIMENT PHARM THER, V17, P31, DOI 10.1046/j.1365-2036.17.s2.20.x; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Gottlieb AB, 2014, J DRUGS DERMATOL, V13, P1441; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Kavanaugh A, 2015, ARTHRIT CARE RES, V67, P1739, DOI 10.1002/acr.22645; Konidari Anastasia, 2014, World J Gastrointest Pharmacol Ther, V5, P63, DOI 10.4292/wjgpt.v5.i2.63; Lichtenstein GR, 2012, AM J GASTROENTEROL, V107, P1051, DOI 10.1038/ajg.2012.89; Papp KA, 2013, BRIT J DERMATOL, V168, P844, DOI 10.1111/bjd.12214; Papp K, 2015, J DRUGS DERMATOL, V14, P58; Rutgeerts PJ, 2001, ALIMENT PHARM THER, V15, P1515, DOI 10.1046/j.1365-2036.2001.01060.x; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sandborn WJ, 2004, GUT, V53, P780, DOI 10.1136/gut.2003.020552; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P512, DOI 10.1053/gast.2002.31072; Sands BE, 2014, GASTROENTEROLOGY, V147, P618, DOI 10.1053/j.gastro.2014.05.008; Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012	19	886	923	1	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1946	1960		10.1056/NEJMoa1602773	http://dx.doi.org/10.1056/NEJMoa1602773			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC1HS	27959607	Green Published, Green Accepted			2022-12-28	WOS:000387856100007
J	Osman, C; Clark, TW				Osman, Chinar; Clark, Tristan W.			Tabes Dorsalis and Argyll Robertson Pupils	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Osman, Chinar; Clark, Tristan W.] Univ Southampton, Southampton, Hants, England	University of Southampton	Osman, C (corresponding author), Univ Southampton, Southampton, Hants, England.	chinar.osman@uhs.nhs.uk							0	1	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					E40	E40		10.1056/NEJMicm1507564	http://dx.doi.org/10.1056/NEJMicm1507564			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC1HS	27959596	Green Accepted			2022-12-28	WOS:000387856100011
J	Loibl, S; Gianni, L				Loibl, Sibylle; Gianni, Luca			HER2-positive breast cancer	LANCET			English	Article							PATHOLOGICAL COMPLETE RESPONSE; LAPATINIB PLUS CAPECITABINE; MULTICENTER PHASE-II; CONTROLLED SUPERIORITY TRIAL; TRASTUZUMAB EMTANSINE T-DM1; OPEN-LABEL; ADJUVANT TRASTUZUMAB; NEOADJUVANT CHEMOTHERAPY; PIK3CA MUTATIONS; DOUBLE-BLIND	Anti-HER2 treatment for HER2-positive breast cancer has changed the natural biology of this disease. This Series article reviews the main achievements so far in the treatment of both metastatic and early HER2-positive breast cancer. The success of neoadjuvant therapy in HER2-positive early breast cancer is especially acknowledged, as pertuzumab has been approved on the basis of a higher proportion of patients achieving a pathological complete response with pertuzumab and trastuzumab than with trastuzumab alone in a neoadjuvant study. Event-free survival after the confirmatory adjuvant trial completed recruitment was numerically better with pertuzumab plus trastuzumab than with trastuzumab alone. With survival rates of almost 5 years in women with metastatic HER2-positive breast cancer and 75% of patients achieving a pathological complete response, new treatments in the past decade have clearly improved the prognosis of HER2-positive breast cancer. Despite these achievements, however, the persisting high toll of deaths resulting from HER2-positive breast cancer calls for continued, intensive clinical research of newer therapies and combinations.	[Loibl, Sibylle] GB Forsch GmbH, German Breast Grp, Martin Behaim Str 12, D-63263 Neu Isenburg, Germany; [Gianni, Luca] Osped San Raffaele, Sci Inst, Milan, Italy	German Breast Group; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Loibl, S (corresponding author), GB Forsch GmbH, German Breast Grp, Martin Behaim Str 12, D-63263 Neu Isenburg, Germany.	sibylle.loibl@gbg.de		GIANNI, LUCA/0000-0002-2372-9625	Pfizer; Amgen; Roche; Novartis; Celgene; AstraZeneca	Pfizer(Pfizer); Amgen(Amgen); Roche(Roche Holding); Novartis(Novartis); Celgene(Bristol-Myers SquibbCelgene Corporation); AstraZeneca(AstraZeneca)	SL's institution has received grants from Pfizer, Amgen, Roche, Novartis, Celgene, and AstraZeneca, during the course of the study. LG is on the advisory boards of Genentech, Roche, Lilly, Synthon, Synaffix, and Pfizer.	Alba E, 2014, BRIT J CANCER, V110, P1139, DOI 10.1038/bjc.2013.831; Andersson M, 2011, J CLIN ONCOL, V29, P264, DOI 10.1200/JCO.2010.30.8213; Andre F, 2014, LANCET ONCOL, V15, P580, DOI 10.1016/S1470-2045(14)70138-X; Awada A, 2016, JAMA ONCOL, V2, P1557, DOI 10.1001/jamaoncol.2016.0237; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Baselga J, 2010, CLIN BREAST CANCER, V10, P489, DOI 10.3816/CBC.2010.n.065; Bianchini G, 2015, ANN ONCOL, V26, P2429, DOI 10.1093/annonc/mdv395; Bianchini G, 2014, LANCET ONCOL, V15, pE58, DOI 10.1016/S1470-2045(13)70477-7; Blackwell KL, 2012, J CLIN ONCOL, V30, P2585, DOI 10.1200/JCO.2011.35.6725; Bonadonna G, 1977, Prog Clin Biol Res, V12, P437; Buzdar AU, 2007, CLIN CANCER RES, V13, P228, DOI 10.1158/1078-0432.CCR-06-1345; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; Cameron D, 2010, ONCOLOGIST, V15, P924, DOI 10.1634/theoncologist.2009-0181; Carey LA, 2016, J CLIN ONCOL, V34, P542, DOI 10.1200/JCO.2015.62.1268; Chan A, 2016, LANCET ONCOL, V17, P367, DOI 10.1016/S1470-2045(15)00551-3; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Cortes J, 2015, LANCET ONCOL, V16, P1700, DOI 10.1016/S1470-2045(15)00373-3; Denkert C, 2015, J CLIN ONCOL, V33, P983, DOI 10.1200/JCO.2014.58.1967; Ellis PA, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.507; European Medicines Agency, 2014, EMACHMP1518532014; Gelmon KA, 2015, J CLIN ONCOL, V33, P1574, DOI 10.1200/JCO.2014.56.9590; Geyer CE, 2007, NEW ENGL J MED, V356, P1487; Gianni L, 2011, CANCER RES, V71, pS5; Gianni L, 2016, LANCET ONCOL, V17, P791, DOI 10.1016/S1470-2045(16)00163-7; Gianni L, 2014, LANCET ONCOL, V15, P640, DOI 10.1016/S1470-2045(14)70080-4; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Giordano SH, 2014, J CLIN ONCOL, V32, P2078, DOI 10.1200/JCO.2013.54.0948; Goldhirsch A, 2013, LANCET, V382, P1021, DOI 10.1016/S0140-6736(13)61094-6; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Goss PE, 2013, LANCET ONCOL, V14, P88, DOI 10.1016/S1470-2045(12)70508-9; Guarneri V, 2015, ONCOLOGIST, V20, P1001, DOI 10.1634/theoncologist.2015-0138; Guarneri V, 2012, J CLIN ONCOL, V30, P1989, DOI 10.1200/JCO.2011.39.0823; Harbeck N, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-S5-03; Holmes FA, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.506; Hurvitz SA, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-S1-02; Hurvitz SA, 2016, ASCO ANN M CHIC IL J, P500; Hurvitz SA, 2015, LANCET ONCOL, V16, P816, DOI 10.1016/S1470-2045(15)00051-0; Ismael G, 2012, LANCET ONCOL, V13, P869, DOI 10.1016/S1470-2045(12)70329-7; Jackisch C, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-PD5-01; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Johnston SRD, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv212; Junttila TT, 2011, BREAST CANCER RES TR, V128, P347, DOI 10.1007/s10549-010-1090-x; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Korkola JE, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.SABCS14-S6-07; Krop IE, 2015, ANN ONCOL, V26, P113, DOI 10.1093/annonc/mdu486; Krop IE, 2014, LANCET ONCOL, V15, P689, DOI 10.1016/S1470-2045(14)70178-0; Lin NU, 2009, CLIN CANCER RES, V15, P1452, DOI 10.1158/1078-0432.CCR-08-1080; Loibl S, 2016, ANN ONCOL, V27, P1519, DOI 10.1093/annonc/mdw197; Loibl S, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-P1-14-01; Loibl S, 2016, CLIN CANCER RES, V22, P2675, DOI 10.1158/1078-0432.CCR-15-0965; Loibl S, 2014, J CLIN ONCOL, V32, P3212, DOI 10.1200/JCO.2014.55.7876; Majewski IJ, 2015, J CLIN ONCOL, V33, P1334, DOI 10.1200/JCO.2014.55.2158; Miles D, 2015, EUR J CANCER, V51, pS271, DOI 10.1016/S0959-8049(16)30768-7; Miller KD, 2014, J CLIN ONCOL, V32, P1437, DOI 10.1200/JCO.2013.52.6590; Niikura N, 2016, ANN ONCOL, V27, P480, DOI 10.1093/annonc/mdv611; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; O'Sullivan CC, 2015, J CLIN ONCOL, V33, P2600, DOI 10.1200/JCO.2015.60.8620; Paik S, 2002, JNCI-J NATL CANCER I, V94, P852, DOI 10.1093/jnci/94.11.852; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Perez EA, 2011, J CLIN ONCOL, V29, P4491, DOI 10.1200/JCO.2011.36.7045; Piccart-Gebhart M, 2016, J CLIN ONCOL, V34, P1034, DOI 10.1200/JCO.2015.62.1797; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pivot X, 2015, J CLIN ONCOL, V33, P1564, DOI 10.1200/JCO.2014.57.1794; Pivot X, 2013, LANCET ONCOL, V14, P741, DOI 10.1016/S1470-2045(13)70225-0; Rimawi MF, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.SABCS14-S6-02; Rimawi MF, 2013, J CLIN ONCOL, V31, P1726, DOI 10.1200/JCO.2012.44.8027; Robidoux A, 2013, LANCET ONCOL, V14, P1183, DOI 10.1016/S1470-2045(13)70411-X; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rugo HS, 2016, ASCO ANN M CHIC IL J; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Schneeweiss A, 2013, ANN ONCOL, V24, P2278, DOI 10.1093/annonc/mdt182; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Slamon DJ, 2016, CANCER RES, V76, pS5; Soni A, 2015, AM J CLIN PATHOL, V143, P471, DOI 10.1309/AJCPYO5FSV3UPEXS; Spielmann M, 2009, J CLIN ONCOL, V27, P6129, DOI 10.1200/JCO.2009.23.0946; Storniolo AM, 2008, J CLIN ONCOL, V26, P3317, DOI 10.1200/JCO.2007.13.5202; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Untch M, 2016, LANCET ONCOL, V17, P345, DOI 10.1016/S1470-2045(15)00542-2; Untch M, 2012, LANCET ONCOL, V13, P135, DOI 10.1016/S1470-2045(11)70397-7; Untch M, 2011, J CLIN ONCOL, V29, P3351, DOI 10.1200/JCO.2010.31.4930; Untch M, 2010, J CLIN ONCOL, V28, P2024, DOI 10.1200/JCO.2009.23.8451; US Department of Health and Human Services, 2014, PATH COMPL RESP NEOA; van Ramshorst MS, 2016, CANCER RES, V76, pS6; Verma S, 2013, NEW ENGL J MED, V368, P2442; von Minckwitz G, 1999, J CLIN ONCOL, V17, P1999, DOI 10.1200/JCO.1999.17.7.1999; von Minckwitz G, 2014, LANCET ONCOL, V15, P747, DOI 10.1016/S1470-2045(14)70160-3; von Minckwitz G, 2011, EUR J CANCER, V47, P2273, DOI 10.1016/j.ejca.2011.06.021; Wildiers H, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-S5-05; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774	96	401	414	18	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2415	2429		10.1016/S0140-6736(16)32417-5	http://dx.doi.org/10.1016/S0140-6736(16)32417-5			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX6ED	27939064				2022-12-28	WOS:000403334400027
J	Turner, NC; Neven, P; Loibl, S; Andre, F				Turner, Nicholas C.; Neven, Patrick; Loibl, Sibylle; Andre, Fabrice			Advances in the treatment of advanced oestrogen-receptor-positive breast cancer	LANCET			English	Article							RANDOMIZED PHASE-II; KINASE 4/6 INHIBITOR; FULVESTRANT 500 MG; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; MEDIATE RESISTANCE; GENE AMPLIFICATION; 1ST-LINE TREATMENT; ENDOCRINE THERAPY; ESR1 MUTATIONS	Oestrogen-receptor-positive breast cancer is the most common subtype of breast cancer. Endocrine therapies that target the dependence of this subtype on the oestrogen receptor have substantial activity, yet the development of resistance to therapy is inevitable in advanced cancer. Major progress has been made in identifying the drivers of oestrogen-receptor-positive breast cancer and the mechanisms of resistance to endocrine therapy. This progress has translated into major advances in the treatment of advanced breast cancer, with several targeted therapies that enhance the efficacy of endocrine therapy; inhibitors of mTOR and inhibitors of the cyclin-dependent kinases CDK4 and CDK6 substantially improve progression-free survival. A new wave of targeted therapies is being developed, including inhibitors of PI3K, AKT, and HER2, and a new generation of oestrogen-receptor degraders. Considerable challenges remain in patient selection, deciding on the most appropriate order in which to administer therapies, and establishing whether cross-resistance occurs between therapies.	[Turner, Nicholas C.] Royal Marsden Hosp, London, England; [Turner, Nicholas C.] Inst Canc Res, London, England; [Neven, Patrick] Univ Hosp Leuven, Dept Oncol, Multidisciplinary Breast Ctr, Leuven, Belgium; [Neven, Patrick] Univ Hosp Leuven, Dept Oncol, Dept Gynaecol Oncol, Leuven, Belgium; [Loibl, Sibylle] GBG Forsch GmbH, GBG, D-63263 Neu Isenburg, Germany; [Loibl, Sibylle] Bethanien, Ctr Haematol & Oncol, Frankfurt, Germany; [Andre, Fabrice] Univ Paris Sud, Gustave Roussy Canc Ctr, INSERM U981, Villejuif, France	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; German Breast Group; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Loibl, S (corresponding author), GBG Forsch GmbH, GBG, D-63263 Neu Isenburg, Germany.	sibylle.loibl@GBG.de	ANDRE, Fabrice/AAL-2683-2020	ANDRE, Fabrice/0000-0001-5795-8357; Turner, Nicholas/0000-0001-8937-0873	Pfizer; Roche/Genentech; AstraZeneca; Clovis; Servier; Novartis; Biomarin; Lilly; Synthon; Astellas; NHS	Pfizer(Pfizer); Roche/Genentech(Roche HoldingGenentech); AstraZeneca(AstraZeneca); Clovis; Servier(Servier); Novartis(Novartis); Biomarin; Lilly(Eli Lilly); Synthon; Astellas(Astellas Pharmaceuticals); NHS	NCT has received research grants from Pfizer, Roche/Genentech, AstraZeneca, Clovis, and Servier; personal fees from Novartis, Biomarin, Lilly, Synthon, Astellas; and acknowledges NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden and the Institute of Cancer Research. PN has served on international advisory boards for Lilly, Novartis, Pfizer, and Puma. SL's institution has received grants from Pfizer, Novartis, and AstraZeneca. FA has received research grants from Pfizer, AstraZeneca, Novartis, and Lilly.	Akcakanat A, 2008, CANCER-AM CANCER SOC, V112, P2352, DOI 10.1002/cncr.23456; Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-88; Andre F, 2014, LANCET ONCOL, V15, P267, DOI 10.1016/S1470-2045(13)70611-9; Arnedos M, 2016, AACR 107 ANN M NEW O; Awada A, 2008, EUR J CANCER, V44, P84, DOI 10.1016/j.ejca.2007.10.003; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Baselga J, 2015, SAN ANT BREAST CANC; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Beagle B, 2011, CANCER CELL, V19, P693, DOI 10.1016/j.ccr.2011.05.020; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Bosch A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4442; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Bowles DW, 2013, BRIT J CANCER, V109, P1085, DOI 10.1038/bjc.2013.474; Cardoso F, 2014, ANN ONCOL, V25, P1871, DOI 10.1093/annonc/mdu385; Carlson RW, 2012, J NATL COMPR CANC NE, V10, P821, DOI 10.6004/jnccn.2012.0086; Carpenter JT, 2005, J CLIN ONCOL, V23, p19S; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Chandarlapaty S SP, 2015, SAN ANT BREAST CANC; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Crowder RJ, 2009, CANCER RES, V69, P3955, DOI 10.1158/0008-5472.CAN-08-4450; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Desmedt C, 2016, J CLIN ONCOL, V34, P1872, DOI 10.1200/JCO.2015.64.0334; Di Cosimo S, 2015, CLIN CANCER RES, V21, P49, DOI 10.1158/1078-0432.CCR-14-0940; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Dickler M, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-CT231; Dickler MN, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.510; Dickson MA, 2009, CURR ONCOL, V16, P120; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Ellard SL, 2009, J CLIN ONCOL, V27, P4536, DOI 10.1200/JCO.2008.21.3033; Ellis MJ, 2015, J CLIN ONCOL, V33, P3781, DOI 10.1200/JCO.2015.61.5831; Ellis MJ, 2016, EUR SOC MED ONC 2016; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Finn RS, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.507; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fleming GF, 2012, BREAST CANCER RES TR, V136, P355, DOI 10.1007/s10549-011-1910-7; Fribbens C, 2016, J CLIN ONCOL, V34, P2961, DOI 10.1200/JCO.2016.67.3061; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Harper Jane V., 2004, V296, P113; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; Hirsch E, PI3K CANC STROMA INT; Hong DS, 2012, CLIN CANCER RES, V18, P4173, DOI 10.1158/1078-0432.CCR-12-0714; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Hortobagyi GN, 2016, J CLIN ONCOL, V34, P419, DOI 10.1200/JCO.2014.60.1971; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hu WY, 2016, CLIN CANCER RES, V22, P2000, DOI 10.1158/1078-0432.CCR-15-1421; Hyman D, 2015, AACR NCI EORTC INT C; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Janku F, 2014, SAN ANT BREAST CANC; Juric D, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-PD1-3; Juric D, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.568; King TA, 2016, J CLIN ONCOL, V34, P2359, DOI 10.1200/JCO.2015.63.1960; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krop I, 2015, SAN ANT BREAST CAN 1; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lehmann BD, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0406-x; Loi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053292; Ma CX, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.516; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Markman B, 2012, ANN ONCOL, V23, P2399, DOI 10.1093/annonc/mds011; Mehta RS, 2012, NEW ENGL J MED, V367, P435, DOI 10.1056/NEJMoa1201622; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Osborne CK, 2011, CLIN CANCER RES, V17, P1147, DOI 10.1158/1078-0432.CCR-10-1869; Patnaik A, 2016, CANCER DISCOV, V6, P740, DOI 10.1158/2159-8290.CD-16-0095; Piccart M, 2014, ANN ONCOL, V25, P2357, DOI 10.1093/annonc/mdu456; Robertson JFR, 2013, LANCET ONCOL, V14, P228, DOI 10.1016/S1470-2045(13)70026-3; Robertson JFR, 2009, J CLIN ONCOL, V27, P4530, DOI 10.1200/JCO.2008.21.1136; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Ross JS, 2016, CANCER-AM CANCER SOC, V122, P2654, DOI 10.1002/cncr.30102; Rugo H, 2015, SAN ANT BREAST CANC; Rugo HS, 2014, ANN ONCOL, V25, P808, DOI 10.1093/annonc/mdu009; Rugo HS, 2014, J CLIN ONCOL S, V32, p5s; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Serra V, 2013, J CLIN INVEST, V123, P2551, DOI 10.1172/JCI66343; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Soler A, 2013, J EXP MED, V210, P1937, DOI 10.1084/jem.20121571; Soria JC, 2014, ANN ONCOL, V25, P2244, DOI 10.1093/annonc/mdu390; Swanton C, 2016, ANN ONCOL, V27, P1443, DOI 10.1093/annonc/mdw192; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Treilleux I, 2015, ANN ONCOL, V26, P120, DOI 10.1093/annonc/mdu497; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Warenius HM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-72; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Wolff AC, 2013, J CLIN ONCOL, V31, P195, DOI 10.1200/JCO.2011.38.3331; YAMAMOTO K, 1990, J BIOL CHEM, V265, P22086; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251	103	105	110	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2403	2414		10.1016/S0140-6736(16)32419-9	http://dx.doi.org/10.1016/S0140-6736(16)32419-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX6ED	27939057				2022-12-28	WOS:000403334400026
J	Torres, J; Mehandru, S; Colombel, JF; Peyrin-Biroulet, L				Torres, Joana; Mehandru, Saurabh; Colombel, Jean-Frederic; Peyrin-Biroulet, Laurent			Crohn's disease	LANCET			English	Review							INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; INNATE LYMPHOID-CELLS; C-REACTIVE PROTEIN; POPULATION-BASED COHORT; ULCERATIVE-COLITIS; FECAL CALPROTECTIN; RISK-FACTORS; MAINTENANCE THERAPY; NATURAL-HISTORY	Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract, with increasing incidence worldwide. Crohn's disease might result from a complex interplay between genetic susceptibility, environmental factors, and altered gut microbiota, leading to dysregulated innate and adaptive immune responses. The typical clinical scenario is a young patient presenting with abdominal pain, chronic diarrhoea, weight loss, and fatigue. Assessment of disease extent and of prognostic factors for complications is paramount to guide therapeutic decisions. Current strategies aim for deep and long-lasting remission, with the goal of preventing complications, such as surgery, and blocking disease progression. Central to these strategies is the introduction of early immunosuppression or combination therapy with biologicals in high-risk patients, combined with a tight and frequent control of inflammation, and adjustment of therapy on the basis of that assessment (treat to target strategy). The therapeutic armamentarium for Crohn's disease is expanding, and therefore the need to develop biomarkers that can predict response to therapies will become increasingly important for personalised medicine decisions in the near future. In this Seminar, we provide a physician-oriented overview of Crohn's disease in adults, ranging from epidemiology and cause to clinical diagnosis, natural history, patient stratification and clinical management, and ending with an overview of emerging therapies and future directions for research.	[Torres, Joana; Mehandru, Saurabh; Colombel, Jean-Frederic] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA; [Peyrin-Biroulet, Laurent] Univ Hosp Nancy Brabois, Dept Gastroenterol, Vandoeuvre Les Nancy, France	Icahn School of Medicine at Mount Sinai; CHU de Nancy	Colombel, JF (corresponding author), Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA.	jean-frederic.colombel@mssm.edu		peyrin-biroulet, laurent/0000-0003-2536-6618; Torres, Joana/0000-0003-2895-5821	Takeda Pharmaceuticals; Merck; Abbvie; Janssen Janssen; Genentech; Mitsubishi; Ferring; Norgine; Tillots; Vifor; Therakos; Pharmacosmos; Pilege; Bristol Meyers Squibb; UCB Pharmaceuticals; Hospira; Celltrion; Takeda; Biogaran; Boehringer-Ingelheim; Lilly; Pfizer; HAC-Pharma; Index Pharmaceuticals; Amgen; Sandoz; Forward Pharma GmbH; Celgene; Biogen; Lycera; Samsung Bioepis	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Merck(Merck & Company); Abbvie(AbbVie); Janssen Janssen; Genentech(Roche HoldingGenentech); Mitsubishi; Ferring(Ferring Pharmaceuticals); Norgine; Tillots; Vifor; Therakos; Pharmacosmos; Pilege; Bristol Meyers Squibb(Bristol-Myers Squibb); UCB Pharmaceuticals(UCB Pharma SA); Hospira; Celltrion; Takeda(Takeda Pharmaceutical Company Ltd); Biogaran; Boehringer-Ingelheim(Boehringer Ingelheim); Lilly(Eli Lilly); Pfizer(Pfizer); HAC-Pharma; Index Pharmaceuticals; Amgen(Amgen); Sandoz(Novartis); Forward Pharma GmbH; Celgene(Bristol-Myers SquibbCelgene Corporation); Biogen(Biogen); Lycera; Samsung Bioepis(Samsung)	JT has served as a consultant for AbbVie and Takeda, and as a speaker for Ferring and Falk. SM has served as a consultant for Pfizer, and receives research funding support from Takeda Pharmaceuticals. J-FC has served as consultant or advisory board member for Abbvie, Amgen, AstraZeneca, AB Science, Boehringer Ingelheim, Bristol Meyers Squibb, Celgene, Celltrion, Danone, Enterome, Evidera, Ferring, Genentech, Giuliani SPA, Given Imaging, Janssen & Janssen, Immune Pharmaceuticals, Intestinal Biotech Development, Kyowa Kirin Pharma, Lilly, Medimmune, Merck Sharp Dohme, Merck, Millennium Pharmaceuticals, Navigant Consulting, Neovacs, Nestle Nutrition Sciences Partner, Nutrition Science Partners, Pfizer, Prometheus Laboratories, Protagonist Therapies, Receptos, Sanofi, Schering Plough, Second Genome, Shire, Takeda, Teva Pharmaceuticals, Tigenix, UCB Pharmaceuticals, UEGW Abbvie Advisory Board, UEGW Abbvie Symposium, Vertex, and Dr August Wolff GmbH. LP-B has received consulting fees from Merck, Abbvie, Janssen & Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillots, Vifor, Therakos, Pharmacosmos, Pilege, Bristol Meyers Squibb, UCB Pharmaceuticals, Hospira, Celltrion, Takeda, Biogaran, Boehringer-Ingelheim, Lilly, Pfizer, HAC-Pharma, Index Pharmaceuticals, Amgen, Sandoz, Forward Pharma GmbH, Celgene, Biogen, Lycera, and Samsung Bioepis; and lecture fees from Merck, Abbvie, Takeda, Janssen & Janssen, Takeda, Ferring, Norgine, Tillots, Vifor, Therakos, Mitsubishi, and HAC-pharma.	Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Ananthakrishnan AN, 2014, GUT, V63, P776, DOI 10.1136/gutjnl-2013-305304; Ananthakrishnan AN, 2012, ANN INTERN MED, V156, P350, DOI 10.7326/0003-4819-156-5-201203060-00007; Annese V, 2015, J CROHNS COLITIS, V9, P945, DOI 10.1093/ecco-jcc/jjv141; Annese V, 2013, J CROHNS COLITIS, V7, P982, DOI 10.1016/j.crohns.2013.09.016; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Bakan S, 2015, IRAN J RADIOL, V12, DOI 10.5812/iranjradiol.29084; Beaugerie L, 2015, NEW ENGL J MED, V373, P195, DOI 10.1056/NEJMc1505689; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Ben-Horin S, 2013, CLIN GASTROENTEROL H, V11, P444, DOI 10.1016/j.cgh.2012.10.020; Benchimol EI, 2008, COCHRANE DB SYST REV, V2; Benchimol EI, 2009, COCHRANE DB SYST REV, V1; Benchimol EI, 2015, AM J GASTROENTEROL, V110, P553, DOI 10.1038/ajg.2015.52; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bernstein CN, 2008, GUT, V57, P1185, DOI 10.1136/gut.2007.122143; Bernstein CN, 2016, CLIN GASTROENTEROL H, V14, P50, DOI 10.1016/j.cgh.2015.08.005; Boltin D, 2013, J CLIN GASTROENTEROL, V47, P106, DOI 10.1097/MCG.0b013e3182688e73; Bourrier A, 2016, ALIMENT PHARM THER, V43, P252, DOI 10.1111/apt.13466; Brandtzaeg P, 2006, ADV EXP MED BIOL, V579, P149; Buisson A, 2012, ALIMENT PHARM THER, V35, P625, DOI 10.1111/j.1365-2036.2012.05002.x; Chande N, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub3; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Colombel JF, 2009, GUT, V58, P940, DOI 10.1136/gut.2008.159251; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Cornish JA, 2008, AM J GASTROENTEROL, V103, P2394, DOI 10.1111/j.1572-0241.2008.02064.x; Cosnes J, 2013, GASTROENTEROLOGY, V145, P758, DOI 10.1053/j.gastro.2013.04.048; Cosnes J, 2012, GUT, V61, P1140, DOI 10.1136/gutjnl-2011-301971; D'Haens G, 2016, J CROHNS COLITIS, V10; Danese S, 2016, AM J PHYSIOL-GASTR L, V310, pG155, DOI 10.1152/ajpgi.00311.2015; Danese S, 2015, NAT REV GASTRO HEPAT, V12, P537, DOI 10.1038/nrgastro.2015.135; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; de Chambrun GP, 2016, EXPERT REV GASTROENT, V10, P915, DOI 10.1586/17474124.2016.1174064; Deepak P, 2013, AM J GASTROENTEROL, V108, P99, DOI 10.1038/ajg.2012.334; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Dubinsky MC, 2008, CLIN GASTROENTEROL H, V6, P1105, DOI 10.1016/j.cgh.2008.04.032; Dulai PS, 2014, GUT, V63, P1843, DOI 10.1136/gutjnl-2014-307126; Eglinton TW, 2012, DIS COLON RECTUM, V55, P773, DOI 10.1097/DCR.0b013e31825228b0; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; Feagan BG, 2014, GASTROENTEROLOGY, V146, P681, DOI 10.1053/j.gastro.2013.11.024; Feakins RM, 2013, J CLIN PATHOL, V66, P1005, DOI 10.1136/jclinpath-2013-201885; Ford AC, 2013, AM J GASTROENTEROL, V108, P1268, DOI 10.1038/ajg.2013.138; Ford AC, 2011, AM J GASTROENTEROL, V106, P413, DOI 10.1038/ajg.2010.317; Gecse KB, 2014, GUT, V63, P1381, DOI 10.1136/gutjnl-2013-306709; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Grigg Erika L, 2012, Gastroenterol Hepatol (N Y), V8, P103; Hansen JJ, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0562-9; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hirahara K, 2016, INT IMMUNOL, V28, P163, DOI 10.1093/intimm/dxw006; Holder-Murray J, 2015, INFLAMM BOWEL DIS, V21, P1443, DOI 10.1097/MIB.0000000000000316; Huang CR, 2015, GASTROENTEROLOGY, V149, P1575, DOI 10.1053/j.gastro.2015.07.065; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Khanna R, 2015, LANCET, V386, P1825, DOI 10.1016/S0140-6736(15)00068-9; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kristensen V, 2015, SCAND J GASTROENTERO, V50, P1183, DOI 10.3109/00365521.2015.1025830; Laharie D, 2006, ALIMENT PHARM THER, V23, P1621, DOI 10.1111/j.1365-2036.2006.02929.x; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Limketkai BN, 2016, INFLAMM BOWEL DIS, V22, P1209, DOI 10.1097/MIB.0000000000000698; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Louis E, 2012, GASTROENTEROLOGY, V142, P63, DOI 10.1053/j.gastro.2011.09.034; Magro F, 2013, J CROHNS COLITIS, V7, P827, DOI 10.1016/j.crohns.2013.06.001; Mahadevan U, 2013, CLIN GASTROENTEROL H, V11, P286, DOI 10.1016/j.cgh.2012.11.011; Mahadevan U, 2012, GASTROENTEROLOGY, V142, pS149; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Matsumoto T, 2016, J CROHNS COLITIS, V10, P1259, DOI 10.1093/ecco-jcc/jjw152; McConnell RA, 2016, GASTROENTEROL CLIN N, V45, P285, DOI 10.1016/j.gtc.2016.02.006; McDonald John W D, 2014, Cochrane Database Syst Rev, pCD003459, DOI 10.1002/14651858.CD003459.pub4; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Menees SB, 2015, AM J GASTROENTEROL, V110, P444, DOI 10.1038/ajg.2015.6; Moller FT, 2015, AM J GASTROENTEROL, V110, P564, DOI 10.1038/ajg.2015.50; Monteleone G, 2015, NEW ENGL J MED, V372, P1104, DOI 10.1056/NEJMoa1407250; Moon W, 2016, ALIMENT PHARM THER, V43, P863, DOI 10.1111/apt.13559; Mora JR, 2008, INFLAMM BOWEL DIS, V14, P275, DOI 10.1002/ibd.20280; Mosli MH, 2015, AM J GASTROENTEROL, V110, P802, DOI 10.1038/ajg.2015.120; Mosli MH, 2014, AM J GASTROENTEROL, V109, P994, DOI 10.1038/ajg.2014.110; Ng SC, 2015, GUT, V64, P1063, DOI 10.1136/gutjnl-2014-307410; Ng SC, 2013, GASTROENTEROLOGY, V145, P158, DOI 10.1053/j.gastro.2013.04.007; Nguyen GC, 2016, GASTROENTEROLOGY, V150, P734, DOI 10.1053/j.gastro.2015.12.003; NICE, 2010, INFL AD TREAT CROHN; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; O'Toole A, 2015, DIGEST DIS SCI, V60, P2750, DOI 10.1007/s10620-015-3677-x; Ordas I, 2014, GASTROENTEROLOGY, V146, P374, DOI 10.1053/j.gastro.2013.10.055; Ouellette AJ, 2010, CURR OPIN GASTROEN, V26, P547, DOI 10.1097/MOG.0b013e32833dccde; Panes J, 2013, J CROHNS COLITIS, V7, P556, DOI 10.1016/j.crohns.2013.02.020; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; Panes J, 2016, LANCET, V388, P1281, DOI 10.1016/S0140-6736(16)31203-X; Panes J, 2013, GASTROENTEROLOGY, V145, P766, DOI 10.1053/j.gastro.2013.06.009; Papamichael K, 2015, ALIMENT PHARM THER, V42, P1158, DOI 10.1111/apt.13402; Pariente B, 2015, GASTROENTEROLOGY, V148, P52, DOI 10.1053/j.gastro.2014.09.015; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Patel Vishal, 2014, Cochrane Database Syst Rev, pCD006884, DOI 10.1002/14651858.CD006884.pub3; Peyrin-Biroulet L, 2014, GUT, V63, P88, DOI 10.1136/gutjnl-2013-304984; Peyrin-Biroulet L, 2013, NAT REV GASTRO HEPAT, V10, P345, DOI 10.1038/nrgastro.2013.31; Peyrin-Biroulet L, 2011, GASTROENTEROLOGY, V141, P1621, DOI 10.1053/j.gastro.2011.06.050; Peyrin-Biroulet L, 2011, GUT, V60, P930, DOI 10.1136/gut.2010.227884; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Prantera C, 2012, GASTROENTEROLOGY, V142, P473, DOI 10.1053/j.gastro.2011.11.032; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quan S, 2011, GASTROENTEROLOGY, V140, pS730; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Ramadas AV, 2010, GUT, V59, P1200, DOI 10.1136/gut.2009.202101; Rezaie A, 2015, COCHRANE DB SYST REV, V6; Ruemmele FM, 2014, J CROHNS COLITIS, V8, P1179, DOI 10.1016/j.crohns.2014.04.005; Ryan JD, 2013, ALIMENT PHARM THER, V38, P274, DOI 10.1111/apt.12368; Sandborn W, 2016, INFLAMM BOWEL DIS, V22, pS1, DOI 10.1097/MIB.0000000000000720; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Sands BE, 2014, GASTROENTEROLOGY, V147, P618, DOI 10.1053/j.gastro.2014.05.008; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schreiber S, 2010, AM J GASTROENTEROL, V105, P1574, DOI 10.1038/ajg.2010.78; Shah SC, 2016, ALIMENT PHARM THER, V43, P317, DOI 10.1111/apt.13475; Siegel CA, 2016, ALIMENT PHARM THER, V43, P262, DOI 10.1111/apt.13460; Siegel CA, 2018, GUT, V67, P244, DOI 10.1136/gutjnl-2016-312648; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Song GG, 2015, PHARMACOGENOMICS, V16, P1427, DOI [10.2217/PGS.15.90, 10.2217/pgs.15.90]; Spinelli A, 2014, ALIMENT PHARM THER, V40, P1009, DOI 10.1111/apt.12947; Steenholdt C, 2014, GUT, V63, P919, DOI 10.1136/gutjnl-2013-305279; Strong S, 2015, DIS COLON RECTUM, V58, P1021, DOI 10.1097/DCR.0000000000000450; Thia KT, 2010, GASTROENTEROLOGY, V139, P1147, DOI 10.1053/j.gastro.2010.06.070; Torres J, 2016, GUT, V65, P1061, DOI 10.1136/gutjnl-2016-311785; Torres J, 2016, LANCET, V387, P98, DOI 10.1016/S0140-6736(15)00464-X; Torres J, 2015, GASTROENTEROLOGY, V149, P1, DOI 10.1053/j.gastro.2015.08.055; Ungaro R, 2016, AM J GASTROENTEROL, V111, P1416, DOI 10.1038/ajg.2016.233; Ungaro R, 2014, AM J GASTROENTEROL, V109, P1728, DOI 10.1038/ajg.2014.246; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Van Assche G, 2010, J CROHNS COLITIS, V4, P63, DOI 10.1016/j.crohns.2009.09.009; van der Woude CJ, 2015, J CROHNS COLITIS, V9, P107, DOI 10.1093/ecco-jcc/jju006; van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369; Vande Casteele N, 2015, GASTROENTEROLOGY, V148, P1320, DOI 10.1053/j.gastro.2015.02.031; Vermeire S, 2001, INFLAMM BOWEL DIS, V7, P8, DOI 10.1097/00054725-200102000-00002; Vuitton L, 2016, GUT, V65, P1447, DOI 10.1136/gutjnl-2015-309903; Vuitton L, 2013, DRUGS, V73, P1749, DOI 10.1007/s40265-013-0128-x; Wang YZ, 2016, GASTROENT RES PRACT, V2016; Wright EK, 2015, GASTROENTEROLOGY, V148, P938, DOI 10.1053/j.gastro.2015.01.026; Zachos M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000542.pub2; Zallot C, 2012, DIGEST DIS, V30, P67, DOI 10.1159/000342608; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhao XS, 2014, INFLAMM BOWEL DIS, V20, P916, DOI 10.1097/MIB.0000000000000025	149	961	997	18	194	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2017	389	10080					1741	1755		10.1016/S0140-6736(16)31711-1	http://dx.doi.org/10.1016/S0140-6736(16)31711-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET3BG	27914655				2022-12-28	WOS:000400151000032
J	Shen, Y; Li, YD; Wo, HL; Li, YS; Shen, SD; Pan, BY; Wang, QS; Walker, HC; Steffens, P; Boehm, M; Hao, YQ; Quintero-Castro, DL; Harriger, LW; Frontzek, MD; Hao, LJ; Meng, SQ; Zhang, QM; Chen, G; Zhao, J				Shen, Yao; Li, Yao-Dong; Wo, Hongliang; Li, Yuesheng; Shen, Shoudong; Pan, Bingying; Wang, Qisi; Walker, H. C.; Steffens, P.; Boehm, M.; Hao, Yiqing; Quintero-Castro, D. L.; Harriger, L. W.; Frontzek, M. D.; Hao, Lijie; Meng, Siqin; Zhang, Qingming; Chen, Gang; Zhao, Jun			Evidence for a spinon Fermi surface in a triangular-lattice quantum-spin-liquid candidate	NATURE			English	Article							VALENCE-BOND STATE; KAGOME-LATTICE; GROUND-STATE; EXCITATIONS; TOPOLOGY; PHYSICS	A quantum spin liquid is an exotic quantum state of matter in which spins are highly entangled and remain disordered down to zero temperature. Such a state of matter is potentially relevant to high-temperature superconductivity and quantum-information applications, and experimental identification of a quantum spin liquid state is of fundamental importance for our understanding of quantum matter. Theoretical studies have proposed various quantum-spin-liquid ground states1-4, most of which are characterized by exotic spin excitations with fractional quantum numbers (termed 'spinons'). Here we report neutron scattering measurements of the triangular-lattice antiferromagnet YbMgGaO4 that reveal broad spin excitations covering a wide region of the Brillouin zone. The observed diffusive spin excitation persists at the lowest measured energy and shows a clear upper excitation edge, consistent with the particle-hole excitation of a spinon Fermi surface. Our results therefore point to the existence of a quantum spin liquid state with a spinon Fermi surface in YbMgGaO4, which has a perfect spin-1/2 triangular lattice as in the original proposal(4) of quantum spin liquids.	[Shen, Yao; Wo, Hongliang; Shen, Shoudong; Pan, Bingying; Wang, Qisi; Hao, Yiqing; Chen, Gang; Zhao, Jun] Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China; [Shen, Yao; Wo, Hongliang; Shen, Shoudong; Pan, Bingying; Wang, Qisi; Hao, Yiqing; Chen, Gang; Zhao, Jun] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; [Li, Yao-Dong] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Li, Yuesheng; Zhang, Qingming] Renmin Univ China, Beijing Key Lab Optoelect Funct Mat & Micronano D, Dept Phys, Beijing 100872, Peoples R China; [Walker, H. C.] STFC, Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; [Steffens, P.; Boehm, M.] Inst Laue Langevin, 71 Ave Martyrs, F-38042 Grenoble 9, France; [Quintero-Castro, D. L.] Helmholtz Zentrum Berlin Mat & Energie, D-14109 Berlin, Germany; [Harriger, L. W.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Frontzek, M. D.] Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA; [Hao, Lijie; Meng, Siqin] China Inst Atom Energy, Neutron Scattering Lab, Beijing 102413, Peoples R China; [Zhang, Qingming] Shanghai Jiao Tong Univ, Dept Phys & Astron, Shanghai 200240, Peoples R China; [Zhang, Qingming; Chen, Gang; Zhao, Jun] Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Chen, Gang] Fudan Univ, Ctr Field Theory & Particle Phys, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Renmin University of China; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Institut Laue-Langevin (ILL); Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); National Institute of Standards & Technology (NIST) - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory; China Institute of Atomic Energy; Shanghai Jiao Tong University; Fudan University	Chen, G; Zhao, J (corresponding author), Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China.; Chen, G; Zhao, J (corresponding author), Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.; Chen, G; Zhao, J (corresponding author), Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China.; Chen, G (corresponding author), Fudan Univ, Ctr Field Theory & Particle Phys, Shanghai 200433, Peoples R China.	gchen_physics@fudan.edu.cn; zhaoj@fudan.edu.cn	Shen, Yao/GPS-4936-2022; Walker, Helen C/C-4201-2011; Li, Yuesheng/F-6728-2019; Wang, Qisi/F-9613-2013; Zhao, Jun/A-2492-2010	Shen, Yao/0000-0003-4697-4719; Walker, Helen C/0000-0002-7859-5388; Li, Yuesheng/0000-0002-5967-3061; Wang, Qisi/0000-0002-8741-7559; Zhao, Jun/0000-0002-0421-8934; Li, Yaodong/0000-0003-3742-1944; Chen, Gang/0000-0001-9339-6398	National Key RAMP;D Program of the MOST of China [2016YFA0300203]; Ministry of Science and Technology of China (Program 973) [2015CB921302]; National Natural Science Foundation of China [91421106]; Thousand Youth Talent Program of China; NSF of China; Ministry of Science and Technology of China [2016YFA0300504]	National Key RAMP;D Program of the MOST of China; Ministry of Science and Technology of China (Program 973); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Youth Talent Program of China; NSF of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank D. Lee, S. Li, Y. Lu, X. Wang and, especially, J.-W. Mei for discussions, and F. Song for assistance with magnetic susceptibility measurements. This work was supported by the National Key R&D Program of the MOST of China (grant number 2016YFA0300203), the Ministry of Science and Technology of China (Program 973: 2015CB921302), and the National Natural Science Foundation of China (grant number 91421106). Y.-D.L. and G.C. were supported by the Thousand Youth Talent Program of China. Q.M.Z. was supported by the NSF of China and the Ministry of Science and Technology of China (grant number 2016YFA0300504). A portion of this research used resources at the High Flux Isotope Reactor, a DOE Office of Science User Facility operated by the Oak Ridge National Laboratory.	ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Coldea R, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.134424; Han TH, 2012, NATURE, V492, P406, DOI 10.1038/nature11659; Hastings MB, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.104431; Hermele M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214437; Itou T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104413; KIVELSON SA, 1987, PHYS REV B, V35, P8865, DOI 10.1103/PhysRevB.35.8865; Kurosaki Y, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177001; Le MD, 2013, NUCL INSTRUM METH A, V729, P220, DOI 10.1016/j.nima.2013.07.007; LEE PA, 1992, PHYS REV B, V46, P5621, DOI 10.1103/PhysRevB.46.5621; Lee PA, 2008, SCIENCE, V321, P1306, DOI 10.1126/science.1163196; Lee SS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.036403; Lee SS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.067006; Lee SS, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165102; Lee SS, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085129; Li Y.-D., 2016, PREPRINT; Li YD, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.035107; Li YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16419; Li YS, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.167203; LIEB E, 1961, ANN PHYS-NEW YORK, V16, P407, DOI 10.1016/0003-4916(61)90115-4; Metlitski MA, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.115111; Moessner R, 2002, PROG THEOR PHYS SUPP, P37, DOI 10.1143/PTPS.145.37; Motrunich OI, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045105; Paddison J. A. M., 2016, PREPRINT; Polyakov A. M, 1987, GAUGE FIELDS STRINGS; Punk M, 2014, NAT PHYS, V10, P289, DOI [10.1038/nphys2887, 10.1038/NPHYS2887]; Ran Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117205; RODRIGUEZCARVAJAL J, 1993, PHYSICA B, V192, P55, DOI 10.1016/0921-4526(93)90108-I; Ross KA, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021002; SACHDEV S, 1992, PHYS REV B, V45, P12377, DOI 10.1103/PhysRevB.45.12377; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; Wang QS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12182; Watanabe H, 2015, P NATL ACAD SCI USA, V112, P14551, DOI 10.1073/pnas.1514665112; Wen XG, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165113; Zhao J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.177002	38	212	215	16	299	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					559	+		10.1038/nature20614	http://dx.doi.org/10.1038/nature20614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27919078	Green Submitted			2022-12-28	WOS:000391190500046
J	Giummarra, M				Giummarra, Melita			Augmented reality for treatment of phantom limb pain-are we there yet?	LANCET			English	Editorial Material							MIRROR VISUAL FEEDBACK; DEAFFERENTATION; THERAPY; BRAIN		[Giummarra, Melita] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3000, Australia	Monash University	Giummarra, M (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3000, Australia.	melita.giummarra@monash.edu	Giummarra, Melita/H-8387-2012	Giummarra, Melita/0000-0001-7839-6058				Boesch E, 2016, PAIN, V157, P516, DOI 10.1097/j.pain.0000000000000423; Deconinck FJA, 2015, NEUROREHAB NEURAL RE, V29, P349, DOI 10.1177/1545968314546134; Flor Herta, 2008, Expert Rev Neurother, V8, P809, DOI 10.1586/14737175.8.5.809; Giummarra MJ, 2007, BRAIN RES REV, V54, P219, DOI 10.1016/j.brainresrev.2007.01.009; Jutzeler CR, 2015, NEUROIMAGE-CLIN, V9, P599, DOI 10.1016/j.nicl.2015.09.018; Lenggenhager B, 2014, WIRES COGN SCI, V5, P221, DOI 10.1002/wcs.1277; Nikolajsen L., 2010, EVIDENCE BASED CHRON, P237; Ortiz-Catalan M., 2016, LANCET; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; Timms J, 2015, INT J THER REHABIL, V22, P135, DOI 10.12968/ijtr.2015.22.3.135	10	1	1	0	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2844	2845		10.1016/S0140-6736(16)32416-3	http://dx.doi.org/10.1016/S0140-6736(16)32416-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27916233				2022-12-28	WOS:000389631700009
J	Stodden, V; McNutt, M; Bailey, DH; Deelman, E; Gil, Y; Hanson, B; Heroux, MA; Ioannidis, JPA; Taufer, M				Stodden, Victoria; McNutt, Marcia; Bailey, David H.; Deelman, Ewa; Gil, Yolanda; Hanson, Brooks; Heroux, Michael A.; Ioannidis, John P. A.; Taufer, Michela			Enhancing reproducibility for computational methods	SCIENCE			English	Editorial Material									[Stodden, Victoria] Univ Illinois, Urbana, IL 61801 USA; [McNutt, Marcia] Natl Acad Sci, 2101 Constitut Ave Nw, Washington, DC 20418 USA; [Bailey, David H.] Univ Calif Davis, Davis, CA 95616 USA; [Deelman, Ewa; Gil, Yolanda] Univ Southern Calif, Los Angeles, CA 90007 USA; [Hanson, Brooks] Amer Geophys Union, Washington, DC 20009 USA; [Heroux, Michael A.] Sandia Natl Labs, Avon, MN 56310 USA; [Ioannidis, John P. A.] Stanford Univ, Stanford, CA 94305 USA; [Taufer, Michela] Univ Delaware, Newark, DE 19716 USA	University of Illinois System; University of Illinois Urbana-Champaign; National Academies of Sciences, Engineering & Medicine; University of California System; University of California Davis; University of Southern California; United States Department of Energy (DOE); Sandia National Laboratories; Stanford University; University of Delaware	Stodden, V (corresponding author), Univ Illinois, Urbana, IL 61801 USA.	vcs@stodden.net	Ioannidis, John P. A./G-9836-2011; Heroux, Michael/AAG-5894-2020	Heroux, Michael/0000-0002-5893-0273; McNutt, Marcia/0000-0003-0117-7716; Hanson, R. Brooks/0000-0001-6230-7145; Taufer, Michela/0000-0002-0031-6377; Gil, Yolanda/0000-0001-8465-8341				Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; Bailey D.H., 2013, NOT AM MATH SOC, V60, P679; Bailey D. H., 2015, REPRODUCIBILITY PRIN, P205; Donoho D., 2016, PRINCETON COMPANION, P916; DONOHO DL, 2009, IEEE COMPUT SCI ENG, V11, P8; Fuentes M., 2016, AMSTAT NEWS      JUL; Garijo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080278; Gentleman R, 2007, J COMPUT GRAPH STAT, V16, P1, DOI 10.1198/106186007X178663; Heroux MA, 2015, ACM T MATH SOFTWARE, V41, DOI 10.1145/2743015; LeVeque R. J., 2013, SIAM NEWS, V46; McNutt M, 2016, SCIENCE, V351, P1024, DOI 10.1126/science.aad7048; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Stodden V., 2013, IMS B ONLINE; Stodden V, 2014, J OPEN RES SOFTWARE, V2, pe21, DOI DOI 10.5334/J0RS.AY; Stodden V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067111; Stodden V, 2009, COMPUT SCI ENG, V11, P35, DOI 10.1109/MCSE.2009.19	16	153	155	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1240	1241		10.1126/science.aah6168	http://dx.doi.org/10.1126/science.aah6168			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4TS	27940837				2022-12-28	WOS:000389598800044
J	Lycette, J				Lycette, Jennifer			Neglected - Cancer Care and Mental Health in Rural America	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lycette, Jennifer] Oregon Hlth & Sci Univ, Div Community Hematol Oncol, Knight Canc Inst, Portland, OR 97201 USA; [Lycette, Jennifer] Oregon Hlth & Sci Univ, Columbia Mem Hosp, Canc Care Ctr, Astoria, OR USA	Oregon Health & Science University	Lycette, J (corresponding author), Oregon Hlth & Sci Univ, Div Community Hematol Oncol, Knight Canc Inst, Portland, OR 97201 USA.; Lycette, J (corresponding author), Oregon Hlth & Sci Univ, Columbia Mem Hosp, Canc Care Ctr, Astoria, OR USA.							Department of Health and Human Services Health Resources and Services Administration, HLTH WORKF 2016 HLTH; Friedman LC, 2006, J BEHAV MED, V29, P327, DOI 10.1007/s10865-006-9059-2; Stevenson Bryan, 2014, JUST MERCY STORY JUS	3	3	3	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2220	2221		10.1056/NEJMp1612129	http://dx.doi.org/10.1056/NEJMp1612129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0ZQ	27959671				2022-12-28	WOS:000389310000004
J	Rimmer, A				Rimmer, Abi			Return of the "firm" gets cautious welcome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						Hunt J, 2016, NHS PROV ANN C SPEEC	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2016	355								i6556	10.1136/bmj.i6556	http://dx.doi.org/10.1136/bmj.i6556			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SX	27927644				2022-12-28	WOS:000390037400011
J	Gillingham, K; Bushnell, J; Fowlie, M; Greenstone, M; Kolstad, C; Krupnick, A; Morris, A; Schmalensee, R; Stock, J				Gillingham, Kenneth; Bushnell, James; Fowlie, Meredith; Greenstone, Michael; Kolstad, Charles; Krupnick, Alan; Morris, Adele; Schmalensee, Richard; Stock, James			ENERGY AND ENVIRONMENTAL ECONOMICS Reforming the US coal leasing program	SCIENCE			English	Editorial Material									[Gillingham, Kenneth] Yale Univ, New Haven, CT 06520 USA; [Bushnell, James] Univ Calif Davis, Davis, CA 95616 USA; [Fowlie, Meredith] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Greenstone, Michael] Univ Chicago, Chicago, IL 60637 USA; [Kolstad, Charles] Stanford Univ, Stanford, CA 94305 USA; [Krupnick, Alan] Resources Future Inc, 1616 P St NW, Washington, DC 20036 USA; [Morris, Adele] Brookings Inst, Washington, DC 20036 USA; [Schmalensee, Richard] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Stock, James] Harvard Univ, Cambridge, MA 02138 USA	Yale University; University of California System; University of California Davis; University of California System; University of California Berkeley; University of Chicago; Stanford University; Resources for the Future; Brookings Institution; Massachusetts Institute of Technology (MIT); Harvard University	Gillingham, K (corresponding author), Yale Univ, New Haven, CT 06520 USA.	kenneth.gillingham@yale.edu						[Anonymous], 2016, EC COAL LEAS FED LAN; Caldeira K., 2016, COMMUNICATION; EIA, 2016, COAL MARK REP; EIA, 2016, 0383 EIA; EPA, 2014, EM FACT GREENH INV; Fowlie M, 2014, SCIENCE, V346, P815, DOI 10.1126/science.1261349; Gerarden T, 2016, 22214 NAT BUR EC RES; Greenstone M., 2015, FOSSIL FUEL TRENDS S; Haggerty M., 2016, STEAM COAL ARMS LENG; Interagency Working Group on Social Cost of Greenhouse Gases, 2016, TECHN SUPP DOC TECHN; Krupnick A., 2015, 1513 RES FUT; Luppens J.A., 2015, 1809 US GEOL SURV; National Research Council, 2010, HIDD COSTS EN UNPR C, DOI 10.17226/12794; Peterson I., 2015, PUBLIC POLICY, V13, P165; Squillace M., 2013, NAT RESOUR ENV, V27; U.S. Government Accountability Office, 2013, 14140 GAO US GOV ACC	16	7	7	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1096	1098		10.1126/science.aak9851	http://dx.doi.org/10.1126/science.aak9851			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5TY	27934718				2022-12-28	WOS:000388916400016
J	Feinmann, J				Feinmann, Jane			The BMJ Christmas appeal 2016-7: Orbis, the sight savers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2016	355								i6425	10.1136/bmj.i6425	http://dx.doi.org/10.1136/bmj.i6425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZO	27908873				2022-12-28	WOS:000389309800005
J	Ledford, H				Ledford, Heidi			Weaponized antibodies use new tricks to fight cancer	NATURE			English	News Item																			0	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					19	20		10.1038/540019a	http://dx.doi.org/10.1038/540019a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905466	Bronze			2022-12-28	WOS:000388916600022
J	Karthikesalingam, A; Vidal-Diez, A; Holt, PJ; Loftus, IM; Schermerhorn, ML; Soden, PA; Landon, BE; Thompson, MM				Karthikesalingam, Alan; Vidal-Diez, Alberto; Holt, Peter J.; Loftus, Ian M.; Schermerhorn, Marc L.; Soden, Peter A.; Landon, Bruce E.; Thompson, Matthew M.			Thresholds for Abdominal Aortic Aneurysm Repair in England and the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOVASCULAR REPAIR; RISK-FACTORS; SURVEILLANCE; MORTALITY; SURGERY; RUPTURE; VOLUME	BACKGROUND Thresholds for repair of abdominal aortic aneurysms vary considerably among countries. METHODS We examined differences between England and the United States in the frequency of aneurysm repair, the mean aneurysm diameter at the time of the procedure, and rates of aneurysm rupture and aneurysm-related death. Data on the frequency of repair of intact (nonruptured) abdominal aortic aneurysms, in-hospital mortality among patients who had undergone aneurysm repair, and rates of aneurysm rupture during the period from 2005 through 2012 were extracted from the Hospital Episode Statistics database in England and the U.S. Nationwide Inpatient Sample. Data on the aneurysm diameter at the time of repair were extracted from the U.K. National Vascular Registry (2014 data) and from the U.S. National Surgical Quality Improvement Program (2013 data). Aneurysm-related mortality during the period from 2005 through 2012 was determined from data obtained from the Centers for Disease Control and Prevention and the U.K. Office of National Statistics. Data were adjusted with the use of direct standardization or conditional logistic regression for differences between England and the United States with respect to population age and sex. RESULTS During the period from 2005 through 2012, a total of 29,300 patients in England and 278,921 patients in the United States underwent repair of intact abdominal aortic aneurysms. Aneurysm repair was less common in England than in the United States (odds ratio, 0.49; 95% confidence interval [CI], 0.48 to 0.49; P<0.001), and aneurysm-related death was more common in England than in the United States (odds ratio, 3.60; 95% CI, 3.55 to 3.64; P<0.001). Hospitalization due to an aneurysm rupture occurred more frequently in England than in the United States (odds ratio, 2.23; 95% CI, 2.19 to 2.27; P<0.001), and the mean aneurysm diameter at the time of repair was larger in England (63.7 mm vs. 58.3 mm, P<0.001). CONCLUSIONS We found a lower rate of repair of abdominal aortic aneurysms and a larger mean aneurysm diameter at the time of repair in England than in the United States and lower rates of aneurysm rupture and aneurysm-related death in the United States than in England. (Funded by the Circulation Foundation and others.)	[Karthikesalingam, Alan; Vidal-Diez, Alberto; Holt, Peter J.; Loftus, Ian M.; Thompson, Matthew M.] St Georges Univ London, St Georges Vasc Inst, Rm 0-231,Cranmer Ter, London SW17 0RE, England; [Schermerhorn, Marc L.; Soden, Peter A.] Beth Israel Deaconess Med Ctr, Div Vasc & Endovasc Surg, Boston, MA 02215 USA; [Schermerhorn, Marc L.; Soden, Peter A.] Harvard Med Sch, Boston, MA USA; [Landon, Bruce E.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA	St Georges University London; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Karthikesalingam, A (corresponding author), St Georges Univ London, St Georges Vasc Inst, Rm 0-231,Cranmer Ter, London SW17 0RE, England.	alankarthi@gmail.com		Vidal-Diez, Alberto/0000-0001-6380-3925	Circulation Foundation; United Kingdom National Institute for Health Research (NIHR); National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH); Circulation Foundation Surgeon Scientist Award; NIHR Clinician Scientist Award [NIHR-CS-011-008]; NHLBI [5R01HL105453-03]; NIH [HL007734]; Endologix; Medtronic; Gore; Cordis; British Heart Foundation [PG/13/98/30490] Funding Source: researchfish; National Institute for Health Research [NIHR-CS-011-008, CL-2007-16-002] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007734, R01HL105453] Funding Source: NIH RePORTER	Circulation Foundation; United Kingdom National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Circulation Foundation Surgeon Scientist Award; NIHR Clinician Scientist Award; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endologix; Medtronic(Medtronic); Gore; Cordis; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Circulation Foundation, the United Kingdom National Institute for Health Research (NIHR), the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), a Circulation Foundation Surgeon Scientist Award (to Dr. Karthikesalingam), an NIHR Clinician Scientist Award (NIHR-CS-011-008, to Dr. Holt), a grant from the NHLBI (5R01HL105453-03, to Dr. Schermerhorn), and an NIH T32 Harvard-Longwood Research Training in Vascular Surgery grant (HL007734, to Dr. Soden).; Drs. Loftus and Thompson report receiving consulting fees from Endologix, Medtronic, and Gore and grant support to their institution from Endologix and Medtronic; and Dr. Schermerhorn, receiving fees for serving on a data and safety monitoring board from Endologix and consulting fees from Endologix and Cordis. No other potential conflict of interest relevant to this article was reported.	Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Cao P, 2011, EUR J VASC ENDOVASC, V41, P13, DOI 10.1016/j.ejvs.2010.08.026; De Martino RR, 2015, J VASC SURG, V61, P1010, DOI 10.1016/j.jvs.2014.11.073; Dimick JB, 2008, J VASC SURG, V47, P1150, DOI 10.1016/j.jvs.2008.01.054; Holt PJE, 2009, CIRC-CARDIOVASC QUAL, V2, P624, DOI 10.1161/CIRCOUTCOMES.109.848465; Karthikesalingam A, 2016, J VASC SURG, V64, P321, DOI 10.1016/j.jvs.2016.01.057; Karthikesalingam A, 2014, LANCET, V383, P963, DOI 10.1016/S0140-6736(14)60109-4; Kent KC, 2010, J VASC SURG, V52, P539, DOI 10.1016/j.jvs.2010.05.090; Lederle FA, 2002, JAMA-J AM MED ASSOC, V287, P2968, DOI 10.1001/jama.287.22.2968; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Mani K, 2015, EUR J VASC ENDOVASC, V49, P646, DOI 10.1016/j.ejvs.2015.01.021; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Ouriel K, 2010, J VASC SURG, V51, P1081, DOI 10.1016/j.jvs.2009.10.113; Paraskevas KI, 2011, J ENDOVASC THER, V18, P308, DOI 10.1583/10-3371.1; Powell JT, 2007, BRIT J SURG, V94, P702, DOI 10.1002/bjs.5778; Schermerhorn ML, 2015, NEW ENGL J MED, V373, P328, DOI 10.1056/NEJMoa1405778; Schermerhorn ML, 2012, ANN SURG, V256, P651, DOI 10.1097/SLA.0b013e31826b4f91; Sidloff D, 2014, CIRCULATION, V129, P747, DOI 10.1161/CIRCULATIONAHA.113.005457	19	99	103	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2051	2059		10.1056/NEJMoa1600931	http://dx.doi.org/10.1056/NEJMoa1600931			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC9KU	27959727	Green Accepted, Bronze			2022-12-28	WOS:000388464300007
J	Gifford, DR				Gifford, David R.			The Veterans Affairs Pharmacy System: Perfectly Designed to Achieve the Outcomes It Gets	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DECISION-SUPPORT-SYSTEMS		[Gifford, David R.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Gifford, DR (corresponding author), Amer Hlth Care Assoc, 1201 L St Northwest, Washington, DC 20005 USA.	dgifford@ahca.org						Creswell J., 2014, NY TIMES, pB1; Greene D., 2016, 49 STAT COMB OP EP P; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Lambrew J.M., 2005, CHOICE HLTH CARE WHA; Levinson D., 2010, OEI060900090 US DEP; Moukheiber Z., 2014, SURESCRIPTS BECAME D; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Sujansky WV, 2009, J AM MED INFORM ASSN, V16, P285, DOI 10.1197/jamia.M2610; Thorpe JM, 2017, ANN INTERN MED, V166, P157, DOI 10.7326/M16-0551	10	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					221	222		10.7326/M16-2590	http://dx.doi.org/10.7326/M16-2590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	27919102				2022-12-28	WOS:000394781200012
J	Huter, P; Muller, C; Beckert, B; Arenz, S; Berninghausen, O; Beckmann, R; Wilson, DN				Huter, Paul; Mueller, Claudia; Beckert, Bertrand; Arenz, Stefan; Berninghausen, Otto; Beckmann, Roland; Wilson, Daniel N.			Structural basis for ArfA-RF2-mediated translation termination on mRNAs lacking stop codons	NATURE			English	Article							RIBOSOME-RESCUE FACTOR; RELEASE FACTOR RF2; ESCHERICHIA-COLI; STALLED RIBOSOMES; PEPTIDE RELEASE; TMRNA-SMPB; ARFA; MECHANISM; DISTINCT; ABSENCE	In bacteria, ribosomes stalled on truncated mRNAs that lack a stop codon are rescued by the transfer-messenger RNA (tmRNA), alternative rescue factor A (ArfA) or ArfB systems(1). Although tmRNA-ribosome and ArfB-ribosome structures have been determined(2-7), how ArfA recognizes the presence of truncated mRNAs and recruits the canonical termination release factor RF2 to rescue the stalled ribosomes is unclear. Here we present a cryoelectron microscopy reconstruction of the Escherichia coli 70S ribosome stalled on a truncated mRNA in the presence of ArfA and RF2. The structure shows that the C terminus of ArfA binds within the mRNA entry channel on the small ribosomal subunit, and explains how ArfA distinguishes between ribosomes that bear truncated or full-length mRNAs. The N terminus of ArfA establishes several interactions with the decoding domain of RF2, and this finding illustrates how ArfA recruits RF2 to the stalled ribosome. Furthermore, ArfA is shown to stabilize a unique conformation of the switch loop of RF2, which mimics the canonical translation termination state by directing the catalytically important GGQ motif within domain 3 of RF2 towards the peptidyl-transferase centre of the ribosome. Thus, our structure reveals not only how ArfA recruits RF2 to the ribosome but also how it promotes an active conformation of RF2 to enable translation termination in the absence of a stop codon.	[Huter, Paul; Mueller, Claudia; Beckert, Bertrand; Arenz, Stefan; Berninghausen, Otto; Beckmann, Roland; Wilson, Daniel N.] Ludwig Maximilians Univ Munchen, Gene Ctr Dept Biochem, Feodor Lynen Str 2, D-81377 Munich, Germany; [Huter, Paul; Mueller, Claudia; Beckert, Bertrand; Arenz, Stefan; Berninghausen, Otto; Beckmann, Roland; Wilson, Daniel N.] Ludwig Maximilians Univ Munchen, Ctr integrated Prot Sci Munich CiPSM, Feodor Lynen Str 2, D-81377 Munich, Germany; [Beckert, Bertrand; Wilson, Daniel N.] Univ Hamburg, Inst Biochem & Mol Biol, Martin Luther King Pl 6, D-20146 Hamburg, Germany	University of Munich; University of Munich; University of Hamburg	Wilson, DN (corresponding author), Ludwig Maximilians Univ Munchen, Gene Ctr Dept Biochem, Feodor Lynen Str 2, D-81377 Munich, Germany.; Wilson, DN (corresponding author), Ludwig Maximilians Univ Munchen, Ctr integrated Prot Sci Munich CiPSM, Feodor Lynen Str 2, D-81377 Munich, Germany.; Wilson, DN (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Martin Luther King Pl 6, D-20146 Hamburg, Germany.	daniel.wilson@chemie.uni-hamburg.de	Wilson, Daniel/AAE-8504-2019	Wilson, Daniel/0000-0003-3816-3828; Mueller, Claudia/0000-0001-6044-7128	Deutsche Forschungsgemeinschaft [WI3285/4-1, SPP-1879, GRK 1721, FOR1805]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank H. Sieber, S. Rieder and C. Ungewickell for technical assistance and L. Bischoff and R. Green for providing expression plasmids for E. coli ArfA Delta 17 and RF2, respectively. This research was supported by grants from the Deutsche Forschungsgemeinschaft WI3285/4-1, SPP-1879 (to D.N.W.), GRK 1721 and FOR1805 (to R.B. and D.N.W.).	Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Chadani Y, 2011, GENES GENET SYST, V86, P151; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Franckenberg S, 2012, CURR OPIN STRUC BIOL, V22, P786, DOI 10.1016/j.sbi.2012.08.002; Fu J, 2010, EMBO J, V29, P3819, DOI 10.1038/emboj.2010.255; Gagnon MG, 2012, SCIENCE, V335, P1370, DOI 10.1126/science.1217443; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Keiler KC, 2015, NAT REV MICROBIOL, V13, P285, DOI 10.1038/nrmicro3438; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Kurita D, 2014, NUCLEIC ACIDS RES, V42, P13339, DOI 10.1093/nar/gku1069; Neubauer C, 2012, SCIENCE, V335, P1366, DOI 10.1126/science.1217039; Ramrath DJF, 2012, NATURE, V485, P526, DOI 10.1038/nature11006; Schaub RE, 2012, J BIOL CHEM, V287, P29765, DOI 10.1074/jbc.M112.374074; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Simms C. L., 2016, REV RNA; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Weis F, 2010, EMBO J, V29, P3810, DOI 10.1038/emboj.2010.252; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323; Zeng FX, 2016, RNA, V22, P49, DOI 10.1261/rna.053082.115; Zhou J, 2012, CURR OPIN STRUC BIOL, V22, P733, DOI 10.1016/j.sbi.2012.08.004	25	27	56	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					546	549		10.1038/nature20821	http://dx.doi.org/10.1038/nature20821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6LX	27906161				2022-12-28	WOS:000396116600054
J	Nault, JC				Nault, Jean-Charles			The end of almost 10 years of negative RCTs in advanced hepatocellular carcinoma	LANCET			English	Editorial Material							SORAFENIB		[Nault, Jean-Charles] INSERM, Genom Fonct Tumeurs Solides, Unite Mixte Rech 1162, Paris, France; [Nault, Jean-Charles] Hop Univ Paris Seine St Denis, Hop Jean Verdier, AP HP, Liver Unit, Bondy, France; [Nault, Jean-Charles] Univ Paris 13, Unite Format & Rech Sante Med & Biol Humaine, Communaute Univ & Etablissements, Sorbonne Paris Cite, Paris, France; [Nault, Jean-Charles] Hop Univ Paris Seine St Denis, AP HP, Pole Act Cancerol Specialisee, Serv Hepatol, Site Jean Verdier, F-93143 Bondy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP	Nault, JC (corresponding author), INSERM, Genom Fonct Tumeurs Solides, Unite Mixte Rech 1162, Paris, France.; Nault, JC (corresponding author), Hop Univ Paris Seine St Denis, Hop Jean Verdier, AP HP, Liver Unit, Bondy, France.; Nault, JC (corresponding author), Univ Paris 13, Unite Format & Rech Sante Med & Biol Humaine, Communaute Univ & Etablissements, Sorbonne Paris Cite, Paris, France.; Nault, JC (corresponding author), Hop Univ Paris Seine St Denis, AP HP, Pole Act Cancerol Specialisee, Serv Hepatol, Site Jean Verdier, F-93143 Bondy, France.	naultjc@gmail.com		nault, jean charles/0000-0002-4875-9353				Bruix J, 2016, LANCET; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Bruix J, 2015, LANCET ONCOL, V16, P1344, DOI 10.1016/S1470-2045(15)00198-9; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Lencioni R, 2016, J HEPATOL, V64, P1090, DOI 10.1016/j.jhep.2016.01.012; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Reig M, 2014, J HEPATOL, V61, P318, DOI 10.1016/j.jhep.2014.03.030; Santoro A, 2013, LANCET ONCOL, V14, P55, DOI 10.1016/S1470-2045(12)70490-4; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	12	19	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2017	389	10064					4	6		10.1016/S0140-6736(16)32480-1	http://dx.doi.org/10.1016/S0140-6736(16)32480-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG7VH	27932228				2022-12-28	WOS:000391264000012
J	Kaddourah, A; Basu, RK; Bagshaw, SM; Goldstein, SL				Kaddourah, Ahmad; Basu, Rajit K.; Bagshaw, Sean M.; Goldstein, Stuart L.		AWARE Investigators	Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE-RENAL-FAILURE; LENGTH-OF-STAY; SERUM CREATININE; RIFLE CRITERIA; MORTALITY; AKI; RISK; CARE; ASSOCIATION; IMPROVEMENT	BACKGROUND The epidemiologic characteristics of children and young adults with acute kidney injury have been described in single-center and retrospective studies. We conducted a multinational, prospective study involving patients admitted to pediatric intensive care units to define the incremental risk of death and complications associated with severe acute kidney injury. METHODS We used the Kidney Disease: Improving Global Outcomes criteria to define acute kidney injury. Severe acute kidney injury was defined as stage 2 or 3 acute kidney injury (plasma creatinine level >= 2 times the baseline level or urine output <0.5 ml per kilogram of body weight per hour for >= 12 hours) and was assessed for the first 7 days of intensive care. All patients 3 months to 25 years of age who were admitted to 1 of 32 participating units were screened during 3 consecutive months. The primary outcome was 28-day mortality. RESULTS A total of 4683 patients were evaluated; acute kidney injury developed in 1261 patients (26.9%; 95% confidence interval [CI], 25.6 to 28.2), and severe acute kidney injury developed in 543 patients (11.6%; 95% CI, 10.7 to 12.5). Severe acute kidney injury conferred an increased risk of death by day 28 after adjustment for 16 covariates (adjusted odds ratio, 1.77; 95% CI, 1.17 to 2.68); death occurred in 60 of the 543 patients (11.0%) with severe acute kidney injury versus 105 of the 4140 patients (2.5%) without severe acute kidney injury (P<0.001). Severe acute kidney injury was associated with increased use of mechanical ventilation and renal-replacement therapy. A stepwise increase in 28-day mortality was associated with worsening severity of acute kidney injury (P<0.001 by log-rank test). Assessment of acute kidney injury according to the plasma creatinine level alone failed to identify acute kidney injury in 67.2% of the patients with low urine output. CONCLUSIONS Acute kidney injury is common and is associated with poor outcomes, including increased mortality, among critically ill children and young adults. (Funded by the Pediatric Nephrology Center of Excellence at Cincinnati Children's Hospital Medical Center and others; AWARE ClinicalTrials.gov number, NCT01987921.)	[Kaddourah, Ahmad; Basu, Rajit K.; Goldstein, Stuart L.] Cincinnati Childrens Hosp Med Ctr, Ctr Acute Care Nephrol, 3333 Burnet Ave.,MLC 7022, Cincinnati, OH 45229 USA; [Basu, Rajit K.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care, Cincinnati, OH 45229 USA; [Kaddourah, Ahmad] Sidra Med & Res Ctr, Doha, Qatar; [Bagshaw, Sean M.] Univ Alberta, Fac Med & Dent, Dept Crit Care Med, Edmonton, AB, Canada	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Sidra Medical & Research Center; University of Alberta	Goldstein, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Acute Care Nephrol, 3333 Burnet Ave.,MLC 7022, Cincinnati, OH 45229 USA.	stuart.goldstein@cchmc.org		HAHN, Deirdre/0000-0002-2105-146X; Faustino, Edward Vincent S./0000-0001-6155-2691; Akcan Arikan, Ayse/0000-0002-5123-6713; Woroniecki, Robert/0000-0002-5578-4514	Pediatric Nephrology Center of Excellence at Cincinnati Children's Hospital Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096418] Funding Source: NIH RePORTER	Pediatric Nephrology Center of Excellence at Cincinnati Children's Hospital Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the Pediatric Nephrology Center of Excellence at Cincinnati Children's Hospital Medical Center and others.	Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Arikan AA, 2012, PEDIATR CRIT CARE ME, V13, P253, DOI 10.1097/PCC.0b013e31822882a3; Bailey D, 2007, PEDIATR CRIT CARE ME, V8, P29, DOI 10.1097/01.pcc.0000256612.40265.67; Basu RK, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0016-6; Basu RK, 2012, PEDIATR NEPHROL, V27, P1067, DOI 10.1007/s00467-011-2024-5; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Davis KF, 2014, PEDIATRICS, V134, pE857, DOI 10.1542/peds.2013-3470; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goldstein SL, 2013, CLIN J AM SOC NEPHRO, V8, P476, DOI 10.2215/CJN.12101112; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Kellum JA, 2015, J AM SOC NEPHROL, V26, P2231, DOI 10.1681/ASN.2014070724; Lex DJ, 2014, ANN THORAC SURG, V97, P202, DOI 10.1016/j.athoracsur.2013.09.014; Markovitz BP, 2016, PEDIATR CRIT CARE ME, V17, P483, DOI 10.1097/PCC.0000000000000697; Menon S, 2014, J PEDIAT, V165, DOI DOI 10.1014/J.JPEDS.2014.04.058; Pollack MM, 2016, PEDIATR CRIT CARE ME, V17, P2, DOI 10.1097/PCC.0000000000000558; Sanchez-Pinto LN, 2015, PEDIATR CRIT CARE ME, V16, P703, DOI 10.1097/PCC.0000000000000461; Schneider J, 2010, CRIT CARE MED, V38, P933, DOI 10.1097/CCM.0b013e3181cd12e1; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Selewski DT, 2014, INTENS CARE MED, V40, P1481, DOI 10.1007/s00134-014-3391-8; Silver Samuel A, 2015, Can J Kidney Health Dis, V2, P36, DOI 10.1186/s40697-015-0071-8; Slater MB, 2012, KIDNEY INT, V81, P791, DOI 10.1038/ki.2011.466; Sutherland SM, 2015, CLIN J AM SOC NEPHRO, V10, P554, DOI 10.2215/CJN.01900214; Sutherland SM, 2014, PEDIATR NEPHROL, V29, P2069, DOI 10.1007/s00467-013-2594-5; Sutherland SM, 2013, CLIN J AM SOC NEPHRO, V8, P1661, DOI 10.2215/CJN.00270113; Sutherland SM, 2010, AM J KIDNEY DIS, V55, P316, DOI 10.1053/j.ajkd.2009.10.048; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Zappitelli M, 2008, CLIN J AM SOC NEPHRO, V3, P948, DOI 10.2215/CJN.05431207	27	493	516	5	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2017	376	1					11	20		10.1056/NEJMoa1611391	http://dx.doi.org/10.1056/NEJMoa1611391			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SS	27959707	Green Accepted			2022-12-28	WOS:000391177100004
J	Ribeiro, CMS; Sarrami-Forooshani, R; Setiawan, LC; Zijlstra-Willems, EM; van Hamme, JL; Tigchelaar, W; van der Wel, NN; Kootstra, NA; Gringhuis, SI; Geijtenbeek, TBH				Ribeiro, Carla M. S.; Sarrami-Forooshani, Ramin; Setiawan, Laurentia C.; Zijlstra-Willems, Esther M.; van Hamme, John L.; Tigchelaar, Wikky; van der Wel, Nicole N.; Kootstra, Neeltje A.; Gringhuis, Sonja I.; Geijtenbeek, Teunis B. H.			Receptor usage dictates HIV-1 restriction by human TRIM5 alpha in dendritic cell subsets	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LANGERHANS CELLS; DC-SIGN; RETROVIRUS RESTRICTION; B30.2(SPRY) DOMAIN; OLD-WORLD; T-CELLS; INFECTION; TRANSMISSION; AUTOPHAGY	The most prevalent route of HIV-1 infection is across mucosal tissues after sexual contact. Langerhans cells (LCs) belong to the subset of dendritic cells (DCs) that line the mucosal epithelia of vagina and foreskin and have the ability to sense and induce immunity to invading pathogens(1). Anatomical and functional characteristics make LCs one of the primary targets of HIV-1 infection(2). Notably, LCs form a protective barrier against HIV-1 infection and transmission(3-5). LCs restrict HIV-1 infection through the capture of HIV-1 by the C-type lectin receptor Langerin and subsequent internalization into Birbeck granules(5). However, the underlying molecular mechanism of HIV-1 restriction in LCs remains unknown. Here we show that human E3-ubiquitin ligase tri-partite-containing motif 5 alpha (TRIM5 alpha) potently restricts HIV-1 infection of LCs but not of subepithelial DC-SIGN+ DCs. HIV-1 restriction by TRIM5 alpha was thus far considered to be reserved to non-human primate TRIM5 alpha orthologues(6-9), but our data strongly suggest that human TRIM5 alpha is a cell-specific restriction factor dependent on C-type lectin receptor function. Our findings highlight the importance of HIV-1 binding to Langerin for the routeing of HIV-1 into the human TRIM5 alpha-mediated restriction pathway. TRIM5 alpha mediates the assembly of an autophagy-activating scaffold to Langerin, which targets HIV-1 for autophagic degradation and prevents infection of LCs. By contrast, HIV-1 binding to DC-SIGN(+) DCs leads to disassociation of TRIM5 alpha from DC-SIGN, which abrogates TRIM5 alpha restriction. Thus, our data strongly suggest that restriction by human TRIM5 alpha is controlled by C-type-lectin-receptor-dependent uptake of HIV-1, dictating protection or infection of human DC subsets. Therapeutic interventions that incorporate C-type lectin receptors and autophagy-targeting strategies could thus provide cell-mediated resistance to HIV-1 in humans.	[Ribeiro, Carla M. S.; Sarrami-Forooshani, Ramin; Setiawan, Laurentia C.; Zijlstra-Willems, Esther M.; van Hamme, John L.; Kootstra, Neeltje A.; Gringhuis, Sonja I.; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Tigchelaar, Wikky; van der Wel, Nicole N.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Ribeiro, CMS; Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.m.ribeiro@amc.uva.nl; t.b.geijtenbeek@amc.uva.nl	Van Der Wel, Nicole/AAE-7569-2020	Kootstra, Neeltje A./0000-0001-9429-7754; van Hamme, John/0000-0003-0765-9441; Sarrami-Forooshani, Ramin/0000-0002-6999-9145; Gringhuis, Sonja/0000-0003-0383-4978; Garcia Cassani, Bethania/0000-0002-1315-133X; Ribeiro, Carla/0000-0002-5682-4143; van der Wel, Nicole/0000-0001-6392-3417	Dutch Scientific Organization NWO [VENI 863.13.025, VICI 918.10.619]; Aids Fonds [2010038]; European Research Council [670424]	Dutch Scientific Organization NWO(Netherlands Organization for Scientific Research (NWO)); Aids Fonds; European Research Council(European Research Council (ERC)European Commission)	We are grateful to the members of the Host Defense group and Laboratory for Viral Immune Pathogenesis (Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands) for their input and D. Picavet (van Leeuwenhoek Centrum for Advanced Microscopy, Academic Medical Center, Amsterdam, The Netherlands) for technical assistance during confocal experiments. We wish to thank the Boerhaave Medical Centre (Amsterdam, The Netherlands) and A. Knottenbelt (Flevoclinic, Almere, The Netherlands) for the provision of human skin tissues. This work was supported by the Dutch Scientific Organization NWO (VENI 863.13.025 and VICI 918.10.619), Aids Fonds (2010038) and European Research Council (Advanced grant 670424).	Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bjorndal A, 1997, J VIROL, V71, P7478; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Chan LLY, 2012, AUTOPHAGY, V8, P1371, DOI 10.4161/auto.21028; de Jong MAWP, 2010, J LEUKOCYTE BIOL, V87, P637, DOI 10.1189/jlb.0809577; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gramberg T, 2008, VIROLOGY, V373, P189, DOI 10.1016/j.virol.2007.11.001; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kootstra NA, 2003, P NATL ACAD SCI USA, V100, P1298, DOI 10.1073/pnas.0337541100; Mandell MA, 2014, DEV CELL, V30, P394, DOI 10.1016/j.devcel.2014.06.013; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Ribeiro CMS, 2015, FUTURE VIROL, V10, P1231, DOI 10.2217/fvl.15.79; Sarrami-Forooshani R, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-52; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Setiawan LC, 2015, VIROLOGY, V486, P239, DOI 10.1016/j.virol.2015.09.017; Shi J, 2006, VIROLOGY, V350, P493, DOI 10.1016/j.virol.2006.03.013; Smith AL, 2007, J EXP MED, V204, P421, DOI 10.1084/jem.20061604; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; van den Berg LM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0123-7; Ward EM, 2006, J BIOL CHEM, V281, P15450, DOI 10.1074/jbc.M511502200; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042	36	80	83	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					448	+		10.1038/nature20567	http://dx.doi.org/10.1038/nature20567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27919079				2022-12-28	WOS:000389716800045
J	Mann, DL				Mann, Douglas L.			Searching for the perfect agent to improve cardiac contractility	LANCET			English	Editorial Material							HEART-FAILURE; OMECAMTIV MECARBIL; MECHANISMS		[Mann, Douglas L.] Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Med,Div Cardiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mann, DL (corresponding author), Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Med,Div Cardiol, St Louis, MO 63110 USA.	dmann@dom.wustl.edu	Mann, Douglas Lowell/AAQ-3524-2021					Bozkurt B, 2012, J CARD FAIL, V18, P183, DOI 10.1016/j.cardfail.2011.11.004; Francis GS, 2014, J AM COLL CARDIOL, V63, P2069, DOI 10.1016/j.jacc.2014.01.016; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Teerlink JR, 2016, J AM COLL CARDIOL, V67, P1444, DOI 10.1016/j.jacc.2016.01.031; Teerlink JR, 2011, LANCET, V378, P667, DOI 10.1016/S0140-6736(11)61219-1; Teerlink JR, 2016, LANCET	7	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2845	2847		10.1016/S0140-6736(16)31725-1	http://dx.doi.org/10.1016/S0140-6736(16)31725-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27914658				2022-12-28	WOS:000389631700010
J	Maslin, M				Maslin, Mark			Forty years of linking orbits to ice ages	NATURE			English	Editorial Material							OBLIQUITY	In 1976, it was demonstrated that tiny wobbles in Earth's orbit led to the great ice-age cycles of the past few million years. This finding had wide implications for climate science and the details remain hotly debated today.	[Maslin, Mark] UCL, Dept Geog, London WC1E 6BT, England	University of London; University College London	Maslin, M (corresponding author), UCL, Dept Geog, London WC1E 6BT, England.	m.maslin@ucl.ac.uk		Maslin, Mark/0000-0001-9957-3463				Archer D, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000891; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; Huybers P, 2011, NATURE, V480, P229, DOI 10.1038/nature10626; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Maslin MA, 2015, QUATERN INT, V389, P47, DOI 10.1016/j.quaint.2015.01.047; Maslin MA, 2014, QUATERNARY SCI REV, V101, P1, DOI 10.1016/j.quascirev.2014.06.012; Milankovic MM, 1941, CANON INSOLATION ICE; Ridgwell AJ, 1999, PALEOCEANOGRAPHY, V14, P437, DOI 10.1029/1999PA900018; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Tzedakis PC, 2012, NAT GEOSCI, V5, P138, DOI [10.1038/ngeo1358, 10.1038/NGEO1358]; Zhang SC, 2015, P NATL ACAD SCI USA, V112, pE1406, DOI 10.1073/pnas.1502239112	13	12	14	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					208	210		10.1038/540208a	http://dx.doi.org/10.1038/540208a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27929020	Green Submitted			2022-12-28	WOS:000389548700044
J	Sherman, RE; Anderson, SA; Dal Pan, GJ; Gray, GW; Gross, T; Hunter, NL; LaVange, L; Marinac-Dabic, D; Marks, PW; Robb, MA; Shuren, J; Temple, R; Woodcock, J; Yue, LQ; Califf, RM				Sherman, Rachel E.; Anderson, Steven A.; Dal Pan, Gerald J.; Gray, Gerry W.; Gross, Thomas; Hunter, Nina L.; LaVange, Lisa; Marinac-Dabic, Danica; Marks, Peter W.; Robb, Melissa A.; Shuren, Jeffrey; Temple, Robert; Woodcock, Janet; Yue, Lilly Q.; Califf, Robert M.			Real-World Evidence - What Is It and What Can It Tell Us?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRAGMATIC CLINICAL-TRIALS; REGULATORY ISSUES; APP		[Sherman, Rachel E.; Hunter, Nina L.; Califf, Robert M.] US FDA, Off Commissioner, Silver Spring, MD USA; [Sherman, Rachel E.; Hunter, Nina L.; Califf, Robert M.] US FDA, Off Biostat & Epidemiol, Silver Spring, MD USA; [Marks, Peter W.; Temple, Robert; Woodcock, Janet] US FDA, Off Ctr Director, Silver Spring, MD USA; [Dal Pan, Gerald J.] US FDA, Ctr Biol Evaluat & Res, Off Surveillance & Epidemiol, Silver Spring, MD USA; [LaVange, Lisa] US FDA, Off Biostat, Off Translat Sci, Silver Spring, MD USA; [Robb, Melissa A.] US FDA, Off Med Policy, Silver Spring, MD USA; [Gray, Gerry W.; Yue, Lilly Q.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Gray, Gerry W.; Yue, Lilly Q.] US FDA, Div Biostat, Silver Spring, MD USA; [Marinac-Dabic, Danica] US FDA, Div Epidemiol, Silver Spring, MD USA; [Gross, Thomas] US FDA, Off Surveillance & Biometr, Silver Spring, MD USA; [Shuren, Jeffrey] US FDA, Ctr Devices & Radiol Hlth, Off Ctr Director, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Robb, MA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off Med Policy, 10903 New Hampshire Ave,Bldg 51,Rm 6346, Silver Spring, MD 20993 USA.	melissa.robb@fda.hhs.gov		Marinac-Dabic, Danica/0000-0002-1824-0104				Anderson ML, 2015, CLIN TRIALS, V12, P276, DOI 10.1177/1740774515571140; Berndt ER, 2014, BUREAU LABOR STA JUN; Booth CM, 2014, BRIT J CANCER, V110, P551, DOI 10.1038/bjc.2013.725; Califf RM, 2016, CLIN TRIALS, V13, P471, DOI 10.1177/1740774516656944; Califf RM, 2015, CLIN TRIALS, V12, P436, DOI 10.1177/1740774515598334; Cattell J, 2013, BIG DATA CAN REVOLUT; ClinicalTrials.gov, WHAT IS CLIN STUD; Cziraky M., 2015, APPL CLIN TRIALS; Food and Drug Administration, NAT EV SYST HLTH TEC; Food and Drug Administration, SUMM SAF EFF DAT HEA, VX; Food and Drug Administration, 2016, US REAL WORLD EV SUP; Food and Drug Administration, PDUFA REUTH PERF GOA; Food and Drug Administration, 2016, FDA IND MDUFA 4 REAU; Food and Drug Administration, PRAD DAB ET MES DRUG; Gradman AH, 2014, J CARD FAIL, V20, P853, DOI 10.1016/j.cardfail.2014.08.006; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Kramer JM, 2012, ENVISIONING TRANSFOR; Kuehn BM, 2015, JAMA-J AM MED ASSOC, V313, P1405, DOI 10.1001/jama.2015.2381; Meldrum M, 1998, BRIT MED J, V317, P1233, DOI 10.1136/bmj.317.7167.1233; Mora S, 2016, JAMA-J AM MED ASSOC, V316, P709, DOI 10.1001/jama.2016.8362; National Institutes of Health Health Care Systems Research Collaboratory, PHEN DAT STAND DAT Q; National Institutes of Health Health Care Systems Research Collaboratory, US; National Institutes of Health - Health Care Systems Research Collaboratory, DEM PROJ; National Patient-Centered Clinical Research Network, ADAPTABLE ASP STUD P; Network for excellence in health innovation, 2015, REAL WORLD EV NEW ER; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Plante TB, 2016, JAMA INTERN MED, V176, P700, DOI 10.1001/jamainternmed.2016.0157; Richesson Rachel, 2014, RETHINKING CLIN TRIA; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Shuren J, 2016, JAMA-J AM MED ASSOC, V316, P1153, DOI 10.1001/jama.2016.8708; Tavris Dale R, 2005, J Invasive Cardiol, V17, P644; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	33	1023	1110	13	136	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2293	2297		10.1056/NEJMsb1609216	http://dx.doi.org/10.1056/NEJMsb1609216			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0ZQ	27959688				2022-12-28	WOS:000389310000016
J	Hess, EP; Hollander, JE; Schaffer, JT; Kline, JA; Torres, CA; Diercks, DB; Jones, R; Owen, KP; Meisel, ZF; Demers, M; Leblanc, A; Shah, ND; Inselman, J; Herrin, J; Castaneda-Guarderas, A; Montori, VM				Hess, Erik P.; Hollander, Judd E.; Schaffer, Jason T.; Kline, Jeffrey A.; Torres, Carlos A.; Diercks, Deborah B.; Jones, Russell; Owen, Kelly P.; Meisel, Zachary F.; Demers, Michel; Leblanc, Annie; Shah, Nilay D.; Inselman, Jonathan; Herrin, Jeph; Castaneda-Guarderas, Ana; Montori, Victor M.			Shared decision making in patients with low risk chest pain: prospective randomized pragmatic trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EMERGENCY-DEPARTMENT PATIENTS; OPTION SCALE; AID; MULTICENTER; VALIDATION	OBJECTIVE To compare the effectiveness of shared decision making with usual care in choice of admission for observation and further cardiac testing or for referral for outpatient evaluation in patients with possible acute coronary syndrome. DESIGN Multicenter pragmatic parallel randomized controlled trial. SETTING Six emergency departments in the United States. PARTICIPANTS 898 adults (aged >17 years) with a primary complaint of chest pain who were being considered for admission to an observation unit for cardiac testing (451 were allocated to the decision aid and 447 to usual care), and 361 emergency clinicians (emergency physicians, nurse practitioners, and physician assistants) caring for patients with chest pain. INTERVENTIONS Patients were randomly assigned (1: 1) by an electronic, web based system to shared decision making facilitated by a decision aid or to usual care. The primary outcome, selected by patient and caregiver advisers, was patient knowledge of their risk for acute coronary syndrome and options for care; secondary outcomes were involvement in the decision to be admitted, proportion of patients admitted for cardiac testing, and the 30 day rate of major adverse cardiac events. RESULTS Compared with the usual care arm, patients in the decision aid arm had greater knowledge of their risk for acute coronary syndrome and options for care (questions correct: decision aid, 4.2 v usual care, 3.6; mean difference 0.66, 95% confidence interval 0.46 to 0.86), were more involved in the decision (observing patient involvement scores: decision aid, 18.3 v usual care, 7.9; 10.3, 9.1 to 11.5), and less frequently decided with their clinician to be admitted for cardiac testing (decision aid, 37% v usual care, 52%; absolute difference 15%; P < 0.001). There were no major adverse cardiac events due to the intervention. CONCLUSIONS Use of a decision aid in patients at low risk for acute coronary syndrome increased patient knowledge about their risk, increased engagement, and safely decreased the rate of admission to an observation unit for cardiac testing.	[Hess, Erik P.; Castaneda-Guarderas, Ana] Mayo Clin, Dept Emergency Med, Coll Med, 200 First St SW, Rochester, MN 55906 USA; [Hess, Erik P.; Leblanc, Annie; Castaneda-Guarderas, Ana; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Hess, Erik P.; Inselman, Jonathan] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Healthcare Del, Rochester, MN USA; [Hollander, Judd E.] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA; [Schaffer, Jason T.; Kline, Jeffrey A.] Indiana Univ, Dept Emergency Med, Indianapolis, IN 46204 USA; [Torres, Carlos A.] Mayo Clin, Dept Emergency Med, Jacksonville, FL 32224 USA; [Diercks, Deborah B.] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA; [Jones, Russell; Owen, Kelly P.] Univ Calif Davis, Med Ctr, Dept Emergency Med, Sacramento, CA 95817 USA; [Meisel, Zachary F.] Perelman Sch Med, Dept Emergency Med, Philadelphia, PA USA; [Leblanc, Annie; Shah, Nilay D.] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN USA; Yale Univ, Sch Med, New Haven, CT USA; [Herrin, Jeph] Hlth Res & Educ Trust, Chicago, IL USA; [Castaneda-Guarderas, Ana] Aventura Hosp & Med Ctr, Dept Emergency Med, Aventura, FL USA; [Montori, Victor M.] Mayo Clin, Dept Internal Med, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Jefferson University; Indiana University System; Indiana University-Purdue University Indianapolis; Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Davis; University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Yale University; Mayo Clinic	Hess, EP (corresponding author), Mayo Clin, Dept Emergency Med, Coll Med, 200 First St SW, Rochester, MN 55906 USA.; Hess, EP (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA.; Hess, EP (corresponding author), Mayo Clin, Robert D & Patricia E Kern Ctr Sci Healthcare Del, Rochester, MN USA.	hess.erik@mayo.edu	Torres, Carlos/GRS-7240-2022; Meisel, Zachary F/C-8631-2018; LeBlanc, Annie/AAZ-1381-2020	Meisel, Zachary F/0000-0001-8474-7993; Montori, Victor/0000-0003-0595-2898	Patient-Centered Outcomes Research Institute (PCORI) award [952]	Patient-Centered Outcomes Research Institute (PCORI) award(Patient-Centered Outcomes Research Institute - PCORI)	Research reported in this publication was funded through a Patient-Centered Outcomes Research Institute (PCORI) award (contract 952). The views presented in this publication are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its board of governors, or the methodology committee. The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. All involved researchers' maintained independence from the funder of the study.	Anderson RT, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-166; Bhuiya Farida A, 2010, NCHS Data Brief, P1; Cullen L, 2010, EMERG MED AUSTRALAS, V22, P35, DOI 10.1111/j.1742-6723.2010.01256.x; Durand MA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0823-2; Elwyn G, 2005, HEALTH EXPECT, V8, P34, DOI 10.1111/j.1369-7625.2004.00311.x; Elwyn G, 2003, QUAL SAF HEALTH CARE, V12, P93, DOI 10.1136/qhc.12.2.93; FERGUSSON D, 2002, BMJ-BRIT MED J, V325, P652, DOI DOI 10.1136/BMJ.325.7365.652; Gattellari M, 2004, J MED SCREEN, V11, P165, DOI 10.1258/0969141042467386; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Graff Louis G, 2014, Crit Pathw Cardiol, V13, P99, DOI 10.1097/HPC.0000000000000021; Grudzen CR, 2016, ACAD EMERG MED, V23, P1313, DOI 10.1111/acem.13047; Hargraves I, 2016, HEALTH AFFAIR, V35, P627, DOI 10.1377/hlthaff.2015.1354; Hess EP, 2015, ACAD EMERG MED, V22, P856, DOI 10.1111/acem.12703; Hess EP, 2012, CIRC-CARDIOVASC QUAL, V5, P251, DOI 10.1161/CIRCOUTCOMES.111.964791; Hollander JE, 2004, ANN EMERG MED, V44, P589, DOI 10.1016/j.annemergmed.2004.08.009; Huntington Beth, 2003, Proc (Bayl Univ Med Cent), V16, P157; Karanicolas PJ, 2009, J CLIN EPIDEMIOL, V62, P479, DOI 10.1016/j.jclinepi.2008.02.009; Kline Jeffrey A, 2005, BMC Med Inform Decis Mak, V5, P26, DOI 10.1186/1472-6947-5-26; Kline JA, 2014, CIRC-CARDIOVASC IMAG, V7, P66, DOI 10.1161/CIRCIMAGING.113.001080; Kline JA, 2009, ANN EMERG MED, V53, P727, DOI 10.1016/j.annemergmed.2008.09.034; Ladapo JA, 2014, ANN INTERN MED, V161, P482, DOI 10.7326/M14-0296; Lindor RA, 2016, ACAD EMERG MED, V23, P1428, DOI 10.1111/acem.13078; McNaughton C, 2011, ACAD EMERG MED, V18, P1148, DOI 10.1111/j.1553-2712.2011.01210.x; Mitchell AM, 2006, ANN EMERG MED, V47, P438, DOI 10.1016/j.annemergmed.2005.10.013; Montori VM, 2007, PLOS MED, V4, P1303, DOI 10.1371/journal.pmed.0040233; Nasrallah N, 2011, EUR HEART J, V32, P656; Niska Richard, 2010, Natl Health Stat Report, P1; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Pierce MA, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-57; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Stacey D., 2014, COCHRANE DB SYST REV, V4, pCD001431, DOI [10.1002/14651858.CD001431.pub5, DOI 10.1002/14651858.CD001431.PUB5, 10.1002/14651858.CD001431.pub4, DOI 10.1002/14651858.CD001431.PUB4]; Than M, 2013, INT J CARDIOL, V166, P752, DOI 10.1016/j.ijcard.2012.09.171; Thom DH, 1999, MED CARE, V37, P510, DOI 10.1097/00005650-199905000-00010; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076	38	87	89	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2016	355								i6165	10.1136/bmj.i6165	http://dx.doi.org/10.1136/bmj.i6165			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SU	27919865	hybrid, Green Published			2022-12-28	WOS:000390037100001
J	Engel, TA; Steinmetz, NA; Gieselmann, MA; Thiele, A; Moore, T; Boahen, K				Engel, Tatiana A.; Steinmetz, Nicholas A.; Gieselmann, Marc A.; Thiele, Alexander; Moore, Tirin; Boahen, Kwabena			Selective modulation of cortical state during spatial attention	SCIENCE			English	Article							SPIKE COUNT CORRELATIONS; VISUAL-CORTEX; INTERNEURONAL CORRELATIONS; BARREL CORTEX; AREA V4; PERFORMANCE; RESPONSIVENESS; FLUCTUATIONS; VARIABILITY; RESPONSES	Neocortical activity is permeated with endogenously generated fluctuations, but how these dynamics affect goal-directed behavior remains a mystery. We found that ensemble neural activity in primate visual cortex spontaneously fluctuated between phases of vigorous (On) and faint (Off) spiking synchronously across cortical layers. These On-Off dynamics, reflecting global changes in cortical state, were also modulated at a local scale during selective attention. Moreover, the momentary phase of local ensemble activity predicted behavioral performance. Our results show that cortical state is controlled locally within a cortical map according to cognitive demands and reveal the impact of these local changes in cortical state on goal-directed behavior.	[Engel, Tatiana A.; Boahen, Kwabena] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Engel, Tatiana A.; Boahen, Kwabena] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Engel, Tatiana A.; Moore, Tirin] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Steinmetz, Nicholas A.; Moore, Tirin] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Gieselmann, Marc A.; Thiele, Alexander] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Newcastle University - UK	Engel, TA (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Engel, TA (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.; Engel, TA (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	tatiana.engel@stanford.edu	Steinmetz, Nick/B-8555-2018	Steinmetz, Nick/0000-0001-7029-2908; Thiele, Alexander/0000-0003-4894-0213	NIH [EY014924, NS076460]; Stanford NeuroVentures grant; Medical Research Council (MRC) [MRK0137851]; Wellcome Trust [093104]; BBSRC [BB/F021399/1] Funding Source: UKRI; MRC [MR/K013785/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F021399/1] Funding Source: researchfish; Medical Research Council [MR/K013785/1] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY014924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076460] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford NeuroVentures grant; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants EY014924 and NS076460, a Stanford NeuroVentures grant, Medical Research Council (MRC) grant MRK0137851, and Wellcome Trust grant 093104. We thank E. I. Knudsen, K. Harris, S. Ganguli, R. N. S. Sachdev, and M. Zirnsak for their comments on the manuscript. We thank D. S. Aldrich for technical assistance. All behavioral and electrophysiological data are presented in (14) and are archived at the Stanford Neuroscience Institute server at Stanford University. T.A.E., N. A. S., T.M., and K.B. designed the study. N. A. S. and T.M. designed the experiments. N. A. S. performed experiments, spike sorting, microsaccade detection, and RF measurements. M.A.G. and A.T. performed experiments for the additional laminar data set. T.A.E. analyzed and modeled the data. T.A.E., N. A. S., T.M., and K.B. discussed the findings and wrote the paper.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Goris RLT, 2014, NAT NEUROSCI, V17, P858, DOI 10.1038/nn.3711; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Lee S. B., 2012, INT J TOUR RES, V15, P209, DOI DOI 10.1016/J.NEUR0N.2012.09.012; Luczak A, 2013, J NEUROSCI, V33, P1684, DOI 10.1523/JNEUROSCI.2928-12.2013; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moran J., 1985, NATURE, V229, P782, DOI [10.1126/science.4023713, DOI 10.1126/SCIENCE.4023713]; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rabinowitz NC, 2015, ELIFE, V4, DOI 10.7554/eLife.08998; Rainer G, 2000, NEUROCOMPUTING, V32, P961, DOI 10.1016/S0925-2312(00)00266-6; Reimer J, 2014, NEURON, V84, P355, DOI 10.1016/j.neuron.2014.09.033; Renart A, 2014, CURR OPIN NEUROBIOL, V25, P211, DOI 10.1016/j.conb.2014.02.013; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Ruff DA, 2016, J NEUROSCI, V36, P7523, DOI 10.1523/JNEUROSCI.0610-16.2016; Ruff DA, 2014, NAT NEUROSCI, V17, P1591, DOI 10.1038/nn.3835; Seidemann E, 1996, J NEUROSCI, V16, P752; Steinmetz NA, 2014, NEURON, V83, P496, DOI 10.1016/j.neuron.2014.06.014; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Tan AYY, 2014, NATURE, V509, P226, DOI 10.1038/nature13159; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Zagha E, 2013, NEURON, V79, P567, DOI 10.1016/j.neuron.2013.06.008	39	95	97	4	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1140	1144		10.1126/science.aag1420	http://dx.doi.org/10.1126/science.aag1420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934763	Green Submitted			2022-12-28	WOS:000388916400040
J	Hamilton, DP; Stern, SA; Moore, JM; Young, LA				Hamilton, Douglas P.; Stern, S. A.; Moore, J. M.; Young, L. A.		New Horizons Geology Geophys	The rapid formation of Sputnik Planitia early in Pluto's history	NATURE			English	Article							INSOLATION; CHARON; OBLIQUITY; EVOLUTION	Pluto's Sputnik Planitia is a bright, roughly circular feature that resembles a polar ice cap. It is approximately 1,000 kilometres across and is centred on a latitude of 25 degrees north and a longitude of 175 degrees, almost directly opposite the side of Pluto that always faces Charon as a result of tidal locking(1). One explanation for its location includes the formation of a basin in a giant impact, with subsequent upwelling of a dense interior ocean(2). Once the basin was established, ice would naturally have accumulated there(3). Then, provided that the basin was a positive gravity anomaly (with or without the ocean), true polar wander could have moved the feature towards the Pluto-Charon tidal axis, on the far side of Pluto from Charon(2,4). Here we report modelling that shows that ice quickly accumulates on Pluto near latitudes of 30 degrees north and south, even in the absence of a basin, because, averaged over its orbital period, those are Pluto's coldest regions. Within a million years of Charon's formation, ice deposits on Pluto concentrate into a single cap centred near a latitude of 30 degrees, owing to the runaway albedo effect. This accumulation of ice causes a positive gravity signature that locks, as Pluto's rotation slows, to a longitude directly opposite Charon. Once locked, Charon raises a permanent tidal bulge on Pluto, which greatly enhances the gravity signature of the ice cap. Meanwhile, the weight of the ice in Sputnik Planitia causes the crust under it to slump, creating its own basin (as has happened on Earth in Greenland(5)). Even if the feature is now a modest negative gravity anomaly, it remains locked in place because of the permanent tidal bulge raised by Charon. Any movement of the feature away from 30 degrees latitude is countered by the preferential recondensation of ices near the coldest extremities of the cap. Therefore, our modelling suggests that Sputnik Planitia formed shortly after Charon did and has been stable, albeit gradually losing volume, over the age of the Solar System.	[Hamilton, Douglas P.] Univ Maryland, College Pk, MD 20742 USA; [Stern, S. A.; Young, L. A.] SWRI, Boulder, CO USA; [Moore, J. M.] NASA Ames, Mountain View, CA USA	University System of Maryland; University of Maryland College Park; Southwest Research Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Hamilton, DP (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	dphamil@umd.edu		Grundy, Will/0000-0002-8296-6540	NASA; NASA Origins	NASA(National Aeronautics & Space Administration (NASA)); NASA Origins	We thank NASA for its support of the New Horizons mission and the New Horizons mission team for making the July 2015 flyby possible. We thank V. Bray, B. Carcich, J. Hofgartner and F. Nimmo for helpful comments. This research was supported by a grant from NASA Origins (to D.P.H.).	Bagenal F, 2016, SCIENCE, V351, DOI 10.1126/science.aad9045; Bertrand T., 2016, NATURE; Binzel R. P, 2016, ICARUS; BINZEL RP, 1992, ICARUS, V100, P274, DOI 10.1016/0019-1035(92)90100-L; BUIE MW, 1992, ICARUS, V97, P211, DOI 10.1016/0019-1035(92)90129-U; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; Cheng WH, 2014, ICARUS, V233, P242, DOI 10.1016/j.icarus.2014.01.046; CRSS CA, 1971, ICARUS, V15, P110, DOI 10.1016/0019-1035(71)90041-8; Dobrovolskis A. R, 1997, PLUTO CHARON, P159; DOBROVOLSKIS AR, 1983, ICARUS, V55, P231, DOI 10.1016/0019-1035(83)90077-5; Earle A.M., 2016, ICARUS; Earle AM, 2015, ICARUS, V250, P405, DOI 10.1016/j.icarus.2014.12.028; Gladstone GR, 2016, SCIENCE, V351, DOI 10.1126/science.aad8866; Grundy WM, 2016, SCIENCE, V351, DOI 10.1126/science.aad9189; Hamilton D. P, 2015, 47 DIV PLAN SCI M AM; Johnson BC, 2016, GEOPHYS RES LETT, V43, P10068, DOI 10.1002/2016GL070694; Keane J. T., 2016, NATURE; Lissauer JJ, 2012, ICARUS, V217, P77, DOI 10.1016/j.icarus.2011.10.013; Matsuyama I, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002447; McKinnon WB, 2016, NATURE, V534, P82, DOI 10.1038/nature18289; Moore JM, 2016, SCIENCE, V351, P1284, DOI 10.1126/science.aad7055; Murray C. D., 2000, SOLAR SYSTEM DYNAMIC, V165; Nadeau A., 2015, PREPRINT; Nimmo F., 2016, NATURE; Peale S. J., 1977, IAU C, P87; Protopapa S., 2016, ICARUS IN PRESS; Showalter MR, 2015, NATURE, V522, P45, DOI 10.1038/nature14469; Spada G, 2012, GEOPHYS J INT, V189, P1457, DOI 10.1111/j.1365-246X.2012.05443.x; Spencer J.R., 1997, PLUTO CHARON, P435; Spencer JR, 2010, SCIENCE, V327, P432, DOI 10.1126/science.1177132; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; VANHEMELRIJCK E, 1985, EARTH MOON PLANETS, V33, P163, DOI 10.1007/BF00116793; VANHEMELRIJCK E, 1982, ICARUS, V52, P560, DOI 10.1016/0019-1035(82)90015-X; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375	34	21	21	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					97	+		10.1038/nature20586	http://dx.doi.org/10.1038/nature20586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27905411				2022-12-28	WOS:000388916600055
J	Marshall, JD; Li, JZ; Zhang, YP; Gong, YY; St-Pierre, F; Lin, MZ; Schnitzer, MJ				Marshall, Jesse D.; Li, Jin Zhong; Zhang, Yanping; Gong, Yiyang; St-Pierre, Francois; Lin, Michael Z.; Schnitzer, Mark J.			Cell-Type-Specific Optical Recording of Membrane Voltage Dynamics in Freely Moving Mice	CELL			English	Article							IN-VIVO; POTENTIAL SYNCHRONY; RECEPTOR OCCUPANCY; INDIRECT PATHWAYS; CIRCUIT DYNAMICS; VISUAL-CORTEX; MOTOR CORTEX; DOPAMINE D1; BRAIN; NEURONS	Electrophysiological field potential dynamics are of fundamental interest in basic and clinical neuroscience, but how specific cell types shape these dynamics in the live brain is poorly understood. To empower mechanistic studies, we created an optical technique, TEMPO, that records the aggregate transmembrane voltage dynamics of genetically specified neurons in freely behaving mice. TEMPO has > 10-fold greater sensitivity than prior fiber-optic techniques and attains the noise minimum set by quantum mechanical photon shot noise. After validating TEMPO's capacity to track established oscillations in the delta, theta, and gamma frequency bands, we compared the D1- and D2-dopamine-receptor-expressing striatal medium spiny neurons (MSNs), which are interspersed and electrically indistinguishable. Unexpectedly, MSN population dynamics exhibited two distinct coherent states that were commonly indiscernible in electrical recordings and involved synchronized hyperpolarizations across both MSN subtypes. Overall, TEMPO allows the deconstruction of normal and pathologic neurophysiological states into trans-membrane voltage activity patterns of specific cell types.	[Marshall, Jesse D.; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; [Marshall, Jesse D.; Li, Jin Zhong; Zhang, Yanping; Gong, Yiyang; Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Marshall, Jesse D.; Zhang, Yanping; Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [St-Pierre, Francois; Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [St-Pierre, Francois; Lin, Michael Z.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Schnitzer, MJ (corresponding author), Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA.; Schnitzer, MJ (corresponding author), Stanford Univ, CNC Program, Stanford, CA 94305 USA.; Schnitzer, MJ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mschnitz@stanford.edu	Core, Vector/CAF-4832-2022	Lin, Michael/0000-0002-0492-1961; Gong, Yiyang/0000-0002-1855-930X	Stanford Graduate Fellowship; NSF; Keck Future Initiatives; Stanford Bio-X Program; DARPA; NIH BRAIN Initiative [U01NS090600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090600] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); NSF(National Science Foundation (NSF)); Keck Future Initiatives; Stanford Bio-X Program; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH BRAIN Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Li, S. Harvey, and J. Parker for experimental assistance and P. Bonnavion, T. Davidson, L. Grosenick, E.J.O. Hamel, J. Huguenard, L. de Lecea, L.J. Kitch, M.F.C. Larkin, J. Paz, and J. Parker for helpful conversations. Research support was provided by a Stanford Graduate Fellowship (J.D.M.), grants to M.J.S. from NSF and the Keck Future Initiatives, and by the Stanford Bio-X Program, DARPA, and NIH BRAIN Initiative grant U01NS090600 (M.J.S. and M.Z.L).	Adrian E.D., 1928, BASIS SENSATION ACTI; Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; BUZSAKI G, 1990, NEUROSCIENCE, V36, P1, DOI 10.1016/0306-4522(90)90345-5; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Carandini M, 2015, J NEUROSCI, V35, P53, DOI 10.1523/JNEUROSCI.0594-14.2015; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KARLSSON P, 1995, PSYCHOPHARMACOLOGY, V121, P309, DOI 10.1007/BF02246068; Kim CK, 2016, NAT METHODS, V13, P325, DOI [10.1038/NMETH.3770, 10.1038/nmeth.3770]; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Massi L, 2012, J NEUROSCI, V32, P16496, DOI 10.1523/JNEUROSCI.3475-12.2012; MAYEVSKY A, 1982, SCIENCE, V217, P537, DOI 10.1126/science.7201167; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; McCormick DA, 2015, CURR OPIN NEUROBIOL, V31, P133, DOI 10.1016/j.conb.2014.10.003; Mukherjee J, 2001, NEUROPSYCHOPHARMACOL, V25, P476, DOI 10.1016/S0893-133X(01)00251-2; Neisewander JL, 1998, SYNAPSE, V30, P194; Oldenburg IA, 2015, NEURON, V86, P1174, DOI 10.1016/j.neuron.2015.05.008; Peacock L, 1999, NEUROPSYCHOPHARMACOL, V20, P35, DOI 10.1016/S0893-133X(98)00049-9; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Sales-Carbonell C, 2013, P NATL ACAD SCI USA, V110, P719, DOI 10.1073/pnas.1217144110; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Tan AYY, 2014, NATURE, V509, P226, DOI 10.1038/nature13159; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vo-Dinh T., 2015, BIOMEDICAL PHOTONICS; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Yang HH, 2016, CELL, V166, P245, DOI 10.1016/j.cell.2016.05.031; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	54	56	58	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1650	+		10.1016/j.cell.2016.11.021	http://dx.doi.org/10.1016/j.cell.2016.11.021			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912066	Green Accepted, Bronze			2022-12-28	WOS:000389470500024
J	Bagley, N				Bagley, Nicholas			Trouble on the Exchanges - Does the United States Owe Billions to Health Insurers?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bagley, N (corresponding author), Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA.							Center for Consumer Information and Insurance Oversight, 2015, RISK CORR PAYM 2014; Cox C, 2016, PRELIMINARY DATA INS	2	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2017	2019		10.1056/NEJMp1612486	http://dx.doi.org/10.1056/NEJMp1612486			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC9KU	27959725				2022-12-28	WOS:000388464300003
J	Manson, JE; Brannon, PM; Rosen, CJ; Taylor, CL				Manson, JoAnn E.; Brannon, Patsy M.; Rosen, Clifford J.; Taylor, Christine L.			Vitamin D Deficiency - Is There Really a Pandemic?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EUROPE		[Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Manson, JoAnn E.] Harvard Med Sch, Boston, MA 02115 USA; [Brannon, Patsy M.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Rosen, Clifford J.] Maine Med Ctr Res Inst, Ctr Clin & Translat Med, Scarborough, ME USA; [Taylor, Christine L.] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Cornell University; Maine Medical Center; National Institutes of Health (NIH) - USA	Manson, JE (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Manson, JE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.				NCI NIH HHS [R01 CA138962] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA138962] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akkermans MD, 2016, J PEDIATR GASTR NUTR, V62, P635, DOI 10.1097/MPG.0000000000001015; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Institute of Medicine, 2011, DIETARY REFERENCE IN; Ng K, 2014, AM J CLIN NUTR, V99, P587, DOI 10.3945/ajcn.113.067777; Taylor CL, 2015, J NUTR, V145, P1623, DOI 10.3945/jn.115.211185	5	166	172	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					1817	1820		10.1056/NEJMp1608005	http://dx.doi.org/10.1056/NEJMp1608005			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB6ZK	27959647				2022-12-28	WOS:000387534200004
J	Singer, PM				Singer, Phillip M.			The Future of Health Care Reform - Section 1332 Waivers and State-Led Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Singer, Phillip M.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Singer, PM (corresponding author), Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA.							[Anonymous], 2016, HLTH AFFAIRS BLOG; Greer SL, 2011, J HEALTH POLIT POLIC, V36, P469, DOI 10.1215/03616878-1271108; Ingram J, 2016, HLTH AFFAIRS BLOG; McDonough JE, 2014, J HEALTH POLIT POLIC, V39, P1099, DOI 10.1215/03616878-2744824; Oberlander J, 2016, NEW ENGL J MED, V375, P1309, DOI 10.1056/NEJMp1610712	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2017	376	2					108	111		10.1056/NEJMp1612830	http://dx.doi.org/10.1056/NEJMp1612830			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI0XI	27959698				2022-12-28	WOS:000392198400004
J	Pekel, JF; Cottam, A; Gorelick, N; Belward, AS				Pekel, Jean-Francois; Cottam, Andrew; Gorelick, Noel; Belward, Alan S.			High-resolution mapping of global surface water and its long-term changes	NATURE			English	Article							CLIMATE-CHANGE; TIME-SERIES; LAKES; RESOURCES; DYNAMICS; IMAGERY	The location and persistence of surface water (inland and coastal) is both affected by climate and human activity(1) and affects climate(2,3), biological diversity(4) and human wellbeing(5,6). Global data sets documenting surface water location and seasonality have been produced from inventories and national descriptions(7), statistical extrapolation of regional data(8) and satellite imagery(9-12), but measuring long-term changes at high resolution remains a challenge. Here, using three million Landsat satellite images(13), we quantify changes in global surface water over the past 32 years at 30-metre resolution. We record the months and years when water was present, where occurrence changed and what form changes took in terms of seasonality and persistence. Between 1984 and 2015 permanent surface water has disappeared from an area of almost 90,000 square kilometres, roughly equivalent to that of Lake Superior, though new permanent bodies of surface water covering 184,000 square kilometres have formed elsewhere. All continental regions show a net increase in permanent water, except Oceania, which has a fractional (one per cent) net loss. Much of the increase is from reservoir filling, although climate change(14) is also implicated. Loss is more geographically concentrated than gain. Over 70 per cent of global net permanent water loss occurred in the Middle East and Central Asia, linked to drought and human actions including river diversion or damming and unregulated withdrawal(15,16). Losses in Australia(17) and the USA(18) linked to long-term droughts are also evident. This globally consistent, validated data set shows that impacts of climate change and climate oscillations on surface water occurrence can be measured and that evidence can be gathered to show how surface water is altered by human activities. We anticipate that this freely available data will improve the modelling of surface forcing, provide evidence of state and change in wetland ecotones (the transition areas between biomes), and inform water-management decision-making.	[Pekel, Jean-Francois; Cottam, Andrew; Belward, Alan S.] European Commiss, Joint Res Ctr, Directorate Sustainable Resources, I-20127 Ispra, Lombardy, Italy; [Gorelick, Noel] Google Switzerland GmbH, Brandschenkestr 110, CH-8002 Zurich, Switzerland	European Commission Joint Research Centre; EC JRC ISPRA Site; Google Incorporated	Pekel, JF (corresponding author), European Commiss, Joint Res Ctr, Directorate Sustainable Resources, I-20127 Ispra, Lombardy, Italy.	jean-francois.pekel@jrc.ec.europa.eu		Pekel, Jean-Francois/0000-0002-9992-6385; Gorelick, Noel/0000-0002-5548-2436				Acuna V, 2014, SCIENCE, V343, P1080, DOI 10.1126/science.1246666; [Anonymous], 2016, SHUTTL RAD TOP MISS; [Anonymous], 1996, GLOB 30 ARC 2 EL DAT; [Anonymous], 2012, GLOB ADM AR GADM VER; [Anonymous], 2003, SHUTTL RAD TOP MISS; Arendt A., 2015, RANDOLPH GLACIER INV; Arst H, 2003, MARINE SCI COASTAL M; Arvidson T, 2001, REMOTE SENS ENVIRON, V78, P13, DOI 10.1016/S0034-4257(01)00263-2; Belward AS, 2015, ISPRS J PHOTOGRAMM, V103, P115, DOI 10.1016/j.isprsjprs.2014.03.009; BONETTO A A, 1989, Regulated Rivers Research and Management, V4, P333, DOI 10.1002/rrr.3450040402; Chen J, 2011, REMOTE SENS ENVIRON, V115, P1053, DOI 10.1016/j.rse.2010.12.010; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; Danielson J. J., 2011, 20111073 USGS; Delaunay B., B ACAD SCI USSR, V7, P793; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Feng M, 2016, INT J DIGIT EARTH, V9, P113, DOI 10.1080/17538947.2015.1026420; Goward S, 2006, PHOTOGRAMM ENG REM S, V72, P1155, DOI 10.14358/PERS.72.10.1155; Gutman G, 2013, REMOTE SENS ENVIRON, V134, P249, DOI 10.1016/j.rse.2013.02.026; Holgerson MA, 2016, NAT GEOSCI, V9, P222, DOI 10.1038/NGEO2654; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; KARTIKEYAN B, 1995, IEEE T GEOSCI REMOTE, V33, P58, DOI 10.1109/36.368222; Keim DA, 2008, LECT NOTES COMPUT SC, V4404, P76, DOI 10.1007/978-3-540-71080-6_6; Klein I, 2015, REMOTE SENS LETT, V6, P78, DOI 10.1080/2150704X.2014.1002945; Kosarev AN, 2009, AQUAT GEOCHEM, V15, P223, DOI 10.1007/s10498-008-9054-z; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Liu BK, 2016, IEEE GEOSCI REMOTE S, V13, P570, DOI 10.1109/LGRS.2016.2525778; Loveland TR, 2012, REMOTE SENS ENVIRON, V122, P22, DOI 10.1016/j.rse.2011.09.022; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Lutz AF, 2014, NAT CLIM CHANGE, V4, P587, DOI [10.1038/NCLIMATE2237, 10.1038/nclimate2237]; MacDonald GM, 2010, P NATL ACAD SCI USA, V107, P21256, DOI 10.1073/pnas.0909651107; Markham BL, 2004, IEEE T GEOSCI REMOTE, V42, P2691, DOI 10.1109/TGRS.2004.840720; Micklin P, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5614-5; Mueller N, 2016, REMOTE SENS ENVIRON, V174, P341, DOI 10.1016/j.rse.2015.11.003; Najafi A., 2011, INT J WATER RESOUR A, V1, P16, DOI DOI 10.1029/2007WR006609; NASA, LANDS 7 SCI DAT US H; Papa F, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012674; Pekel JF, 2014, REMOTE SENS ENVIRON, V140, P704, DOI 10.1016/j.rse.2013.10.008; Pesarese M., 2016, OPERATING PROCEDURE; Pesaresi M, 2013, IEEE J-STARS, V6, P2102, DOI 10.1109/JSTARS.2013.2271445; Pethick J, 2013, GLOBAL PLANET CHANGE, V111, P237, DOI 10.1016/j.gloplacha.2013.09.019; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Prigent C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051276; Seipp K., 2016, MENSCH COMP 2016 WOR, P1; Shoshany M, 2015, INT SOC PHOTOGRAMM R, P1085; Smith A., 1978, COMPUT GRAPH-UK, V12, P12; Subin ZM, 2012, J ADV MODEL EARTH SY, V4, DOI 10.1029/2011MS000072; Tulbure MG, 2016, REMOTE SENS ENVIRON, V178, P142, DOI 10.1016/j.rse.2016.02.034; United Nations, 2015, WORKING PAPER NO ESA; US Geological Survey, 2016, USGS PUBL; van Dijk AIJM, 2013, WATER RESOUR RES, V49, P1040, DOI 10.1002/wrcr.20123; Verpoorter C, 2014, GEOPHYS RES LETT, V41, P6396, DOI 10.1002/2014GL060641; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty C.J., 2005, CONDITIONS TRENDS WO, V1, P165; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; World Economic Forum, 2016, GLOB RISKS REP 2016; Wulder MA, 2016, REMOTE SENS ENVIRON, V185, P271, DOI 10.1016/j.rse.2015.11.032; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010; Yamazaki D, 2015, REMOTE SENS ENVIRON, V171, P337, DOI 10.1016/j.rse.2015.10.014; Yang JB, 2002, IEEE T SYST MAN CY A, V32, P289, DOI 10.1109/TSMCA.2002.802746; Zafarnejad Fatemeh, 2009, International Journal of Environmental Studies, V66, P327, DOI 10.1080/00207230902798648; Zhang 62. Y., 2014, GLOB CHANGE RES DATA; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028	64	1910	2021	138	1337	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					418	+		10.1038/nature20584	http://dx.doi.org/10.1038/nature20584			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27926733				2022-12-28	WOS:000389716800039
J	Spiegelhalter, E				Spiegelhalter, Eddie			CHRISTMAS 2016: IN LOVE AND WAR 68 years-a record breaking thoracoplasty?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Spiegelhalter, Eddie] Univ Cambridge, Cambridge CB3 0WB, England	University of Cambridge	Spiegelhalter, E (corresponding author), Univ Cambridge, Cambridge CB3 0WB, England.								0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2016	355								i6513	10.1136/bmj.i6513	http://dx.doi.org/10.1136/bmj.i6513			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SZ	27941005				2022-12-28	WOS:000390037600003
J	Freedman, JD; Green, L; Landon, BE				Freedman, John D.; Green, Linda; Landon, Bruce E.			All-Payer Claims Databases - Uses and Expanded Prospects after Gobeille	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Freedman, John D.; Green, Linda] Freedman HealthCare, Newton, MA USA; [Landon, Bruce E.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA 02215 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Freedman, JD (corresponding author), Freedman HealthCare, Newton, MA USA.							Ayanian JZ, 2012, NEW ENGL J MED, V367, P790, DOI 10.1056/NEJMp1208710; Cooper Z, 2015, 21815 NBER; Department of Labor Department of Treasury Pension Benefit Guaranty Corporation, 2016, FED REG, V81, P47534; Fuse Brown E, 2016, HLTH AFFAIRS BL 0310; Tu H, 2015, MOVING MARKETS LESSO	5	18	18	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2215	2217		10.1056/NEJMp1613276	http://dx.doi.org/10.1056/NEJMp1613276			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0ZQ	27959673				2022-12-28	WOS:000389310000002
J	Gossner, MM; Lewinsohn, TM; Kahl, T; Grassein, F; Boch, S; Prati, D; Birkhofer, K; Renner, SC; Sikorski, J; Wubet, T; Arndt, H; Baumgartner, V; Blaser, S; Bluthgen, N; Borschig, C; Buscot, F; Diekotter, T; Jorge, LR; Jung, K; Keyel, AC; Klein, AM; Klemmer, S; Krauss, J; Lange, M; Muller, J; Overmann, J; Pasalic, E; Penone, C; Perovic, DJ; Purschke, O; Schall, P; Socher, SA; Sonnemann, I; Tschapka, M; Tscharntke, T; Turke, M; Venter, PC; Weiner, CN; Werner, M; Wolters, V; Wurst, S; Westphal, C; Fischer, M; Weisser, WW; Allan, E				Gossner, Martin M.; Lewinsohn, Thomas M.; Kahl, Tiemo; Grassein, Fabrice; Boch, Steffen; Prati, Daniel; Birkhofer, Klaus; Renner, Swen C.; Sikorski, Johannes; Wubet, Tesfaye; Arndt, Hartmut; Baumgartner, Vanessa; Blaser, Stefan; Bluethgen, Nico; Boerschig, Carmen; Buscot, Francois; Diekoetter, Tim; Jorge, Leonardo Re; Jung, Kirsten; Keyel, Alexander C.; Klein, Alexandra-Maria; Klemmer, Sandra; Krauss, Jochen; Lange, Markus; Mueller, Joerg; Overmann, Joerg; Pasalic, Esther; Penone, Caterina; Perovic, David J.; Purschke, Oliver; Schall, Peter; Socher, Stephanie A.; Sonnemann, Ilja; Tschapka, Marco; Tscharntke, Teja; Tuerke, Manfred; Venter, Paul Christiaan; Weiner, Christiane N.; Werner, Michael; Wolters, Volkmar; Wurst, Susanne; Westphal, Catrin; Fischer, Markus; Weisser, Wolfgang W.; Allan, Eric			Land-use intensification causes multitrophic homogenization of grassland communities	NATURE			English	Article							BIOTIC HOMOGENIZATION; BETA-DIVERSITY; USE INTENSITY; MICROBIAL COMMUNITIES; SPECIES-DIVERSITY; PLANT; FOREST; BIODIVERSITY; FERTILIZATION; ECHOLOCATION	Land-use intensification is a major driver of biodiversity loss(1,2). Alongside reductions in local species diversity, biotic homogenization at larger spatial scales is of great concern for conservation. Biotic homogenization means a decrease in beta-diversity (the compositional dissimilarity between sites). Most studies have investigated losses in local (alpha)-diversity(1,3) and neglected biodiversity loss at larger spatial scales. Studies addressing beta-diversity have focused on single or a few organism groups (for example, ref. 4), and it is thus unknown whether land-use intensification homogenizes communities at different trophic levels, above-and belowground. Here we show that even moderate increases in local land-use intensity (LUI) cause biotic homogenization across microbial, plant and animal groups, both above- and belowground, and that this is largely independent of changes in alpha-diversity. We analysed a unique grassland biodiversity dataset, with abundances of more than 4,000 species belonging to 12 trophic groups. LUI, and, in particular, high mowing intensity, had consistent effects on beta-diversity across groups, causing a homogenization of soil microbial, fungal pathogen, plant and arthropod communities. These effects were nonlinear and the strongest declines in beta-diversity occurred in the transition from extensively managed to intermediate intensity grassland. LUI tended to reduce local alpha-diversity in aboveground groups, whereas the alpha-diversity increased in belowground groups. Correlations between the alpha-diversity of different groups, particularly between plants and their consumers, became weaker at high LUI. This suggests a loss of specialist species and is further evidence for biotic homogenization. The consistently negative effects of LUI on landscape-scale biodiversity underscore the high value of extensively managed grasslands for conserving multitrophic biodiversity and ecosystem service provision. Indeed, biotic homogenization rather than local diversity loss could prove to be the most substantial consequence of land-use intensification.	[Gossner, Martin M.; Lewinsohn, Thomas M.; Lange, Markus; Pasalic, Esther; Tuerke, Manfred; Weisser, Wolfgang W.] Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany; [Gossner, Martin M.; Lange, Markus; Pasalic, Esther; Tuerke, Manfred; Weisser, Wolfgang W.] Friedrich Schiller Univ Jena, Inst Ecol, Dornburger Str 159, D-07743 Jena, Germany; [Gossner, Martin M.] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Lewinsohn, Thomas M.; Jorge, Leonardo Re] Univ Estadual Campinas, IB, Dept Anim Biol, BR-13083970 Sao Paulo, Brazil; [Kahl, Tiemo] Univ Freiburg, Fac Environm & Nat Resources, Chair Silviculture, Tennenbacherstr 4, D-79106 Freiburg, Germany; [Kahl, Tiemo] Biosphere Reserve Vessertal Thuringian Forest, Brunnenstr 1, D-98711 Schmiedefeld, Germany; [Grassein, Fabrice; Boch, Steffen; Prati, Daniel; Blaser, Stefan; Penone, Caterina; Fischer, Markus; Allan, Eric] Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland; [Birkhofer, Klaus] Lund Univ, Dept Biol Biodivers & Conservat Sci, Solvegatan 37, S-22362 Lund, Sweden; [Birkhofer, Klaus] BTU Cottbus Senftenberg, Fac Environm & Nat Sci, Chair Ecol, Grossenhainer Str 57, D-01968 Senftenberg, Germany; [Renner, Swen C.] Univ Nat Resources & Life Sci, Inst Zool, A-1180 Vienna, Austria; [Renner, Swen C.; Jung, Kirsten; Tschapka, Marco] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany; [Sikorski, Johannes; Baumgartner, Vanessa; Overmann, Joerg] Leibniz Inst DSMZ German Collect Microorganisms &, Inhoffenstr 7B, D-38302 Braunschweig, Germany; [Wubet, Tesfaye; Buscot, Francois; Klemmer, Sandra] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, D-06120 Halle, Germany; [Wubet, Tesfaye; Buscot, Francois; Tuerke, Manfred] Univ Leipzig, Inst Biol, Johannisallee 21, D-04103 Leipzig, Germany; [Arndt, Hartmut; Venter, Paul Christiaan] Univ Cologne, Inst Zool, Bioctr, Gen Ecol, Zuelpicher Str 47b, D-50674 Cologne, Germany; [Bluethgen, Nico; Weiner, Christiane N.; Werner, Michael] Tech Univ Darmstadt, Dept Biol, Ecol Networks, Schnittspahnstr 3, D-64287 Darmstadt, Germany; [Boerschig, Carmen; Krauss, Jochen] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97074 Wurzburg, Germany; [Diekoetter, Tim; Wolters, Volkmar] Univ Giessen, Anim Ecol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany; [Diekoetter, Tim] Univ Kiel, Inst Nat Resource Conservat, Landscape Ecol, Olshausenstr 75, D-24118 Kiel, Germany; [Keyel, Alexander C.] Univ Gottingen, Dept Ecosyst Modelling, Busgenweg 4, D-37077 Gottingen, Germany; [Klein, Alexandra-Maria] Univ Freiburg, Fac Environm & Nat Resources, Chair Nat Conservat & Landscape Ecol, Tennenbacherstr 4, D-79106 Freiburg, Germany; [Klemmer, Sandra; Purschke, Oliver; Tuerke, Manfred] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Lange, Markus] Max Planck Inst Biogeochem, Hans Knoell Str 10, D-07745 Jena, Germany; [Mueller, Joerg] Univ Potsdam, Inst Biochem & Biol, Maulbeerallee 1, D-14469 Potsdam, Germany; [Perovic, David J.] Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China; [Perovic, David J.; Tscharntke, Teja; Westphal, Catrin] Univ Gottingen, Dept Crop Sci, Agroecol, D-37077 Gottingen, Germany; [Purschke, Oliver] Univ Halle Wittenberg, Dept Comp Sci, D-06120 Halle, Saale, Germany; [Purschke, Oliver] Univ Halle Wittenberg, Geobot, Inst Biol, D-06108 Halle, Saale, Germany; [Purschke, Oliver] Univ Halle Wittenberg, Bot Garden, Inst Biol, D-06108 Halle, Saale, Germany; [Schall, Peter] Univ Gottingen, Dept Silviculture & Forest Ecol Temperate Zones, D-37077 Gottingen, Germany; [Socher, Stephanie A.] Salzburg Univ, Dept Ecol & Evolut, Bot Garden, Hellbrunnerstr 34, A-5020 Salzburg, Austria; [Sonnemann, Ilja; Wurst, Susanne] Free Univ Berlin, Inst Biol, Funct Biodivers, Konigin Luise Str 1-3, D-14195 Berlin, Germany; [Allan, Eric] Univ Bern, Ctr Dev & Environm, Hallerstr 10, CH-3012 Bern, Switzerland	Technical University of Munich; Friedrich Schiller University of Jena; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Universidade Estadual de Campinas; University of Freiburg; University of Bern; Lund University; Brandenburg University of Technology Cottbus; University of Natural Resources & Life Sciences, Vienna; Ulm University; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; University of Cologne; Technical University of Darmstadt; University of Wurzburg; Justus Liebig University Giessen; University of Kiel; University of Gottingen; University of Freiburg; Max Planck Society; University of Potsdam; Fujian Agriculture & Forestry University; University of Gottingen; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University of Gottingen; Salzburg University; Free University of Berlin; University of Bern	Gossner, MM (corresponding author), Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany.; Gossner, MM (corresponding author), Friedrich Schiller Univ Jena, Inst Ecol, Dornburger Str 159, D-07743 Jena, Germany.; Gossner, MM (corresponding author), Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland.	martin.gossner@wsl.ch	Fischer, Markus/C-6411-2008; Penone, Caterina/F-9223-2017; Jorge, Leonardo Ré/A-1528-2009; Wolters, Volkmar/B-4635-2010; Arndt, Hartmut/K-9364-2017; Blüthgen, Nico/F-5983-2010; Tscharntke, Teja/N-5123-2014; Schall, Peter/Q-5962-2019; Allan, Eric/AAR-9566-2020; Lewinsohn, Thomas M/D-5880-2012; Perovic, David/GLR-9137-2022; Birkhofer, Klaus/AAA-2374-2021; Westphal, Catrin/F-9560-2015; Weisser, Wolfgang W/B-9718-2014; Krauss, Jochen/C-6216-2014; Sikorski, Johannes/AAX-1960-2020; Türke, Manfred/AFE-8308-2022; Sikorski, Johannes/AAD-9775-2019; Perovic, David/AAF-2654-2020; Klein, Alexandra-Maria/J-5871-2016; Wubet, Tesfaye/C-6241-2012; Buscot, Francois/A-4125-2016; Gossner, Martin M./J-2730-2015	Fischer, Markus/0000-0002-5589-5900; Penone, Caterina/0000-0002-8170-6659; Jorge, Leonardo Ré/0000-0003-4518-4328; Wolters, Volkmar/0000-0002-7556-4578; Arndt, Hartmut/0000-0003-2811-3595; Schall, Peter/0000-0003-4808-818X; Allan, Eric/0000-0001-9641-9436; Lewinsohn, Thomas M/0000-0001-5950-5343; Birkhofer, Klaus/0000-0002-9301-2443; Westphal, Catrin/0000-0002-2615-1339; Weisser, Wolfgang W/0000-0002-2757-8959; Krauss, Jochen/0000-0003-2304-9117; Sikorski, Johannes/0000-0002-1890-5540; Türke, Manfred/0000-0002-8957-5454; Klein, Alexandra-Maria/0000-0003-2139-8575; Wubet, Tesfaye/0000-0001-8572-4486; Buscot, Francois/0000-0002-2364-0006; Keyel, Alexander C./0000-0001-5256-6274; Perovic, David/0000-0002-7301-5591; Socher, Stephanie/0000-0002-0090-4005; /0000-0002-6893-4219; Purschke, Oliver/0000-0003-0444-0882; Gossner, Martin M./0000-0003-1516-6364; Overmann, Jorg/0000-0003-3909-7201	DFG Priority Program 1374 'Infrastructure-Biodiversity-Exploratories'	DFG Priority Program 1374 'Infrastructure-Biodiversity-Exploratories'	We are grateful to J. Chase and M. Fitzpatrick for their comments and suggestions on a previous version of the manuscript; B. Buche, R. Achtziger, T Wagner, F. Kohler, T Blick and M.-A. Fritze for arthropod species identification and U. Kern for creating the small icons of the 12 trophic groups used in the figures. We thank the managers of the three Exploratories, K. Hartwich, S. Gockel, K. Wiesner and M. Gorke for their work in maintaining the plot and project infrastructure; C. Fischer and S. Pfeiffer for giving support through the central office, M. Owonibi for managing the central data base; and E. Linsenmair, D. Hessenmoller, J. Nieschulze, I. Schbning and the late E. Kalko for their role in setting up the Biodiversity Exploratories project. We are also grateful to E. Kalko for her invaluable inspiration and for launching the studies on hats and birds. The work has been funded by the DFG Priority Program 1374 Infrastructure-Biodiversity-Exploratories'. Field work permits were issued by the responsible state environmental offices of Baden-Wurttemberg, Thuringen and Brandenburg (according to 72 BbgNatSchG).	Allan E, 2014, P NATL ACAD SCI USA, V111, P308, DOI 10.1073/pnas.1312213111; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2015, VEGAN COMMUNITY ECOL; [Anonymous], 2016, GDM FUNCTIONS GEN DI; [Anonymous], 2014, INEXT INTERPOLATION; [Anonymous], 2016, VEGAN COMMUNITY ECOL; [Anonymous], 2016, IMPERM PERMUTATION T; [Anonymous], 2016, NLME LINEAR NONLINEA; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Birkhofer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043292; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Boch S, 2016, BIODIVERS CONSERV, V25, P225, DOI 10.1007/s10531-015-1037-y; Borschig C, 2013, BASIC APPL ECOL, V14, P547, DOI 10.1016/j.baae.2013.09.002; Borschig C., 2012, THESIS; Carvalho JC, 2013, OIKOS, V122, P825, DOI 10.1111/j.1600-0706.2012.20980.x; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Solar RRD, 2015, ECOL LETT, V18, P1108, DOI 10.1111/ele.12494; De Deyn GB, 2005, TRENDS ECOL EVOL, V20, P625, DOI 10.1016/j.tree.2005.08.009; Denzinger A, 2001, J COMP PHYSIOL A, V187, P521, DOI 10.1007/s003590100223; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Estrada-Villegas S, 2010, BIOL CONSERV, V143, P597, DOI 10.1016/j.biocon.2009.11.009; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fenton M. B., 2004, BAT ECHOLOCATION RES, P133; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fitzpatrick MC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1201; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gamez-Virues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9568; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Haimi J, 2000, FOREST ECOL MANAG, V129, P53, DOI 10.1016/S0378-1127(99)00158-9; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L., 2011, BIOL DIVERSITY FRONT, V12, P66; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jung K, 2012, J APPL ECOL, V49, P523, DOI 10.1111/j.1365-2664.2012.02116.x; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; Kempson D., 1963, Pedobiologia, V3, P1; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Manning P, 2015, ECOLOGY, V96, P1492, DOI 10.1890/14-1307.1; Maurer B. A., 2011, BIOL DIVERSITY FRONT, V12, P55; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Morris EK, 2013, BIODIVERS CONSERV, V22, P2193, DOI 10.1007/s10531-013-0527-z; Muller J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051520; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Obrist MK, 2004, MAMMALIA, V68, P307, DOI 10.1515/mamm.2004.030; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Pellissier L, 2013, ECOL LETT, V16, P600, DOI 10.1111/ele.12083; Perovic D, 2015, J APPL ECOL, V52, P505, DOI 10.1111/1365-2664.12394; R Foundation for Statistical Computing, 2015, R LANG ENV STAT COMP; Renner SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112347; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simons NK, 2015, J ANIM ECOL, V84, P143, DOI 10.1111/1365-2656.12278; Simons NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107033; Smart SM, 2006, P ROY SOC B-BIOL SCI, V273, P2659, DOI 10.1098/rspb.2006.3630; Socher SA, 2013, BASIC APPL ECOL, V14, P126, DOI 10.1016/j.baae.2012.12.003; Socher SA, 2012, J ECOL, V100, P1391, DOI 10.1111/j.1365-2745.2012.02020.x; van der Plas F, 2016, P NATL ACAD SCI USA, V113, P3557, DOI 10.1073/pnas.1517903113; Weiner CN, 2014, ECOLOGY, V95, P466, DOI 10.1890/13-0436.1	69	253	260	34	584	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					266	+		10.1038/nature20575	http://dx.doi.org/10.1038/nature20575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27919075	Green Accepted			2022-12-28	WOS:000389548700056
J	Gulland, A				Gulland, Anne			HOMELESSNESS "I didn't want to be known": finding healthcare when you are homeless	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						NHS, 2015, PAT REG STAND OP PRI; Royal College of Emergency Medicine, 2015, INCL HLTH CLIN AUD 2; St Mungos, 2014, FUT	3	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2016	355								i6511	10.1136/bmj.i6511	http://dx.doi.org/10.1136/bmj.i6511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SY	27932320				2022-12-28	WOS:000390037500003
J	Olivares-Chauvet, P; Mukamel, Z; Lifshitz, A; Schwartzman, O; Elkayam, NO; Lubling, Y; Deikus, G; Sebra, RP; Tanay, A				Olivares-Chauvet, Pedro; Mukamel, Zohar; Lifshitz, Aviezer; Schwartzman, Omer; Elkayam, Noa Oded; Lubling, Yaniv; Deikus, Gintaras; Sebra, Robert P.; Tanay, Amos			Capturing pairwise and multi-way chromosomal conformations using chromosomal walks	NATURE			English	Article							CHROMATIN ARCHITECTURE; ORGANIZATION; GENOME; DOMAINS; PRINCIPLES; COHESIN	Chromosomes are folded into highly compacted structures to accommodate physical constraints within nuclei and to regulate access to genomic information(1,2). Recently, global mapping of pairwise contacts showed that loops anchoring topological domains (TADs) are highly conserved between cell types and species(3-8). Whether pairwise loops(9-14) synergize to form higher-order structures is still unclear. Here we develop a conformation capture assay to study higher-order organization using chromosomal walks (C-walks) that link multiple genomic loci together into proximity chains in human and mouse cells. This approach captures chromosomal structure at varying scales. Inter-chromosomal contacts constitute only 7-10% of the pairs and are restricted by interfacing TADs. About half of the C-walks stay within one chromosome, and almost half of those are restricted to intra-TAD spaces. C-walks that couple 2-4 TADs indicate stochastic associations between transcriptionally active, early replicating loci. Targeted analysis of thousands of 3-walks anchored at highly expressed genes support pairwise, rather than hub-like, chromosomal topology at active loci. Polycomb-repressed Hox domains are shown by the same approach to enrich for synergistic hubs. Together, the data indicate that chromosomal territories, TADs, and intra-TAD loops are primarily driven by nested, possibly dynamic, pairwise contacts.	[Olivares-Chauvet, Pedro; Mukamel, Zohar; Lifshitz, Aviezer; Schwartzman, Omer; Elkayam, Noa Oded; Lubling, Yaniv; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Olivares-Chauvet, Pedro; Mukamel, Zohar; Lifshitz, Aviezer; Schwartzman, Omer; Elkayam, Noa Oded; Lubling, Yaniv; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Deikus, Gintaras; Sebra, Robert P.] Icahn Sch Med Mt Sinai, Icahn Inst, New York, NY 10029 USA; [Deikus, Gintaras; Sebra, Robert P.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Weizmann Institute of Science; Weizmann Institute of Science; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.; Tanay, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	amos.tanay@weizmann.ac.il		Lubling, Yaniv/0000-0003-3461-9621; Schwartzman, Omer/0000-0002-4122-8111	European Research Council (EVOEPIC); Flight Attendant Medical Research Institute (FAMRI); Israel Science Foundation (ISF)	European Research Council (EVOEPIC); Flight Attendant Medical Research Institute (FAMRI); Israel Science Foundation (ISF)(Israel Science Foundation)	We acknowledge E. Yaffe for help with early stages of the experiments, N. Mor for help with mES cells, and members of the A.T. group for discussions. Research at the A.T. group was supported by the European Research Council (EVOEPIC), Flight Attendant Medical Research Institute (FAMRI), and the Israel Science Foundation (ISF). A.T. is a Kimmel investigator.	Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Ay F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1236-7; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Cheutin T, 2014, CURR OPIN GENET DEV, V25, P30, DOI 10.1016/j.gde.2013.11.016; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Fabre PJ, 2015, P NATL ACAD SCI USA, V112, P13964, DOI 10.1073/pnas.1517972112; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Imakaev MV, 2015, FEBS LETT, V589, P3031, DOI 10.1016/j.febslet.2015.09.004; Nagano T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0753-7; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Ryba T, 2011, NAT PROTOC, V6, P870, DOI 10.1038/nprot.2011.328; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schuettengruber B, 2014, CELL REP, V9, P219, DOI 10.1016/j.celrep.2014.08.072; Schwartzman O, 2016, NAT METHODS, V13, P685, DOI 10.1038/nmeth.3922; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Williamson I, 2014, GENE DEV, V28, P2778, DOI 10.1101/gad.251694.114; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	33	73	75	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					296	+		10.1038/nature20158	http://dx.doi.org/10.1038/nature20158			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27919068				2022-12-28	WOS:000389548700063
J	Sagi, I; Benvenisty, N				Sagi, Ido; Benvenisty, Nissim			Aspiring to naivety	NATURE			English	Editorial Material							STATE; CIRCUITRY; INDUCTION; CELLS	Human stem cells that can give rise to every cell type in the body are major players in biomedical research. A molecular analysis of human embryos might help to make these cultured cells more authentic imitations of their in vivo counterparts.	[Sagi, Ido; Benvenisty, Nissim] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, Azrieli Ctr Stem Cells & Genet Res, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, Azrieli Ctr Stem Cells & Genet Res, IL-91904 Jerusalem, Israel.	nissimb@mail.huji.ac.il						Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Pastor WA, 2016, CELL STEM CELL, V18, P323, DOI 10.1016/j.stem.2016.01.019; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Theunissen TW, 2016, CELL STEM CELL, V19, P502, DOI 10.1016/j.stem.2016.06.011; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002	11	4	4	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					211	212		10.1038/nature20484	http://dx.doi.org/10.1038/nature20484			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27919070				2022-12-28	WOS:000389548700046
J	Hauer, KE; Vandergrift, J; Hess, B; Lipner, RS; Holmboe, ES; Hood, S; Iobst, W; Hamstra, SJ; McDonald, FS				Hauer, Karen E.; Vandergrift, Jonathan; Hess, Brian; Lipner, Rebecca S.; Holmboe, Eric S.; Hood, Sarah; Iobst, William; Hamstra, Stanley J.; McDonald, Furman S.			Correlations Between Ratings on the Resident Annual Evaluation Summary and the Internal Medicine Milestones and Association With ABIM Certification Examination Scores Among US Internal Medicine Residents, 2013-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CERTIFYING EXAMINATION; TRAINING EXAMINATION; PERFORMANCE; COMPETENCES; VALIDITY	IMPORTANCE US internal medicine residency programs are now required to rate residents using milestones. Evidence of validity of milestone ratings is needed. OBJECTIVE To compare ratings of internal medicine residents using the pre-2015 resident annual evaluation summary (RAES), a nondevelopmental rating scale, with developmental milestone ratings. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study of US internal medicine residency programs in the 2013-2014 academic year, including 21 284 internal medicine residents (7048 postgraduate-year 1 [PGY-1], 7233 PGY-2, and 7003 PGY-3). EXPOSURES Program director ratings on the RAES and milestone ratings. MAIN OUTCOMES AND MEASURES Correlations of RAES and milestone ratings by training year; correlations of medical knowledge ratings with American Board of Internal Medicine (ABIM) certification examination scores; rating of unprofessional behavior using the 2 systems. RESULTS Corresponding RAES ratings and milestone ratings showed progressively higher correlations across training years, ranging among competencies from 0.31 (95% CI, 0.29 to 0.33) to 0.35 (95% CI, 0.33 to 0.37) for PGY-1 residents to 0.43 (95% CI, 0.41 to 0.45) to 0.52 (95% CI, 0.50 to 0.54) for PGY-3 residents (all P values <. 05). Linear regression showed ratings differed more between PGY-1 and PGY-3 years using milestone ratings than the RAES (all P values <. 001). Of the 6260 residents who attempted the certification examination, the 618 who failed had lower ratings using both systems for medical knowledge than did those who passed (RAES difference, -0.9; 95% CI, -1.0 to -0.8; P <.001; milestone medical knowledge 1 difference, -0.3; 95% CI, -0.3 to -0.3; P <.001; and medical knowledge 2 difference, -0.2; 95% CI, -0.3 to -0.2; P <.001). Of the 26 PGY-3 residents with milestone ratings indicating deficiencies on either of the 2 medical knowledge subcompetencies, 12 failed the certification examination. Correlation of RAES ratings for professionalism with residents' lowest professionalism milestone ratings was 0.44 (95% CI, 0.43 to 0.45; P <.001). CONCLUSIONS AND RELEVANCE Among US internal medicine residents in the 2013-2014 academic year, milestone-based ratings correlated with RAES ratings but with a greater difference across training years. Both rating systems for medical knowledge correlated with ABIM certification examination scores. Milestone ratings may better detect problems with professionalism. These preliminary findings may inform establishment of the validity of milestone-based assessment.	[Hauer, Karen E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Vandergrift, Jonathan; Lipner, Rebecca S.; Hood, Sarah; McDonald, Furman S.] Amer Board Internal Med, Philadelphia, PA USA; [Hess, Brian] Hess Consulting, Levis, PQ, Canada; [Holmboe, Eric S.; Hamstra, Stanley J.] Accreditat Council Grad Med Educ, Chicago, IL USA; [Iobst, William] Commonwealth Med Coll, Scranton, PA USA	University of California System; University of California San Francisco; American Board of Internal Medicine; Geisinger Commonwealth School of Medicine	Hauer, KE (corresponding author), Univ Calif San Francisco, Dept Med, 533 Parnassus Ave,U80,Box 0710, San Francisco, CA 94143 USA.	karen.hauer@ucsf.edu	Hamstra, Stanley/N-1310-2019; Hamstra, Stanley/A-3808-2016	Hamstra, Stanley/0000-0002-0680-366X; Hamstra, Stanley/0000-0002-0680-366X				AERA, 2014, STAND ED PSYCH TEST; Bartlett Kathleen W, 2015, J Grad Med Educ, V7, P75, DOI 10.4300/JGME-D-14-00389.1; Beeson MS, 2015, ACAD EMERG MED, V22, P838, DOI 10.1111/acem.12697; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Carraccio C, 2016, ACAD MED, V91, P645, DOI 10.1097/ACM.0000000000001048; Carraccio C, 2016, ACAD MED, V91, P199, DOI 10.1097/ACM.0000000000000985; Carraccio CL, 2013, ACAD MED, V88, P1067, DOI 10.1097/ACM.0b013e318299396f; Cook D. A., 2006, AM J MED, V119, DOI [10.1016/j.amjmed.2005.10.036, DOI 10.1016/J.AMJMED.2005.10.036]; Green Michael L, 2009, J Grad Med Educ, V1, P5, DOI 10.4300/01.01.0003; GROSSMAN RS, 1992, J GEN INTERN MED, V7, P63, DOI 10.1007/BF02599105; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Hauer KE, 2016, ANN INTERN MED, V165, P356, DOI 10.7326/M15-2411; Holmboe Eric S, 2015, J Grad Med Educ, V7, P506, DOI 10.4300/JGME-07-03-43; Ingram Deborah D, 2014, Vital Health Stat 2, P1; Iobst William, 2013, J Grad Med Educ, V5, P14, DOI 10.4300/JGME-05-01s1-03; Kay C, 2015, ACAD MED, V90, P100, DOI 10.1097/ACM.0000000000000500; Li STT, 2017, ACAD MED, V92, P385, DOI 10.1097/ACM.0000000000001322; Lipner RS, 2016, ACAD MED, V91, P376, DOI 10.1097/ACM.0000000000001055; Lipner RS, 2002, ACAD MED, V77, pS64, DOI 10.1097/00001888-200210001-00021; McDonald FS, 2008, MAYO CLIN PROC, V83, P449, DOI 10.4065/83.4.449; McDonald FS, 2007, J GEN INTERN MED, V22, P962, DOI 10.1007/s11606-007-0206-4; Messick S., 1995, ED MEASUREMENT ISSUE, V14, P5, DOI [10.1111/j.17453992.1995.tb00881.x, DOI 10.1111/J.1745-3992.1995.TB00881.X]; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; Papadakis MA, 2008, ANN INTERN MED, V148, P869, DOI 10.7326/0003-4819-148-11-200806030-00009; Regan Linda, 2016, J Grad Med Educ, V8, P18, DOI 10.4300/JGME-D-15-00060.1; SHEA JA, 1993, ACAD MED, V68, pS22, DOI 10.1097/00001888-199310000-00034; Sisson Stephen D, 2015, J Grad Med Educ, V7, P42, DOI 10.4300/JGME-D-14-00054.1; Swing SR, 2007, MED TEACH, V29, P648, DOI 10.1080/01421590701392903; Wynia MK, 2014, ACAD MED, V89, P712, DOI 10.1097/ACM.0000000000000212	30	36	36	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2016	316	21					2253	2262		10.1001/jama.2016.17357	http://dx.doi.org/10.1001/jama.2016.17357			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YV	27923089	Bronze			2022-12-28	WOS:000389307400011
J	Shah, R				Shah, Rahman			Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents	ANNALS OF INTERNAL MEDICINE			English	Letter									[Shah, Rahman] Vet Affairs Med Ctr, Memphis, TN 38104 USA; [Shah, Rahman] Univ Tennessee, Memphis, TN 38163 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center	Shah, R (corresponding author), Vet Affairs Med Ctr, Memphis, TN 38104 USA.; Shah, R (corresponding author), Univ Tennessee, Memphis, TN 38163 USA.		shah, Rahman/AAR-3354-2020					Colombo A, 2016, JACC-CARDIOVASC INTE, V9, P25, DOI 10.1016/j.jcin.2015.09.021; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Puricel S, 2016, J AM COLL CARDIOL, V67, P921, DOI 10.1016/j.jacc.2015.12.019; Zhang XL, 2016, ANN INTERN MED, V164, P752, DOI 10.7326/M16-0006	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					828	829		10.7326/L16-0420	http://dx.doi.org/10.7326/L16-0420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27919089				2022-12-28	WOS:000389263900020
J	Baker, M				Baker, Monya			A SPELLCHECKER FOR STATISTICS	NATURE			English	Editorial Material																		Nuijten MB, 2016, BEHAV RES METHODS, V48, P1205, DOI 10.3758/s13428-015-0664-2	1	1	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					151	152		10.1038/540151a	http://dx.doi.org/10.1038/540151a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905454	Bronze			2022-12-28	WOS:000388916600070
J	Barr, AC				Barr, Amy C.			PLANETARY SCIENCE Pluto's telltale heart	NATURE			English	Editorial Material								Studies of a large frost-filled basin on Pluto show that this feature altered the dwarf planet's spin axis, driving tectonic activity on its surface, and hint at the presence of a subsurface ocean. See Letters p.86, p.90, p.94 & p.97	[Barr, Amy C.] Planetary Sci Inst, Tucson, AZ 85719 USA		Barr, AC (corresponding author), Planetary Sci Inst, Tucson, AZ 85719 USA.	amy@psi.edu						Bertrand T, 2016, NATURE, V540, P86, DOI 10.1038/nature19337; Elliot JL, 2007, ASTRON J, V134, P1, DOI 10.1086/517998; Grundy WM, 2016, SCIENCE, V351, DOI 10.1126/science.aad9189; Hamilton DP, 2016, NATURE, V540, P97, DOI 10.1038/nature20586; Hammond NP, 2016, GEOPHYS RES LETT, V43, P6775, DOI 10.1002/2016GL069220; JAMES PB, 1992, MARS, P934; Keane JT, 2016, NATURE, V540, P90, DOI 10.1038/nature20120; Keane JT, 2014, GEOPHYS RES LETT, V41, P6610, DOI 10.1002/2014GL061195; Moore JM, 2016, SCIENCE, V351, P1284, DOI 10.1126/science.aad7055; Nimmo F, 2016, NATURE, V540, P94, DOI 10.1038/nature20148; Nimmo F, 2006, NATURE, V441, P614, DOI 10.1038/nature04821; Perron JT, 2007, NATURE, V447, P840, DOI 10.1038/nature05873; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815	13	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					42	43		10.1038/540042a	http://dx.doi.org/10.1038/540042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905412				2022-12-28	WOS:000388916600040
J	Bhogaraju, S; Kalayil, S; Liu, YB; Bonn, F; Colby, T; Matic, I; Dikic, I				Bhogaraju, Sagar; Kalayil, Sissy; Liu, Yaobin; Bonn, Florian; Colby, Thomas; Matic, Ivan; Dikic, Ivan			Phosphoribosylation of Ubiquitin Promotes Serine Ubiquitination and Impairs Conventional Ubiquitination	CELL			English	Article							PROTEIN ADP-RIBOSYLATION; LEGIONELLA EFFECTOR; STRUCTURAL BASIS; BACTERIAL; BINDING; PARKIN; PHOSPHORYLATION; TRANSLOCATION; RECOGNITION; AUTOPHAGY	Conventional ubiquitination involves the ATP-dependent formation of amide bonds between the ubiquitin C terminus and primary amines in substrate proteins. Recently, SdeA, an effector protein of pathogenic Legionella pneumophila, was shown to mediate NAD-dependent and ATP-independent ubiquitin transfer to host proteins. Here, we identify a phosphodiesterase domain in SdeA that efficiently catalyzes phosphoribosylation of ubiquitin on a specific arginine via an ADP-ribose-ubiquitin intermediate. SdeA also catalyzes a chemically and structurally distinct type of substrate ubiquitination by conjugating phosphoribosylated ubiquitin to serine residues of protein substrates via a phosphodiester bond. Furthermore, phosphoribosylation of ubiquitin prevents activation of E1 and E2 enzymes of the conventional ubiquitination cascade, thereby impairing numerous cellular processes including mitophagy, TNF signaling, and proteasomal degradation. We propose that phosphoribosylation of ubiquitin potently modulates ubiquitin functions in mammalian cells.	[Bhogaraju, Sagar; Kalayil, Sissy; Liu, Yaobin; Bonn, Florian; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Bhogaraju, Sagar; Kalayil, Sissy; Liu, Yaobin; Dikic, Ivan] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Max von Laue Str 15, D-60438 Frankfurt, Germany; [Colby, Thomas; Matic, Ivan] Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany; [Dikic, Ivan] Univ Split, Sch Med, Dept Immunol & Med Genet, Split 21000, Croatia	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; University of Split	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.; Dikic, I (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Max von Laue Str 15, D-60438 Frankfurt, Germany.; Dikic, I (corresponding author), Univ Split, Sch Med, Dept Immunol & Med Genet, Split 21000, Croatia.	ivan.dikic@biochem2.de	Matic, Ivan/F-7284-2010; Dikic, Ivan/O-4650-2015; Matic, Ivan/HFZ-7772-2022	Matic, Ivan/0000-0003-0170-7991; Dikic, Ivan/0000-0001-8156-9511; Matic, Ivan/0000-0003-0170-7991; Bhogaraju, Sagar/0000-0001-9998-5927; Kalayil, Sissy/0000-0002-6731-2055	DFG [SFB 1177, EXC115, SPP 1580, EXC229]; LOEWE program Ubiquitin Networks (Ub-Net); State of Hesse/Germany	DFG(German Research Foundation (DFG)); LOEWE program Ubiquitin Networks (Ub-Net); State of Hesse/Germany	We thank Zhao-Qing Luo for the kind gift of Legionella strains, Marcel Hahn for molecular cloning of SdeA constructs, Evgenij Fiskin for the inducible HA-Parkin Hela cell line, Dr. Harald Hofbauer for gratuitous help in yeast work, Elena Veshkova for her technical assistance, and Sofia Rodriguez Gomez for her assistance in protein purification and biochemistry. We are thankful to Daniela Hoeller and Kerstin Koch for critical reading and commenting on the manuscript and Craig Wenger for generously providing a new version of Morpheus implementing Neutral Loss Scoring. We acknowledge the staff of Swiss Light Source (SLS) for their support during diffraction data collection. Work in the I.D. laboratories was supported by the DFG-funded Collaborative Research Centre on Selective Autophagy (SFB 1177); by the DFG-funded Cluster of Excellence "Macromolecular Complexes" (EXC115); by the DFG-funded SPP 1580 program "Intracellular Compartments as Places of Pathogen-Host-Interactions"; and by the LOEWE program Ubiquitin Networks (Ub-Net) and the LOEWE Center for Gene and Cell Therapy Frankfurt (CGT), both funded by the State of Hesse/Germany. Work in the I.M. laboratory was supported by the DFG-funded Cluster of Excellence "Cellular Stress Responses in Aging-Associated Diseases" (EXC229).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Bock FJ, 2015, MOL CELL, V58, P911, DOI 10.1016/j.molcel.2015.06.012; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Daniels CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep18271; Daniels CM, 2014, J PROTEOME RES, V13, P3510, DOI 10.1021/pr401032q; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Di Fiore P.P., 2014, COLD SPRING HARB PER, V6; DUERKSENHUGHES PJ, 1987, BIOCHEMISTRY-US, V26, P6980, DOI 10.1021/bi00396a019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Havey JC, 2015, INFECT IMMUN, V83, P3506, DOI 10.1128/IAI.00497-15; Herhaus L, 2015, EMBO REP, V16, P1071, DOI 10.15252/embr.201540891; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hicks SW, 2013, NAT REV MICROBIOL, V11, P316, DOI 10.1038/nrmicro3009; Hospenthal MK, 2013, NAT STRUCT MOL BIOL, V20, P555, DOI 10.1038/nsmb.2547; Hsu FS, 2014, P NATL ACAD SCI USA, V111, P10538, DOI 10.1073/pnas.1402605111; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Jeong KC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004695; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Leidecker O., 2016, NAT CHEM BIOL; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; Maculins T, 2016, CELL RES, V26, P499, DOI 10.1038/cr.2016.30; Matic I, 2012, NAT METHODS, V9, P771, DOI 10.1038/nmeth.2106; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Palazzo L, 2016, FEBS J, V283, P3371, DOI 10.1111/febs.13811; Palazzo L, 2015, BIOCHEM J, V468, P293, DOI 10.1042/BJ20141554; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Pu YY, 2016, MOL CELL, V62, P284, DOI 10.1016/j.molcel.2016.03.035; Qiu JZ, 2016, NATURE, V533, P120, DOI 10.1038/nature17657; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Rinaldo S, 2015, J BACTERIOL, V197, P1525, DOI 10.1128/JB.02606-14; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sansonetti PJ, 2006, ANN NY ACAD SCI, V1072, P307, DOI 10.1196/annals.1326.025; Sheedlo MJ, 2015, P NATL ACAD SCI USA, V112, P15090, DOI 10.1073/pnas.1514568112; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Vittal V, 2015, J BIOL CHEM, V290, P21244, DOI 10.1074/jbc.R115.675165; Vizcaino J.A., 2016, NUCLEIC ACIDS RES, DOI [DOI 10.1093/NAR/GKW880, 10.1093/nar/gkw880]; Wang XL, 2012, TRAFFIC, V13, P19, DOI 10.1111/j.1600-0854.2011.01269.x; Wenger CD, 2013, J PROTEOME RES, V12, P1377, DOI 10.1021/pr301024c; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wong K, 2015, J BIOL CHEM, V290, P24727, DOI 10.1074/jbc.M115.671263; Xu L, 2013, MICROBES INFECT, V15, P157, DOI 10.1016/j.micinf.2012.11.001; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358	64	167	172	10	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1636	+		10.1016/j.cell.2016.11.019	http://dx.doi.org/10.1016/j.cell.2016.11.019			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912065	Bronze			2022-12-28	WOS:000389470500023
J	Bielekova, B				Bielekova, Bibi			PERSPECTIVE Who dares, wins	NATURE			English	Editorial Material							MULTIPLE-SCLEROSIS		[Bielekova, Bibi] US Natl Inst Neurol Disorders & Stroke, Neuroimmunol Dis Unit, Intramural Res Program, Bethesda, MD 20824 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bielekova, B (corresponding author), US Natl Inst Neurol Disorders & Stroke, Neuroimmunol Dis Unit, Intramural Res Program, Bethesda, MD 20824 USA.	bibi.bielekova@nih.gov	Bielekova, Bibiana/AAA-8115-2020; Bielekova, Bibiana/V-1452-2017	Bielekova, Bibiana/0000-0002-0959-9430; Bielekova, Bibiana/0000-0002-0959-9430	Intramural NIH HHS [Z01 NS003056-01, Z99 NS999999] Funding Source: Medline; US National Institute of Neurological Disorders and Stroke Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003056] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Komori M, 2016, ANN CLIN TRANSL NEUR, V3, P166, DOI 10.1002/acn3.293; Kosa P, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00131; Lin YC, 2015, ANN CLIN TRANSL NEUR, V2, P445, DOI 10.1002/acn3.181; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x	5	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					S10	S10		10.1038/540S10a	http://dx.doi.org/10.1038/540S10a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27902681	Green Accepted, Bronze			2022-12-28	WOS:000388916600005
J	Fessenden, M				Fessenden, Marissa			METABOLOMICS: SMALL MOLECULES, SINGLE CELLS	NATURE			English	Editorial Material							MASS-SPECTROMETRY											Aerts JT, 2014, ANAL CHEM, V86, P3203, DOI 10.1021/ac500168d; Ali A, 2016, ANAL SCI, V32, P125, DOI 10.2116/analsci.32.125; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Hiyama E, 2015, ANAL SCI, V31, P1215, DOI 10.2116/analsci.31.1215; Ibanez AJ, 2013, P NATL ACAD SCI USA, V110, P8790, DOI 10.1073/pnas.1209302110; Lovric J., ACS NANO IN PRESS; Papagiannakis A., MOL CELL IN PRESS; Walker BN, 2013, ANGEW CHEM INT EDIT, V52, P3650, DOI 10.1002/anie.201207348	8	88	92	8	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					153	155		10.1038/540153a	http://dx.doi.org/10.1038/540153a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905420	Bronze			2022-12-28	WOS:000388916600071
J	Haddad, L; Hawkes, C; Webb, P; Thomas, S; Beddington, J; Waage, J; Flynn, D				Haddad, Lawrence; Hawkes, Corinna; Webb, Patrick; Thomas, Sandy; Beddington, John; Waage, Jeff; Flynn, Derek			A new global research agenda for food	NATURE			English	Editorial Material									[Haddad, Lawrence] Global Alliance Improved Nutr, Geneva, Switzerland; [Hawkes, Corinna] City Univ London, Ctr Food Policy, London, England; [Webb, Patrick] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Thomas, Sandy; Beddington, John; Waage, Jeff; Flynn, Derek] Global Panel Agr & Food Syst Nutr, London, England; [Thomas, Sandy] Univ Sussex, Sci Policy, Sci Policy Res Unit, Brighton BN1 9RH, E Sussex, England; [Beddington, John] Univ Oxford, Nat Resource Management, Oxford OX1 2JD, England	City University London; Tufts University; University of Sussex; University of Oxford	Thomas, S (corresponding author), Global Panel Agr & Food Syst Nutr, London, England.; Thomas, S (corresponding author), Univ Sussex, Sci Policy, Sci Policy Res Unit, Brighton BN1 9RH, E Sussex, England.	sandy.thomas@glopan.org	Webb, Patrick/P-3420-2017	Webb, Patrick/0000-0002-9857-3354				Achadi E, 2016, GLOBAL NUTR REPORT 2; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; FAO, 2015, STATE FOOD INWORLD; Fischer T, 2014, ACIAR MONOGR SER, V158, P1; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Global Panel on Agriculture and Food Systems for Nutrition, 2016, FOOD SYSTEMS DIETS F; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Roehrich JK, 2014, SOC SCI MED, V113, P110, DOI 10.1016/j.socscimed.2014.03.037; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959	10	110	110	2	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					30	32		10.1038/540030a	http://dx.doi.org/10.1038/540030a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905456	Green Accepted, Bronze			2022-12-28	WOS:000388916600027
J	Monteiro, J				Monteiro, Joao			Will Diet and Exercise Save Us All?	CELL			English	Editorial Material																		Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	1	0	0	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1431	1431		10.1016/j.cell.2016.11.027	http://dx.doi.org/10.1016/j.cell.2016.11.027			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912048	Bronze			2022-12-28	WOS:000389470500001
J	Torjesen, I				Torjesen, Ingrid			Many children receive no discharge plan after admission for severe asthma	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Paton J., 2016, NATL PEDIAT ASTHMA A	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2016	355								i6403	10.1136/bmj.i6403	http://dx.doi.org/10.1136/bmj.i6403			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZA	27899342				2022-12-28	WOS:000389308200003
J	Goettler, S; Zanetti-Dallenbach, R				Goettler, Simone; Zanetti-Dallenbach, Rosanna			Heterotopic Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goettler, Simone; Zanetti-Dallenbach, Rosanna] Univ Basel Hosp, CH-4031 Basel, Switzerland	University of Basel	Zanetti-Dallenbach, R (corresponding author), Univ Basel Hosp, CH-4031 Basel, Switzerland.	rosanna.zanetti@unibas.ch							0	4	4	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1982	1982		10.1056/NEJMicm1509537	http://dx.doi.org/10.1056/NEJMicm1509537			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC1HS	27959611				2022-12-28	WOS:000387856100010
J	Sherr, CJ				Sherr, Charles J.			FOCUS ON RESEARCH A New Cell-Cycle Target in Cancer - Inhibiting Cyclin D-Dependent Kinases 4 and 6	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sherr, Charles J.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA; [Sherr, Charles J.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Sherr, CJ (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA.; Sherr, CJ (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Sherr, Charles J/N-8074-2018	Sherr, Charles J/0000-0002-5516-6206				Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293	5	23	23	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1920	1923		10.1056/NEJMp1612343	http://dx.doi.org/10.1056/NEJMp1612343			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC1HS	27959598				2022-12-28	WOS:000387856100004
J	Felker, GM; Whellan, DJ				Felker, G. Michael; Whellan, David J.			Inpatient Management of Heart Failure: Are we shooting at the Right Target?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NATRIURETIC PEPTIDE; MORTALITY; TRIAL		[Felker, G. Michael] Duke Univ Med Ctr, Durham, NC USA; [Whellan, David J.] Sidney Kimmel Med Coll, Philadelphia, PA USA; [Felker, G. Michael] Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA	Duke University; Jefferson University; Duke University	Whellan, DJ (corresponding author), Jefferson Heart Inst, 1015 Chestnut St,Suite 317, Philadelphia, PA 19107 USA.	david.whellan@jefferson.edu	Felker, Michael/AAX-2288-2021					Bergethon KE, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002594; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Carubelli V, 2016, J CARDIOVASC MED, V17, P828, DOI 10.2459/JCM.0000000000000419; DeBusk RF, 2004, ANN INTERN MED, V141, P606, DOI 10.7326/0003-4819-141-8-200410190-00008; McQuade CN, 2017, ANN INTERN MED, V166, P180, DOI 10.7326/M16-1468; Steinen S, 2016, J CARD FAIL, V22, P939, DOI 10.1016/j.cardfail.2016.09.011; Stienen S, 2014, AM HEART J, V168, P30, DOI 10.1016/j.ahj.2014.04.008; Troughton R, 2014, EUR HEART J, V35, P16, DOI 10.1093/eurheartj/eht463; Troughton RW, 2014, EUR HEART J, V35, P1559, DOI 10.1093/eurheartj/ehu090	9	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					223	224		10.7326/M16-2667	http://dx.doi.org/10.7326/M16-2667			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7DL	27894128				2022-12-28	WOS:000394781200020
J	Ben-Othman, N; Vieira, A; Courtney, M; Record, F; Gjernes, E; Avolio, F; Hadzic, B; Druelle, N; Napolitano, T; Navarro-Sanz, S; Silvano, S; Al-Hasani, K; Pfeifer, A; Lacas-Gervais, S; Leuckx, G; Marroqui, L; Thevenet, J; Madsen, OD; Eizirik, DL; Heimberg, H; Kerr-Conte, J; Pattou, F; Mansouri, A; Collombat, P				Ben-Othman, Nouha; Vieira, Andhira; Courtney, Monica; Record, Fabien; Gjernes, Elisabet; Avolio, Fabio; Hadzic, Biljana; Druelle, Noemie; Napolitano, Tiziana; Navarro-Sanz, Sergi; Silvano, Serena; Al-Hasani, Keith; Pfeifer, Anja; Lacas-Gervais, Sandra; Leuckx, Gunter; Marroqui, Laura; Thevenet, Julien; Madsen, Ole Dragsbaek; Eizirik, Decio Laks; Heimberg, Harry; Kerr-Conte, Julie; Pattou, Francois; Mansouri, Ahmed; Collombat, Patrick			Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis	CELL			English	Article							INSULIN-PRODUCING CELLS; ENDOCRINE PANCREAS; EXPRESSION; PAX4; TYPE-1; GENE; MICE; ARX; HYPERPLASIA; PROGENITORS	The recent discovery that genetically modified alpha cells can regenerate and convert into beta-like cells in vivo holds great promise for diabetes research. However, to eventually translate these findings to human, it is crucial to discover compounds with similar activities. Herein, we report the identification of GABA as an inducer of alpha-to- beta-like cell conversion in vivo. This conversion induces a cell replacement mechanisms through the mobilization of duct-lining precursor cells that adopt an a cell identity prior to being converted into b-like cells, solely upon sustained GABA exposure. Importantly, these neo-generated beta-like cells are functional and can repeatedly reverse chemically induced diabetes in vivo. Similarly, the treatment of transplanted human islets with GABA results in a loss of a cells and a concomitant increase in beta- like cell counts, suggestive of alpha-to-beta- like cell conversion processes also in humans. This newly discovered GABA-induced alpha cell-mediated beta-like cell neogenesis could therefore represent an unprecedented hope toward improved therapies for diabetes.	[Napolitano, Tiziana; Silvano, Serena; Marroqui, Laura; Heimberg, Harry; Mansouri, Ahmed; Collombat, Patrick] Univ Cote Azur, CNRS, INSERM, IBV, F-06108 Nice, France; [Vieira, Andhira; Gjernes, Elisabet; Hadzic, Biljana; Navarro-Sanz, Sergi; Pfeifer, Anja; Leuckx, Gunter] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, F-06108 Nice, France; [Avolio, Fabio; Napolitano, Tiziana] Vrije Univ Brussel, Beta Cell Neogenesi, Laarbeeklaan 103, B-1090 Brussels, Belgium; [Record, Fabien; Al-Hasani, Keith; Kerr-Conte, Julie] Univ Libre Bruxelles ULB, Fac Med, Ctr Diabet Res, 808 Route Lennik, B-1070 Brussels, Belgium; Univ Lille, European Genom Inst Diabet, INSERM, CHU Lille, F-59000 Lille, France; [Vieira, Andhira; Record, Fabien; Gjernes, Elisabet; Silvano, Serena; Lacas-Gervais, Sandra; Leuckx, Gunter; Eizirik, Decio Laks; Kerr-Conte, Julie; Pattou, Francois] Univ Lille, European Genom Inst Diabet, INSERM, CHU Lille, F-59000 Lille, France; [Courtney, Monica; Druelle, Noemie; Al-Hasani, Keith; Heimberg, Harry; Pattou, Francois] Univ Copenhagen, Danstem, Danish Stem Cell Ctr, Translat Stem Cell Biol, DK-2200 Copenhagen, Denmark; [Druelle, Noemie; Lacas-Gervais, Sandra; Leuckx, Gunter; Collombat, Patrick] Max Planck Inst Biophys Chem, Dept Mol Dev Biol, D-37077 Gottingen, Germany; [Navarro-Sanz, Sergi; Al-Hasani, Keith; Lacas-Gervais, Sandra; Eizirik, Decio Laks; Pattou, Francois; Mansouri, Ahmed] Univ Gothenburg, Dept Clin Neurophysiol, Robert Koch Str 40, D-37075 Gottingen, Germany; [Record, Fabien; Napolitano, Tiziana; Pfeifer, Anja; Eizirik, Decio Laks; Collombat, Patrick] Erciyes Univ, Genome & Stem Cell Ctr, GENKOK, TR-38039 Kayseri, Turkey; [Ben-Othman, Nouha; Navarro-Sanz, Sergi; Pfeifer, Anja; Eizirik, Decio Laks; Heimberg, Harry; Kerr-Conte, Julie] Evotec GmbH, Marie Curie Str, D-37079 Gottingen, Germany; [Gjernes, Elisabet; Hadzic, Biljana; Silvano, Serena; Lacas-Gervais, Sandra; Eizirik, Decio Laks; Heimberg, Harry] Ore Campus Aulnay Chanteloup, 1 Ave Eugene Schueller, F-93600 Aulnay Sous Bois, France; [Record, Fabien; Hadzic, Biljana; Silvano, Serena; Leuckx, Gunter; Madsen, Ole Dragsbaek; Heimberg, Harry] Monash Univ, Clayton, Vic 3800, Australia; [Gjernes, Elisabet; Hadzic, Biljana; Silvano, Serena; Thevenet, Julien; Heimberg, Harry; Pattou, Francois] Fisher Sci, Blvd Sebastien Brant, F-67403 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Copenhagen; Max Planck Society; Erciyes University; Evotec; Monash University	Collombat, P (corresponding author), Univ Cote Azur, CNRS, INSERM, IBV, F-06108 Nice, France.	collombat@unice.fr	Madsen, Ole D./A-7415-2011; collombat, patrick/P-3741-2019; Druelle, Noémie/T-6899-2019; collombat, patrick/F-4495-2015; Pattou, Francois/O-6151-2017; Marroqui, Laura/B-4942-2016; Druelle, Noemie/P-6319-2016	Madsen, Ole D./0000-0002-2753-5203; collombat, patrick/0000-0001-8232-1438; collombat, patrick/0000-0001-8232-1438; Pattou, Francois/0000-0001-8388-3766; Marroqui, Laura/0000-0003-2931-9317; Druelle, Noemie/0000-0002-8864-8658; Heimberg, Harry/0000-0003-1954-7375; Al-Hasani, Keith/0000-0001-6109-5603; Avolio, Fabio/0000-0003-2067-5315	Juvenile Diabetes Research Foundation (JDRF) [2-2010-567, 17-2011-16, 17-2013-426, 3-SRA-2014-282-Q-R]; INSERM AVENIR program; INSERM; European Research Council [StG-2011-281265]; FRM [DRC20091217179]; ANR/BMBF [GENO 105 01/01KU0906]; French Government (National Research Agency, ANR) through the "Investments for the Future'' LABEX SIGNALIFE [ANR-11-LABX-0028-01]; Max-Planck Society; Club Isatis; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche; NIH-NIDDK-HIRN Consortium (USA) [UC4DK104166-01]; JDRF [3-SRA-2014-32-S-B, 31-2008-416]; Belgian FRFS-Welbio [CR-2015A-06]; European Genomic Institute for Diabetes [ANR-10-LABX-46]; Fund for Scientific Research Flanders [G034613N, G024512N]; Stichting Diabetes Onderzoek Nederland; Belgian FNRS; Novo Nordisk Foundation Section for Basic Stem Cell Biology [Semb group NNF] Funding Source: researchfish	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); INSERM AVENIR program(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council(European Research Council (ERC)European Commission); FRM(Fondation pour la Recherche Medicale); ANR/BMBF(French National Research Agency (ANR)); French Government (National Research Agency, ANR) through the "Investments for the Future'' LABEX SIGNALIFE(French National Research Agency (ANR)); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Club Isatis; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche; NIH-NIDDK-HIRN Consortium (USA); JDRF(Juvenile Diabetes Research Foundation); Belgian FRFS-Welbio(WELBIO); European Genomic Institute for Diabetes; Fund for Scientific Research Flanders(FWO); Stichting Diabetes Onderzoek Nederland; Belgian FNRS(Fonds de la Recherche Scientifique - FNRS); Novo Nordisk Foundation Section for Basic Stem Cell Biology	We thank C. Wright, M. Sander, and P. Herrera for the kind gift of antibodies and mouse lines. We are very grateful to J. Hecksher-Sorensen and H. Jackle for their support and to G. Rutter for sharing unpublished data. We also thank the "PRISM-IBV-CNRS UMR 7277-INSERM U1091-UNS'' platform, Magali Mondin and Gianni Pasquetti for their help with the image quantification and technical assistance. This work was supported by the Juvenile Diabetes Research Foundation (JDRF, 2-2010-567, 17-2011-16, 17-2013-426, 3-SRA-2014-282-Q-R), the INSERM AVENIR program, the INSERM, the European Research Council (StG-2011-281265), the FRM (DRC20091217179), the ANR/BMBF (2009 GENO 105 01/01KU0906), the French Government (National Research Agency, ANR) through the "Investments for the Future'' LABEX SIGNALIFE (ANR-11-LABX-0028-01), the Max-Planck Society, Club Isatis, Mr. and Mrs. Dorato, Mr. and Mrs. Peter de Marffy-Mantuano, the Fondation Generale de Sante and the Foundation Schlumberger pour l'Education et la Recherche to P. C., the NIH-NIDDK-HIRN Consortium (UC4DK104166-01, USA), the JDRF (3-SRA-2014-32-S-B; funding for this grant was made possible through a collaboration between the JDRF and The Leona M. and Harry B. Helmsley Charitable Trust) and the Belgian FRFS-Welbio (CR-2015A-06) to D.L.E., the European Genomic Institute for Diabetes (ANR-10-LABX-46) and JDRF (31-2008-416) to J.K.C. and F.P., the Fund for Scientific Research Flanders (G034613N, G024512N) and Stichting Diabetes Onderzoek Nederland to H.H. A.M. and P.C. share a patent with NovoNordisk on some of the results reported herein. L.M. is the recipient of a post-doctoral fellowship from the Belgian FNRS.	Adeghate E, 2002, TISSUE CELL, V34, P1, DOI 10.1054/tice.2002.0217; Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Bailey SJ, 2007, DIABETES, V56, P320, DOI 10.2337/db06-0712; Caiazzo R, 2008, TRANSPLANTATION, V86, P360, DOI 10.1097/TP.0b013e31817ef846; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; Franklin IK, 2004, J GEN PHYSIOL, V123, P185, DOI 10.1085/jgp.200409016; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067228; KerrConte J, 1996, DIABETES, V45, P1108, DOI 10.2337/diabetes.45.8.1108; KURIYAMA K, 1971, NEUROPHARMACOLOGY, V10, P103, DOI 10.1016/0028-3908(71)90013-X; Li J, 2017, CELL, V168, P86, DOI 10.1016/j.cell.2016.11.010; Longuet C, 2013, DIABETES, V62, P1196, DOI 10.2337/db11-1605; Lord S, 2015, PHARMACOL RES, V98, P3, DOI 10.1016/j.phrs.2015.02.002; Marroqui L, 2015, DIABETES, V64, P3808, DOI 10.2337/db15-0362; Marroqui L, 2015, ELIFE, V4, DOI 10.7554/eLife.06990; Marroqui L, 2015, EBIOMEDICINE, V2, P378, DOI 10.1016/j.ebiom.2015.03.012; Nair G, 2015, CURR OPIN GENET DEV, V32, P171, DOI 10.1016/j.gde.2015.03.004; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Topp J, 1998, TRANSPLANTATION, V66, P1392, DOI 10.1097/00007890-199811270-00023; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	39	181	196	4	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2017	168	1-2					73	+		10.1016/j.cell.2016.11.002	http://dx.doi.org/10.1016/j.cell.2016.11.002			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8JM	27916274	Bronze, Green Published			2022-12-28	WOS:000396246700012
J	Hudson, KL; Collins, FS				Hudson, Kathy L.; Collins, Francis S.			The 21st Century Cures Act - A View from the NIH	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hudson, Kathy L.; Collins, Francis S.] NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Hudson, KL (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Rein L., 2015, WASHINGTON POST	3	49	50	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2017	376	2					111	113		10.1056/NEJMp1615745	http://dx.doi.org/10.1056/NEJMp1615745			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI0XI	27959585	Green Published, Bronze			2022-12-28	WOS:000392198400005
J	Posey, JE; Harel, T; Liu, PF; Rosenfeld, JA; James, RA; Akdemir, ZHC; Walkiewicz, M; Bi, WM; Xiao, R; Ding, Y; Xia, F; Beaudet, AL; Muzny, DM; Gibbs, RA; Boerwinkle, E; Eng, CM; Sutton, VR; Shaw, CA; Plon, SE; Yang, YP; Lupski, JR				Posey, Jennifer E.; Harel, Tamar; Liu, Pengfei; Rosenfeld, Jill A.; James, Regis A.; Akdemir, Zeynep H. Coban; Walkiewicz, Magdalena; Bi, Weimin; Xiao, Rui; Ding, Yan; Xia, Fan; Beaudet, Arthur L.; Muzny, Donna M.; Gibbs, Richard A.; Boerwinkle, Eric; Eng, Christine M.; Sutton, V. Reid; Shaw, Chad A.; Plon, Sharon E.; Yang, Yaping; Lupski, James R.			Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RETINITIS-PIGMENTOSA; EXOME; INHERITANCE; MUTATIONS; ONTOLOGY; UTILITY	BACKGROUND Whole-exome sequencing can provide insight into the relationship between observed clinical phenotypes and underlying genotypes. METHODS We conducted a retrospective analysis of data from a series of 7374 consecutive unrelated patients who had been referred to a clinical diagnostic laboratory for whole-exome sequencing; our goal was to determine the frequency and clinical characteristics of patients for whom more than one molecular diagnosis was reported. The phenotypic similarity between molecularly diagnosed pairs of diseases was calculated with the use of terms from the Human Phenotype Ontology. RESULTS A molecular diagnosis was rendered for 2076 of 7374 patients (28.2%); among these patients, 101 (4.9%) had diagnoses that involved two or more disease loci. We also analyzed parental samples, when available, and found that de novo variants accounted for 67.8% (61 of 90) of pathogenic variants in autosomal dominant disease genes and 51.7% (15 of 29) of pathogenic variants in X-linked disease genes; both variants were de novo in 44.7% (17 of 38) of patients with two mono-allelic variants. Causal copy-number variants were found in 12 patients (11.9%) with multiple diagnoses. Phenotypic similarity scores were significantly lower among patients in whom the phenotype resulted from two distinct mendelian disorders that affected different organ systems (50 patients) than among patients with disorders that had overlapping phenotypic features (30 patients) (median score, 0.21 vs. 0.36; P = 1.77x10(-7)). CONCLUSIONS In our study, we found multiple molecular diagnoses in 4.9% of cases in which whole-exome sequencing was informative. Our results show that structured clinical ontologies can be used to determine the degree of overlap between two mendelian diseases in the same patient; the diseases can be distinct or overlapping. Distinct disease phenotypes affect different organ systems, whereas overlapping disease phenotypes are more likely to be caused by two genes encoding proteins that interact within the same pathway. (Funded by the National Institutes of Health and the Ting Tsung and Wei Fong Chao Foundation.)	[Posey, Jennifer E.; Harel, Tamar; Liu, Pengfei; Rosenfeld, Jill A.; Akdemir, Zeynep H. Coban; Walkiewicz, Magdalena; Bi, Weimin; Xiao, Rui; Xia, Fan; Beaudet, Arthur L.; Muzny, Donna M.; Gibbs, Richard A.; Eng, Christine M.; Sutton, V. Reid; Shaw, Chad A.; Plon, Sharon E.; Yang, Yaping; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Plon, Sharon E.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Liu, Pengfei; Walkiewicz, Magdalena; Bi, Weimin; Xiao, Rui; Ding, Yan; Xia, Fan; Gibbs, Richard A.; Eng, Christine M.; Yang, Yaping] Baylor Coll Med, Baylor Genet, Houston, TX 77030 USA; [James, Regis A.] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Muzny, Donna M.; Gibbs, Richard A.; Boerwinkle, Eric; Plon, Sharon E.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Plon, Sharon E.; Lupski, James R.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Plon, Sharon E.] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center	Posey, JE (corresponding author), Baylor Coll Med, 1 Baylor Plaza,Rm 604B, Houston, TX 77030 USA.	jennifer.posey@bcm.edu; jlupski@bcm.edu	Liu, Pengfei/U-9743-2019; Posey, Jennifer E./J-3048-2019	Liu, Pengfei/0000-0002-4177-709X; Posey, Jennifer E./0000-0003-4814-6765	National Institutes of Health; Ting Tsung and Wei Fong Chao Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542, U01HG006485, UM1HG008898, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ting Tsung and Wei Fong Chao Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institutes of Health and the Ting Tsung and Wei Fong Chao Foundation.	Al-Qattan SM, 2015, GENET MED, V17, P719, DOI 10.1038/gim.2014.184; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.037952; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Fahiminiya S, 2014, CLIN GENET, V86, P134, DOI 10.1111/cge.12280; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; Gonzaga-Jauregui C, 2015, CELL REP, V12, P1169, DOI 10.1016/j.celrep.2015.07.023; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; James RA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0261-8; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Liu PF, 2014, AM J HUM GENET, V94, P462, DOI 10.1016/j.ajhg.2014.01.017; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142; Ratbi Ilham, 2007, Indian J Hum Genet, V13, P122, DOI 10.4103/0971-6866.38988; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Stray-Pedersen A, 2016, J ALLERGY CLIN IMMUN; Timberlake AT, 2016, ELIFE, V5, DOI 10.7554/eLife.20125; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	27	411	413	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2017	376	1					21	31		10.1056/NEJMoa1516767	http://dx.doi.org/10.1056/NEJMoa1516767			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SS	27959697	Green Accepted, Bronze			2022-12-28	WOS:000391177100005
J	Scheucher, M; Hilico, A; Will, E; Volz, J; Rauschenbeutel, A				Scheucher, Michael; Hilico, Adele; Will, Elisa; Volz, Jurgen; Rauschenbeutel, Arno			Quantum optical circulator controlled by a single chirally coupled atom	SCIENCE			English	Article							NON-RECIPROCITY; PHASE-SHIFT; PHOTONS	Integrated nonreciprocal optical components, which have an inherent asymmetry between their forward and backward propagation direction, are key for routing signals in photonic circuits. Here, we demonstrate a fiber-integrated quantum optical circulator operated by a single atom. Its nonreciprocal behavior arises from the chiral interaction between the atom and the transversally confined light. We demonstrate that the internal quantum state of the atom controls the operation direction of the circulator and that it features a strongly nonlinear response at the single-photon level. This enables, for example, photon number-dependent routing and novel quantum simulation protocols. Furthermore, such a circulator can in principle be prepared in a coherent superposition of its operational states and may become a key element for quantum information processing in scalable integrated optical circuits.	[Scheucher, Michael; Hilico, Adele; Will, Elisa; Volz, Jurgen; Rauschenbeutel, Arno] Vienna Univ Technol, Vienna Ctr Quantum Sci & Technol, Atominst, Stadionallee 2, A-1020 Vienna, Austria	Technische Universitat Wien	Volz, J; Rauschenbeutel, A (corresponding author), Vienna Univ Technol, Vienna Ctr Quantum Sci & Technol, Atominst, Stadionallee 2, A-1020 Vienna, Austria.	jvolz@ati.ac.at; arno.rauschenbeutel@ati.ac.at	Volz, Jürgen/N-6457-2016; Rauschenbeutel, Arno/C-1472-2013	Volz, Jürgen/0000-0002-3174-2141; Rauschenbeutel, Arno/0000-0003-2467-4029; Scheucher, Michael/0000-0002-0977-8535; Will, Elisa/0000-0002-7546-6070	Austrian Science Fund (FWF; SFB FoQuS project) [F 4017]; Austrian Science Fund (FWF; DK CoQuS project) [W 1210-N16]; European Commission (IP SIQS) [600645]; Austrian Science Fund (FWF; Meitner Program) [M 1970]	Austrian Science Fund (FWF; SFB FoQuS project); Austrian Science Fund (FWF; DK CoQuS project); European Commission (IP SIQS); Austrian Science Fund (FWF; Meitner Program)	The authors are grateful to J. Simon and M. Levy for helpful discussions. We gratefully acknowledge financial support by the Austrian Science Fund (FWF; SFB FoQuS project no. F 4017 and DK CoQuS project no. W 1210-N16) and the European Commission (IP SIQS, no. 600645). A.H. acknowledges financial support from the Austrian Science Fund (FWF; Meitner Program Project M 1970).	Fan L, 2012, SCIENCE, V335, P447, DOI 10.1126/science.1214383; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Gallo K, 2001, APPL PHYS LETT, V79, P314, DOI 10.1063/1.1386407; Gisin N, 2007, NAT PHOTONICS, V1, P165, DOI 10.1038/nphoton.2007.22; Hafezi M, 2012, OPT EXPRESS, V20, P7672, DOI 10.1364/OE.20.007672; Huang DN, 2016, CONF LASER ELECTR; Jalas D, 2013, NAT PHOTONICS, V7, P579, DOI 10.1038/nphoton.2013.185; Junge C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.213604; Kim J, 2015, NAT PHYS, V11, P275, DOI 10.1038/NPHYS3236; Koch J, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043811; Lenferink EJ, 2014, OPT EXPRESS, V22, P16099, DOI 10.1364/OE.22.016099; Lira H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033901; Metcalf HJ., 1999, LASER COOLING TRAPPI; Nielsen M. A., 2011, QUANTUM COMPUTATION, DOI DOI 10.1017/CBO9780511976667; O'Shea D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.193601; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Pollinger M, 2009, PHYS REV LETT, V103, DOI [10.1103/PhysRevLett.103.053901, 10.1109/CLEOE-EQEC.2009.5192376]; Pollinger M, 2010, OPT EXPRESS, V18, P17764, DOI 10.1364/OE.18.017764; Rosenblum S, 2016, NAT PHOTONICS, V10, P19, DOI [10.1038/nphoton.2015.227, 10.1038/NPHOTON.2015.227]; Sayrin C, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041036; Schmidt M, 2015, OPTICA, V2, P635, DOI 10.1364/OPTICA.2.000635; Shoji Y, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/1/014602; Shomroni I, 2014, SCIENCE, V345, P903, DOI 10.1126/science.1254699; Sollner I, 2015, NAT NANOTECHNOL, V10, P775, DOI [10.1038/NNANO.2015.159, 10.1038/nnano.2015.159]; Stadler BJH, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2013.2293618; Tzuang LD, 2014, NAT PHOTONICS, V8, P701, DOI [10.1038/NPHOTON.2014.177, 10.1038/nphoton.2014.177]; Volz J, 2014, NAT PHOTONICS, V8, P965, DOI [10.1038/nphoton.2014.253, 10.1038/NPHOTON.2014.253]; Walter S, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/11/113029; Xia KY, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043802	31	177	177	18	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1577	1580		10.1126/science.aaj2118	http://dx.doi.org/10.1126/science.aaj2118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	27940579	Green Submitted			2022-12-28	WOS:000390254300050
J	Hekstra, DR; White, KI; Socolich, MA; Henning, RW; Srajer, V; Ranganathan, R				Hekstra, Doeke R.; White, K. Ian; Socolich, Michael A.; Henning, Robert W.; Srajer, Vukica; Ranganathan, Rama			Electric-field-stimulated protein mechanics	NATURE			English	Article							PDZ DOMAIN; ENERGY LANDSCAPE; LIGAND MIGRATION; MOLECULAR MOVIE; GATING CHARGE; DYNAMICS; RECOGNITION; BINDING; CRYSTALLOGRAPHY; PHOTOCYCLE	The internal mechanics of proteins-the coordinated motions of amino acids and the pattern of forces constraining these motions-connects protein structure to function. Here we describe a new method combining the application of strong electric field pulses to protein crystals with time-resolved X-ray crystallography to observe conformational changes in spatial and temporal detail. Using a human PDZ domain (LNX2(PDZ2)) as a model system, we show that protein crystals tolerate electric field pulses strong enough to drive concerted motions on the sub-microsecond timescale. The induced motions are subtle, involve diverse physical mechanisms, and occur throughout the protein structure. The global pattern of electric-field-induced motions is consistent with both local and allosteric conformational changes naturally induced by ligand binding, including at conserved functional sites in the PDZ domain family. This work lays the foundation for comprehensive experimental study of the mechanical basis of protein function.	[Hekstra, Doeke R.; White, K. Ian; Socolich, Michael A.; Ranganathan, Rama] UT Southwestern Med Ctr, Green Ctr Syst Biol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Henning, Robert W.; Srajer, Vukica] Univ Chicago, Ctr Adv Radiat Sources, 929 East 57th St, Chicago, IL 60637 USA; [Ranganathan, Rama] UT Southwestern Med Ctr, Dept Biophys, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Ranganathan, Rama] UT Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Hekstra, Doeke R.] Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA; [Hekstra, Doeke R.] Harvard Univ, Sch Engn & Appl Sci, 52 Oxford St, Cambridge, MA 02138 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Chicago; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University	Ranganathan, R (corresponding author), UT Southwestern Med Ctr, Green Ctr Syst Biol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.; Ranganathan, R (corresponding author), UT Southwestern Med Ctr, Dept Biophys, 6001 Forest Pk Rd, Dallas, TX 75390 USA.; Ranganathan, R (corresponding author), UT Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	White, Kristopher Ian/ABA-4166-2021	White, Kristopher Ian/0000-0001-8182-3655; Hekstra, Doeke/0000-0003-2332-9223; Socolich, Michael/0000-0002-0702-1061	National Institutes of Health (NIH) [R01GM123456]; Robert A. Welch Foundation [I-1366]; Lyda Hill Endowment for Systems Biology; Green Center for Systems Biology; NIH [R24GM111072, P41GM103393]; US Department of Energy [DE-AC02-76SF00515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123456, R24GM111072, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Lyda Hill Endowment for Systems Biology; Green Center for Systems Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.R. dedicates this paper to Alfred G. Gilman, whose contributions were profound and irreplaceable. We thank the staff at BioCARS, Stanford Synchrotron Radiation Lightsource (SSRL) and the UT Southwestern Medical Center Structural Biology Laboratory for technical support, and D. Borek, C. A. Brautigam, S. Leibler, A. Libchaber, K. Moffat, Z. Otwinowski and members of the Ranganathan laboratory for discussions. R.R. acknowledges support from National Institutes of Health (NIH) grant R01GM123456, the Robert A. Welch Foundation (I-1366), the Lyda Hill Endowment for Systems Biology, and the Green Center for Systems Biology. BioCARS is supported by NIH grant R24GM111072 and through a collaboration with P. Anfinrud (NIH/National Institute of Diabetes and Digestive and Kidney Diseases). The SSRL is supported by the US Department of Energy (Contract No. DE-AC02-76SF00515) and by the NIH (P41GM103393).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Borek D, 2013, J SYNCHROTRON RADIAT, V20, P37, DOI 10.1107/S0909049512048807; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Gebhardt JCM, 2010, P NATL ACAD SCI USA, V107, P2013, DOI 10.1073/pnas.0909854107; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; Graber T, 2011, J SYNCHROTRON RADIAT, V18, P658, DOI 10.1107/S0909049511009423; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hoffmann MC, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/8/083001; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Kang BS, 2003, STRUCTURE, V11, P845, DOI 10.1016/S0969-2126(03)00125-4; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kay LE, 1998, BIOCHEM CELL BIOL, V76, P145, DOI 10.1139/bcb-76-2-3-145; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; LEFUR P, 1976, APPL PHYS LETT, V28, P21, DOI 10.1063/1.88565; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Long JF, 2008, J MOL BIOL, V375, P1457, DOI 10.1016/j.jmb.2007.11.088; MATTHEWS BW, 1975, ACTA CRYSTALLOGR A, V31, P480, DOI 10.1107/S0567739475001040; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Moffat K, 2001, CHEM REV, V101, P1569, DOI 10.1021/cr990039q; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morozova TY, 1996, BIOPHYS CHEM, V60, P1, DOI 10.1016/0301-4622(96)00007-5; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Ren Z, 2001, BIOCHEMISTRY-US, V40, P13788, DOI 10.1021/bi0107142; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schmidt M, 2005, P NATL ACAD SCI USA, V102, P11704, DOI 10.1073/pnas.0504932102; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Ursby T, 1997, ACTA CRYSTALLOGR A, V53, P564, DOI 10.1107/S0108767397004522; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; van den Berk LCJ, 2007, BIOCHEMISTRY-US, V46, P13629, DOI 10.1021/bi700954e; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	52	101	102	2	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					400	+		10.1038/nature20571	http://dx.doi.org/10.1038/nature20571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27926732	Green Accepted			2022-12-28	WOS:000389716800035
J	Khera, AV; Emdin, CA; Drake, I; Natarajan, P; Bick, AG; Cook, NR; Chasman, DI; Baber, U; Mehran, R; Rader, DJ; Fuster, V; Boerwinkle, E; Melander, O; Orho-Melander, M; Ridker, PM; Kathiresan, S				Khera, Amit V.; Emdin, Connor A.; Drake, Isabel; Natarajan, Pradeep; Bick, Alexander G.; Cook, Nancy R.; Chasman, Daniel I.; Baber, Usman; Mehran, Roxana; Rader, Daniel J.; Fuster, Valentin; Boerwinkle, Eric; Melander, Olle; Orho-Melander, Marju; Ridker, Paul M.; Kathiresan, Sekar			Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDEAL CARDIOVASCULAR HEALTH; GENOME-WIDE ASSOCIATION; HEART-DISEASE; PRIMARY PREVENTION; SCORE; IMPACT; ATHEROSCLEROSIS; SUSCEPTIBILITY; PREVALENCE; PREDICTION	BACKGROUND Both genetic and lifestyle factors contribute to individual-level risk of coronary artery disease. The extent to which increased genetic risk can be offset by a healthy lifestyle is unknown. METHODS Using a polygenic score of DNA sequence polymorphisms, we quantified genetic risk for coronary artery disease in three prospective cohorts - 7814 participants in the Atherosclerosis Risk in Communities (ARIC) study, 21,222 in the Women's Genome Health Study (WGHS), and 22,389 in the Malmo Diet and Cancer Study (MDCS) - and in 4260 participants in the cross-sectional BioImage Study for whom genotype and covariate data were available. We also determined adherence to a healthy lifestyle among the participants using a scoring system consisting of four factors: no current smoking, no obesity, regular physical activity, and a healthy diet. RESULTS The relative risk of incident coronary events was 91% higher among participants at high genetic risk (top quintile of polygenic scores) than among those at low genetic risk (bottom quintile of polygenic scores) (hazard ratio, 1.91; 95% confidence interval [CI], 1.75 to 2.09). A favorable lifestyle (defined as at least three of the four healthy lifestyle factors) was associated with a substantially lower risk of coronary events than an unfavorable lifestyle (defined as no or only one healthy lifestyle factor), regardless of the genetic risk category. Among participants at high genetic risk, a favorable lifestyle was associated with a 46% lower relative risk of coronary events than an unfavorable lifestyle (hazard ratio, 0.54; 95% CI, 0.47 to 0.63). This finding corresponded to a reduction in the standardized 10-year incidence of coronary events from 10.7% for an unfavorable lifestyle to 5.1% for a favorable lifestyle in ARIC, from 4.6% to 2.0% in WGHS, and from 8.2% to 5.3% in MDCS. In the BioImage Study, a favorable lifestyle was associated with significantly less coronary-artery calcification within each genetic risk category. CONCLUSIONS Across four studies involving 55,685 participants, genetic and lifestyle factors were independently associated with susceptibility to coronary artery disease. Among participants at high genetic risk, a favorable lifestyle was associated with a nearly 50% lower relative risk of coronary artery disease than was an unfavorable lifestyle.	[Khera, Amit V.; Natarajan, Pradeep; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA; [Khera, Amit V.; Natarajan, Pradeep; Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Cook, Nancy R.; Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Khera, Amit V.; Emdin, Connor A.; Bick, Alexander G.; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Drake, Isabel; Melander, Olle; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Baber, Usman; Mehran, Roxana; Fuster, Valentin] Icahn Sch Med Mt Sinai, Cardiovasc Inst, Mt Sinai Med Ctr, New York, NY 10029 USA; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Sch Publ Hlth, Houston, TX USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lund University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan1@mgh.harvard.edu	Girelli, Domenico/B-1183-2008; Natarajan, Pradeep/H-9764-2019; Fuster, Valentin/H-4319-2015; Mehran, Roxana/ABF-4160-2021	Girelli, Domenico/0000-0001-9684-1899; Natarajan, Pradeep/0000-0001-8402-7435; Fuster, Valentin/0000-0002-9043-9986; Bick, Alexander/0000-0001-5824-9595; Melander, Olle/0000-0002-2581-484X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Drake, Isabel/0000-0002-6500-6310	National Institutes of Health; Novo Nordisk Fonden [NNF14OC0011049, NNF13OC0005339, NNF15OC0016320, NNF16OC0021370] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127564, T32HL007208] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funded by the National Institutes of Health and others.	Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; Akesson A, 2014, J AM COLL CARDIOL, V64, P1299, DOI 10.1016/j.jacc.2014.06.1190; Baber U, 2015, J AM COLL CARDIOL, V65, P1065, DOI 10.1016/j.jacc.2015.01.017; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Brautbar A, 2012, ATHEROSCLEROSIS, V223, P421, DOI 10.1016/j.atherosclerosis.2012.05.035; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Chomistek AK, 2015, J AM COLL CARDIOL, V65, P43, DOI 10.1016/j.jacc.2014.10.024; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ganna A, 2013, ARTERIOSCL THROM VAS, V33, P2267, DOI 10.1161/ATVBAHA.113.301218; GERTLER MM, 1951, JAMA-J AM MED ASSOC, V147, P621, DOI 10.1001/jama.1951.03670240005002; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; MULLER C., 1938, ACTA MED SCAND SUPPL, V89, P75; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SLACK J., 1966, J MED GENET, V3, P239, DOI 10.1136/jmg.3.4.239; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Tada H, 2016, EUR HEART J, V37, P561, DOI 10.1093/eurheartj/ehv462; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; WHITE PD, 1957, NEW ENGL J MED, V256, P965, DOI 10.1056/NEJM195705232562101; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Xanthakis V, 2014, CIRCULATION, V130, P1676, DOI 10.1161/CIRCULATIONAHA.114.009273; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	38	603	627	9	167	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2349	2358		10.1056/NEJMoa1605086	http://dx.doi.org/10.1056/NEJMoa1605086			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SO	27959714	Green Accepted			2022-12-28	WOS:000390036500006
J	Cohen, J				Cohen, Jon			GLOBAL HEALTH AIDS epidemic nears control in three African countries	SCIENCE			English	News Item																			0	4	4	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2016	354	6317					1213	1213		10.1126/science.354.6317.1213	http://dx.doi.org/10.1126/science.354.6317.1213			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4TS	27940824				2022-12-28	WOS:000389598800011
J	Greenwood, JP; Herzog, BA; Brown, JM; Everett, CC; Plein, S				Greenwood, John P.; Herzog, Bernhard A.; Brown, Julia M.; Everett, Colin C.; Plein, Sven			Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Suspected Coronary Heart Disease RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Greenwood, John P.; Herzog, Bernhard A.; Plein, Sven] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Greenwood, John P.; Herzog, Bernhard A.; Plein, Sven] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Brown, Julia M.; Everett, Colin C.] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Greenwood, JP (corresponding author), Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England.; Greenwood, JP (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England.			brown, julia/0000-0002-2719-7064	British Heart Foundation [SP/12/1/29062, FS/10/62/28409] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Bruder O, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-9; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4	2	7	7	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					830	831		10.7326/L16-0480	http://dx.doi.org/10.7326/L16-0480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27919091				2022-12-28	WOS:000389263900023
J	Winker, MA				Winker, Margaret A.		World Assoc Med Editors Executive	Stop Predatory Publishers Now	ANNALS OF INTERNAL MEDICINE			English	Letter									[Winker, Margaret A.; World Assoc Med Editors Executive] World Assoc Med Editors, Winnetka, IL 60093 USA		Winker, MA (corresponding author), World Assoc Med Editors, Winnetka, IL 60093 USA.			Moher, David/0000-0003-2434-4206				Anderson P., 2022, PUBLISHING PERSPECTI; Beall J., 2015, SCHOLARLY OPEN ACCES; Clark J., 2015, BMJ BRIT MED J, P1; Committee on Publication Ethics, 2015, PRINC TRANSP BEST PR; Moher D, 2016, ANN INTERN MED, V164, P616, DOI 10.7326/M15-3015	5	5	5	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					826	826		10.7326/L16-0416	http://dx.doi.org/10.7326/L16-0416			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27919085				2022-12-28	WOS:000389263900016
J	Clery, D				Clery, Daniel			ASTRONOMY Hubble uses galactic lens to study universe's first stars	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1087	1087		10.1126/science.354.6316.1087	http://dx.doi.org/10.1126/science.354.6316.1087			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934713				2022-12-28	WOS:000388916400011
J	Brown, C				Brown, Carolyn			Neighbourhood watch	NATURE			English	Editorial Material							MULTIPLE-SCLEROSIS; RISK-FACTORS; CANADA; PREVALENCE; POPULATION											Banwell B, 2011, LANCET NEUROL, V10, P436, DOI 10.1016/S1474-4422(11)70045-X; Beck CA, 2005, MULT SCLER J, V11, P516, DOI 10.1191/1352458505ms1192oa; Belbasis L, 2015, LANCET NEUROL, V14, P263, DOI 10.1016/S1474-4422(14)70267-4; Guimond C, 2014, MULT SCLER J, V20, P1182, DOI 10.1177/1352458513519179; Holmoy T, 2008, MED HYPOTHESES, V70, P66, DOI 10.1016/j.mehy.2007.04.030; McGuigan C, 2005, J NEUROL, V252, P1245, DOI 10.1007/s00415-005-0850-8; Mokry LE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001866; Multiple Sclerosis International Federation, 2013, ATL OF MS; Orton SM, 2010, J NEUROL NEUROSUR PS, V81, P31, DOI 10.1136/jnnp.2008.162784; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Poppe AY, 2008, CAN J NEUROL SCI, V35, P593, DOI 10.1017/S0317167100009380; Rosjo E., 2016, MULT SCLER J; Torabi M, 2014, NEUROEPIDEMIOLOGY, V43, P38, DOI 10.1159/000365761; WARREN S, 1993, NEUROLOGY, V43, P1760, DOI 10.1212/WNL.43.9.1760	14	7	7	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					S4	S6		10.1038/540S4a	http://dx.doi.org/10.1038/540S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27902678	Bronze			2022-12-28	WOS:000388916600003
J	Mayor, S				Mayor, Susan			Individualised advice on type 2 diabetes is no better for changing behaviour, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Godino JG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002185	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2016	355								i6444	10.1136/bmj.i6444	http://dx.doi.org/10.1136/bmj.i6444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZD	27903501				2022-12-28	WOS:000389308600012
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Evidence in a post-truth world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Hern A., 2016, GUARDIAN; Silverman C., 2016, BUZZFEED NEWS   1103; Solon O., 2016, GUARDIAN	3	3	3	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2016	355								i6363	10.1136/bmj.i6363	http://dx.doi.org/10.1136/bmj.i6363			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0YW	27895037	Bronze			2022-12-28	WOS:000389307600009
J	Reddel, HK; Busse, WW; Pedersen, S; Tan, WC; Chen, YZ; Jorup, C; Lythgoe, D; O'Byrne, PM				Reddel, Helen K.; Busse, William W.; Pedersen, Soren; Tan, Wan C.; Chen, Yu-Zhi; Jorup, Carin; Lythgoe, Dan; O'Byrne, Paul M.			Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study	LANCET			English	Article							NEWLY-DIAGNOSED ASTHMA; PERSISTENT ASTHMA; EARLY INTERVENTION; CONTROLLED-TRIAL; LUNG-FUNCTION; DOUBLE-BLIND; BUDESONIDE; BECLOMETHASONE; EXACERBATIONS; INTERMITTENT	Background Low-dose inhaled corticosteroids (ICS) are highly effective for reducing asthma exacerbations and mortality. Conventionally, ICS treatment is recommended for patients with symptoms on more than 2 days per week, but this criterion has scant evidence. We aimed to assess the validity of the previous symptom-based cutoff for starting ICS by establishing whether there was a differential response to budesonide versus placebo for severe asthma exacerbations, lung function, and asthma symptom control across subgroups identified by baseline asthma symptom frequency. Methods We did a post-hoc analysis of the 3 year inhaled Steroid Treatment As Regular Therapy (START) study, done in 32 countries, with clinic visits every 3 months. Patients (aged 4-66 years) with mild asthma diagnosed within the previous 2 years and no previous regular corticosteroids were randomised to receive once daily, inhaled budesonide 400 mu g (those aged < 11 years 200 mu g) or placebo. Coprimary outcomes for this analysis were time to first severe asthma-related event (SARE; hospital admission, emergency treatment, or death) and change from baseline in lung function after bronchodilator. Interaction with baseline symptom frequency was investigated, with patients grouped by more than two symptom days per week and two or fewer symptom days per week (divided into no days to 1 day, and more than 1 day to 2 days). Analysis was done by intention to treat. Findings Of 7138 patients (n=3577 budesonide; n=3561 placebo), baseline symptom frequency was 0-1 days per week for 2184 (31%) participants, more than 1 and less than or equal to 2 symptom days per week for 1914 (27%) participants, and more than 2 symptom days per week for 3040 (43%) participants. For budesonide versus placebo, time to first SARE was longer across symptom frequency subgroups (hazard ratios 0.54 [95% CI 0.34-0.86] for 0-1 symptom days per week, 0.60 [0.39-0.93] for > 1 to <= 2 symptom days per week, 0.57 [0.41-0.79] > 2 symptom days per week, p(interaction) = 0.94), and the decline in postbronchodilator lung function was less at 3 years' follow-up (p(interaction) = 0.32). For budesonide versus placebo, severe exacerbations requiring oral or systemic corticosteroids were reduced (rate ratio 0.48 [0.38-0.61] 0-1 symptom days per week, 0.56 [0.44-0.71] > 1 to <= 2 symptom days per week, and 0.66 [0.55-0.80] > 2 symptom days per week, p(interaction) = 0.11), prebronchodilator lung function was higher, and symptom-free days were more frequent (p< 0.0001 for all three subgroups), with no interaction by symptom frequency (prebronchodilator p(interaction) = 0.43; symptom-free days p(interaction) = 0.53). Similar results were noted when participants were classified by any guidelines criterion as so-called persistent versus so-called intermittent asthma. Interpretation In mild recent-onset asthma, once daily, low-dose budesonide decreases SARE risk, reduces lung function decline, and improves symptom control similarly across all symptom subgroups. The results do not support restriction of inhaled corticosteroids to patients with symptoms on more than 2 days per week and suggest that treatment recommendations for mild asthma should consider both risk reduction and symptoms.	[Reddel, Helen K.] Univ Sydney, Woolcock Inst Med Res, Clin Management Grp, Sydney, NSW, Australia; [Busse, William W.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Pedersen, Soren] Univ Southern Denmark, Dept Paediat, Kolding Hosp, Kolding, Denmark; [Tan, Wan C.] Univ British Columbia, iCapture Ctr Cardiovasc & Pulm Res, St Pauls Hosp, Vancouver, BC, Canada; [Chen, Yu-Zhi] Affiliated Childrens Hosp, Capital Inst Pediat, Beijing, Peoples R China; [Jorup, Carin] AstraZeneca Res & Dev, Gothenburg, Sweden; [Lythgoe, Dan] Phastar, Chiswick, England; [O'Byrne, Paul M.] McMaster Univ, Fac Hlth Sci, Michael G DeGroote Sch Med, Hamilton, ON, Canada	University of Sydney; Woolcock Institute of Medical Research; University of Wisconsin System; University of Wisconsin Madison; Kolding Hospital; University of Southern Denmark; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Capital Institute of Pediatrics (CIP); AstraZeneca; McMaster University	Reddel, HK (corresponding author), Univ Sydney, Woolcock Inst Med Res, 431 Glebe Point Rd, Glebe, NSW 2037, Australia.	helen.reddel@sydney.edu.au	Reddel, Helen/AAC-3394-2020; Reddel, Helen/ABD-6338-2021	Reddel, Helen/0000-0002-6695-6350; O'Byrne, Paul/0000-0003-0979-281X	AstraZeneca	AstraZeneca(AstraZeneca)	AstraZeneca.; Medical writing assistance was provided by Hanna Mourad-Agha of inScience Communications, Springer Healthcare (London, UK). This assistance was funded by AstraZeneca.	Adams N., 2001, COCHRANE DB SYST REV, V4; [Anonymous], 2014, THORAX, V69, P1; [Anonymous], 2014, GLOB STRAT ASTHM MAN; Beasley R, 2014, J ALLERGY CLIN IMMUN, V133, P39, DOI 10.1016/j.jaci.2013.10.053; Boulet LP, 2009, RESP MED, V103, P1554, DOI 10.1016/j.rmed.2009.02.015; Buxton MJ, 2004, EUR RESPIR J, V24, P568, DOI 10.1183/09031936.04.00108703; Calhoun WJ, 2012, JAMA-J AM MED ASSOC, V308, P987, DOI 10.1001/2012.jama.10893; CAMPBELL DA, 1994, EUR RESPIR J, V7, P490, DOI 10.1183/09031936.94.07030490; Dusser D, 2007, ALLERGY, V62, P591, DOI 10.1111/j.1398-9995.2007.01394.x; Fuhlbrigge AL, 2014, LANCET RESP MED, V2, P487, DOI 10.1016/S2213-2600(14)70024-4; Haahtela T, 2006, EUR RESPIR J, V28, P748, DOI 10.1183/09031936.06.00128005; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; Martinez FD, 2011, LANCET, V377, P650, DOI 10.1016/S0140-6736(10)62145-9; Masoli M, 2004, EUR RESPIR J, V23, P552, DOI 10.1183/09031936.04.00076604; National Heart Lung and Blood Institute, 2012, 3 NAT HEART LUNG BLO; O'Byrne PM, 2006, CHEST, V129, P1478, DOI 10.1378/chest.129.6.1478; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Peters SP, 2006, J NATL MED ASSOC, V98, P851; Postma DS, 2011, CHEST, V139, P311, DOI 10.1378/chest.09-1735; Reddel Helen K, 2008, Prim Care Respir J, V17, P39, DOI 10.3132/pcrj.2008.00014; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; ROBERTSON CF, 1990, MED J AUSTRALIA, V152, P511, DOI 10.5694/j.1326-5377.1990.tb125350.x; SHEFFER AL, 1992, EUR RESPIR J, V5, P601; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Sullivan SD, 2003, J ALLERGY CLIN IMMUN, V112, P1229, DOI 10.1016/j.jaci.2003.09.025; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Vignola AM, 1998, AM J RESP CRIT CARE, V157, pS184, DOI 10.1164/ajrccm.157.5.rsaa-3; WOOLCOCK A, 1989, MED J AUSTRALIA, V151, P650, DOI 10.5694/j.1326-5377.1989.tb139640.x	32	118	122	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					157	166		10.1016/S0140-6736(16)31399-X	http://dx.doi.org/10.1016/S0140-6736(16)31399-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9UT	27912982				2022-12-28	WOS:000392117600027
J	Prakash, O; Kumar, A; Thamizhavel, A; Ramakrishnan, S				Prakash, Om; Kumar, Anil; Thamizhavel, A.; Ramakrishnan, S.			Evidence for bulk superconductivity in pure bismuth single crystals at ambient pressure	SCIENCE			English	Article							NONADIABATIC SUPERCONDUCTIVITY; NANOWIRE ARRAYS; BI; TEMPERATURES; ELECTRONS; MAGNETORESISTANCE; SEMICONDUCTORS; TRANSITION; SEMIMETALS; TRANSPORT	At ambient pressure, bulk rhombohedral bismuth is a semimetal that remains in the normal state down to at least 10 millikelvin. Superconductivity in bulk bismuth is thought to be unlikely because of the extremely low carrier density. We observed bulk superconductivity in pure bismuth single crystals below 0.53 millikelvin at ambient pressure, with an estimated critical magnetic field of 5.2 microteslas at 0 kelvin. Superconductivity in bismuth cannot be explained by the conventional Bardeen-Cooper-Schrieffer theory because its adiabatic approximation does not hold true for bismuth. Future theoretical work will be needed to understand superconductivity in the nonadiabatic limit in systems with low carrier densities and unusual band structures, such as bismuth.	[Prakash, Om; Kumar, Anil; Thamizhavel, A.; Ramakrishnan, S.] Tata Inst Fundamental Res, Dept Condensed Matter Phys & Mat Sci, Mumbai 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Ramakrishnan, S (corresponding author), Tata Inst Fundamental Res, Dept Condensed Matter Phys & Mat Sci, Mumbai 400005, Maharashtra, India.	ramky@tifr.res.in	Prakash, Om/L-3214-2019; Thamizhavel, Arumugam/A-1801-2011; Thamizhavel, Arumugam/AAJ-9017-2020; Prakash, Om/P-8241-2018	Prakash, Om/0000-0002-9492-4946; Thamizhavel, Arumugam/0000-0003-1679-4370; Prakash, Om/0000-0002-9492-4946	Tata Institute of Fundamental Research, Mumbai, India	Tata Institute of Fundamental Research, Mumbai, India	The authors thank S. S. Jha for useful discussions and comments. We thank S. Mukhopadhyay, R. Kulkarni, and D. D. Buddhikot for valuable technical help at the early stages of this work. This work was financially supported by the Tata Institute of Fundamental Research, Mumbai, India. The authors declare no competing financial interests. The project was planned by S.R. Single crystals were grown and characterized by O.P. and A. T. All the measurements were conducted by O.P. and A.K. The data analysis was performed by O.P. and S.R. The manuscript was prepared by S.R. and O.P. and discussed with A.K. and A.T.	BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Behnia K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166602; Behnia K, 2007, SCIENCE, V317, P1729, DOI 10.1126/science.1146509; BUCHAL C, 1983, PHYS REV LETT, V50, P64, DOI 10.1103/PhysRevLett.50.64; Cohen M., 1969, SUPERCONDUCTIVITY, V2, P615; Cohen M.L., 1969, SUPERCONDUCTIVITY, P615; COHEN ML, 1964, PHYS REV, V134, pA511, DOI 10.1103/PhysRev.134.A511; EDELMAN VS, 1976, ADV PHYS, V25, P555, DOI 10.1080/00018737600101452; ELIASHBERG GM, 1960, SOV PHYS JETP-USSR, V11, P696; Ettingshausen A.V., 1886, ANN PHYS-NEW YORK, V265, P343, DOI [10.1002/andp.18862651010, DOI 10.1002/ANDP.18862651010]; Fuseya Y, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.012001; HAKONEN PJ, 1991, J PHYS-CONDENS MAT, V3, P7153, DOI 10.1088/0953-8984/3/37/007; HAMADA T, 1981, J PHYS F MET PHYS, V11, P657, DOI 10.1088/0305-4608/11/3/013; HARTMAN R, 1969, PHYS REV, V181, P1070, DOI 10.1103/PhysRev.181.1070; Heremans J, 1998, PHYS REV B, V58, P10091, DOI 10.1103/PhysRevB.58.R10091; Heremans J, 2000, PHYS REV B, V61, P2921, DOI 10.1103/PhysRevB.61.2921; KOONCE CS, 1967, PHYS REV, V163, P380, DOI 10.1103/PhysRev.163.380; KOONCE CS, 1969, PHYS REV, V177, P707, DOI 10.1103/PhysRev.177.707; Li L, 2008, SCIENCE, V321, P547, DOI 10.1126/science.1158908; Lin X, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.207002; LIU Y, 1995, PHYS REV B, V52, P1566, DOI 10.1103/PhysRevB.52.1566; LUTTINGER JM, 1966, PHYS REV, V150, P202, DOI 10.1103/PhysRev.150.202; Mata-Pinzon Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147645; MICHENAUD JP, 1972, J PHYS PART C SOLID, V5, P3061, DOI 10.1088/0022-3719/5/21/011; Migdal A., 1958, SOV PHYS JETP, V34, P1438; Mott N. F., 1958, THEORY PROPERTIES ME; Muntyanu FM, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.132507; Naren HR, 2012, AIP CONF PROC, V1447, P503, DOI 10.1063/1.4710099; PHILLIPS NE, 1960, PHYS REV, V118, P644, DOI 10.1103/PhysRev.118.644; PIETRONERO L, 1995, PHYS REV B, V52, P10516, DOI 10.1103/PhysRevB.52.10516; PIETRONERO L, 1992, EUROPHYS LETT, V18, P627, DOI 10.1209/0295-5075/18/7/010; PIPPARD AB, 1952, P PHYS SOC LOND A, V65, P955, DOI 10.1088/0370-1298/65/11/117; Shoenberg D, 1939, PROC R SOC LON SER-A, V170, P0341, DOI 10.1098/rspa.1939.0036; SMITH GE, 1964, PHYS REV, V135, P1118, DOI 10.1103/PhysRev.135.A1118; SONDHEIMER EH, 1952, P PHYS SOC LOND A, V65, P562, DOI 10.1088/0370-1298/65/7/115; Tian ML, 2009, NANO LETT, V9, P3196, DOI 10.1021/nl901431t; Tian ML, 2006, NANO LETT, V6, P2773, DOI 10.1021/nl0618041; UHER C, 1978, PHYS REV LETT, V40, P1518, DOI 10.1103/PhysRevLett.40.1518; WEITZEL B, 1991, PHYS REV LETT, V66, P385, DOI 10.1103/PhysRevLett.66.385; Wells JW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096802; Wilson AH, 1932, P R SOC LOND A-CONTA, V138, P594, DOI 10.1098/rspa.1932.0205; Yang FY, 1999, SCIENCE, V284, P1335, DOI 10.1126/science.284.5418.1335; ZEIGER HJ, 1992, PHYS REV B, V45, P768, DOI 10.1103/PhysRevB.45.768; Zhilyaev I. N., 1976, SOV PHYS JETP, V43, P507	46	104	107	14	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2017	355	6320					52	+		10.1126/science.aaf8227	http://dx.doi.org/10.1126/science.aaf8227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH4KK	27934703	Green Submitted			2022-12-28	WOS:000391739900040
J	Fathi, AT; Graubert, TA; Kulkarni, NM; Kuo, FC; Hasserjian, RP				Fathi, Amir T.; Graubert, Timothy A.; Kulkarni, Naveen M.; Kuo, Frank C.; Hasserjian, Robert P.			Case 37-2016: An 86-Year-Old Woman with Leukocytosis and Splenomegaly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC NEUTROPHILIC LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; CLONAL HEMATOPOIESIS; ATYPICAL CML; MYELOPROLIFERATIVE NEOPLASMS; MYELODYSPLASTIC SYNDROMES; CSF3R MUTATIONS; DIAGNOSIS; GENETICS; REVISION		[Fathi, Amir T.; Graubert, Timothy A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kulkarni, Naveen M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kuo, Frank C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Fathi, Amir T.; Graubert, Timothy A.] Harvard Med Sch, Dept Med, Boston, MA USA; [Kulkarni, Naveen M.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Kuo, Frank C.; Hasserjian, Robert P.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Fathi, AT (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Fathi, AT (corresponding author), Harvard Med Sch, Dept Med, Boston, MA USA.				Merck; Juno Therapeutics; Tolero Pharmaceuticals; Baxalta; Celgene; Seattle Genetics; Amgen; Incyte; Sanofi; Promedior	Merck(Merck & Company); Juno Therapeutics; Tolero Pharmaceuticals; Baxalta; Celgene(Bristol-Myers SquibbCelgene Corporation); Seattle Genetics; Amgen(Amgen); Incyte; Sanofi; Promedior	Dr. Fathi reports receiving fees for serving on advisory boards from Merck, Juno Therapeutics, Tolero Pharmaceuticals, and Baxalta, consulting fees from Celgene and Seattle Genetics, and clinical trial support from Celgene, Seattle Genetics, Takeda Pharmaceuticals, and Exelixis; and Dr. Hasserjian, receiving fees for serving on advisory boards from Amgen and Incyte and consulting fees from Sanofi and Promedior. No other potential conflict of interest relevant to this article was reported.	Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Elliott MA, 2005, LEUKEMIA, V19, P313, DOI 10.1038/sj.leu.2403562; Elliott MA, 2001, LEUKEMIA, V15, P35, DOI 10.1038/sj.leu.2401993; Elliott MA, 2015, AM J HEMATOL, V90, P653, DOI 10.1002/ajh.24031; Elliott MA, 2014, AM J HEMATOL, V89, P651, DOI 10.1002/ajh.23667; Federici S, 2014, BEST PRACT RES CL RH, V28, P263, DOI 10.1016/j.berh.2014.05.005; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Giat E, 2014, ISR MED ASSOC J, V16, P659; Gotlib J, 2013, BLOOD, V122, P1707, DOI 10.1182/blood-2013-05-500959; Hasle H, 1996, BRIT J HAEMATOL, V94, P628, DOI 10.1046/j.1365-2141.1996.7082329.x; Jaffe ES, 2001, WHO CLASSIFICATION T; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kato Naoko, 1999, Journal of Dermatology (Tokyo), V26, P352; Kluk MJ, 2016, J MOL DIAGN, V18, P507, DOI 10.1016/j.jmoldx.2016.02.003; KWONG YL, 1993, BLOOD, V82, P1035; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Meggendorfer M, 2013, LEUKEMIA, V27, P1852, DOI 10.1038/leu.2013.133; Meggendorfer M, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2014.113159; Pardanani A, 2013, LEUKEMIA, V27, P1870, DOI 10.1038/leu.2013.122; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Reilly JT, 2002, BRIT J HAEMATOL, V116, P10, DOI 10.1046/j.1365-2141.2002.03234.x; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Tefferi A, 2014, LEUKEMIA, V28, P1407, DOI 10.1038/leu.2014.35; Tuohy EL, 1920, AM J MED SCI, V160, P18, DOI 10.1097/00000441-192007000-00003; van de Vijver E, 2013, HEMATOL ONCOL CLIN N, V27, P101, DOI 10.1016/j.hoc.2012.10.001; Wang SA, 2014, BLOOD, V123, P2645, DOI 10.1182/blood-2014-02-553800; WEINSTEIN HJ, 1978, CLIN HAEMATOL, V7, P147; YOU W, 1979, AM J CLIN PATHOL, V72, P233	33	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2273	2283		10.1056/NEJMcpc1509539	http://dx.doi.org/10.1056/NEJMcpc1509539			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZQ	27959687				2022-12-28	WOS:000389310000012
J	Koonin, EV; Krupovic, M				Koonin, Eugene V.; Krupovic, Mart			A parasite's parasite saves host's neighbours	NATURE			English	Editorial Material							GIANT VIRUSES; VIROPHAGE; EVOLUTION; IMMUNITY	Viruses can be attacked by parasitic viruses, which compete with them for cellular resources. It emerges that one such parasitic virus can defend a host-cell population from a viral attack. SEE LETTER p. 288	[Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Krupovic, Mart] Inst Pasteur, Dept Microbiol, F-75015 Paris, France	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Koonin, EV (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	koonin@ncbi.nlm.nih.gov	Krupovic, Mart/ABD-6255-2021; Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Krupovic, Mart/0000-0001-5486-0098				Allen B, 2013, P NATL ACAD SCI USA, V110, P20135, DOI 10.1073/pnas.1317588110; Blanc G, 2015, P NATL ACAD SCI USA, V112, pE5318, DOI 10.1073/pnas.1506469112; Desnues C, 2012, ADV VIRUS RES, V82, P63, DOI 10.1016/B978-0-12-394621-8.00013-3; Durand PM, 2016, CURR BIOL, V26, pR587, DOI 10.1016/j.cub.2016.05.057; Fischer MG, 2016, NATURE, V540, P288, DOI 10.1038/nature20593; Fischer MG, 2016, CURR OPIN MICROBIOL, V31, P50, DOI 10.1016/j.mib.2016.03.001; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; Katzourakis A, 2016, CURR BIOL, V26, pR427, DOI 10.1016/j.cub.2016.03.072; Krupovic M, 2016, ARCH VIROL, V161, P233, DOI 10.1007/s00705-015-2622-9; Krupovic M, 2015, NAT REV MICROBIOL, V13, P105, DOI 10.1038/nrmicro3389; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Parratt SR, 2016, ISME J, V10, P1815, DOI 10.1038/ismej.2015.247; Swift J., 1733, ON POETRY A RAPSODY; Yutin N, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0207-4	15	7	7	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					204	+		10.1038/540204a	http://dx.doi.org/10.1038/540204a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4CF	27929010				2022-12-28	WOS:000389548700041
J	Hancox, S; Howlett, D				Hancox, Sarah; Howlett, David			Constitutional symptoms in a young person	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hancox, Sarah; Howlett, David] Eastbourne Dist Gen Hosp, East Sussex Healthcare Trust, Kings Dr, Eastbourne, England		Hancox, S (corresponding author), Eastbourne Dist Gen Hosp, East Sussex Healthcare Trust, Kings Dr, Eastbourne, England.	sarahhancox@nhs.net							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2016	355								i5781	10.1136/bmj.i5781	http://dx.doi.org/10.1136/bmj.i5781			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SX	27927674				2022-12-28	WOS:000390037400001
J	Stafford, N				Stafford, Ned			Thomas H Shepard Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.net						Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167; Fantel AG, 2009, BIRTH DEFECTS RES A, V85, P657, DOI 10.1002/bdra.20590; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; SHEPARD TH, PUBLICATION LIST	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2016	355								i6539	10.1136/bmj.i6539	http://dx.doi.org/10.1136/bmj.i6539			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SX	27927617				2022-12-28	WOS:000390037400009
J	Sheikh, K; Kumar, S; Ved, R; Kumar, S; Raman, VR; Ghaffar, A; Tran, N; Reddy, S; Swaminathan, S				Sheikh, Kabir; Kumar, Sanjiv; Ved, Rajani; Kumar, Satish; Raman, V. R.; Ghaffar, Abdul; Nhan Tran; Reddy, Srinath; Swaminathan, Soumya			India's new health systems knowledge platform-making research matter	LANCET			English	Editorial Material							POLICY		[Sheikh, Kabir; Raman, V. R.; Reddy, Srinath] Inst Area Gurgaon, Publ Hlth Fdn India, Gurgaon 122002, Haryana, India; [Kumar, Sanjiv; Ved, Rajani; Kumar, Satish] Natl Hlth Syst Resource Ctr, New Delhi, India; [Ghaffar, Abdul; Nhan Tran] WHO, Alliance Hlth Policy & Syst Res, Geneva, Switzerland; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India; [Swaminathan, Soumya] Govt India, Minist Hlth & Family Welf, Dept Hlth Res, New Delhi, India	Public Health Foundation of India; World Health Organization; Indian Council of Medical Research (ICMR)	Sheikh, K (corresponding author), Inst Area Gurgaon, Publ Hlth Fdn India, Gurgaon 122002, Haryana, India.	kabir.sheikh@phfi.org		Reddy, K Srinath/0000-0003-3416-3548; Sheikh, Kabir/0000-0003-4755-2075	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Australian Agency for International Development, 2011, REV IND KNOWL SECT D; Freedman LP, 2016, LANCET, V388, P2068, DOI 10.1016/S0140-6736(16)31530-6; Ghaffar A, 2013, LANCET, V381, P436, DOI 10.1016/S0140-6736(12)61858-3; Government of India Ministry of Health and Family Welfare (NRHM-I Division), 2016, 71942014NRHMI MIN HL; Gutierrez H, 2015, POPUL HEALTH MANAG, V18, P265, DOI 10.1089/pop.2014.0099; Kalita A, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27576; Rao KD, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-37; Scott K, 2016, BMJ GLOBAL HLTH S1, V1, pA15; Sundararaman T, 2012, BMC P, V6, DOI [DOI 10.1186/1753-6561-6-S5-O30, 10.1186/1753-6561-6-s5-o30]; Tangcharoensathien V, 2004, B WORLD HEALTH ORGAN, V82, P750; WHO, 2013, WORLD MALARIA REPORT 2013, P1	11	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2724	+		10.1016/S0140-6736(16)32391-1	http://dx.doi.org/10.1016/S0140-6736(16)32391-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FB	27924765				2022-12-28	WOS:000389629800009
J	Rose, NS; LaRocque, JJ; Riggall, AC; Gosseries, O; Starrett, MJ; Meyering, EE; Postle, BR				Rose, Nathan S.; LaRocque, Joshua J.; Riggall, Adam C.; Gosseries, Olivia; Starrett, Michael J.; Meyering, Emma E.; Postle, Bradley R.			Reactivation of latent working memories with transcranial magnetic stimulation	SCIENCE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; PARIETAL CORTEX; ATTENTION	The ability to hold information in working memory is fundamental for cognition. Contrary to the long-standing view that working memory depends on sustained, elevated activity, we present evidence suggesting that humans can hold information in working memory via "activity-silent" synaptic mechanisms. Using multivariate pattern analyses to decode brain activity patterns, we found that the active representation of an item in working memory drops to baseline when attention shifts away. A targeted pulse of transcranial magnetic stimulation produced a brief reemergence of the item in concurrently measured brain activity. This reactivation effect occurred and influenced memory performance only when the item was potentially relevant later in the trial, which suggests that the representation is dynamic and modifiable via cognitive control. The results support a synaptic theory of working memory.	[Rose, Nathan S.; LaRocque, Joshua J.; Riggall, Adam C.; Gosseries, Olivia; Starrett, Michael J.; Meyering, Emma E.; Postle, Bradley R.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Rose, Nathan S.] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA; [LaRocque, Joshua J.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Gosseries, Olivia] Univ Liege, Coma Sci Grp, B-4000 Liege, Belgium; [Riggall, Adam C.; Postle, Bradley R.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Notre Dame; University of Wisconsin System; University of Wisconsin Madison; University of Liege; University of Wisconsin System; University of Wisconsin Madison	Rose, NS; Postle, BR (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.; Rose, NS (corresponding author), Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA.; Postle, BR (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	nrose1@nd.edu; postle@wisc.edu	Starrett, Michael J./AAD-5077-2021; Gosseries, Olivia/AAB-6469-2020	Starrett, Michael J./0000-0002-1746-2688; Gosseries, Olivia/0000-0001-9011-7496; Rose, Nathan/0000-0002-7619-4441	NIH [MH095984]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Samaha, A. Sheldon, B. Kundu, J. Lewis-Peacock, and J. Johnson for assistance and helpful discussions. Supported by NIH grant MH095984 (B.R.P.). The data are stored at curate.nd.edu. Author contributions: N.S.R., B.R.P., J.J.L., and A.C.R. designed the research; N.S.R., O.G., M.J.S., and E.M.M. conducted the research; N.S.R., J.J.L., and A.C.R. analyzed the data; and N.S.R., B.R.P., and J.J.L. wrote the manuscript. The authors declare no conflict of interest.	Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Christophel TB, 2012, J NEUROSCI, V32, P12983, DOI 10.1523/JNEUROSCI.0184-12.2012; Cowan Nelson, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Ester EF, 2013, J COGNITIVE NEUROSCI, V25, P754, DOI 10.1162/jocn_a_00357; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hayden BY, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00018; Itskov V, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00040; Kundu B, 2015, NEUROIMAGE, V114, P320, DOI 10.1016/j.neuroimage.2015.04.001; LaRocque JJ, 2017, CEREB CORTEX, V27, P4881, DOI 10.1093/cercor/bhw283; LaRocque JJ, 2013, J COGNITIVE NEUROSCI, V25, P127, DOI 10.1162/jocn_a_00305; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; McElree B, 2006, PSYCHOL LEARN MOTIV, V46, P155, DOI 10.1016/S0079-7421(06)46005-9; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; MONSELL S, 1978, COGNITIVE PSYCHOL, V10, P465, DOI 10.1016/0010-0285(78)90008-7; Myers N. E., ELIFE, V4; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Sugase-Miyamoto Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000073; Wolff MJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00123	25	225	226	11	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1136	1139		10.1126/science.aah7011	http://dx.doi.org/10.1126/science.aah7011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27934762	Green Accepted, Green Submitted			2022-12-28	WOS:000388916400039
J	Davis, JH; Tan, YZ; Carragher, B; Potter, CS; Lyumkis, D; Williamson, JR				Davis, Joseph H.; Tan, Yong Zi; Carragher, Bridget; Potter, Clinton S.; Lyumkis, Dmitry; Williamson, James R.			Modular Assembly of the Bacterial Large Ribosomal Subunit	CELL			English	Article							QUANTITATIVE MASS-SPECTROMETRY; PARTICLE CRYO-EM; ELECTRON-MICROSCOPY; DATABASE SEARCH; RESOLUTION; MS/MS; LANDSCAPE; FREALIGN; LIBRARY; GENES	The ribosome is a complex macromolecular machine and serves as an ideal system for understanding biological macromolecular assembly. Direct observation of ribosome assembly in vivo is difficult, as few intermediates have been isolated and thoroughly characterized. Herein, we deploy a genetic system to starve cells of an essential ribosomal protein, which results in the accumulation of assembly intermediates that are competent for maturation. Quantitative mass spectrometry and single-particle cryo-electron microscopy reveal 13 distinct intermediates, which were each resolved to similar to 4-5 angstrom resolution and could be placed in an assembly pathway. We find that ribosome biogenesis is a parallel process, that blocks of structured rRNA and proteins assemble cooperatively, and that the entire process is dynamic and can be "re-routed'' through different pathways as needed. This work reveals the complex landscape of ribosome assembly in vivo and provides the requisite tools to characterize additional assembly pathways for ribosomes and other macromolecular machines.	[Davis, Joseph H.; Williamson, James R.] Scripps Res Inst, Dept Chem, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Davis, Joseph H.; Williamson, James R.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Tan, Yong Zi; Carragher, Bridget; Potter, Clinton S.] New York Struct Biol Ctr, Simons Electron Microscopy Ctr, Natl Resource Automated Mol Microscopy, New York, NY 10027 USA; [Tan, Yong Zi; Carragher, Bridget; Potter, Clinton S.] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Lyumkis, Dmitry] Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Lyumkis, Dmitry] Salk Inst Biol Studies, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Columbia University; Salk Institute; Salk Institute	Williamson, JR (corresponding author), Scripps Res Inst, Dept Chem, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Williamson, JR (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.; Lyumkis, D (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Lyumkis, D (corresponding author), Salk Inst Biol Studies, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dlyumkis@salk.edu; jrwill@scripps.edu	Williamson, James R/B-2891-2009; Williamson, James/AAL-2104-2021	Williamson, James R/0000-0002-8772-468X; Williamson, James/0000-0002-8772-468X; Davis, Joseph H./0000-0002-8858-8907; Tan, Yong Zi/0000-0001-6656-6320	Jane Coffin Child's post-doctoral fellowship; NIH/NIA K99 award [AG050749]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; NIH/NIGMS [GM103310, GM053757]; Simons Foundation [349247]; Agency for Science, Technology and Research Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053757, P41GM103310, R01GM053757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG050749, K99AG050749] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021396] Funding Source: NIH RePORTER	Jane Coffin Child's post-doctoral fellowship; NIH/NIA K99 award; Leona M. and Harry B. Helmsley Charitable Trust; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Simons Foundation; Agency for Science, Technology and Research Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. MacLean (University of Washington), H. Lam (HKUST), and V. Patsalo (TSRI) for guidance in processing proteomics datasets, J. Albrecht for help with initial EM studies, B. Anderson and J.C. Ducom (TSRI) for help with EM data collection and network infrastructure, and F. Dwyer (Salk) for computational support. The work was supported by a Jane Coffin Child's post-doctoral fellowship and a NIH/NIA K99 award (AG050749; J.H.D); the Leona M. and Harry B. Helmsley Charitable Trust Grant 2012-PG-MED002 (D.L.); NIH/NIGMS (GM103310 to C.S.P, B.C.; GM053757 to J.R.W.); Simons Foundation (349247 to C.S.P, B.C); and the Agency for Science, Technology and Research Singapore (to Y.Z.T.).	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bokov K, 2009, NATURE, V457, P977, DOI 10.1038/nature07749; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chen SS, 2013, J MOL BIOL, V425, P767, DOI 10.1016/j.jmb.2012.11.040; Chen SS, 2012, MOL BIOSYST, V8, P3325, DOI 10.1039/c2mb25310k; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dontsova Olga A, 2005, Int J Biomed Sci, V1, P1; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Gulati M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004694; HEROLD M, 1987, J BIOL CHEM, V262, P8826; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Jomaa A, 2014, NUCLEIC ACIDS RES, V42, P3419, DOI 10.1093/nar/gkt1295; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lam H, 2007, PROTEOMICS, V7, P655, DOI 10.1002/pmic.200600625; Leidig C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4491; Li NN, 2013, NUCLEIC ACIDS RES, V41, P7073, DOI 10.1093/nar/gkt423; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyumkis D, 2013, J STRUCT BIOL, V184, P417, DOI 10.1016/j.jsb.2013.10.009; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; Ni XD, 2016, NUCLEIC ACIDS RES, V44, P8442, DOI 10.1093/nar/gkw678; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Petrov AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088222; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; Sashital DG, 2014, ELIFE, V3, DOI 10.7554/eLife.04491; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Shoji S, 2011, J MOL BIOL, V413, P751, DOI 10.1016/j.jmb.2011.09.004; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sperling E, 2008, ANAL CHEM, V80, P4906, DOI 10.1021/ac800080v; Stokes JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03574; Sykes MT, 2009, ANNU REV BIOPHYS, V38, P197, DOI 10.1146/annurev.biophys.050708.133615; Thurlow B., 2016, NUCL ACIDS RES; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003	54	90	91	2	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2016	167	6					1610	+		10.1016/j.cell.2016.11.020	http://dx.doi.org/10.1016/j.cell.2016.11.020			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EN	27912064	Green Accepted, Bronze			2022-12-28	WOS:000389470500021
J	Sukhdev, P; May, P; Muller, A				Sukhdev, Pavan; May, Peter; Mueller, Alexander			Fix food metrics	NATURE			English	Editorial Material									[Sukhdev, Pavan] United Nations Environm Programme, New Haven, CT 06501 USA; [Sukhdev, Pavan] GIST India, Gurugram, Haryana, India; [Sukhdev, Pavan] Econ Ecosyst & Biodivers TEEB, Geneva, Switzerland; [May, Peter] Univ Fed Rural Rio de Janeiro, Dev Agr & Soc, Seropedica, RJ, Brazil; [May, Peter] Int Soc Ecol Econ, Boston, MA USA; [May, Peter] Project Steering Comm TEEBAgriFood, Geneva, Switzerland; [Mueller, Alexander] Food & Agr Org United Nations, Agr, Rome, Italy; [Mueller, Alexander] TEEBAgriFood Project, Geneva, Switzerland; [Mueller, Alexander] TMG, New York, NY USA	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Food & Agriculture Organization of the United Nations (FAO)	Sukhdev, P (corresponding author), United Nations Environm Programme, New Haven, CT 06501 USA.; Sukhdev, P (corresponding author), GIST India, Gurugram, Haryana, India.; Sukhdev, P (corresponding author), Econ Ecosyst & Biodivers TEEB, Geneva, Switzerland.	pavan@gistadvisory.com		May, Peter/0000-0003-3535-8363				Alexandratos N., 2012, WORLD AGR 2030 2050; [Anonymous], 2015, AFSUN FOOD SECURITY; International Food Policy Research Institute, 2016, GLOB NUTR REP PROM I; International Labour Office, 2015, WORLD EMPL SOC OUTL; Lowder S. K., 2014, 1402 ESA; UNEP, 2016, FOOD SYST NAT RES; World Bank, 2016, COST FIR EC AN IND 2	7	17	17	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					33	34		10.1038/540033a	http://dx.doi.org/10.1038/540033a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED5UA	27905460	Bronze			2022-12-28	WOS:000388916600028
J	Leebeek, FWG; Eikenboom, JCJ				Leebeek, Frank W. G.; Eikenboom, Jeroen C. J.			Von Willebrand's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INHERITED BLEEDING DISORDERS; OPEN-LABEL TRIAL; QUALITY-OF-LIFE; RECOMBINANT INTERLEUKIN-11; ADULT PATIENTS; HEMOPHILIA-A; FACTOR LEVEL; FACTOR-VIII; TYPE-1; MENORRHAGIA		[Leebeek, Frank W. G.] Erasmus Univ, Med Ctr, Dept Hematol, Rm Na 820,POB 2040, NL-3000 CA Rotterdam, Netherlands; [Eikenboom, Jeroen C. J.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Leebeek, FWG (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, Rm Na 820,POB 2040, NL-3000 CA Rotterdam, Netherlands.	f.leebeek@erasmusmc.nl	Eikenboom, Jeroen/F-9156-2018	Eikenboom, Jeroen/0000-0002-3268-5759	UniQure; Baxalta (Shire); CSL Behring; Baxter; Roche	UniQure; Baxalta (Shire); CSL Behring; Baxter; Roche(Roche Holding)	Dr. Leebeek reports receiving consulting fees from UniQure and Baxalta (Shire) and grant support from CSL Behring and Baxter, all paid to his institution, and lecture fees and travel support from Roche; and Dr. Eikenboom, receiving lecture fees from Roche and grant support from CSL Behring, all paid to his institution. No other potential conflict of interest relevant to this article was reported.	Abshire T, 2015, J THROMB HAEMOST, V13, P1585, DOI 10.1111/jth.12995; Abshire T, 2009, THROMB RES, V124, pS15, DOI 10.1016/S0049-3848(09)70153-7; Batlle J, 2016, THROMB HAEMOSTASIS, V115, P40, DOI 10.1160/TH15-04-0282; Berntorp E, 2005, BLOOD COAGUL FIBRIN, V16, pS23, DOI 10.1097/01.mbc.0000167659.23262.18; Bodo I, 2015, J THROMB HAEMOST, V13, P1345, DOI 10.1111/jth.12964; Borel-Derlon A, 2007, J THROMB HAEMOST, V5, P1115, DOI 10.1111/j.1538-7836.2007.02562.x; Bowman M, 2013, J THROMB HAEMOST, V11, P512, DOI 10.1111/jth.12130; Castaman G, 2008, BLOOD, V111, P3531, DOI 10.1182/blood-2007-08-109231; Castaman G, 2013, HAEMATOLOGICA, V98, P667, DOI 10.3324/haematol.2012.077263; Chi C, 2011, CONTRACEPTION, V83, P242, DOI 10.1016/j.contraception.2010.07.010; Coppola A, 2012, HAEMOPHILIA, V18, pe173, DOI 10.1111/j.1365-2516.2012.02758.x; Cuker A, 2009, NEW ENGL J MED, V361, P1887, DOI 10.1056/NEJMcps066546; de Wee EM, 2010, J THROMB HAEMOST, V8, P1492, DOI 10.1111/j.1538-7836.2010.03864.x; de Wee EM, 2012, THROMB HAEMOSTASIS, V108, P683, DOI 10.1160/TH12-04-0244; de Wee EM, 2011, THROMB HAEMOSTASIS, V106, P885, DOI 10.1160/TH11-03-0180; Elbatarny M, 2014, HAEMOPHILIA, V20, P831, DOI 10.1111/hae.12503; Engelen ET, 2015, HAEMOPHILIA, V21, P419, DOI 10.1111/hae.12701; Favaloro EJ, 2010, THROMB HAEMOSTASIS, V104, P1009, DOI 10.1160/TH10-06-0360; Federici AB, 2014, BLOOD, V123, P4037, DOI 10.1182/blood-2014-02-557264; Flood VH, 2016, BLOOD, V127, P2481, DOI 10.1182/blood-2015-10-673681; Flood VH, 2011, BLOOD, V117, pE67, DOI 10.1182/blood-2010-08-299016; Gill JC, 2015, BLOOD, V126, P2038, DOI 10.1182/blood-2015-02-629873; Goodeve A, 2007, BLOOD, V109, P112, DOI 10.1182/blood-2006-05-020784; Gudmundsdottir BR, 2007, J THROMB HAEMOST, V5, P274, DOI 10.1111/j.1538-7836.2007.02326.x; Gupta M, 2011, PEDIATR BLOOD CANCER, V57, P1081, DOI 10.1002/pbc.23120; Haberichter SL, 2006, BLOOD, V108, P3344, DOI 10.1182/blood-2006-04-015065; Hampshire DJ, 2011, SEMIN THROMB HEMOST, V37, P470, DOI 10.1055/s-0031-1281031; James AH, 2015, HAEMOPHILIA, V21, P81, DOI 10.1111/hae.12568; James AH, 2007, THROMB RES, V120, pS17, DOI 10.1016/j.thromres.2007.03.012; James PD, 2007, BLOOD, V109, P145, DOI 10.1182/blood-2006-05-021105; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Kadir RA, 2010, HAEMOPHILIA, V16, P832, DOI 10.1111/j.1365-2516.2010.02269.x; Kadir RA, 1998, LANCET, V351, P485, DOI 10.1016/S0140-6736(97)08248-2; Kouides PA, 2015, CURR OPIN HEMATOL, V22, P397, DOI 10.1097/MOH.0000000000000167; Kouides PA, 2009, BRIT J HAEMATOL, V145, P212, DOI 10.1111/j.1365-2141.2009.07610.x; Laffan MA, 2014, BRIT J HAEMATOL, V167, P453, DOI 10.1111/bjh.13064; Leissinger C, 2014, HAEMOPHILIA, V20, P158, DOI 10.1111/hae.12254; Lenting PJ, 2012, J THROMB HAEMOST, V10, P2428, DOI 10.1111/jth.12008; Lethagen S, 2004, HAEMOPHILIA, V10, P243, DOI 10.1111/j.1365-2516.2004.00893.x; Makris M, 2015, HAEMOPHILIA, V21, P338, DOI 10.1111/hae.12571; Mannucci PM, 2013, BLOOD, V122, P648, DOI 10.1182/blood-2013-01-479527; Mannucci PM, 2004, NEW ENGL J MED, V351, P683, DOI 10.1056/NEJMra040403; Miller CH, 2011, HAEMOPHILIA, V17, pE223, DOI 10.1111/j.1365-2516.2010.02382.x; Nichols WL, 2008, HAEMOPHILIA, V14, P171, DOI 10.1111/j.1365-2516.2007.01643.x; Ragni MV, 2016, HAEMOPHILIA, V22, P397, DOI 10.1111/hae.12898; Ragni MV, 2013, THROMB HAEMOSTASIS, V109, P248, DOI 10.1160/TH12-06-0447; Ragni MV, 2011, THROMB HAEMOSTASIS, V106, P641, DOI 10.1160/TH11-04-0274; Roberts JC, 2016, BLOOD, V127, P2472, DOI 10.1182/blood-2015-11-664680; Rodeghiero F, 2010, J THROMB HAEMOST, V8, P2063, DOI 10.1111/j.1538-7836.2010.03975.x; RODEGHIERO F, 1987, BLOOD, V69, P454; Rydz N, 2015, HAEMOPHILIA, V21, P636, DOI 10.1111/hae.12664; Rydz N, 2013, BLOOD, V121, P5228, DOI 10.1182/blood-2012-10-457507; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 2000, THROMB HAEMOSTASIS, V84, P160; Sadler JE, 2003, BLOOD, V101, P2089, DOI 10.1182/blood-2002-09-2892; Sanders YV, 2015, J THROMB HAEMOST, V13, P956, DOI 10.1111/jth.12927; Sanders YV, 2014, J THROMB HAEMOST, V12, P1066, DOI 10.1111/jth.12586; Sanders YV, 2013, J THROMB HAEMOST, V11, P845, DOI 10.1111/jth.12194; Sanders YV, 2014, NED TIJDSCHR GENEES, V158, pA6518; Sanders YV, 2015, AM J HEMATOL, V90, P1142, DOI 10.1002/ajh.24195; Sanders YV, 2015, BLOOD, V125, P3006, DOI 10.1182/blood-2014-09-603241; Seaman CD, 2015, J THROMB HAEMOST, V13, P1999, DOI 10.1111/jth.13142; Siew DA, 2014, BLOOD COAGUL FIBRIN, V25, P820, DOI 10.1097/MBC.0000000000000158; SILWER J, 1973, ACTA PAEDIATR SCAND, P1; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; Stoof SCM, 2016, HAEMOPHILIA, V22, P39, DOI 10.1111/hae.12732; Stoof SCM, 2015, HAEMOPHILIA, V21, P505, DOI 10.1111/hae.12635; Stufano F, 2014, HAEMOPHILIA, V20, P147, DOI 10.1111/hae.12264; Tosetto A, 2006, J THROMB HAEMOST, V4, P766, DOI 10.1111/j.1538-7836.2006.01847.x; van Galen KPM, 2012, BLOOD REV, V26, P261, DOI 10.1016/j.blre.2012.09.002; van Galen KP, 2015, COCHRANE DB SYST REV, V12; Veyradier A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003038; von Willebrand AE, 1926, FIN LAKARESALLSK HAN, V67, P7; ZIMMERMAN TS, 1971, J CLIN INVEST, V50, P244, DOI 10.1172/JCI106480	75	260	265	1	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2016	375	21					2067	2080		10.1056/NEJMra1601561	http://dx.doi.org/10.1056/NEJMra1601561			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC9KU	27959741				2022-12-28	WOS:000388464300009
J	Finn, RS; Martin, M; Rugo, HS; Jones, S; Im, SA; Gelmon, K; Harbeck, N; Lipatov, ON; Walshe, JM; Moulder, S; Gauthier, E; Lu, DRR; Randolph, S; Dieras, V; Slamon, DJ				Finn, Richard S.; Martin, Miguel; Rugo, Hope S.; Jones, Stephen; Im, Seock-Ah; Gelmon, Karen; Harbeck, Nadia; Lipatov, Oleg N.; Walshe, Janice M.; Moulder, Stacy; Gauthier, Eric; Lu, Dongrui R.; Randolph, Sophia; Dieras, Veronique; Slamon, Dennis J.			Palbociclib and Letrozole in Advanced Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPENDENT KINASE 4/6; ENDOCRINE THERAPY; 1ST-LINE TREATMENT; TRIAL; BEVACIZUMAB; INHIBITOR	BACKGROUND A phase 2 study showed that progression-free survival was longer with palbociclib plus letrozole than with letrozole alone in the initial treatment of postmenopausal women with estrogen-receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. We performed a phase 3 study that was designed to confirm and expand the efficacy and safety data for palbociclib plus letrozole for this indication. METHODS In this double-blind study, we randomly assigned, in a 2: 1 ratio, 666 postmenopausal women with ER-positive, HER2-negative breast cancer, who had not had prior treatment for advanced disease, to receive palbociclib plus letrozole or placebo plus letrozole. The primary end point was progression-free survival, as assessed by the investigators; secondary end points were overall survival, objective response, clinical benefit response, patient-reported outcomes, pharmacokinetic effects, and safety. RESULTS The median progression-free survival was 24.8 months (95% confidence interval [CI], 22.1 to not estimable) in the palbociclib-letrozole group, as compared with 14.5 months (95% CI, 12.9 to 17.1) in the placebo-letrozole group (hazard ratio for disease progression or death, 0.58; 95% CI, 0.46 to 0.72; P<0.001). The most common grade 3 or 4 adverse events were neutropenia (occurring in 66.4% of the patients in the palbociclibletrozole group vs. 1.4% in the placebo-letrozole group), leukopenia (24.8% vs. 0%), anemia (5.4% vs. 1.8%), and fatigue (1.8% vs. 0.5%). Febrile neutropenia was reported in 1.8% of patients in the palbociclib-letrozole group and in none of the patients in the placebo-letrozole group. Permanent discontinuation of any study treatment as a result of adverse events occurred in 43 patients (9.7%) in the palbociclib-letrozole group and in 13 patients (5.9%) in the placebo-letrozole group. CONCLUSIONS Among patients with previously untreated ER-positive, HER2-negative advanced breast cancer, palbociclib combined with letrozole resulted in significantly longer progression-free survival than that with letrozole alone, although the rates of myelotoxic effects were higher with palbociclib-letrozole. (Funded by Pfizer; PALOMA-2 ClinicalTrials.govnumber, NCT01740427.)	[Finn, Richard S.; Slamon, Dennis J.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USA; [Rugo, Hope S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Gauthier, Eric; Lu, Dongrui R.; Randolph, Sophia] Pfizer, La Jolla, CA USA; [Martin, Miguel] Univ Complutense, Hosp Gregorio Maranon, Madrid, Spain; [Jones, Stephen] US Oncol Res, The Woodlands, TX USA; [Im, Seock-Ah] Seoul Natl Univ, Canc Res Inst, Seoul Natl Univ Hosp, Coll Med, Seoul, South Korea; [Gelmon, Karen] British Columbia Canc Agcy, Vancouver, BC, Canada; [Harbeck, Nadia] Univ Munchen LMU, Brustzentrum, Munich, Germany; [Lipatov, Oleg N.] State Budget Med Inst Republican Clin Oncol, Ufa, Russia; [Walshe, Janice M.] All Ireland Cooperat Oncol Res Grp, Dublin, Ireland; [Moulder, Stacy] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Dieras, Veronique] Inst Curie, Paris, France	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Pfizer; Complutense University of Madrid; General University Gregorio Maranon Hospital; US Oncology Network; Seoul National University (SNU); Seoul National University Hospital; British Columbia Cancer Agency; University of Munich; All-Ireland Cooperative Oncology Research Group; University of Texas System; UTMD Anderson Cancer Center; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Finn, RS (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USA.	rfinn@mednet.ucla.edu	Perren, Timothy J/D-5387-2013; Martin, Miguel/AAJ-9242-2020	Perren, Timothy J/0000-0001-8472-8856; Martin, Miguel/0000-0001-9237-3231	Pfizer	Pfizer(Pfizer)	Funded by Pfizer; PALOMA-2 ClinicalTrials.gov number, NCT01740427.	Beaver JA, 2015, CLIN CANCER RES, V21, P4760, DOI 10.1158/1078-0432.CCR-15-1185; Chlebowski RT, 2013, CLIN BREAST CANCER, V13, P159, DOI 10.1016/j.clbc.2012.11.002; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Dickler MN, 2016, J CLIN ONCOL, V34, P2602, DOI 10.1200/JCO.2015.66.1595; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Finn RS, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0661-5; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fry DW, 2004, MOL CANCER THER, V3, P1427; Johnston SRD, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv212; Martin M, 2015, J CLIN ONCOL, V33, P1045, DOI 10.1200/JCO.2014.57.2388; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006	12	1343	1414	4	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2016	375	20					1925	1936		10.1056/NEJMoa1607303	http://dx.doi.org/10.1056/NEJMoa1607303			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC1HS	27959613	Bronze			2022-12-28	WOS:000387856100005
J	Creaton, A				Creaton, Anne			Embodying the Three Rs in Fiji	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Creaton, Anne] Fiji Natl Univ, Suva, Fiji	Fiji National University (FNU)	Creaton, A (corresponding author), Fiji Natl Univ, Suva, Fiji.							Epstein RM, 2013, ACAD MED, V88, P301, DOI 10.1097/ACM.0b013e318280cff0; Monroe Alicia D H, 2013, Virtual Mentor, V15, P509, DOI 10.1001/virtualmentor.2013.15.6.medu1-1306; Oman KM, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-9	3	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					1820	1821		10.1056/NEJMp1608837	http://dx.doi.org/10.1056/NEJMp1608837			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB6ZK	27959658				2022-12-28	WOS:000387534200005
J	O'Shea, L; Bindman, AB				O'Shea, Luke; Bindman, Andrew B.			Personal Health Budgets for Patients with Complex Needs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[O'Shea, Luke; Bindman, Andrew B.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Bindman, Andrew B.] AHRQ, Rockville, MD USA	University of California System; University of California San Francisco; Agency for Healthcare Research & Quality	O'Shea, L (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							[Anonymous], 2015, BBC NEWS        0901; Carlson BL, 2007, HEALTH SERV RES, V42, P467, DOI 10.1111/j.1475-6773.2006.00673.x; Forder J., 2012, EVALUATION PERSONAL; Jones K, 2013, J HEALTH SERV RES PO, V18, P59, DOI 10.1177/1355819613503152	4	16	16	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2016	375	19					1815	1817		10.1056/NEJMp1606040	http://dx.doi.org/10.1056/NEJMp1606040			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB6ZK	27959646	Green Published			2022-12-28	WOS:000387534200003
